Citrus Sinensis ID: 010730

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500--
Protein Sequence
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEAAMNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAAYGRCPVSRS
Secondary Structure (PSIPRED)
ccccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEccccccEEEcccHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccEEEEEEEEccccccccEEEccccccccHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEEccccEEEEccccHHEEEcccccccEEcccHHHccHHHHHcccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccHHHcccHHHHHcccccccccccccccccccccccccccccHHHHHHHHcHHHHHcccccEEEEcccccccccEEEEEEEccccccEEEEEcccccccccHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccEccccHHHHHHHHHHHHHHHHHHHHHHHHHcccHEccccccccccccccccccccc
Coil and Loop (DISEMBL)
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYlhghdppvihrdlkcdnifvnghlgqikiGDLGLAAILRGSqqahsvigtpefmapelyeedYNELVDIYSFGMCVLEMltseypysecsnpaqIYKKVtsgklpgafhrIQDAEARRFVGKCLENVskrlpakellldpflasdagepllipqvpsfqnlnpngavmelvpkfavdsdrrkstdmtitgtmnpeddTIFLKVQitdkdgqarniyfpfdifnDTATEVALEMVKEleitdweplEIAEMIEQEISSlvpnwkecgspqfchqhsfsyededddndddgiyhpfysnsshssshaslpafftnnansppswlqqedllgnddassngsvssfkysswdyhsgneddsefshrageplCIARATqkstrfcpeaamnndrcnsedvnsrkacrsnsnnhrklsRIRSLVDVRSQLLHRSLVEEIHKRRlfktvgavenigfhepancaaygrcpvsrs
Flexible Loop (DISEMBL)
mftsgtlreyrkkytrvdiraVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPkfavdsdrrkstdmtitgtmnpeddtiFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEaamnndrcnsedvnsrkacrsnsnnhrklsrirslvdVRSQLLHRslveeihkrrlFKTVGAvenigfhepancaaygrcpvsrs
Low Complexity Region (SEG)
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYededddndddGIYHPFYsnsshssshasLPAFFTNNANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEAAMNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAAYGRCPVSRS
Disordered region (IsUnstruct)
********EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFA********************DDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHS******************************************************************************************************************************************IRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAAYGRC*****
Disordered Region (DISOPRED)
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL**A**RIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAG**********************************************PEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLV*******************************************************************************************************************************************************************QLLHRSLVEEIHKRRLFKTVGAVENIGFHEPA*************
Disordered Region (DISEMBL)
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHS*********HRAGEPLCIARATQKSTRFCPEAAMNND**********************LSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAAYGRCPVSRS
Disordered Region (DISPRO)
***SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSH********************WLQQE*LLG****S***************************************************************************KLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANC***********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEAAMNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAAYGRCPVSRS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	502	2.2.26 [Sep-21-2011]
Q9SCU5	549	Probable serine/threonine	yes	no	0.635	0.581	0.722	1e-137
Q9LVL5	571	Probable serine/threonine	no	no	0.914	0.803	0.515	1e-126
Q2RBE3	622	Probable serine/threonine	yes	no	0.633	0.511	0.594	2e-96
Q2QYL8	619	Probable serine/threonine	yes	no	0.633	0.513	0.596	9e-96
Q0D598	704	Probable serine/threonine	no	no	0.607	0.433	0.525	3e-94
A2YMV6	704	Probable serine/threonine	N/A	no	0.607	0.433	0.525	3e-94
Q8S8Y9	568	Serine/threonine-protein	no	no	0.589	0.521	0.533	6e-93
Q65X23	621	Probable serine/threonine	no	no	0.581	0.470	0.513	1e-91
Q2V338	492	Probable serine/threonine	no	no	0.585	0.597	0.537	2e-91
Q9STK6	516	Probable serine/threonine	no	no	0.567	0.552	0.573	2e-90

>sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2

 Score =  488 bits (1255), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 237/328 (72%), Positives = 267/328 (81%), Gaps = 9/328 (2%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLREYR+KY +VDIRA+K+WARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 107 LFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 166

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT EYP
Sbjct: 167 QVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYP 226

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS- 179
           YSEC+NPAQIYKKVTSGKLP +FH IQ  EA+RFVGKCLE VS+RLPAKELL DPFLA+ 
Sbjct: 227 YSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAAT 286

Query: 180 ---DAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
              D      +PQ  + QNL  NG V+E +P     +D  ++TDM+ITG MN ED TIFL
Sbjct: 287 DERDLAPLFRLPQQLAIQNLAANGTVVEHLPS---TTDPTRTTDMSITGKMNSEDHTIFL 343

Query: 237 KVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
           +VQI D DG  RNI FPF+I +DT  EVALEMVKELEITDW+PLEIA MIE EIS LVPN
Sbjct: 344 QVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPN 403

Query: 297 WKECGSPQFCHQHSFSYEDEDDDNDDDG 324
           W+   S       SF +ED++D+ D +G
Sbjct: 404 WRANDSS--IRHESFGHEDDEDNGDTEG 429

Regulates flowering time by modulating the photoperiod pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LVL5|WNK4_ARATH Probable serine/threonine-protein kinase WNK4 OS=Arabidopsis thaliana GN=WNK4 PE=1 SV=1

 Score =  452 bits (1163), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 264/512 (51%), Positives = 334/512 (65%), Gaps = 53/512 (10%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLR+Y+ KY R+DIRA+K+WARQIL G+ YLH HDPPVIHRDLKCDNIFVNGHLG
Sbjct: 101 LFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLG 160

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLA +LR    AHS+IGTPEFMAPELYEE+YNEL+D+YSFGMC LEM+TSE+P
Sbjct: 161 QVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFP 220

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC++PAQIYKKV  GKLPGAF+R+ D EA+RF+GKCL + SKR+ AKELL DPFLASD
Sbjct: 221 YSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280

Query: 181 ---------AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPED 231
                    AG P        F N N    +     K   D  R   T+M+I G +  ED
Sbjct: 281 ESWMVYTSGAGNP------KPFLNENEMDTL-----KLEDDELR---TEMSIAGKLGAED 326

Query: 232 DTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEIS 291
           + I L+VQI   +G A N++FPFDI NDT+ +VA EMVKELEI DWEP+EIA+MI+  IS
Sbjct: 327 NKIDLEVQIAYDNGLANNVFFPFDIMNDTSIDVAKEMVKELEIIDWEPVEIAKMIDGAIS 386

Query: 292 SLVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNAN 351
           SLV +WK              YE++D+   D   +     +SS S + +S  +     A 
Sbjct: 387 SLVSDWK--------------YEEDDETPHDHHRHRTDSFHSSSSHASSSQASLSNYMAR 432

Query: 352 SPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKS 411
               W+ Q+DL  +D+  S  S  S  YS+ +Y + +E  S+       P  +   T   
Sbjct: 433 GLQDWV-QDDL--HDETYSQSSSHSGSYSNLNYIAVDEYSSQ------SP--VMSRTHNM 481

Query: 412 TRFCPEAA--MNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIH 469
           TRFCPE +  + + + N+   +S    RS ++++R L+R RSLVDV+ QLLHRS  EE  
Sbjct: 482 TRFCPEESSHLQSGQANAYAASS-STNRSLASDNRTLTRNRSLVDVQRQLLHRSPGEEAR 540

Query: 470 KRRLFKTVGAVENIGFHEPANCAAYGRCPVSR 501
           KRRLFKTVG VE +GF  P   A   + P SR
Sbjct: 541 KRRLFKTVGDVETVGFQSP--YAVSRKPPSSR 570

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2RBE3|WNK7_ORYSJ Probable serine/threonine-protein kinase WNK7 OS=Oryza sativa subsp. japonica GN=WNK7 PE=2 SV=2

 Score =  353 bits (905), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 198/333 (59%), Positives = 234/333 (70%), Gaps = 15/333 (4%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +F+SGTLR YR +Y RV  RAV  WAR ILRG+AYLH     VIHRDLKCDNIFVNGHLG
Sbjct: 117 LFSSGTLRSYRLRYPRVSRRAVAAWARAILRGLAYLHARG--VIHRDLKCDNIFVNGHLG 174

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAA+LRG   A SVIGTPEFMAPE+Y+E Y   VD+YSFGMC+LEMLT+EYP
Sbjct: 175 QVKIGDLGLAAVLRGCASARSVIGTPEFMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYP 234

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC NPAQIYKKVT+GKLP AF+R+ DA+ARRF+G+CL + + R  A+ELLLDPFL+  
Sbjct: 235 YSECDNPAQIYKKVTAGKLPDAFYRLTDADARRFIGRCLVDAAHRPSAEELLLDPFLSPS 294

Query: 181 AGEP---LLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLK 237
                  ++         L    +      + A  +   K+TDM ITG +N E DTIFLK
Sbjct: 295 QNHDDHNIIAHATAPPPPLPLACSNSSEEQEEAAPAPAAKTTDMAITGKLNKEHDTIFLK 354

Query: 238 VQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
           VQI       RNIYFPFD+ NDTA EVA EMVKEL+I D EP EIA MIEQEI  LVP +
Sbjct: 355 VQIGGGR-NVRNIYFPFDVANDTAMEVATEMVKELDIADREPTEIAAMIEQEIVRLVPGY 413

Query: 298 KECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFY 330
           K         QH +SY D++DD+D  G  +PFY
Sbjct: 414 K---------QHEYSYADDNDDDDVSGHPNPFY 437

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QYL8|WNK8_ORYSJ Probable serine/threonine-protein kinase WNK8 OS=Oryza sativa subsp. japonica GN=WNK8 PE=2 SV=1

 Score =  351 bits (900), Expect = 9e-96,   Method: Compositional matrix adjust.
 Identities = 198/332 (59%), Positives = 235/332 (70%), Gaps = 14/332 (4%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +F+SGTLR YR +Y RV  RAV  WAR ILRG+AYLH     VIHRDLKCDNIFVNGHLG
Sbjct: 117 LFSSGTLRSYRLRYPRVSRRAVAAWARAILRGLAYLHSRG--VIHRDLKCDNIFVNGHLG 174

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAA+LRG   A SVIGTPEFMAPE+Y+E Y   VD+YSFGMC+LEMLT+EYP
Sbjct: 175 QVKIGDLGLAAVLRGCTSARSVIGTPEFMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYP 234

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLA-- 178
           YSEC NPAQIYKKVT+GKLP AF+ + DA+ARRF+G+CL + + R  A+ELLLDPFL+  
Sbjct: 235 YSECDNPAQIYKKVTAGKLPDAFYLLTDADARRFIGRCLVDAAHRPSAEELLLDPFLSPP 294

Query: 179 SDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
            +  +   I    +     P         +   ++   K+T M ITG +N E DTIFLKV
Sbjct: 295 QNHDDHNTIAHATAPPPPLPLACSNSSEEQEEEEAPAAKTTGMAITGKLNKEHDTIFLKV 354

Query: 239 QITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK 298
           QI    G  RNIYFPFD+ NDTA EVA EMVKEL+I D EP EIA MIEQEI  LVP +K
Sbjct: 355 QI-GGGGNVRNIYFPFDVANDTAMEVATEMVKELDIADREPTEIAAMIEQEIVRLVPGYK 413

Query: 299 ECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFY 330
                    QH +SY D+DDD+D +G  +PFY
Sbjct: 414 ---------QHEYSYADDDDDDDVNGQPNPFY 436

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1

 Score =  346 bits (887), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 184/350 (52%), Positives = 229/350 (65%), Gaps = 45/350 (12%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLR+YR+K+ RV+I AVK+W RQIL G+ YLH HDPP+IHRDLKCDNIFVNG+ G
Sbjct: 109 MFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQG 168

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAAILR S   H V GTPEFMAPE+YEE+YNELVDIYSFGMCVLEM+T EYP
Sbjct: 169 EVKIGDLGLAAILRKSHAVHCV-GTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYP 227

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC++P QIYKKV SG  P A ++++D   R+FV KCL   S+RL A+ELL DPFL  D
Sbjct: 228 YSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD 287

Query: 181 -------AGEPLLIPQV--PSFQNLNPNGAVMELVPKFAVDSDR---------------- 215
                   G+  L+  +  P  ++   N ++M      ++D D                 
Sbjct: 288 DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKAD 347

Query: 216 ------------RKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATE 263
                         + D+TI G  + ED +IFL+++I D DG  RNIYFPFDI  DTA  
Sbjct: 348 GIDLFNGHEDEPLGNVDITIKGRKS-EDGSIFLRLRIADNDGHVRNIYFPFDIEADTALS 406

Query: 264 VALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK------ECGSPQFCH 307
           VA EMV EL+ITD E   IAEMI+ E+S+LVP+W+      E     +CH
Sbjct: 407 VATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCH 456

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2

 Score =  346 bits (887), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 184/350 (52%), Positives = 229/350 (65%), Gaps = 45/350 (12%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLR+YR+K+ RV+I AVK+W RQIL G+ YLH HDPP+IHRDLKCDNIFVNG+ G
Sbjct: 109 MFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQG 168

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAAILR S   H V GTPEFMAPE+YEE+YNELVDIYSFGMCVLEM+T EYP
Sbjct: 169 EVKIGDLGLAAILRKSHAVHCV-GTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYP 227

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC++P QIYKKV SG  P A ++++D   R+FV KCL   S+RL A+ELL DPFL  D
Sbjct: 228 YSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD 287

Query: 181 -------AGEPLLIPQV--PSFQNLNPNGAVMELVPKFAVDSDR---------------- 215
                   G+  L+  +  P  ++   N ++M      ++D D                 
Sbjct: 288 DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKAD 347

Query: 216 ------------RKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATE 263
                         + D+TI G  + ED +IFL+++I D DG  RNIYFPFDI  DTA  
Sbjct: 348 GIDLFNGHEDEPLGNVDITIKGRKS-EDGSIFLRLRIADNDGHVRNIYFPFDIEADTALS 406

Query: 264 VALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK------ECGSPQFCH 307
           VA EMV EL+ITD E   IAEMI+ E+S+LVP+W+      E     +CH
Sbjct: 407 VATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCH 456

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1

 Score =  341 bits (875), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 168/315 (53%), Positives = 223/315 (70%), Gaps = 19/315 (6%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLR+YR ++ RV+IRAVK W +QIL+G+ YLH   PP+IHRDLKCDNIF+NG+ G
Sbjct: 106 LFTSGTLRQYRLRHRRVNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQG 165

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAAILR S  A   +GTPEFMAPE+Y+E+YNELVD+Y+FGMCVLEM+T +YP
Sbjct: 166 EVKIGDLGLAAILRKSH-AVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYP 224

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC++PAQIYKKVTSGK P AF+ ++D E R FV KCL NV+ RL A ELL DPFL  D
Sbjct: 225 YSECTHPAQIYKKVTSGKKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDD 284

Query: 181 AGEPLLIPQVPSFQNLNPNGAVM-----------------ELVPKFAVDSDRRKSTDMTI 223
             +  ++  +  +   +  G  +                 ++       +D     D++I
Sbjct: 285 NMDGFVMRPIDYYNGYDETGVFLRHPLIDDPLYHDQFESSQICEIDLFANDDEDHVDISI 344

Query: 224 TGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIA 283
            G  N  DD IFL+++I+D +G+ RNIYFPF+   DTA  VA+EMV EL+IT+ +  +IA
Sbjct: 345 KGKRNG-DDGIFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIA 403

Query: 284 EMIEQEISSLVPNWK 298
           EMI+ EI++LVP+WK
Sbjct: 404 EMIDAEIAALVPDWK 418

Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1

 Score =  337 bits (865), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 169/329 (51%), Positives = 221/329 (67%), Gaps = 37/329 (11%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLR+YR K+ +VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIFVNG+ G
Sbjct: 110 VFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQG 169

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLA IL  ++ AHS+IGTPEFMAPELY+E+YNELVDIY+FGMC+LE++T EYP
Sbjct: 170 EVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYP 229

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           Y ECSN AQIYKKV+ G+ P +  +I+D E R F+ KC+   S+RL A+ELL+DPFL  D
Sbjct: 230 YCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDD 289

Query: 181 AGEPLLIPQVPSFQNLNPNG-----------------AVMELVPKFAVDSDRRKSTDMTI 223
            GE +  P   + +  +  G                 A+ E    FA        +D  I
Sbjct: 290 -GEKIFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFA----EEHPSDRYI 344

Query: 224 TGTMNPED---------------DTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEM 268
             TM+P+                +TIFLK++I D  G A+NI+FPFDI  DT+  VA EM
Sbjct: 345 HSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEM 404

Query: 269 VKELEITDWEPLEIAEMIEQEISSLVPNW 297
           V +L++TD +   IAEMI+ EI + +P+W
Sbjct: 405 VVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1

 Score =  337 bits (863), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 181/337 (53%), Positives = 220/337 (65%), Gaps = 43/337 (12%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLR+YR K+ RV+IRAVKNW RQILRG+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 107 MFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQG 166

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAA L+ S  AH V GTPEFMAPE+Y+E+YN+LVDIYSFGMCVLEM+T +YP
Sbjct: 167 EVKIGDLGLAACLQHSHAAHCV-GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYP 225

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECS+PAQIYK+V SGK P    +++D E R F+ KCL  VS RL A ELL D FL  D
Sbjct: 226 YSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID 285

Query: 181 ----------------AGEPLLIP-QVPSFQN----------LNPNGAVMELVPKFAVD- 212
                           AG PL     +P + N           + NG   E V    +D 
Sbjct: 286 ESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNGD--ETVESHEIDL 343

Query: 213 ------------SDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDT 260
                         R  S D++I G      D +FL+++  +K+G  RNIYFPFDI  DT
Sbjct: 344 LEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDT 403

Query: 261 ATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
           A  VA EMV+ELE+ D +  +IA MI+ EI+SLVPNW
Sbjct: 404 AISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1

 Score =  333 bits (853), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 172/300 (57%), Positives = 217/300 (72%), Gaps = 15/300 (5%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSG LR+YRKK+  VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 104 VFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQG 163

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAAIL  ++ AHSVIGTPEFMAPELYEEDYN LVDIY+FGMC+LE++T EYP
Sbjct: 164 EVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYP 223

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC+N AQIY+KVTSG  P A   + D + R F+ KC+  VS+RL AKELL DPFL   
Sbjct: 224 YSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCY 283

Query: 181 AGEPLLIPQVPSFQ--NLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
                    V S +    N NG V +L       SD      +T+ G    + +TIFLK+
Sbjct: 284 KENT---ENVSSHKENGYNGNGIVDKL-------SDSEVGL-LTVEG-QRKDLNTIFLKL 331

Query: 239 QITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLE-IAEMIEQEISSLVPNW 297
           +ITD  GQ RNI+FPF+I  DT+  VA+EMV+EL++TD + +  IA+MI+ EI S +P+W
Sbjct: 332 RITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	502
224140589	601	predicted protein [Populus trichocarpa]	0.952	0.795	0.675	1e-179
359481240	626	PREDICTED: probable serine/threonine-pro	0.952	0.763	0.664	1e-167
225434355	631	PREDICTED: probable serine/threonine-pro	0.932	0.741	0.633	1e-166
255584247	617	kinase, putative [Ricinus communis] gi|2	0.950	0.773	0.663	1e-165
224124748	608	predicted protein [Populus trichocarpa]	0.926	0.764	0.623	1e-160
356496301	609	PREDICTED: probable serine/threonine-pro	0.952	0.784	0.611	1e-153
224145457	606	predicted protein [Populus trichocarpa]	0.926	0.767	0.595	1e-150
148469851	610	WNK1 [Glycine max]	0.954	0.785	0.603	1e-150
351721696	607	with no lysine kinase 5 [Glycine max] gi	0.948	0.784	0.603	1e-149
449531499	579	PREDICTED: probable serine/threonine-pro	0.944	0.818	0.553	1e-147

>gi|224140589|ref|XP_002323664.1| predicted protein [Populus trichocarpa] gi|222868294|gb|EEF05425.1| predicted protein [Populus trichocarpa]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 331/490 (67%), Positives = 390/490 (79%), Gaps = 12/490 (2%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLR YRKKY RVDIRA+KNW+RQILRG+A+LHGHDPPVIHRDLKCDNIF+NGHLG
Sbjct: 111 MFTSGTLRAYRKKYQRVDIRAIKNWSRQILRGLAFLHGHDPPVIHRDLKCDNIFINGHLG 170

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
            +KIGDLGLAA+L+GSQ AHSVIGTPEFMAPELYEEDY+ELVDIYSFGMCVLEMLT EYP
Sbjct: 171 HVKIGDLGLAAVLQGSQHAHSVIGTPEFMAPELYEEDYDELVDIYSFGMCVLEMLTFEYP 230

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLP AF+RI+D EA+ F+GKCL   SKRLPA+ELLLDPFLASD
Sbjct: 231 YSECSNPAQIYKKVTSGKLPEAFYRIEDVEAQEFIGKCLATASKRLPARELLLDPFLASD 290

Query: 181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
             E   IP+VPS  + +P     +++P    D    K+T+MT+TGTMNP+DDTIFLKV+I
Sbjct: 291 EAELGTIPKVPSPWS-SPKVTEEKIMPSLLADPT--KATEMTVTGTMNPQDDTIFLKVKI 347

Query: 241 TDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
           ++KDGQ RNIYFPFDI NDTA +VA+EMVKELEITDWEP EIA+MIE++ISSL+P WK+C
Sbjct: 348 SEKDGQTRNIYFPFDIMNDTAIDVAMEMVKELEITDWEPFEIADMIEEQISSLIPGWKQC 407

Query: 301 GSPQFCH-QHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQ 359
            S Q  H QH FSYED+DDD+ +DG  HPF+++SSHSSS ASL AF  +    P      
Sbjct: 408 SSSQIHHPQHCFSYEDDDDDDHNDGPRHPFFASSSHSSSQASLLAFNCSFQTKPC----- 462

Query: 360 EDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEAA 419
            +L  +DDASS  S++SFKYS+ +Y SGNEDD + S R   PL   +   KSTRFCP  +
Sbjct: 463 -ELFIDDDASSQSSLNSFKYSTLNYSSGNEDDYDASLRE-VPLGFGK-IHKSTRFCPADS 519

Query: 420 MNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGA 479
           ++  +    +         +SN  RKLSRIRS VDVR+QLLHRSL+EEI+KRRLFKTVGA
Sbjct: 520 LSAKQYKHRNARLDSGGCCSSNPQRKLSRIRSQVDVRNQLLHRSLLEEINKRRLFKTVGA 579

Query: 480 VENIGFHEPA 489
           VENIG+HEP 
Sbjct: 580 VENIGYHEPG 589

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481240|ref|XP_002266913.2| PREDICTED: probable serine/threonine-protein kinase WNK5-like [Vitis vinifera] gi|297735557|emb|CBI18051.3| unnamed protein product [Vitis vinifera]

 Score =  595 bits (1535), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 332/500 (66%), Positives = 392/500 (78%), Gaps = 22/500 (4%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLREYR+KY RVDI AVKNWARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 111 MFTSGTLREYRQKYKRVDIGAVKNWARQILHGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 170

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+Y+ELVD+YSFGMCVLEMLTSEYP
Sbjct: 171 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYDELVDVYSFGMCVLEMLTSEYP 230

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           Y ECSNPAQIYKKVTSGKLP AF+RI+D EAR FVG+CLE+V+KRLPAKELL+DPFLA D
Sbjct: 231 YCECSNPAQIYKKVTSGKLPEAFYRIEDVEAREFVGRCLEHVAKRLPAKELLMDPFLAVD 290

Query: 181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
            GE +L     S Q  +PNG V E +P F  +  R++STDMTITGT+NP+D TIFLKV I
Sbjct: 291 HGEQMLPMLKISSQKPSPNGTV-EKIPSFQTNP-RKRSTDMTITGTINPDDYTIFLKVAI 348

Query: 241 TDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
           +DKDG +RNIYFPFDI +DT  +VA EMV+ELEITDWEP EIA+MIE+EI +LVP+WK+C
Sbjct: 349 SDKDGLSRNIYFPFDIGSDTPIDVAAEMVRELEITDWEPFEIAKMIEEEIFALVPSWKQC 408

Query: 301 GSPQFCHQHSF-SYEDEDDDNDDDGIYHPFYSNSSHSSSHA--------SLPAFFTNNAN 351
            SP+  HQHSF   E+E++++DDD  YHPFY  +S SS  A         + +   N+  
Sbjct: 409 TSPE-NHQHSFEYEEEEEEEDDDDETYHPFYCYASESSRVALQDLSISCEIQSQHRNHMI 467

Query: 352 SPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSE-FSHRAGEPLCIARATQK 410
           S   W  QE LL NDDASS  S++S KYS+  Y S  E+D +  + +  EP+  A +T K
Sbjct: 468 SGEDWF-QEGLLINDDASSQSSLNSDKYSTLVYCSVTENDIDHLAPKRVEPIFTA-STHK 525

Query: 411 STRFCPEAAMNN-DRCNSEDVNSRKACRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIH 469
           STRFCPE   ++ ++CN     SR+    +SN HRKLSRI+S VDVRSQLL RSL+E I+
Sbjct: 526 STRFCPEEGTSSWNQCN----GSRRP--YDSNCHRKLSRIKSFVDVRSQLLRRSLMEMIN 579

Query: 470 KRRLFKTVGAVENIGFHEPA 489
           KRRLFKT+GAVENIG+ EP 
Sbjct: 580 KRRLFKTIGAVENIGYQEPG 599

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225434355|ref|XP_002268300.1| PREDICTED: probable serine/threonine-protein kinase WNK4 [Vitis vinifera] gi|297745773|emb|CBI15829.3| unnamed protein product [Vitis vinifera]

 Score =  591 bits (1524), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 328/518 (63%), Positives = 371/518 (71%), Gaps = 50/518 (9%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
            FTSGTLREYRKKY RVDIRA+K WARQILRG+ YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 111 FFTSGTLREYRKKYKRVDIRAIKCWARQILRGLVYLHGHDPPVIHRDLKCDNIFVNGHLG 170

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           ++KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVD+YSFGMCVLEMLTSEYP
Sbjct: 171 EVKIGDLGLAAILRGSQSAHSVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYP 230

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLPGAF+RIQD EA+RF+GKCL   SKRLPAKELLLDPFLASD
Sbjct: 231 YSECSNPAQIYKKVTSGKLPGAFYRIQDLEAQRFIGKCLVTASKRLPAKELLLDPFLASD 290

Query: 181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
             + L  P++ S +    +  + +L       SD R  T+MTITGT+NP+DDTIFLKVQ 
Sbjct: 291 EAKRLPKPKLGSQKPFLNDIRIEKLRL-----SDDRVRTNMTITGTLNPDDDTIFLKVQT 345

Query: 241 TDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
            DKDG ARNIYFPFDI  DT  +VA+EMVKELEITDWEP EIA+MI+ EIS+LVP WK+ 
Sbjct: 346 ADKDGSARNIYFPFDIVTDTPIDVAMEMVKELEITDWEPFEIADMIDGEISALVPQWKKW 405

Query: 301 GSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFT----NNANSPPSW 356
             PQ  H ++F Y++E     D+G  HPF S SS SSS AS P   T    +       W
Sbjct: 406 DMPQ-QHHYAFDYQEE-----DEGHNHPFRSFSSCSSSQASFPCLSTSHRLDTMAQGGDW 459

Query: 357 LQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCP 416
           L ++DL   DD SS  S  S KYS+ +Y SGNE  SE S    E    A+ TQKSTRFCP
Sbjct: 460 L-KDDLF--DDTSSESSAHSGKYSNLNYFSGNEHCSETSTLRREQHPGAK-TQKSTRFCP 515

Query: 417 EAAMNNDRCNSEDVNSRKACRSNSNNHRK---------------------LSRIRSLVDV 455
           E          E+ ++RKA    S    K                     L+R RSLVDV
Sbjct: 516 E----------ENSSTRKALPGKSYKQGKVLQESQRAPGSKDKFAMETIRLTRNRSLVDV 565

Query: 456 RSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPANCAA 493
           RSQLLHR+LVEE+HKRRL KTVGAVENIGF  P N + 
Sbjct: 566 RSQLLHRTLVEEVHKRRLSKTVGAVENIGFQAPCNVSG 603

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584247|ref|XP_002532861.1| kinase, putative [Ricinus communis] gi|223527373|gb|EEF29515.1| kinase, putative [Ricinus communis]

 Score =  588 bits (1517), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 335/505 (66%), Positives = 390/505 (77%), Gaps = 28/505 (5%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLREYRKKY  VDIRAVKNWARQIL+G+AYLHGHDPPVIHRDLKCDNIF+NGHLG
Sbjct: 113 MFTSGTLREYRKKYQHVDIRAVKNWARQILQGLAYLHGHDPPVIHRDLKCDNIFINGHLG 172

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ A SVIGTPEFMAPELYEE+YNELVDIYSFGMCVLEM TSEYP
Sbjct: 173 QVKIGDLGLAAILRGSQHARSVIGTPEFMAPELYEEEYNELVDIYSFGMCVLEMFTSEYP 232

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLP AF++I+D EA++FVGKCLE+ SKRLPA+ELLLDPFL+SD
Sbjct: 233 YSECSNPAQIYKKVTSGKLPEAFYKIKDTEAQKFVGKCLESASKRLPARELLLDPFLSSD 292

Query: 181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
            G+ L + ++P  Q  + N A  E++P    D    K T+MTITGTMNP+DDT+FLKVQI
Sbjct: 293 EGKLLPVTKIP-IQRSSSN-ASEEIIPSLLADP--TKDTEMTITGTMNPDDDTVFLKVQI 348

Query: 241 TDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
           +DKDG  RNIYFP+D  NDTA +VA+EMVKELEITDWE L+IAEMIE++I+SL+P+ KE 
Sbjct: 349 SDKDGHTRNIYFPYDTMNDTAIDVAVEMVKELEITDWESLDIAEMIEEQIASLIPSSKEW 408

Query: 301 GSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFT------------N 348
           G   F  QHSF+  D+DD+ D+DG +HPF+S SS SSS ASL A  +             
Sbjct: 409 G--LFQQQHSFN-YDDDDEYDNDGNHHPFHSFSSRSSSQASLLALSSPYENPHLHGGSNT 465

Query: 349 NANSPPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARAT 408
           N      WLQ E L  NDD SS  S +S KYS+ +Y SGNED  E S R GE L  A+A 
Sbjct: 466 NVTCSLDWLQGE-LFTNDDTSSQSSFNSIKYSNLNYCSGNEDSCETSTRGGEHLSFAKA- 523

Query: 409 QKSTRFCPEAAMNNDRCNSEDVNSRKACRS----NSNNHRKLSRIRSLVDVRSQLLHRSL 464
            KSTRFCP    +++ C+ +         S    +S++  KLSR RSLVDVRSQLLH+SL
Sbjct: 524 HKSTRFCP---ADSNLCSKQHKQRNAQLGSWECSSSSSQPKLSRHRSLVDVRSQLLHKSL 580

Query: 465 VEEIHKRRLFKTVGAVENIGFHEPA 489
           +E+IHKRRLFKTVGAVENIGFHEP 
Sbjct: 581 LEQIHKRRLFKTVGAVENIGFHEPG 605

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124748|ref|XP_002319412.1| predicted protein [Populus trichocarpa] gi|222857788|gb|EEE95335.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 315/505 (62%), Positives = 366/505 (72%), Gaps = 40/505 (7%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLREYRKKYTRV+IRA+K WARQIL GI YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 113 MFTSGTLREYRKKYTRVNIRAIKKWARQILEGIVYLHGHDPPVIHRDLKCDNIFVNGHLG 172

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVD+YSFGMCVLEMLTSEYP
Sbjct: 173 QVKIGDLGLAAILRGSQSAHSVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYP 232

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSEC+NPAQIYKKVTSGKLP  FHRIQD EA+RF+GKCL   +KRL AKELLLDPFLASD
Sbjct: 233 YSECTNPAQIYKKVTSGKLPAVFHRIQDLEAQRFIGKCLVTAAKRLSAKELLLDPFLASD 292

Query: 181 AGEPLLIPQVPSFQNLNP--NGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
             E   +P VP F+   P  N   ME   K  ++ D    TDMTITG +NPEDDTIFLKV
Sbjct: 293 EAE---LPHVPRFRKQKPFLNDREME---KLQLN-DHPPRTDMTITGKLNPEDDTIFLKV 345

Query: 239 QITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK 298
           QI ++DG  RNI+FPFDI +DT  +VA+EMVKELEI DWEP EIA+MI+  IS+LVPNWK
Sbjct: 346 QIANEDGTLRNIFFPFDILHDTPIDVAMEMVKELEIDDWEPFEIADMIDGAISALVPNWK 405

Query: 299 ECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQ 358
           +   P     H+F Y+      +DDG  HPF+S+SS SSS ASL     +        L 
Sbjct: 406 KWDLPHIESHHTFDYQ------EDDGHDHPFHSSSSCSSSPASLSGLMPH--------LL 451

Query: 359 QEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEA 418
           Q+DL   DD SS  S  S  YS  +Y SG+E   + S    +   I R TQ STRFCP+ 
Sbjct: 452 QDDLF--DDTSSQSSSHSGSYSCLNYISGDEHKFDLSSTRRDKHLITR-TQNSTRFCPQE 508

Query: 419 AMNNDRCNSEDVNSRKAC--------RSNSN------NHRKLSRIRSLVDVRSQLLHRSL 464
             N++   +   N+   C        R++S+      + R+L+R RSLVD+RSQLLHRSL
Sbjct: 509 NSNSNIGQALATNAYNHCKVLLESQTRASSSKSKRMMDSRRLTRNRSLVDIRSQLLHRSL 568

Query: 465 VEEIHKRRLFKTVGAVENIGFHEPA 489
           VEE+HKRRL KTVG VE++GF +P 
Sbjct: 569 VEEVHKRRLSKTVGDVEDVGFQKPT 593

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496301|ref|XP_003517007.1| PREDICTED: probable serine/threonine-protein kinase WNK5-like [Glycine max]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 318/520 (61%), Positives = 383/520 (73%), Gaps = 42/520 (8%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 225

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLP A++RI D EA+RFVGKCL NVS+RL AKELLLDPFLA +
Sbjct: 226 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQRFVGKCLANVSERLSAKELLLDPFLAKE 285

Query: 181 AGE-PLLIPQVPSFQ--NLNPNGAVMELV--PKFAVDSDRRKSTDMTITGTMNPEDDTIF 235
             + PL  P +P  Q   LN   ++ + +  PK    S++ K + MTITG++N EDDT+F
Sbjct: 286 QLDSPLPSPTLPKKQAPTLNFTASLAKELSQPK----SNQTKDSHMTITGSINEEDDTVF 341

Query: 236 LKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVP 295
           LKVQI++KDGQ RNI+FPFD   DTA +VA+EMVKELEI+D EPLEIA+MIE+EIS+LVP
Sbjct: 342 LKVQISNKDGQKRNIFFPFDTIYDTAIDVAMEMVKELEISDLEPLEIAKMIEEEISALVP 401

Query: 296 NWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAF---FTNNA-- 350
            W++ GS ++  QHSFSYE+E D ++    +HPF+S SS SSSHASLP F   + NN+  
Sbjct: 402 KWRDWGSAEYQKQHSFSYEEEYDMSN----HHPFFSTSSRSSSHASLPVFGSSYKNNSHY 457

Query: 351 --NSPP---SWLQQEDLLGNDDASSNGSVSSFKYSSWD-YHSGNED--DSEFSHRAGEPL 402
             N  P    W Q E L  NDDASS  S++SFK  +++    GNED  D      A    
Sbjct: 458 RGNHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNFNCCDPGNEDEHDPTLVLGAEHLY 516

Query: 403 CIARATQKSTRFCP-EAAMNNDRCNSEDVNSRKACRSNSNNHR-----KLSRIRSLVDVR 456
              +  +K  RFCP E  M+ D        +++ C    ++HR     +L+RIRS VD+R
Sbjct: 517 YTPKGNEKCIRFCPREEVMDADF-------TKQLCNMRMDSHRCHGMHRLTRIRSFVDLR 569

Query: 457 SQLLHRSLVEEIHKRRLFKTVGAVENIGFHEP--ANCAAY 494
            Q L RSL+EEIHKRR+FKTVGAVENIGF  P    C +Y
Sbjct: 570 RQQLQRSLMEEIHKRRMFKTVGAVENIGFQNPEGGGCFSY 609

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224145457|ref|XP_002325649.1| predicted protein [Populus trichocarpa] gi|222862524|gb|EEF00031.1| predicted protein [Populus trichocarpa]

 Score =  538 bits (1387), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 300/504 (59%), Positives = 350/504 (69%), Gaps = 39/504 (7%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLR+YR+KYTRV+IRA+K WARQIL GI YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 112 MFTSGTLRQYRQKYTRVNIRAIKKWARQILEGIEYLHGHDPPVIHRDLKCDNIFVNGHLG 171

Query: 61  QIKIGDLGLAAILRGSQQAHSVIG-TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEY 119
           Q+KIGDLGLAAILRGSQ AHSVIG TPEFMAPELYEE+YNELVD+YSFGMCVLEMLT+EY
Sbjct: 172 QVKIGDLGLAAILRGSQSAHSVIGSTPEFMAPELYEENYNELVDVYSFGMCVLEMLTAEY 231

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS 179
           PYSEC+NPAQIYKKVTSGKLP  F+RIQD EA+RF+GKCLE  SKRLPAKELLLDPFLAS
Sbjct: 232 PYSECTNPAQIYKKVTSGKLPAVFYRIQDLEAQRFIGKCLETASKRLPAKELLLDPFLAS 291

Query: 180 DAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQ 239
           D  E   +P++ + Q    N   ME   K  ++ D    TDM ITG +N  DDTIFLKVQ
Sbjct: 292 DEAELSRVPRIRN-QKSFLNDREME---KLQLN-DHPPRTDMIITGKLN-RDDTIFLKVQ 345

Query: 240 ITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKE 299
           I ++DG  RNI+FPFDI +DT  +VA+EMVKELEI DWEP EIA+MI+  IS LVPNWK+
Sbjct: 346 IANEDGTPRNIFFPFDILHDTPIDVAMEMVKELEIGDWEPFEIADMIDGAISDLVPNWKK 405

Query: 300 CGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQ 359
              P    +H F Y+      +DDG  HPF         H+S  +   ++ +     L Q
Sbjct: 406 WDLPHTEPRHIFDYQ------EDDGHNHPF---------HSSSYSSSHSSLSGSTPHLLQ 450

Query: 360 EDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKSTRFCPEAA 419
           +DL   DD SS  S  S  YS  +Y SG E   + S    E     R TQ STRFCP   
Sbjct: 451 DDLF--DDTSSQSSSHSGSYSCLNYISGYEHKLDLSTTRREKHLDTR-TQNSTRFCPREN 507

Query: 420 MNNDRCNSEDVNSRKACR--------------SNSNNHRKLSRIRSLVDVRSQLLHRSLV 465
            N++       N+   C+                  + R+L+R RSLVD+RSQLLHRSLV
Sbjct: 508 SNSNIGQVLATNAYNNCKVLLESKSRVSSSKSKRMMDSRRLTRNRSLVDIRSQLLHRSLV 567

Query: 466 EEIHKRRLFKTVGAVENIGFHEPA 489
           EE+HKRRL KTVG VE++GF  PA
Sbjct: 568 EEVHKRRLSKTVGDVEDVGFQAPA 591

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|148469851|gb|ABQ65855.1| WNK1 [Glycine max]

 Score =  538 bits (1385), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 314/520 (60%), Positives = 379/520 (72%), Gaps = 41/520 (7%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 225

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLP A++RI D EA++FVGKC  NVS+RL AKELLLDPFLA++
Sbjct: 226 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQKFVGKCSANVSERLSAKELLLDPFLATE 285

Query: 181 A-GEPLLIPQVPSFQNLNPNGAVM---ELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
               PL  P +P  Q    N   +   EL P     S++ K T MTITG+ N E+DT+FL
Sbjct: 286 QLDSPLPSPTLPKKQTPTLNFTALLAKELPPP---KSNQTKDTHMTITGSTNEENDTVFL 342

Query: 237 KVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
           KVQI++K+GQ RNI+FPFD  NDTA +VA+EMVKELEI+D EPLEIAEMIE+EIS+LVP 
Sbjct: 343 KVQISNKNGQKRNIFFPFDTINDTAIDVAMEMVKELEISDLEPLEIAEMIEEEISALVPT 402

Query: 297 WKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAF----FTNNA-- 350
           W++ GS ++  QHSFSYE+  D ++    +HPF+S +S SSSHASLP F    + N++  
Sbjct: 403 WRDWGSAKYQKQHSFSYEEAYDMSN----HHPFFSPTSRSSSHASLPVFGSSSYKNSSHH 458

Query: 351 --NSPP---SWLQQEDLLGNDDASSNGSVSSFKYSSWD-YHSGNED--DSEFSHRAGEPL 402
             N  P    W Q E L  NDDASS  S++SFK  + +    GNED  D   +  A    
Sbjct: 459 RENHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNLNCCDPGNEDEHDPTLALGAEHLF 517

Query: 403 CIARATQKSTRFCP-EAAMNNDRCNSEDVNSRKACRSNSNNHR-----KLSRIRSLVDVR 456
              +  +K TRFCP E  M +D        +++ C    ++HR     +L+RIRS VD+R
Sbjct: 518 YTPKGNEKYTRFCPREEVMESDF-------TKQFCNMRMDSHRCHGMHRLTRIRSFVDLR 570

Query: 457 SQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPA--NCAAY 494
            Q   RSLVEEIHKRR+FKTVGA+ENIGF +P    C +Y
Sbjct: 571 RQQQQRSLVEEIHKRRMFKTVGAIENIGFQDPEGDGCFSY 610

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721696|ref|NP_001237474.1| with no lysine kinase 5 [Glycine max] gi|225348639|gb|ACN87281.1| with no lysine kinase [Glycine max]

 Score =  534 bits (1375), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 314/520 (60%), Positives = 379/520 (72%), Gaps = 44/520 (8%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAILRGSQ AHS   TPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHS---TPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 222

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
           YSECSNPAQIYKKVTSGKLP A++RI D EA++FVGKCL NVS+RL AKELLLDPFLA++
Sbjct: 223 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQKFVGKCLANVSERLSAKELLLDPFLATE 282

Query: 181 A-GEPLLIPQVPSFQNLNPNGAVM---ELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
               PL  P +P  Q    N   +   EL P     S++ K T MTITG+MN E+DT+FL
Sbjct: 283 QLDSPLPSPTLPKKQTPTLNFTALLAKELPPP---KSNQTKDTHMTITGSMNEENDTVFL 339

Query: 237 KVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
           KVQI++K+GQ RNI+FPFD  NDTA +VA+EMVKELEI+D EPLEIAEMIE+EIS+LVP 
Sbjct: 340 KVQISNKNGQKRNIFFPFDTINDTAIDVAMEMVKELEISDLEPLEIAEMIEEEISALVPT 399

Query: 297 WKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAF----FTNNA-- 350
           W++ GS ++  QHSFSYE+E D ++    +HPF+S +S SSSHASLP F    + N++  
Sbjct: 400 WRDWGSAKYQKQHSFSYEEEYDMSN----HHPFFSPTSRSSSHASLPVFGSSSYKNSSHH 455

Query: 351 --NSPP---SWLQQEDLLGNDDASSNGSVSSFKYSSWD-YHSGNED--DSEFSHRAGEPL 402
             N  P    W Q E L  NDDASS  S++SFK  + +    GNED  D   +  A    
Sbjct: 456 RENHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNLNCCDPGNEDEHDPTLALGAEHLF 514

Query: 403 CIARATQKSTRFCP-EAAMNNDRCNSEDVNSRKACRSNSNNHR-----KLSRIRSLVDVR 456
              +  +K TRFCP E  M +D        +++ C    ++HR     +L+RIRS VD+R
Sbjct: 515 YTPKGNEKYTRFCPREEVMESDF-------TKQFCNMRMDSHRCHGMHRLTRIRSFVDLR 567

Query: 457 SQLLHRSLVEEIHKRRLFKTVGAVENIGFHEPA--NCAAY 494
            Q   RSLVEEIHKRR+FKTVGA+ENIGF +P    C +Y
Sbjct: 568 RQQQQRSLVEEIHKRRMFKTVGAIENIGFQDPEGDGCFSY 607

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449531499|ref|XP_004172723.1| PREDICTED: probable serine/threonine-protein kinase WNK5-like, partial [Cucumis sativus]

 Score =  528 bits (1359), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 284/513 (55%), Positives = 370/513 (72%), Gaps = 39/513 (7%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFTSGTLREYR+KY  +DI A+KNWARQIL G+ YLHGHDPP+IHRDLKCDN+F+NGHLG
Sbjct: 81  MFTSGTLREYRQKYRNIDIEAIKNWARQILHGLVYLHGHDPPIIHRDLKCDNVFINGHLG 140

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           Q+KIGDLGLAAIL  SQ AHSVIGTPEFMAPELY+E+YNELVD+YSFGMC++EMLT EYP
Sbjct: 141 QVKIGDLGLAAILHDSQHAHSVIGTPEFMAPELYDEEYNELVDVYSFGMCMIEMLTLEYP 200

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLA-S 179
           YSECSNPAQIYKKVTSGKLP AF+ I+D EA+RFV KCLENVSKR+ A+ELLLDPFLA S
Sbjct: 201 YSECSNPAQIYKKVTSGKLPNAFYEIKDLEAQRFVRKCLENVSKRVSARELLLDPFLAPS 260

Query: 180 DAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQ 239
           +A       ++ S  +L+P  ++M             + TD+ I+G++NP+DD+IFLKVQ
Sbjct: 261 NANHASHNEELLS-SSLSPEKSIMA------------RRTDLAISGSINPKDDSIFLKVQ 307

Query: 240 ITDKDGQARNIYFPFDIFNDTATEVALEMVKELE-ITDWEPLEIAEMIEQEISSLVPNWK 298
           I  K+G+++N+YF FDI NDT  +VA EMVKELE I+DW+PLEIA MIE+EISSL+P+W+
Sbjct: 308 IKVKNGKSKNVYFAFDILNDTTIDVATEMVKELEIISDWDPLEIAVMIEKEISSLIPDWE 367

Query: 299 ECGSPQFCHQHSFSYEDEDDDNDDD---------GIYHPF-YSNSSHSSSHASLPAFFTN 348
           E   P+  HQ SF+YE + D ++D+            HPF Y  SSH SS  SL AF+++
Sbjct: 368 EWKLPKIQHQDSFNYEQDHDGDNDNDNDDDDENYATPHPFYYCGSSHGSSSDSLHAFYSS 427

Query: 349 NANSPPSWLQQED------LLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSH--RAGE 400
             N    +   +D          DD SS  S++SF YS   ++S NED+ E+    +  E
Sbjct: 428 RENPNHYFGGMKDTSNTTEWFREDDTSSCCSLNSFNYSDLSFYSNNEDEYEYDSNIKGRE 487

Query: 401 PLCIARATQKSTRFCPEAAMNNDRCNSED---VNSRKA--CRSNSNNHRKLSRIRSLVDV 455
           P  ++  T++ TRFCP   +++     +D   + +R+    RS SNN  +L+R++S+V++
Sbjct: 488 PQYVS-TTKQPTRFCPTMKIDSHHLRHKDNKIIPNREVFESRSRSNNSPRLTRVKSMVNL 546

Query: 456 RSQLLHRSLVEEIHKRRLFKTVGAVENIGFHEP 488
           RS+ LHR LVE + K+RLF TVGA+ENIG+ +P
Sbjct: 547 RSETLHRYLVEMLLKKRLFNTVGAMENIGYQKP 579

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	502
TAIR|locus:2098242	549	WNK5 "with no lysine (K) kinas	0.762	0.697	0.630	7.4e-121
TAIR|locus:2161278	571	WNK4 "with no lysine (K) kinas	0.603	0.530	0.625	8.4e-121
TAIR|locus:2114845	700	WNK1 "with no lysine (K) kinas	0.362	0.26	0.704	3.9e-89
TAIR|locus:2182039	492	WNK9 [Arabidopsis thaliana (ta	0.362	0.369	0.693	8.1e-87
TAIR|locus:504955638	516	WNK3 "with no lysine (K) kinas	0.571	0.556	0.570	5.6e-84
TAIR|locus:2093994	567	WNK6 "with no lysine (K) kinas	0.376	0.333	0.626	1.2e-77
TAIR|locus:2028521	557	WNK7 [Arabidopsis thaliana (ta	0.376	0.339	0.606	1.6e-75
TAIR|locus:2165790	563	WNK8 "with no lysine (K) kinas	0.426	0.380	0.595	8.5e-75
TAIR|locus:2019404	524	WNK10 "with no lysine (K) kina	0.525	0.503	0.477	4.3e-61
ZFIN|ZDB-GENE-030131-2656	1909	wnk1b "WNK lysine deficient pr	0.360	0.094	0.546	2.1e-59

TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
 Identities = 253/401 (63%), Positives = 288/401 (71%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSGTLREYR+KY +VDIRA+K+WARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct:   107 LFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 166

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             Q+KIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT EYP
Sbjct:   167 QVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYP 226

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS- 179
             YSEC+NPAQIYKKVTSGKLP +FH IQ  EA+RFVGKCLE VS+RLPAKELL DPFLA+ 
Sbjct:   227 YSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAAT 286

Query:   180 DAGE--PLL-IPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
             D  +  PL  +PQ  + QNL  NG V+E +P     +D  ++TDM+ITG MN ED TIFL
Sbjct:   287 DERDLAPLFRLPQQLAIQNLAANGTVVEHLPS---TTDPTRTTDMSITGKMNSEDHTIFL 343

Query:   237 KVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
             +VQI D DG  RNI FPF+I +DT  EVALEMVKELEITDW+PLEIA MIE EIS LVPN
Sbjct:   344 QVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPN 403

Query:   297 WKECGSPQFCHQHSFSYXXXXXXXXXXGIYHPFYXXXXXXXXXXXLPAFFTNNANSPPSW 356
             W+   S    H+ SF +          G    F              A   NN +S    
Sbjct:   404 WRANDS-SIRHE-SFGHEDDEDNGDTEGRTRLFSSASSSHDSPV---AVRENNDDSSNDV 458

Query:   357 LQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHR 397
             +   D  GN   SSN  ++S   S++ Y    +DD     R
Sbjct:   459 IPDMDD-GN--RSSNRLLNS---STYHYSPAIDDDQNQQQR 493

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043424 "protein histidine kinase binding" evidence=IPI

GO:0048573 "photoperiodism, flowering" evidence=IMP

TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1003 (358.1 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
 Identities = 194/310 (62%), Positives = 239/310 (77%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSGTLR+Y+ KY R+DIRA+K+WARQIL G+ YLH HDPPVIHRDLKCDNIFVNGHLG
Sbjct:   101 LFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLG 160

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             Q+KIGDLGLA +LR    AHS+IGTPEFMAPELYEE+YNEL+D+YSFGMC LEM+TSE+P
Sbjct:   161 QVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFP 220

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             YSEC++PAQIYKKV  GKLPGAF+R+ D EA+RF+GKCL + SKR+ AKELL DPFLASD
Sbjct:   221 YSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280

Query:   181 AGEPLLIPQVPSFQNLNPNGAVMEL-VPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQ 239
               E  ++    S    NP   + E  +    ++ D  + T+M+I G +  ED+ I L+VQ
Sbjct:   281 --ESWMV--YTSGAG-NPKPFLNENEMDTLKLEDDELR-TEMSIAGKLGAEDNKIDLEVQ 334

Query:   240 ITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKE 299
             I   +G A N++FPFDI NDT+ +VA EMVKELEI DWEP+EIA+MI+  ISSLV +WK 
Sbjct:   335 IAYDNGLANNVFFPFDIMNDTSIDVAKEMVKELEIIDWEPVEIAKMIDGAISSLVSDWKY 394

Query:   300 CGSPQFCHQH 309
                 +  H H
Sbjct:   395 EEDDETPHDH 404

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010260 "organ senescence" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 3.9e-89, Sum P(2) = 3.9e-89
 Identities = 129/183 (70%), Positives = 154/183 (84%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSGTLR+YR ++ RV+IRA+K+W RQILRG+ YLH HDPPVIHRDLKCDNIFVNG+ G
Sbjct:   106 LFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQG 165

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLAAILR S  AH V GTPEFMAPE+YEE YNELVDIYSFGMC+LEM+T +YP
Sbjct:   166 EVKIGDLGLAAILRKSHAAHCV-GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYP 224

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             YSEC++PAQIYKKV SGK P A ++++D E + F+ KCL  VS R+ A+ELL DPFL  D
Sbjct:   225 YSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRID 284

Query:   181 AGE 183
              GE
Sbjct:   285 DGE 287

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)]

 Score = 672 (241.6 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
 Identities = 127/183 (69%), Positives = 149/183 (81%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             MFTSGTLR+YR K+ RV+IRAVKNW RQILRG+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct:   107 MFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQG 166

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLAA L+ S  AH V GTPEFMAPE+Y+E+YN+LVDIYSFGMCVLEM+T +YP
Sbjct:   167 EVKIGDLGLAACLQHSHAAHCV-GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYP 225

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             YSECS+PAQIYK+V SGK P    +++D E R F+ KCL  VS RL A ELL D FL  D
Sbjct:   226 YSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID 285

Query:   181 AGE 183
               +
Sbjct:   286 ESD 288

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 841 (301.1 bits), Expect = 5.6e-84, P = 5.6e-84
 Identities = 170/298 (57%), Positives = 215/298 (72%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSG LR+YRKK+  VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct:   104 VFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQG 163

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLAAIL  ++ AHSVIGTPEFMAPELYEEDYN LVDIY+FGMC+LE++T EYP
Sbjct:   164 EVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYP 223

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             YSEC+N AQIY+KVTSG  P A   + D + R F+ KC+  VS+RL AKELL DPFL   
Sbjct:   224 YSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCY 283

Query:   181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
                   +         N NG V +L       SD      +T+ G    + +TIFLK++I
Sbjct:   284 KENTENVSSHKE-NGYNGNGIVDKL-------SDSEVGL-LTVEG-QRKDLNTIFLKLRI 333

Query:   241 TDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLE-IAEMIEQEISSLVPNW 297
             TD  GQ RNI+FPF+I  DT+  VA+EMV+EL++TD + +  IA+MI+ EI S +P+W
Sbjct:   334 TDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.2e-77, Sum P(2) = 1.2e-77
 Identities = 121/193 (62%), Positives = 154/193 (79%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSG+LR YRKK+ +V+++AVKNWARQIL G+ YLHG +PP+IHRDLKCDNIF+NG+ G
Sbjct:   110 LFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHG 169

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLA ++  +  A SVIGTPEFMAPELY+E+YNEL DIYSFGMC+LEM+T +YP
Sbjct:   170 EVKIGDLGLATVMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYP 228

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             Y EC N AQIYKKV+SG  P +  R++D E ++F+ KCL   S+RL AKELLLDPFL  +
Sbjct:   229 YCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLN 288

Query:   181 A---GEPLLIPQV 190
                   PL +P +
Sbjct:   289 GLTMNNPLPLPDI 301

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)]

 Score = 631 (227.2 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
 Identities = 117/193 (60%), Positives = 151/193 (78%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSG+LR+YRKK+ +V+++AVK WARQIL G+ YLH  DPP+IHRD+KCDNIF+NG+ G
Sbjct:   110 LFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHG 169

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLA ++  +  A SVIGTPEFMAPELY+E+YNEL DIYSFGMC+LEM+T EYP
Sbjct:   170 EVKIGDLGLATVMEQAN-AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYP 228

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             Y EC N AQIYKKV+SG  P +  +++D E  +F+ KCL   S+RL A+ELLLD FL  +
Sbjct:   229 YCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVN 288

Query:   181 A---GEPLLIPQV 190
                   PL +P +
Sbjct:   289 GLVMNNPLPLPDI 301

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 8.5e-75, Sum P(2) = 8.5e-75
 Identities = 131/220 (59%), Positives = 161/220 (73%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSG+LR YRKK+ +VD +A+KNWARQIL+G+ YLH  +PPVIHRDLKCDNIFVNG+ G
Sbjct:   111 LFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTG 170

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLA +L+    A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYP
Sbjct:   171 EVKIGDLGLATVLQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYP 229

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             Y+EC N AQIYKKVTS   P +  ++ D + R+F+ KCL   S R  A EL  DPFLA D
Sbjct:   230 YNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARD 289

Query:   181 AGEP--LLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKS 218
              G+   LL     S + + P    +E +P   VD +  KS
Sbjct:   290 GGKDSALLASSSTSSKYVRP--PQLEHLP-MDVDHNENKS 326

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048573 "photoperiodism, flowering" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0009911 "positive regulation of flower development" evidence=IMP

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA;IMP

GO:0009909 "regulation of flower development" evidence=IMP

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
 Identities = 128/268 (47%), Positives = 171/268 (63%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             +FTSG+L  YRKK+ +VD +A+ NWARQIL+G+ YLH   PPVIHRDLKCDNIFVNG+ G
Sbjct:    98 LFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTG 157

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
             ++KIGDLGLAA+++    A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYP
Sbjct:   158 KVKIGDLGLAAVMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYP 216

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
             Y EC N AQIYKKVTSG  P +  ++ D + ++F+ KCL     R  A ELL D  LA D
Sbjct:   217 YRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVD 276

Query:   181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
               +   +    S     P  A+        +D + +K+T ++I  +     +   L+   
Sbjct:   277 GAKDSTLT-ASSNTTFKP--AMPPQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTME 333

Query:   241 TDKDGQARNIYFPFDIFNDTATEVALEM 268
               +  ++       +  +D A  +AL +
Sbjct:   334 VQRVAESTEFKLSGERRDDVAASMALRI 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=ISS

ZFIN|ZDB-GENE-030131-2656 wnk1b "WNK lysine deficient protein kinase 1b" [Danio rerio (taxid:7955)]

 Score = 546 (197.3 bits), Expect = 2.1e-59, Sum P(4) = 2.1e-59
 Identities = 100/183 (54%), Positives = 133/183 (72%)

Query:     1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
             + TSGTL+ Y K++  + I+ +++W RQIL+G+ +LH   PP+IHRDLKCDNIF+ G  G
Sbjct:   296 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLHFLHTRAPPIIHRDLKCDNIFITGPTG 355

Query:    61 QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
              +KIGDLGLA + R S  A SVIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYP
Sbjct:   356 SVKIGDLGLATLKRSSF-AKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 414

Query:   121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLAS 179
             YSEC NPAQIY++VTSG  PG+F ++   E +  +  C+ +N  +R   K+LL   F   
Sbjct:   415 YSECQNPAQIYRRVTSGVKPGSFDKVAIPEVKEIIEGCIRQNKDERYAIKDLLNHAFFQE 474

Query:   180 DAG 182
             + G
Sbjct:   475 ETG 477

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0048919 "posterior lateral line neuromast development" evidence=IGI;IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SCU5	WNK5_ARATH	2, ., 7, ., 1, 1, ., 1	0.7225	0.6354	0.5810	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XVI.263.1 hypothetical protein (570 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	502
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-35
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-19
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-05
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-04
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	0.001
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	0.001
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	0.002
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  170 bits (433), Expect = 1e-49
 Identities = 62/177 (35%), Positives = 94/177 (53%), Gaps = 8/177 (4%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  KK  R+     + + RQIL  + YLH     ++HRDLK +NI ++   G +K+
Sbjct: 82  GDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENILLDED-GHVKL 138

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPYS 122
            D GLA  L   ++  + +GTPE+MAPE L  + Y + VDI+S G  +L E+LT + P+ 
Sbjct: 139 ADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFP 197

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                 +++KK+   K P          EA+  + K L  +  KRL A+E L  PF 
Sbjct: 198 GDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  163 bits (415), Expect = 7e-47
 Identities = 68/178 (38%), Positives = 94/178 (52%), Gaps = 8/178 (4%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L    KK+ ++    ++ + RQIL G+AYLH +   ++HRD+K  NI V    G +K+
Sbjct: 86  GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV-DSDGVVKL 142

Query: 65  GDLGLAAILRGSQQA---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP 120
            D G A  L   +      SV GTP +MAPE+   E+Y    DI+S G  V+EM T + P
Sbjct: 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           +SE  NP     K+ S   P         EA+ F+ KCL  +  KR  A ELL  PFL
Sbjct: 203 WSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (373), Expect = 6e-41
 Identities = 62/181 (34%), Positives = 93/181 (51%), Gaps = 11/181 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y  +   +     K  A QILRG+ YLH +   +IHRDLK +NI ++ + G +KI
Sbjct: 83  GDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLDEN-GVVKI 139

Query: 65  GDLGLAAILRGSQQ-AHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            D GLA  L  S     + +GTP +MAPE  L    Y   VD++S G+ + E+LT + P+
Sbjct: 140 ADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF 199

Query: 122 SECSNPAQIYK--KVTSGKLPGAF--HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           S  +   Q+    ++    L            EA+  + KCL  + SKR  A+E+L  P+
Sbjct: 200 SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Query: 177 L 177
            
Sbjct: 260 F 260

Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  132 bits (335), Expect = 3e-35
 Identities = 60/161 (37%), Positives = 91/161 (56%), Gaps = 16/161 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIG 84
            R++L+G+ YLH     VIHRD+K DNI ++   G +K+ D G AA L +   + +SV+G
Sbjct: 122 CREVLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178

Query: 85  TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TP +MAPE+ + +DY   VDI+S G+  +EM   E PY     P +    +T+  +P   
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP--- 234

Query: 144 HRIQDA-----EARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
             +++      E + F+ KCL  +  KR  A+ELL  PFL 
Sbjct: 235 -PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  131 bits (330), Expect = 7e-35
 Identities = 66/181 (36%), Positives = 97/181 (53%), Gaps = 13/181 (7%)

Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
             G+L +  KKY       ++ + RQIL G+ YLH  +   +HRD+K  NI V+ + G +
Sbjct: 85  PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVV 141

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYP 120
           K+ D G+A  +     A S  G+P +MAPE+   +  Y    DI+S G  VLEM T + P
Sbjct: 142 KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           +S+    A ++K   S +LP     I D    EA+ F+ KCL+ + S R  A ELL  PF
Sbjct: 202 WSQLEGVAAVFKIGRSKELP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Query: 177 L 177
           +
Sbjct: 258 V 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (323), Expect = 6e-34
 Identities = 53/156 (33%), Positives = 89/156 (57%), Gaps = 11/156 (7%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
            +++L+G+ YLH +   +IHRD+K  NI +    G++K+ D GL+A L  ++  ++++GT
Sbjct: 104 CKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGT 160

Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP-G 141
           P +MAPE +  + Y+   DI+S G+  +E+   + PYSE      ++K  T+G   L   
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220

Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
                   E + F+ KCL+ N  KR  A++LL  PF
Sbjct: 221 EKW---SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  121 bits (307), Expect = 4e-32
 Identities = 38/114 (33%), Positives = 66/114 (57%), Gaps = 6/114 (5%)

Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L++  K+   ++    +     QIL G+ YLH +   +IHRDLK +NI ++   G++K
Sbjct: 76  GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVK 133

Query: 64  IGDLGLAAILR-GSQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEM 114
           + D GL+ +L        +++GTP +MAPE+      Y+E  DI+S G+ + E+
Sbjct: 134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  121 bits (305), Expect = 2e-31
 Identities = 69/184 (37%), Positives = 96/184 (52%), Gaps = 14/184 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GTL E  +    +D   ++ +  Q+L G+AYLH H   ++HRD+K  NIF+  H G IK+
Sbjct: 84  GTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL-DHNGVIKL 140

Query: 65  GDLGLAAIL-RGSQQAH----SVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEML 115
           GD G A  L   +        S+ GTP +MAPE+        +    DI+S G  VLEM 
Sbjct: 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLL 173
           T + P+SE  N  QI   V +G  P     +Q   E + F+ +CLE +  KR  A ELL 
Sbjct: 201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260

Query: 174 DPFL 177
            PF+
Sbjct: 261 HPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (304), Expect = 5e-31
 Identities = 56/178 (31%), Positives = 94/178 (52%), Gaps = 7/178 (3%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  KK  ++    +   ARQIL+G+ YLH     +IHRD+K  N+ +N   G++KI
Sbjct: 84  GSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLIN-SKGEVKI 141

Query: 65  GDLGLAAIL-RGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D G++ +L     Q ++ +GT  +M+PE +  E Y+   DI+S G+ +LE    ++P+ 
Sbjct: 142 ADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201

Query: 123 --ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                +  ++ + +  G  P         E R F+  CL+ +  KR  A ELL  PF+
Sbjct: 202 PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 6e-28
 Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 9/165 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  +  K  R      + +A +I+  + YLH     +I+RDLK +NI ++   G IK+
Sbjct: 78  GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKL 134

Query: 65  GDLGLAAIL-RGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D GLA  L     + ++  GTPE++APE L  + Y + VD +S G+ + EMLT + P+ 
Sbjct: 135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF- 193

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
              +  +IY+K+    L   F      EAR  +   L+ + +KRL
Sbjct: 194 YAEDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKRL 236

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (277), Expect = 2e-27
 Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 26/164 (15%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
            Q L+G+ YLH +    IHRD+K  NI +N   GQ K+ D G++  L  +  + ++VIGT
Sbjct: 106 YQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC----------SNPAQIYKKV 134
           P +MAPE + E  YN   DI+S G+  +EM   + PYS+           + P       
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD- 221

Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
                P  +      E   FV KCL ++  +R  A +LL  PF+
Sbjct: 222 -----PEKWSP----EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (269), Expect = 2e-26
 Identities = 51/158 (32%), Positives = 86/158 (54%), Gaps = 10/158 (6%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSV 82
           +W  Q+   + YLH     ++HRD+K  NIF+    G +K+GD G++ +L  +   A +V
Sbjct: 107 DWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTV 163

Query: 83  IGTPEFMAPELYEED-YNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGKLP 140
           +GTP +++PEL +   YN   DI+S G CVL E+ T ++P+ E  N  ++  K+  G+ P
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLG-CVLYELCTLKHPF-EGENLLELALKILKGQYP 221

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                   +E R  V   L+ +  +R    ++L  PF+
Sbjct: 222 -PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 64/188 (34%), Positives = 94/188 (50%), Gaps = 30/188 (15%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G+LR+  KK+       V  +  Q+L+G+AYLH     VIHRD+K  NI      G +K
Sbjct: 83  NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVK 139

Query: 64  IGDLGLAAILRG-SQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           + D G+A  L   S+   SV+GTP +MAPE+ E    +   DI+S G  V+E+LT   PY
Sbjct: 140 LADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRI-QD----------AEARRFVGKCLE-NVSKRLPAK 169
            +  NP              A  RI QD           E + F+ +C + + + R  AK
Sbjct: 200 YDL-NPMA------------ALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAK 246

Query: 170 ELLLDPFL 177
           +LL  P++
Sbjct: 247 QLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/169 (31%), Positives = 85/169 (50%), Gaps = 30/169 (17%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-----RGSQQAHS 81
           +++L+G+ YLH +    IHRD+K  NI +    G +KI D G++A L     R  +   +
Sbjct: 109 KEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 82  VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSEC-----------SNPA 128
            +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PYS+            ++P 
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225

Query: 129 QIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
            +       K   +F        R+ +  CL+ + SKR  A+ELL   F
Sbjct: 226 SLETGADYKKYSKSF--------RKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 58/162 (35%), Positives = 87/162 (53%), Gaps = 7/162 (4%)

Query: 21  AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA 79
            +  + +QIL G+ YLH  D  ++HRD+K DN+ VN + G +KI D G +  L G +   
Sbjct: 109 TIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 80  HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
            +  GT ++MAPE+ ++    Y    DI+S G  ++EM T + P+ E   P     KV  
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226

Query: 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            K+         AEA+ F+ +C E +  KR  A +LL DPFL
Sbjct: 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 62/183 (33%), Positives = 94/183 (51%), Gaps = 16/183 (8%)

Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
             G++++  K Y  +     + + RQIL G+ YLH +   ++HRD+K  NI  +   G +
Sbjct: 87  PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNV 143

Query: 63  KIGDLG----LAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS 117
           K+GD G    L  I        SV GTP +M+PE+   E Y    D++S G  V+EMLT 
Sbjct: 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203

Query: 118 EYPYSECSNPAQIYK---KVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLL 173
           + P++E    A I+K   + T+ +LP         +AR F+ +   EN  KR  A+ELL 
Sbjct: 204 KPPWAEFEAMAAIFKIATQPTNPQLPSHV----SPDARNFLRRTFVENAKKRPSAEELLR 259

Query: 174 DPF 176
             F
Sbjct: 260 HFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 9e-24
 Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 16/180 (8%)

Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           E  +  T   IR V    RQ+L  + +LH H   VIHRDLK  NI +    G +K+ D G
Sbjct: 95  ELERGLTEPQIRYV---CRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFG 148

Query: 69  LAAILRGS-QQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           ++A  + + Q+  + IGTP +MAPE+       +  Y+   DI+S G+ ++E+   E P+
Sbjct: 149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208

Query: 122 SECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
            E  NP ++  K+   + P         +    F+  CL  +   R  A ELL  PF++ 
Sbjct: 209 HE-LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 9/180 (5%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPP---VIHRDLKCDNIFVNGHLG 60
           +  +++ +K+   ++   +     Q+L  +   H    P   V+HRDLK  NIF++ +  
Sbjct: 89  AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-N 147

Query: 61  QIKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
            +K+GD GLA IL   S  A + +GTP +M+PE L    Y+E  DI+S G  + E+    
Sbjct: 148 NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            P+    N  Q+  K+  GK     +R    E    +   L  +  KR   +ELL  P +
Sbjct: 208 PPF-TARNQLQLASKIKEGKFRRIPYRYSS-ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 60/165 (36%), Positives = 86/165 (52%), Gaps = 14/165 (8%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL-----AAILRGS 76
           V+N+ RQIL+G+ YLH     +IHRD+K  NI V+   G IKI D G+     A  L   
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTK 164

Query: 77  QQAH--SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
                 S+ G+  +MAPE+ ++  Y    DI+S G  V+EMLT ++P+ +C+    I+K 
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK- 223

Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                          +EA  F+ K  E + +KR  A ELL  PFL
Sbjct: 224 -IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 9/177 (5%)

Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-IL 73
           TR++   +      +L+ +++LH     VIHRD+K D+I +    G++K+ D G  A + 
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVS 166

Query: 74  RGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           +   +  S++GTP +MAPE+     Y   VDI+S G+ V+EM+  E PY     P Q  K
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMK 225

Query: 133 KVTSGKLPGAFHRIQ-DAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLI 187
           ++     P   +  +     R F+ + L  + ++R  A ELL  PFLA  AG P  I
Sbjct: 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK-AGPPSSI 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 7/154 (4%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R++L G+ YLH      IHRD+K  NI ++   G +K+ D G++  L  +  + ++ +GT
Sbjct: 105 REVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGT 161

Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+  +  Y+E  DI+S G+  +E+   E P S+   P ++   +     P    
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEG 220

Query: 145 RIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
                  + FV  CL ++  +R  AKELL   F+
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 11/180 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G++     KY       + N+  Q+LRG++YLH  +  +IHRD+K  N+ ++    +++I
Sbjct: 88  GSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRI 145

Query: 65  GDLGLAA-----ILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
            D G AA          +    ++GT  FMAPE L  E Y    D++S G  ++EM T++
Sbjct: 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Query: 119 YPYS--ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
            P++  + SN   +  K+ S     +         R    +CLE     R P++ELL  P
Sbjct: 206 PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 61/177 (34%), Positives = 90/177 (50%), Gaps = 9/177 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G++++  K Y  +     + + RQIL G++YLH +   ++HRD+K  NI  +   G +K+
Sbjct: 91  GSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDS-AGNVKL 147

Query: 65  GDLG----LAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
           GD G    L  I        SV GTP +M+PE+   E Y    D++S G  V+EMLT + 
Sbjct: 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPF 176
           P++E    A I+K  T    P     I +  AR F+G        R  A+ELL  PF
Sbjct: 208 PWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 58/169 (34%), Positives = 90/169 (53%), Gaps = 16/169 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGT 85
           R++L  + Y+H     VIHRD+K  NI V    G +K+ D G+AA+L + S +  + +GT
Sbjct: 108 REVLVALKYIH-KVG-VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGT 164

Query: 86  PEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           P +MAPE+  E   Y+   DI+S G+ + EM T   PYS+  +  +    +   K P   
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKPP--- 220

Query: 144 HRIQD----AEARRFVGKCLENVSK-RLPAKELLLDPFLASDAGEPLLI 187
            R++D       R FV  CL+   K RL A+ELL   ++ + +  P+ I
Sbjct: 221 -RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSI 268

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 3e-22
 Identities = 50/203 (24%), Positives = 78/203 (38%), Gaps = 27/203 (13%)

Query: 2   FTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
              G+L +  KK      +          QIL  + YLH     +IHRD+K +NI ++  
Sbjct: 80  VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRD 137

Query: 59  LGQIKIGDLGLAAILRGSQQA-------HSVIGTPEFMAPELY----EEDYNELVDIYSF 107
              +K+ D GLA +L              + +GTP +MAPE+         +   DI+S 
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197

Query: 108 GMCVLEMLTSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQ-------DAEARRFVGK 157
           G+ + E+LT   P+      S  +Q  K +     P     +           A   + K
Sbjct: 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKK 257

Query: 158 CLE-NVSKRLPAKELLLDPFLAS 179
            L  +   RL +   L    LA 
Sbjct: 258 LLAKDPKNRLSSSSDLSHDLLAH 280

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 33/199 (16%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y +KY  +D +  + +A +IL  + YLH     +IHRDLK +NI ++     IKI
Sbjct: 87  GELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKI 143

Query: 65  GDLGLAAIL---------------------RGSQQAHSVIGTPEFMAPELYEE-DYNELV 102
            D G A +L                     +  ++  S +GT E+++PEL  E    +  
Sbjct: 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203

Query: 103 DIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-N 161
           D+++ G  + +MLT + P+   SN    ++K+   +    F      +A+  + K L  +
Sbjct: 204 DLWALGCIIYQMLTGKPPFR-GSNEYLTFQKILKLEYS--FPPNFPPDAKDLIEKLLVLD 260

Query: 162 VSKRL----PAKELLLDPF 176
              RL       EL   PF
Sbjct: 261 PQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 53/166 (31%), Positives = 92/166 (55%), Gaps = 14/166 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + +K  R      + +A Q++  + YLH  D  +++RDLK +N+ +    G IKI
Sbjct: 86  GELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKI 142

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
            D G A  ++G    +++ GTPE++APE +  + Y + VD ++ G+ + EML   YP  +
Sbjct: 143 TDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG-YPPFF 199

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
            +  NP QIY+K+  GK+   F      +A+  +   L+ +++KRL
Sbjct: 200 DD--NPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 61/155 (39%), Positives = 86/155 (55%), Gaps = 8/155 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ-IYKKVTSGKLPGAF 143
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP + +Y   T+G      
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQN 237

Query: 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                A  R F+ +CLE +V KR  AKELL  PFL
Sbjct: 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 61/178 (34%), Positives = 95/178 (53%), Gaps = 14/178 (7%)

Query: 5   GTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           GTL EY +K     +D   + ++  QIL  +A  H H   ++HRDLK  NI ++ H   +
Sbjct: 84  GTLAEYIQKRCNSLLDEDTILHFFVQIL--LALHHVHTKLILHRDLKTQNILLDKHKMVV 141

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           KIGD G++ IL    +A++V+GTP +++PEL E + YN+  DI++ G CVL  L S    
Sbjct: 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALG-CVLYELASLKRA 200

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELLLDP 175
            E +N   +  K+ SG     F  I D    + R+ +   L  + SKR    +++  P
Sbjct: 201 FEAANLPALVLKIMSGT----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 13/182 (7%)

Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
             G LR +  +  +     VK W  +I+  + YLH     +IHRD+K DNI ++   G +
Sbjct: 83  LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHV 139

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
            I D  +A  +       S  GTP +MAPE+   + Y+  VD +S G+   E L  + PY
Sbjct: 140 HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Query: 122 ---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL--PAKELLLDP 175
              S         K+ T+  L  A       EA   + K LE +  KRL    K+L   P
Sbjct: 200 RGHSRTIRDQIRAKQETADVLYPATWST---EAIDAINKLLERDPQKRLGDNLKDLKNHP 256

Query: 176 FL 177
           + 
Sbjct: 257 YF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 17/178 (9%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
            ++   R+  R +   A  +L+G+ YLH     +IHRD+K  NI VN   GQIK+ D G+
Sbjct: 90  LKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGV 147

Query: 70  AAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           +  L  S  A + +GT  +MAPE +   DY+   DI+S G+ ++E+ T  +PY   ++P 
Sbjct: 148 SGQLVNSL-AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206

Query: 129 ----QIYKKVTSG---KLP-GAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
               ++ + + +    +LP G F      + + FV  CL ++  +R   KELL  PF+
Sbjct: 207 DGIFELLQYIVNEPPPRLPSGKF----SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 6/142 (4%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
            ++    YLH     +I+RDLK +N+ ++   G +K+ D G A  L+  Q+  +  GTPE
Sbjct: 101 CVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157

Query: 88  FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPGAFHR 145
           ++APE+   + Y+  VD +S G+ + E+LT   P+ E   +P +IY  +  G     F  
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217

Query: 146 IQDAEARRFVGK-CLENVSKRL 166
             D  A+  + +    N  +RL
Sbjct: 218 YIDKAAKDLIKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 26/179 (14%)

Query: 18  DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA------- 70
           D    + +  +I+  + YLH +   +IHRDLK DNI ++ + G +K+ D GL+       
Sbjct: 91  DEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRR 147

Query: 71  --AILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              +    ++   ++GTP+++APE +  + +++ VD +S G  + E L    P+     P
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETP 206

Query: 128 AQIYKKVTSGKLPGAFHRIQDA----EARRFVGKCLE-NVSKRLPAK---ELLLDPFLA 178
            +I++ + +GK+       +D     EA   + K L  +  KRL AK   E+   PF  
Sbjct: 207 EEIFQNILNGKIE----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 54/180 (30%), Positives = 98/180 (54%), Gaps = 14/180 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWAR--QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G L +  K      +   + W    QIL G+A+LH     ++HRD+K  N+F++ +   +
Sbjct: 84  GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NV 140

Query: 63  KIGDLGLAAILRGSQQ-AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
           KIGDLG+A +L  +   A++++GTP +++PEL E+  YNE  D+++ G+ + E  T ++P
Sbjct: 141 KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Query: 121 YSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFL 177
           + + +N   +  K+  G  P     +  Q A+    + +CL    ++ P   +LL +P L
Sbjct: 201 F-DANNQGALILKIIRGVFPPVSQMYSQQLAQ---LIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 13/182 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G++    + Y R + + V+ +  Q+L G+AYLH     ++HRDLK DN+ V+   G  KI
Sbjct: 93  GSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKI 149

Query: 65  GDLGLA---AILRGSQQAHSVIGTPEFMAPE---LYEEDYNELVDIYSFGMCVLEMLTSE 118
            D G++     +  + Q  S+ G+  +MAPE    Y + Y+  VDI+S G  VLEM    
Sbjct: 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Query: 119 YPYSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
            P+S+    A ++K         +P          A  F+  C   N   R  A+ELL  
Sbjct: 210 RPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269

Query: 175 PF 176
           PF
Sbjct: 270 PF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 9/178 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G++++  K Y  +     + + RQIL G++YLH +   ++HRD+K  NI  +  +G +K+
Sbjct: 91  GSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDS-VGNVKL 147

Query: 65  GDLG----LAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
           GD G    L  I        SV GTP +M+PE+   E Y    DI+S G  V+EMLT + 
Sbjct: 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
           P++E    A I+K  T    P     + D   R F+ +       R  A ELL   F+
Sbjct: 208 PWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 6e-20
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 38/204 (18%)

Query: 7   LREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           L++Y  K+   +    +K+   Q+LRG+AY H H   ++HRDLK  NI +N   G +K+ 
Sbjct: 84  LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLA 140

Query: 66  DLGLAAILRGSQQA--HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT----- 116
           D GLA       +   H V+ T  + APE+    + Y+  VDI+S G    EM+T     
Sbjct: 141 DFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Query: 117 ---------------------SEYP-YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
                                  +P  ++  +    + K     L     R+ D E    
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRL-DPEGIDL 258

Query: 155 VGKCLE-NVSKRLPAKELLLDPFL 177
           + K L+ N +KR+ AKE L  P+ 
Sbjct: 259 LSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 6/156 (3%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           ++ ++K+   +  R +  +  Q+   + ++H     ++HRD+K  N+F+    G +K+GD
Sbjct: 93  IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGD 149

Query: 67  LGLAAILRG-SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSE 123
           LGL       +  AHS++GTP +M+PE ++E  YN   DI+S G  + EM   + P Y +
Sbjct: 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159
             N   + KK+     P         E R  V +C+
Sbjct: 210 KMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 59/159 (37%), Positives = 87/159 (54%), Gaps = 16/159 (10%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DN+ + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 122 RECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP---- 233

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CLE +V KR  AKELL  PFL
Sbjct: 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 62/186 (33%), Positives = 95/186 (51%), Gaps = 16/186 (8%)

Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           E  +  T   IR V    +Q L  + YLH  +  +IHRDLK  NI      G IK+ D G
Sbjct: 95  ELERPLTEPQIRVV---CKQTLEALNYLH--ENKIIHRDLKAGNILFTLD-GDIKLADFG 148

Query: 69  LAAI-LRGSQQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           ++A   R  Q+  S IGTP +MAPE+       +  Y+   D++S G+ ++EM   E P+
Sbjct: 149 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
            E  NP ++  K+   + P      +  +E + F+ KCLE NV  R    +LL  PF+  
Sbjct: 209 HEL-NPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267

Query: 180 DAGEPL 185
           ++ +P+
Sbjct: 268 NSNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSVIGT 85
           R+ L+G+AYLH      IHRD+K  NI +    G +K+ D G++A L  +  +  S IGT
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGT 164

Query: 86  PEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
           P +MAPE+        Y+   DI++ G+  +E+   + P  +  +P +    ++    P 
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPP 223

Query: 142 AFHRIQDAEA-----RRFVGKCL-ENVSKRLPAKELLLDPF 176
              +++D E        F+ KCL ++  KR  A +LL  PF
Sbjct: 224 P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G++++  K Y  +     + + RQIL+G++YLH +   ++HRD+K  NI  +   G +K+
Sbjct: 91  GSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSA-GNVKL 147

Query: 65  GDLG----LAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
           GD G    +  I        SV GTP +M+PE+   E Y    D++S    V+EMLT + 
Sbjct: 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPF 176
           P++E    A I+K  T    P     + DA  R F+ +      +R  A+ LL  PF
Sbjct: 208 PWAEYEAMAAIFKIATQPTKPMLPDGVSDA-CRDFLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 8e-19
 Identities = 59/159 (37%), Positives = 87/159 (54%), Gaps = 16/159 (10%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 122 RECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP---- 233

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CLE +V +R  AKELL  PFL
Sbjct: 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 11/140 (7%)

Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y +K   ++ +  + ++A QI RG+ YL       IHRDL   N  V  +L  +K
Sbjct: 86  GDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL-VVK 142

Query: 64  IGDLGLAAILRGSQQAHSVIGTPE---FMAPELYEED-YNELVDIYSFGMCVLEMLTS-E 118
           I D GL+  L      +   G      +MAPE  +E  +    D++SFG+ + E+ T  E
Sbjct: 143 ISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE 201

Query: 119 YPYSECSNPAQIYKKVTSGK 138
            PY   SN  ++ + + +G 
Sbjct: 202 QPYPGMSN-EEVLEYLKNGY 220

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 8/152 (5%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+  LH  +  ++HRDLK  NI +  +   +KIGDLG++ +L+ +  A + IGTP 
Sbjct: 111 QLLRGLQALH--EQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN-MAKTQIGTPH 166

Query: 88  FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146
           +MAPE+++   Y+   DI+S G  + EM T   P+ E  +   +  KV  GK P      
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIY 225

Query: 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
              + + F+   L+     R    ++L  P +
Sbjct: 226 SQ-DLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 12/141 (8%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G L +Y +K    ++      ++A QI RG+ YL       IHRDL   N  V  +L  +
Sbjct: 86  GDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL-VV 142

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPE---FMAPELYEED-YNELVDIYSFGMCVLEMLTS- 117
           KI D GL+  L      + V G      +MAPE  +E  +    D++SFG+ + E+ T  
Sbjct: 143 KISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201

Query: 118 EYPYSECSNPAQIYKKVTSGK 138
           E PY   SN A++ + +  G 
Sbjct: 202 EEPYPGMSN-AEVLEYLKKGY 221

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 13/160 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-HSVIGT 85
           R+ LRG+AYLH +   VIHRD+K  NI +     ++K+ D G++A L  +    ++ IGT
Sbjct: 120 RETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176

Query: 86  PEFMAPEL------YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE+       +  Y+   D++S G+  +E+   + P  +  +P +   K+     
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPP 235

Query: 140 PGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           P          +   F+ +CL  N  +R   +ELL  PF+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 11/179 (6%)

Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 110 HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 166

Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +  S++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKA 224

Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLI 187
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P  I
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPPSCI 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 18/158 (11%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAHSVIGT 85
           QI+  ++Y+H     ++HRD+K  NIF+    G IK+GD G++ IL GS+   A +V+GT
Sbjct: 109 QIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKIL-GSEYSMAETVVGT 164

Query: 86  PEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGK---LP 140
           P +M+PEL +   YN   DI++ G CVL E+LT +  + + +NP  +  K+  G    + 
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALG-CVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVV 222

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
             +     +E    V   L+ +  KR  A E+L  P L
Sbjct: 223 SVY----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 16/175 (9%)

Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEF 88
           I++ + YLH     VIHRD+K  N+ +N   GQ+K+ D G++  L  S       G   +
Sbjct: 112 IVKALEYLH-SKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169

Query: 89  MAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV---TSGKLP 140
           MAPE    +     Y+   D++S G+ ++E+ T  +PY     P Q  K+V    S +LP
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229

Query: 141 -GAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLASDAGEPLLIPQVPSF 193
              F      E + FV KCL+   K  P   ELL  PF      +   +    S 
Sbjct: 230 AEKF----SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSL 280

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 58/159 (36%), Positives = 86/159 (54%), Gaps = 16/159 (10%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CL+ +V KR  AKELL   FL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 45/123 (36%), Positives = 71/123 (57%), Gaps = 6/123 (4%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ 78
             V  W  QI   + YLH  +  ++HRDLK  N+F+      IK+GDLG+A +L      
Sbjct: 102 NQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDM 158

Query: 79  AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           A ++IGTP +M+PEL+  + YN   D+++ G CV EM T ++ ++     + +Y ++  G
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEG 217

Query: 138 KLP 140
           KLP
Sbjct: 218 KLP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 10/185 (5%)

Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-IL 73
           TR++   +      +L+ + YLH     VIHRD+K D+I +    G++K+ D G  A I 
Sbjct: 112 TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQIS 168

Query: 74  RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           +   +  S++GTP +MAPE+     Y   VDI+S G+ V+EM+  E PY    +P Q  K
Sbjct: 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMK 227

Query: 133 KVTSGKLPGA--FHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQ 189
           ++     P     H+I     R F+ + L     +R  A+ELL  PFL        L+P 
Sbjct: 228 RLRDSPPPKLKNAHKISPV-LRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPL 286

Query: 190 VPSFQ 194
           +  ++
Sbjct: 287 IQQYR 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 13/176 (7%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L E +     +    V  W  Q+L G+ Y+H     ++HRDLK  NIF+  +L  +KIGD
Sbjct: 93  LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGD 148

Query: 67  LGLAAILRGS-QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
            G++ +L GS   A +  GTP +M+PE L  + Y+   DI+S G  + EM    + + E 
Sbjct: 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EG 207

Query: 125 SNPAQIYKKVTSG---KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
            N   +  ++  G    LP  + R  ++  +  + K   + S R  A E+L +PF+
Sbjct: 208 QNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNK---DPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++ RK   ++ ++ +   A QI +G+ YL       +HRDL   N  V      +K
Sbjct: 86  GDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK--NFVHRDLAARNCLV-TENLVVK 142

Query: 64  IGDLGLAAILRGSQQAHSVIGTPE---FMAPELYEED-YNELVDIYSFGMCVLEMLT-SE 118
           I D GL+  +          G      +MAPE  ++  +    D++SFG+ + E+ T  E
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202

Query: 119 YPYSECSNPAQIYKKVTSGK 138
            PY   SN  ++ + +  G 
Sbjct: 203 QPYPGMSN-EEVLELLEDGY 221

Length = 258

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 62/182 (34%), Positives = 94/182 (51%), Gaps = 17/182 (9%)

Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +LR ++YLH     VIHRD+K D+I +    G+IK+ D G  A +
Sbjct: 112 HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQV 168

Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +  S++GTP +MAPE+     Y   VDI+S G+ V+EM+  E PY     P Q  
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAM 227

Query: 132 KKVTSGKLPGAFHRIQDAEA-----RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPL 185
           +++     P    R++D+       R F+   L    S+R  A+ELL  PFL   AG P 
Sbjct: 228 RRIRDNLPP----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL-AGPPS 282

Query: 186 LI 187
            I
Sbjct: 283 CI 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 14/121 (11%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L     K+T      +K + +Q+L G+ YLH +   ++HRD+K  NI +N   G +K
Sbjct: 87  TGLLDSPEVKFT---ESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLK 140

Query: 64  IGDLGLAAILRGSQQA---HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTS 117
           + D GLA        A   + VI T  +  PEL      Y   VD++S G C+L E+   
Sbjct: 141 LADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFLG 198

Query: 118 E 118
           +
Sbjct: 199 K 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 63/207 (30%), Positives = 80/207 (38%), Gaps = 65/207 (31%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ YLH  +  VIHRDLK  NI VN +   +KI D GLA   RG            
Sbjct: 111 QILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLA---RGVDPDED---EKG 161

Query: 88  FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT-------SEY-------- 119
           F+          APE  L    Y + +DI+S G C+  E+LT        +Y        
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIV 220

Query: 120 -----PYSE----CSNPA--------QIYKKVT-SGKLPGAFHRIQDAEARRFVGKCLE- 160
                P  E     ++              K   S   PGA       EA   + K L  
Sbjct: 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-----SPEAIDLLEKMLVF 275

Query: 161 NVSKRLPAKELLLDPFLAS---DAGEP 184
           +  KR+ A E L  P+LA       EP
Sbjct: 276 DPKKRITADEALAHPYLAQLHDPEDEP 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 43/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ- 78
             + +W  QI   +A  H HD  ++HRD+K  NIF+    G IK+GD G+A +L  + + 
Sbjct: 101 DQILDWFVQIC--LALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVEL 157

Query: 79  AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           A + IGTP +++PE+ E   YN   DI++ G  + EM T ++ + E  N   +  K+  G
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRG 216

Query: 138 KLP 140
             P
Sbjct: 217 SYP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 14/175 (8%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  L  ++K    V+I AV + A   L+G+AYLH H+  +IHRD+K  NI ++   G +K
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVK 155

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
           +GD G A+I+     A+  +GTP +MAPE+     E  Y+  VD++S G+  +E+   + 
Sbjct: 156 LGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD 174
           P    +  + +Y  +   + P           R FV  CL+ + +  P  E+LL 
Sbjct: 213 PLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 48/138 (34%), Positives = 80/138 (57%), Gaps = 9/138 (6%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +I+  + YLH  +  +++RDLK +NI ++   G IK+ D G A  LR   +  ++ G
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLR--DRTWTLCG 160

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TPE++APE +  + +N+ VD ++ G+ + EML    P+ +  NP  IY+K+ +GKL   F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EF 217

Query: 144 HRIQDAEARRFVGKCLEN 161
            R  D  A+  + K L  
Sbjct: 218 PRHLDLYAKDLIKKLLVV 235

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 61/189 (32%), Positives = 95/189 (50%), Gaps = 15/189 (7%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  L  ++K    V+I A+ + A   L+G+AYLH H+  +IHRD+K  NI +    GQ+K
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 161

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
           + D G A+    S  A+S +GTP +MAPE+     E  Y+  VD++S G+  +E+   + 
Sbjct: 162 LADFGSASK---SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAK-ELLLDPFLA 178
           P    +  + +Y  +     P           R FV  CL+ + +  PA  ELL   F+ 
Sbjct: 219 PLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277

Query: 179 SDAGEPLLI 187
            D    +LI
Sbjct: 278 RDRPARVLI 286

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 53/158 (33%), Positives = 86/158 (54%), Gaps = 8/158 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +Q + ++ +GT
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P ++   +     P    
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLE 222

Query: 145 RIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
                  + FV  CL +  S R  AKELL   F+   A
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 14/141 (9%)

Query: 7   LREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           LR+ R  +     + + ++ + ++A QI +G+ YL       +HRDL   N  V   L  
Sbjct: 87  LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDL-V 143

Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPE---FMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           +KI D GL+  +          G      +MAPE L +  +    D++SFG+ + E+ T 
Sbjct: 144 VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Query: 117 SEYPYSECSNPAQIYKKVTSG 137
              PY   SN  ++ + +  G
Sbjct: 204 GATPYPGLSN-EEVLEYLRKG 223

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 55/189 (29%), Positives = 92/189 (48%), Gaps = 15/189 (7%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  L  ++K    V+I A+       L+G+AYLH H+   IHRD+K  NI +    G +K
Sbjct: 102 SDILEVHKKPLQEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVK 155

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
           + D G A+++     A+S +GTP +MAPE+     E  Y+  VD++S G+  +E+   + 
Sbjct: 156 LADFGSASLV---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENV-SKRLPAKELLLDPFLA 178
           P    +  + +Y  +     P           R FV  CL+ +   R  ++ELL   F+ 
Sbjct: 213 PLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271

Query: 179 SDAGEPLLI 187
            +    ++I
Sbjct: 272 RERPPTVII 280

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 18/167 (10%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAAILRGSQQA 79
            K +  +++ G+  LH     +IHRD+K +N+ +   GHL   K+ D GL+   R   + 
Sbjct: 99  AKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHL---KLTDFGLS---RNGLEN 150

Query: 80  HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
              +GTP+++APE       +++ D +S G  + E L   YP      P  ++  + S +
Sbjct: 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPPFHAETPDAVFDNILSRR 209

Query: 139 L--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLAS 179
           +  P         EA   + + L  + +KRL A    E+   PF  S
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 13/162 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVIGT 85
           RQ+L  + YLH     +IHRDLK  N+ +    G IK+ D G++A  ++  Q+  S IGT
Sbjct: 117 RQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 86  PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P+ E  NP ++  K+   + 
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEP 232

Query: 140 PGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           P      +   E R F+   L+ +   R  A +LL  PF++S
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 8e-16
 Identities = 60/189 (31%), Positives = 99/189 (52%), Gaps = 15/189 (7%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  L  ++K    V+I A+ + A   L+G+AYLH H+  +IHRD+K  NI +    GQ+K
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 165

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
           + D G A+I   +  A+S +GTP +MAPE+     E  Y+  VD++S G+  +E+   + 
Sbjct: 166 LADFGSASI---ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFLA 178
           P    +  + +Y  +   + P           R FV  CL+ + +  P ++ELL   F+ 
Sbjct: 223 PLFNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281

Query: 179 SDAGEPLLI 187
            +  E +LI
Sbjct: 282 RERPETVLI 290

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 52/161 (32%), Positives = 88/161 (54%), Gaps = 14/161 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           ++IL+G+ YLH      IHRD+K  N+ ++   G +K+ D G+A  L  +Q + ++ +GT
Sbjct: 108 KEILKGLDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY---KKVTSGKLPG 141
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P S+  +P ++     K     L G
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNNPPTLTG 223

Query: 142 AFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
            F +      + F+  CL ++ S R  AKELL   F+  +A
Sbjct: 224 EFSK----PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 59/165 (35%), Positives = 82/165 (49%), Gaps = 18/165 (10%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-----AILRG--SQ 77
           + +QIL G+AYLH  +  V+HRD+K +N+ +  + G IK+ D G A       L G  S 
Sbjct: 107 YTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 78  QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
              S+ GTP +MAPE+  E  Y    DI+S G  V EM T + P +     A ++     
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YI 220

Query: 137 GKLPGAFHRIQD---AEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
           G   G   R+ D   A A  FV  CL  +  +R  A +LL   FL
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 14/115 (12%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           LR+  +         VK++ R +L+G+AY+H +   ++HRDLK  N+ ++   G +KI D
Sbjct: 89  LRDEERPLPE---AQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIAD 142

Query: 67  LGLAAIL---RGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EML 115
            GLA +         +H V  T  + APEL      Y+  VD+++ G C+  E+L
Sbjct: 143 FGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVG-CIFAELL 195

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 6/117 (5%)

Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA 71
           K+   + I       +QIL G+ YLH     +IHRD+K +NIF+N  + Q+ IGDLG A 
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIND-VDQVCIGDLGAAQ 205

Query: 72  ILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
               +     + GT E  APE+   D YN   DI+S G+ + EML   YP +   +P
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260

Length = 357

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 36/179 (20%)

Query: 29  ILRGIAY--LHG-----HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +LR I Y  + G      +  +IHRD+K  N+ VNG+ GQ+K+ D G++  L  S  A +
Sbjct: 103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASL-AKT 160

Query: 82  VIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            IG   +MAPE  +         Y    D++S G+ +LEM    YPY     P + Y  +
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANI 215

Query: 135 TSG----------KLPGAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLASDAG 182
            +            LP  +      +A+ FV KCL  +  R P   +LL  P+L     
Sbjct: 216 FAQLSAIVDGDPPTLPSGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 15/159 (9%)

Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAHSVIGTPEFMA 90
           +A  H H   +I+RD+K +NI ++   G + + D GL+      +  +A+S  GT E+MA
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 91  PELY---EEDYNELVDIYSFGMCVLEMLTSEYPYS---ECSNPAQIYKKVTSGKLPGAFH 144
           PE+       +++ VD +S G+   E+LT   P++   E ++ ++I +++   K P  F 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FP 232

Query: 145 RIQDAEARRFVGKCLE-NVSKRL---PAKELLLDPFLAS 179
           +   AEAR F+ K LE +  KRL    A E+   PF   
Sbjct: 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 53/167 (31%), Positives = 80/167 (47%), Gaps = 14/167 (8%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSVIG 84
           ARQIL GIAYLH     ++HRD+K  N+ +N     +KI D G++ IL  +    +S +G
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVG 230

Query: 85  TPEFMAPELYEEDYNELV------DIYSFGMCVLEMLTSEYPY--SECSNPAQIYKKVTS 136
           T  +M+PE    D N         DI+S G+ +LE     +P+      + A +   +  
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290

Query: 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            + P A       E R F+  CL+   +KR  A +LL  PF+     
Sbjct: 291 SQPPEA-PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336

Length = 353

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 32/202 (15%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L    KK   + +  +   A  ++ G+ YL+ +   ++HRD+K  NI VN   GQIK+
Sbjct: 88  GSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY-NVHRIMHRDIKPSNILVNSR-GQIKL 145

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G++  L  S  A + +GT  +M+PE +    Y    D++S G+ ++E+   ++P++ 
Sbjct: 146 CDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Query: 124 -------CSNPAQIYK-----------KVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSK 164
                    +P  I             ++ S   P         + R FV  CL ++ ++
Sbjct: 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP--------EDLRDFVDACLLKDPTE 256

Query: 165 RLPAKELL-LDPFLASDAGEPL 185
           R   ++L  + PF+ +     +
Sbjct: 257 RPTPQQLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 6/167 (3%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  ++ ++K+   +  + V  +  Q+   + ++H     V+HRD+K  N+F+    G +K
Sbjct: 90  SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVK 146

Query: 64  IGDLGLAAILRG-SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
           +GDLGL       +  AHS++GTP +M+PE ++E  YN   DI+S G  + EM   + P 
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLP 167
           Y +  N   + KK+     P         E R+ V  C+    ++ P
Sbjct: 207 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 40/111 (36%), Positives = 66/111 (59%), Gaps = 5/111 (4%)

Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LR 74
           R D    + +A +I+ G+ +LH     +I+RDLK DN+ ++   G IKI D G+    + 
Sbjct: 92  RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMN 148

Query: 75  GSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
           G  +A +  GTP+++APE+ + + YNE VD +SFG+ + EML  + P+   
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 37/98 (37%), Positives = 59/98 (60%), Gaps = 4/98 (4%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+ G+   H H   +++RDLK +N+ ++ H G ++I DLGLA  L+G ++     G
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG 156

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           TP +MAPE L  E Y+  VD ++ G  + EM+    P+
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 5/99 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I+ G+ +LH     +I+RDLK DN+ ++   G IKI D G+    + G     +  
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP+++APE L  + Y   VD ++ G+ + EML  + P+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 29  ILRGIAYL---HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           I++ + YL   HG    VIHRD+K  NI ++   G +K+ D G++  L  S+      G 
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKAKTRSAGC 177

Query: 86  PEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
             +MAPE  +       Y+   D++S G+ ++E+ T ++PY  C    ++  K+   + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Query: 141 GAFHRIQ-DAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
                     +   FV  CL ++  KR   +ELL  PF+
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 43/146 (29%), Positives = 82/146 (56%), Gaps = 10/146 (6%)

Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV 82
           K +  +++    YLH  D  +I+RDLK +N+ ++   G +K+ D G A   +   +  ++
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAK--KVPDRTFTL 175

Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
            GTPE++APE+ + + + + VD ++ G+ + E +    P+ + + P +IY+K+ +G+L  
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGRL-- 232

Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRL 166
            F    D  AR  V   L+ + +KRL
Sbjct: 233 KFPNWFDGRARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 8/99 (8%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +K++  Q+L+G+A+ H H   ++HRDLK +N+ +N   G +K+ D GLA       + ++
Sbjct: 100 IKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYT 156

Query: 82  -VIGTPEFMAPELYEED--YNELVDIYSFGMCVL-EMLT 116
             + T  + APEL   D  Y+  VDI+S G C+  E+L+
Sbjct: 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVG-CIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 5/100 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI- 83
           +A  ++ G+ YLH +   +++RDLK DN+ ++   G +KI D GL     G     S   
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
           GTPEF+APE L E  Y   VD +  G+ + EML  E P+ 
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 41/117 (35%), Positives = 68/117 (58%), Gaps = 5/117 (4%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSVI 83
           W  QI  G+   H HD  ++HRD+K  NIF++ +    K+GD G+A  L  S + A++ +
Sbjct: 106 WFVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV 163

Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           GTP +++PE+ +   YN   DI+S G  + E+ T ++P+ E +N  Q+  K+  G  
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYF 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 55/191 (28%), Positives = 80/191 (41%), Gaps = 48/191 (25%)

Query: 29  ILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           +LRG+ YL   H   ++HRD+K  NI VN   G+IK+ D G++  L  S  A+S +GT  
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRS 163

Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP---------------YSECSNPAQIY 131
           +M+PE L    Y    DI+S G+ ++EM    YP                       + +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223

Query: 132 KKVTSG-----------------------KLPGAFHRIQDAEARRFVGKCL-ENVSKRLP 167
           + V+                         KLP         E + FV KCL +N  +R  
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERAD 280

Query: 168 AKELLLDPFLA 178
            KEL   PF+ 
Sbjct: 281 LKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 8/154 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R+IL+G+ YLH      IHRD+K  N+ ++   G +K+ D G+A  L  +Q + ++ +GT
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P S+  +P ++   +     P    
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLE 222

Query: 145 RIQDAEARRFVGKCLENVSKRLP-AKELLLDPFL 177
                  + FV  CL    +  P AKELL   F+
Sbjct: 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 37/99 (37%), Positives = 61/99 (61%), Gaps = 5/99 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQAHSVI 83
           +  QI+ G+ +LH     +I+RDLK +N+ ++   G ++I DLGLA  L+ G  +     
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYA 158

Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP FMAPEL + E+Y+  VD ++ G+ + EM+ +  P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 17/142 (11%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEED 97
           H+   IHRDLK +N F+    G IK+ D GL+        A+SV+G+P++MAPE L  + 
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRGKG 174

Query: 98  YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY------KKV---TSGKLPGAFHRIQD 148
           Y+  VD +S G  + E L    P+S  S P + +      K+         P        
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSD-- 231

Query: 149 AEARRFVGKCLENVSKRLPAKE 170
            EA   + K + + S+R  + E
Sbjct: 232 -EAWDLITKLINDPSRRFGSLE 252

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 6/159 (3%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  ++ ++K+   +  R V  +  Q+   + ++H     V+HRD+K  N+F+    G +K
Sbjct: 90  SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVK 146

Query: 64  IGDLGLAAILRG-SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
           +GDLGL       +  AHS++GTP +M+PE ++E  YN   DI+S G  + EM   + P 
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159
           Y +  N   + +K+     P         + R  V  C+
Sbjct: 207 YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 35/202 (17%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L E  K    V    +K    Q L+ + + H H+   IHRD+K +NI +    GQIK+ D
Sbjct: 87  LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCD 143

Query: 67  LGLAAILRGSQQAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
            G A IL G    ++  + T  + APEL   D  Y   VD+++ G    E+LT +  +  
Sbjct: 144 FGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203

Query: 124 CSNPAQIYK-KVTSGKL----------PGAFHRIQDAEARR-----------------FV 155
            S+  Q+Y  + T G L             F  +   E                    F+
Sbjct: 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFL 263

Query: 156 GKCLE-NVSKRLPAKELLLDPF 176
             CL+ + ++RL  +ELL  P+
Sbjct: 264 KGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 45/119 (37%), Positives = 62/119 (52%), Gaps = 13/119 (10%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGD 66
            + K   +    VK+   QIL G+ YLH +   V+HRDLK  NI V G     G +KIGD
Sbjct: 98  RQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGD 155

Query: 67  LGLAAI----LRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
           LGLA +    L+       V+ T  + APEL      Y + +DI++ G C+  E+LT E
Sbjct: 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 55/185 (29%), Positives = 75/185 (40%), Gaps = 31/185 (16%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA 79
             +K+  RQ+LRG+ +LH H   ++HRDLK  NI V    GQ+KI D GLA I       
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMAL 163

Query: 80  HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP----YSECSNPAQIYKK- 133
            SV+ T  + APE L +  Y   VD++S G C+   L    P     SE     +I+   
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVI 222

Query: 134 ---------VTSGKLPGAFHRIQ-----------DAEARRFVGKCLE-NVSKRLPAKELL 172
                            +F                 E    + K L  N  KR+ A E L
Sbjct: 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282

Query: 173 LDPFL 177
             P+ 
Sbjct: 283 QHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 22/165 (13%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   V+ +  QILRGI + H H+  +IHRD+K +NI V+   G +K+ D G A  L   
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP 153

Query: 77  QQAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
            + ++  + T  + APEL   D  Y   VDI++ G  V EMLT E  +   S+  Q+Y  
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213

Query: 134 VT-----SGKLPGAFHRIQDAEARRFVG------KCLENVSKRLP 167
           +        +    F +        F G      K +E + KR P
Sbjct: 214 IKCLGNLIPRHQEIFQK-----NPLFAGMRLPEVKEIEPLEKRFP 253

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)

Query: 6   TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           TL E  +     +   AV+++  Q+L+ IAY H H+  +IHRD+K +NI V+   G +K+
Sbjct: 85  TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKL 141

Query: 65  GDLGLAAILRGSQQAH--SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYP 120
            D G A  LR    +     + T  + APEL   D  Y + VD+++ G  + E+L  E  
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201

Query: 121 YSECSNPAQIYK-KVTSGKLPGA----------FHRIQ-------DAEARR--------- 153
           +   S+  Q+Y  +   G LP +          F  +        ++  RR         
Sbjct: 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA 261

Query: 154 --FVGKCLE-NVSKRLPAKELLLDPFL 177
             F+  CL  +  +RL   ELL  P+ 
Sbjct: 262 LDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 11/105 (10%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---QQ 78
           +K++    LRG+ YLH +   ++HRDLK +N+ +    G +K+ D GLA    GS   + 
Sbjct: 104 IKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSF-GSPNRKM 159

Query: 79  AHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
            H V+ T  + APEL      Y   VD++S G C+   L    P+
Sbjct: 160 THQVV-TRWYRAPELLFGARHYGVGVDMWSVG-CIFAELLLRVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 38/103 (36%), Positives = 59/103 (57%), Gaps = 12/103 (11%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GS--Q 77
           VK    Q+L G+A+LH  D  ++HRDLK  N+ +N + G +KI D GLA   R  GS  +
Sbjct: 108 VKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLK 161

Query: 78  QAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
               ++ T  + APEL    ++Y+  +D++S G    E+LT +
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 24/185 (12%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L  YRK    V  R     A  +++G+ YL      ++HRD+K  N+ VN   GQ+K+
Sbjct: 84  GSLDVYRKIPEHVLGRI----AVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKL 136

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-- 121
            D G++  L  S  A + +GT  +MAPE +  E Y    D++S G+  +E+    +PY  
Sbjct: 137 CDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195

Query: 122 ---SECS-NPAQIYKKVTSGKLPGAFHRIQDAEAR----RFVGKCLENVSKRLPAKELLL 173
              ++ S  P Q+ + +     P     +   +       F+ +C+    K  PA E L+
Sbjct: 196 IQKNQGSLMPLQLLQCIVDEDPP----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Query: 174 D-PFL 177
           D PF+
Sbjct: 252 DHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 5/104 (4%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSV 82
            W  Q+  G+   H H+  V+HRD+K  NIF+  + G++K+GD G A +L      A + 
Sbjct: 104 QWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTY 160

Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS 125
           +GTP ++ PE++E   YN   DI+S G  + E+ T ++P+   S
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 46/187 (24%), Positives = 91/187 (48%), Gaps = 23/187 (12%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
             ++ +K+  R+  + +   A  +L+G++YLH     +IHRD+K  NI +    GQ+K+ 
Sbjct: 91  IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRK-GQVKLC 147

Query: 66  DLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY--- 121
           D G++  L  +  A +  GT  +MAPE +  + Y+   D++S G+ +LE+  + +P+   
Sbjct: 148 DFGVSGEL-VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206

Query: 122 -SECSNPAQIYKKVTSGKLPGAFHRIQDAEA---------RRFVGKCLENVSKRLPA-KE 170
                 P ++   + +   P     ++D            + F+ +CLE    R P   +
Sbjct: 207 GEPPLGPIELLSYIVNMPNP----ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262

Query: 171 LLLDPFL 177
           +L  P++
Sbjct: 263 MLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 12/159 (7%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGT 85
           R+ILRG+++LH H   VIHRD+K  N+ +  +  ++K+ D G++A L R   + ++ IGT
Sbjct: 118 REILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 174

Query: 86  PEFMAPELYEED------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE+   D      Y+   D++S G+  +EM     P  +  +P +    +     
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 233

Query: 140 PGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
           P    +    + + F+  CL +N S+R   ++L+  PF+
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.5 bits (172), Expect = 1e-12
 Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 24/158 (15%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPP----VIHRDLKCDNIFVNG- 57
           S  +++  K + +++  A+ +  RQ+L  +AY H   D P    V+HRDLK  NIF++  
Sbjct: 102 SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161

Query: 58  --HLGQI-------------KIGDLGLAAILRGSQQAHSVIGTPEFMAPELY---EEDYN 99
             H+G+I             KIGD GL+  +     AHS +GTP + +PEL     + Y+
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221

Query: 100 ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           +  D+++ G  + E+ + + P+ + +N +Q+  ++  G
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 38/108 (35%), Positives = 63/108 (58%), Gaps = 5/108 (4%)

Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LR 74
           R D+     +A +I+ G+ +LH     +I+RDLK DN+ ++   G IKI D G+    + 
Sbjct: 92  RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVF 148

Query: 75  GSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           G  +A +  GTP+++APE+ +   Y   VD +SFG+ + EML  + P+
Sbjct: 149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 38/108 (35%), Positives = 63/108 (58%), Gaps = 5/108 (4%)

Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILR 74
           + D+     +A +I+ G+ +LH     +++RDLK DNI ++   G IKI D G+    + 
Sbjct: 92  KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENML 148

Query: 75  GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           G  +  +  GTP+++APE L  + YN  VD +SFG+ + EML  + P+
Sbjct: 149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 12/159 (7%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGT 85
           R+ILRG+A+LH H   VIHRD+K  N+ +  +  ++K+ D G++A L R   + ++ IGT
Sbjct: 128 REILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 184

Query: 86  PEFMAPELYEED------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE+   D      Y+   DI+S G+  +EM     P  +  +P +    +     
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPP 243

Query: 140 PGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
           P    +    +   F+  CL +N   R   ++LL  PF+
Sbjct: 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +++   QIL+G+A++H H     HRDLK +N+ V+G    +KI D GLA  +R       
Sbjct: 101 IRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTD 157

Query: 82  VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT 116
            + T  + APE  L    Y+  VDI++ G C++ E+ T
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  KK  ++    VK   RQ++  +  LH H+  +IH D+K +N+  +    +I +
Sbjct: 94  GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-- 121
            D GL  I  G+   +   GT ++ +PE +   +Y+   D ++ G+   E+LT ++P+  
Sbjct: 152 CDYGLCKI-IGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208

Query: 122 --SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
              E  +   +  K    KLP  F +     A  FV   L+ N++ RL
Sbjct: 209 DEDEELDLESL-LKRQQKKLP--FIKNVSKNANDFVQSMLKYNINYRL 253

Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 56/199 (28%), Positives = 105/199 (52%), Gaps = 17/199 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + ++  R D+   + +  ++L  +  LH  +  VI+RDLK +NI ++ + G I +
Sbjct: 78  GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134

Query: 65  GDLGLAAI-LRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D GL  + ++   + ++  GTPE++APEL     Y + VD ++ G+ + EMLT   P+ 
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194

Query: 123 ECSNPAQIYKKVTSGKL--PGAFHRIQDAEARR-FVGKCLENVSKRL---PAKELLLDPF 176
           +  N  ++Y+K+    L  P  F    D +A+   +G    + ++RL    A+E+   PF
Sbjct: 195 D-ENVNEMYRKILQEPLRFPDGF----DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Query: 177 LASDAGEPLLIPQV-PSFQ 194
            +  + + LL+  + P F+
Sbjct: 250 FSQLSWKKLLMKGIQPPFK 268

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 50/195 (25%)

Query: 24  NWAR----QILRGIAYLH--GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ 77
             AR    +++  +  +H  G     IHRD+K DNI ++   G IK+ D GL   +  ++
Sbjct: 101 ETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155

Query: 78  Q------------------------------AHSVIGTPEFMAPE-LYEEDYNELVDIYS 106
                                          A+S +GTP+++APE L    Y    D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215

Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV 162
            G+ + EML    P+       + Y K+ + K     P         EA   + + L + 
Sbjct: 216 LGVILYEMLYGFPPFYS-DTLQETYNKIINWKESLRFP--PDPPVSPEAIDLICRLLCDP 272

Query: 163 SKRL-PAKELLLDPF 176
             RL   +E+   PF
Sbjct: 273 EDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 7/137 (5%)

Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMAP 91
           +A  H H   +I+RDLK +NI ++   G +K+ D GL    +      H+  GT E+MAP
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 92  E-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           E L    + + VD +S G  + +MLT   P++   N  +   K+  GKL          E
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKL--NLPPYLTPE 226

Query: 151 ARRFVGKCLE-NVSKRL 166
           AR  + K L+ N S RL
Sbjct: 227 ARDLLKKLLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 44/203 (21%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV----- 82
           Q+LRG+ Y+H  +  VIHRDLK  N+ VN    +++IGD G+A  L  S   H       
Sbjct: 115 QLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 83  IGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE--YPYSECSN----------- 126
           + T  + APEL     +Y   +D++S G C+  EML     +P     +           
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230

Query: 127 -PAQIYKKVTS-----------GKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKE 170
              ++  ++ S            K P  + +I      EA   + + L+ +  +R+  ++
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290

Query: 171 LLLDPFLA---SDAGEPLLIPQV 190
            L  PFLA       EP   P  
Sbjct: 291 ALQHPFLAQYHDPDDEPTCPPPF 313

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 56/188 (29%), Positives = 79/188 (42%), Gaps = 46/188 (24%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG--- 84
           QILRG+ Y+H     +IHRDLK  NI VN    ++KI D GLA           + G   
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA-----RHTDDEMTGYVA 177

Query: 85  TPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTS--GKL 139
           T  + APE  L    YN+ VDI+S G C++ E+LT +      S+     K++ +  G  
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTP 235

Query: 140 PGAF-HRIQDAEARRFV--------------------------GKCLE-NVSKRLPAKEL 171
                 +I    AR ++                           K L  +  KR+ A E 
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295

Query: 172 LLDPFLAS 179
           L  P+LA 
Sbjct: 296 LAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 38/113 (33%), Positives = 57/113 (50%), Gaps = 7/113 (6%)

Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
              R     +  + +K++  Q+L+G+A+ H H   V+HRDLK  N+ V+   G +KI DL
Sbjct: 98  SNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155

Query: 68  GL--AAILRGSQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
           GL  A  +      H ++ T  + APE  L    Y+  VDI+S G    EM  
Sbjct: 156 GLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 43/128 (33%), Positives = 57/128 (44%), Gaps = 22/128 (17%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           SG L     K T   I   K +  Q+L GI YLH  +  ++HRD+K  NI ++   G +K
Sbjct: 102 SGLLENPSVKLTESQI---KCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQ-GILK 155

Query: 64  IGDLGLAAILRGSQQAH------------SVIGTPEFMAPELY--EEDYNELVDIYSFGM 109
           I D GLA    G                 +++ T  +  PEL   E  Y   VDI+  G 
Sbjct: 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG- 214

Query: 110 CVL-EMLT 116
           CV  EM T
Sbjct: 215 CVFAEMFT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 17/216 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + +K  R      K +  +++  + +LH +D  +++RDLK +NI ++   G I +
Sbjct: 81  GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIAL 137

Query: 65  GDLGLA-AILRGSQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
            D GL+ A L  ++  ++  GT E++APE  L E+ Y + VD +S G+ V EM     P 
Sbjct: 138 CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL----PAKELLLDP 175
           Y+E  +  Q+Y+ +  GK+    + + D E R+FV   L  N   RL     A EL   P
Sbjct: 198 YAE--DTQQMYRNIAFGKVRFPKNVLSD-EGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254

Query: 176 FLASDAGEPLLIPQV-PSFQ-NLNPNGAVMELVPKF 209
           F A    + L   Q+ P F+  ++ +  V    P+F
Sbjct: 255 FFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEF 290

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 8/117 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R     +  + + NW  QI +G++YL      ++HRDL   N+ V      +K
Sbjct: 93  GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVK 149

Query: 64  IGDLGLAAIL-RGSQQAHSVIG-TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L    ++ H+  G  P ++MA E +    Y    D++S+G+ V E++T
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 8/99 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSVIGT 85
           R+ L+G+AYLH      +HRD+K  NI +  + G +K+ D G+AA +  +  +  S IGT
Sbjct: 113 RETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGT 169

Query: 86  PEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYP 120
           P +MAPE+   +    YN+L DI++ G+  +E+   + P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 18/172 (10%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + +K  R D    + +A +I   + +LH  D  +I+RDLK DN+ ++ H G  K+
Sbjct: 81  GDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLD-HEGHCKL 137

Query: 65  GDLGLA--AILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            D G+    I  G   + +  GTP+++APE L E  Y   VD ++ G+ + EML    P+
Sbjct: 138 ADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Query: 122 SECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLENVSKRLPAKEL 171
            E  N   +++ + + ++  P      QDA         L+    + P   L
Sbjct: 197 -EAENEDDLFEAILNDEVVYPTWLS--QDAVD------ILKAFMTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 11/150 (7%)

Query: 37  HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGTPEFMAPEL-- 93
           H H+  +IHRD+K +NI +    G +K+ D G++A L  ++ + ++ +GTP +MAPE+  
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 94  ----YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149
               Y+  Y+   D++S G+  +E+   + P  +  +P +   K+     P   H  +  
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRNPPPTLLHPEKWC 260

Query: 150 EA-RRFVGKCL-ENVSKRLPAKELLLDPFL 177
            +   F+ +CL ++   R     LL  PF+
Sbjct: 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 43/117 (36%), Positives = 61/117 (52%), Gaps = 18/117 (15%)

Query: 12  KKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           KKY      T +D   +K++  Q+L+GIAY H H   V+HRDLK  N+ ++   G +K+ 
Sbjct: 85  KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLA 141

Query: 66  DLGLAAI----LRGSQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
           D GLA      +R     H V+ T  + APE  L    Y+  VDI+S G    EM+ 
Sbjct: 142 DFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 7/92 (7%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSV 82
           ARQ+L  I Y+HG    +IHRD+K +N+ VNG    I +GD G A   RGS      + +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGI 322

Query: 83  IGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
            GT +  APE+   D Y   VDI+S G+ + E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 41/100 (41%), Positives = 53/100 (53%), Gaps = 4/100 (4%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           V    +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GLA I    
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 163

Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
               SV+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 35/108 (32%), Positives = 61/108 (56%), Gaps = 4/108 (3%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +++  V +++ QI  GI  LH H   +++RD+K +N+ ++   G  ++ DLGLA  L+  
Sbjct: 92  LEMERVIHYSAQITCGI--LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDG 148

Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
           +      GT  +MAPE L EE Y+  VD ++ G  + EM+    P+ +
Sbjct: 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 41/117 (35%), Positives = 66/117 (56%), Gaps = 4/117 (3%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  K+  R+    +   +  +LRG+AYL      ++HRD+K  NI VN   G+IK+
Sbjct: 88  GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSR-GEIKL 145

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
            D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++E+    YP
Sbjct: 146 CDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 13/144 (9%)

Query: 4   SGTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           SG+L+EY  +   +++++    +A QI +G+ YL       +HRDL   N+ V     Q+
Sbjct: 92  SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQV 148

Query: 63  KIGDLGLAAILRGSQQAHSV---IGTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           KIGD GL   +   ++ ++V   + +P F  APE L +  +    D++SFG+ + E+LT 
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT- 207

Query: 118 EYPYSECSNPAQIYKKV--TSGKL 139
            Y  SE S      K +  T G++
Sbjct: 208 -YCDSESSPMTLFLKMIGPTHGQM 230

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 12/101 (11%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI----LRGSQ 77
           +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA      +R   
Sbjct: 102 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVR--T 156

Query: 78  QAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
             H V+ T  + APE  L  + Y+  VDI+S G    EM+T
Sbjct: 157 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 33/170 (19%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSVIG 84
           +R+ L+G+ YLH      +HRD+K  NI +  + G +K+ D G++A +  +  +  S IG
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIG 168

Query: 85  TPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECS-------------NP 127
           TP +MAPE+   +    YN+L DI++ G+  +E+   + P  +                P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228

Query: 128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPF 176
            ++  K+   K   +FH         FV   L +N  KR  A++LL  PF
Sbjct: 229 PKLKDKM---KWSNSFH--------HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 8/101 (7%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG--SQQA 79
            + +  Q+LRG+ Y+H  +  V+HRDLK  N+F+N     +KIGD GLA I+    S + 
Sbjct: 116 ARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173

Query: 80  HSVIG--TPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
           +   G  T  + +P   L   +Y + +D+++ G    EMLT
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 30/230 (13%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I   + YLH  +  +I+RDLK +NI ++   G + + D GL    +  S+   +  
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-------T 135
           GTPE++APE L ++ Y+  VD +  G  + EML    P+    + A++Y  +        
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLK 216

Query: 136 SGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD----PFLASDAGEPLLIPQVP 191
                 A H ++        G   ++ +KRL AK+  L+     F +S   + L+  ++ 
Sbjct: 217 PNISVSARHLLE--------GLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKIT 268

Query: 192 SFQNLNPNGA--VMELVPKF---AVDSDRRKSTDMTITGTMNPEDDTIFL 236
              N N +G   +    P+F    V +   KS D  +      E D  FL
Sbjct: 269 PPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFL 318

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 9/132 (6%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE+      YN+ VDI+S G  + E+LT    +P ++  +  ++  ++         
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242

Query: 144 HRIQDAEARRFV 155
            +I    AR ++
Sbjct: 243 KKISSESARNYI 254

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 33/87 (37%), Positives = 52/87 (59%), Gaps = 3/87 (3%)

Query: 37  HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMAPELY- 94
           H H   +I+RDLK +NI ++   G IK+ D GL+   +   ++A+S  GT E+MAPE+  
Sbjct: 113 HLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 95  EEDYNELVDIYSFGMCVLEMLTSEYPY 121
              + +  D +SFG+ + EMLT   P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 14/117 (11%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILRGSQQA------ 79
           Q+L  +A    H+  ++HRDLK  NI V+  G     K+ D G+  +L G + A      
Sbjct: 87  QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 80  --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
               V+GTP + APE L  E      D+Y++G+  LE LT +    + ++ A+I  +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 41/119 (34%), Positives = 61/119 (51%), Gaps = 7/119 (5%)

Query: 18  DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ 77
           + R +K +  QILRGIAY H H   V+HRDLK  N+ ++     +K+ D GLA       
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157

Query: 78  QA--HSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           +   H V+ T  + APE  L    Y+  VDI+S G    EM+  +  +   S   +++K
Sbjct: 158 RTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215

Length = 294

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 13/108 (12%)

Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG 75
            ++ + ++ +  QILRG+ Y+H     V+HRDLK  NI +N +   +KI D GLA I   
Sbjct: 104 PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENC-DLKICDFGLARI--- 157

Query: 76  SQQAHSVIG---TPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSE 118
             Q   + G   T  + APE  L  + Y+  VDI+S G    EML  +
Sbjct: 158 --QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 11/133 (8%)

Query: 4   SGTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           SG+LR+Y ++   +++++ +  ++ QI +G+ YL       IHRDL   NI V      +
Sbjct: 92  SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVE-SEDLV 148

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           KI D GLA +L   +  + V    E      APE L    ++   D++SFG+ + E+ T 
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT- 207

Query: 118 EYPYSECSNPAQI 130
            Y     S PA+ 
Sbjct: 208 -YGDPSQSPPAEF 219

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 11/101 (10%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--- 78
           +K++ +Q+L G+ Y H      +HRD+KC NI +N   GQIK+ D GLA +    +    
Sbjct: 118 IKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPY 174

Query: 79  AHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
            + VI T  +  PEL   EE Y   +D++S G C+L E+ T
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +K+  RQ LRG+ +LH +   ++HRDLK +NI V    GQ+K+ D GLA I         
Sbjct: 110 IKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTP 166

Query: 82  VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           V+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 21/183 (11%)

Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA--ILRGSQQAHSVIGTPEFMA 90
           +A  H H   +I+RD+K +NI ++ + G + + D GL+        ++A+S  GT E+MA
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 91  PELY---EEDYNELVDIYSFGMCVLEMLTSEYPYS---ECSNPAQIYKKVTSGKLPGAFH 144
           P++    +  +++ VD +S G+ + E+LT   P++   E ++ A+I +++   + P  + 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YP 232

Query: 145 RIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVME 204
           +   A A+  + + L     + P K L   P   SDA E   I + P FQ +N +    +
Sbjct: 233 QEMSALAKDIIQRLL----MKDPKKRLGCGP---SDADE---IKKHPFFQKINWDDLAAK 282

Query: 205 LVP 207
            VP
Sbjct: 283 KVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 7/100 (7%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I  G+ +LH     +I+RDLK DN+ ++   G IKI D G+    + G +   +  
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162

Query: 84  GTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP+++APE   Y+  Y + VD ++FG+ + EML  + P+
Sbjct: 163 GTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 40/117 (34%), Positives = 66/117 (56%), Gaps = 4/117 (3%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK+
Sbjct: 88  GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKL 145

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
            D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 146 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 8/113 (7%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +A ++   + +LH H   VI+RDLK DNI ++   G  K+ D G+    IL G     + 
Sbjct: 101 YAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT-TF 156

Query: 83  IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            GTP+++APE L E +Y   VD ++ G+ + EM+  + P+ E  N   +++ +
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 56/183 (30%), Positives = 91/183 (49%), Gaps = 26/183 (14%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSVIGT 85
           +I+  + YLH  D  V++RDLK +N+ ++   G IKI D GL    I  G+    +  GT
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-TFCGT 158

Query: 86  PEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGAF 143
           PE++APE+ E+ DY   VD +  G+ + EM+    P Y++     ++++ +   ++   F
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEI--RF 214

Query: 144 HRIQDAEARRFV-GKCLENVSKRL-----PAKELLLDPFLAS--------DAGEPLLIPQ 189
            R    EA+  + G   ++  +RL      AKE++   F AS           EP   PQ
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQ 274

Query: 190 VPS 192
           V S
Sbjct: 275 VTS 277

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 41/111 (36%), Positives = 60/111 (54%), Gaps = 9/111 (8%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           ++     DI A++   R +LR I YLH +   +IHRD+K +NIF+N H G + +GD G A
Sbjct: 176 KRNIAICDILAIE---RSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAA 229

Query: 71  A--ILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSE 118
              +   + + +   GT    APEL   D Y   VDI+S G+ + EM T  
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.4 bits (150), Expect = 3e-10
 Identities = 55/212 (25%), Positives = 83/212 (39%), Gaps = 60/212 (28%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV----- 82
           Q+L+ + Y+H  +  VIHRDLK  NI +N    ++K+ D GLA  L   ++         
Sbjct: 115 QLLKALKYIHSGN--VIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTD 171

Query: 83  -IGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT---------------------- 116
            + T  + APE  L    Y + VD++S G C+L EML                       
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230

Query: 117 -----------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSK 164
                      S +  +   +     +K     LP A       +A   + K L  N +K
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-----SDDALDLLKKLLVFNPNK 285

Query: 165 RLPAKELLLDPFLA--------SDAGEPLLIP 188
           RL A+E L  P++A             P+ IP
Sbjct: 286 RLTAEEALEHPYVAQFHNPSDEPVLPYPITIP 317

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 17/176 (9%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++      +  
Sbjct: 100 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157

Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+    +  ++++ +   ++   
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--R 214

Query: 143 FHRIQDAEARRFVGKCL-ENVSKRL-----PAKELLLDPFLAS----DAGEPLLIP 188
           F R    EA+  +   L ++  +RL      AKE++   F A     D  E  L+P
Sbjct: 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 7/100 (7%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+    + 
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM-KTF 155

Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 6/96 (6%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA--HSVIG 84
           +Q+L  + Y+H  D  +IHRD+K +NIF+N   G+I +GD G A      ++A  +  +G
Sbjct: 274 KQLLCAVEYIH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 85  TPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEY 119
           T    +PE+   D Y E+ DI+S G+ +L+ML+ ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 12/141 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIF-VNGHLGQIK 63
           G L +Y KK   + +  +K  A Q+  G+AYL       +HRDL   N+  VN H  Q K
Sbjct: 80  GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRH--QAK 135

Query: 64  IGDLGLAAILR-GSQ--QAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           I D G++  L  GS   +A +    P ++ APE +    ++   D++S+G+ + E  +  
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG 195

Query: 118 EYPYSECSNPAQIYKKVTSGK 138
             PY E     ++   + SG+
Sbjct: 196 AKPYGEMKGA-EVIAMLESGE 215

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 23/163 (14%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +I  G+  LH     +++RDLK +NI ++ H G I+I DLGLA  +   Q     +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 163

Query: 85  TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           T  +MAPE+ + E Y    D ++ G  + EM+  + P+       Q  KK          
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKK---------- 206

Query: 144 HRIQDAEARRFVGKCLENVSKRL-PAKELLLDPFLASDAGEPL 185
            +I+  E  R V +  E  S++  P    L    L  D  E L
Sbjct: 207 -KIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 48/133 (36%), Positives = 73/133 (54%), Gaps = 15/133 (11%)

Query: 4   SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
            G+LR+Y +K+  R+D R +  +A QI +G+ YL       +HRDL   NI V     ++
Sbjct: 91  YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRV 147

Query: 63  KIGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           KIGD GL  +L   ++ + V     +P F  APE L E  ++   D++SFG+ + E+ T 
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT- 206

Query: 118 EYPYSE--CSNPA 128
              YS+  CS PA
Sbjct: 207 ---YSDKSCSPPA 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +I  G+  LH     +++RDLK +NI ++ + G I+I DLGLA  +   +     +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVG 163

Query: 85  TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           T  +MAPE+ + E Y    D +  G  + EM+  + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 16/106 (15%)

Query: 21  AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH 80
            VK    Q+LRG+ YLH +   +IHRDLK  N+ +    G +KI D GLA        A 
Sbjct: 109 QVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAK 163

Query: 81  SVIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
            +  TP+     + APEL      Y   +D+++ G C+L E+L  +
Sbjct: 164 PM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 9/121 (7%)

Query: 2   FTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
           +    L++Y   +     +D   VK++  Q+L+GIA+ H +   V+HRDLK  N+ +N  
Sbjct: 79  YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR 136

Query: 59  LGQIKIGDLGLA-AILRGSQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
            G++K+ D GLA A         + + T  + AP+  L    Y+  +DI+S G  + EM+
Sbjct: 137 -GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Query: 116 T 116
           T
Sbjct: 196 T 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 23/114 (20%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--------- 78
           +I   I Y+H     V+HRDLK DNI + G  G++ I D G A   +  ++         
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 79  ---AHS-------VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
               +S       ++GTP++MAPE L     +E  DIY+ G+ + +MLT  +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 13/101 (12%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           VK +  QILRG+ YLH     ++HRD+K  N+ VN +   +KI D GLA   R  +   S
Sbjct: 105 VKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNC-VLKICDFGLA---RVEEPDES 158

Query: 82  VIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVLEML 115
              T E     + APE+      Y   VDI+S G    E+L
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 25/187 (13%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L+G+ Y+H     +IHRDLK  N+ VN    ++KI D GLA   +   +    + T  
Sbjct: 126 QMLKGLKYIHAAG--IIHRDLKPGNLAVNEDC-ELKILDFGLAR--QTDSEMTGYVVTRW 180

Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--KVTSGKLPGAF 143
           + APE  L    Y + VDI+S G  + EMLT +  +    +  Q+ +  KVT G     F
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT-GTPSKEF 239

Query: 144 -HRIQDAEARRFV-----------GKCLENVSK---RLPAKELLLDPFLASDAGEPLLIP 188
             ++Q  +A+ +V              L N +     +  K L+LD      A E L  P
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299

Query: 189 QVPSFQN 195
               F +
Sbjct: 300 YFEEFHD 306

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 39/109 (35%), Positives = 62/109 (56%), Gaps = 7/109 (6%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQQAHSVIGTP 86
           Q+LRG+AY+HG    ++HRDLK  N+ ++ +LG++K+ D GLA A    SQ   S + T 
Sbjct: 111 QLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTL 167

Query: 87  EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN-PAQIYK 132
            +  P+  L   DY+  +DI+  G   +EML  +  +   S+   Q+ K
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 9/142 (6%)

Query: 43  VIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL----YEEDY 98
           +IHRD+K  NI ++ + G IK+ D G++  L  S       G   +MAPE       + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187

Query: 99  NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---KLPGAFHRIQDAEARRFV 155
           +   D++S G+ + E+ T ++PY + ++      +V  G    L  +  R        F+
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247

Query: 156 GKCL-ENVSKRLPAKELLLDPF 176
             CL ++ SKR   KELL  PF
Sbjct: 248 NLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 35/125 (28%), Positives = 68/125 (54%), Gaps = 6/125 (4%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G L  +  ++     + ++ +A +I+ G+   H H+  V++RDLK  NI ++ H G
Sbjct: 78  LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLDEH-G 134

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSE 118
            ++I DLGLA      ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L   
Sbjct: 135 HVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Query: 119 YPYSE 123
            P+ +
Sbjct: 194 SPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 34/100 (34%), Positives = 58/100 (58%), Gaps = 7/100 (7%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA--ILRGSQQAHSV 82
           +A +I  G+ +LH     +I+RDLK DN+ ++   G IKI D G+    +  G     + 
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT-TKTF 161

Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
            GTP+++APE+   + Y + VD ++FG+ + EML  + P+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 49/132 (37%), Positives = 66/132 (50%), Gaps = 19/132 (14%)

Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLG 68
           KK  ++    VK+   QIL GI YLH +   V+HRDLK  NI V G     G++KI D+G
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157

Query: 69  LAAI----LRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            A +    L+       V+ T  + APEL      Y + +DI++ G    E+LTSE P  
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 216

Query: 123 EC-------SNP 127
            C       SNP
Sbjct: 217 HCRQEDIKTSNP 228

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 32/223 (14%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YL   +  +++RDLK +N+ ++   G IK+ D G A ++    + +++ G
Sbjct: 136 YAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV--DTRTYTLCG 190

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TPE++APE L    + +  D ++ G+ + E+L    P+   + P  IY+K+  G +   F
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGII--YF 247

Query: 144 HRIQDAEARRFVGKCL-ENVSKRL-----PAKELLLDPFLASDAGEPLL-----IPQVPS 192
            +  D   +  + K L  +++KR       A+ +   P+  +     LL     +P  P 
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307

Query: 193 FQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIF 235
           ++N+            F   +  R   D+TI   +  E+D  F
Sbjct: 308 YKNV------------FDSSNFERVQEDLTIADKITNENDPFF 338

Length = 340

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 6/104 (5%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +A +I+ G+   H H+  V++RDLK  NI ++ H G ++I DLGLA      ++ H+
Sbjct: 99  MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF-SKKKPHA 154

Query: 82  VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
            +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ +
Sbjct: 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 49/132 (37%), Positives = 66/132 (50%), Gaps = 19/132 (14%)

Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLG 68
           KK  ++    VK+   QIL GI YLH +   V+HRDLK  NI V G     G++KI D+G
Sbjct: 100 KKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157

Query: 69  LAAI----LRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            A +    L+       V+ T  + APEL      Y + +DI++ G    E+LTSE P  
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 216

Query: 123 EC-------SNP 127
            C       SNP
Sbjct: 217 HCRQEDIKTSNP 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 39/125 (31%), Positives = 65/125 (52%), Gaps = 9/125 (7%)

Query: 2   FTSGTLREYRKKYTR----VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           F   T+ +Y K Y R    + +  VK ++ Q+ R +AY+H     + HRDLK  N+ ++ 
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDP 205

Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEML 115
           +   +K+ D G A  L   Q++ S I +  + APEL     +Y   +D++S G  + EM+
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Query: 116 TSEYP 120
              YP
Sbjct: 266 LG-YP 269

Length = 440

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q++  + YLH  +  ++HRDL  +NI + G   ++ I D GLA   +   +  SV+GT  
Sbjct: 121 QMVLALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 88  FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           +  PE+ + E Y E  D+++FG  + +M T + P+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 40/106 (37%), Positives = 59/106 (55%), Gaps = 10/106 (9%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE 95
           H   ++HRDLK  NIF+    G IK+GD G +     S     A S  GTP ++APEL+E
Sbjct: 186 HSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244

Query: 96  ED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--IYKKVTSGK 138
              Y++  D++S G+ + E+LT   P+     P+Q  I ++V  GK
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGK 287

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 13/97 (13%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N +   +KI D GLA I    +  H+      
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIA-DPEHDHTGFLTEY 169

Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT 116
           + T  + APE  L  + Y + +DI+S G C+L EML+
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 41/138 (29%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---------------------- 76
           H    IHRD+K DN+ ++   G +K+ D GL   L+ +                      
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 77  --------------QQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
                         Q A+S +GTP+++APE++ +  YN+L D +S G+ + EML    P+
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 122 SECS-NPAQIYKKVTSGK 138
             CS  P + Y+KV + K
Sbjct: 237 --CSETPQETYRKVMNWK 252

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 18/176 (10%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH     +++RDLK +N+ ++   G IKI D GL    +  +    +  
Sbjct: 100 YGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156

Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+    +  ++++ +    +   
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--K 213

Query: 143 FHRIQDAEARRFV-GKCLENVSKRL-----PAKELLLDPFLA----SDAGEPLLIP 188
           F R   A+A+  + G  +++ +KRL      AKE++   F       D  +  L+P
Sbjct: 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 18/99 (18%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV----- 82
           QIL G+ Y+H  +  V+HRDLK  N+ VN    ++KI D GLA   RG  +         
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLA---RGFSENPGENAGFM 166

Query: 83  ---IGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EML 115
              + T  + APE  L  + Y + +D++S G C+L E+L
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 13/151 (8%)

Query: 37  HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGTPEFMAPEL-- 93
           H H    IHRD+K +NI +    G +K+ D G++A L  ++ + ++ +GTP +MAPE+  
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 94  ----YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQ 147
                +  Y+   D++S G+  +E+   + P ++  +P +   K+     P   H+  + 
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNP-PPTLHQPELW 255

Query: 148 DAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
             E   F+ KCL ++  KR    +LL   F+
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 40/124 (32%), Positives = 58/124 (46%), Gaps = 17/124 (13%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-------RGS 76
             A +I  G+AYL       +HRDL   N  V   L  +KIGD G+   +       +G 
Sbjct: 123 QMAAEIADGMAYL--AAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGG 179

Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKV 134
           +    V     +MAPE L +  +    D++SFG+ + EM T +E PY   SN  ++ K V
Sbjct: 180 KGLLPV----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFV 234

Query: 135 TSGK 138
             G 
Sbjct: 235 IDGG 238

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG---SQQAHSVI 83
           R++L  +AYLHG    +IHRD+K +NIF++       +GD G A  L     + Q +   
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 84  GTPEFMAPELYEED-YNELVDIYSFGMCVLEML 115
           GT E  +PEL   D Y    DI+S G+ + EM 
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 13/93 (13%)

Query: 39  HDPPVIHRDLKCDNIF--VNGHLGQIKIGDLG--LAAILRGSQQAHSVIGTPEFMAPELY 94
           H    +HRD+K DN+   +NGH   I++ D G  L     G+ Q+   +GTP++++PE+ 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 95  E--ED----YNELVDIYSFGMCVLEMLTSEYPY 121
           +  ED    Y    D +S G+C+ EML  E P+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 41/138 (29%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---------------------- 76
           H    IHRD+K DN+ ++   G +K+ D GL   L+ +                      
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 77  --------------QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
                         Q A S +GTP+++APE++ +  YN+L D +S G+ + EML    P+
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 122 SECS-NPAQIYKKVTSGK 138
             CS  P + YKKV + K
Sbjct: 237 --CSETPQETYKKVMNWK 252

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 38/130 (29%), Positives = 66/130 (50%), Gaps = 8/130 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + ++  ++     + ++ +I   + YLH  +  +I+RDLK DN+ ++   G IK+
Sbjct: 81  GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIKL 137

Query: 65  GDLGLAAI-LRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D G+    LR      +  GTP ++APE+   EDY   VD ++ G+ + EM+    P+ 
Sbjct: 138 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Query: 123 ---ECSNPAQ 129
                 NP Q
Sbjct: 198 IVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 5/99 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           ++ +I   + +LH  +  +I+RDLK DN+ ++   G IK+ D G+    +R      +  
Sbjct: 101 YSAEISLALNFLH--ERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFC 157

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP ++APE L  EDY   VD ++ G+ + EM+    P+
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 16/164 (9%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L G+ Y+H     +IHRDLK  N+ VN    ++KI D GLA         + V  T  
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGYVV--TRW 179

Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--KVTSGKLPGAF 143
           + APE  L    YN+ VDI+S G  + EMLT +  +       Q+ +  KVT    P   
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKEL-LLDPFLASDAGEPLL 186
            +++D  A+ ++ K L     + P K+   L P  AS     LL
Sbjct: 240 QKLEDKAAKSYI-KSL----PKYPRKDFSTLFP-KASPQAVDLL 277

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 9/91 (9%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLG--LAAILRGSQQAHSVIGTPEFMAPELYE- 95
           H    +HRD+K DNI ++ + G I++ D G  L  +  G+ Q+   +GTP++++PE+ + 
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 96  -ED----YNELVDIYSFGMCVLEMLTSEYPY 121
            ED    Y    D +S G+C+ EML  E P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 25/189 (13%)

Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV 82
           + +A +I   + YLH  +  +++RDLK +NI ++   G + + D GL     G  Q+ + 
Sbjct: 99  RFYAAEIASALGYLHSIN--IVYRDLKPENILLDS-QGHVVLTDFGLCK--EGIAQSDTT 153

Query: 83  I---GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
               GTPE++APE + ++ Y+  VD +  G  + EML    P+  C + A++Y  +    
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHKP 212

Query: 139 L---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD----PFLASDAGEPLLIPQV 190
           L   PGA        A   + + LE +  +RL AKE  L+    PF  S +   L   ++
Sbjct: 213 LVLRPGA-----SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267

Query: 191 PSFQNLNPN 199
           P     NPN
Sbjct: 268 PP--PFNPN 274

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 39/134 (29%), Positives = 60/134 (44%), Gaps = 48/134 (35%)

Query: 44  IHRDLKCDNIFV--NGHLGQIKIGDLGLAAILRGS------------------------- 76
           IHRD+K DN+ +   GH   IK+ D GL   L+ S                         
Sbjct: 123 IHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 77  --------------QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
                           A+S +GTP+++APE++ +  YN+  D +S G+ + EML    P+
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 122 SECS-NPAQIYKKV 134
             CS NP + Y+K+
Sbjct: 240 --CSDNPQETYRKI 251

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 15/145 (10%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L EY        + +  + + A Q+  G+AYL   +   IHRDL   N+ V  +    
Sbjct: 86  GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NIC 142

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
           K+ D GLA +++    +A      P ++ APE     YN      D++SFG+ + E++T 
Sbjct: 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTY 200

Query: 117 SEYPYSECSNPAQIYKKVTSG-KLP 140
              PY   +N A++ ++V  G ++P
Sbjct: 201 GRMPYPGMTN-AEVLQQVDQGYRMP 224

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 33/100 (33%), Positives = 59/100 (59%), Gaps = 7/100 (7%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +A +I  G+ +LH     +I+RDLK DN+ ++   G IKI D G+    ++ G     + 
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGV-TTRTF 161

Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
            GTP+++APE+   + Y + VD +++G+ + EML  + P+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 26/142 (18%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H  +  V+HRDLK  N+ +N +   +KI D GLA   R + +        +
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGLA---RTTSEKG------D 163

Query: 88  FM----------APELY--EEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKK 133
           FM          APEL     +Y   +D++S G    E+L  +  +P  +  +  ++  +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223

Query: 134 VTSGKLPGAFHRIQDAEARRFV 155
           +           I++ +ARR++
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYI 245

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 8/117 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   +  ++HRDL   N+ V      +K
Sbjct: 93  GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EERRLVHRDLAARNVLVKTP-QHVK 149

Query: 64  IGDLGLAAILRGSQQAHSVIG--TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G   P ++MA E +    Y    D++S+G+ V E++T
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 35/128 (27%), Positives = 50/128 (39%), Gaps = 46/128 (35%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--------------------- 77
           H    IHRD+K DNI ++   G IK+ D GL    R +                      
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 78  -----------------------QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLE 113
                                   AHS++GTP ++APE L    Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 114 MLTSEYPY 121
           ML  + P+
Sbjct: 237 MLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 36/117 (30%), Positives = 63/117 (53%), Gaps = 6/117 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I   + YLH  +  +++RDLK +NI ++   G I + D GL    +  +    +  
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           GTPE++APE L+++ Y+  VD +  G  + EML    P+    N A++Y  + +  L
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 15/154 (9%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIG 84
           Q+L  +A  H H   +IHRD+K  NI +  + G +K+GD G + +   +       +  G
Sbjct: 151 QVL--LAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 85  TPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK---LP 140
           TP ++APE++    Y++  D++S G+ + E+LT + P+ +  N  ++  K  +G+   LP
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYDPLP 266

Query: 141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD 174
            +       E +  V   L +  KR P+   LL+
Sbjct: 267 PSI----SPEMQEIVTALLSSDPKRRPSSSKLLN 296

Length = 496

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 6/97 (6%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           VK++  Q+L+ + ++H +   + HRD+K +NI +   +  +K+ D G    +        
Sbjct: 102 VKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTE 157

Query: 82  VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
            I T  + APE  L +  Y   +DI++ G    E+L+
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 42/123 (34%), Positives = 67/123 (54%), Gaps = 11/123 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  K+ ++++  +  +A+QI  G+AYLH      IHRDL   N+ + N  L  +K
Sbjct: 93  GSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRL--VK 147

Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GLA  +    + + V     +P F  A E L E  ++   D++SFG+ + E+LT  
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207

Query: 119 YPY 121
              
Sbjct: 208 DSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           MFT    R+   +        V+ ++ +I+  +A  H H   +++RD+K +NI ++   G
Sbjct: 92  MFTHLYQRDNFSE------DEVRFYSGEII--LALEHLHKLGIVYRDIKLENILLDSE-G 142

Query: 61  QIKIGDLGLAA--ILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
            + + D GL+   +    ++ +S  GT E+MAPE+   +  + + VD +S G+ + E+LT
Sbjct: 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202

Query: 117 SEYPYS---ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL-----P 167
              P++   E +  +++ +++   K    F      EA+  + K L ++  KRL      
Sbjct: 203 GASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260

Query: 168 AKELLLDPFLASDAGEPLLIPQVPS 192
           A E+   PF      E L + +V  
Sbjct: 261 ASEIKEHPFFKGLDWEALALRKVNP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +IL G+  LH  +   ++RDLK +NI ++ + G I+I DLGLA  +   +     +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIRGRVG 163

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           T  +MAPE L  + Y    D +  G  + EM+  + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I   + +LH  +  +I+RDLK DN+ ++   G IK+ D G+    L       +  
Sbjct: 101 YAAEICIALNFLH--ERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC 157

Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP ++APE+   E+Y   VD ++ G+ + EM+    P+
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 19/155 (12%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV--IGTPEFMAPELYEE 96
           H    +HRD+K +N+ ++   G IK+ D G AA L  ++  +S   +GTP+++APE+   
Sbjct: 119 HQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 97  -------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD- 148
                   Y    D +S G+   EM+    P+ E    A+ Y  + + +    F +  + 
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQ---RFLKFPED 233

Query: 149 ----AEARRFVGKCLENVSKRLPAKELLLDPFLAS 179
               ++    +   L    +RL  + L   PF + 
Sbjct: 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 35/104 (33%), Positives = 61/104 (58%), Gaps = 12/104 (11%)

Query: 44  IHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GSQQAHSVIGTPEFMAPELYE--ED-- 97
           +HRD+K DN+ ++ + G I++ D G    L   G+ Q++  +GTP++++PE+ +  ED  
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 98  --YNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGK 138
             Y    D +S G+C+ EML  E P Y+E  +  + Y K+ + K
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 224

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 38/122 (31%), Positives = 64/122 (52%), Gaps = 8/122 (6%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A ++   I YLH  +  +I+RDLK +NI ++   G + + D GL    +   +   +  
Sbjct: 101 YAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP 140
           GTPE++APE L +E Y+  VD +  G  + EML    P+    + +Q+Y  +     +LP
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPLQLP 216

Query: 141 GA 142
           G 
Sbjct: 217 GG 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 26/64 (40%), Positives = 41/64 (64%), Gaps = 8/64 (12%)

Query: 12  KKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           KKY       +D   VK++  Q+L+G+A+ H H+  V+HRDLK  N+ +N + G++K+ D
Sbjct: 86  KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLAD 142

Query: 67  LGLA 70
            GLA
Sbjct: 143 FGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 39/104 (37%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   VK++  QIL+GI + H     V+HRDLK  N+ ++   G IK+ D GLA      
Sbjct: 98  MDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP 154

Query: 77  QQA--HSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
            +   H V+ T  + APE  L    Y+  VDI+S G    EM T
Sbjct: 155 VRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 21/124 (16%)

Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--------------LRGSQQ 78
           + YLH +   ++HRDLK DN+ +   +G IK+ D GL+ I               + +++
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 79  --AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
                V GTPE++APE +  + Y + VD ++ G+ + E L    P+     P +++ +V 
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVI 229

Query: 136 SGKL 139
           S  +
Sbjct: 230 SDDI 233

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQ----Q 78
           ++A QI  G+ YL       IHRDL   NI +     ++KIGD GL  A+ +       +
Sbjct: 101 DYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVME 157

Query: 79  AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKV 134
            H  +    + APE L    ++   D++ FG+ + EM T  E P++  S  +QI KK+
Sbjct: 158 EHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 9/132 (6%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H     +IHRDLK  N+ VN    +++I D GLA   +   +    + T  
Sbjct: 126 QLLRGLKYIH--SAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180

Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE  L    YN+ VDI+S G  + E+L  +  +P ++  +  +   +V     P   
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240

Query: 144 HRIQDAEARRFV 155
            +I    AR+++
Sbjct: 241 KKISSEHARKYI 252

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAH--SVI 83
           Q+LR + Y+H  +  V HRDLK  NI  N    ++KI D GLA  A             +
Sbjct: 111 QLLRALKYIHTAN--VFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 84  GTPEFMAPEL---YEEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGK 138
            T  + APEL   +   Y   +DI+S G    E+LT +  +P     +   +   +    
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227

Query: 139 LPGAFHRIQDAEARRFVGKCLENVSKRLP 167
            P    R+++ +ARR+    L ++ K+ P
Sbjct: 228 SPETISRVRNEKARRY----LSSMRKKQP 252

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 38/119 (31%), Positives = 50/119 (42%), Gaps = 20/119 (16%)

Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---- 70
            R+    VK    QIL G+  LH      +HRDL   NIF+N   G  KI D GLA    
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIADFGLARRYG 170

Query: 71  ------AILRGSQQAHSVIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
                  + +          T +     + APEL    E Y+  VD++S G    E+LT
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 33/121 (27%), Positives = 64/121 (52%), Gaps = 8/121 (6%)

Query: 1   MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           +   G L +Y  ++   +  + + NW  QI +G+ YL   +  ++HRDL   N+ V    
Sbjct: 89  LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSP- 145

Query: 60  GQIKIGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
             +KI D GLA +L G ++ ++  G     ++MA E ++   +    D++S+G+ + E++
Sbjct: 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205

Query: 116 T 116
           T
Sbjct: 206 T 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 14/133 (10%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           + A Q+  G+AYL   +   IHRDL   NI V   L   K+ D GLA +++      S  
Sbjct: 108 DMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDK 164

Query: 84  GTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG--- 137
             P ++ APE      ++   D++SFG+ + EM T  + PY   +N  ++Y ++T+G   
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRM 223

Query: 138 ----KLPGAFHRI 146
               K P   ++I
Sbjct: 224 PCPAKCPQEIYKI 236

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 9/124 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L ++ R+    +D + + NW  QI +G+ YL  H   ++HR+L   NI +      ++
Sbjct: 93  GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDS-IVQ 149

Query: 64  IGDLGLAAIL--RGSQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           I D G+A +L     +  +S   TP ++MA E +    Y    D++S+G+ V EM++   
Sbjct: 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209

Query: 119 YPYS 122
            PY+
Sbjct: 210 EPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 8/117 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+   R+  + + NW  QI +G++YL   +  ++HRDL   N+ V      +K
Sbjct: 93  GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARNVLVKSP-NHVK 149

Query: 64  IGDLGLAAILRGSQQAHSVIG--TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   +  +   G   P ++MA E +    +    D++S+G+ V E++T
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 42/122 (34%), Positives = 64/122 (52%), Gaps = 14/122 (11%)

Query: 29  ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +LRGIA    YL   +   +HRDL   NI VN +L   K+ D GL+  L  S+  ++  G
Sbjct: 111 MLRGIASGMKYLSEMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKG 167

Query: 85  --TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG-K 138
              P  + APE +    +    D++SFG+ + E+++  E PY + SN   + K V  G +
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYR 226

Query: 139 LP 140
           LP
Sbjct: 227 LP 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)

Query: 43  VIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNEL 101
           +++RDLK +NI ++   G I+I DLGLA  +   +     +GT  +MAPE +  E Y   
Sbjct: 123 IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 102 VDIYSFGMCVLEMLTSEYPY 121
            D +  G  + EM+  + P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 26/90 (28%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH--SVIGTPEFMAPELYEE 96
           H   +IHRD+K DN+ ++ H G +K+ D G    +  +      + +GTP++++PE+ + 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPY 121
                 Y    D +S G+ + EML  + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 21/121 (17%)

Query: 7   LREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           L++Y       + +  V+ +  Q+LRG+AY H     V+HRDLK  N+ ++   G++K+ 
Sbjct: 89  LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLA 145

Query: 66  DLGLAAILRGSQQAHSV--------IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
           D GLA       +A SV        + T  +  P+  L   +Y+  +D++  G    EM 
Sbjct: 146 DFGLA-------RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198

Query: 116 T 116
           T
Sbjct: 199 T 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 31/118 (26%), Positives = 61/118 (51%), Gaps = 8/118 (6%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH--SVI 83
             QI  G+ +L       +HRDL   N  V+    ++K+  L L+  +  S+     + +
Sbjct: 123 CTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKL 139
               ++APE + E+D++   D++SFG+ + E+ T  E P+   S+  ++  ++ +GKL
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKL 236

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 14/143 (9%)

Query: 3   TSGTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G L +Y ++  R ++ AV     A QI   + YL   +   IHRDL   N  V  +  
Sbjct: 85  TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-H 141

Query: 61  QIKIGDLGLAAILRG-SQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
            +K+ D GL+ ++ G +  AH+    P ++ APE L    ++   D+++FG+ + E+ T 
Sbjct: 142 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201

Query: 117 --SEYPYSECSNPAQIYKKVTSG 137
             S YP  + S   Q+Y+ +  G
Sbjct: 202 GMSPYPGIDLS---QVYELLEKG 221

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 40/123 (32%), Positives = 65/123 (52%), Gaps = 15/123 (12%)

Query: 29  ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-HSVI 83
           +LRGIA    YL   D   +HRDL   NI VN +L + K+ D GL+ +L    +  ++  
Sbjct: 112 MLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTS 168

Query: 84  GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG- 137
           G      + APE +    +    D++SFG+ + E+++  E PY + SN  ++ K +  G 
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGF 227

Query: 138 KLP 140
           +LP
Sbjct: 228 RLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 6/103 (5%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +++  VK +  Q+LRG+ Y H     V+HRDLK  N+ +N   G++K+ D GLA      
Sbjct: 101 INMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157

Query: 77  QQAHS-VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
            + +S  + T  +  P+  L   DY+  +D++  G    EM T
Sbjct: 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRY 182

Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 14/108 (12%)

Query: 25  WAR----QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH 80
           WAR    +++  +  +H      IHRD+K DN+ ++   G +K+ D G    +  +    
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVR 199

Query: 81  S--VIGTPEFMAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPY 121
               +GTP++++PE+ +       Y    D +S G+ + EML  + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 6/101 (5%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           + +  VK +  QILRG+AY H     V+HRDLK  N+ +N   G++K+ D GLA      
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVP 157

Query: 77  QQAHS-VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
            + +S  + T  +  P+  L   +Y+  +D++  G    EM
Sbjct: 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 13/135 (9%)

Query: 4   SGTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K    + +   K  + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 84  NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETL-C 140

Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 198

Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 199 YGRIPYPGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 14/105 (13%)

Query: 30  LRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG-LAAILRGSQQAHSVIGTPEF 88
           LRG+ YLH +    IHR++K  +I ++G  G + +  L  L +++R  Q+A  V   P+F
Sbjct: 111 LRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167

Query: 89  -------MAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSE 123
                  ++PEL  +D   YN   DIYS G+   E+ T   P+ +
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 13/134 (9%)

Query: 5   GTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K  + ++  +  + +++ QI  G+A++   +   IHRDL+  NI V+  L   
Sbjct: 85  GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VC 141

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
           KI D GLA ++  ++  A      P ++ APE    ++       D++SFG+ ++E++T 
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTY 199

Query: 117 SEYPYSECSNPAQI 130
              PY   SNP  I
Sbjct: 200 GRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 16/105 (15%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA   RG         T
Sbjct: 140 AYQVARGMEYLESRR--CIHRDLAARNVLVTED-NVMKIADFGLA---RGVHDIDYYKKT 193

Query: 86  P------EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
                  ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 35/132 (26%), Positives = 51/132 (38%), Gaps = 50/132 (37%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-------------------- 78
           H    IHRD+K DNI ++   G IK+ D GL    R +                      
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 79  ----------------------------AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGM 109
                                       AHS++GTP ++APE L  + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 110 CVLEMLTSEYPY 121
            + EML  + P+
Sbjct: 237 ILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 10/111 (9%)

Query: 13  KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA- 71
           K  +  +  +K   + +L G+ Y+H +   ++HRD+K  NI +    G +K+ D GLA  
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARA 168

Query: 72  -ILRGSQQAHSVIG---TPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
             L  + + +       T  +  PEL   E DY   +D++  G  + EM T
Sbjct: 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 15/123 (12%)

Query: 29  ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSVI 83
           +LRGIA    YL   D   +HRDL   NI VN +L   K+ D GL+ +L    + A++  
Sbjct: 111 MLRGIASGMKYLS--DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTR 167

Query: 84  GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG- 137
           G      + APE +    +    D++S+G+ + E+++  E PY E SN   + K +  G 
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGY 226

Query: 138 KLP 140
           +LP
Sbjct: 227 RLP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 46/192 (23%), Positives = 77/192 (40%), Gaps = 62/192 (32%)

Query: 44  IHRDLKCDNIFVNGHLGQIKIGDLGLA--------------------------------- 70
           IHRD+K DNI ++   G IK+ D GL+                                 
Sbjct: 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 71  -------------AILRGSQQ--AHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEM 114
                        A  + +++  A+S +GTP+++APE++ ++ Y +  D +S G  + E 
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241

Query: 115 LTSEYPYSECS-NPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENVSKRL--- 166
           L    P+  CS N  + Y+K+ + +     P   H     EA   + + + N   RL   
Sbjct: 242 LIGWPPF--CSENSHETYRKIINWRETLYFPDDIH--LSVEAEDLIRRLITNAENRLGRG 297

Query: 167 PAKELLLDPFLA 178
            A E+   PF  
Sbjct: 298 GAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 8/90 (8%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GSQQAHSVIGTPEFMAPELYEE 96
           H    IHRD+K DN+ ++   G +K+ D G    +   G  +  + +GTP++++PE+ + 
Sbjct: 159 HSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPY 121
                 Y    D +S G+ + EML  + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 20/116 (17%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLA----- 70
           + +  + ++A QI RG+ YL   +  ++HRDL   N+ V  G   ++KI D GL+     
Sbjct: 124 LTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYE 179

Query: 71  --AILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             + ++ S+    V    ++MA E L++  Y    D++SFG+ + E++T   + YP
Sbjct: 180 EDSYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 13/136 (9%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           LRE+ K++    +  +    + +  G+AYL       IHRDL   N  V+   G +K+ D
Sbjct: 90  LREHGKRFQPSQLLEM---CKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSD 143

Query: 67  LGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPY 121
            GL+  +   +   SV G+     +  PE L    ++   D+++FG+ + E+ +  + PY
Sbjct: 144 FGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Query: 122 SECSNPAQIYKKVTSG 137
              +N ++  +KV+ G
Sbjct: 203 ERFNN-SETVEKVSQG 217

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 6/98 (6%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           VK +  Q+LRG++Y H     ++HRDLK  N+ +N   G++K+ D GLA       + +S
Sbjct: 105 VKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYS 161

Query: 82  -VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
             + T  +  P+  L   +Y+  +D++  G  + EM T
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 35/132 (26%), Positives = 50/132 (37%), Gaps = 50/132 (37%)

Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-------------------- 78
           H    IHRD+K DNI ++   G IK+ D GL    R +                      
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 79  ----------------------------AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGM 109
                                       AHS++GTP ++APE L    Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 110 CVLEMLTSEYPY 121
            + EML  + P+
Sbjct: 237 ILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 12/118 (10%)

Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ----IKIGDLGLAAILRGS---QQAHS 81
           + +G  YL       IHRDL   N  V+         +KIGD GLA  +  S   ++   
Sbjct: 115 VAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 82  VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            +    +MAPE L +  +    D++SFG+ + E+LT  + PY   +N  ++ + VT+G
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 10/116 (8%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAA-ILRGSQ--QAHSVI 83
           Q+  G+ +L   +   +HRDL   N+ +  G L  +KI D GLA  I+R S      S  
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTF 302

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
              ++MAPE ++   Y  L D++SFG+ + E+ T    PY E     Q Y  +  G
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHS 81
           A QI  G+ YL  H    +HRDL   N  V   L  +KI D GL+  +  +     Q+ S
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKS 186

Query: 82  VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
           ++    +M PE  LY +   E  DI+SFG+ + E+
Sbjct: 187 LLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 27/70 (38%), Positives = 35/70 (50%), Gaps = 4/70 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG--SQQAHSVIG 84
           RQIL  +  LH     ++HRD+K  NI  +   G  KI DLG AA LR   +      + 
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 85  TPEFMAPELY 94
            P + APE Y
Sbjct: 320 DPRYAAPEQY 329

Length = 566

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 12/105 (11%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A QI  G++YLH     VIH+D+   N  ++  L Q+KI D  L+  L      +  +G 
Sbjct: 123 AIQIACGMSYLHKRG--VIHKDIAARNCVIDEEL-QVKITDNALSRDLFPMD--YHCLGD 177

Query: 86  PE-----FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSE 123
            E     +MA E L  ++Y+   D++SFG+ + E++T  + PY E
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 7/115 (6%)

Query: 5   GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR Y +     +D+ ++  ++ Q+   +AYL       +HRD+   N+ V+     +K
Sbjct: 91  GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVK 147

Query: 64  IGDLGLAAILRGSQQAHSVIGT-P-EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           +GD GL+  L       +  G  P ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 43.8 bits (104), Expect = 9e-05
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 13/131 (9%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K      +R  +  + A QI  G+AYL   +   IHRDL   NI V  +L   
Sbjct: 86  GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENL-VC 142

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
           KI D GLA ++   +  A      P ++ APE    +Y       D++SFG+ + E++T 
Sbjct: 143 KIADFGLARLIEDDEYTAREGAKFPIKWTAPE--AANYGRFTIKSDVWSFGILLTEIVTY 200

Query: 117 SEYPYSECSNP 127
              PY   +N 
Sbjct: 201 GRVPYPGMTNR 211

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 38/130 (29%), Positives = 69/130 (53%), Gaps = 13/130 (10%)

Query: 5   GTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K  +  +V +  + +++ QI  G+AY+   +   IHRDL+  N+ V+  L   
Sbjct: 86  GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESL-MC 142

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
           KI D GLA ++  ++  A      P ++ APE    ++       D++SFG+ + E++T 
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTY 200

Query: 117 SEYPYSECSN 126
            + PY   SN
Sbjct: 201 GKIPYPGMSN 210

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIG 65
            R   +  T+ D+ +   +A Q+ RG+ +L       IHRDL   N+ V   H+  +KI 
Sbjct: 122 PRPPEETLTQKDLVS---FAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHV--MKIA 174

Query: 66  DLGLAAIL------RGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-- 116
           D GLA  +      R +      +   ++MAPE L++  Y    D++SFG+ + E+ T  
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231

Query: 117 -SEYP 120
            S YP
Sbjct: 232 GSPYP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 190

Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 41/121 (33%), Positives = 60/121 (49%), Gaps = 15/121 (12%)

Query: 26  ARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           A QI  G+ YL   H    +HRDL   N  V   L  +KIGD G++  +  S   + V G
Sbjct: 128 ASQIASGMVYLASLH---FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIY-STDYYRVGG 182

Query: 85  TP----EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
                  +M PE  LY +   E  DI+SFG+ + E+ T  + P+ + SN   I + +T G
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-ECITQG 240

Query: 138 K 138
           +
Sbjct: 241 R 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     +      + T  
Sbjct: 131 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRY 187

Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + E++
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 127 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 14/114 (12%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL------AAILRGSQQA 79
           A+Q+  G+AYL   +   +HRDL   N  V  ++  +KI D GL      A   + S+  
Sbjct: 136 AKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASEND 192

Query: 80  HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131
              I    +M PE ++   Y    D++++G+ + E+ +    PY   ++   IY
Sbjct: 193 AIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG--- 84
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 145 QVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 11/126 (8%)

Query: 3   TSGTLREYRKKYTRVDIR--AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           + G+L ++ K      +R   + + A QI  G+AY+   +   +HRDL+  NI V  +L 
Sbjct: 83  SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL- 139

Query: 61  QIKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
             K+ D GLA ++  ++  A      P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT 198

Query: 117 S-EYPY 121
               PY
Sbjct: 199 KGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 6/97 (6%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           VK +  Q+LRG++Y+H     ++HRDLK  N+ ++   G++K+ D GLA         +S
Sbjct: 105 VKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYS 161

Query: 82  -VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
             + T  +  P+  L   +Y+  +D++  G   +EM+
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 8/115 (6%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAH--SVIG 84
           Q+ RG+ +L   +   +HRDL   N+ +      +KI D GLA  I+  S      S   
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
             ++MAPE +++  Y  L D++S+G+ + E+ +    PY      +  Y K+ SG
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG- 84
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 140 AYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 85  --TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG- 84
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 146 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 85  --TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 10/117 (8%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIG 84
           A Q+  G+AY+   +   IHRDL+  NI V   L   KI D GLA ++  ++  A     
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAK 164

Query: 85  TP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSG 137
            P ++ APE  LY   +    D++SFG+ + E++T    PY   +N  ++ ++V  G
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERG 219

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 48/214 (22%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--GHDPPVIHRDLKCDNIFV--NGHL- 59
             L+    K    ++   + +A ++L  + YLH  G    +++RDLK +NI +  +GH+ 
Sbjct: 90  RLLQRQPGKCLSEEV--ARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIM 143

Query: 60  ----------------------------GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAP 91
                                           I     +     S +++S +GT E++AP
Sbjct: 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE--PSFRSNSFVGTEEYIAP 201

Query: 92  ELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           E+   D +   VD ++ G+ + EML    P+ + SN  + +  +   ++         + 
Sbjct: 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETFSNILKKEVTFPGSPPVSSS 260

Query: 151 ARRFVGKCLE-NVSKRL----PAKELLLDPFLAS 179
           AR  + K L  + SKRL     A E+   PF   
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 37/139 (26%), Positives = 67/139 (48%), Gaps = 11/139 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R +  +     +      +  G+AYL   +  VIHRDL   N  V G    +K
Sbjct: 84  GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVK 140

Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-E 118
           + D G+   +   Q   S  GT    ++ +PE++    Y+   D++SFG+ + E+ +  +
Sbjct: 141 VSDFGMTRFVLDDQYTSST-GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY   SN +++ + + +G
Sbjct: 200 TPYENRSN-SEVVETINAG 217

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 28/125 (22%), Positives = 60/125 (48%), Gaps = 15/125 (12%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQQAHSVIGT 85
           + +L  + Y+H      IHR +K  +I ++G  G++ +  L  + ++++  ++   V   
Sbjct: 108 KDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 86  PEF-------MAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
           P+        ++PE+ +++   YNE  DIYS G+   E+     P+ +     Q+  +  
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD-MPATQMLLEKV 223

Query: 136 SGKLP 140
            G +P
Sbjct: 224 RGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 7/102 (6%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH- 80
           V+++  Q+++ I + H +D  ++HRD+K +N+ ++ H   +K+ D G A  L     A+ 
Sbjct: 102 VRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANY 158

Query: 81  -SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
              + T  + +PE L    Y + VD++S G C+L  L+   P
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVG-CILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 13/136 (9%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           LRE + K     +  +      +   + YL  +    IHRDL   N  V G    +K+ D
Sbjct: 90  LRERKGKLGTEWLLDM---CSDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSD 143

Query: 67  LGLAAILRGSQQAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPY 121
            GLA  +   Q   S  GT    ++  PE+++   ++   D++SFG+ + E+ +  + PY
Sbjct: 144 FGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Query: 122 SECSNPAQIYKKVTSG 137
              SN +++ + V++G
Sbjct: 203 ERFSN-SEVVESVSAG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 13/121 (10%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A QI  G+ YL       +HRDL   N  V G+   +KIGD G++  +  +   + V G 
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVY-TTDYYRVGGH 183

Query: 86  P----EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK 138
                 +M PE  +Y +   E  D++SFG+ + E+ T  + P+   SN  ++ + +T G+
Sbjct: 184 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQGR 241

Query: 139 L 139
           L
Sbjct: 242 L 242

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 13/140 (9%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L+E   KY +  +  + + A QI  G+AY+   +   IHRDL+  NI V  +L   KI D
Sbjct: 91  LKEGDGKYLK--LPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIAD 145

Query: 67  LGLAAILRGSQ-QAHSVIGTP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS-EYPY 121
            GLA ++  ++  A      P ++ APE  LY   +    D++SFG+ + E++T    PY
Sbjct: 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY 204

Query: 122 SECSNPAQIYKKVTSG-KLP 140
               N  ++ ++V  G ++P
Sbjct: 205 PGMVN-REVLEQVERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 36/128 (28%), Positives = 66/128 (51%), Gaps = 12/128 (9%)

Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI-KIGDLGLAAILRG 75
           +D   + +++ Q+ +G+++L   +   IHRDL   NI +    G+I KI D GLA  +R 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTH--GRITKICDFGLARDIR- 265

Query: 76  SQQAHSVIGTP----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQ 129
           +   + V G      ++MAPE ++   Y    D++S+G+ + E+ +    PY      ++
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Query: 130 IYKKVTSG 137
            YK +  G
Sbjct: 326 FYKMIKEG 333

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 19/42 (45%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE 123
              P FMAPE+ +   Y E  DIYS G+ + E L  E PY+E
Sbjct: 65  RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 33/139 (23%), Positives = 67/139 (48%), Gaps = 11/139 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y R++  ++    + +  + +  G+ YL  +    IHRDL   N  V+   G +K
Sbjct: 84  GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSS-TGVVK 140

Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-E 118
           + D G+   +   +   S  G     ++  PE++    Y+   D++SFG+ + E+ T  +
Sbjct: 141 VSDFGMTRYVLDDEYTSSS-GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Query: 119 YPYSECSNPAQIYKKVTSG 137
            P+ + SN  ++ + ++ G
Sbjct: 200 MPFEKKSN-YEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 15/110 (13%)

Query: 29  ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +LRGIA    YL   +   +HRDL   NI VN +L   K+ D GL+  L       +   
Sbjct: 111 MLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTS 167

Query: 85  T-----P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSN 126
           +     P  + APE +    +    D++S+G+ + E+++  E PY + SN
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 22/53 (41%), Positives = 31/53 (58%), Gaps = 3/53 (5%)

Query: 18  DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           DI  +K   RQ+L G+  LH     ++HRD+K +N+ V    GQ+KI D G A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	502
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.98
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.98
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
PTZ00284	467	protein kinase; Provisional	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.94
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
PHA02882	294	putative serine/threonine kinase; Provisional	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.93
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.93
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.93
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.93
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.93
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.91
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.91
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.9
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.9
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.89
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.88
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.86
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.86
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.85
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.83
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.83
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.83
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.83
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.82
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG3653	534	consensus Transforming growth factor beta/activin	99.81
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.81
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.8
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.8
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.8
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.8
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.79
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.78
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.77
KOG1152	772	consensus Signal transduction serine/threonine kin	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.57
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.57
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.52
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.51
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.43
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.39
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.35
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.32
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.3
PRK09188	365	serine/threonine protein kinase; Provisional	99.27
PRK12274	218	serine/threonine protein kinase; Provisional	99.26
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.17
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.15
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.11
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.02
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.96
PRK10345	210	hypothetical protein; Provisional	98.87
smart00090	237	RIO RIO-like kinase.	98.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.67
PRK14879	211	serine/threonine protein kinase; Provisional	98.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.61
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.59
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.59
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.5
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.36
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.91
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.73
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.66
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.39
KOG1243	690	consensus Protein kinase [General function predict	97.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.33
KOG3087	229	consensus Serine/threonine protein kinase [General	97.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	96.69
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.48
PRK09902	216	hypothetical protein; Provisional	96.44
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	96.42
PF12202	38	OSR1_C: Oxidative-stress-responsive kinase 1 C ter	96.39
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.29
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.11
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	94.7
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	91.75
COG0478	304	RIO-like serine/threonine protein kinase fused to	91.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	90.3
PF01636	239	APH: Phosphotransferase enzyme family This family	90.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	89.25
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	88.83
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	88.8
PRK05231	319	homoserine kinase; Provisional	88.53
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	87.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	87.65
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	86.62
KOG0584	632	consensus Serine/threonine protein kinase [General	85.78
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	84.73
PLN02236	344	choline kinase	84.55
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	84.44
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	83.5
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	83.09
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	82.97
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	82.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	81.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	81.43
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	81.08
PRK10271	188	thiK thiamine kinase; Provisional	80.25

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-64  Score=535.01  Aligned_cols=453  Identities=46%  Similarity=0.667  Sum_probs=322.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      +||+|||++|++++++++.+.++.|++|||.||.|||++.||||||||||+||||+++.|.|||+|+|||+..... ...
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~ak  202 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-HAK  202 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-ccc
Confidence            6999999999999999999999999999999999999999999999999999999999999999999999977653 455


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      .++|||.|||||+++..|++.+|||||||||+||+|+.+||++|.+++|||++|.+|..|..+..+.++++++||.+||.
T Consensus       203 svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~  282 (632)
T KOG0584|consen  203 SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA  282 (632)
T ss_pred             eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence            69999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCHHHHhcCCCCcCCCCCCCC-------CCCCC--------Ccc-CCCCC--cchh-----------ccccccc-
Q 010730          161 NVSKRLPAKELLLDPFLASDAGEPLL-------IPQVP--------SFQ-NLNPN--GAVM-----------ELVPKFA-  210 (502)
Q Consensus       161 dP~kRpSa~ELL~hPff~~~~~~~l~-------~p~~p--------~~~-~~~~~--~~~~-----------e~~~~~~-  210 (502)
                      ....|+||.|||+||||+.+......       .+.+-        ... ....+  ....           ..+.... 
T Consensus       283 ~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~  362 (632)
T KOG0584|consen  283 TKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEI  362 (632)
T ss_pred             CchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhcc
Confidence            89999999999999999886442100       00000        000 00000  0000           0000110 


Q ss_pred             -cCcc------ccccccceecccCCCCCCceEEEEEEEcCCCCeeeeccCCCcccccHHHHHHHHHhcccCCCCCHHHHH
Q 010730          211 -VDSD------RRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIA  283 (502)
Q Consensus       211 -~~~~------~~~~~~~~i~g~~~~e~~~i~L~l~i~d~~G~~~~i~f~fd~~~Dt~~~VA~EMV~~l~l~~~d~~~ia  283 (502)
                       ...+      ..+.+.+.|.|+.+.+...++|.|+|.+++|..++|+|+|++..|||.+||.|||++++++++++..||
T Consensus       363 ~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia  442 (632)
T KOG0584|consen  363 VSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIA  442 (632)
T ss_pred             CCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHH
Confidence             0111      123477899999987766999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhCCCcccCCCC--CccccccccccCCCCCCCCCCCCCCcccCCCC--CCCCCCccccccCCCC-CCCCccc
Q 010730          284 EMIEQEISSLVPNWKECGSP--QFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSH--SSSHASLPAFFTNNAN-SPPSWLQ  358 (502)
Q Consensus       284 ~~Id~~i~~l~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~  358 (502)
                      +|||.+|.+|+|.|+....-  ..+.||..                  .+.|.+  ++++....+.+..+.+ ....|-+
T Consensus       443 ~mid~~i~~L~p~~~~~~~~~~s~~~~~~~------------------~~~s~~~~~~s~~~~~~~~~~~~~~~~~~~~~  504 (632)
T KOG0584|consen  443 EMIDGEISALVPNWKASTPNDESPHEQHTD------------------NSVSIQRSSESATQSQKSFSSADPQQVAPFVQ  504 (632)
T ss_pred             HHHhchhhhcCCccCCCCCccccchhccCc------------------ccccccCCCccccccccccccccccccccccc
Confidence            99999999999999765411  22212221                  112221  1111111111111111 3344655


Q ss_pred             cccCCCCCCCCCCCCCCCcccccccccCCCCCCccccccCCCchhhhcccc-c--cccccCccccCCCCCCccccccccc
Q 010730          359 QEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQ-K--STRFCPEAAMNNDRCNSEDVNSRKA  435 (502)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~  435 (502)
                      +.   +.|..++.......+.....+....+.+.        .+..+..++ +  +-.||......-  .....+. -..
T Consensus       505 ~~---~~~~~~~~~~~r~~~~~~~~~~~~~~~~~--------~~~~q~~t~~~~~~~~~~~~~~~~~--~~~~~~~-~~~  570 (632)
T KOG0584|consen  505 QS---MEDPLSSDVESRFSKNELVQTQVSPLGER--------LVQCQLETHHKQETFEFDQPLSSPE--EIAKAMS-EQE  570 (632)
T ss_pred             cc---ccCCCccccccccccccccccccccchhh--------hhhhhhccccceeeecccccCCchh--hhhhhhh-ccc
Confidence            53   33332222112222222222222111111        110111222 2  445555443310  0000010 001


Q ss_pred             cCCCCCCCCCccccchhhhhhhhhhhhhHHHHHhhhhcccccccccccccC
Q 010730          436 CRSNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAVENIGFH  486 (502)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (502)
                      ++......+-.++.|++++...++||+...+...|+..+|+....+-.|++
T Consensus       571 ~~l~~e~~~~~~q~r~~~q~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (632)
T KOG0584|consen  571 EQLKTELERIESQLRSLVQDALELLSRAVEEAKDKVIATKQKSVNSAHPAQ  621 (632)
T ss_pred             hhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHhhhhhccccccccccCCC
Confidence            122224456788999999999999999999999999999998888887777

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-39  Score=330.02  Aligned_cols=178  Identities=26%  Similarity=0.393  Sum_probs=161.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++-.++.+.+..-+.+++|||.||.|||++|  |+||||||+|||++.+  .-.+||+|||+|+.......
T Consensus       257 ~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf  334 (475)
T KOG0615|consen  257 YVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF  334 (475)
T ss_pred             EecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence            6889999999999999999999999999999999999999  9999999999999765  23689999999999988888


Q ss_pred             cccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~  152 (502)
                      +.+.||||.|.|||++..+    |..++||||+||+||.+|+|.+||++......++++|..|+++  +..|...+.+++
T Consensus       335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~  414 (475)
T KOG0615|consen  335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEAL  414 (475)
T ss_pred             hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHH
Confidence            9999999999999999643    5569999999999999999999999866666689999999885  345566789999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +||..||. ||.+|||+.|+|+||||+..
T Consensus       415 dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  415 DLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             HHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999998 99999999999999999754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=317.51  Aligned_cols=176  Identities=33%  Similarity=0.577  Sum_probs=161.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      ||.||+|..++++.++++|..+..++.+||+||.|||. ++  ||||||||+|||++.. |+|||||||+++.+..+ ..
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a  234 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IA  234 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hc
Confidence            79999999999999999999999999999999999995 77  9999999999999987 89999999999988765 67


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCC----CCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE----CSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~----~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .+++||..|||||.+.+ .|+.++||||||+.++||++|++||..    ..+..+++..|..+..|.......++++++|
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F  314 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF  314 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            89999999999998876 599999999999999999999999976    2467888999998887755555689999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |..||. ||.+|++++|||+|||++..
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            999998 99999999999999999754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-37  Score=333.02  Aligned_cols=178  Identities=28%  Similarity=0.535  Sum_probs=165.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||.|++|+.+.+++.+.+++.+++||+.|+.|||..+  |+||||||+|+|++.+ +.|||+|||+|..-.++..+.
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCCcccc
Confidence            6899999999999999999999999999999999999999  9999999999999988 569999999999888888899


Q ss_pred             cccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      +.||+|.|.|||++.+. | +.++||||+|||||.||||.+||.+ +|...++.||..|.+  ..+..+++++++||.+|
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~m  246 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRM  246 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHH
Confidence            99999999999988764 4 7799999999999999999999986 899999999999998  45577899999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCCCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDAGEP  184 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~~~~  184 (502)
                      |. ||.+|+|.+||++|||+......+
T Consensus       247 l~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  247 LDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             hccCccccccHHHHhhCchhhcCCCCC
Confidence            99 999999999999999998765443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=308.42  Aligned_cols=180  Identities=32%  Similarity=0.532  Sum_probs=162.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~-~~~~~~   79 (502)
                      |+.||.|+..+++.+.+++..++.|+..|+.||.|||+.|  ||||||||+|||++.. |+++|+||||++.. ..+...
T Consensus       106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhcccCCCcc
Confidence            6889999999999999999999999999999999999999  9999999999999987 89999999999854 444566


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .++|||+.|||||++. ..|+.++|+||||+++|+|++|.+||.+ .+..+++++|..++.+ ..+...+.+++++|.++
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHHHHHHH
Confidence            7899999999999875 5699999999999999999999999977 8889999999999854 34455689999999999


Q ss_pred             hh-CcCCCC----CHHHHhcCCCCcCCCCCCC
Q 010730          159 LE-NVSKRL----PAKELLLDPFLASDAGEPL  185 (502)
Q Consensus       159 L~-dP~kRp----Sa~ELL~hPff~~~~~~~l  185 (502)
                      |. +|.+|+    .+.++-.||||...+|..+
T Consensus       261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             hccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence            98 999996    5899999999998877553

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=319.05  Aligned_cols=179  Identities=32%  Similarity=0.544  Sum_probs=161.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+||++++.|++.-++.|+.||+.||+|||++|  ||||||||||||++++ +++||+|||-|+.+.....  
T Consensus       155 ~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             ecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhccc
Confidence            6789999999999999999999999999999999999999  9999999999999998 8999999999998753211  


Q ss_pred             ------------cccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           79 ------------AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        79 ------------~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                                  ..++|||..|++||+|... .+..+|||+||||||.|++|.+||.+ .|.-.++++|+.-.+  .|+.
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y--~fp~  308 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDY--EFPE  308 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhcc--cCCC
Confidence                        2568999999999999755 78899999999999999999999977 788899999998766  4556


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCCCC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPL  185 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~~l  185 (502)
                      ..++.+++||.++|. ||.+|+|+.||.+||||..-.+.-+
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            667899999999998 9999999999999999998777554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-36  Score=321.68  Aligned_cols=174  Identities=32%  Similarity=0.553  Sum_probs=159.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+..|+|.+++++.+.++|.+++.+++||+.||.|||+++  |||||||..|||++.+ -+|||+|||||..+... ...
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecccceeeeecCccccc
Confidence            5778999999999999999999999999999999999999  9999999999999998 48999999999998744 667


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.||||.|+|||++. ...+..+||||+||+||.||+|++||.. .+..+.|++|....+  .++...+.++++||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence            8899999999999886 4599999999999999999999999976 778999999998877  45557789999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+|||++++|.|+||...
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhhCC
Confidence            99 99999999999999999443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=299.66  Aligned_cols=178  Identities=33%  Similarity=0.615  Sum_probs=163.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |..||.|+.|+++.+++++..++.|+.||+.||+|||+.+  |++|||||||||++.+ |.+||+|||+|+.+...  ..
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r--T~  199 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR--TW  199 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc--EE
Confidence            5789999999999999999999999999999999999999  9999999999999987 89999999999988653  67


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.||||.|+|||++.. .|+.++|.|||||++|||++|.+||.. .++.++|++|..++.  .++...++++++||.++|
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence            8999999999998864 599999999999999999999999987 788999999999988  567777899999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCCCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAGEPLL  186 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~~~l~  186 (502)
                      + |-.+|.     ...++..||||+...|..+.
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~  309 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL  309 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence            8 999994     47899999999988876643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=310.91  Aligned_cols=175  Identities=29%  Similarity=0.587  Sum_probs=159.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~-~~~~~~   79 (502)
                      |+.||+|.+|+.+.+++.+..++.+++||+.||+|||++|  |+||||||+|||++.+.+.+||+|||++... .....+
T Consensus       101 y~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l  178 (370)
T KOG0583|consen  101 YCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLL  178 (370)
T ss_pred             ecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcc
Confidence            6789999999999999999999999999999999999999  9999999999999987569999999999988 466778


Q ss_pred             ccccCCCcccCcccccc-C-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccc-cHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-D-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFV  155 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~-s~~l~~LI  155 (502)
                      .+.+|||.|+|||++.+ . | +.++||||+||+||.|++|.+||.+ .+...++.+|..+.+.  ++... +++++.||
T Consensus       179 ~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~~~Li  255 (370)
T KOG0583|consen  179 KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEARSLI  255 (370)
T ss_pred             cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHHHHHH
Confidence            99999999999999975 3 5 5789999999999999999999988 7888899999988774  33334 89999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. +|.+|+++.+++.||||+..
T Consensus       256 ~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  256 EKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             HHHcCCCcccCCCHHHHhhChhhccC
Confidence            99999 99999999999999999873

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-36  Score=293.10  Aligned_cols=175  Identities=27%  Similarity=0.523  Sum_probs=158.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      +|..|.|++|+...-.+++++.+.+++||+.|++|||..+  ||||||||+|||++++ -++||.|||+++.+..+.++.
T Consensus       104 l~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~GekLr  180 (411)
T KOG0599|consen  104 LMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEPGEKLR  180 (411)
T ss_pred             hcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCCchhHH
Confidence            4788999999999889999999999999999999999999  9999999999999988 589999999999999999999


Q ss_pred             cccCCCcccCccccc-------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHH
Q 010730           81 SVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEA  151 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l  151 (502)
                      ..||||+|+|||.++       ..|+..+|+|++|||||.||.|.+||.. ...--+.+.|+.|++.  .+.|...+..+
T Consensus       181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadis~~~  259 (411)
T KOG0599|consen  181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADISATV  259 (411)
T ss_pred             HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhccccH
Confidence            999999999999774       3599999999999999999999999975 2333457888898874  45566778899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ++||.+||+ ||.+|+|++|+|+||||..
T Consensus       260 KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  260 KDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            999999999 9999999999999999954

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=300.39  Aligned_cols=178  Identities=36%  Similarity=0.607  Sum_probs=153.0

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC----
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~----   75 (502)
                      |+.||+|.+++++++ +|++..++.+++|||+||+|||++|  ||||||||+|||++...+.+||+|||+++....    
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            789999999999988 7999999999999999999999999  999999999999998337999999999987653    


Q ss_pred             CCCcccccCCCcccCccccccCC--CCcccchhHHHHHHHHhhccCCCCC-CCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           76 SQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEYPYSE-CSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl~~~y--s~~~DIWSLGviLyeLLTG~~Pf~~-~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ......+.|||.|||||++...+  ..++|||||||++.||+||..||.+ ......++........| .++...+.+++
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~  253 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAK  253 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHH
Confidence            12244688999999999987443  3499999999999999999999987 34455566666566555 67777899999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +||.+|+. +|.+||||.+||.|||++...
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999 999999999999999997654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=284.63  Aligned_cols=177  Identities=27%  Similarity=0.502  Sum_probs=159.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      +|+||+|..-|-+.-.+++..+..+++|||.+|.|||.++  |||||+||+|+++...  ...|||+|||+|..+..+..
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            5899999988877677899999999999999999999999  9999999999999643  35799999999999887666


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI  155 (502)
                      ...++|||.|||||++. ..|+..+|||+.|||||.||.|.+||.+ .....+|+.|..|.+  +.+.|...++++++||
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI  247 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence            77899999999999986 4699999999999999999999999987 678899999999875  5556777899999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. ||.+|+||.|+|+|||+...
T Consensus       248 rrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  248 RRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHhccChhhhccHHHHhCCchhcch
Confidence            99998 99999999999999999754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=305.70  Aligned_cols=175  Identities=33%  Similarity=0.583  Sum_probs=159.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      ||.||+|-+.+.+.. ++|.+|+.+++++|.||+|||.+|  |||||||.+|||+..+ |.+||+|||++..+.... +.
T Consensus       351 ym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             ecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeeeeeccccccCcc
Confidence            789999999997754 999999999999999999999999  9999999999999877 899999999999876544 56


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+|||+|||||++.. .|++++||||||++++||+-|++||........+|..-..|......+...++.+++|+.+|
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            78999999999999875 59999999999999999999999998755567788888888887778888899999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |+ |+.+|++|.|||+||||+.
T Consensus       507 L~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  507 LVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             hhcchhcCCCHHHHhcChhhhh
Confidence            99 9999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-34  Score=301.63  Aligned_cols=182  Identities=26%  Similarity=0.431  Sum_probs=158.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-----   75 (502)
                      |+.||++.++|.+.+.|++..++.|+.+++.|++.||.+|  +|||||||+|+||+.. |++||.||||++.+..     
T Consensus       222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhhhhhhhh
Confidence            7899999999999999999999999999999999999999  9999999999999987 9999999999854311     


Q ss_pred             --------------------C-----------------------CCcccccCCCcccCcccccc-CCCCcccchhHHHHH
Q 010730           76 --------------------S-----------------------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV  111 (502)
Q Consensus        76 --------------------~-----------------------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviL  111 (502)
                                          .                       ....+.+|||.||||||+.+ +|+..+|+|||||||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                                0                       01135689999999998865 499999999999999


Q ss_pred             HHHhhccCCCCCCCChHHHHHHhhcCC--CCCcccccccHHHHHHHHHhhhCcCCCCC---HHHHhcCCCCcCCCCCCCC
Q 010730          112 LEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEPLL  186 (502)
Q Consensus       112 yeLLTG~~Pf~~~~~~~ql~~kI~~g~--~p~~~~~~~s~~l~~LI~kcL~dP~kRpS---a~ELL~hPff~~~~~~~l~  186 (502)
                      ||||.|.+||.. .++.+.|++|...+  +..+-....+.++++||.+||.||.+|+.   ++||..||||+.-.|.-+.
T Consensus       379 yEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  379 YEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             HHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhh
Confidence            999999999987 89999999999876  33333334579999999999999999986   9999999999998886643

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=278.88  Aligned_cols=181  Identities=22%  Similarity=0.375  Sum_probs=159.1

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~   76 (502)
                      +|.||.|+..|+..+.  ++|+++..+++||..|+.|||+.+  |.||||||+|+|...+  +..+||+|||+|+.....
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            4789999999988765  999999999999999999999999  9999999999999754  357999999999988777


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCC--CCcccccccHH
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKL--PGAFHRIQDAE  150 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~--p~~~~~~~s~~  150 (502)
                      ..+.+.+.||+|.|||++. .+|+..+|+||+|||+|.||||.+||+....   ...+-.+|..|.+  |.+.|...+.+
T Consensus       218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~  297 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEA  297 (400)
T ss_pred             ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHH
Confidence            7788899999999999996 5699999999999999999999999976432   2345677887765  56667778999


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      ++++|+++|. +|.+|+|+.+++.|||+......
T Consensus       298 aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  298 AKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             HHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence            9999999998 99999999999999999865443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-33  Score=274.18  Aligned_cols=170  Identities=29%  Similarity=0.513  Sum_probs=151.2

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPP--VIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~--IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+.|+.+    +.++++.+++++.|++.||..||+.-+.  |+||||||.|||++.+ |.|||+||||++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhHhc
Confidence            57789999998653    5699999999999999999999985444  9999999999999987 899999999999886


Q ss_pred             CCC-CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           75 GSQ-QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        75 ~~~-~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ... ..++.+|||.||+||++. ..|+.++||||+||++|||..-++||.+ .+..++.++|.+|.+|+.+....+..++
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l~  258 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDLR  258 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence            543 467899999999999876 5699999999999999999999999988 6999999999999998777688899999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHh
Q 010730          153 RFVGKCLE-NVSKRLPAKELL  172 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL  172 (502)
                      .+|..|+. ||..||+.-.++
T Consensus       259 ~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  259 ELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             HHHHHHccCCcccCCCcchHH
Confidence            99999998 999999863333

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.98  E-value=2.8e-32  Score=276.94  Aligned_cols=176  Identities=28%  Similarity=0.494  Sum_probs=152.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~  152 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcc
Confidence            6789999999999899999999999999999999999998  9999999999999876 789999999987532 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+..  .++...+.++++||.+|
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~  229 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGL  229 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            55789999999998864 589999999999999999999999976 556677777766544  34455688999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. ||.+||     ++.++++||||....+
T Consensus       230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         230 LKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             ccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            98 999999     8999999999987544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=296.38  Aligned_cols=178  Identities=28%  Similarity=0.524  Sum_probs=157.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |..||++.. +++.+.+++.+++.|+..|+.||+|||.+|  ||+||||.+|||++.. |.+||+|||+++... .+..+
T Consensus       450 y~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~~T  525 (694)
T KOG0694|consen  450 YVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGDRT  525 (694)
T ss_pred             ecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccCCCCCcc
Confidence            678899443 345578999999999999999999999999  9999999999999987 899999999998743 55677


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .++||||.|||||++.+ .|+.++|+|||||+|||||+|++||.+ ++.++++..|.....  .++...+.++.+++.++
T Consensus       526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~--~yP~~ls~ea~~il~~l  602 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSKEAIAIMRRL  602 (694)
T ss_pred             ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--CCCCcccHHHHHHHHHH
Confidence            89999999999999865 599999999999999999999999987 888999999987655  35556788999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~~~l  185 (502)
                      |. +|.+|+.     +.+|.+||||+..+|..+
T Consensus       603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  603 LRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             hccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence            98 9999986     689999999998887653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-32  Score=268.88  Aligned_cols=174  Identities=32%  Similarity=0.548  Sum_probs=152.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.....  ..
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~~  156 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--TW  156 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC--cc
Confidence            6789999999999889999999999999999999999998  9999999999999876 79999999999765432  33


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++.+..+..  .++...+..+++||.+||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHc
Confidence            4679999999998864 488999999999999999999999976 567788888887765  344455889999999999


Q ss_pred             h-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      . ||.+|++     +.+++.||||....+
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            9 9999995     999999999976444

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=281.88  Aligned_cols=176  Identities=31%  Similarity=0.528  Sum_probs=157.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~---g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|++.+.+. .+++..+..+++||+.++.|||+.|  |+||||||+|+|+....   +.+|++|||++.......
T Consensus       117 L~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  117 LCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             ecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            57899999999887 5999999999999999999999998  99999999999996542   479999999999988766


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~L  154 (502)
                      .....+|||.|+|||++. ..|+..+||||+||++|.|++|.+||.+ ......+.+|..+.+  +...|...+..+++|
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISESAKDF  272 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence            788999999999999998 6799999999999999999999999987 555666778888765  455666679999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. ||.+|+||.++|+|||++..
T Consensus       273 i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  273 IRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHhcccCcccCCCHHHHhcCccccCC
Confidence            999998 99999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=1.1e-31  Score=273.57  Aligned_cols=175  Identities=27%  Similarity=0.527  Sum_probs=153.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++......  ..
T Consensus        99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~--~~  173 (329)
T PTZ00263         99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR--TF  173 (329)
T ss_pred             CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCCC--cc
Confidence            5789999999999899999999999999999999999998  9999999999999876 79999999999876432  33


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++++..+..+  ++...+..+++||.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDLVKGLL  250 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHHHHHHh
Confidence            5689999999998865 488999999999999999999999976 5677888888877653  34456789999999999


Q ss_pred             h-CcCCCCC-----HHHHhcCCCCcCCCCC
Q 010730          160 E-NVSKRLP-----AKELLLDPFLASDAGE  183 (502)
Q Consensus       160 ~-dP~kRpS-----a~ELL~hPff~~~~~~  183 (502)
                      . ||.+|++     +++++.||||....+.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            8 9999997     7999999999865443

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=270.74  Aligned_cols=175  Identities=29%  Similarity=0.512  Sum_probs=151.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus        74 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~  150 (312)
T cd05585          74 FINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKT  150 (312)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999876 7999999999975432 2233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++.+..+..  .++...+..+++||.+|
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  227 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGL  227 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence            45689999999998865 589999999999999999999999976 566777888776654  34455688999999999


Q ss_pred             hh-CcCCCC---CHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRL---PAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRp---Sa~ELL~hPff~~~~  181 (502)
                      |. +|.+|+   ++.|+|.||||....
T Consensus       228 L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         228 LSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             cCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            99 999997   589999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-32  Score=280.49  Aligned_cols=174  Identities=29%  Similarity=0.448  Sum_probs=149.9

Q ss_pred             CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            5 GTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         5 GsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      -+|.+.++. .+.|++..|+.|+.||++||+|+|.+|  ++||||||||||+.++ ..|||+|||+|+.+......+.++
T Consensus        94 ~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPYTeYV  170 (538)
T KOG0661|consen   94 CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRSKPPYTEYV  170 (538)
T ss_pred             hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccccCCCcchhh
Confidence            478888875 456999999999999999999999999  9999999999999976 589999999999998888888899


Q ss_pred             CCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-C-------------------CCCC
Q 010730           84 GTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-G-------------------KLPG  141 (502)
Q Consensus        84 GTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g-------------------~~p~  141 (502)
                      .|.+|.|||++.  +.|+.++||||+|||++|+++-++.|++....+|||+...- |                   .+|.
T Consensus       171 STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~  250 (538)
T KOG0661|consen  171 STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQ  250 (538)
T ss_pred             hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCc
Confidence            999999999774  56999999999999999999999999998888999876431 1                   1110


Q ss_pred             ----cc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          142 ----AF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       142 ----~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                          .+   -...+.++.++|.+||. ||.+||||.|+|+||||+...
T Consensus       251 ~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  251 VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             CCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                00   11257889999999999 999999999999999998653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-32  Score=277.03  Aligned_cols=178  Identities=25%  Similarity=0.503  Sum_probs=157.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--C---CcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--L---GQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~---g~vKL~DFGlA~~~~~   75 (502)
                      |+.||+|..|+++.+.+++..++.++.||+.||++||+.+  ||||||||+|||++..  .   ..+||+|||+|+.+..
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            7899999999999999999999999999999999999999  9999999999999764  1   3589999999999998


Q ss_pred             CCCcccccCCCcccCcccc-ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CCcccccccHHHHH
Q 010730           76 SQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARR  153 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl-~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~~~~~~~s~~l~~  153 (502)
                      +....+.+|+|.|||||++ ..+|+.|+|+||+|+|+|+|++|+.||.. .+..+++..+..+.. ...++...+..+.+
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~  246 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLRE  246 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhh
Confidence            8888999999999999988 57899999999999999999999999976 677888777776653 23445555667778


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      ++...|. ++..|.+..+-+.|+++....
T Consensus       247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  247 LLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8888887 999999999999999997654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2e-31  Score=275.21  Aligned_cols=180  Identities=26%  Similarity=0.441  Sum_probs=148.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....   
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCccccccccccc
Confidence            6789999999999899999999999999999999999998  9999999999999876 799999999987543210   


Q ss_pred             ---------------------------------CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCC
Q 010730           78 ---------------------------------QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE  123 (502)
Q Consensus        78 ---------------------------------~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~  123 (502)
                                                       .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                             013468999999999875 4589999999999999999999999976


Q ss_pred             CCChHHHHHHhhcCCCCCccc--ccccHHHHHHHHHhhhCc---CCCCCHHHHhcCCCCcCCCCCC
Q 010730          124 CSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVGKCLENV---SKRLPAKELLLDPFLASDAGEP  184 (502)
Q Consensus       124 ~~~~~ql~~kI~~g~~p~~~~--~~~s~~l~~LI~kcL~dP---~kRpSa~ELL~hPff~~~~~~~  184 (502)
                       .+..++++++........++  ...+++++++|.+|+.+|   ..||+++||++||||+...+..
T Consensus       239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         239 -ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             -CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence             56677788877643222222  235789999999977644   4568999999999998765543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=2.4e-31  Score=270.13  Aligned_cols=176  Identities=24%  Similarity=0.459  Sum_probs=152.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcc
Confidence            6789999999999889999999999999999999999998  9999999999999877 799999999987642 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+...  ++...+.+++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~  230 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLSQDAVDILKAF  230 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence            45679999999998864 589999999999999999999999976 5677788888766542  3344678999999999


Q ss_pred             hh-CcCCCCCH------HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA------KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa------~ELL~hPff~~~~~  182 (502)
                      |. ||.+|+++      ++++.||||....+
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            98 99999998      99999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1.9e-31  Score=274.30  Aligned_cols=175  Identities=25%  Similarity=0.473  Sum_probs=153.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+..  ...
T Consensus       112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~--~~~  186 (340)
T PTZ00426        112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT--RTY  186 (340)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeecCC--Ccc
Confidence            6789999999999899999999999999999999999998  9999999999999876 7999999999987643  234


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+++.+..+..  .++...+..++++|.+||
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l  263 (340)
T PTZ00426        187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLL  263 (340)
T ss_pred             eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence            5789999999998864 488999999999999999999999976 566777888887764  234456788999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAGE  183 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~~  183 (502)
                      . +|.+|+     +++++++||||+...+.
T Consensus       264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        264 SHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            8 999995     89999999999875543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=270.84  Aligned_cols=178  Identities=25%  Similarity=0.409  Sum_probs=149.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++.+ +.+||+|||++..+....   
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCcccCccc
Confidence            5789999999998889999999999999999999999988  9999999999999887 799999999997654332   


Q ss_pred             ---------------------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH
Q 010730           78 ---------------------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ  129 (502)
Q Consensus        78 ---------------------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q  129 (502)
                                                 .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS-DTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC-CCHHH
Confidence                                       2344679999999998864 589999999999999999999999977 44566


Q ss_pred             HHHHhhc--CCCCCcccccccHHHHHHHHHhhhCcCCCCC-HHHHhcCCCCcCCCC
Q 010730          130 IYKKVTS--GKLPGAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFLASDAG  182 (502)
Q Consensus       130 l~~kI~~--g~~p~~~~~~~s~~l~~LI~kcL~dP~kRpS-a~ELL~hPff~~~~~  182 (502)
                      .+.++..  .....+.....++.+++||.+||.+|.+|++ ++++|.||||+...+
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence            6666665  2222122223588999999999999999999 999999999986544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=3.2e-31  Score=270.35  Aligned_cols=176  Identities=26%  Similarity=0.483  Sum_probs=150.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|..++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~  152 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATM  152 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccc
Confidence            6789999999998889999999999999999999999998  9999999999999876 799999999987532 22333


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++.+.+..+..  .++...++++++||.+|
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~  229 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGL  229 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHH
Confidence            4568999999999886 4589999999999999999999999976 455666666655544  34455688999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+     ++.|+++||||....+
T Consensus       230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             cCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            98 999997     8999999999976443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=272.73  Aligned_cols=178  Identities=28%  Similarity=0.474  Sum_probs=148.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....   
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceecccccccc
Confidence            5789999999998889999999999999999999999998  9999999999999887 799999999987643211   


Q ss_pred             ------------------------------------CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCC
Q 010730           78 ------------------------------------QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP  120 (502)
Q Consensus        78 ------------------------------------~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~P  120 (502)
                                                          ...+.+||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                112357999999999875 4589999999999999999999999


Q ss_pred             CCCCCChHHHHHHhhcCCCCCcc--cccccHHHHHHHHHhhhCcCCCCC---HHHHhcCCCCcCCCC
Q 010730          121 YSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAG  182 (502)
Q Consensus       121 f~~~~~~~ql~~kI~~g~~p~~~--~~~~s~~l~~LI~kcL~dP~kRpS---a~ELL~hPff~~~~~  182 (502)
                      |.. .+..+.+..+........+  ....++.+++||.+||.+|.+|++   +.|+|.||||+...+
T Consensus       239 f~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         239 FCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            976 4556666666654332222  223578999999999999999998   999999999987544

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=4.3e-31  Score=262.79  Aligned_cols=179  Identities=23%  Similarity=0.390  Sum_probs=146.7

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe
Confidence            57899999888653  46999999999999999999999998  9999999999999876 7899999999987654444


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.....   ...+...+.....  .++...+..+.+|
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  235 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSI  235 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence            45678999999999886 4589999999999999999999999976432   1233333333222  3344467899999


Q ss_pred             HHHhhh-CcCCCCC-----HHHHhcCCCCcCCCCCC
Q 010730          155 VGKCLE-NVSKRLP-----AKELLLDPFLASDAGEP  184 (502)
Q Consensus       155 I~kcL~-dP~kRpS-----a~ELL~hPff~~~~~~~  184 (502)
                      |.+||. +|.+|++     ++++++||||....+..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence            999999 9999997     99999999998765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=278.85  Aligned_cols=176  Identities=25%  Similarity=0.437  Sum_probs=159.5

Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      .+|+|++||-++ ..+++..+++|+.||+.|+.|||...  ||||||||+|+.+-...|-|||.|||++..+.+++++.+
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            579999999886 56999999999999999999999988  999999999998877789999999999999999999999


Q ss_pred             ccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           82 VIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      .||+..|-|||++.+. | .+++||||||||||.|+||++||.+ .|..+..-+|+.+++  ..+...+.++++||..||
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-ANDSETLTmImDCKY--tvPshvS~eCrdLI~sML  254 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-ANDSETLTMIMDCKY--TVPSHVSKECRDLIQSML  254 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-ccchhhhhhhhcccc--cCchhhhHHHHHHHHHHH
Confidence            9999999999987653 5 5689999999999999999999988 666777888999988  456667899999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          160 E-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      . ||.+|.+.+||..++|++.....
T Consensus       255 vRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  255 VRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             hcCchhhccHHHHhccccccCCCCC
Confidence            9 99999999999999999876543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=276.27  Aligned_cols=179  Identities=27%  Similarity=0.496  Sum_probs=150.4

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      ||.+|++.+.++.+  ..++|..|+.+++++|.||.|||.+|  -||||||+.|||++.+ |.|||+|||++..+.... 
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCceeeeeecccCc
Confidence            68999999999864  45999999999999999999999999  9999999999999987 899999999987653322 


Q ss_pred             C----cccccCCCcccCccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-------CCcc
Q 010730           78 Q----AHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-------PGAF  143 (502)
Q Consensus        78 ~----~~s~vGTp~Y~APEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-------p~~~  143 (502)
                      .    ..+++|||+|||||++.   ..|+.|+||||||++..||++|..||.......-+..++.....       +...
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE  261 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence            1    15679999999999964   35999999999999999999999999987666666766655432       1122


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ....+..++.+|..||. ||.+||||++||+|+||+....
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            22346689999999998 9999999999999999986543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=2.5e-31  Score=269.94  Aligned_cols=175  Identities=27%  Similarity=0.499  Sum_probs=149.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+ .+  |+||||||+|||++.+ +.+||+|||+++... ....
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcc
Confidence            67899999999988899999999999999999999997 67  9999999999999876 799999999987543 2233


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+..++++.+..+..  .++...++++.+||.+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~  229 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSG  229 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHH
Confidence            44567999999999885 4589999999999999999999999976 555667777665544  3445568899999999


Q ss_pred             hhh-CcCCCC-----CHHHHhcCCCCcCCC
Q 010730          158 CLE-NVSKRL-----PAKELLLDPFLASDA  181 (502)
Q Consensus       158 cL~-dP~kRp-----Sa~ELL~hPff~~~~  181 (502)
                      ||. ||.+|+     ++.++|+||||....
T Consensus       230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             HhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            998 999997     899999999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=4.3e-31  Score=268.01  Aligned_cols=176  Identities=24%  Similarity=0.447  Sum_probs=152.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCcc
Confidence            5789999999999889999999999999999999999998  9999999999999887 799999999997643 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+...+++.+.....  .++...+.+++++|.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHH
Confidence            45789999999998864 589999999999999999999999976 566777888776654  34455688999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. +|.+|++     ..+++.||||+...+
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            98 9999998     489999999986554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-31  Score=268.33  Aligned_cols=176  Identities=25%  Similarity=0.402  Sum_probs=148.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++.....  ...
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc--ccC
Confidence            6789999999999889999999999999999999999998  9999999999999876 7999999999976543  345


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC----CCcc--cccccHHHHH
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----PGAF--HRIQDAEARR  153 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~----p~~~--~~~~s~~l~~  153 (502)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+.....    |...  ....+.++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            5789999999998764 589999999999999999999999976 566666666554321    1111  1134789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ||.+||. +|.+|+++.+++.||||....+
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            9999998 8899999999999999986543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=4.9e-31  Score=267.56  Aligned_cols=176  Identities=27%  Similarity=0.429  Sum_probs=151.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcc
Confidence            6789999999999889999999999999999999999998  9999999999999876 799999999987542 22233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+...  +....+..+.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~  230 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLR--LKPNISVSARHLLEGL  230 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence            45679999999998764 588999999999999999999999976 5667788888766542  3344588999999999


Q ss_pred             hh-CcCCCCCH----HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA----KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa----~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++    .+++.||||....+
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            99 99999997    69999999986544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=6.4e-31  Score=266.52  Aligned_cols=176  Identities=24%  Similarity=0.455  Sum_probs=151.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCccc
Confidence            5789999999999889999999999999999999999998  9999999999999877 799999999987643 22233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+...  ++...+.++.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~  230 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVL--YPVWLSKEAVSILKAF  230 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence            45679999999998864 589999999999999999999999976 5677778887766542  3344578999999999


Q ss_pred             hh-CcCCCC-------CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-------PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-------Sa~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+       ++.+++.||||....+
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            98 999999       8999999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=274.20  Aligned_cols=171  Identities=32%  Similarity=0.510  Sum_probs=147.1

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++.+  .+.++...+..|+.||+.|+.|||++++ ||||||||+|||++.+.-.+||+|||+++..... .
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT  199 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence            7899999999988  6789999999999999999999999987 9999999999999987228999999999877654 3


Q ss_pred             CcccccCCCcccCccccccC---CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~---ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ......||+.|||||++.+.   |+.++||||||++||||+||..||.+... .++...+..+.....++....+.+..+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l  278 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSL  278 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            44557899999999999853   99999999999999999999999998766 555444443333335555578999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||+..+++.
T Consensus       279 ~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  279 MERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHhCCCCCCcCCCHHHHHH
Confidence            999998 9999999998875

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=7.5e-31  Score=266.31  Aligned_cols=176  Identities=24%  Similarity=0.462  Sum_probs=151.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCce
Confidence            5789999999999889999999999999999999999998  9999999999999876 799999999987532 22333


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+..+++..+.....  .++...+.++.++|.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            45689999999998865 489999999999999999999999976 566777887776654  34455688999999999


Q ss_pred             hh-CcCCCCCH-----HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA-----KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa-----~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++     ++++.||||+...+
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            98 99999976     89999999986544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=5.6e-31  Score=267.77  Aligned_cols=176  Identities=27%  Similarity=0.483  Sum_probs=150.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~  152 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999876 799999999987532 22333


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+++.+.....  .++...+++++++|.+|
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~  229 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL  229 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            4568999999999885 4589999999999999999999999976 455666666665543  24455688999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+     ++.++++||||....+
T Consensus       230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             ccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            98 999998     8999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=6.8e-31  Score=266.36  Aligned_cols=175  Identities=27%  Similarity=0.528  Sum_probs=149.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCce
Confidence            6789999999998889999999999999999999999998  9999999999999877 799999999987532 22234


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+..  .++...+.+++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKL  230 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence            45789999999998864 589999999999999999999999976 566777777765543  33445678999999999


Q ss_pred             hh-CcCCCCCH-HHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPA-KELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa-~ELL~hPff~~~~  181 (502)
                      |. ||.+|+++ ++++.||||+...
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCC
Confidence            98 99999997 5899999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=271.12  Aligned_cols=176  Identities=30%  Similarity=0.477  Sum_probs=151.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCc
Confidence            5789999999999899999999999999999999999998  9999999999999876 799999999987532 22334


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ...+||+.|+|||++.+  .++.++|||||||++|+|++|..||.. .+..++++.+..+..... ....+..+++||.+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~  231 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKG  231 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHH
Confidence            56789999999998754  378999999999999999999999976 567778888877655322 22457899999999


Q ss_pred             hhh-CcCCCC----CHHHHhcCCCCcCCC
Q 010730          158 CLE-NVSKRL----PAKELLLDPFLASDA  181 (502)
Q Consensus       158 cL~-dP~kRp----Sa~ELL~hPff~~~~  181 (502)
                      ||. +|.+||    ++.+++.||||....
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            998 999998    699999999997644

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=6e-31  Score=267.24  Aligned_cols=177  Identities=24%  Similarity=0.413  Sum_probs=147.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.....  ..
T Consensus        86 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~~~~~  162 (332)
T cd05614          86 YVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKER  162 (332)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCccccccCCCc
Confidence            6789999999998889999999999999999999999998  9999999999999877 79999999999765322  22


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCC---CChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~---~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      ....+||+.|+|||++.+  .++.++|||||||++|+|+||..||...   .....+...+.....  .++...+..+++
T Consensus       163 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  240 (332)
T cd05614         163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEAQD  240 (332)
T ss_pred             cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence            345689999999998864  3788999999999999999999999642   233455555554332  344556889999


Q ss_pred             HHHHhhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          154 FVGKCLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       154 LI~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      +|.+||. +|.+|+     +++++++||||+...+
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999998 999999     7899999999986543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=7.7e-31  Score=266.23  Aligned_cols=179  Identities=23%  Similarity=0.408  Sum_probs=148.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+..... 
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCCCce
Confidence            57899999999886 68999999999999999999999998  9999999999999876 7999999999987654332 


Q ss_pred             -cccccCCCcccCccccc-------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc--ccccc
Q 010730           79 -AHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQD  148 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~--~~~~s  148 (502)
                       .....||+.|+|||++.       ..++.++|||||||++|+|++|..||.. .+....+.++........+  ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCC
Confidence             23357999999999874       3478899999999999999999999976 4555666666554322122  22357


Q ss_pred             HHHHHHHHHhhhCcCCCCCHHHHhcCCCCcCCCCC
Q 010730          149 AEARRFVGKCLENVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       149 ~~l~~LI~kcL~dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      ..+++||.+||.+|.+|+++.+++.||||+...+.
T Consensus       238 ~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             HHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHH
Confidence            88999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=1.1e-30  Score=264.87  Aligned_cols=176  Identities=30%  Similarity=0.532  Sum_probs=150.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.||+|.+++...+.+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus        77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999876 7999999999976432 2333


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+.....  .++...+.+++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            45689999999998864 589999999999999999999999976 566777777765433  34455688999999999


Q ss_pred             hh-CcCCCCCH-HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA-KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa-~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++ .+++.||||....+
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCCH
Confidence            98 99999986 58999999986543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.3e-30  Score=264.87  Aligned_cols=176  Identities=29%  Similarity=0.413  Sum_probs=150.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+.+..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence            5789999999999899999999999999999999999998  9999999999999876 799999999987543 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+..+..  .++...++.+++||.+|
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  234 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKKL  234 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            45679999999998864 488899999999999999999999976 555666777766654  34445678999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+     ++.+++.||||....+
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            98 999999     8999999999976543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=271.67  Aligned_cols=178  Identities=26%  Similarity=0.445  Sum_probs=144.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....   
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeecccccccccccccc
Confidence            5789999999999899999999999999999999999998  9999999999999876 799999999986321100   


Q ss_pred             ---------------------------------------------CcccccCCCcccCcccccc-CCCCcccchhHHHHH
Q 010730           78 ---------------------------------------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV  111 (502)
Q Consensus        78 ---------------------------------------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviL  111 (502)
                                                                   .....+||+.|+|||++.+ .|+.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                         0013579999999998754 589999999999999


Q ss_pred             HHHhhccCCCCCCCChHHHHHHhhcCCCCCccc--ccccHHHHHHHHHhhhCcCC---CCCHHHHhcCCCCcCCCC
Q 010730          112 LEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVGKCLENVSK---RLPAKELLLDPFLASDAG  182 (502)
Q Consensus       112 yeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~--~~~s~~l~~LI~kcL~dP~k---RpSa~ELL~hPff~~~~~  182 (502)
                      |+|++|.+||.. .+..+.+.++........++  ...+.++++||.+||.+|.+   |+++.|+|.||||+...+
T Consensus       239 ~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         239 FECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            999999999976 45566677666533222222  23578999999999986665   469999999999986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=5e-31  Score=271.65  Aligned_cols=180  Identities=26%  Similarity=0.470  Sum_probs=148.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....   
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCcccccccccc
Confidence            6789999999999889999999999999999999999998  9999999999999876 799999999987542110   


Q ss_pred             ---------------------------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCC
Q 010730           78 ---------------------------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE  123 (502)
Q Consensus        78 ---------------------------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~  123 (502)
                                                       ...+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                             0124679999999998764 589999999999999999999999976


Q ss_pred             CCChHHHHHHhhcCCCCCccc--ccccHHHHHHHHHhhhCcCCCC---CHHHHhcCCCCcCCCCCC
Q 010730          124 CSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVGKCLENVSKRL---PAKELLLDPFLASDAGEP  184 (502)
Q Consensus       124 ~~~~~ql~~kI~~g~~p~~~~--~~~s~~l~~LI~kcL~dP~kRp---Sa~ELL~hPff~~~~~~~  184 (502)
                       .+....+.++........++  ...+.+++++|.+|+.+|.+|+   ++.|++.||||+...+..
T Consensus       239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         239 -ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             -CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence             56677777776543221122  2357899999999888999988   489999999998765544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=279.34  Aligned_cols=178  Identities=22%  Similarity=0.314  Sum_probs=138.5

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC---------------CcEEEEe
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHL---------------GQIKIGD   66 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~---------------g~vKL~D   66 (502)
                      .||+|.+++.+.+.+++..++.++.||+.||+|||+ .+  ||||||||+|||++...               ..+||+|
T Consensus       214 ~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~D  291 (467)
T PTZ00284        214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD  291 (467)
T ss_pred             cCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCceEEECC
Confidence            488999999998899999999999999999999997 47  99999999999997642               1499999


Q ss_pred             cCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh-cCCCCCcc-
Q 010730           67 LGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-SGKLPGAF-  143 (502)
Q Consensus        67 FGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~-~g~~p~~~-  143 (502)
                      ||++....  ......+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+..+...+..... .+.+|..+ 
T Consensus       292 fG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~  369 (467)
T PTZ00284        292 LGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWA  369 (467)
T ss_pred             CCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH
Confidence            99885432  22345789999999998764 599999999999999999999999976443332211110 01111000 


Q ss_pred             -------------------------------------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCCC
Q 010730          144 -------------------------------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP  184 (502)
Q Consensus       144 -------------------------------------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~~  184 (502)
                                                           ....++.+.+||.+||. ||.+||||+|+|.||||.......
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        370 GRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC  448 (467)
T ss_pred             hhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence                                                 01124567899999999 999999999999999998654433

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-31  Score=294.46  Aligned_cols=190  Identities=24%  Similarity=0.452  Sum_probs=164.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      ||.||+|..++.++.+++++.+++|+..|+.||+-||+.|  .|||||||+|||++.. |+|||+|||.+-.+.....  
T Consensus       156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcEE
Confidence            8999999999999999999999999999999999999999  9999999999999987 9999999999977764433  


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc--ccccHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAE  150 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~--~~~s~~  150 (502)
                      ....||||.|++||++.      +.|+..+|+||+||++|||+.|..||+. ....+.|.+|+..+-...||  ...+.+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            34578999999999883      4599999999999999999999999987 67788899999875333333  347899


Q ss_pred             HHHHHHHhhhCcCCCCC---HHHHhcCCCCcCCCCCCC---CCCCCCCcc
Q 010730          151 ARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEPL---LIPQVPSFQ  194 (502)
Q Consensus       151 l~~LI~kcL~dP~kRpS---a~ELL~hPff~~~~~~~l---~~p~~p~~~  194 (502)
                      +++||.++|.+|..|+.   +.++..||||.+..|..+   .+|.+|.+.
T Consensus       312 akdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs  361 (1317)
T KOG0612|consen  312 AKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS  361 (1317)
T ss_pred             HHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence            99999999999999998   999999999999988543   345555544

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1.3e-30  Score=265.64  Aligned_cols=177  Identities=22%  Similarity=0.437  Sum_probs=147.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~-~~~~~~   79 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.. ......
T Consensus        77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999876 79999999998753 223334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--------CChHHHHHHhhcCCCCCcccccccHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||...        .....+++.+.....  .++...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~  231 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK  231 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHH
Confidence            55789999999998864 5889999999999999999999999531        122345566655543  234456789


Q ss_pred             HHHHHHHhhh-CcCCCCC------HHHHhcCCCCcCCCC
Q 010730          151 ARRFVGKCLE-NVSKRLP------AKELLLDPFLASDAG  182 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpS------a~ELL~hPff~~~~~  182 (502)
                      ++++|.+||. +|.+|++      +.+++.||||....+
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999998 9999987      789999999976443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=1.7e-30  Score=257.36  Aligned_cols=170  Identities=34%  Similarity=0.499  Sum_probs=138.6

Q ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +|+|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++...........
T Consensus        92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  168 (290)
T cd07862          92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS  168 (290)
T ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccccceEeccCCccccc
Confidence            57899999764  45899999999999999999999998  9999999999999876 7999999999987655444556


Q ss_pred             ccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CCC--Cc---------------
Q 010730           82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP--GA---------------  142 (502)
Q Consensus        82 ~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~p--~~---------------  142 (502)
                      ..||+.|+|||++. ..++.++|||||||++|+|++|.+||.+..... .+.++... ..+  ..               
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (290)
T cd07862         169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVALPRQAFHSK  247 (290)
T ss_pred             ccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchhhhcccchhccCC
Confidence            78999999999875 458999999999999999999999998744433 33333221 100  00               


Q ss_pred             -------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          143 -------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       143 -------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                             +....+..++++|.+||. +|.+|||+.|+|+||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         248 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                   112346788999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=2.4e-30  Score=267.89  Aligned_cols=177  Identities=27%  Similarity=0.423  Sum_probs=144.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+...    
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccccc
Confidence            6789999999999889999999999999999999999998  9999999999999876 79999999997532100    


Q ss_pred             ----------------------------------------CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHh
Q 010730           77 ----------------------------------------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEML  115 (502)
Q Consensus        77 ----------------------------------------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLL  115 (502)
                                                              ......+||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                    00123579999999998864 5899999999999999999


Q ss_pred             hccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHHHHhhhCcCCCC---CHHHHhcCCCCcCCC
Q 010730          116 TSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLENVSKRL---PAKELLLDPFLASDA  181 (502)
Q Consensus       116 TG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI~kcL~dP~kRp---Sa~ELL~hPff~~~~  181 (502)
                      +|..||.+ .+..+....+.....  +.......++++.++|.+|+.+|.+|+   ++.+++.||||+...
T Consensus       239 ~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         239 VGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hCCCCCCC-CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            99999976 444455555543322  112223457899999999888999999   999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=278.13  Aligned_cols=175  Identities=29%  Similarity=0.425  Sum_probs=141.8

Q ss_pred             CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            4 SGTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         4 gGsL~~yi~----k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      +|+|.+++.    ....+++..++.++.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||+++.+......
T Consensus       150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  227 (440)
T PTZ00036        150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS  227 (440)
T ss_pred             CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc
Confidence            467877775    3467999999999999999999999998  9999999999999876557999999999877655555


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC------------------C
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------L  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~------------------~  139 (502)
                      ...+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.....++.+.+....                  +
T Consensus       228 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~  307 (440)
T PTZ00036        228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKF  307 (440)
T ss_pred             ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccC
Confidence            56789999999998754  589999999999999999999999987655554444332100                  0


Q ss_pred             C--------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 P--------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 p--------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |        ..++...+.++++||.+||. +|.+|+|+.|+|+||||...
T Consensus       308 ~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        308 PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            1        01122346789999999999 99999999999999999754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=1.8e-30  Score=263.50  Aligned_cols=176  Identities=27%  Similarity=0.516  Sum_probs=150.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCce
Confidence            6789999999998888999999999999999999999998  9999999999999887 799999999987542 22233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+..  .++...+..++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKL  230 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            45679999999998864 589999999999999999999999976 556777777765543  23345678899999999


Q ss_pred             hh-CcCCCCCHH-HHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPAK-ELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa~-ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++. +++.||||+...+
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCCH
Confidence            98 999999996 8999999987554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.6e-30  Score=269.95  Aligned_cols=178  Identities=26%  Similarity=0.401  Sum_probs=145.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+...    
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCcccccccccc
Confidence            6789999999998888999999999999999999999998  9999999999999876 79999999997532100    


Q ss_pred             --------------------------------------------CCcccccCCCcccCccccc-cCCCCcccchhHHHHH
Q 010730           77 --------------------------------------------QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCV  111 (502)
Q Consensus        77 --------------------------------------------~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviL  111 (502)
                                                                  ....+.+||+.|+|||++. ..|+.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                        0112457999999999875 4599999999999999


Q ss_pred             HHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHHHHhhhCcCCCCC---HHHHhcCCCCcCCCC
Q 010730          112 LEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAG  182 (502)
Q Consensus       112 yeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI~kcL~dP~kRpS---a~ELL~hPff~~~~~  182 (502)
                      |+|++|.+||.. .+..+...++.....  +.+.....+++++++|.+|+.+|.+|++   +.+++.||||+...+
T Consensus       239 ~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         239 YEMLVGQPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHhCCCCCCC-CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            999999999976 445555555544322  2222234578999999998889999987   999999999986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=2.4e-30  Score=263.56  Aligned_cols=178  Identities=22%  Similarity=0.413  Sum_probs=149.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCce
Confidence            6789999999998889999999999999999999999998  9999999999999887 799999999997532 22334


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC------CChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~------~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ...+||+.|+|||++. ..++.++|||||||++|+|++|..||...      .....+++.+.....  .++...+..++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~  231 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKAS  231 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHH
Confidence            5578999999999875 45899999999999999999999999532      233455666655433  34555678999


Q ss_pred             HHHHHhhh-CcCCCCC------HHHHhcCCCCcCCCCC
Q 010730          153 RFVGKCLE-NVSKRLP------AKELLLDPFLASDAGE  183 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpS------a~ELL~hPff~~~~~~  183 (502)
                      ++|.+||. +|.+|++      +.+++.||||+...+.
T Consensus       232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            99999998 9999998      5799999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.3e-30  Score=262.37  Aligned_cols=176  Identities=27%  Similarity=0.504  Sum_probs=151.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcc
Confidence            5789999999999889999999999999999999999998  9999999999999887 799999999987532 22233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+.....  .++...+..+++||.+|
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSF  230 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence            45679999999998864 589999999999999999999999976 566777777766554  33445678999999999


Q ss_pred             hh-CcCCCCCH-----HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA-----KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa-----~ELL~hPff~~~~~  182 (502)
                      |. +|.+||++     .+++.||||+...+
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            98 99999999     99999999987544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-31  Score=266.17  Aligned_cols=174  Identities=32%  Similarity=0.458  Sum_probs=144.3

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC---CCCcc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG---SQQAH   80 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~---~~~~~   80 (502)
                      +-+|.+.++..+.|+...++.++.|||.||.|+|+.+  |+||||||.|+|++.+ ..+||+|||+|+....   ...++
T Consensus       109 etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~~~~~~mT  185 (359)
T KOG0660|consen  109 ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKFFEDGFMT  185 (359)
T ss_pred             hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeeccccCcccchh
Confidence            4578888988888999999999999999999999999  9999999999999998 5899999999998753   44567


Q ss_pred             cccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHH--------------Hhhc--------
Q 010730           81 SVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--------------KVTS--------  136 (502)
Q Consensus        81 s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~--------------kI~~--------  136 (502)
                      ..+-|.+|.|||++.  ..|+.++||||+|||+.||++|++-|++.....|+-.              .+.+        
T Consensus       186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~  265 (359)
T KOG0660|consen  186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK  265 (359)
T ss_pred             cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence            788999999999774  4699999999999999999999999988655555422              1110        


Q ss_pred             --CCCC-Ccc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          137 --GKLP-GAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       137 --g~~p-~~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                        ...| ..|   -...++.+.+|+.+||. ||.+|+||+|+|+||||...
T Consensus       266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence              1111 111   12357899999999999 99999999999999999753

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.4e-30  Score=265.23  Aligned_cols=189  Identities=28%  Similarity=0.442  Sum_probs=154.7

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC---
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG---   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~---   75 (502)
                      |+.||+|...++++  +.+++..++.|+..|+.||+|||..|  ||+||||||||||..+ |+|-|.||.|+.....   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCCCCCe
Confidence            78999999999875  56999999999999999999999999  9999999999999987 8999999998743210   


Q ss_pred             ------------------------------C-C-----------------------CcccccCCCcccCccccccC-CCC
Q 010730           76 ------------------------------S-Q-----------------------QAHSVIGTPEFMAPELYEED-YNE  100 (502)
Q Consensus        76 ------------------------------~-~-----------------------~~~s~vGTp~Y~APEvl~~~-ys~  100 (502)
                                                    . .                       ...++|||-.|+|||++.+. -+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                       01347899999999999865 789


Q ss_pred             cccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCC----HHHHhcCC
Q 010730          101 LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP----AKELLLDP  175 (502)
Q Consensus       101 ~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpS----a~ELL~hP  175 (502)
                      ++|+|+|||++||||.|..||.+..+.+. +.+|....+..+-....+..+++||+++|. ||.+|+.    |.||-+||
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence            99999999999999999999988555444 445554444323333557899999999998 9999998    99999999


Q ss_pred             CCcCCCCCCCC---CCCCCCc
Q 010730          176 FLASDAGEPLL---IPQVPSF  193 (502)
Q Consensus       176 ff~~~~~~~l~---~p~~p~~  193 (502)
                      ||++-+|..+.   +|.+|..
T Consensus       394 FF~gVnWaLir~~~PP~iP~~  414 (459)
T KOG0610|consen  394 FFEGVNWALIRCARPPEIPKP  414 (459)
T ss_pred             cccCCChhheeccCCCcCCCc
Confidence            99999987532   4444544

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=2.9e-30  Score=268.25  Aligned_cols=177  Identities=22%  Similarity=0.448  Sum_probs=148.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.||+|.+++.+. .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++.......  .
T Consensus       124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeeccCCCccc
Confidence            67899999999764 5899999999999999999999998  9999999999999876 799999999998764332  2


Q ss_pred             cccccCCCcccCcccccc-----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccc--cccHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~--~~s~~l  151 (502)
                      ....+||+.|+|||++..     .++.++|||||||++|+|++|..||.. .+....+.++..+.....++.  ..+.++
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            245689999999998753     378899999999999999999999976 556677778776543222222  458899


Q ss_pred             HHHHHHhhh-CcCC--CCCHHHHhcCCCCcCCCC
Q 010730          152 RRFVGKCLE-NVSK--RLPAKELLLDPFLASDAG  182 (502)
Q Consensus       152 ~~LI~kcL~-dP~k--RpSa~ELL~hPff~~~~~  182 (502)
                      ++||.+||. +|.+  |+++.|++.||||+...+
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            999999998 7876  999999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=277.11  Aligned_cols=174  Identities=29%  Similarity=0.518  Sum_probs=151.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      |+.||++.+.++..+.+++..+..++++++.||.|||.++  .||||||+.|||+..+ |.|||+|||++.++..... .
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeechhhcc
Confidence            5789999999998888899999999999999999999999  9999999999999988 8999999999988765443 4


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+++|||.||||||+.+ .|+.++||||||++.+||++|.+|+.++....-++ .| ....|+.+....++.+++||..|
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-lI-pk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-LI-PKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-ec-cCCCCCccccccCHHHHHHHHHH
Confidence            78999999999999876 69999999999999999999999998865433222 12 22334455667789999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |+ +|..||+|.+||+|+|++.
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHh
Confidence            99 9999999999999999986

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.9e-30  Score=263.56  Aligned_cols=176  Identities=27%  Similarity=0.426  Sum_probs=150.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+.+..++.++.||+.||.|||++|  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCc
Confidence            6789999999999888999999999999999999999998  9999999999999876 799999999997542 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++.+.....  .+....+..++++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGL  230 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHH
Confidence            55789999999998865 588999999999999999999999976 566777777766544  33445678999999999


Q ss_pred             hh-CcCCCCCHH----HHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPAK----ELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa~----ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++.    ++++|+||....+
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            98 999999865    8999999976554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=2.8e-30  Score=263.58  Aligned_cols=177  Identities=22%  Similarity=0.417  Sum_probs=147.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.+|+|..++.+.+.+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999887 799999999987532 22334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--------CChHHHHHHhhcCCCCCcccccccHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||...        .....+++.+.....  .++...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~  231 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK  231 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHH
Confidence            45789999999998864 5889999999999999999999999521        122345555555443  344556789


Q ss_pred             HHHHHHHhhh-CcCCCCC------HHHHhcCCCCcCCCC
Q 010730          151 ARRFVGKCLE-NVSKRLP------AKELLLDPFLASDAG  182 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpS------a~ELL~hPff~~~~~  182 (502)
                      ++++|.+||. +|.+|++      +.+++.||||+...+
T Consensus       232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999998 9999998      589999999986544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=265.13  Aligned_cols=178  Identities=28%  Similarity=0.512  Sum_probs=161.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~-~~~~~~~   79 (502)
                      |..||.|+-.+.+.+.+++..++.|...|+.||.|||+++  ||.||||.+|+|++.+ |++||+|||+++. +..+..+
T Consensus       249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhccccccee
Confidence            5789999999999999999999999999999999999999  9999999999999987 8999999999985 4555667


Q ss_pred             ccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .++||||.|+|||++... |+.++|+|.+||++|||+||++||++ .+-..++..|..+.+  .++...+++++.|+..+
T Consensus       326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGL  402 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTLLSGL  402 (516)
T ss_pred             ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHHHHHH
Confidence            899999999999999865 99999999999999999999999988 555778888877766  57777899999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAGEP  184 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~~~  184 (502)
                      |. ||.+|+.     |+|+.+|+||+.-+|..
T Consensus       403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             hhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            98 9999986     99999999999887754

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=1.8e-30  Score=263.73  Aligned_cols=175  Identities=26%  Similarity=0.431  Sum_probs=149.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|..++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCc
Confidence            6789999999999899999999999999999999999998  9999999999999877 799999999987532 22333


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++++......  +....+..+.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~l  230 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEEL  230 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHH
Confidence            45689999999998864 588999999999999999999999976 5667777777765542  2334578899999999


Q ss_pred             hh-CcCCCCCH----HHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPA----KELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa----~ELL~hPff~~~~  181 (502)
                      |. +|.+||++    .+++.||||....
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            98 99999986    5999999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=9.7e-31  Score=260.68  Aligned_cols=170  Identities=29%  Similarity=0.501  Sum_probs=142.4

Q ss_pred             cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCccccc
Q 010730            6 TLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQAHSVI   83 (502)
Q Consensus         6 sL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~~s~v   83 (502)
                      |+.+-+.++ ..++.+.++.++.|++.|+.|||+++  +|||||||+|||++.+ |.+||||||+|+.+. ++...+.++
T Consensus        86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~YTDYV  162 (396)
T KOG0593|consen   86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNYTDYV  162 (396)
T ss_pred             HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcCCcchhhhhh
Confidence            444444444 46999999999999999999999999  9999999999999988 899999999999887 444556689


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC-------------------CC
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-------------------PG  141 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~-------------------p~  141 (502)
                      -|.+|.|||++-+  .|+..+||||+||++.||++|.+-|++.++.+|+|..... |.+                   |.
T Consensus       163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~  242 (396)
T KOG0593|consen  163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE  242 (396)
T ss_pred             hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence            9999999998754  5999999999999999999999999999999999876532 221                   11


Q ss_pred             c-----cc---ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          142 A-----FH---RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       142 ~-----~~---~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .     ++   ...+..+.+|+.+||. ||.+|++.+|+|.||||.
T Consensus       243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            0     00   1134578899999999 999999999999999994

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=4.2e-30  Score=254.09  Aligned_cols=174  Identities=22%  Similarity=0.363  Sum_probs=137.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.+|.|..+......+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+....  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccccccc
Confidence            5667777666655667999999999999999999999998  9999999999999876 799999999998764322  2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC-----------------
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-----------------  139 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~-----------------  139 (502)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|++||........+...... +.+                 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            234679999999998754 5899999999999999999999999875443333221110 110                 


Q ss_pred             --CC---------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 --PG---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 --p~---------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                        +.         ......+..+++||.+||. ||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              00         0111246789999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=5.7e-30  Score=259.88  Aligned_cols=174  Identities=28%  Similarity=0.515  Sum_probs=147.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.||+|..++.+ +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus        83 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          83 YAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             CCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCCcc
Confidence            6789999999865 57999999999999999999999998  9999999999999887 7999999999875432 2234


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..+..  .++...+..+.++|.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~  235 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence            45789999999998764 588999999999999999999999976 566677777766544  23445678899999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~  181 (502)
                      |. +|.+||     ++.+++.||||+...
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            99 999999     699999999997643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=3.9e-30  Score=260.47  Aligned_cols=176  Identities=24%  Similarity=0.382  Sum_probs=150.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|..++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++... .....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCcc
Confidence            6789999999998888999999999999999999999998  9999999999999886 799999999987532 22233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+.....  .++...+..+.++|.+|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGL  230 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            45679999999998864 588999999999999999999999976 566777888776644  34445678899999999


Q ss_pred             hh-CcCCCCCH----HHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLPA----KELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpSa----~ELL~hPff~~~~~  182 (502)
                      |. +|.+|+++    .+++.|+||....+
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            99 99999875    59999999976443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=280.17  Aligned_cols=181  Identities=34%  Similarity=0.602  Sum_probs=156.5

Q ss_pred             CCCCcHHHHHH-hCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            2 FTSGTLREYRK-KYTRV--DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         2 ~tgGsL~~yi~-k~~~L--~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      ..||+|..+++ +.+++  ++..+..|.+|||+||.|||.+.  |||||||-+|+|++.-.|.+||.|||.++.+..- .
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP  731 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP  731 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence            47999999996 46888  99999999999999999999998  9999999999999987799999999999887543 3


Q ss_pred             CcccccCCCcccCccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ...++-||..|||||++.   ..|+.++|||||||++.||.||++||.+..++....-++.--+.-++++...+++++.|
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F  811 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF  811 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence            356788999999999985   35999999999999999999999999987777655555544444456666778999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCCCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEP  184 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~~~~~  184 (502)
                      |.+|+. +|.+||+|++||.+||++..+..+
T Consensus       812 ilrcFepd~~~R~sA~~LL~DpFlq~~~kk~  842 (1226)
T KOG4279|consen  812 ILRCFEPDPCDRPSAKDLLQDPFLQHNNKKP  842 (1226)
T ss_pred             HHHHcCCCcccCccHHHhccCcccccCCCCC
Confidence            999999 999999999999999998775443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=8.2e-30  Score=265.13  Aligned_cols=178  Identities=26%  Similarity=0.379  Sum_probs=142.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+...    
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCcccccccccc
Confidence            5789999999999889999999999999999999999998  9999999999999876 79999999997533100    


Q ss_pred             --------------------------------------------CCcccccCCCcccCcccccc-CCCCcccchhHHHHH
Q 010730           77 --------------------------------------------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV  111 (502)
Q Consensus        77 --------------------------------------------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviL  111 (502)
                                                                  ....+.+||+.|+|||++.+ .|+.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        01134689999999998764 589999999999999


Q ss_pred             HHHhhccCCCCCCCChHHHHHHhhcC--CCCCcccccccHHHHHHHHHhhh---CcCCCCCHHHHhcCCCCcCCCC
Q 010730          112 LEMLTSEYPYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE---NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       112 yeLLTG~~Pf~~~~~~~ql~~kI~~g--~~p~~~~~~~s~~l~~LI~kcL~---dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      |+|++|..||... +..+...++...  ..........++++++||.+|+.   ++..|+++.+++.||||....+
T Consensus       239 ~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         239 FEMLVGQPPFLAP-TPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHhCCCCCcCC-CHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9999999999764 344444444432  22222222457899999999664   5566999999999999986544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.1e-30  Score=262.06  Aligned_cols=175  Identities=27%  Similarity=0.435  Sum_probs=150.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++.+...+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCce
Confidence            5789999999998888999999999999999999999998  9999999999999876 79999999999765433 334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+.....  .++...++.++++|.+|
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~  232 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRAL  232 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            45789999999998864 588899999999999999999999976 455666666665554  23445678999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~  181 (502)
                      |. +|.+||+     +.+++.||||....
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            98 9999999     77899999997654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=6.9e-30  Score=259.76  Aligned_cols=176  Identities=23%  Similarity=0.434  Sum_probs=151.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCccc
Confidence            6789999999999889999999999999999999999998  9999999999999977 79999999998754322 223


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++.+.....  .++...+.++.+++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            45679999999998864 589999999999999999999999976 566777888776654  33445678999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. +|.+|++     .++++.||||+...+
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            98 9999997     579999999987544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=6.1e-30  Score=266.28  Aligned_cols=176  Identities=24%  Similarity=0.462  Sum_probs=144.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.||+|.+++.+. .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+.....  
T Consensus       124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceecccCCcee
Confidence            67899999999765 5899999999999999999999998  9999999999999876 7999999999987643222  


Q ss_pred             cccccCCCcccCcccccc-----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc--ccccHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~--~~~s~~l  151 (502)
                      ..+.+||+.|+|||++.+     .++.++|||||||++|+|++|..||.. .+....+.++........++  ...+..+
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence            245789999999998853     278899999999999999999999976 45566677776543222222  2357889


Q ss_pred             HHHHHHhhhC-c--CCCCCHHHHhcCCCCcCCC
Q 010730          152 RRFVGKCLEN-V--SKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       152 ~~LI~kcL~d-P--~kRpSa~ELL~hPff~~~~  181 (502)
                      +++|.+||.+ +  ..|+++.|+++||||+...
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            9999999973 3  3488999999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=1.3e-30  Score=275.73  Aligned_cols=171  Identities=27%  Similarity=0.458  Sum_probs=151.4

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-cccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSV   82 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~~s~   82 (502)
                      -|+|++++...+.++|+.++.++.|++.||.|||+++  |+|||+||.|||+.+. |.+|++|||+|+.+..... +.++
T Consensus        84 ~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   84 VGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCceeeeec
Confidence            4599999999999999999999999999999999999  9999999999999987 8999999999998765444 4567


Q ss_pred             cCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-
Q 010730           83 IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-  160 (502)
Q Consensus        83 vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-  160 (502)
                      .|||.|||||++++ .|+..+|+||||||+|||++|++||.. ....++.+.|.....  .++...+..+.+|+..+|. 
T Consensus       161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v--~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPV--KPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCC--CCcccccHHHHHHHHHHhhc
Confidence            89999999999875 499999999999999999999999976 556677777776554  3344668899999999998 


Q ss_pred             CcCCCCCHHHHhcCCCCcCC
Q 010730          161 NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       161 dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||.+|++..+|+.|||.+..
T Consensus       238 dP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ChhhcccHHHHhcChHHhhh
Confidence            99999999999999998754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=271.77  Aligned_cols=162  Identities=23%  Similarity=0.512  Sum_probs=141.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC------CcccccCCCcccC
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ------QAHSVIGTPEFMA   90 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~------~~~s~vGTp~Y~A   90 (502)
                      +++.+++.|++.++.||+|||.||  ||||||||+|+|++.+ |+|||+|||++..+..+.      .+...+|||.|||
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A  283 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA  283 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence            899999999999999999999999  9999999999999988 899999999998763321      2344789999999


Q ss_pred             ccccccC-----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCC
Q 010730           91 PELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSK  164 (502)
Q Consensus        91 PEvl~~~-----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~k  164 (502)
                      ||++.+.     .+.+.||||+||+||.|+.|++||.+ ....++|++|....+..+........+++||.+||. ||.+
T Consensus       284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~  362 (576)
T KOG0585|consen  284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQ  362 (576)
T ss_pred             hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhh
Confidence            9987542     46789999999999999999999977 777899999999887555555568899999999998 9999


Q ss_pred             CCCHHHHhcCCCCcCCCC
Q 010730          165 RLPAKELLLDPFLASDAG  182 (502)
Q Consensus       165 RpSa~ELL~hPff~~~~~  182 (502)
                      |++..++..|||......
T Consensus       363 Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  363 RITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             eeehhhheecceeccCCC
Confidence            999999999999976543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.6e-30  Score=264.41  Aligned_cols=176  Identities=31%  Similarity=0.469  Sum_probs=149.3

Q ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            5 GTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         5 GsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      -||.++++.    ..+++...++-++.||++||.|||++|  |+||||||+|+|+|.+.|.+||+|||.|+.+..+....
T Consensus       106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni  183 (364)
T KOG0658|consen  106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI  183 (364)
T ss_pred             HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence            367777764    577999999999999999999999988  99999999999999998999999999999998888888


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC------------------CCC
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG------------------KLP  140 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g------------------~~p  140 (502)
                      +++.|..|.|||++-+  .|+.++||||.||++.||+-|++-|++.+..+|+...+.--                  ++|
T Consensus       184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p  263 (364)
T KOG0658|consen  184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP  263 (364)
T ss_pred             eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence            8999999999997754  59999999999999999999999999876666664433210                  111


Q ss_pred             ----Cc----ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          141 ----GA----FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       141 ----~~----~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                          ..    +....++++-+|+.++|. +|.+|.++.|+|.||||.....
T Consensus       264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                11    333458899999999999 9999999999999999975433

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=7.1e-30  Score=258.19  Aligned_cols=175  Identities=29%  Similarity=0.409  Sum_probs=138.4

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ----QA   79 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~----~~   79 (502)
                      +++|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++......    ..
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  163 (338)
T cd07859          87 ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFW  163 (338)
T ss_pred             CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCccccccccccCccccc
Confidence            6899999998889999999999999999999999998  9999999999999876 799999999997543211    12


Q ss_pred             ccccCCCcccCccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHH--------------HHHhhcC-----
Q 010730           80 HSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--------------YKKVTSG-----  137 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql--------------~~kI~~g-----  137 (502)
                      ...+||+.|+|||++.   ..++.++|||||||++|+|++|++||.+.....++              ...+...     
T Consensus       164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  243 (338)
T cd07859         164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY  243 (338)
T ss_pred             cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence            3467999999999875   35899999999999999999999999764322211              1111100     


Q ss_pred             ------CCCCcc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          138 ------KLPGAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       138 ------~~p~~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                            ..+..+   ....++.+.++|.+||. +|.+|||++|+|.||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                  001000   11246788999999998 999999999999999997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=1e-29  Score=259.10  Aligned_cols=177  Identities=29%  Similarity=0.502  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ +.+||+|||++..+... ...
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~  160 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MAN  160 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCC-CcEEEccCccccccccc-ccc
Confidence            6789999999999888999999999999999999999752 29999999999999877 79999999999765432 234


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHh-------------------------
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-------------------------  134 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI-------------------------  134 (502)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +..++...+                         
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccccccc
Confidence            5679999999998864 5899999999999999999999999652 222222211                         


Q ss_pred             ---------------------hcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          135 ---------------------TSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       135 ---------------------~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                           .....+.......+.++++||.+||. ||.+|||+.|||+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                 11111111122356789999999999 999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.7e-30  Score=272.92  Aligned_cols=175  Identities=36%  Similarity=0.595  Sum_probs=157.4

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.||+|.+.|++.+  .++++.+..|+.||+.||.|||+..  |+|||||+.|||++.+ +.|||+|||+|+.+.... 
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcCCchh
Confidence            789999999997654  6999999999999999999999887  9999999999999987 678999999999987765 


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...+++|||.||+||++.+ .|+.++||||||||+|||++-+++|.. .+...+..+|..+... +.+...+.+++.+|.
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~~-Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLYS-PLPSMYSSELRSLVK  239 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccCC-CCCccccHHHHHHHH
Confidence            6788999999999999986 599999999999999999999999976 7788888888887753 455667889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .||. +|..||+|.+||.+|.++..
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhH
Confidence            9998 99999999999999888643

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=9.2e-30  Score=252.63  Aligned_cols=179  Identities=26%  Similarity=0.470  Sum_probs=145.2

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+...
T Consensus        74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCC
Confidence            6789999988843    356999999999999999999999998  9999999999999876 78999999999766443


Q ss_pred             C-CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCCCcccccccHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      . ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....   ...+...+.....  .++...+..+
T Consensus       151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  228 (280)
T cd05608         151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDKFSPAS  228 (280)
T ss_pred             CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCcccCCHHH
Confidence            2 234467999999999886 4588999999999999999999999975332   2333444433322  3344567899


Q ss_pred             HHHHHHhhh-CcCCCC-----CHHHHhcCCCCcCCCCCC
Q 010730          152 RRFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP  184 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~~~  184 (502)
                      ++++.+||. +|.+|+     ++++++.||||+...+..
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            999999998 999999     899999999998754443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=1.2e-29  Score=250.54  Aligned_cols=170  Identities=31%  Similarity=0.461  Sum_probs=136.7

Q ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      .++|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...........
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~  166 (288)
T cd07863          90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTP  166 (288)
T ss_pred             ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCccccccCcccCCC
Confidence            46899999764  34899999999999999999999998  9999999999999876 7999999999987654444455


Q ss_pred             ccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-------CCCC------------
Q 010730           82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-------KLPG------------  141 (502)
Q Consensus        82 ~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-------~~p~------------  141 (502)
                      ..||+.|+|||++. ..++.++|||||||++|+|++|.+||........ +.++...       .++.            
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T cd07863         167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPRDVTLPRGAFSPR  245 (288)
T ss_pred             ccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCcccccccccccCCC
Confidence            78999999999875 4589999999999999999999999976433332 2222110       0000            


Q ss_pred             ------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 ------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 ------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                            ......+..++++|.+||. ||.+|||+.|+|.||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  0111246678999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=1.4e-29  Score=258.21  Aligned_cols=178  Identities=22%  Similarity=0.416  Sum_probs=145.3

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+ ...+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+..... 
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccCCcc
Confidence            6789999999987 467999999999999999999999998  9999999999999876 7999999999976533222 


Q ss_pred             -cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc---cccc
Q 010730           79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH---RIQD  148 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~---~~~s  148 (502)
                       ....+||+.|+|||++.      ..++.++|||||||++|+|++|..||.. .+..+.+.++........++   ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccCC
Confidence             23357999999999874      3488999999999999999999999976 55666777776544221222   2357


Q ss_pred             HHHHHHHHHhhh---CcCCCCCHHHHhcCCCCcCCCC
Q 010730          149 AEARRFVGKCLE---NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       149 ~~l~~LI~kcL~---dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .++++||.+||.   ++..|+++.|+++||||....+
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            899999999996   3344789999999999986544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.96  E-value=1.1e-29  Score=254.45  Aligned_cols=174  Identities=23%  Similarity=0.389  Sum_probs=137.1

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +|+|.+++.+. +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          86 HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceeccCCCccCCC
Confidence            57888888764 57999999999999999999999998  9999999999999876 79999999998754322 22345


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCC---------------CCc
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL---------------PGA  142 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~---------------p~~  142 (502)
                      .+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+..+.....+.+..  +..               +..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            678999999998754  4788999999999999999999999875554433332211  000               000


Q ss_pred             c------------c-ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          143 F------------H-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       143 ~------------~-~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +            . ...+..+++||.+||. ||.+|+|+.|+|.||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            0            0 0123578999999999 99999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.96  E-value=1.1e-29  Score=253.12  Aligned_cols=170  Identities=22%  Similarity=0.423  Sum_probs=134.9

Q ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      .|+|.+++...+ .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus        86 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          86 DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeeccCCCccccC
Confidence            469999997654 5899999999999999999999998  9999999999999876 79999999999765432 22344


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CC-------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GK-------------------  138 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~-------------------  138 (502)
                      ..||+.|+|||++.+  .++.++|||||||++|+|+||.+||.+...... ...+..  +.                   
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhhccc
Confidence            678999999998753  489999999999999999999999976433322 222211  00                   


Q ss_pred             CCC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          139 LPG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       139 ~p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++.       ......+.++++||.+||. ||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            000       0011246789999999999 99999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=2e-29  Score=262.20  Aligned_cols=176  Identities=22%  Similarity=0.421  Sum_probs=146.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.||+|.+++++. .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+....  .
T Consensus       124 y~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         124 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCCccc
Confidence            57899999999764 5899999999999999999999998  9999999999999876 799999999998764332  2


Q ss_pred             cccccCCCcccCcccccc-----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc--ccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~--~~~~~s~~l  151 (502)
                      ....+||+.|+|||++..     .++.++|||||||++|+|++|..||.. .+....+.++........  .....+..+
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            245689999999998853     278899999999999999999999976 566777888776542222  223467899


Q ss_pred             HHHHHHhhhCcCC---CCCHHHHhcCCCCcCCC
Q 010730          152 RRFVGKCLENVSK---RLPAKELLLDPFLASDA  181 (502)
Q Consensus       152 ~~LI~kcL~dP~k---RpSa~ELL~hPff~~~~  181 (502)
                      +++|.+||.+|.+   |+++.++++||||+...
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            9999999985433   78999999999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.3e-29  Score=257.04  Aligned_cols=175  Identities=29%  Similarity=0.496  Sum_probs=143.7

Q ss_pred             CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            4 SGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         4 gGsL~~yi~k~~----~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      .-+|.+|+...+    .++...++.+++||+.||+|||+++  |+||||||+|||++.. |.+||+|||+|+...-. ..
T Consensus       100 d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKlaDFGlAra~~ip~~~  176 (323)
T KOG0594|consen  100 DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLADFGLARAFSIPMRT  176 (323)
T ss_pred             cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeeeccchHHHhcCCccc
Confidence            457889998765    5888999999999999999999999  9999999999999986 89999999999876533 33


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC---------------C
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---------------G  141 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p---------------~  141 (502)
                      ....++|.+|.|||++-+  .|+..+||||+|||++||+++++-|++..+.+++.+...--..|               .
T Consensus       177 yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~  256 (323)
T KOG0594|consen  177 YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA  256 (323)
T ss_pred             ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc
Confidence            566889999999998754  49999999999999999999999999877777765544321111               0


Q ss_pred             cccc------------cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          142 AFHR------------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       142 ~~~~------------~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .++.            ..++...+++.+||. +|.+|.||+.+|.||||....
T Consensus       257 ~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  257 PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            0100            113578999999999 999999999999999997653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.3e-29  Score=265.91  Aligned_cols=171  Identities=26%  Similarity=0.364  Sum_probs=140.0

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--Ccccc
Q 010730            6 TLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAHSV   82 (502)
Q Consensus         6 sL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~~~s~   82 (502)
                      +|.-++.. .-.|++.+|+.|++||+.||+|||++|  |+|||||++|||+|.+ |.+||+|||||+++....  .++..
T Consensus       203 DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~~~~T~r  279 (560)
T KOG0600|consen  203 DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGSAPYTSR  279 (560)
T ss_pred             hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEeccccceeeccCCCCcccccc
Confidence            45555544 236999999999999999999999999  9999999999999987 899999999999775443  46778


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--Cccc--------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFH--------------  144 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~--------------  144 (502)
                      +-|.+|.|||++.|  .|+.++|+||+||||.||++|++.|.+....+|+-+...-+--|  ..|+              
T Consensus       280 VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~  359 (560)
T KOG0600|consen  280 VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQ  359 (560)
T ss_pred             eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCC
Confidence            89999999998764  59999999999999999999999999977777764433221111  0011              


Q ss_pred             ----------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 ----------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 ----------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                ...++.+.+|+..||. ||.+|.||.++|+++||..
T Consensus       360 ~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  360 PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                      1236778899999999 9999999999999999943

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=2.4e-29  Score=253.33  Aligned_cols=188  Identities=26%  Similarity=0.371  Sum_probs=151.6

Q ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCcccc
Q 010730            5 GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSV   82 (502)
Q Consensus         5 GsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s~   82 (502)
                      -+|+..+.+-+ ++...+++.++.|+|.||+|||.+.  |+|||||++|+|++.. |.+||+|||+|+.+... ...+..
T Consensus       161 hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~l  237 (419)
T KOG0663|consen  161 HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKPYTPL  237 (419)
T ss_pred             hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccchhhhhcCCcccCcce
Confidence            46778887654 8999999999999999999999999  9999999999999876 89999999999988654 345667


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--------------------  140 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--------------------  140 (502)
                      +-|.+|.|||++.+  .|++++|+||+|||+.||+++.+.|++....+|+.+.+.---.|                    
T Consensus       238 VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~  317 (419)
T KOG0663|consen  238 VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFS  317 (419)
T ss_pred             EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccC
Confidence            88999999998754  49999999999999999999999999988888876654321111                    


Q ss_pred             --------Cccccc-ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC--CCCCCCCCCCccC
Q 010730          141 --------GAFHRI-QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG--EPLLIPQVPSFQN  195 (502)
Q Consensus       141 --------~~~~~~-~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~--~~l~~p~~p~~~~  195 (502)
                              ..|... .+....+|+..+|. ||.+|.||.|.|+|.||...+.  .+-..|++|....
T Consensus       318 ~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~  384 (419)
T KOG0663|consen  318 EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE  384 (419)
T ss_pred             CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence                    011112 35778899999998 9999999999999999986433  2333555555443

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-29  Score=242.43  Aligned_cols=173  Identities=32%  Similarity=0.573  Sum_probs=144.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||..+  |+||||||+||+++.+ +.++|+|||+++.......  
T Consensus        85 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          85 YMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             ECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecccccccc
Confidence            4679999999999889999999999999999999999998  9999999999999876 7999999999976543211  


Q ss_pred             --cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        .....|++.|+|||++.+ .++.++|||||||++|+|++|..||.......... .+........++...+..++++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHHHH
Confidence              133568899999998864 48899999999999999999999997754444444 33333333345556788999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+||. +|.+|||+.++|+||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99998 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.4e-29  Score=254.68  Aligned_cols=178  Identities=22%  Similarity=0.397  Sum_probs=143.7

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++.+ ...+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+......
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCCCCc
Confidence            6789999999987 467999999999999999999999998  9999999999999876 79999999999765433222


Q ss_pred             --ccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC---ccccccc
Q 010730           80 --HSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQD  148 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~---~~~~~~s  148 (502)
                        ...+||+.|+|||++.      +.++.++|||||||++|+|++|..||.. .+..+.+.++.......   ......+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCCCC
Confidence              2356999999999885      3478899999999999999999999976 45566666665432211   1122357


Q ss_pred             HHHHHHHHHhhh---CcCCCCCHHHHhcCCCCcCCCC
Q 010730          149 AEARRFVGKCLE---NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       149 ~~l~~LI~kcL~---dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ..+++||.+||.   ++..|+++.++|.||||....+
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            889999999986   3344789999999999976544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=3e-29  Score=252.22  Aligned_cols=173  Identities=31%  Similarity=0.435  Sum_probs=130.9

Q ss_pred             CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC---CCCcEEEEecCCc
Q 010730            3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQIKIGDLGLA   70 (502)
Q Consensus         3 tgGsL~~yi~k~---------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~---~~g~vKL~DFGlA   70 (502)
                      .+++|.+++...         ..+++..++.++.||+.||+|||+++  |+||||||+|||+..   ..+.+||+|||++
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            467888887632         25899999999999999999999998  999999999999942   2368999999999


Q ss_pred             eeccCCC----CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCCh---------HHHHHHhh
Q 010730           71 AILRGSQ----QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------AQIYKKVT  135 (502)
Q Consensus        71 ~~~~~~~----~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---------~ql~~kI~  135 (502)
                      ..+....    .....+||+.|+|||++.+  .|+.++||||+||++|+|++|.+||......         .++.+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            8764321    2345689999999998754  4889999999999999999999999643210         11111100


Q ss_pred             cCCCC------------C-----------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          136 SGKLP------------G-----------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       136 ~g~~p------------~-----------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ....|            .                       ......+..+.+||.+||. ||.+|+|++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000            0                       0011134578899999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.3e-29  Score=259.82  Aligned_cols=174  Identities=21%  Similarity=0.420  Sum_probs=158.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |..+|.|.+|+...+.|++.+++.+++||++|+.|||.++  |+|||||.+|||++.| +.+||+||||+..+.....+.
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccccHHH
Confidence            6789999999999999999999999999999999999999  9999999999999998 799999999999998888899


Q ss_pred             cccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ++||+|-|.+||++.+.  -++.+|.|||||+||.|+.|..||.+ .+-..+.++|..|.+..+.   .+..+.-||+-|
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwm  286 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREPE---TPSDASGLIRWM  286 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCCC---CCchHHHHHHHH
Confidence            99999999999999875  47899999999999999999999977 6667888899998874332   345789999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. ||.+|.|+.++..|=|+.-+.
T Consensus       287 LmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  287 LMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             HhcCcccchhHHHHhhhheeeccc
Confidence            97 999999999999998886443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=267.60  Aligned_cols=180  Identities=25%  Similarity=0.432  Sum_probs=167.1

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +-||.|...+++.+.++...++.++..+++|++|||++|  ||.|||||+|++++.+ |.+||.|||+|+.+..+.+..+
T Consensus       502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCceee
Confidence            469999999999999999999999999999999999999  9999999999999987 8999999999999999999999


Q ss_pred             ccCCCcccCcccc-ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           82 VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        82 ~vGTp~Y~APEvl-~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      +||||.|+|||++ ...-+.++|.||||+++||||+|.+||++ .++-..|..|..|.-...++..+...+.++|.++..
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr  657 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR  657 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence            9999999999965 56689999999999999999999999987 788999999999987777888888999999999887


Q ss_pred             -CcCCCCC-----HHHHhcCCCCcCCCCCCC
Q 010730          161 -NVSKRLP-----AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       161 -dP~kRpS-----a~ELL~hPff~~~~~~~l  185 (502)
                       +|.+|+.     +.+|-+|.||.+.+|.-+
T Consensus       658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  658 DNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             cCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence             9999987     899999999998887654

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=3.4e-29  Score=257.72  Aligned_cols=171  Identities=27%  Similarity=0.389  Sum_probs=135.0

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++..  .+++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++............
T Consensus       109 ~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~  183 (359)
T cd07876         109 DANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYV  183 (359)
T ss_pred             CcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCCccccccCccCCCCc
Confidence            4667777643  5889999999999999999999998  9999999999999887 799999999997655444445678


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh---------------------cC--CC
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT---------------------SG--KL  139 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~---------------------~g--~~  139 (502)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.                     ..  ..
T Consensus       184 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (359)
T cd07876         184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQY  263 (359)
T ss_pred             ccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCC
Confidence            9999999998864 589999999999999999999999986443222211110                     00  00


Q ss_pred             C---------C-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          140 P---------G-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       140 p---------~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +         .       ......+..+++||.+||. ||.+|||+.|+|+||||..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         264 PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             CCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            0         0       0112235678999999999 9999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=5.1e-29  Score=256.81  Aligned_cols=170  Identities=29%  Similarity=0.421  Sum_probs=136.0

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +++|.+++..  .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++...........+
T Consensus       112 ~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~  186 (364)
T cd07875         112 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  186 (364)
T ss_pred             CCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCccccCCCCcccCCc
Confidence            4678888754  5889999999999999999999998  9999999999999877 799999999998765544445678


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CC--------------------C-
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KL--------------------P-  140 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~--------------------p-  140 (502)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+.++... ..                    | 
T Consensus       187 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (364)
T cd07875         187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK  265 (364)
T ss_pred             ccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCC
Confidence            9999999998764 589999999999999999999999976433 3333332210 00                    0 


Q ss_pred             ------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          141 ------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       141 ------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                        .......+..+++||.+||. ||.+|||+.|+|+||||..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             cCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                              00111234678999999999 9999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=3.5e-29  Score=245.92  Aligned_cols=171  Identities=27%  Similarity=0.409  Sum_probs=140.1

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc-cccc
Q 010730            6 TLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-HSVI   83 (502)
Q Consensus         6 sL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~-~s~v   83 (502)
                      +|...|+. ...+....++.|+.++++||+|||.+.  |+||||||.|+|++.+ |.+||+|||+|+.+...... ...+
T Consensus        86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~~~~~V  162 (318)
T KOG0659|consen   86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRIQTHQV  162 (318)
T ss_pred             cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccCCCCcccccce
Confidence            67777754 456999999999999999999999999  9999999999999987 89999999999987644332 2347


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCccc---------------
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFH---------------  144 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~---------------  144 (502)
                      -|.+|.|||++-|  .|+..+||||+|||+.||+-|.+-|++.++.+|+-..+..--.  +..|+               
T Consensus       163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P  242 (318)
T KOG0659|consen  163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP  242 (318)
T ss_pred             eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence            8999999997754  5999999999999999999999889988888887544332111  11111               


Q ss_pred             --------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 --------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 --------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                              ...+.++-+|+.+||. ||.+|++|.|+|+|+||..
T Consensus       243 ~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  243 KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                    1235677999999999 9999999999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.4e-29  Score=247.96  Aligned_cols=178  Identities=25%  Similarity=0.436  Sum_probs=145.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus        78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~  153 (279)
T cd05633          78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH  153 (279)
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceecccc-Ccc
Confidence            6789999999998889999999999999999999999998  9999999999999876 79999999998765432 223


Q ss_pred             cccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...||+.|+|||++.  ..++.++|||||||++|+|++|..||....  ....+.....  ..+..++...+.+++++|.
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHH
Confidence            457999999999875  347899999999999999999999996532  2222222211  1222344456789999999


Q ss_pred             Hhhh-CcCCCC-----CHHHHhcCCCCcCCCCCC
Q 010730          157 KCLE-NVSKRL-----PAKELLLDPFLASDAGEP  184 (502)
Q Consensus       157 kcL~-dP~kRp-----Sa~ELL~hPff~~~~~~~  184 (502)
                      +||. +|.+|+     +++|+++||||+......
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            9998 999999     699999999998755433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=4.8e-29  Score=247.09  Aligned_cols=178  Identities=23%  Similarity=0.414  Sum_probs=144.9

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++...+  .+++..+..++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++........
T Consensus        74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCce
Confidence            578999999986543  5899999999999999999999998  9999999999999876 7899999999987655444


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .....||+.|+|||++. ..++.++|||||||++|+|++|..||....   +..++.+.+.....+.. ....+.+++++
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  229 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDI  229 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHH
Confidence            44567999999999875 458999999999999999999999997532   23344455444443322 22457889999


Q ss_pred             HHHhhh-CcCCCCCH----HHHhcCCCCcCCCC
Q 010730          155 VGKCLE-NVSKRLPA----KELLLDPFLASDAG  182 (502)
Q Consensus       155 I~kcL~-dP~kRpSa----~ELL~hPff~~~~~  182 (502)
                      |.+||. +|.+||++    ++++.||||+...+
T Consensus       230 i~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         230 CRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             HHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence            999998 99999999    67889999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=6e-29  Score=242.28  Aligned_cols=179  Identities=27%  Similarity=0.466  Sum_probs=152.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+...+++..+..++.||+.||.|||+++  ++|+||||+||+++.+ +.+||+|||++..........
T Consensus        74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~  150 (262)
T cd05572          74 YCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTW  150 (262)
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccc
Confidence            5679999999998888999999999999999999999988  9999999999999886 799999999998775543344


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCC-ChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...|++.|+|||++. ..++.++|+||||+++|+|++|..||.... +..++++++..+.....++...+..++++|.+|
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  230 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL  230 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence            567899999999875 458899999999999999999999997643 356677777654433344444578999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. +|.+|++     ++|+++||||+...+
T Consensus       231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            98 9999999     999999999986543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=4.8e-29  Score=255.87  Aligned_cols=171  Identities=29%  Similarity=0.402  Sum_probs=134.9

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      .|+|.+++..  .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++...........+
T Consensus       105 ~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  179 (355)
T cd07874         105 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  179 (355)
T ss_pred             cccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcccccCCCccccCCcc
Confidence            4567777754  5889999999999999999999998  9999999999999876 799999999998765544455678


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---------------------C----
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---------------------G----  137 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---------------------g----  137 (502)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+..                     .    
T Consensus       180 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (355)
T cd07874         180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY  259 (355)
T ss_pred             ccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcc
Confidence            9999999998764 5899999999999999999999999764322222111110                     0    


Q ss_pred             ---CCC-----------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          138 ---KLP-----------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       138 ---~~p-----------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                         .++           .......+..+++||.+||. ||.+|||+.|+|+||||..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             ccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence               000           00112235678999999999 9999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=5.7e-29  Score=253.88  Aligned_cols=179  Identities=21%  Similarity=0.415  Sum_probs=145.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++.+ .+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+......
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCCCce
Confidence            6789999999987 467999999999999999999999998  9999999999999876 79999999999876443222


Q ss_pred             --ccccCCCcccCcccccc------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc---cccc
Q 010730           80 --HSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH---RIQD  148 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~~------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~---~~~s  148 (502)
                        ...+||+.|+|||++.+      .++.++|||||||++|+|++|..||.. .+..+.+.++........++   ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~~  237 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITDVS  237 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccccCC
Confidence              23579999999998753      478899999999999999999999976 45566677766543211121   2247


Q ss_pred             HHHHHHHHHhhhCcCC---CCCHHHHhcCCCCcCCCCC
Q 010730          149 AEARRFVGKCLENVSK---RLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       149 ~~l~~LI~kcL~dP~k---RpSa~ELL~hPff~~~~~~  183 (502)
                      .+++++|.+||..+.+   |+++++++.||||+...+.
T Consensus       238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence            8999999999983333   5689999999999865443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.4e-29  Score=270.17  Aligned_cols=174  Identities=25%  Similarity=0.452  Sum_probs=149.6

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++...    ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus       120 y~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~vkL~DFGls~~~~~~  196 (496)
T PTZ00283        120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVKLGDFGFSKMYAAT  196 (496)
T ss_pred             CCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCEEEEecccCeecccc
Confidence            67899999999653    46999999999999999999999998  9999999999999987 79999999999865432


Q ss_pred             ---CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           77 ---QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        77 ---~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                         ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++.++..+..+ .++...+++++
T Consensus       197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~  274 (496)
T PTZ00283        197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSISPEMQ  274 (496)
T ss_pred             ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence               22345789999999998865 589999999999999999999999976 5667777777776654 34455678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ++|.+||. +|.+||++.++|.|||++.
T Consensus       275 ~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        275 EIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            99999998 9999999999999999864

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=5.1e-29  Score=267.97  Aligned_cols=173  Identities=30%  Similarity=0.466  Sum_probs=147.8

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+    ..++++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence            6789999998754    356999999999999999999999998  9999999999999876 79999999999876543


Q ss_pred             CC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           77 QQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        77 ~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ..   ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+..+ .++...+..++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~s~~~~  300 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCPVSSGMK  300 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCccCCHHHH
Confidence            22   345679999999998864 589999999999999999999999976 5566777777666554 23445678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      ++|.+||. +|.+||++.++|.|+|++
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            99999998 999999999999999985

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=7.4e-29  Score=245.87  Aligned_cols=178  Identities=26%  Similarity=0.443  Sum_probs=147.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++..+... ...
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~  153 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH  153 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCc
Confidence            6789999999998889999999999999999999999988  9999999999999877 78999999998765432 234


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ..+|++.|+|||++.+  .++.++||||+||++|+|++|..||....  ....+.+.+...  +..++...+..+.++|.
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~  231 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLE  231 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--CCCCCCcCCHHHHHHHH
Confidence            5679999999998853  48899999999999999999999997642  223333333222  22344455889999999


Q ss_pred             Hhhh-CcCCCC-----CHHHHhcCCCCcCCCCCC
Q 010730          157 KCLE-NVSKRL-----PAKELLLDPFLASDAGEP  184 (502)
Q Consensus       157 kcL~-dP~kRp-----Sa~ELL~hPff~~~~~~~  184 (502)
                      +||. +|.+|+     ++.++++||||+...+..
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            9998 999999     999999999998765544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.5e-29  Score=246.29  Aligned_cols=178  Identities=25%  Similarity=0.423  Sum_probs=145.3

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence            67899999988653  46999999999999999999999998  9999999999999876 7899999999987654444


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh---HHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ....+|++.|+|||++. ..++.++||||+||++|+|++|..||.+....   .++...+..+.  ..++...+..+++|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  235 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--EEYSEKFSEAARSI  235 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--cccCcccCHHHHHH
Confidence            45568999999999875 45889999999999999999999999764322   12233333222  22334467889999


Q ss_pred             HHHhhh-CcCCCC-----CHHHHhcCCCCcCCCCC
Q 010730          155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGE  183 (502)
Q Consensus       155 I~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~~  183 (502)
                      |.+||. ||.+||     ++++++.||||....+.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            999998 999999     89999999999865443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=7.5e-29  Score=260.43  Aligned_cols=174  Identities=29%  Similarity=0.398  Sum_probs=135.4

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CCcc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQAH   80 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~~~   80 (502)
                      .+|+|.+++...+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.....  ....
T Consensus       165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCcccccccccccccc
Confidence            36899999988888999999999999999999999998  9999999999999876 79999999999753221  2234


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC-------hHHHHHHhhc-CCCCC----------
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-------PAQIYKKVTS-GKLPG----------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~-------~~ql~~kI~~-g~~p~----------  141 (502)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+...       ..++...+.. +..|.          
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            5689999999998864 589999999999999999999988754221       1111111100 10000          


Q ss_pred             ----------------c---ccc--cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          142 ----------------A---FHR--IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       142 ----------------~---~~~--~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                      .   +..  ..+.++.+||.+||. ||.+||||+|+|+||||+.
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                            0   000  124578999999999 9999999999999999975

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=262.18  Aligned_cols=179  Identities=26%  Similarity=0.451  Sum_probs=153.6

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      +|.||+|+-+|-+.+  .++++.++.|+.+|+.||++||...  ||.|||||+|||+|++ |+|+|.|+|||..+..++.
T Consensus       266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH-GHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC-CCeEeeccceEEecCCCCc
Confidence            589999999998776  7999999999999999999999998  9999999999999987 8999999999999988888


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ....+||.+|||||++. +.|+..+|+|||||++|+|+.|+.||.....   -+++-+.+...  +..++..-+++++++
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSEEAKSL  420 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCHHHHHH
Confidence            88889999999999886 5599999999999999999999999965221   12333333332  223445568999999


Q ss_pred             HHHhhh-CcCCCCC-----HHHHhcCCCCcCCCCCC
Q 010730          155 VGKCLE-NVSKRLP-----AKELLLDPFLASDAGEP  184 (502)
Q Consensus       155 I~kcL~-dP~kRpS-----a~ELL~hPff~~~~~~~  184 (502)
                      .+.+|. ||.+|+.     ++++.+||||+..++..
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            999998 9999985     88999999999887754

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=2.2e-28  Score=236.81  Aligned_cols=172  Identities=31%  Similarity=0.580  Sum_probs=145.2

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++..  ...+++..++.++.||+.||+|||+.+  |+||||||+||+++.+ +.++|+|||++...... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence            4678999999976  346899999999999999999999998  9999999999999876 79999999999876432 2


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ......|++.|+|||++.+ .++.++|||||||++++|++|..||.. .+...+...+..+..+. .+...+..+.++|.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHHHHH
Confidence            2344678999999998764 488899999999999999999999976 44455555666666543 34456789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=269.22  Aligned_cols=168  Identities=26%  Similarity=0.466  Sum_probs=147.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      ++.||.|.+-|.+.+.+. ..+..|++||+.++.|||++|  ||||||||+|||++++.+.++|+|||.++.....  ..
T Consensus       397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~  471 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CD  471 (612)
T ss_pred             hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--hc
Confidence            356788888887766555 788899999999999999998  9999999999999645589999999999887654  33


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +-+-|..|.|||++.. .|++++||||||++||+||+|+.||....+..+++.++..+++.    ...+.++++||.+||
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQLL  547 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHhc
Confidence            4466889999999874 59999999999999999999999998877778899999887664    566899999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCC
Q 010730          160 E-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff  177 (502)
                      + +|.+|+++.+++.||||
T Consensus       548 ~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  548 QVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCChhhCcChhhhccCcch
Confidence            9 99999999999999999

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=1.2e-28  Score=241.06  Aligned_cols=173  Identities=27%  Similarity=0.517  Sum_probs=140.7

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++...  ..+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++...... .
T Consensus        90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~~~~~  166 (272)
T cd06637          90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG  166 (272)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEccCCCceecccccc
Confidence            56789999999864  46899999999999999999999998  9999999999999987 78999999999765432 2


Q ss_pred             CcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           78 QAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ......|++.|+|||++.      ..|+.++|||||||++|+|++|..||.........+ .+.....+.......+..+
T Consensus       167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  245 (272)
T cd06637         167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSKKF  245 (272)
T ss_pred             cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhcCCCCCCCCCCcCHHH
Confidence            234567999999999874      247889999999999999999999997644333332 3333322223333456789


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++||.+||. +|.+|||+.+++.||||
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         246 QSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999998 99999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=9.6e-29  Score=252.65  Aligned_cols=175  Identities=30%  Similarity=0.532  Sum_probs=140.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. +  |+||||||+|||++.+ +.+||+|||++..+... ..
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-cc
Confidence            578999999999988899999999999999999999974 5  9999999999999876 78999999998765332 23


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHH---------------------------
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY---------------------------  131 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~---------------------------  131 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||... ...++.                           
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP-DAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-chhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            44679999999998865 4889999999999999999999999652 222221                           


Q ss_pred             -----------------HHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          132 -----------------KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       132 -----------------~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                       ..+.....+.......+.++++||.+||. ||.+|||+.|+|.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                             11111111111112346789999999999 99999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=1.7e-28  Score=239.75  Aligned_cols=173  Identities=28%  Similarity=0.491  Sum_probs=140.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+|+||||+||+++.+ +.+||+|||++....... ..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence            5678999999998889999999999999999999999998  9999999999999876 789999999987654321 22


Q ss_pred             ccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccc--cccHHHHH
Q 010730           80 HSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQDAEARR  153 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~--~~s~~l~~  153 (502)
                      ....|++.|+|||++.    +.++.++|+|||||++|+|++|..||........+.........+..+..  ..+..+++
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            3457999999999873    34888999999999999999999999764443333333222222222211  23578999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPf  176 (502)
                      +|.+||. +|.+||++++++.|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            9999998 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=2e-28  Score=249.05  Aligned_cols=154  Identities=23%  Similarity=0.385  Sum_probs=126.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---QAHSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~~~s~vGTp~Y~APE   92 (502)
                      ++++..+..++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||+++.+....   ......+++.|+|||
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            4788899999999999999999988  9999999999999876 799999999997653221   122345678999999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..|+.++|||||||++|+|++ |..||.+......+.+.+..+..+ ..+...++.++++|.+||. +|.+|||+.
T Consensus       247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~  325 (338)
T cd05102         247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTFS  325 (338)
T ss_pred             HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            875 458999999999999999997 999998755555566666555443 2344567899999999998 999999999


Q ss_pred             HHhc
Q 010730          170 ELLL  173 (502)
Q Consensus       170 ELL~  173 (502)
                      |+++
T Consensus       326 el~~  329 (338)
T cd05102         326 ALVE  329 (338)
T ss_pred             HHHH
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.3e-29  Score=243.08  Aligned_cols=172  Identities=25%  Similarity=0.486  Sum_probs=155.6

Q ss_pred             CCCCCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~--k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |.++|+|...++  +.+++++..+..|++|++.||.|||..+  ||||||||+|+|+... +.+||+|||.+.... ...
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNK  178 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeecC-CCC
Confidence            578999999999  6788999999999999999999999988  9999999999999877 799999999997654 566


Q ss_pred             cccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ..+.|||..|.+||+.++. ++..+|+|++|+++||++.|.+||.. .+..+.|++|..-.+  .++...+..++++|.+
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~~--~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVDL--KFPSTISGGAADLISR  255 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHccc--cCCcccChhHHHHHHH
Confidence            7889999999999998764 89999999999999999999999977 448899999988776  3456778999999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ||. +|.+|++..|++.|||+..
T Consensus       256 ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  256 LLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HhccCccccccHHHHhhhHHHHh
Confidence            998 9999999999999999853

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.1e-28  Score=246.39  Aligned_cols=168  Identities=21%  Similarity=0.299  Sum_probs=144.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++.....++.||+.||.|||.. +  ++||||||+||+++.+ +.+||+|||+++.....  .
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--P  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhccc--c
Confidence            678999999999988999999999999999999999974 6  8899999999999987 79999999998765432  2


Q ss_pred             ccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...+||+.|+|||++.+   .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.....++...+..+++||.
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~  256 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE  256 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence            34578999999998864   689999999999999999999999976 45677777776554443444456789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. ||.+|||++|++..
T Consensus       257 ~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        257 ACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHhcCCcccCcCHHHHHHH
Confidence            9999 99999999999864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=1.3e-28  Score=245.41  Aligned_cols=176  Identities=25%  Similarity=0.417  Sum_probs=142.3

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc
Confidence            57899999998654  35999999999999999999999988  9999999999999876 7899999999977654444


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh--HHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP--AQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~--~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .....||+.|+|||++. ..++.++|||||||++|+|++|..||......  ......+... .+..+....++.+++||
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHH
Confidence            44568999999999885 45899999999999999999999999763321  1112222111 11233445678899999


Q ss_pred             HHhhh-CcCCCCC-----HHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLP-----AKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpS-----a~ELL~hPff~~~  180 (502)
                      .+||. +|.+|+|     ++|++.||||+..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            99999 9999999     9999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2e-28  Score=249.85  Aligned_cols=171  Identities=29%  Similarity=0.431  Sum_probs=136.1

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .+++|.++++. +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.....  .....
T Consensus       102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~--~~~~~  175 (343)
T cd07878         102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADD--EMTGY  175 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCccceecCC--CcCCc
Confidence            47889888754 56999999999999999999999998  9999999999999877 7999999999987543  23456


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--C--------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--K--------------------  138 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--~--------------------  138 (502)
                      +||+.|+|||++.+  .++.++|||||||++|+|++|..||.+... .+.+..+...  .                    
T Consensus       176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (343)
T cd07878         176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS  254 (343)
T ss_pred             cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc
Confidence            89999999998864  488999999999999999999999976332 2222222110  0                    


Q ss_pred             CC---C----cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          139 LP---G----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       139 ~p---~----~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++   .    ......++.+.+||.+||. ||.+|||+.|+|.||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            00   0    0001235678899999999 99999999999999999753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-28  Score=245.40  Aligned_cols=181  Identities=24%  Similarity=0.383  Sum_probs=145.8

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.||+|.+++.+.  ..+++..++.++.||+.||+|||+.+  |+|+||||+||+++.+ +.++|+|||++....... 
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccccccc
Confidence            46789999999864  56999999999999999999999998  9999999999999876 799999999986542211 


Q ss_pred             -----------------------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCCh
Q 010730           78 -----------------------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP  127 (502)
Q Consensus        78 -----------------------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~  127 (502)
                                                   .....+||..|+|||++.+ .++.++||||||+++|+|++|..||.+... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR-  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-
Confidence                                         1123478999999998764 488899999999999999999999976444 


Q ss_pred             HHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCC----HHHHhcCCCCcCCCCCCC
Q 010730          128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP----AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       128 ~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpS----a~ELL~hPff~~~~~~~l  185 (502)
                      ...+..+.............+..++++|.+||. +|.+||+    ++|+|.||||+...+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence            444444444333222222257899999999998 9999999    999999999987655443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=1.9e-28  Score=239.24  Aligned_cols=174  Identities=32%  Similarity=0.484  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-----   75 (502)
                      |+.+|+|.+++.+.+++++..+..++.||+.||+|||+.+  |+|+||||+||+++.+ +.+||+|||++.....     
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhccccc
Confidence            5689999999998888999999999999999999999988  9999999999999876 7999999999875421     


Q ss_pred             --CCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           76 --SQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        76 --~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                        ........|++.|+|||++.+ .++.++|+|||||++|+|++|..||......................+...+.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence              111234568999999998864 48899999999999999999999997654444444333221222234445678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++|.+||. +|.+||++.++|.||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999998 99999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=3e-28  Score=240.48  Aligned_cols=170  Identities=27%  Similarity=0.464  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+.+  |+||||||+||+++.+.+.++|+|||++......   .
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~  164 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S  164 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence            5789999999998889999999999999999999999998  9999999999999987348999999998765432   2


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCCh----HHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP----AQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~----~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ...|++.|+|||++.+ .++.++|||||||++|+|++|..||......    ..+.... .  .+.......++.+++||
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--KKLPFIKNVSKNANDFV  241 (267)
T ss_pred             cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--ccCCcccccCHHHHHHH
Confidence            3468999999998864 5889999999999999999999999753221    2222222 2  12233446789999999


Q ss_pred             HHhhh-CcCCCCC-HHHHhcCCCCc
Q 010730          156 GKCLE-NVSKRLP-AKELLLDPFLA  178 (502)
Q Consensus       156 ~kcL~-dP~kRpS-a~ELL~hPff~  178 (502)
                      .+||. +|.+|++ ++|+|+||||.
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHhccChhhCCchHHHHhcCCccc
Confidence            99999 9999996 69999999996

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=4.5e-28  Score=234.12  Aligned_cols=172  Identities=30%  Similarity=0.573  Sum_probs=146.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.|++|.+++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+ +.+||+|||+++.+.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence            57899999999774  57999999999999999999999988  9999999999999986 7899999999987654322


Q ss_pred             -cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       .....|++.|+|||++.+ .++.++|+|||||++++|++|..||.. .+...+.+++..+..+. .....+..+.++|.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  234 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQLID  234 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence             234578999999998754 488999999999999999999999976 45666677777666543 33356788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+||++.++++|||+
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCcCHHHHhhCCCC
Confidence            9998 99999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.8e-28  Score=256.48  Aligned_cols=176  Identities=25%  Similarity=0.360  Sum_probs=139.0

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---Ccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---QAH   80 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~~~   80 (502)
                      +++|.+++.+.+.+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+....   ...
T Consensus       169 ~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccccCccccccccc
Confidence            5789999988889999999999999999999999998  9999999999999877 799999999997654322   123


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhh---cC----------------
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVT---SG----------------  137 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~---~g----------------  137 (502)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+...   ..++...+.   ..                
T Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  325 (392)
T PHA03207        246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF  325 (392)
T ss_pred             ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence            4679999999998864 589999999999999999999999976432   111111111   00                


Q ss_pred             ------CCC-Cccc-----ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          138 ------KLP-GAFH-----RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       138 ------~~p-~~~~-----~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                            ..+ ...+     ...+.++++||.+||. +|.+|||+.|+|.||||...+.
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence                  000 0000     1235678899999999 9999999999999999976544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=2e-28  Score=253.42  Aligned_cols=173  Identities=29%  Similarity=0.453  Sum_probs=139.3

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CCccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~~~s   81 (502)
                      +++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++......  .....
T Consensus        87 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~~~~~~  163 (372)
T cd07853          87 QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQ  163 (372)
T ss_pred             ccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccCccccCCC
Confidence            5789999988888999999999999999999999998  9999999999999887 79999999999865432  22334


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-----------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-----------------------  136 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-----------------------  136 (502)
                      .++|+.|+|||++.+  .|+.++|||||||++|+|++|+.||.+.. ..+....+..                       
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  242 (372)
T cd07853         164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEGARAHILR  242 (372)
T ss_pred             CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHh
Confidence            578999999998864  37899999999999999999999997633 3332222211                       


Q ss_pred             C-CCCC------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          137 G-KLPG------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       137 g-~~p~------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      . ..+.      .+....+.++.+||.+||. ||.+|||+.|+|.||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1 0111      1112346789999999999 99999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=3.4e-29  Score=242.09  Aligned_cols=174  Identities=32%  Similarity=0.620  Sum_probs=141.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~-~~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++  |+|+||||+||+++.+ +.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccccc
Confidence            3567799999998889999999999999999999999998  9999999999999966 79999999999764 233344


Q ss_pred             ccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCccc--ccccHHHHH
Q 010730           80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFH--RIQDAEARR  153 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~--~~~s~~l~~  153 (502)
                      ....+|+.|+|||++.  ..++.++||||||+++|+|++|..||.+..  +......+......+....  ......+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5678999999999886  568999999999999999999999998741  2233333333322211111  112378999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +|.+||. +|.+||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999 99999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=262.88  Aligned_cols=176  Identities=30%  Similarity=0.509  Sum_probs=146.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~   78 (502)
                      ||.||-+...+-.- ..|.+..|..+++|+|.||.|||+++  |||||||..|||++-+ |.|+|+|||++.... ....
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchhHHhh
Confidence            56778887777664 56999999999999999999999999  9999999999999987 899999999986543 3345


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l  151 (502)
                      ..+++|||+|||||++.      ..|+.++||||||++|.||..+.+|..+ -++-.+.-+|.....| -..+..++..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            67899999999999774      3599999999999999999999999987 4554444455444433 23344557889


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++|+.+||. ||..||++++||+||||...
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            999999998 99999999999999999843

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-28  Score=236.66  Aligned_cols=174  Identities=24%  Similarity=0.459  Sum_probs=147.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++++.+.+++..+..++.||+.||.|||+.+  |+||||+|+||+++.+ +.+||+|||++.....   ..
T Consensus        78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~  151 (260)
T cd05611          78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NK  151 (260)
T ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc---cc
Confidence            5789999999998888999999999999999999999998  9999999999999876 7899999999876432   23


Q ss_pred             cccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI~k  157 (502)
                      ...|++.|+|||.+.+. ++.++||||||+++|+|++|..||.. .+..+++..+..+..  +.......+..+.++|.+
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence            45689999999987654 78999999999999999999999976 555666766665543  223333467899999999


Q ss_pred             hhh-CcCCCCC---HHHHhcCCCCcCCC
Q 010730          158 CLE-NVSKRLP---AKELLLDPFLASDA  181 (502)
Q Consensus       158 cL~-dP~kRpS---a~ELL~hPff~~~~  181 (502)
                      ||. +|.+||+   ++|+|.||||+...
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            998 9999995   57999999997544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=4.3e-28  Score=237.02  Aligned_cols=174  Identities=32%  Similarity=0.560  Sum_probs=143.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++  |+|+||||+||+++.+ +.+||+|||++......    
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~  163 (265)
T cd06652          87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTICLSG  163 (265)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCccccccccccccc
Confidence            4678999999998888999999999999999999999998  9999999999999876 79999999998765321    


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .......|+..|+|||++. ..++.++|||||||++|+|++|..||........+.+ +.........+...+..+.++|
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i  242 (265)
T cd06652         164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRDFL  242 (265)
T ss_pred             cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHHHH
Confidence            1223456899999999875 4588899999999999999999999976544444433 3333222334445577899999


Q ss_pred             HHhhhCcCCCCCHHHHhcCCCCc
Q 010730          156 GKCLENVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       156 ~kcL~dP~kRpSa~ELL~hPff~  178 (502)
                      .+|+.+|.+||+++|+++|||+.
T Consensus       243 ~~~l~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         243 KRIFVEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHhcChhhCCCHHHHhcCcccC
Confidence            99999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=3.9e-28  Score=237.81  Aligned_cols=173  Identities=34%  Similarity=0.602  Sum_probs=141.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.+++|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++..+...    
T Consensus        87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd06651          87 YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICMSG  163 (266)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccccccC
Confidence            4678999999998888999999999999999999999988  9999999999999876 78999999998765321    


Q ss_pred             CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .......++..|+|||++.+ .++.++|||||||++|+|++|..||........+.+...... ...++...++.++++|
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  242 (266)
T cd06651         164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLPSHISEHARDFL  242 (266)
T ss_pred             CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCchhcCHHHHHHH
Confidence            11233568999999998764 478899999999999999999999987555555544433332 2344555678899999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      . ||. +|.+||+++|++.||||+
T Consensus       243 ~-~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         243 G-CIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HhcCChhhCcCHHHHhcCcccc
Confidence            5 555 999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=5.4e-28  Score=248.51  Aligned_cols=172  Identities=30%  Similarity=0.516  Sum_probs=136.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|...    ...++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+.... ..
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceecccccccc
Confidence            5778888653    34678888999999999999999998  9999999999999877 799999999998765332 23


Q ss_pred             ccccCCCcccCcccccc-----C-CCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCcccccccHHH
Q 010730           80 HSVIGTPEFMAPELYEE-----D-YNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-----~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ...+||+.|+|||++..     . ++.++|||||||++|+|++|+.||....  ....+...+..... .......+.++
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  304 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREF  304 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-CCCCCccCHHH
Confidence            45689999999998742     2 3568999999999999999999996422  22223333332222 23344567899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++||.+||. +|.+||++.|+|+||||...
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            999999998 99999999999999999764

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=3.7e-28  Score=239.59  Aligned_cols=173  Identities=28%  Similarity=0.507  Sum_probs=140.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.++|+|||++...... .
T Consensus       100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~~~~~  176 (282)
T cd06636         100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG  176 (282)
T ss_pred             eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCcchhhhhcccc
Confidence            56789999999763  45889999999999999999999998  9999999999999876 78999999998765322 2


Q ss_pred             CcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           78 QAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      .....+|++.|+|||++.      ..++.++|||||||++|+|++|..||........+.. +.....+.......+..+
T Consensus       177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  255 (282)
T cd06636         177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPPPKLKSKKWSKKF  255 (282)
T ss_pred             CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhCCCCCCcccccCHHH
Confidence            234567999999999874      3478899999999999999999999976544344332 333323323333457899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+||.+||. +|.+||++.|||+||||
T Consensus       256 ~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         256 IDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=4.8e-28  Score=240.85  Aligned_cols=174  Identities=31%  Similarity=0.578  Sum_probs=149.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+  |+||||||.|||++.+ +.+||+|||++......  ..
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--CC
Confidence            4679999999999899999999999999999999999988  9999999999999887 79999999999876543  34


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ...|++.|+|||.+. ..++.++||||||+++|+|++|..||.. ....+.++.+..+..+  ++...+..++++|.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l  233 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVR--FPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcc--CCccCCHHHHHHHHHHc
Confidence            457899999999775 4478899999999999999999999976 4456667777665542  34445789999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      . +|.+|+     +++|++.||||+...+
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCCH
Confidence            8 999999     8999999999976554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.95  E-value=4.1e-28  Score=243.81  Aligned_cols=174  Identities=25%  Similarity=0.426  Sum_probs=136.2

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      .++|.+++.+. ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          87 DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecCCCcccccc
Confidence            46899998765 45899999999999999999999998  9999999999999877 79999999999764322 22334


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---CC------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GK------------------  138 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---g~------------------  138 (502)
                      ..+|+.|+|||++.+  .++.++|||||||++|+|+||..||.+....+. ...+..   ..                  
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            578999999998753  478999999999999999999999976433222 111110   00                  


Q ss_pred             CCC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          139 LPG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       139 ~p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .+.       ......+.++++||.+||. ||.+|+|+.|+|.||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            000       0011246789999999999 999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=5.7e-28  Score=233.29  Aligned_cols=172  Identities=30%  Similarity=0.506  Sum_probs=147.4

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLH-----GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLH-----s~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.+++..    ..++++..++.++.||+.||.|||     +.+  |+|+||||+||+++.+ +.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEecccccc
Confidence            4678999999976    367999999999999999999999     766  9999999999999976 799999999998


Q ss_pred             eccCCCC-cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           72 ILRGSQQ-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        72 ~~~~~~~-~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||.. .+...+.+.+..+..+ .++...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  236 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIKEGKFR-RIPYRYSS  236 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC-cCHHHHHHHHhcCCCC-CCccccCH
Confidence            7654333 345679999999998754 478899999999999999999999976 4467777777776654 34445678


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+.+++.+||. +|.+||++.++|+|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=4.4e-28  Score=236.49  Aligned_cols=172  Identities=36%  Similarity=0.639  Sum_probs=143.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.+++|.+++.+.+.+++..+..++.||+.||+|||+++  ++||||||+||+++.+ +.+||+|||+++.+....   
T Consensus        87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06628          87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLST  163 (267)
T ss_pred             ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCcccccccccC
Confidence            4678999999999889999999999999999999999998  9999999999999876 789999999987664211   


Q ss_pred             ----CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           78 ----QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        78 ----~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                          ......|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+......+. .+.....+ ..+...+..++
T Consensus       164 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~  241 (267)
T cd06628         164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASP-EIPSNISSEAI  241 (267)
T ss_pred             CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCCC-cCCcccCHHHH
Confidence                1123468899999998754 58889999999999999999999998755444433 33333222 34445678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++|.+||. +|.+||++.++++||||
T Consensus       242 ~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         242 DFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-28  Score=259.85  Aligned_cols=171  Identities=26%  Similarity=0.429  Sum_probs=138.4

Q ss_pred             CcHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---cc
Q 010730            5 GTLREYRKKYTRVDI-RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AH   80 (502)
Q Consensus         5 GsL~~yi~k~~~L~e-~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---~~   80 (502)
                      -+|..++++.....+ -.++.|+.|||.++.++|.+|  |||.||||.|+|+-.  |.+||+|||+|+.+.....   ..
T Consensus       444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~DTTsI~kd  519 (677)
T KOG0596|consen  444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK--GRLKLIDFGIANAIQPDTTSIVKD  519 (677)
T ss_pred             ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe--eeEEeeeechhcccCccccceeec
Confidence            578899988765443 589999999999999999999  999999999998864  7899999999998865432   35


Q ss_pred             cccCCCcccCcccccc------------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccccc
Q 010730           81 SVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD  148 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~------------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s  148 (502)
                      +.+||+.||+||.+..            +.+.++||||||||||+|+.|++||....+...-+..|+...-...++.+..
T Consensus       520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~  599 (677)
T KOG0596|consen  520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE  599 (677)
T ss_pred             cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC
Confidence            6899999999997631            2578999999999999999999999764444343444444433335555554


Q ss_pred             HH-HHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          149 AE-ARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       149 ~~-l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      .. +.++++.||. ||.+|+++.+||+|||++.
T Consensus       600 ~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  600 NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            44 9999999999 9999999999999999974

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.9e-28  Score=251.68  Aligned_cols=173  Identities=32%  Similarity=0.450  Sum_probs=132.5

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++.+ .+.+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++............
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCccccccccCcccccc
Confidence            5789999865 467999999999999999999999998  9999999999999877 78999999999754433334456


Q ss_pred             cCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC----------hHHHHHHhhc-CCCCCccc------
Q 010730           83 IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN----------PAQIYKKVTS-GKLPGAFH------  144 (502)
Q Consensus        83 vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~----------~~ql~~kI~~-g~~p~~~~------  144 (502)
                      .||+.|+|||++.+ .|+.++|||||||++|+|+++..|+.....          ...+.+.+.. +..|..++      
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            79999999998754 589999999999999999985555432111          1122222211 11111111      


Q ss_pred             ------------------------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 ------------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 ------------------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                              ...+..+.+||.+||. ||.+||||.|+|+||||+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                    1234567789999999 9999999999999999974

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.95  E-value=2.3e-28  Score=237.73  Aligned_cols=175  Identities=33%  Similarity=0.565  Sum_probs=145.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+++|.+++... ..+++..+..++.||+.||+|||+ .+  ++|+||||+||+++.+ +.+||+|||++..+.....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence            46789999999876 789999999999999999999999 77  9999999999999986 7999999999876533221


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC----CChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~----~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                       ....|++.|+|||.+.+ .++.++|||||||++|+|++|..||...    ....+..+.+..+..+.......+.++++
T Consensus       157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence             22678999999998754 5889999999999999999999999764    23444555555554443333336788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +|.+||. +|.+|||+.+++.||||+.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            9999998 9999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=4.7e-28  Score=233.99  Aligned_cols=173  Identities=33%  Similarity=0.558  Sum_probs=140.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+.+++|.+++.. ...+++..++.++.||+.||.|||..+  |+||||+|+||+++.+ +.+||+|||++..+.... .
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhcccCccc
Confidence            4678999999976 457899999999999999999999988  9999999999999886 789999999998765433 2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l~~LI~  156 (502)
                      .....|+..|+|||++.+ .++.++|||||||++|+|++|..||.......... .+.....+ ...+...+..+.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhccCCCCCCCchhhcCHHHHHHHH
Confidence            344568999999998764 48889999999999999999999997643333222 22222111 1222345678999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+|||+.|+|.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9998 99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=6.2e-28  Score=239.46  Aligned_cols=174  Identities=26%  Similarity=0.475  Sum_probs=139.0

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.++++.    ...+++..++.++.||+.||+|||.++  |+||||||+||+++.+ +.+||+|||++..+...
T Consensus       105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTST  181 (291)
T ss_pred             ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEeecccchhcccc
Confidence            5679999999863    457899999999999999999999988  9999999999999876 78999999998765432


Q ss_pred             C-CcccccCCCcccCcccccc------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-ccccccc
Q 010730           77 Q-QAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQD  148 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~~------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s  148 (502)
                      . ......|++.|+|||++..      .++.++|||||||++|+|++|.+||........+. .+..+..+. .......
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  260 (291)
T cd06639         182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEKWC  260 (291)
T ss_pred             cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcCCCCCCCcccccC
Confidence            2 2234578999999998743      26789999999999999999999997644333333 333332221 1122345


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      ..++++|.+||. +|.+||++.|+++||||+
T Consensus       261 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         261 RSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            689999999998 999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=7.9e-28  Score=237.62  Aligned_cols=176  Identities=32%  Similarity=0.538  Sum_probs=142.1

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+.+|+|..++.+ ..++++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEccccccccccccccc
Confidence            5678999998865 467999999999999999999999998  9999999999999876 79999999998754322 22


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l  151 (502)
                      .....|++.|+|||++.      ..++.++|||||||++|+|++|..||... +..+....+.....+ ...+...+..+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc-CHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            34467899999999873      23678999999999999999999999763 344444444333222 22334457889


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++||.+||. +|.+||++.++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999998 99999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=8.6e-28  Score=232.19  Aligned_cols=173  Identities=29%  Similarity=0.509  Sum_probs=145.2

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.+|.|||+++  |+|+||||+||+++.+.+.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            56799999999764  35899999999999999999999998  999999999999986656789999999987765444


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||... +.......+..+..+ .++...+..++++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHHH
Confidence            455678999999998864 4788999999999999999999999764 444555555554433 3334467889999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff  177 (502)
                      ||. +|.+|||+.|+|+||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=1.6e-28  Score=246.10  Aligned_cols=173  Identities=31%  Similarity=0.444  Sum_probs=129.6

Q ss_pred             CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC---CCCcEEEEecCCc
Q 010730            3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQIKIGDLGLA   70 (502)
Q Consensus         3 tgGsL~~yi~k~---------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~---~~g~vKL~DFGlA   70 (502)
                      .+++|.+++...         ..+++..++.++.||+.||.|||+++  |+||||||+|||+..   ..+.+||+|||++
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            457888887532         24889999999999999999999998  999999999999942   2368999999999


Q ss_pred             eeccCCC----CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCCh---------HHHH----
Q 010730           71 AILRGSQ----QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------AQIY----  131 (502)
Q Consensus        71 ~~~~~~~----~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---------~ql~----  131 (502)
                      +.+....    .....+||+.|+|||++.+  .++.++|||||||++|+|+||.+||......         .++.    
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            8764322    2344678999999998854  4789999999999999999999999642210         1111    


Q ss_pred             ----------HHhhcC-CCC--------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          132 ----------KKVTSG-KLP--------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       132 ----------~kI~~g-~~p--------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                ..+... .++                    .......+..+.++|.+||. ||.+|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      000000 000                    00011234568899999999 99999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=4.9e-28  Score=240.85  Aligned_cols=177  Identities=25%  Similarity=0.413  Sum_probs=144.0

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc
Confidence            57889999988653  46999999999999999999999998  9999999999999877 6899999999976654444


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh---HHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .....|++.|+|||++. ..++.++|+|||||++|+|++|..||......   ..+...+..+.  ..+....+.++.+|
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  235 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEAKSI  235 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHHHHH
Confidence            45568999999999875 45899999999999999999999999764332   22233333222  12334457789999


Q ss_pred             HHHhhh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          155 VGKCLE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       155 I~kcL~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      +.+||. +|.+||+     +.+++.|+||+....
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999 9999999     899999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.2e-28  Score=237.04  Aligned_cols=175  Identities=29%  Similarity=0.527  Sum_probs=146.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++... ++++..++.++.||+.||.|||+++  |+||||+|+||+++.+ +.++|+|||+++.+... ...
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccccccc
Confidence            56789999999875 8999999999999999999999988  9999999999999986 79999999999877543 233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|++.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..+....+..+..+.......+..+.++|.+|
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc-CchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            45678999999998754 589999999999999999999999966 3455555555555443322222678899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+|||+++++.||||+..
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCC
Confidence            98 99999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=4.9e-28  Score=238.62  Aligned_cols=171  Identities=25%  Similarity=0.409  Sum_probs=135.3

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHS   81 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~s   81 (502)
                      +|+|.+++.+ .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++....... ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCcCC
Confidence            5789888865 567999999999999999999999998  9999999999999876 799999999997654322 2234


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC-------------------CC
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-------------------LP  140 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~-------------------~p  140 (502)
                      ..+++.|+|||++.+  .++.++|||||||++|+|+||..||....+....++.+....                   .+
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            568999999998754  378999999999999999999988755444444333332100                   00


Q ss_pred             C--------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          141 G--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       141 ~--------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .        ......+.++++||.+||. +|.+|||++++|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0        0011246789999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=245.14  Aligned_cols=179  Identities=25%  Similarity=0.443  Sum_probs=152.2

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC---
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS---   76 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~---   76 (502)
                      |.||.|...|.+.+.+++.++..+.++|..||+|||..|  |.||||||+|||-...  ...|||+||.|...+...   
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            679999999999999999999999999999999999998  9999999999998643  246899999998654321   


Q ss_pred             -----CCcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCC--------------CChHHHH
Q 010730           77 -----QQAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPAQIY  131 (502)
Q Consensus        77 -----~~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------------~~~~ql~  131 (502)
                           ..+.+.+|+..|||||+..      ..|+.++|.||||||||.||+|.+||.+.              .-...++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                 2245678999999999763      34999999999999999999999999651              0135689


Q ss_pred             HHhhcCCC--CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          132 KKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       132 ~kI~~g~~--p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ..|+.|++  |..-|..++.+++++|+.+|. ++..|.+|.++|+|||++.-..
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            99999986  455566789999999999998 9999999999999999976443

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.3e-28  Score=235.20  Aligned_cols=173  Identities=29%  Similarity=0.519  Sum_probs=139.6

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+++|.+++..    ...+++..++.++.||+.||.|||+++  |+|+||+|+||+++.+ +.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDST  166 (275)
T ss_pred             cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEEECCCccceecccc
Confidence            5678999999865    357999999999999999999999998  9999999999999886 78999999998765432


Q ss_pred             C-CcccccCCCcccCcccccc------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc-ccccc
Q 010730           77 Q-QAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQD  148 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~~------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~-~~~~s  148 (502)
                      . ......|++.|+|||++..      .++.++|||||||++|+|++|..||........+. .+..+..+... ....+
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  245 (275)
T cd06608         167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPPTLKSPENWS  245 (275)
T ss_pred             hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-HhhccCCCCCCchhhcC
Confidence            2 2344678999999998742      36788999999999999999999997643333333 34433332211 12246


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ..+++||.+||. ||.+|||+.++++|||+
T Consensus       246 ~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         246 KKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            789999999998 99999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=8.9e-28  Score=235.18  Aligned_cols=175  Identities=34%  Similarity=0.585  Sum_probs=140.3

Q ss_pred             CCCCCcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKY-TRV--DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L--~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+++|.+++... ..+  ++..+..++.||+.||.|||+.+  |+||||||+||+++...+.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            56899999999864 556  88899999999999999999988  99999999999998755789999999987654322


Q ss_pred             -CcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                       ......|++.|+|||++..   .++.++|+||||+++|+|++|..||...........++........++...+.++++
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence             2334568999999998753   378899999999999999999999976444333222222112222445556789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      |+.+||. +|.+|||+.|++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999998 99999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=9.4e-28  Score=233.85  Aligned_cols=176  Identities=28%  Similarity=0.517  Sum_probs=142.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++.+.+++++..++.|+.||+.||.|||+++  ++||||||+||+++.+...+||+|||++.......   
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  161 (268)
T cd06630          84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA  161 (268)
T ss_pred             ccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence            5688999999998889999999999999999999999998  99999999999998764469999999987654321   


Q ss_pred             --CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC--hHHHHHHhhcCCCCCcccccccHHHH
Q 010730           78 --QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        78 --~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                        ......||..|+|||++.+ .++.++|+||||+++|+|++|..||.....  .......+.........+...++.++
T Consensus       162 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06630         162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR  241 (268)
T ss_pred             CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHH
Confidence              1123568999999998754 588999999999999999999999964322  22222233222333344555678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      +++.+||. +|.+||++.++++||||+
T Consensus       242 ~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         242 DVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999998 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=6.5e-28  Score=241.36  Aligned_cols=177  Identities=33%  Similarity=0.568  Sum_probs=142.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++.. +.+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccC
Confidence            5789999999855 56899999999999999999999998  9999999999999877 79999999998754322 223


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~k  157 (502)
                      ....|++.|+|||++.+ .++.++|||||||++|+|++|..||... ...+.+..+.....+. ......+..++++|.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            44678999999998754 5889999999999999999999999763 3444444443322111 1122356789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ||. +|.+|||++++|+||||+....
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCC
Confidence            998 9999999999999999985543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=1.1e-27  Score=231.25  Aligned_cols=176  Identities=28%  Similarity=0.510  Sum_probs=147.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||.++  |+|+||+|+||+++.+ +.+||+|||++.......   
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          74 YLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccc
Confidence            4678999999998889999999999999999999999988  9999999999999987 799999999987543221   


Q ss_pred             ------CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHH
Q 010730           78 ------QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        78 ------~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                            ......+++.|+|||++. ..++.++|+||||+++|+|++|..||.. ....+++..+..+..+.......+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDE  229 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHH
Confidence                  223456889999999775 4478899999999999999999999976 55667777777655532222223789


Q ss_pred             HHHHHHHhhh-CcCCCCCH---HHHhcCCCCcCC
Q 010730          151 ARRFVGKCLE-NVSKRLPA---KELLLDPFLASD  180 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa---~ELL~hPff~~~  180 (502)
                      +.++|.+||. +|.+|||+   .++|.||||+.-
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999998 99999999   999999999743

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=5.2e-28  Score=260.50  Aligned_cols=174  Identities=26%  Similarity=0.434  Sum_probs=140.0

Q ss_pred             CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCCc
Q 010730            3 TSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         3 tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      -+-+|.+|++++  ..|+...++.+++|||.||.+||+.+  |||+||||||||+... ...|||+|||.+.....  ..
T Consensus       270 L~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--~v  345 (586)
T KOG0667|consen  270 LSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--RV  345 (586)
T ss_pred             hhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCC--cc
Confidence            357899999875  46999999999999999999999998  9999999999999643 35799999999987643  34


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC------------------
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL------------------  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~------------------  139 (502)
                      .+.+.+..|.|||++- ..|+.+.||||||||++||++|.+.|++....+|+...+.- |..                  
T Consensus       346 ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~  425 (586)
T KOG0667|consen  346 YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSL  425 (586)
T ss_pred             eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhcc
Confidence            5889999999999775 56999999999999999999999889886666666433311 100                  


Q ss_pred             ----------------------------------CC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 ----------------------------------PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 ----------------------------------p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                                        |.       .........+.+||.+||. ||.+|+|+.|+|+||||
T Consensus       426 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl  505 (586)
T KOG0667|consen  426 KGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFL  505 (586)
T ss_pred             CCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccc
Confidence                                              00       0000123457899999999 99999999999999999


Q ss_pred             cCC
Q 010730          178 ASD  180 (502)
Q Consensus       178 ~~~  180 (502)
                      ...
T Consensus       506 ~~~  508 (586)
T KOG0667|consen  506 TGT  508 (586)
T ss_pred             ccc
Confidence            754

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=9.6e-28  Score=236.77  Aligned_cols=173  Identities=25%  Similarity=0.475  Sum_probs=139.3

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~  177 (286)
T cd06638         101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTST  177 (286)
T ss_pred             ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEEccCCceeecccC
Confidence            5689999998753    356899999999999999999999998  9999999999999887 78999999999876432


Q ss_pred             C-CcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CCccccccc
Q 010730           77 Q-QAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQD  148 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~~~~~~~s  148 (502)
                      . ......|++.|+|||++.      ..++.++|||||||++|+|++|..||........+.+ +..... ....+...+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  256 (286)
T cd06638         178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQPELWS  256 (286)
T ss_pred             CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCcccCCCCcC
Confidence            2 233457999999999874      3478899999999999999999999977544343332 222221 122233456


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ..++++|.+||. +|.+||++.|+|+|+||
T Consensus       257 ~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         257 NEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            789999999998 99999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=8.3e-28  Score=232.92  Aligned_cols=176  Identities=31%  Similarity=0.588  Sum_probs=149.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+++|.+++.+...+++..+..++.||+.||+|||+ .+  ++||||+|+||+++.+ +.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence            56789999999988899999999999999999999999 88  9999999999999887 79999999999876543332


Q ss_pred             -ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 -HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 -~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       ....++..|+|||.+.. .++.++|+||||+++|+|+||..||....  ...++.+.+.....+.......+..+.++|
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence             25678999999998754 47889999999999999999999997754  556666666655444332222678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      .+||. +|.+||++.++++|||++.
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHh
Confidence            99998 9999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=7.3e-28  Score=241.16  Aligned_cols=176  Identities=34%  Similarity=0.561  Sum_probs=143.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.||+|.+++.+ ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccccchhcccccccc
Confidence            5789999999965 46899999999999999999999998  9999999999999876 799999999987654322 12


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........++.....+..+...+...+..+.++|.+|
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence            34578999999998764 47899999999999999999999997644434444444333322223344567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.+++.||||...
T Consensus       254 l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         254 LDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CcCCcccCcCHHHHhhChhhhcc
Confidence            98 99999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-28  Score=237.48  Aligned_cols=165  Identities=28%  Similarity=0.522  Sum_probs=143.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCccc
Q 010730           14 YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL   93 (502)
Q Consensus        14 ~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEv   93 (502)
                      +++++|..+-.+..-|+.||.||-... +|||||+||+|||++.. |.|||||||++..+..+.......|.+.|||||-
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPER  262 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPER  262 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccC-CCEEeecccccceeecccccccccCCccccCccc
Confidence            467999999999999999999998543 39999999999999987 8999999999988876655556789999999998


Q ss_pred             cc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc--ccHHHHHHHHHhhh-CcCCCC
Q 010730           94 YE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI--QDAEARRFVGKCLE-NVSKRL  166 (502)
Q Consensus        94 l~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~--~s~~l~~LI~kcL~-dP~kRp  166 (502)
                      +.    .+|+..+||||||++++||+||++||.+|....+..-+|.+...| .++..  -++.+++|+..||. |+.+||
T Consensus       263 idp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~~fv~~CL~kd~r~RP  341 (391)
T KOG0983|consen  263 IDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQSFVKDCLTKDHRKRP  341 (391)
T ss_pred             cCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHHHHHHHHhhcCcccCc
Confidence            74    359999999999999999999999999998888888888874443 33332  58999999999998 999999


Q ss_pred             CHHHHhcCCCCcCCC
Q 010730          167 PAKELLLDPFLASDA  181 (502)
Q Consensus       167 Sa~ELL~hPff~~~~  181 (502)
                      -..+||+|||+....
T Consensus       342 ~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  342 KYNKLLEHPFIKRYE  356 (391)
T ss_pred             chHHHhcCcceeecc
Confidence            999999999997543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=1.3e-27  Score=230.73  Aligned_cols=173  Identities=36%  Similarity=0.588  Sum_probs=145.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+++|.+++.+.+.+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+ +.+||+|||++..........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccccccc
Confidence            5678999999998888999999999999999999999998  9999999999999876 799999999998765444345


Q ss_pred             cccCCCcccCcccccc-C-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...|++.|+|||.+.. . ++.++|+|||||++|+|++|..||........+.+....... ..++...+..++++|.+|
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  238 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKDFILKC  238 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-CCcCCCcCHHHHHHHHHH
Confidence            5779999999997753 3 789999999999999999999999775543444433322323 234455678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff  177 (502)
                      |. +|.+||++.++|.|||+
T Consensus       239 l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         239 LQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hhcCcccCcCHHHHhcCCCC
Confidence            98 99999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=1.1e-27  Score=232.52  Aligned_cols=173  Identities=31%  Similarity=0.567  Sum_probs=140.5

Q ss_pred             CCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~---~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      ++.+++|.+++.+.   ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence            46799999999764   45999999999999999999999998  9999999999999987 789999999987654322


Q ss_pred             C-----cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc----ccc
Q 010730           78 Q-----AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF----HRI  146 (502)
Q Consensus        78 ~-----~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~----~~~  146 (502)
                      .     ....+|++.|+|||++..  .++.++|+|||||++|+|++|..||..... .+.+.++.....+...    ...
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCcccccc
Confidence            2     234578999999998754  488899999999999999999999976433 3444444433222111    123


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+..+++++.+||. +|.+||++.+|+.||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            46789999999998 99999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-28  Score=249.73  Aligned_cols=179  Identities=25%  Similarity=0.479  Sum_probs=161.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~-~~~~~~~   79 (502)
                      |+.||+|--.|++.+++.+..+..|+..|+-||=|||+.|  ||.||||.+||+++.. |+|||+|||+++. +-.....
T Consensus       431 yvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~TT  507 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGVTT  507 (683)
T ss_pred             EecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCcce
Confidence            6789999999999999999999999999999999999999  9999999999999987 8999999999985 3455667


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+++|||.|+|||++. ..|+.++|+||+||+||||+.|++||.+ .+..++++.|.....  .++...+.++..++..+
T Consensus       508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSKEAVAICKGL  584 (683)
T ss_pred             eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccHHHHHHHHHH
Confidence            8899999999999775 5699999999999999999999999976 888999999988765  56677789999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~~~l  185 (502)
                      |. .|.+|+.     -.++-.||||+...|..+
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence            98 9999986     478999999998777553

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-29  Score=280.40  Aligned_cols=176  Identities=35%  Similarity=0.554  Sum_probs=157.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+.+...+-.++...+.|..|++.||.|||++|  ||||||||+|||++.+ |.+|++|||-|..+....   
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhcC
Confidence            6899999999998888899999999999999999999999  9999999999999988 799999999998876542   


Q ss_pred             --CcccccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           78 --QAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        78 --~~~s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                        .+....|||.|||||++.+    +-..++|||||||++.||+||+.||.+.++.-+|.-++..|..|..... .+++.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~g 1470 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSEG 1470 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHhH
Confidence              2356789999999999864    2567899999999999999999999999999899889999988754444 78999


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++||..||. ||.+|-++.|||+|.|-+..
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            999999998 99999999999999887543

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=1.9e-27  Score=227.72  Aligned_cols=174  Identities=39%  Similarity=0.653  Sum_probs=148.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+++|.+++.+.+.+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.+||+|||.+........  
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence            4578999999998889999999999999999999999988  9999999999999986 7999999999987765442  


Q ss_pred             -cccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       .....++..|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+..+......+...+..+++||.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence             3456789999999987654 88999999999999999999999977554555555555433334455556889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+||++.+++.||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.6e-27  Score=234.44  Aligned_cols=174  Identities=30%  Similarity=0.475  Sum_probs=140.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+++|..++.+...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+.... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCCcccc
Confidence            5678888888877778999999999999999999999988  9999999999999876 799999999998765433 23


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--------------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--------------------  137 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--------------------  137 (502)
                      ....++..|+|||++.+  .++.++|||||||++|+|++|..||.+..+...++......                    
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            34568899999998754  47889999999999999999999998755554444322110                    


Q ss_pred             CCCCc--------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          138 KLPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       138 ~~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ..+..        .....+..+.+||.+||. +|.+||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000        011236788999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=1.3e-27  Score=242.56  Aligned_cols=176  Identities=20%  Similarity=0.422  Sum_probs=136.2

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++..+  +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+++.||+.+...... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccccc
Confidence            57899999999763  45999999999999999999999998  9999999999999876 78999999865433211 1


Q ss_pred             C-------cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC------
Q 010730           78 Q-------AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG------  141 (502)
Q Consensus        78 ~-------~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~------  141 (502)
                      .       .....++..|+|||++.+   .|+.++|||||||++|+|++|..||........+... ..+..+.      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccc
Confidence            0       122356788999998853   4889999999999999999999999764433322222 2221110      


Q ss_pred             --------------------------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          142 --------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       142 --------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                                            ......++.+++||.+||. ||.+|||++|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                  0111235689999999999 99999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=1.8e-27  Score=238.67  Aligned_cols=176  Identities=33%  Similarity=0.559  Sum_probs=142.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      |+.+|+|.+++.+. .+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ .
T Consensus        97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          97 YLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             ecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchhcccccccC
Confidence            56899999999764 6899999999999999999999998  9999999999999876 7999999999876543322 2


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........+.........+...+...++.++++|.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence            34578999999998764 48899999999999999999999997744434433332222222223344578899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.+++.||||+..
T Consensus       253 l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         253 LEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             hhcChhhCCCHHHHhhChHhhhc
Confidence            98 99999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=1.6e-27  Score=234.47  Aligned_cols=176  Identities=31%  Similarity=0.509  Sum_probs=140.8

Q ss_pred             CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            4 SGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         4 gGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      .|+|.+++..    ...+++..++.++.||+.||+|||++ +  ++||||||+||+++.+ +.+||+|||++..+.....
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence            4788888754    24689999999999999999999987 7  9999999999999887 7999999999987644333


Q ss_pred             cccccCCCcccCcccccc-----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      .....|+..|+|||++.+     .++.++|+|||||++|+|++|..||.......+.+..+..+..+.......+.++.+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD  239 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence            334578999999998753     367899999999999999999999976444433344444443332222345788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      +|.+||. +|.+||++.+++.||||.....
T Consensus       240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         240 FVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            9999998 9999999999999999986543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=3.1e-27  Score=234.86  Aligned_cols=177  Identities=31%  Similarity=0.491  Sum_probs=142.9

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+.+|+|..++.+ ...+++..++.++.||+.+|.|||+++  |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccceeccccccc
Confidence            5789999988765 456899999999999999999999988  9999999999999876 79999999998754322 22


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l  151 (502)
                      .....+++.|+|||++.      ..++.++|||||||++|+|++|..||.. .+..+.+.++.....+ ...+...+..+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc-ccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence            34467899999999873      2367899999999999999999999976 3445555555444332 12233456789


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .++|.+||. +|.+||++.++++||||....
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            999999998 999999999999999997543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=2e-27  Score=239.31  Aligned_cols=174  Identities=32%  Similarity=0.534  Sum_probs=139.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++++.+++++..++.++.||+.||.|||+ ++  ++||||||+|||++.+ +.+||+|||++...... ..
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence            57899999999998999999999999999999999997 46  9999999999999876 78999999998765332 23


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc----------------------
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS----------------------  136 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~----------------------  136 (502)
                      ...+|++.|+|||++.+ .++.++|+|||||++|+|++|..||... +...+...+..                      
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP-DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc-chhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            45689999999998864 4888999999999999999999999642 22222222211                      


Q ss_pred             --------------CCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          137 --------------GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       137 --------------g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                    ...|.......+.++++||.+||. +|.+||++.+++.||||..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                          111111112246789999999998 9999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-27  Score=231.04  Aligned_cols=172  Identities=28%  Similarity=0.508  Sum_probs=139.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+.+++|.+++... ..+++..+..++.||+.||.|||+++  |+|+||||+||+++.+ +.+||+|||++..+.... .
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence            46789999999876 78999999999999999999999998  9999999999999976 789999999987654322 2


Q ss_pred             cccccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC---cccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~---~~~~~~s~~l  151 (502)
                      .....++..|+|||++..    .++.++|+|||||++|+|++|..||.+.......+. +....++.   ......+.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCCCccccchhhhhHHH
Confidence            344678999999998753    578899999999999999999999987544444333 33232211   1122335789


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPf  176 (502)
                      ++||.+||. +|..||++.+++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999998 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=1.8e-27  Score=231.33  Aligned_cols=172  Identities=31%  Similarity=0.503  Sum_probs=144.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.|++|.+++.+...+++..+..|+.||+.||.|||.++  |+|+||||+||+++.+ +.++|+|||++..........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCcccc
Confidence            5789999999988888999999999999999999999998  9999999999999887 799999999987765544445


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC--hHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ...|+..|+|||++.. .++.++|+||||+++|+|++|..||.....  ..++.......  ....+...+..+.++|.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~  235 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA--DVLYPATWSTEAIDAINK  235 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc--cccCcccCcHHHHHHHHH
Confidence            5678999999998764 478999999999999999999999976543  34444433322  223344457899999999


Q ss_pred             hhh-CcCCCCCH--HHHhcCCCC
Q 010730          158 CLE-NVSKRLPA--KELLLDPFL  177 (502)
Q Consensus       158 cL~-dP~kRpSa--~ELL~hPff  177 (502)
                      ||. +|.+|+++  +|++.||||
T Consensus       236 ~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         236 LLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HccCChhHcCCccHHHHhcCCCC
Confidence            998 99999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.95  E-value=2.6e-27  Score=235.66  Aligned_cols=175  Identities=32%  Similarity=0.582  Sum_probs=145.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.|++|.+++.. +++++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.++|+|||++....... ..
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCccc
Confidence            5689999999987 67999999999999999999999998  9999999999999876 799999999887553322 22


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc-cccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~-~~~~s~~l~~LI~k  157 (502)
                      ....|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .++...+.++..+..+... ....+..+.+||.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            34579999999998764 488999999999999999999999976 4556666666655332211 22256789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. +|.+||++.++++||||+..
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccC
Confidence            998 99999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=1.6e-27  Score=234.67  Aligned_cols=171  Identities=30%  Similarity=0.431  Sum_probs=135.0

Q ss_pred             CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            4 SGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         4 gGsL~~yi~k~---~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      .|+|.+++...   +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ .
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCCCcccc
Confidence            47899998653   46999999999999999999999998  9999999999999876 7999999999876533222 2


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC------------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL------------------  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~------------------  139 (502)
                      ....+++.|+|||++.+  .++.++|||||||++|+|+||.+||.+......++..+.....                  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            33467899999998754  3788999999999999999999999765444443332211000                  


Q ss_pred             -C-------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 -P-------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 -p-------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                       +       .......+.+++++|.+||. ||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             0       00112347788999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-27  Score=234.52  Aligned_cols=176  Identities=31%  Similarity=0.541  Sum_probs=143.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+.+|+|.+++.+. +.+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+ +.++|+|||++...... ..
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence            57899999999774 56999999999999999999999998  9999999999999876 79999999998654322 22


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l  151 (502)
                      .....||+.|+|||++.      ..++.++|+|||||++|+|++|..||... +..+...++..+..+. ..+...+.++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            23457899999999874      23677899999999999999999999764 4445555555554331 2233457889


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .++|.+||. +|.+||++.++|+||||...
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999998 99999999999999999743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.5e-28  Score=222.06  Aligned_cols=159  Identities=26%  Similarity=0.314  Sum_probs=128.1

Q ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         5 GsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      |+|.+++.+. +++++..++.|+.||+.||.|||+++        ||+|||++.+ +.+|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeecccc----CC
Confidence            8999999874 56999999999999999999999875        9999999877 78888  99998764322    36


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc-----ccccccH--HHHHHH
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-----FHRIQDA--EARRFV  155 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~-----~~~~~s~--~l~~LI  155 (502)
                      ||+.|||||++.+ .|+.++|||||||++|+|+||..||.........+..+..+..+..     .....+.  .++++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            8999999998864 5899999999999999999999999765444445555443332211     1111222  689999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+||. +|.+||++.|++.|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            99999 999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=231.55  Aligned_cols=173  Identities=29%  Similarity=0.534  Sum_probs=144.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+|+||||+||+++.+ +.++|+|||++......    
T Consensus        87 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  163 (264)
T cd06653          87 YMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSG  163 (264)
T ss_pred             eCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECccccccccccccccC
Confidence            4678999999998888999999999999999999999998  9999999999999876 78999999999765321    


Q ss_pred             CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .......|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+......+.+.. ....+..++...+..++++|
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~i  242 (264)
T cd06653         164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTKPMLPDGVSDACRDFL  242 (264)
T ss_pred             ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-cCCCCCCCCcccCHHHHHHH
Confidence            11234578999999998864 47889999999999999999999998754445444433 33333445666778999999


Q ss_pred             HHhhhCcCCCCCHHHHhcCCCC
Q 010730          156 GKCLENVSKRLPAKELLLDPFL  177 (502)
Q Consensus       156 ~kcL~dP~kRpSa~ELL~hPff  177 (502)
                      .+||.++.+||++.++|.|||+
T Consensus       243 ~~~l~~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         243 KQIFVEEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHhcCcccCccHHHHhcCCCC
Confidence            9999988999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=1.5e-27  Score=235.51  Aligned_cols=177  Identities=26%  Similarity=0.447  Sum_probs=145.3

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.+  .+++..++.++.||+.||.|||..+  |+||||||+||+++.+ +.+||+|||++........
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCc
Confidence            578999999998765  7999999999999999999999998  9999999999999876 7999999999876654444


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .....++..|+|||++.+ .++.++|||||||++|+|++|..||.....   ..++.+.+...  +...+...++.++++
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  228 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--AVEYPDKFSPEAKDL  228 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--cccCCccCCHHHHHH
Confidence            445678899999998754 488899999999999999999999965322   23343333322  223444558899999


Q ss_pred             HHHhhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       155 I~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |.+||. +|.+||     ++.+++.||||....+
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         229 CEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             HHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            999998 999999     8999999999976544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=4.1e-27  Score=228.21  Aligned_cols=172  Identities=31%  Similarity=0.523  Sum_probs=146.9

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.+||+|||++....... 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence            57899999999875  46899999999999999999999988  9999999999999987 789999999998764433 


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+..++...+..+.++.. ....+..+.++|.
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~  234 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPV-VSVYSSELISLVH  234 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHHHHHH
Confidence            3345679999999998754 478899999999999999999999976 566677777776665432 3455788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+||+++++|+|||+
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCCCHHHHhhCcCC
Confidence            9998 99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=1.7e-27  Score=235.60  Aligned_cols=163  Identities=28%  Similarity=0.469  Sum_probs=132.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010730           14 YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE   92 (502)
Q Consensus        14 ~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APE   92 (502)
                      .+.+++..+..++.||+.||+|||+. +  |+||||||+||+++.+ +.+||+|||++..+..........|++.|+|||
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE  177 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE  177 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHHhccCCccccccCccCccCHH
Confidence            46799999999999999999999974 7  9999999999999876 789999999997665443334457899999999


Q ss_pred             cccc----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc---ccccccHHHHHHHHHhhh-CcCC
Q 010730           93 LYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDAEARRFVGKCLE-NVSK  164 (502)
Q Consensus        93 vl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~---~~~~~s~~l~~LI~kcL~-dP~k  164 (502)
                      ++..    .++.++|||||||++|+|++|..||.......+...++..+..+..   .+...+.++.+||.+||. +|.+
T Consensus       178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  257 (288)
T cd06616         178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESK  257 (288)
T ss_pred             HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhh
Confidence            8864    4889999999999999999999999765433333333333333221   222357889999999998 9999


Q ss_pred             CCCHHHHhcCCCCcC
Q 010730          165 RLPAKELLLDPFLAS  179 (502)
Q Consensus       165 RpSa~ELL~hPff~~  179 (502)
                      |||+++++.||||+.
T Consensus       258 Rpt~~~i~~~~~~~~  272 (288)
T cd06616         258 RPKYKELLEHPFIKD  272 (288)
T ss_pred             CcCHHHHhcChhhhc
Confidence            999999999999974

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.7e-27  Score=255.89  Aligned_cols=173  Identities=32%  Similarity=0.484  Sum_probs=136.6

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---c
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---A   79 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---~   79 (502)
                      .|+|.+++.+. +.+++..++.|+.||+.||.|||+++  ||||||||+|||++.+ +.+||+|||+++.+.....   .
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence            57899998764 56999999999999999999999998  9999999999999876 7899999999987643221   2


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC-------ChHHHHHHhhcCCCC-----C-----
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-------NPAQIYKKVTSGKLP-----G-----  141 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-------~~~ql~~kI~~g~~p-----~-----  141 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..|+....       ...++.+.+......     .     
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            34679999999998864 48999999999999999999886653321       134455544432211     0     


Q ss_pred             --------------------ccc--ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          142 --------------------AFH--RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       142 --------------------~~~--~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                          .|.  ...+..+++||.+||. ||.+|||+.|||+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                010  0234678999999999 9999999999999999964

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=1.6e-27  Score=232.87  Aligned_cols=172  Identities=28%  Similarity=0.495  Sum_probs=138.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++..+.... ..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccceeeccccccc
Confidence            5688999999988888999999999999999999999988  9999999999999876 789999999998764322 23


Q ss_pred             ccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CCcc--cccccHHHH
Q 010730           80 HSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAF--HRIQDAEAR  152 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~~~--~~~~s~~l~  152 (502)
                      ....|++.|+|||++.    ..++.++|+|||||++|+|++|..||.......... .+....+ +..+  ....+..+.
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeecCCCCCCCCccccccCHHHH
Confidence            3467899999999873    337789999999999999999999996543322222 2222222 1111  122467899


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPf  176 (502)
                      +||.+||. +|.+||+++++|+|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999998 9999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=3.9e-27  Score=224.56  Aligned_cols=172  Identities=33%  Similarity=0.612  Sum_probs=140.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+++|.+++... +.+++..+..++.||+.+|.|||..+  ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  154 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKAR  154 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeeccccccccccccc
Confidence            56789999999876 68999999999999999999999988  9999999999999986 79999999999876544323


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc-cccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~-~~~~s~~l~~LI~k  157 (502)
                      ....|+..|+|||++.+ .++.++|+||||+++|+|++|..||........+..... ...+... ....+..+.++|.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence            45678999999998754 478899999999999999999999976544344333332 2222221 11226789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPf  176 (502)
                      ||. +|.+|||+.++|.|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            998 9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=2.7e-27  Score=233.17  Aligned_cols=169  Identities=23%  Similarity=0.360  Sum_probs=142.0

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.                ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~-~~~~L  165 (283)
T cd05048          89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG-LTVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC-CcEEE
Confidence            56789999999865                45888999999999999999999998  9999999999999876 78999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||++.......   ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ ....+++..+..+..
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i~~~~~  244 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMIRSRQL  244 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence            9999997653321   123456788999999765 568999999999999999998 9999976 456677888777665


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +. .+...+.++.+|+.+||. +|.+||++.|++++
T Consensus       245 ~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         245 LP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43 344567899999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=4.1e-27  Score=234.02  Aligned_cols=176  Identities=26%  Similarity=0.396  Sum_probs=139.2

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+ +|+|.+++.... .+++..++.++.||+.||.|||+++  |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus        83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCCCcc
Confidence            45 899999998766 7999999999999999999999998  9999999999999986 799999999998765432 2


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CCC--C------------
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP--G------------  141 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~p--~------------  141 (502)
                      .....+++.|+|||++.+  .++.++|||||||++|+|++|.+||....... .+.++... ..+  .            
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccccccc
Confidence            334467889999998743  47889999999999999999988876543332 23332210 000  0            


Q ss_pred             -----------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          142 -----------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       142 -----------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                 ......+..+.++|.+||. +|.+|||++|+|.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                       0012235788999999999 999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=3.8e-27  Score=233.13  Aligned_cols=172  Identities=26%  Similarity=0.512  Sum_probs=138.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|..+    ..+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+ +.+||+|||++..+... ...
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~  151 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAK  151 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-ccc
Confidence            5778888765    35789999999999999999999998  9999999999999887 79999999999765432 234


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC------ChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS------NPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~------~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      ..+||+.|+|||++.+ .++.++|+|||||++|+|++|..||....      ....+.+.+.....+.......++++++
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            4689999999998754 58899999999999999999999996421      1223333333333322223345788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +|.+||. +|.+||+++|++.||||+..
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            9999998 99999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=3.6e-27  Score=231.92  Aligned_cols=174  Identities=27%  Similarity=0.428  Sum_probs=136.9

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+ +++|.+++.. .+.+++..++.++.||+.||.|||+++  |+|+||||+||+++.+ +.++|+|||++.......  
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence            45 9999999975 456999999999999999999999998  9999999999999986 789999999998764332  


Q ss_pred             CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC----------------
Q 010730           78 QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----------------  139 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~----------------  139 (502)
                      ......|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+..+...+...+..-..                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            1334678999999998753  3689999999999999999998888664433332222211000                


Q ss_pred             ----CC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          140 ----PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       140 ----p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                          +.       ......+..+.++|.+||. +|.+||+++++|.||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                00       0011235789999999999 999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=5.4e-27  Score=227.64  Aligned_cols=173  Identities=39%  Similarity=0.657  Sum_probs=142.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+++|.+++.+.+.+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+ +.+||+|||++........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence            5678999999998888999999999999999999999998  9999999999999886 7999999999977643222  


Q ss_pred             ---cccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc--ccH
Q 010730           79 ---AHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI--QDA  149 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~--~s~  149 (502)
                         .....+++.|+|||++.+.    +..++||||||+++|+|++|..||....+...+...+..+..+ .++..  .+.
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSP  235 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCcccccCH
Confidence               1235688999999987532    6889999999999999999999997655544444444443322 22222  378


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+.++|.+||. +|.+||++.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            89999999998 99999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=3.2e-27  Score=236.80  Aligned_cols=176  Identities=23%  Similarity=0.455  Sum_probs=139.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccc
Confidence            57889999999864  46899999999999999999999998  9999999999999976 7999999998865432111


Q ss_pred             --------cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--------
Q 010730           79 --------AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--------  139 (502)
Q Consensus        79 --------~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--------  139 (502)
                              .....++..|+|||++..   .|+.++|||||||++|+|++|..||........+..++.....        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence                    133457889999998854   4889999999999999999999999875554444444321110        


Q ss_pred             C-----------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          140 P-----------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       140 p-----------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +                       .......+.++.+||.+||. +|.+|||++++|.||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~  300 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ  300 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence            0                       00011124578899999998 9999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=4.7e-27  Score=235.67  Aligned_cols=179  Identities=26%  Similarity=0.431  Sum_probs=146.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.||+|.++++..+.+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++.....    
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcCcccc
Confidence            5789999999998888999999999999999999999998  9999999999999876 79999999998642100    


Q ss_pred             ------------CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc-
Q 010730           77 ------------QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-  142 (502)
Q Consensus        77 ------------~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~-  142 (502)
                                  .......|++.|+|||.+. ..++.++|+|||||++|+|++|..||.+ ....+++..+..+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCC
Confidence                        0012346788999999764 4589999999999999999999999976 456677777665543221 


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCC---HHHHhcCCCCcCCCCC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLP---AKELLLDPFLASDAGE  183 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpS---a~ELL~hPff~~~~~~  183 (502)
                      .....+.+++++|.+||. +|.+||+   +.++|.||||......
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            122457889999999999 9999998   8999999999765443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=1.8e-27  Score=230.69  Aligned_cols=165  Identities=23%  Similarity=0.350  Sum_probs=135.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+...+++..+..++.||+.||+|||..+  |+||||||+||+++.+ +.++++|||++..+...  ..
T Consensus        66 ~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~  140 (237)
T cd05576          66 HAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CD  140 (237)
T ss_pred             cCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhccccc--cc
Confidence            5789999999988888999999999999999999999988  9999999999999987 78999999987655432  23


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ...++..|+|||++. ..++.++|+||+||++|+|++|..|+.....  .+.     ......++...+..++++|.+||
T Consensus       141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~li~~~l  213 (237)
T cd05576         141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GIN-----THTTLNIPEWVSEEARSLLQQLL  213 (237)
T ss_pred             cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hcc-----cccccCCcccCCHHHHHHHHHHc
Confidence            345678899999886 4588899999999999999999988754211  111     01111233445788999999999


Q ss_pred             h-CcCCCCCH-----HHHhcCCCC
Q 010730          160 E-NVSKRLPA-----KELLLDPFL  177 (502)
Q Consensus       160 ~-dP~kRpSa-----~ELL~hPff  177 (502)
                      . ||.+|+++     .+++.||||
T Consensus       214 ~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         214 QFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCHHHhcCCCccchHHHHcCCCC
Confidence            8 99999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=2.2e-27  Score=237.88  Aligned_cols=176  Identities=34%  Similarity=0.572  Sum_probs=142.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      |+.+|+|.+++.+ ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++........ .
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCccceEccCCccCc
Confidence            5789999999965 46899999999999999999999998  9999999999999876 7999999999976543322 2


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||........++.....+..+...+...+..+++||.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC  252 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence            34578999999998764 48899999999999999999999997644333333332223222233444577899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||+++++|.||||+..
T Consensus       253 l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         253 LEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             ccCChhhCcCHHHHhcCchhccc
Confidence            98 99999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.3e-27  Score=231.08  Aligned_cols=176  Identities=31%  Similarity=0.547  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+++|.+++.. +.+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus        83 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          83 YAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             cCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence            5789999999976 47999999999999999999999998  9999999999999986 799999999998765432 23


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ....|++.|+|||.+.+  .++.++|+|||||++|+|++|..||.+. ........+.....+.......+.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-ChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence            44579999999998753  3688999999999999999999999763 33333333333322222222256789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      ||. +|.+||++.+++.||||+...
T Consensus       238 ~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         238 CLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HcCCCcccCcCHHHHhhChHhhccc
Confidence            998 999999999999999997543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=2.1e-27  Score=271.25  Aligned_cols=178  Identities=26%  Similarity=0.440  Sum_probs=147.2

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEecCCCCCcEEEeCC-------------
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHD-----PPVIHRDLKCDNIFVNGH-------------   58 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g-----~~IIHRDLKPeNILl~~~-------------   58 (502)
                      |+.+|+|.++|.+    .+.+++..++.|+.||+.||.|||..+     .+||||||||+|||++..             
T Consensus        95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n  174 (1021)
T PTZ00266         95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN  174 (1021)
T ss_pred             CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence            6789999999975    357999999999999999999999854     359999999999999632             


Q ss_pred             ---CCcEEEEecCCceeccCCCCcccccCCCcccCccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHH
Q 010730           59 ---LGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK  132 (502)
Q Consensus        59 ---~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~  132 (502)
                         .+.+||+|||++..+.........+||+.|+|||++.   ..++.++||||||||||+|+||..||.......++..
T Consensus       175 ~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~  254 (1021)
T PTZ00266        175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS  254 (1021)
T ss_pred             cCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence               2358999999998765444455678999999999874   2488999999999999999999999987667777777


Q ss_pred             HhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       133 kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+..+...  .....+..+.+||..||. +|.+||++.|+|.|||++..
T Consensus       255 ~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        255 ELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            66654321  112347889999999999 99999999999999999643

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=4.9e-27  Score=230.46  Aligned_cols=169  Identities=24%  Similarity=0.368  Sum_probs=134.9

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      +|+|.+++... +.+++..++.++.||+.||.|||+.+  |+||||||+||+++.  +.+||+|||++..+.........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence            46888888763 57899999999999999999999998  999999999999987  79999999999876544444456


Q ss_pred             cCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---------------C-----CCC
Q 010730           83 IGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---------------G-----KLP  140 (502)
Q Consensus        83 vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---------------g-----~~p  140 (502)
                      .+++.|+|||++.  +.++.++|||||||++|+|++|..||.+. +....+..+..               .     ..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            7899999999763  34788999999999999999999999763 33332222211               0     000


Q ss_pred             Cc-------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          141 GA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       141 ~~-------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ..       +....+..+.++|.+||. +|.+||++.++|.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00       011346889999999999 99999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=4.7e-27  Score=234.89  Aligned_cols=174  Identities=24%  Similarity=0.421  Sum_probs=136.3

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~s   81 (502)
                      +|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++....... ....
T Consensus        87 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          87 DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhccCCCCCcccc
Confidence            47899998764 56899999999999999999999998  9999999999999876 799999999987643222 2234


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---CC------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GK------------------  138 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---g~------------------  138 (502)
                      ..+++.|+|||++.+  .++.++|||||||++|+|++|.+||...... +....+..   ..                  
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            567999999998754  4788999999999999999999999764332 22222111   00                  


Q ss_pred             CCC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          139 LPG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       139 ~p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .+.       ......+..+++||.+||. +|.+|||++|+|+||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            000       0112346788999999999 999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=7.2e-27  Score=226.55  Aligned_cols=172  Identities=27%  Similarity=0.506  Sum_probs=144.5

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++....  .+++..+..|+.||+.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence            578999999997643  5899999999999999999999988  9999999999999876 6899999999976543221


Q ss_pred             -cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       .....|++.|+|||++.+ .++.++|+|||||++++|++|..||.. .+...++..+..+..+. .+...+..++++|.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  234 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHHHH
Confidence             234568999999998754 478899999999999999999999976 45566666666666542 33445788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+||++.++|+||||
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCcCHHHHhhCcCC
Confidence            9998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=7.1e-27  Score=231.58  Aligned_cols=173  Identities=28%  Similarity=0.392  Sum_probs=135.4

Q ss_pred             CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            4 SGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         4 gGsL~~yi~k~-----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      .|+|.+++...     ..+++..++.++.||+.||.|||.++  |+||||||+||+++.+.+.+||+|||++..+... .
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~  166 (295)
T cd07837          89 DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK  166 (295)
T ss_pred             CcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCCCcc
Confidence            36899998643     35899999999999999999999998  9999999999999984479999999998765322 2


Q ss_pred             CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC----------------
Q 010730           78 QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----------------  139 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~----------------  139 (502)
                      ......+++.|+|||++.+  .++.++|||||||++|+|++|..||.+.....++.+.+..-..                
T Consensus       167 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T cd07837         167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH  246 (295)
T ss_pred             ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh
Confidence            2233467899999997753  4789999999999999999999999875554444332211000                


Q ss_pred             --CC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          140 --PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       140 --p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                        +.       ......+..+.+||.+||. +|.+||++.|+|.||||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         247 EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence              00       0012246789999999998 999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=7e-27  Score=224.39  Aligned_cols=172  Identities=30%  Similarity=0.569  Sum_probs=145.8

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+++|.+++.+.    +.+++..+..++.||+.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence            45789999999874    77999999999999999999999998  9999999999999876 78999999999776443


Q ss_pred             C-CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      . ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||.. .+..++...+.....+ ..+...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYP-PIPSQYSSELRNL  234 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence            3 234467899999999775 4488899999999999999999999966 4466666666655443 3444567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      |.+||. +|.+||++.++|.||||
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcCCCC
Confidence            999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=7.1e-27  Score=224.86  Aligned_cols=169  Identities=23%  Similarity=0.389  Sum_probs=143.6

Q ss_pred             CCCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~---------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.+++...         ..+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||.+.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~  153 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLSR  153 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEccccccc
Confidence            46799999999886         78999999999999999999999988  9999999999999987 799999999998


Q ss_pred             eccCCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           72 ILRGSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        72 ~~~~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      ......   ......+++.|+|||++.. .++.++|||||||++|+|++ |..||.. ....++++.+..+... ..+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~  231 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRKGYRL-PKPEY  231 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence            765432   2334567899999998764 68999999999999999999 6999977 4667777777765433 33444


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.++.+++.+||. +|.+||++.|++.+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            57899999999998 99999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=6.8e-27  Score=234.58  Aligned_cols=175  Identities=32%  Similarity=0.582  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++.. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+.... ..
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhcccccccc
Confidence            5788999998865 56899999999999999999999998  9999999999999876 799999999987553322 23


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~k  157 (502)
                      ....|++.|+|||++.+ .++.++|||||||++|+|++|..||.. ....+....+.....+. ......+..+.++|.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            44679999999998764 588999999999999999999999976 34444444554433221 1122346789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. +|.+||++.++++||||...
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccC
Confidence            998 99999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.95  E-value=8.9e-27  Score=233.76  Aligned_cols=173  Identities=25%  Similarity=0.354  Sum_probs=137.2

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +++|.+++... ..+++..++.++.||+.||.|||+.+  ++||||||+||+++.+ +.+||+|||++...... .....
T Consensus        91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~  167 (309)
T cd07845          91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTP  167 (309)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeeecCCccCCCCc
Confidence            56899988763 67999999999999999999999998  9999999999999876 79999999999876533 22233


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC-------------------C-
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-------------------L-  139 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~-------------------~-  139 (502)
                      ..+++.|+|||++.+  .++.++|||||||++|+|++|.+||... +..+.+..+....                   . 
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
T cd07845         168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT  246 (309)
T ss_pred             ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhhccccccccc
Confidence            456889999998753  4789999999999999999999999764 4444444333210                   0 


Q ss_pred             -CCc-c------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 -PGA-F------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 -p~~-~------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                       +.. +      ....++.+++||.+||. ||.+|||+.++|.||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         247 LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence             000 0      01136788999999999 99999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=5.9e-27  Score=240.54  Aligned_cols=169  Identities=29%  Similarity=0.433  Sum_probs=135.2

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++...  +++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++.............
T Consensus       104 ~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  178 (353)
T cd07850         104 DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  178 (353)
T ss_pred             CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccceeCCCCCCCCCCc
Confidence            57888888654  899999999999999999999998  9999999999999887 799999999998765544445567


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCC---------------------
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL---------------------  139 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~---------------------  139 (502)
                      |++.|+|||++.+ .++.++|||||||++|+|++|..||....... .+.++..  +..                     
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (353)
T cd07850         179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK  257 (353)
T ss_pred             ccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCC
Confidence            8999999998754 58999999999999999999999997643322 2222211  000                     


Q ss_pred             ----------CCc-c-------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          140 ----------PGA-F-------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       140 ----------p~~-~-------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                                +.. +       +...+..++++|.+||. ||.+|||+.|+|.||||+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             CCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                      000 0       11235578999999999 999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.1e-26  Score=229.63  Aligned_cols=174  Identities=30%  Similarity=0.568  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~---~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++...   ..+++..++.++.||+.||.|||. ++  |+||||||+||+++.+ +.+||+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence            57899999999763   479999999999999999999996 46  9999999999999886 79999999998765332


Q ss_pred             CCcccccCCCcccCcccccc-------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHH---HhhcCCCCCccccc
Q 010730           77 QQAHSVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK---KVTSGKLPGAFHRI  146 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~---kI~~g~~p~~~~~~  146 (502)
                       ......|++.|+|||++.+       .++.++|||||||++|+|++|..||... .....+.   .+..+..+ ..+..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~-~~~~~  233 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-TYANIFAQLSAIVDGDPP-TLPSG  233 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc-chhhHHHHHHHHhhcCCC-CCCcc
Confidence             2344578999999998743       2578999999999999999999999653 2233332   33444333 33444


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+.++++||.+||. +|.+||++.+++.||||...
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            68899999999998 99999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=1.2e-26  Score=227.93  Aligned_cols=168  Identities=22%  Similarity=0.389  Sum_probs=139.8

Q ss_pred             CCCCCcHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 010730            1 MFTSGTLREYRKKYT--------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD   66 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~D   66 (502)
                      |+.+|+|.+++...+              .+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~kl~d  165 (280)
T cd05049          89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD-LVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC-CeEEECC
Confidence            578999999997653              4788999999999999999999998  9999999999999887 7999999


Q ss_pred             cCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCC
Q 010730           67 LGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        67 FGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~  141 (502)
                      ||++..+....   ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.. .+...+...+..+..+.
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~~~~~~~~~~~~  244 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECITQGRLLQ  244 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCcCC
Confidence            99997653221   123345678999999875 458899999999999999999 9999976 45566677777666543


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                       .+...+..++++|.+||. +|.+||++.|+++
T Consensus       245 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         245 -RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             334567899999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=1.2e-26  Score=226.09  Aligned_cols=169  Identities=21%  Similarity=0.361  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||+|||+++  |+||||||.||+++.+ +.+||+|||++..+.....  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCee
Confidence            5678999999998888999999999999999999999998  9999999999999876 7899999999976543321  


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+.+.+..+..+ ..+...+++++++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l  230 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDL  230 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence              11223467899999875 458889999999999999998 9999976 4566777777776543 3445568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.+|...
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHHHhccCchhCcCHHHHHHH
Confidence            999998 99999999988653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1.2e-26  Score=227.37  Aligned_cols=174  Identities=33%  Similarity=0.577  Sum_probs=141.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  ++||||||+||+++.+ +.++|+|||++......   .
T Consensus        89 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~  165 (272)
T cd06629          89 YVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDND  165 (272)
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeecccccccccccccc
Confidence            5689999999999889999999999999999999999988  9999999999999876 79999999998764321   1


Q ss_pred             CcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC---CCCcccccccHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK---LPGAFHRIQDAEA  151 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~---~p~~~~~~~s~~l  151 (502)
                      ......|+..|+|||++..   .++.++|+||||+++|+|++|..||........+.+......   .+.......+..+
T Consensus       166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (272)
T cd06629         166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA  245 (272)
T ss_pred             ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHH
Confidence            1233568899999998753   378899999999999999999999976554444443332221   2222323457899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +++|.+||. +|.+||+++++|+|||+
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         246 LDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            999999998 99999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-28  Score=254.96  Aligned_cols=170  Identities=32%  Similarity=0.510  Sum_probs=147.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+..|-|.+.++....+.......|.++|+.|+.|||.|.  |||||||.-||||..+ ..|||+|||.++........-
T Consensus       193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhh
Confidence            6788999999999999999999999999999999999999  9999999999999987 589999999998876655556


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +++||..|||||++.. ..++++|||||||+|||||||..||.+-...+.|| -+....+.-..+..++.-++-||+.||
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHH
Confidence            7899999999999975 58999999999999999999999997743333333 334444444556667788999999999


Q ss_pred             h-CcCCCCCHHHHhcC
Q 010730          160 E-NVSKRLPAKELLLD  174 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~h  174 (502)
                      . +|..||++.++|.|
T Consensus       349 ~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLH  364 (904)
T ss_pred             hcCCCCCccHHHHHHH
Confidence            8 99999999999999

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=1e-26  Score=229.17  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=135.6

Q ss_pred             CCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010730            4 SGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAH   80 (502)
Q Consensus         4 gGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~   80 (502)
                      .++|.+++..  ...+++..++.++.||+.||+|||.++  ++||||||+||+++.+ +.+||+|||++..+.... ...
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccCccccc
Confidence            4689999865  356899999999999999999999998  9999999999999987 799999999987654322 223


Q ss_pred             cccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-----------------
Q 010730           81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-----------------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-----------------  141 (502)
                      ...+++.|+|||++.+.  ++.++|||||||++|+|+||..||........+.+.+.....+.                 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            34678999999987543  67889999999999999999999977554444444332211110                 


Q ss_pred             ---------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 ---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 ---------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                               ......+++++++|.+||. ||.+|||++++|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                     0012346788999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.94  E-value=1.2e-26  Score=230.60  Aligned_cols=168  Identities=22%  Similarity=0.382  Sum_probs=139.7

Q ss_pred             CCCCCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 010730            1 MFTSGTLREYRKKYT-------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL   67 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DF   67 (502)
                      |+.+|+|.+++...+             .+++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-CcEEeccC
Confidence            578999999998654             3899999999999999999999988  9999999999999877 79999999


Q ss_pred             CCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           68 GLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        68 GlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      |++..+.....   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+. 
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~~~~~~~-  242 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGRVLQ-  242 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCcCC-
Confidence            99976533211   12344678899999876 458899999999999999998 9999976 45566777777776542 


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .....+.++.+|+.+||. +|.+|||+.+++.
T Consensus       243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            334567899999999999 9999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=1.1e-26  Score=224.64  Aligned_cols=173  Identities=27%  Similarity=0.482  Sum_probs=142.2

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+++|.+++.+..  .+++..++.|+.||+.||.|||+.+  |+|+||||+||+++.+...+||+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            577999999997654  4799999999999999999999998  999999999999987744579999999876643322


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       .....|++.|+|||++. ..++.++|+|||||++++|++|..||.. .+..+....+..+..+ ......+..++++|.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVLKICQGYFA-PISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHhcccCC-CCCCCCCHHHHHHHH
Confidence             23356899999999875 4588999999999999999999999975 4445555555555443 223345678999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +||. +|.+|||+.+++.||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.2e-26  Score=229.80  Aligned_cols=176  Identities=26%  Similarity=0.484  Sum_probs=142.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.+|.|||+ ++  |+||||||+||+++.+ +.++|+|||++...... ..
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~~  159 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IA  159 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhhh-cc
Confidence            67899999999988899999999999999999999996 56  9999999999999876 79999999998654322 22


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh----------HHHHHHhhcCCCCCccccccc
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP----------AQIYKKVTSGKLPGAFHRIQD  148 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~----------~ql~~kI~~g~~p~~~~~~~s  148 (502)
                      ...+|+..|+|||++. +.++.++|||||||++|+|++|..||......          ..+.+.+.....+.......+
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3467999999999774 56888999999999999999999999753321          123344443333222222256


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ..+.+||.+||. +|.+|||+.|+++|+||...
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            789999999998 99999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-26  Score=227.83  Aligned_cols=174  Identities=30%  Similarity=0.504  Sum_probs=139.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.++.|..++.+...+++..+..++.||+.||.|||.++  |+||||||+||+++.+ +.+||+|||++.......  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCCcccc
Confidence            4567777777777677999999999999999999999998  9999999999999986 799999999998765433  3


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CC-----------------
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK-----------------  138 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~-----------------  138 (502)
                      ....++++.|+|||++.+  .++.++||||||+++|+|++|.+||.+......++..... +.                 
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            345678999999998753  5788999999999999999999999875544444332110 00                 


Q ss_pred             --CCC---------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          139 --LPG---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       139 --~p~---------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                        ++.         .++...+.++++||.+||. +|.+||+++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              000         1122336889999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=1.5e-26  Score=230.28  Aligned_cols=169  Identities=22%  Similarity=0.406  Sum_probs=139.8

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+..++                .+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN-LLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-CcEEE
Confidence            578999999997643                3889999999999999999999998  9999999999999987 79999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||++.......   ......|++.|+|||++. ..++.++|||||||++|+|+| |..||.. .+...+.+.+..+..
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~  243 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECITQGRV  243 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhCCCC
Confidence            9999997653321   123345788999999775 458889999999999999999 9999876 455566667766655


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +. .....+..+.+++.+||. +|.+||++.++++.
T Consensus       244 ~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         244 LE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             CC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            43 344557889999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=1.1e-26  Score=227.19  Aligned_cols=169  Identities=20%  Similarity=0.325  Sum_probs=138.6

Q ss_pred             CCCCCcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKK------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k------~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++..      ...+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus        87 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  163 (272)
T cd05075          87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADFGLSKKIY  163 (272)
T ss_pred             eCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCCCcccccC
Confidence            5788999999843      234899999999999999999999988  9999999999999876 789999999998764


Q ss_pred             CCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           75 GSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        75 ~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. ....++++.+..+..+. .....+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~  241 (272)
T cd05075         164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPPDCLD  241 (272)
T ss_pred             cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence            3221   122346778999998764 58999999999999999999 8999976 45667777777765432 2334567


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .++++|.+||. +|.+|||+.+|++.
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         242 GLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999998 99999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=251.63  Aligned_cols=170  Identities=29%  Similarity=0.506  Sum_probs=146.2

Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +=|+-.+.+..+ +++.+-+|..++.+.|.||.|||+++  .||||||..|||++.+ |.|||+|||.|....   ...+
T Consensus       108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~---PAns  181 (948)
T KOG0577|consen  108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP-GLVKLADFGSASIMA---PANS  181 (948)
T ss_pred             HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC-CeeeeccccchhhcC---chhc
Confidence            346777777654 57999999999999999999999999  9999999999999987 899999999987753   4578


Q ss_pred             ccCCCcccCcccc----ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           82 VIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        82 ~vGTp~Y~APEvl----~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ++|||+||||||+    +|.|+-++||||||+++.||.-.++|+.++.-...+|....+. .|.-...-++..+++||..
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCCCchhHHHHHHHHHH
Confidence            9999999999976    4779999999999999999999999999877777888765543 3323334457889999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ||. -|..|||.+++|.|+|+..
T Consensus       261 CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHhhCcccCCcHHHHhhcchhcc
Confidence            999 8999999999999999863

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=221.90  Aligned_cols=172  Identities=34%  Similarity=0.590  Sum_probs=144.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      |+.+++|.+++.+...+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.++|+|||++........ .
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence            4678999999998889999999999999999999999998  9999999999999876 7999999999987654332 2


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.........++.. ....+ .++...+..++++|.+|
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHP-PLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCC-CCCCCCCHHHHHHHHHH
Confidence            34578999999998754 47889999999999999999999997654434444433 33332 34455678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff  177 (502)
                      |. +|.+||++.+++.||||
T Consensus       235 l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         235 FQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HhCChhhCcCHHHHhcCCCC
Confidence            98 99999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.4e-26  Score=221.28  Aligned_cols=171  Identities=33%  Similarity=0.566  Sum_probs=146.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+++|.+++.+.+.+++..+..++.||+.||.|||..+  ++|+||||+||+++.+ +.++|+|||++...... ...
T Consensus        74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~  150 (250)
T cd05123          74 YAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRT  150 (250)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcc
Confidence            4568999999998888999999999999999999999988  9999999999999886 79999999999776443 233


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....++..|++||.+.+ ..+.++|+||||+++|+|++|..||.. ....++++.+....+  .++...+..+.++|.+|
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~  227 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL--RFPEFLSPEARDLISGL  227 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            45678999999998754 477899999999999999999999965 444667777766544  34455578999999999


Q ss_pred             hh-CcCCCCCH---HHHhcCCCC
Q 010730          159 LE-NVSKRLPA---KELLLDPFL  177 (502)
Q Consensus       159 L~-dP~kRpSa---~ELL~hPff  177 (502)
                      |. +|.+||++   ++++.||||
T Consensus       228 l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         228 LQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hcCCHhhCCCcccHHHHHhCCCC
Confidence            98 99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.94  E-value=1.6e-26  Score=229.48  Aligned_cols=170  Identities=27%  Similarity=0.408  Sum_probs=135.4

Q ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +++|.+++.... .+++..++.++.||+.||+|||+++  |+|+||||+||+++.+ +.+||+|||++..+... .....
T Consensus        89 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~  165 (293)
T cd07843          89 EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQ  165 (293)
T ss_pred             CcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeeccCCcccccc
Confidence            469999987654 5999999999999999999999998  9999999999999887 79999999999876543 22344


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC----------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG----------------------  137 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g----------------------  137 (502)
                      ..+++.|+|||++.+  .++.++|||||||++|+|++|..||........ +.++...                      
T Consensus       166 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd07843         166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGAKKKT  244 (293)
T ss_pred             ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchhcccc
Confidence            568999999998754  368899999999999999999999976443322 2222110                      


Q ss_pred             -------CCCCccccc-ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          138 -------KLPGAFHRI-QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       138 -------~~p~~~~~~-~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                             .+...++.. .+..++++|.+||. +|.+|||++|+|.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                   000112222 46789999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=2.8e-26  Score=227.24  Aligned_cols=169  Identities=25%  Similarity=0.426  Sum_probs=138.8

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++... +.+++..+..|+.||+.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++.+..... 
T Consensus        89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccceeccCCCcc
Confidence            56799999999764 57999999999999999999999988  9999999999999876 7899999999987543221 


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. +.++.++|||||||++|||++ |..||.+ .....+.+.+..+..+ ..+...+..+.++
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  243 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERL-AQPQICTIDVYMV  243 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCCCCCHHHHHH
Confidence              22345678899999875 568999999999999999998 9999976 3445555555555443 2334456788999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. +|.+|||+.|+++.
T Consensus       244 i~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         244 MVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             HHHHcCCCcccCcCHHHHHHH
Confidence            999998 99999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=227.38  Aligned_cols=171  Identities=29%  Similarity=0.449  Sum_probs=135.6

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAH   80 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~   80 (502)
                      +++|.+++....  .+++..+..++.||+.||+|||+++  ++||||+|+||+++.+ +.++|+|||++....... ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccccC
Confidence            578999998766  7999999999999999999999988  9999999999999886 799999999987653222 123


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-------------------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-------------------  139 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-------------------  139 (502)
                      ...+++.|+|||++.+  .++.++||||||+++|+|++|.+||.......++++.+.....                   
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            3467899999998754  3688999999999999999999999764443333332211000                   


Q ss_pred             C-------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 P-------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 p-------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +       .......+..+.++|.+||. +|.+|||++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0       00112345789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=3.8e-26  Score=224.70  Aligned_cols=171  Identities=29%  Similarity=0.435  Sum_probs=138.6

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +|+|.+++....  .+++..+..++.||+.+|.|||+++  ++|+||||+||+++.+ +.++|+|||++...........
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcCC
Confidence            889999998764  7899999999999999999999998  9999999999999986 7999999999987655444455


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--------------------  139 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--------------------  139 (502)
                      ..|+..|+|||++..  .++.++|+||||+++++|++|.+||.......++++.......                    
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678999999998743  4788999999999999999999999775544444332211000                    


Q ss_pred             CC-------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +.       ......+..+.++|.+||. +|.+|||++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00       0001125789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.94  E-value=3.2e-26  Score=220.85  Aligned_cols=171  Identities=30%  Similarity=0.503  Sum_probs=144.8

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+++|.+++.+    ...+++..+..++.||+.||.|||+.+  ++|+||||+||+++.+ +.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence            4678999999876    356899999999999999999999998  9999999999999986 78999999999776544


Q ss_pred             CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+...+...+..+..+. .....+.+++++|
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  233 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPP-IPPIYSQDLQNFI  233 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC-CchhhCHHHHHHH
Confidence             3344678999999998754 478899999999999999999999976 45556666666665543 3335678899999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .+||. +|.+||++.++|+||++
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         234 RSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHhcCCCC
Confidence            99998 99999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=1.7e-26  Score=228.63  Aligned_cols=177  Identities=36%  Similarity=0.621  Sum_probs=143.6

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+.+++|.+++...+ .++...+..++.||+.||.|||+.+  |+|+||||+||+++.+ +.++|+|||++....... .
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchhhhhccchhh
Confidence            567899999999876 8999999999999999999999988  9999999999999876 799999999986543221 2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~  156 (502)
                      .....+++.|+|||++.+ .++.++|+|||||++|+|++|..||... +.......+.....+. ......+..++++|.
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence            234568899999998754 4889999999999999999999999763 4333333443333322 222225678999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +||. +|.+||++.++|.||||....
T Consensus       252 ~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHhccChhhCcCHHHHhhChHhhccC
Confidence            9999 999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=2e-26  Score=225.10  Aligned_cols=171  Identities=31%  Similarity=0.542  Sum_probs=143.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  ++|+||||+||+++.+ +.++|+|||++.......   
T Consensus        83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCccccc
Confidence            4679999999999889999999999999999999999998  9999999999999876 799999999987654322   


Q ss_pred             ------------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC
Q 010730           78 ------------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK  138 (502)
Q Consensus        78 ------------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~  138 (502)
                                        ......|++.|+|||++.. .++.++||||||+++++|++|..||... ...+.++.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~  238 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKILKLE  238 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhcC
Confidence                              1233568899999997754 4788999999999999999999999764 3445555555433


Q ss_pred             CCCcccccccHHHHHHHHHhhh-CcCCCCCH----HHHhcCCCC
Q 010730          139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPA----KELLLDPFL  177 (502)
Q Consensus       139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa----~ELL~hPff  177 (502)
                      .  .++...++.+.+||.+||. +|.+||++    .++|.||||
T Consensus       239 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 Y--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             C--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3  2333447889999999998 99999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=1.8e-26  Score=230.56  Aligned_cols=169  Identities=24%  Similarity=0.356  Sum_probs=136.5

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.+                .+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN-LASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC-CeEEE
Confidence            467899999997643                4888999999999999999999988  9999999999999876 78999


Q ss_pred             EecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           65 GDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      +|||++..............+..|+|||++.. .++.++|||||||++|+|++ |..||.. ....+++.++..+..+ .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~~~-~  238 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRM-E  238 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-C
Confidence            99999864322111112223557999998754 58999999999999999997 9999976 5566677777665432 2


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...+..+++||.+||. +|.+||++.++++.
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            344567899999999998 99999999999865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=2.3e-26  Score=226.89  Aligned_cols=169  Identities=25%  Similarity=0.429  Sum_probs=137.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++... +.+++..+..++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||+++........
T Consensus        89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCceeecccccce
Confidence            56899999999764 56999999999999999999999998  9999999999999876 68999999999876432221


Q ss_pred             ---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....+++.|+|||++. ..++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...+..+.++
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  243 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERL-PQPPICTIDVYMI  243 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCccCCHHHHHH
Confidence               1223467899999875 458999999999999999998 9999865 4445566666555433 2334467889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.+++..
T Consensus       244 i~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         244 MVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999998 99999999999954

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=1.6e-26  Score=240.83  Aligned_cols=155  Identities=21%  Similarity=0.358  Sum_probs=125.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APE   92 (502)
                      ++++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+.....   .....+++.|+|||
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  284 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE  284 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence            4788899999999999999999998  9999999999999876 7899999999976543221   12234567899999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..++.++|||||||++|+|++ |..||........+++.+..+. ....+...+++++++|.+||. +|.+||++.
T Consensus       285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  363 (374)
T cd05106         285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIYSIMKMCWNLEPTERPTFS  363 (374)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            775 569999999999999999997 9999987554445555554443 223344457899999999999 999999999


Q ss_pred             HHhcC
Q 010730          170 ELLLD  174 (502)
Q Consensus       170 ELL~h  174 (502)
                      ++++.
T Consensus       364 ~l~~~  368 (374)
T cd05106         364 QISQL  368 (374)
T ss_pred             HHHHH
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=1.3e-26  Score=235.67  Aligned_cols=173  Identities=25%  Similarity=0.403  Sum_probs=137.6

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-----   77 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-----   77 (502)
                      .+++|.+++.....+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+....     
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~  164 (332)
T cd07857          88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAG  164 (332)
T ss_pred             ccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceecccccccccc
Confidence            46899999988889999999999999999999999998  9999999999999887 799999999998654321     


Q ss_pred             CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh---------------cC---
Q 010730           78 QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT---------------SG---  137 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~---------------~g---  137 (502)
                      .....+||+.|+|||++.+  .++.++|||||||++|+|++|.+||...... ..+..+.               ..   
T Consensus       165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (332)
T cd07857         165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSRIGSPKAQ  243 (332)
T ss_pred             cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhhhhhHH
Confidence            1234579999999997754  4889999999999999999999999763321 1111111               00   


Q ss_pred             -------CCC----CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          138 -------KLP----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       138 -------~~p----~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                             ..+    .......+..+++||.+||. +|.+|||+.+++.||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~  297 (332)
T cd07857         244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI  297 (332)
T ss_pred             HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence                   000    01122246789999999998 9999999999999999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.8e-27  Score=254.57  Aligned_cols=177  Identities=26%  Similarity=0.467  Sum_probs=159.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |..+|.|++|+.+++++.+..++.++.|++++++|||+++  |+|||||++|||++.+ -.+||+|||++..+.......
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceeeccccccc
Confidence            5789999999999999999999999999999999999999  9999999999999988 479999999999998888889


Q ss_pred             cccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      +.+|+|.|.|||++.+.  .++++|+||+|+++|.|++|.+||.+ .+...+-..+..+++.  ++...+.+++++|.++
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKF  289 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechhHHHHHHh
Confidence            99999999999999764  57899999999999999999999976 6777777788888773  4445678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      |. +|.+|++.++++.|.|.......
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hccCccccCCHHHhhhhcccchhhhh
Confidence            98 99999999999999999755433

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=1.9e-26  Score=232.71  Aligned_cols=169  Identities=25%  Similarity=0.450  Sum_probs=138.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..++...+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+......
T Consensus        89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  165 (316)
T cd05108          89 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKE  165 (316)
T ss_pred             cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEccccccccccCCCcc
Confidence            57899999999875 46899999999999999999999998  9999999999999876 68999999999876533222


Q ss_pred             ---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.++
T Consensus       166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  243 (316)
T cd05108         166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI  243 (316)
T ss_pred             eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence               1223467899999775 458999999999999999998 9999976 4455555555544332 2334567889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. +|.+||++.+++.+
T Consensus       244 i~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         244 MVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999998 99999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.9e-26  Score=233.14  Aligned_cols=175  Identities=30%  Similarity=0.382  Sum_probs=141.4

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ----QA   79 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~----~~   79 (502)
                      +++|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.++|+|||++.......    ..
T Consensus        87 ~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~  163 (330)
T cd07834          87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFL  163 (330)
T ss_pred             hhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeecccccccccc
Confidence            4689999988889999999999999999999999998  9999999999999987 899999999998765432    23


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC--CCC--------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPG--------------  141 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~--~p~--------------  141 (502)
                      ....+++.|+|||++.+  .++.++|+||||+++|+|++|.+||... +..+.++.+....  .+.              
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  242 (330)
T cd07834         164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR-DYIDQLNLIVEVLGTPSEEDLKFITSEKARNY  242 (330)
T ss_pred             cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHhcCCCChhHhhhccccchhhH
Confidence            45678999999998754  4888999999999999999999999764 3344344333210  000              


Q ss_pred             ----------c---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          142 ----------A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       142 ----------~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                                .   .....+..+.++|.+||. +|.+||++.++|.||||+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                      0   011236788999999998 9999999999999999975443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=2.4e-26  Score=228.61  Aligned_cols=171  Identities=23%  Similarity=0.383  Sum_probs=132.4

Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---
Q 010730            3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---   78 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---   78 (502)
                      .+++|.+++.+. ..+++..++.++.||+.||.|||+++  |+|+||||+||+++.+ +.+||+|||++..+.....   
T Consensus       101 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  177 (310)
T cd07865         101 CEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP  177 (310)
T ss_pred             CCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEECcCCCcccccCCcccCC
Confidence            356888888764 36999999999999999999999998  9999999999999877 7999999999976533211   


Q ss_pred             --cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCCCc----------
Q 010730           79 --AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPGA----------  142 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p~~----------  142 (502)
                        .....+++.|+|||++.+  .++.++||||||+++|+|++|..||... +.......+..  +..+..          
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (310)
T cd07865         178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN-TEQHQLTLISQLCGSITPEVWPGVDKLEL  256 (310)
T ss_pred             CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhcccccchhh
Confidence              123567899999998754  3788999999999999999999999763 32222111111  111100          


Q ss_pred             ------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          143 ------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       143 ------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                        .....+..+++||.+||. +|.+|||++|+|+||||
T Consensus       257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                              011235678899999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=1.6e-26  Score=231.18  Aligned_cols=177  Identities=34%  Similarity=0.564  Sum_probs=142.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++.+. .+++..+..++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++....... ..
T Consensus        97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcceeccccccccc
Confidence            57899999999764 5889999999999999999999998  9999999999999876 789999999987654322 22


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|++.|+|||.+. ..++.++|+|||||++|+|++|..||.......++......+......+...+..++++|.+|
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence            3457899999999775 458889999999999999999999997644333333222222222222333567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. +|.+||++.+++.||||+...
T Consensus       253 l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         253 LEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ccCChhhCcCHHHHhcCHHHhcCc
Confidence            98 999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=3e-26  Score=227.24  Aligned_cols=177  Identities=25%  Similarity=0.429  Sum_probs=144.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~   78 (502)
                      |+.+|+|.+++...+.+++..+..++.||+.||.|||+.+  ++||||||+|||++.+ +.+||+|||++......  ..
T Consensus        86 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~  162 (290)
T cd05613          86 YINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVER  162 (290)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecccccccc
Confidence            5789999999998888999999999999999999999988  9999999999999876 79999999999765432  22


Q ss_pred             cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      .....|++.|+|||.+..   .++.++||||||+++|+|++|..||....   ....+.+.+.....  .++...++.++
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  240 (290)
T cd05613         163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK  240 (290)
T ss_pred             cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHHH
Confidence            235679999999998753   46789999999999999999999996421   22334444433332  23445678899


Q ss_pred             HHHHHhhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       153 ~LI~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      +++.+||. +|.+|+     ++.+++.||||+...+
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            99999998 999997     8999999999976543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=2.6e-26  Score=229.06  Aligned_cols=174  Identities=28%  Similarity=0.507  Sum_probs=139.8

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +++|.+++.. .+.+++..+..++.||+.||+|||+ ++  |+||||||+||+++.+ +.+||+|||++..+........
T Consensus        97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~~~~~  173 (296)
T cd06618          97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTR  173 (296)
T ss_pred             CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchhccCCCcccC
Confidence            5677777765 4579999999999999999999997 46  9999999999999876 7999999999876644333334


Q ss_pred             ccCCCcccCccccccC-----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc-ccccccHHHHHHH
Q 010730           82 VIGTPEFMAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-FHRIQDAEARRFV  155 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~~-----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~-~~~~~s~~l~~LI  155 (502)
                      ..+++.|+|||++.+.     ++.++||||||+++|+|++|..||.......+.+..+.....+.. .....+.++.+||
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV  253 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence            5688999999988533     788999999999999999999999765444455555554443321 1123577899999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. +|.+||++.+++.||||...
T Consensus       254 ~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         254 DLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHccCChhhCCCHHHHhcChhhhcc
Confidence            99998 99999999999999999743

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=3.3e-26  Score=222.64  Aligned_cols=166  Identities=19%  Similarity=0.343  Sum_probs=138.5

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++++.+  .+++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceeccccC-
Confidence            567899999998654  4889999999999999999999998  9999999999999877 799999999987654322 


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ......++.++++|.
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  233 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMK  233 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHH
Confidence             23345678999998764 48889999999999999998 9999975 5666777777665433 344556789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhc
Q 010730          157 KCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~  173 (502)
                      +||. +|.+|||+.+++.
T Consensus       234 ~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         234 QCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            9998 9999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.3e-26  Score=247.48  Aligned_cols=181  Identities=26%  Similarity=0.405  Sum_probs=146.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-----   75 (502)
                      |..||++-.++-+-+-|.|..+++|+..+.+|+++.|..|  +|||||||+|||||.+ |+|||+||||+..+.-     
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceeccccc
Confidence            6789999999999999999999999999999999999999  9999999999999987 8999999999964420     


Q ss_pred             ----C----------------------------------CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh
Q 010730           76 ----S----------------------------------QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT  116 (502)
Q Consensus        76 ----~----------------------------------~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT  116 (502)
                          +                                  ...++.+||+.|+|||++. ..|+..+|+||.|||||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence                0                                  0124568999999999886 569999999999999999999


Q ss_pred             ccCCCCCCCChHHHHHHhhcC-CCCCcccccccHHHHHHHHHhhhCcCCCCC---HHHHhcCCCCcCCCCCC
Q 010730          117 SEYPYSECSNPAQIYKKVTSG-KLPGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEP  184 (502)
Q Consensus       117 G~~Pf~~~~~~~ql~~kI~~g-~~p~~~~~~~s~~l~~LI~kcL~dP~kRpS---a~ELL~hPff~~~~~~~  184 (502)
                      |++||-........++.+.-. -+........+.++.++|.++...+..|+.   ++|+..||||+......
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence            999997633222222222111 111223345689999999999988888886   88899999999876544

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4e-26  Score=222.18  Aligned_cols=168  Identities=24%  Similarity=0.379  Sum_probs=139.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..+..++.||+.||+|||.++  |+||||||+||+++.+ +.+||+|||+++.........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCccc
Confidence            4678999999998888999999999999999999999998  9999999999999887 799999999998664332211


Q ss_pred             ----cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           81 ----SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        81 ----s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                          ...++..|+|||.+. ..++.++|||||||++|+|++ |.+||.. .+..++.+.+..+... ..+...+..++++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  230 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLESGERL-PRPEECPQEIYSI  230 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHH
Confidence                122356799999775 458899999999999999998 9999976 4456667777665432 3344557889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            999998 9999999999886

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=2.4e-26  Score=226.53  Aligned_cols=169  Identities=24%  Similarity=0.408  Sum_probs=137.0

Q ss_pred             CCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKYT----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+|+.+..          .++...+..++.||+.||.|||+.+  ++||||||+||+++.+ +.+||+|||++
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~-~~~~l~dfg~~  166 (277)
T cd05062          90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-CCEEECCCCCc
Confidence            578999999997632          3577889999999999999999988  9999999999999986 79999999998


Q ss_pred             eeccCCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           71 AILRGSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        71 ~~~~~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      ..+.....   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+...+.+.+..+..+ ..+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~  244 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGGLL-DKPD  244 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-CCCC
Confidence            75532211   122356788999998764 58999999999999999999 7889876 4556666666655543 2334


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..++++|.+||. +|.+|||+.|++.+
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         245 NCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            557789999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-28  Score=240.89  Aligned_cols=178  Identities=31%  Similarity=0.551  Sum_probs=148.1

Q ss_pred             CCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~-k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+-.|++.+.++ +.++|.+.++..+++..|.||+|||...  -||||||..|||++.+ |..||+|||+|.++... .+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhhHHh
Confidence            556699999886 5678999999999999999999999887  8999999999999987 89999999999877543 33


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc--cccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~--~~~~s~~l~~LI  155 (502)
                      ..+++|||.|||||++.. .|+.++||||||++..||..|++||.+......++- |-. +.|+.|  +...+.++-+||
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT-~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPT-KPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-ccC-CCCCCCCChHhhhhHHHHHH
Confidence            578999999999999975 699999999999999999999999987544444432 211 222222  234578899999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      ++||. +|.+|.||.+|++|||++..+..
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence            99998 99999999999999999876543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=3.3e-26  Score=238.30  Aligned_cols=155  Identities=24%  Similarity=0.381  Sum_probs=127.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc---ccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~---~s~vGTp~Y~APE   92 (502)
                      .+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+......   ....+++.|+|||
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  286 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE  286 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence            4788899999999999999999998  9999999999999876 68999999999866432221   1234567899999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..++.++|||||||++|+|++ |..||........+++.+..+..+ ..+...+.+++++|.+||. +|.+||++.
T Consensus       287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (375)
T cd05104         287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFK  365 (375)
T ss_pred             HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            875 458999999999999999998 899998766666777777665433 2334457889999999999 999999999


Q ss_pred             HHhcC
Q 010730          170 ELLLD  174 (502)
Q Consensus       170 ELL~h  174 (502)
                      |+++.
T Consensus       366 eil~~  370 (375)
T cd05104         366 QIVQL  370 (375)
T ss_pred             HHHHH
Confidence            99874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=2.2e-26  Score=253.14  Aligned_cols=179  Identities=25%  Similarity=0.336  Sum_probs=130.1

Q ss_pred             CCCCCcHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 010730            1 MFTSGTLREYRKKYTR--------------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG   60 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--------------------L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g   60 (502)
                      |+.+|+|.+++.....                    .....++.++.||+.||+|||+++  |+||||||+|||++...+
T Consensus       216 y~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~~~  293 (566)
T PLN03225        216 YEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSG  293 (566)
T ss_pred             ecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCCCC
Confidence            5678899999865321                    123457789999999999999998  999999999999987557


Q ss_pred             cEEEEecCCceeccCC--CCcccccCCCcccCcccccc-----------------------CCCCcccchhHHHHHHHHh
Q 010730           61 QIKIGDLGLAAILRGS--QQAHSVIGTPEFMAPELYEE-----------------------DYNELVDIYSFGMCVLEML  115 (502)
Q Consensus        61 ~vKL~DFGlA~~~~~~--~~~~s~vGTp~Y~APEvl~~-----------------------~ys~~~DIWSLGviLyeLL  115 (502)
                      .+||+|||+++.+...  ......+||+.|+|||++..                       .+..++|||||||+||||+
T Consensus       294 ~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~  373 (566)
T PLN03225        294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA  373 (566)
T ss_pred             cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence            8999999999865432  22346789999999996521                       2345679999999999999


Q ss_pred             hccCCCCCCCChHHHHHHhhcCCCC-------------Cc------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCC
Q 010730          116 TSEYPYSECSNPAQIYKKVTSGKLP-------------GA------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       116 TG~~Pf~~~~~~~ql~~kI~~g~~p-------------~~------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hP  175 (502)
                      ++..|+.  .+..++.+.+......             ..      .....+....+||.+||. ||.+|||++|+|+||
T Consensus       374 ~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp  451 (566)
T PLN03225        374 FPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP  451 (566)
T ss_pred             hCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence            9876653  2333333333222111             00      001112345689999998 999999999999999


Q ss_pred             CCcCCCCC
Q 010730          176 FLASDAGE  183 (502)
Q Consensus       176 ff~~~~~~  183 (502)
                      ||+.....
T Consensus       452 ff~~~~~~  459 (566)
T PLN03225        452 YFDREGLL  459 (566)
T ss_pred             CcCCCCcc
Confidence            99865443

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.94  E-value=3.3e-26  Score=234.80  Aligned_cols=155  Identities=23%  Similarity=0.383  Sum_probs=126.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---QAHSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~~~s~vGTp~Y~APE   92 (502)
                      ++++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++..+....   ......+++.|+|||
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            6889999999999999999999998  9999999999999976 789999999998653221   123345678899999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++++.+++.+||. +|.+||++.
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~  324 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFS  324 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            775 558999999999999999998 999997644444444555444332 3334557889999999998 999999999


Q ss_pred             HHhcC
Q 010730          170 ELLLD  174 (502)
Q Consensus       170 ELL~h  174 (502)
                      |++++
T Consensus       325 ell~~  329 (337)
T cd05054         325 ELVEI  329 (337)
T ss_pred             HHHHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=4.4e-26  Score=223.93  Aligned_cols=170  Identities=34%  Similarity=0.488  Sum_probs=135.8

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +++|.+++.+..  .+++..++.++.||+.||.|||+.+  ++|+||||+||+++.+ +.+||+|||++...........
T Consensus        89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~  165 (287)
T cd07838          89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTS  165 (287)
T ss_pred             ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcceeccCCccccc
Confidence            468999987743  4999999999999999999999998  9999999999999988 7999999999987655444455


Q ss_pred             ccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CC-----------------C--
Q 010730           82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KL-----------------P--  140 (502)
Q Consensus        82 ~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~-----------------p--  140 (502)
                      ..+++.|+|||++. ..++.++|+|||||++|+|++|.+||..... .+.+.++... ..                 +  
T Consensus       166 ~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (287)
T cd07838         166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY  244 (287)
T ss_pred             ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCcccchhhcccc
Confidence            67899999999875 4588899999999999999999999976433 3333333210 00                 0  


Q ss_pred             --Ccc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          141 --GAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       141 --~~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                        ..+   ....+..+.++|.+||. +|.+||++.++|.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         245 TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence              000   01124678899999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=2.3e-26  Score=227.01  Aligned_cols=174  Identities=28%  Similarity=0.546  Sum_probs=142.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.||+|.+++.. +++++..+..++.||+.||+|||+.+  ++|+||+|+||+++.+ +.++|+|||++..+.... ..
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCCcccc
Confidence            5789999999975 56899999999999999999999988  9999999999999876 789999999997664322 22


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....++..|+|||++.+ .++.++|+|||||++|+|+||..||... .+......+..+.. .......+..+.++|.+|
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNNP-PTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCCC-CCCchhhhHHHHHHHHHH
Confidence            34568999999998754 4788999999999999999999999763 34444444433332 234444577899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.+++.||||...
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhc
Confidence            98 99999999999999999644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=2.6e-26  Score=233.82  Aligned_cols=175  Identities=28%  Similarity=0.450  Sum_probs=138.0

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-----
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-----   78 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-----   78 (502)
                      +|+|.+++...+.+++..++.++.||+.||.|||.++  |+||||||+||+++.+ +.+||+|||++........     
T Consensus        91 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~  167 (334)
T cd07855          91 ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYF  167 (334)
T ss_pred             hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceeecccCcCCCcc
Confidence            5789999988888999999999999999999999998  9999999999999986 7999999999976543221     


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh-cCC-----------------
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-SGK-----------------  138 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~-~g~-----------------  138 (502)
                      ....+|+..|+|||++..  .++.++|||||||++|+|++|..||.+.....++...+. .|.                 
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~  247 (334)
T cd07855         168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKY  247 (334)
T ss_pred             cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHH
Confidence            234578999999998753  488999999999999999999999976432222111000 000                 


Q ss_pred             ---CC----Cc---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          139 ---LP----GA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       139 ---~p----~~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                         .+    ..   .....+..++++|.+||. +|.+||++.+++.||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         248 IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence               00    00   112347889999999998 999999999999999997543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=3.4e-26  Score=222.03  Aligned_cols=169  Identities=28%  Similarity=0.474  Sum_probs=141.5

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|.+++..  ...+++..++.|+.||+.||.|||+++  |+|+||||+||+++.+ +.++|+|||++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence            5789999999865  345899999999999999999999998  9999999999999876 799999999997664322 


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+...++..+..+..+. .+...+..++++|.
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  233 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSLIK  233 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHHHH
Confidence            2334679999999998864 488899999999999999999999976 55566666666665542 33445788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. +|.+||++.+++.-
T Consensus       234 ~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         234 QMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhCCcccCCCHHHHhhc
Confidence            9999 99999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=5.1e-26  Score=222.51  Aligned_cols=169  Identities=24%  Similarity=0.386  Sum_probs=139.0

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...  ..+++..++.++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCcccccccccee
Confidence            57899999999764  35899999999999999999999988  9999999999999876 7899999999976543221


Q ss_pred             c--ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~--~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .  ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+..++++.+..+..+ ..+...+..+.++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  237 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYEL  237 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence            1  1223467899999775 458889999999999999998 9999976 5667777777665332 3445567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.++++.
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHH
Confidence            999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=3.2e-26  Score=225.55  Aligned_cols=174  Identities=31%  Similarity=0.486  Sum_probs=137.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+++|.++....+.+++..++.++.||+.||+|||+.+  |+|+||+|+||+++.+ +.+||+|||++..+.... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCcccc
Confidence            5678889888877777999999999999999999999998  9999999999999876 799999999998764332 23


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-------------------CC
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-------------------GK  138 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-------------------g~  138 (502)
                      ....+++.|+|||++.+  .++.++||||||+++|+|++|.+||........+.+....                   +.
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34678999999998754  3778999999999999999999999764433332221110                   00


Q ss_pred             -CCCc--------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          139 -LPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       139 -~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                       .+..        .....+..+.+|+.+||. +|.+||++.++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0000        011236779999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=250.92  Aligned_cols=171  Identities=28%  Similarity=0.494  Sum_probs=148.6

Q ss_pred             CcHHHHH-H-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCCcc
Q 010730            5 GTLREYR-K-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         5 GsL~~yi-~-k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+..+.| . ..++|++...+.++.|||.||.|||-.+  |+|+||||+|||+...  ..++||||||+|+++.......
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            4555555 2 4678999999999999999999999999  9999999999999754  4689999999999999888889


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--CCCCcccccccHHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--~~p~~~~~~~s~~l~~LI~k  157 (502)
                      +++|||.|+|||++. ..|+...|+||+|||+|.-|+|.+||.+.   ++|-++|++.  .+|...|.-+++++-+||..
T Consensus       725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            999999999999986 45999999999999999999999999664   4455566554  34666667778999999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +|+ +..+|.|++..|.|||++..
T Consensus       802 LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHhcchHhhccchhhhcc
Confidence            999 99999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=2e-26  Score=227.11  Aligned_cols=173  Identities=29%  Similarity=0.546  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-A   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~   79 (502)
                      |+.+|+|.+++.. +.+++..++.++.||+.||.|||+++  |+|+||+|+||+++.+ +.+||+|||++..+..... .
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccCcchhh
Confidence            5788999999865 56899999999999999999999988  9999999999999876 7899999999976543221 2


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|+..|+|||++.+ .++.++|+|||||++|+|++|..||... .+..+...+..+..+ .+....+..+.++|.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~  236 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPP-TLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCCCC-CCCcccCHHHHHHHHHH
Confidence            33568999999998864 4788999999999999999999999753 333333333333322 33344567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |. +|.+||++.+++.||||..
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         237 LNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             ccCCcccCcCHHHHHHhHHHHH
Confidence            98 9999999999999999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.8e-26  Score=222.03  Aligned_cols=169  Identities=19%  Similarity=0.316  Sum_probs=138.5

Q ss_pred             CCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++...      ..+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++...
T Consensus        88 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~  164 (273)
T cd05035          88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVADFGLSKKIY  164 (273)
T ss_pred             ccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEECCccceeecc
Confidence            56889999998543      36899999999999999999999988  9999999999999876 789999999998654


Q ss_pred             CCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           75 GSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        75 ~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....   .....++..|+|||++.. .++.++|||||||++|+|++ |..||.+ ....++++.+..+..+. .+...+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~  242 (273)
T cd05035         165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK-QPEDCLD  242 (273)
T ss_pred             ccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcCCCH
Confidence            3221   112335678999998754 58899999999999999999 8999976 45566777777665432 3445678


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.++|.+||. +|.+||++.|++.+
T Consensus       243 ~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         243 ELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.94  E-value=3.7e-26  Score=226.73  Aligned_cols=171  Identities=28%  Similarity=0.468  Sum_probs=132.6

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +++|.+++.. .+.+.+..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++..... .....
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          86 HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccccCCCCCCCCC
Confidence            5788887765 356889999999999999999999998  9999999999999876 79999999998754322 12234


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--C-----------CCC----Cc
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--G-----------KLP----GA  142 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g-----------~~p----~~  142 (502)
                      ..+++.|+|||++.+  .++.++|||||||++|+|++|..||.......+...++..  +           ..+    ..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            568999999998854  4788999999999999999999999765443333222211  0           000    00


Q ss_pred             ------------cc-ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          143 ------------FH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       143 ------------~~-~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                  +. ...+..+.+++.+||. +|.+|||+.|+|.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                        00 0125688999999999 99999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=3.7e-26  Score=233.20  Aligned_cols=173  Identities=27%  Similarity=0.390  Sum_probs=138.2

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCcccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s~   82 (502)
                      +++|.+++.+.+++++..++.++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++...... ......
T Consensus        92 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  168 (337)
T cd07858          92 DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEY  168 (337)
T ss_pred             CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCccccccCCCccccccc
Confidence            5799999998889999999999999999999999998  9999999999999876 79999999999865433 233456


Q ss_pred             cCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh---cC--------------------
Q 010730           83 IGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT---SG--------------------  137 (502)
Q Consensus        83 vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~---~g--------------------  137 (502)
                      .++..|+|||++.  ..++.++|||||||++|+|++|..||.+.. ....+..+.   ..                    
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (337)
T cd07858         169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS  247 (337)
T ss_pred             ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh
Confidence            7899999999775  358899999999999999999999996532 211111111   00                    


Q ss_pred             ----CCC--CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          138 ----KLP--GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       138 ----~~p--~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          ..+  .......++.++++|.+||. +|.+|||++++|.||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                000  01122357789999999999 99999999999999999753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=3.4e-26  Score=247.87  Aligned_cols=176  Identities=27%  Similarity=0.410  Sum_probs=131.2

Q ss_pred             CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            4 SGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         4 gGsL~~yi~k~-----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      +++|.+++...     .......++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+.....
T Consensus       246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~  322 (501)
T PHA03210        246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKERE  322 (501)
T ss_pred             ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEeCCCceecCcccc
Confidence            56788887542     23446778899999999999999998  9999999999999876 7999999999987654322


Q ss_pred             --cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCC-C-CC-hHHHHHHhhcCC-----CCC------
Q 010730           79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE-C-SN-PAQIYKKVTSGK-----LPG------  141 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~-~-~~-~~ql~~kI~~g~-----~p~------  141 (502)
                        ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+++.. . .+ ..++.+.+....     +|.      
T Consensus       323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  402 (501)
T PHA03210        323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLF  402 (501)
T ss_pred             cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHH
Confidence              234689999999998864 589999999999999999998765432 2 12 233333222110     110      


Q ss_pred             -------------c----c-cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          142 -------------A----F-HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       142 -------------~----~-~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                                   .    + ....+..+.++|.+||. ||.+||||.|+|.||||.....
T Consensus       403 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        403 DYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence                         0    0 00134567788999999 9999999999999999976543

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=5.5e-26  Score=225.72  Aligned_cols=176  Identities=28%  Similarity=0.522  Sum_probs=139.9

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++..    ...+++..+..++.||+.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence            5678999998753    356899999999999999999999998  9999999999999876 78999999998765432


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC----CChHHHHHHhhcCCCCC---ccc--cc
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTSGKLPG---AFH--RI  146 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~----~~~~ql~~kI~~g~~p~---~~~--~~  146 (502)
                      . .....++..|+|||.+. ..++.++|||||||++|+|++|..||...    ....++...+.....+.   ...  ..
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            2 22456789999999775 45889999999999999999999999764    23344454444322221   111  12


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .++.+++||.+||. +|.+|||+.|++.||||+..
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            35789999999998 99999999999999999643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=4.4e-26  Score=224.97  Aligned_cols=169  Identities=20%  Similarity=0.309  Sum_probs=138.8

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+++|.+++...                ..+++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||
T Consensus        89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~kl  165 (283)
T cd05091          89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDK-LNVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCC-CceEe
Confidence            46789999998532                34888899999999999999999998  9999999999999876 68999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.......   .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ ....+++..+..+..
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~  244 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIRNRQV  244 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence            99999876533221   23445678999999774 568999999999999999998 8888876 456677888877665


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+..+.+++..||+ +|.+||++++++..
T Consensus       245 ~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         245 L-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             C-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            3 2334467889999999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=5.9e-26  Score=225.61  Aligned_cols=175  Identities=23%  Similarity=0.386  Sum_probs=140.5

Q ss_pred             CCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKYT----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+++.+.+          .+....+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++
T Consensus        90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~~~~L~Dfg~~  166 (288)
T cd05061          90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-FTVKIGDFGMT  166 (288)
T ss_pred             CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-CcEEECcCCcc
Confidence            578999999997632          3466788999999999999999998  9999999999999986 79999999998


Q ss_pred             eeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           71 AILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        71 ~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      +.+.....   .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+ ....++++.+..+..+. ...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~~-~~~  244 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYLD-QPD  244 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence            76533221   12234577899999875 458999999999999999999 7889976 45566666666554432 233


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhc------CCCCcCC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLL------DPFLASD  180 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~------hPff~~~  180 (502)
                      ..++.+++++.+||. +|.+|||+.++++      ||||++-
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            446889999999998 9999999999986      7888653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=4.6e-26  Score=224.02  Aligned_cols=169  Identities=24%  Similarity=0.357  Sum_probs=135.0

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+..                .+++..++.++.||+.||+|||+.+  ++||||||+||+++.+ +.+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~kl  153 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI  153 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEEE
Confidence            567899999997643                4789999999999999999999988  9999999999999887 79999


Q ss_pred             EecCCceeccCCCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           65 GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      +|||++..............++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+...+++.+..+... .
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~  231 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E  231 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-C
Confidence            9999986432211111223466799999875 458899999999999999997 9999966 4555666666554332 2


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...+.++.+++.+||. +|.+||++.+++..
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            333457789999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=3.4e-26  Score=226.87  Aligned_cols=169  Identities=25%  Similarity=0.401  Sum_probs=138.8

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++...                +.+++..+..++.||+.||+|||+.+  |+||||||+|||++.+ +.+||
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~-~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTED-HVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCC-CeEEe
Confidence            56899999999642                45899999999999999999999988  9999999999999876 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.+.....   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ....++++.+..+..
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~  252 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGYR  252 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence            99999986543221   12223567899999765 458999999999999999998 9999976 456677777766654


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +. .+...+..+.+|+.+||. +|.+|||+.|++++
T Consensus       253 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         253 ME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32 334457889999999998 99999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.94  E-value=5.6e-26  Score=222.71  Aligned_cols=171  Identities=27%  Similarity=0.436  Sum_probs=136.7

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~s   81 (502)
                      +++|.+++... ..+++..+..++.||+.||.|||.++  |+|+||||+||+++.+ +.+||+|||.+....... ....
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccccC
Confidence            46888888764 68999999999999999999999998  9999999999999976 789999999998765433 2334


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CC----------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PG----------------  141 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~----------------  141 (502)
                      ..++..|+|||.+.+  .++.++|+||||+++|+|+||+.||.......++.+.......  +.                
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            568899999997753  4788999999999999999999999775544443332221100  00                


Q ss_pred             ---------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 ---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 ---------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                               ......+..+++||.+||. +|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                     0111246789999999999 99999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=4.5e-26  Score=226.42  Aligned_cols=175  Identities=27%  Similarity=0.380  Sum_probs=136.1

Q ss_pred             CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010730            4 SGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAH   80 (502)
Q Consensus         4 gGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~   80 (502)
                      +++|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+||+++...+.+||+|||++....... ...
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         84 DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            5688888876443  588899999999999999999998  99999999999998654679999999997653322 223


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--Cc--------------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GA--------------  142 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~--------------  142 (502)
                      ...+++.|+|||++.+  .++.++|||||||++|+|+||.+||........+.+.+..-..+  ..              
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            4578899999998754  47889999999999999999999997754444444322110000  00              


Q ss_pred             ----------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          143 ----------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       143 ----------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                .....+..+.++|.+||. +|.+||++.++|.||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                      012246788999999998 99999999999999999753

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=6.6e-26  Score=230.30  Aligned_cols=176  Identities=28%  Similarity=0.344  Sum_probs=138.5

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-------
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-------   76 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-------   76 (502)
                      +|+|.+++.....+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++......       
T Consensus       103 ~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~  179 (335)
T PTZ00024        103 ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLS  179 (335)
T ss_pred             ccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CCEEECCccceeeccccccccccc
Confidence            5799999998888999999999999999999999998  9999999999999876 79999999999765411       


Q ss_pred             --------CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-C--CCCCc-
Q 010730           77 --------QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-G--KLPGA-  142 (502)
Q Consensus        77 --------~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g--~~p~~-  142 (502)
                              .......+++.|+|||++.+  .++.++|||||||++|+|++|.+||........ +..+.. .  ..+.. 
T Consensus       180 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~  258 (335)
T PTZ00024        180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRIFELLGTPNEDNW  258 (335)
T ss_pred             ccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCchhhC
Confidence                    11223457889999998754  378899999999999999999999976443333 322221 0  00000 


Q ss_pred             ----------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          143 ----------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       143 ----------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                                            .....+..+.++|.+||. +|.+||+++|+|.||||+.....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        259 PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             cchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence                                  011236778999999999 99999999999999999865443

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=5.9e-26  Score=224.05  Aligned_cols=170  Identities=20%  Similarity=0.360  Sum_probs=136.2

Q ss_pred             CCCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~   71 (502)
                      |+.||+|.+++.+.+       .+++..+..++.||+.||+|||+++  ++||||||+||+++.+  ...+||+|||+++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCcccc
Confidence            567999999997754       4899999999999999999999998  9999999999999864  2358999999998


Q ss_pred             eccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           72 ILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        72 ~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      .+.....   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+.+.+..+..+ .++..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~~~~~  245 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVTGGGRL-DPPKG  245 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-CCCCC
Confidence            6632211   11223456899999875 559999999999999999997 9999976 3445556665544332 33444


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+..+.+++.+||. +|.+||++.++|+|
T Consensus       246 ~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         246 CPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            57889999999998 99999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=5.7e-26  Score=222.52  Aligned_cols=170  Identities=23%  Similarity=0.346  Sum_probs=132.9

Q ss_pred             CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYT-----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      |+.+|+|.+++.+..     ..++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEecccccccccc
Confidence            578999999997653     2467788999999999999999998  9999999999999987 7999999999865322


Q ss_pred             CC---CcccccCCCcccCccccc--------cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCC---
Q 010730           76 SQ---QAHSVIGTPEFMAPELYE--------EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP---  140 (502)
Q Consensus        76 ~~---~~~s~vGTp~Y~APEvl~--------~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p---  140 (502)
                      ..   ......+++.|+|||++.        ..++.++|||||||++|+|++ |..||....+...+...+..+..+   
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK  232 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence            11   112345677899999864        236789999999999999999 888997755544444444444322   


Q ss_pred             CcccccccHHHHHHHHHhhhCcCCCCCHHHHhc
Q 010730          141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL  173 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~dP~kRpSa~ELL~  173 (502)
                      ..+....+..+++++..|+.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE  265 (269)
T ss_pred             CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence            223334577889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=7.5e-26  Score=220.12  Aligned_cols=168  Identities=20%  Similarity=0.406  Sum_probs=138.2

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCCcee
Confidence            5789999999975 356899999999999999999999998  9999999999999876 78999999998765332211


Q ss_pred             --ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+..+++..+..+..+ ..+...+..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li  234 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYEVM  234 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence              2234567899999876 458899999999999999999 9999976 4556667777766543 23344577899999


Q ss_pred             HHhhh-CcCCCCCHHHHhc
Q 010730          156 GKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+||. +|.+||+++++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            99998 9999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=4.2e-26  Score=233.59  Aligned_cols=171  Identities=30%  Similarity=0.427  Sum_probs=137.8

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|++|.+++.. .++++..++.++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++......  ....
T Consensus       102 ~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~--~~~~  175 (343)
T cd07851         102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLARHTDDE--MTGY  175 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEcccccccccccc--ccCC
Confidence            47899999976 57999999999999999999999998  9999999999999876 79999999999765432  3456


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC-CCC------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-LPG------------------  141 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~-~p~------------------  141 (502)
                      .+++.|+|||++.+  .++.++|||||||++|+|++|..||.+... ...+..+.... .+.                  
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (343)
T cd07851         176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESARNYIQS  254 (343)
T ss_pred             cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHh
Confidence            78999999998754  478899999999999999999999976433 33333332210 000                  


Q ss_pred             ----------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          142 ----------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       142 ----------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                ......+..+.+||.+||. +|.+|||+.+||.||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                      0011237789999999998 99999999999999999754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=4e-26  Score=229.37  Aligned_cols=169  Identities=24%  Similarity=0.351  Sum_probs=135.5

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.+                .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~-~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC-CcEEe
Confidence            567999999997543                5789999999999999999999998  9999999999999876 78999


Q ss_pred             EecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           65 GDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      +|||++.............+++.|+|||++.+ .++.++|||||||++|+|+| |..||.. .+..++++.+..+..+ .
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~  243 (303)
T cd05088         166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E  243 (303)
T ss_pred             CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCCcC-C
Confidence            99999864322111122234678999998754 47899999999999999998 9999975 4455666666554322 2


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...+..+.++|.+||. +|.+||++.++|..
T Consensus       244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            233356789999999998 99999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=5.5e-26  Score=221.67  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=140.6

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++..    ...+++..+..++.||+.||.|||+++  |+|+||||+||+++.+ +.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccceeccch
Confidence            5678999998853    345899999999999999999999998  9999999999999876 78999999998876432


Q ss_pred             C-CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC-CChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~-~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      . ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||... .+...+.+.+..+..+.......+..+++
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            2 123457899999999875 45888999999999999999999998653 23456666666655554444455788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+||++.++++.
T Consensus       240 li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         240 LVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHCCCCcccCcCHHHHHHH
Confidence            9999998 99999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=7.5e-26  Score=224.18  Aligned_cols=177  Identities=29%  Similarity=0.456  Sum_probs=143.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.+|.|||..+  ++||||||.||+++.+ +.++|+|||++..+.....  
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  162 (288)
T cd05583          86 YVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEER  162 (288)
T ss_pred             cCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECccccccccccccc
Confidence            5678999999988888999999999999999999999988  9999999999999876 7899999999876543221  


Q ss_pred             cccccCCCcccCccccccC---CCCcccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~---ys~~~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      .....|++.|+|||.+.+.   .+.++||||||+++|+|++|..||....   ....+.+.+.....  ..+...+..++
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  240 (288)
T cd05583         163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEAR  240 (288)
T ss_pred             cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHH
Confidence            2235689999999987543   6789999999999999999999995421   22334444443332  23344578899


Q ss_pred             HHHHHhhh-CcCCCCC---HHHHhcCCCCcCCCC
Q 010730          153 RFVGKCLE-NVSKRLP---AKELLLDPFLASDAG  182 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpS---a~ELL~hPff~~~~~  182 (502)
                      ++|.+||. +|.+|||   +.++|+||||+.-.+
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            99999998 9999998   678899999986544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=8.6e-26  Score=219.11  Aligned_cols=169  Identities=25%  Similarity=0.381  Sum_probs=137.7

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+..  .+++..++.++.||+.||+|||+.+  ++||||||+||+++.+ +.+||+|||++..+.....
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEecccccccccccccc
Confidence            467999999998754  6899999999999999999999998  9999999999999987 7999999999987643211


Q ss_pred             ----cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 ----AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ----~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                          .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+.+.........+...+..+.
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDKEGERLERPEACPQDIY  231 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence                12345778999999876 458999999999999999999 9999965 4555566555532222223334568899


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhc
Q 010730          153 RFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +++.+||. +|.+||++.+++.
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            99999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=7.1e-26  Score=230.72  Aligned_cols=174  Identities=29%  Similarity=0.447  Sum_probs=133.8

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ----QA   79 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~----~~   79 (502)
                      +++|.+++.. +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......    ..
T Consensus        91 ~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~  166 (336)
T cd07849          91 ETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFL  166 (336)
T ss_pred             ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccceeeccccccccCCc
Confidence            4688888754 56999999999999999999999998  9999999999999876 799999999997654321    12


Q ss_pred             ccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHH--------------HHHhhcCC-----
Q 010730           80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--------------YKKVTSGK-----  138 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql--------------~~kI~~g~-----  138 (502)
                      ...+||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+......+              ++.+....     
T Consensus       167 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (336)
T cd07849         167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYI  246 (336)
T ss_pred             CCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHH
Confidence            3457899999999764  35889999999999999999999999763322111              11111000     


Q ss_pred             --CC----Cc---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          139 --LP----GA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       139 --~p----~~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                        .+    ..   .....+.++.++|.+||. +|.+|||+.|++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         247 KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence              00    00   011236779999999999 999999999999999997543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=1.2e-25  Score=225.59  Aligned_cols=170  Identities=28%  Similarity=0.505  Sum_probs=137.8

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++.. .+.+++..+..++.||+.||.|||+++  |+||||+|+||+++.+ +.+||+|||++.....   ....
T Consensus        98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~---~~~~  171 (307)
T cd06607          98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLVSP---ANSF  171 (307)
T ss_pred             CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecCcceecCC---CCCc
Confidence            4678887764 457999999999999999999999998  9999999999999887 7999999999876532   2346


Q ss_pred             cCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        83 vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .|++.|+|||++.    +.++.++||||||+++|+|++|..||........++ .+.....+.......+..++++|.+|
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            7899999999873    458889999999999999999999997643333333 33333333222333567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.+++.||||...
T Consensus       251 l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         251 LQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             hcCChhhCcCHHHHhcChhhccc
Confidence            98 99999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.94  E-value=5.5e-26  Score=227.68  Aligned_cols=163  Identities=20%  Similarity=0.301  Sum_probs=130.3

Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-------
Q 010730            5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-------   77 (502)
Q Consensus         5 GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-------   77 (502)
                      +++.++++.....++..++.++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||+++.+....       
T Consensus       111 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~-~~~~l~DFGla~~~~~~~~~~~~~~  187 (294)
T PHA02882        111 ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN-NRGYIIDYGIASHFIIHGKHIEYSK  187 (294)
T ss_pred             cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CcEEEEEcCCceeeccCCccccccc
Confidence            466777776666789999999999999999999998  9999999999999876 789999999998653211       


Q ss_pred             -CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH--------HHHHhhcCCCCCcccccc
Q 010730           78 -QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--------IYKKVTSGKLPGAFHRIQ  147 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q--------l~~kI~~g~~p~~~~~~~  147 (502)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......        +++.+..++..   ....
T Consensus       188 ~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  264 (294)
T PHA02882        188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK---IKNA  264 (294)
T ss_pred             ccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc---cCCC
Confidence             1223579999999998764 489999999999999999999999977533222        23444444332   1223


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..+.+++..|+. +|.+||++.+|++
T Consensus       265 ~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        265 NKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             CHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            6789999999999 9999999999876

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.8e-26  Score=262.49  Aligned_cols=172  Identities=16%  Similarity=0.183  Sum_probs=129.8

Q ss_pred             CCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------------------CCcE
Q 010730            2 FTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------LGQI   62 (502)
Q Consensus         2 ~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~------------------~g~v   62 (502)
                      +.+++|.+++.+ ...+++..++.+++||+.||+|||++|  ||||||||+|||++..                  .+.+
T Consensus        61 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~  138 (793)
T PLN00181         61 CEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATT  138 (793)
T ss_pred             cCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcc
Confidence            347899999975 456999999999999999999999998  9999999999999532                  2456


Q ss_pred             EEEecCCceeccCC-----------------CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC
Q 010730           63 KIGDLGLAAILRGS-----------------QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC  124 (502)
Q Consensus        63 KL~DFGlA~~~~~~-----------------~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~  124 (502)
                      |++|||+++.....                 ......+||+.|||||++. ..|+.++|||||||+||||++|.+|+...
T Consensus       139 ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        139 KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             cccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            77777776542110                 0011246899999999875 46999999999999999999999887532


Q ss_pred             CChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          125 SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       125 ~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                         ......+....++... ....+.+..++.+||. +|.+||++.|+|+||||..
T Consensus       219 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        219 ---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             ---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence               2223333333333221 1124567789999998 9999999999999999975

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=8.1e-26  Score=223.72  Aligned_cols=168  Identities=22%  Similarity=0.380  Sum_probs=136.5

Q ss_pred             CCCCCcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 010730            1 MFTSGTLREYRKKYT---------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG   65 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~   65 (502)
                      |+.+|+|.+++...+               .+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~-~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG-LVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC-CCEEEC
Confidence            578999999998753               4889999999999999999999998  9999999999999876 789999


Q ss_pred             ecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCC
Q 010730           66 DLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP  140 (502)
Q Consensus        66 DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p  140 (502)
                      |||++........   .....+++.|+|||++. ..++.++|||||||++|+|++ |.+||... ........+..+..+
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~  243 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECITQGREL  243 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHHHHcCccC
Confidence            9999976533221   12234578899999775 458999999999999999998 99999764 344455556555433


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                       ..+...++.++++|.+||. +|.+||++.+|+.
T Consensus       244 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         244 -ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             2334557889999999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=7.8e-26  Score=221.79  Aligned_cols=169  Identities=24%  Similarity=0.398  Sum_probs=138.1

Q ss_pred             CCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKYT----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+++....          .+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~~kl~dfg~~  166 (277)
T cd05032          90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CCEEECCcccc
Confidence            567899999997532          3678899999999999999999988  9999999999999987 79999999998


Q ss_pred             eeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           71 AILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        71 ~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      +.+....   ......++..|+|||++. +.++.++|||||||++|+|+| |..||.+ .+..++.+.+..+..+ ..+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~  244 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGHL-DLPE  244 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCCC-CCCC
Confidence            7654322   223445788999999775 458899999999999999998 9999976 4556666666655433 2334


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..+.++|.+||. +|.+|||+.+++..
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            457899999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.93  E-value=7.6e-26  Score=224.13  Aligned_cols=171  Identities=23%  Similarity=0.409  Sum_probs=131.7

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~s   81 (502)
                      +|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++....... ....
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccCCCCccccc
Confidence            36999999764 46899999999999999999999998  9999999999999887 799999999986543211 1223


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---CCCCC---------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GKLPG---------------  141 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---g~~p~---------------  141 (502)
                      ..+++.|+|||++.+  .++.++||||+|+++|+|++|..||.+.....+..+.+..   ...+.               
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            457899999998753  4788999999999999999999999765433322222110   00000               


Q ss_pred             -------cc---ccccc--HHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 -------AF---HRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 -------~~---~~~~s--~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                             ..   ....+  ..+.++|.+||. +|.+|||+.++|.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                   00   00122  678899999999 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=9e-26  Score=219.58  Aligned_cols=169  Identities=20%  Similarity=0.353  Sum_probs=135.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+ +.+||+|||++..+....  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence            57889999999764 45788888999999999999999988  9999999999999876 789999999987553211  


Q ss_pred             ---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhc-cCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           78 ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        78 ---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG-~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                         ......+++.|+|||.+. ..++.++|||||||++|+|++| .+||.. .+...+.+.+..+..+ ..+...+..+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPLY  232 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHHH
Confidence               112344678899999775 5588999999999999999995 566654 5566666666665443 23334567899


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +++.+||. +|.+||++.+++..
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=8.4e-26  Score=231.27  Aligned_cols=172  Identities=27%  Similarity=0.434  Sum_probs=133.6

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC----c
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ----A   79 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~----~   79 (502)
                      +++|.+++.. ..+++..++.++.||+.||.|||+++  |+||||||+||+++...+.+||+|||++..+.....    .
T Consensus        99 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (342)
T cd07854          99 ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL  175 (342)
T ss_pred             cccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccc
Confidence            4689888864 46999999999999999999999998  999999999999986556799999999976532211    1


Q ss_pred             ccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--------------------
Q 010730           80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--------------------  137 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--------------------  137 (502)
                      ....|++.|+|||++.  ..++.++|||||||++|+|++|..||........ ...+...                    
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (342)
T cd07854         176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDRNELLNVIPSFV  254 (342)
T ss_pred             ccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence            2346889999999764  3478899999999999999999999976433222 2221110                    


Q ss_pred             ----CCC-C---cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          138 ----KLP-G---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       138 ----~~p-~---~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                          ..+ .   .+....+.++++||.+||. +|.+|||+.|+|.||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             hhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                000 0   0111346789999999999 9999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=3.1e-26  Score=232.68  Aligned_cols=177  Identities=25%  Similarity=0.422  Sum_probs=134.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.||+|||+.+  |+||||||+||+++.+ +.+|++||+.+...... .
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence            46789999999875  35899999999999999999999988  9999999999999876 78999999865332111 1


Q ss_pred             Cc-------ccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-------
Q 010730           78 QA-------HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-------  140 (502)
Q Consensus        78 ~~-------~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-------  140 (502)
                      ..       ....++..|+|||++.+   .++.++|||||||++|+|++|..||........+...+......       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            10       11234567999998864   37899999999999999999999997754444433332211100       


Q ss_pred             -------------------------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 -------------------------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 -------------------------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                                           .......+..+.+||.+||. +|.+|||+.|+|+||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                                 00111235678999999998 99999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=1e-25  Score=219.49  Aligned_cols=169  Identities=21%  Similarity=0.409  Sum_probs=137.6

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||+++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccccccc
Confidence            56799999999764 46899999999999999999999998  9999999999999876 79999999998765432211


Q ss_pred             --ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. ....++...+..+..+ ..+...+.++.+++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  234 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEVYTIM  234 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHH
Confidence              1112345799999875 458899999999999999999 8999976 4455666666655332 34455688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.|+++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99998 99999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.93  E-value=1.2e-25  Score=220.11  Aligned_cols=169  Identities=20%  Similarity=0.358  Sum_probs=137.9

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.. ...+++..++.++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++.........
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccc
Confidence            5689999999975 457999999999999999999999998  9999999999999876 78999999999765332211


Q ss_pred             ----ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           80 ----HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        80 ----~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                          ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+...+..+..+ ..+...+.++.+
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~  229 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYA  229 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHH
Confidence                1122357899999875 458889999999999999996 99999774 445566666666543 344556789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+||++.++++.
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999 99999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=1.1e-25  Score=219.88  Aligned_cols=169  Identities=21%  Similarity=0.412  Sum_probs=138.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++... ..+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+ +.+||+|||.++........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCCCcee
Confidence            56789999999764 46899999999999999999999998  9999999999999876 78999999998765433221


Q ss_pred             c--cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 H--SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 ~--s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .  ...++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ......+..+++++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  234 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRL-YRPHLASEKVYAIM  234 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence            1  123567899999886 458899999999999999999 9999976 4455666677665443 23444578999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.+|+.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99998 99999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.93  E-value=1.4e-25  Score=218.42  Aligned_cols=171  Identities=29%  Similarity=0.505  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+++|.+++.+    ...+++..++.++.||+.||.|||+.+  ++|+||||+||+++.  +.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeecCCC
Confidence            5788999998864    356999999999999999999999998  999999999999975  46999999999776433


Q ss_pred             CC-cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           77 QQ-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        77 ~~-~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .....+...+..+..+. ++...+.++.++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  236 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPS-LPETYSRQLNSI  236 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCCC-CcchhcHHHHHH
Confidence            22 234568999999997753 478899999999999999999999965 44455556665555443 344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      |.+||. +|.+||++.|+++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhhCCCC
Confidence            999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.93  E-value=1.5e-25  Score=217.91  Aligned_cols=170  Identities=28%  Similarity=0.493  Sum_probs=140.1

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++.+.    ..+++..++.|+.||+.||.|||+.+  |+||||||+||+++.+ +.++|+|||++..+...
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceeeeccCC
Confidence            57899999999652    45899999999999999999999998  9999999999999876 78999999998765432


Q ss_pred             C-CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC-CChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~-~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      . ......|++.|+|||.+. ..++.++|||||||++|+|++|..||... .+..++.+.+..+..+.......+..+++
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD  239 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence            2 233457899999999775 45889999999999999999999999653 33445666666665554333356778999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +|.+||. +|.+||++.+|++
T Consensus       240 ~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         240 LVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHcCCCcccCCCHHHHHH
Confidence            9999998 9999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=1e-25  Score=226.50  Aligned_cols=170  Identities=23%  Similarity=0.369  Sum_probs=138.4

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++....  .+++..+..++.||+.||+|||+++  |+|+||||+||+++.+ +.+||+|||+++.+.....
T Consensus       120 ~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~  196 (302)
T cd05055         120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSN  196 (302)
T ss_pred             cCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECCCcccccccCCCc
Confidence            578999999997643  3899999999999999999999998  9999999999999876 6899999999976543221


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+++.+..+..+ ..+...+..+++
T Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  275 (302)
T cd05055         197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYD  275 (302)
T ss_pred             eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence               12345678899999775 458899999999999999998 999998755555555655555432 233445789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++.+||. +|.+||++.|++..
T Consensus       276 li~~cl~~~p~~Rpt~~ell~~  297 (302)
T cd05055         276 IMKTCWDADPLKRPTFKQIVQL  297 (302)
T ss_pred             HHHHHcCCCchhCcCHHHHHHH
Confidence            9999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.93  E-value=1.3e-25  Score=218.81  Aligned_cols=168  Identities=23%  Similarity=0.387  Sum_probs=136.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||+|||+.+  ++||||||+||+++.+ +.+||+|||++........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence            56899999999763  56889999999999999999999988  9999999999999876 7899999999987643221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. +.++.++|||||||++|+|+| |..||.. .....+...+..+... ......+.++.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  236 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRM-PRMENCPDELYDI  236 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              12234677899999875 458889999999999999998 9999976 4455556666555332 2223457789999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++++++.
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.6e-25  Score=211.34  Aligned_cols=174  Identities=35%  Similarity=0.584  Sum_probs=149.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+++|.+++.....++...+..++.+|+.+|.|||..+  |+|+||+|.||+++.+ +.++|+|||.+..........
T Consensus        68 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~  144 (244)
T smart00220       68 YCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLT  144 (244)
T ss_pred             CCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccc
Confidence            4567799999988777999999999999999999999998  9999999999999987 799999999998776544455


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc-ccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI-QDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~-~s~~l~~LI~kc  158 (502)
                      ...+++.|++||++. ..++.++||||||+++++|++|..||....+...+.+.+..+..+...... .+..+.+++.+|
T Consensus       145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  224 (244)
T smart00220      145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL  224 (244)
T ss_pred             cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence            677899999999875 558889999999999999999999997756777777777766554332221 567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff  177 (502)
                      |. +|.+||++.++++||||
T Consensus       225 l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      225 LVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ccCCchhccCHHHHhhCCCC
Confidence            98 99999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=6e-26  Score=226.74  Aligned_cols=171  Identities=33%  Similarity=0.493  Sum_probs=130.3

Q ss_pred             CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEEecCCceecc
Q 010730            4 SGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG----HLGQIKIGDLGLAAILR   74 (502)
Q Consensus         4 gGsL~~yi~k~-----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~----~~g~vKL~DFGlA~~~~   74 (502)
                      +++|.+++...     ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.    + +.+||+|||++..+.
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~~~~~~  163 (316)
T cd07842          87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPER-GVVKIGDLGLARLFN  163 (316)
T ss_pred             CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCcc-ceEEECCCccccccC
Confidence            46787777532     36899999999999999999999998  999999999999987    5 789999999998654


Q ss_pred             CCC----CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChH---------H---HHHHh--
Q 010730           75 GSQ----QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA---------Q---IYKKV--  134 (502)
Q Consensus        75 ~~~----~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~---------q---l~~kI--  134 (502)
                      ...    .....++|+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....         .   +...+  
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  243 (316)
T cd07842         164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT  243 (316)
T ss_pred             CCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCC
Confidence            322    1234578999999997754  47899999999999999999999996532211         0   00000  


Q ss_pred             ----------------------hcCCCC-----Cccc--ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          135 ----------------------TSGKLP-----GAFH--RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       135 ----------------------~~g~~p-----~~~~--~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                            .....+     ....  ...+..+.++|.+||. +|.+|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             CchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                  000000     0000  1345688999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=1.3e-25  Score=225.07  Aligned_cols=176  Identities=31%  Similarity=0.547  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+++|.+++.. +++++..++.++.||+.+|+|||+++  |+|+||||+||+++.+ +.++|+|||++..+.... ..
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccccc
Confidence            5789999998754 56899999999999999999999998  9999999999999876 789999999987654322 22


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~k  157 (502)
                      ....|++.|+|||++. ..++.++|+||+||++|+|++|..||.. ....+....+..+..+. ......+..+.++|.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            3457899999999875 4578899999999999999999999976 33344444443332211 1122357789999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      ||. +|.+||++.++|.||||....
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccC
Confidence            998 999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=1.2e-25  Score=217.56  Aligned_cols=165  Identities=21%  Similarity=0.313  Sum_probs=131.0

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC------CcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL------GQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~------g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|.+++.+.+ .++...+..++.||+.||+|||+++  |+||||||+||+++...      ..+||+|||++...
T Consensus        81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            578999999998766 7999999999999999999999988  99999999999998652      16999999998765


Q ss_pred             cCCCCcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           74 RGSQQAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ..   .....++..|+|||++.+   .++.++|||||||++|+|++ |..||.... ............   ..+.....
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~---~~~~~~~~  231 (259)
T cd05037         159 LS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH---RLPMPDCA  231 (259)
T ss_pred             cc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---CCCCCCch
Confidence            43   223567788999998864   48889999999999999999 688886643 222222222111   11122237


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.++|.+||. +|.+||++.++++.
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~~  257 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILRD  257 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=1.1e-25  Score=221.13  Aligned_cols=168  Identities=18%  Similarity=0.274  Sum_probs=136.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++  ++||||||+|||++.+ +.+|++|||.+.........
T Consensus        87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCcccccccccchh
Confidence            57899999999874 57999999999999999999999998  9999999999999876 78999999987654222111


Q ss_pred             --ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+.+.+..+..+ ..+...+..+.+++
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  241 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRL-PAPRNCPNLLHQLM  241 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence              1234567899999875 568999999999999999775 9999976 3445566666665433 23455678899999


Q ss_pred             HHhhh-CcCCCCCHHHHhc
Q 010730          156 GKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+||. +|.+||++.+|++
T Consensus       242 ~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         242 LDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHcCCCchhCCCHHHHHH
Confidence            99999 9999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.93  E-value=1.2e-25  Score=219.39  Aligned_cols=170  Identities=29%  Similarity=0.469  Sum_probs=138.9

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++..    ...+++..++.++.||+.||.|||+++  ++|+||||+||+++.+ +.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhccccC
Confidence            4678999999874    356899999999999999999999998  9999999999999876 78999999998765432


Q ss_pred             C-CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC-ChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      . ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.+.. ....+.+.+.....+...+...+..+++
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  239 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence            2 2334578999999998754 47889999999999999999999996532 2345555665555444444456789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +|.+||. +|.+|||+.++++
T Consensus       240 li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         240 LVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhcCCCcccCCCHHHHHH
Confidence            9999998 9999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.93  E-value=1e-25  Score=221.80  Aligned_cols=170  Identities=28%  Similarity=0.444  Sum_probs=133.6

Q ss_pred             CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            4 SGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         4 gGsL~~yi~k~---~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      .|+|.+++...   ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcccc
Confidence            36899998764   35899999999999999999999998  9999999999999876 799999999997553322 12


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CCC---------------C
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP---------------G  141 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~p---------------~  141 (502)
                      ....+++.|++||++.+  .++.++|||||||++|+|++|..||.+...... +.++... ..|               .
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            34567899999998754  378899999999999999999999987544333 2222110 000               0


Q ss_pred             c-----------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 A-----------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 ~-----------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      .           +....+..++++|.+||. +|.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0           011236788999999998 99999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.93  E-value=1.6e-25  Score=225.87  Aligned_cols=169  Identities=25%  Similarity=0.402  Sum_probs=137.4

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+...                ..++...+..++.||+.||.|||+++  |+||||||+|||++.+ +.+||
T Consensus        99 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~-~~~kL  175 (314)
T cd05099          99 YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTED-NVMKI  175 (314)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcCC-CcEEE
Confidence            57899999999764                24888999999999999999999998  9999999999999876 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.......   .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.. ....+++..+..+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~  254 (314)
T cd05099         176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLREGHR  254 (314)
T ss_pred             ccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence            99999976543211   12223456899999875 458899999999999999999 8999965 556677777766543


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      . ..+...+.+++++|.+||. +|.+||++.++++.
T Consensus       255 ~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         255 M-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2 2334456789999999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=1.6e-25  Score=219.80  Aligned_cols=170  Identities=23%  Similarity=0.345  Sum_probs=132.0

Q ss_pred             CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYT-----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      |+.+|+|.+++...+     ..++..++.++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccC
Confidence            578999999997532     4567788899999999999999998  9999999999999886 7899999999865432


Q ss_pred             CCC---cccccCCCcccCcccccc--------CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCC---
Q 010730           76 SQQ---AHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP---  140 (502)
Q Consensus        76 ~~~---~~s~vGTp~Y~APEvl~~--------~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p---  140 (502)
                      ...   .....|++.|+|||++..        .++.++|||||||++|+|++ |..||....+...+...+......   
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK  232 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence            211   123457889999998753        25789999999999999996 999997755444433333332221   


Q ss_pred             CcccccccHHHHHHHHHhhhCcCCCCCHHHHhc
Q 010730          141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL  173 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~dP~kRpSa~ELL~  173 (502)
                      ..+....+..+++++.+|+.+|.+|||++||+.
T Consensus       233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~  265 (269)
T cd05087         233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL  265 (269)
T ss_pred             CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence            122233567889999999989999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=9.1e-26  Score=224.57  Aligned_cols=170  Identities=27%  Similarity=0.424  Sum_probs=131.0

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC----
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ----   78 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~----   78 (502)
                      +++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........    
T Consensus        98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~  174 (311)
T cd07866          98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKG  174 (311)
T ss_pred             CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcCccchhccCCCccccc
Confidence            4567777764 457999999999999999999999998  9999999999999887 7999999999976532211    


Q ss_pred             --------cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--CC-------
Q 010730           79 --------AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KL-------  139 (502)
Q Consensus        79 --------~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--~~-------  139 (502)
                              .....|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+... ...+..+...  ..       
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  253 (311)
T cd07866         175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIFKLCGTPTEETWPG  253 (311)
T ss_pred             CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhchh
Confidence                    123467899999997753  478999999999999999999999976333 3322222210  00       


Q ss_pred             ----------------CCcc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          140 ----------------PGAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       140 ----------------p~~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                      +...   .......+.+||.+||. +|.+|||+.|++.||||
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         254 WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                            0000   01123678899999998 99999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.93  E-value=1.5e-25  Score=222.21  Aligned_cols=169  Identities=23%  Similarity=0.332  Sum_probs=135.3

Q ss_pred             CCCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCC
Q 010730            1 MFTSGTLREYRKKYT-----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL   69 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGl   69 (502)
                      |+.+|+|.+++.+..           .+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.++|+|||+
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~  176 (296)
T cd05051         100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKN-YTIKIADFGM  176 (296)
T ss_pred             cCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeecCC-CceEEccccc
Confidence            467899999998766           7999999999999999999999998  9999999999999887 7999999999


Q ss_pred             ceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh--ccCCCCCCCChHHHHHHhhcC------
Q 010730           70 AAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTSG------  137 (502)
Q Consensus        70 A~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT--G~~Pf~~~~~~~ql~~kI~~g------  137 (502)
                      +.......   ......+++.|+|||++. +.++.++|||||||++|+|++  |..||... ...++++.+...      
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~  255 (296)
T cd05051         177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL-TDQQVIENAGHFFRDDGR  255 (296)
T ss_pred             eeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc-ChHHHHHHHHhccccccc
Confidence            97654322   123455788999999875 468999999999999999998  77888653 344444444332      


Q ss_pred             CCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ..........+.++.++|.+||. +|.+|||+.||++
T Consensus       256 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         256 QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            11112223346789999999998 9999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=1.7e-25  Score=223.90  Aligned_cols=169  Identities=27%  Similarity=0.412  Sum_probs=138.8

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+.+.                ..++...+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~~~-~~~kl  178 (304)
T cd05101         102 YASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI  178 (304)
T ss_pred             cCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEcCC-CcEEE
Confidence            56789999999764                24778889999999999999999998  9999999999999876 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.+.....   .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+ ....++++.+..+..
T Consensus       179 ~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~  257 (304)
T cd05101         179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR  257 (304)
T ss_pred             CCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCc
Confidence            99999987643221   22234678899999875 458899999999999999998 8888866 466777777766543


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      . ..+...+..+++||.+||. +|.+||++.|+++.
T Consensus       258 ~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         258 M-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             C-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            3 2334567899999999998 99999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=2e-25  Score=217.93  Aligned_cols=168  Identities=23%  Similarity=0.367  Sum_probs=136.6

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEccCCcc
Confidence            56789999999764  34889999999999999999999988  9999999999999876 7899999999976643221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+ ......+..+..+..+ ..+...+..++++
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  235 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-PCPQGCPESLHEL  235 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence              12234677899999775 458899999999999999999 9999977 4445556666554322 3334457889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            999998 9999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=2.1e-25  Score=217.50  Aligned_cols=168  Identities=23%  Similarity=0.374  Sum_probs=136.2

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence            56789999999763  45899999999999999999999998  9999999999999886 7899999999977543221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..++...+..+..+ ..+...+..++++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  235 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRM-PCPQDCPISLHEL  235 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence              12234567899999775 458889999999999999999 8999976 4445556666544322 3344557889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +.+||. +|.+|||+.+++.
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            999998 9999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=1.6e-25  Score=221.24  Aligned_cols=169  Identities=23%  Similarity=0.368  Sum_probs=138.4

Q ss_pred             CCCCCcHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 010730            1 MFTSGTLREYRKKY-----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK   63 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vK   63 (502)
                      |+.+|+|.+++...                 ..+++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.+|
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~-~~~k  164 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ-LHVK  164 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC-CcEE
Confidence            56789999999532                 23788899999999999999999998  9999999999999876 6899


Q ss_pred             EEecCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCC
Q 010730           64 IGDLGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK  138 (502)
Q Consensus        64 L~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~  138 (502)
                      |+|||+++......   ......++..|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+.+.+....
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~  243 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMVRKRQ  243 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence            99999997653322   123345677899999875 458999999999999999998 9999976 45566677766655


Q ss_pred             CCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+ ..+...+..++++|.+||. +|.+||++.+|+++
T Consensus       244 ~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         244 LL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             cC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44 2344567899999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.93  E-value=1.1e-25  Score=226.02  Aligned_cols=169  Identities=27%  Similarity=0.417  Sum_probs=138.3

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+...+                .++...++.++.||+.||+|||+++  ++||||||+||+++.+ +.+||
T Consensus       105 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~-~~~kL  181 (307)
T cd05098         105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI  181 (307)
T ss_pred             cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcCC-CcEEE
Confidence            567899999997642                4888999999999999999999998  9999999999999877 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||++..+.....   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++.+.+..+..
T Consensus       182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~  260 (307)
T cd05098         182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR  260 (307)
T ss_pred             CCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHcCCC
Confidence            99999876543211   11123457899999775 458899999999999999998 8889865 566777777766654


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+.+++++|.+||. +|.+||++.+++++
T Consensus       261 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         261 M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             C-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3 3344557899999999998 99999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=2.4e-25  Score=214.61  Aligned_cols=168  Identities=26%  Similarity=0.405  Sum_probs=140.0

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.....  +++..+..++.||+.||+|||+.+  ++||||||+||+++.+ +.++|+|||++........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceecccccc
Confidence            4678999999987554  999999999999999999999998  9999999999999887 7899999999987654322


Q ss_pred             cc--cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AH--SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~--s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ..  ...+++.|+|||.+. ..++.++|||||||++|+|++ |.+||.. .+...+++.+..+..+ ......+.++.++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRL-PKPENCPPEIYKL  236 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHHHHH
Confidence            11  123678999999875 458999999999999999998 8888865 5667777777766554 3334467899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +.+||. +|.+|||+.|+++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHh
Confidence            999999 9999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=1.6e-25  Score=217.71  Aligned_cols=169  Identities=25%  Similarity=0.415  Sum_probs=138.7

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence            56789999999763  46899999999999999999999998  9999999999999887 7999999999976543221


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++++.+..+..+ ..+...+..+.++|
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHHH
Confidence             12334577899999875 458889999999999999998 8999976 4556667776655332 33455678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+++|++.
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~~  257 (261)
T cd05148         238 LECWAAEPEDRPSFKALREE  257 (261)
T ss_pred             HHHcCCCchhCcCHHHHHHH
Confidence            99998 99999999998863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=6e-26  Score=227.83  Aligned_cols=170  Identities=28%  Similarity=0.360  Sum_probs=139.5

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      .++|.+.+.  -.++.+.++.++.|++.|++|||+.+  |+||||||+||+++.. ..+||.|||+|..-.....+..++
T Consensus       104 ~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~~~mtpyV  178 (369)
T KOG0665|consen  104 DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTDFMMTPYV  178 (369)
T ss_pred             hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhcccCcccccCchh
Confidence            456777776  46899999999999999999999998  9999999999999987 689999999998766555667789


Q ss_pred             CCCcccCcccc-ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC------------------------
Q 010730           84 GTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------------  138 (502)
Q Consensus        84 GTp~Y~APEvl-~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~------------------------  138 (502)
                      .|..|.|||++ .-.|.+.+||||+|||+.||++|..-|.+....+++.+.+..-.                        
T Consensus       179 vtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y  258 (369)
T KOG0665|consen  179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQY  258 (369)
T ss_pred             heeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHh
Confidence            99999999976 44599999999999999999999999987665666544332110                        


Q ss_pred             --------CCCc-------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          139 --------LPGA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       139 --------~p~~-------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                              +|..       ..+.....+++++.+||. +|.+|.+++++|.|||++
T Consensus       259 ~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  259 QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                    1111       111234568999999998 999999999999999997

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=1.4e-25  Score=224.59  Aligned_cols=169  Identities=21%  Similarity=0.317  Sum_probs=130.2

Q ss_pred             CCCCCcHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 010730            1 MFTSGTLREYRKKYT-------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ   61 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~   61 (502)
                      |+.+|+|.+++....                   .+++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~~~-~~  176 (304)
T cd05096         100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGEN-LT  176 (304)
T ss_pred             cCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEcCC-cc
Confidence            578999999996532                   3677889999999999999999998  9999999999999976 79


Q ss_pred             EEEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh--ccCCCCCCCChHHHHHHhh
Q 010730           62 IKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVT  135 (502)
Q Consensus        62 vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT--G~~Pf~~~~~~~ql~~kI~  135 (502)
                      +||+|||+++.+.....   .....+++.|+|||++. +.++.++|||||||++|+|++  +..||.+.. ..++...+.
T Consensus       177 ~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~~~~~~~~  255 (304)
T cd05096         177 IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT-DEQVIENAG  255 (304)
T ss_pred             EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC-HHHHHHHHH
Confidence            99999999976543221   22345678999999765 568999999999999999986  667887643 333333221


Q ss_pred             c----C--CCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          136 S----G--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       136 ~----g--~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .    .  ......+...+..+.++|.+||. +|.+|||+.+|..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         256 EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            1    1  11112233456789999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2.7e-25  Score=224.63  Aligned_cols=170  Identities=29%  Similarity=0.497  Sum_probs=138.9

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++.. ..++++..++.++.||+.+|.|||+++  |+||||||+||+++.+ +.+||+|||++....   .....
T Consensus       104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~~~~~  177 (313)
T cd06633         104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASKSS---PANSF  177 (313)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCCcccC---CCCCc
Confidence            5678888765 457999999999999999999999998  9999999999999876 789999999986432   23356


Q ss_pred             cCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        83 vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .|++.|+|||++.    +.++.++|||||||++|+|++|..||........+++. .....+.......+..+++||.+|
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDSPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCCCCccccCHHHHHHHHHH
Confidence            7899999999873    45888999999999999999999999775444444443 333333333344567899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.+++.||||+..
T Consensus       257 l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         257 LQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ccCChhhCcCHHHHhcCcccCCC
Confidence            98 99999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=2.1e-25  Score=218.48  Aligned_cols=171  Identities=32%  Similarity=0.474  Sum_probs=134.6

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~~s   81 (502)
                      +++|.+++.+. ..+++..++.++.||+.||.|||.++  |+||||+|+||+++.+ +.+||+|||++....... ....
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCccccCc
Confidence            47999999886 57999999999999999999999998  9999999999999886 799999999997654332 2234


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh-------------------cCCCC
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-------------------SGKLP  140 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~-------------------~g~~p  140 (502)
                      ..++..|+|||++.+  .++.++|||||||++|+|++|.+||........+.+...                   ...++
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            556889999997743  588899999999999999999999976433322211111                   00011


Q ss_pred             Cc-------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          141 GA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       141 ~~-------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ..       .....+..+.++|.+||. +|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            00       001126789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.6e-25  Score=215.95  Aligned_cols=167  Identities=25%  Similarity=0.411  Sum_probs=136.0

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++....  .+++..+..++.||+.||.|||..+  |+||||||+||+++.+ +.+||+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence            457999999997654  6999999999999999999999988  9999999999999987 7899999999987653221


Q ss_pred             cccccC---CCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 AHSVIG---TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~~s~vG---Tp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                       ....|   +..|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..+++..+..+... ......+..+.+
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (261)
T cd05068         159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPKELYD  235 (261)
T ss_pred             -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence             12223   45799999875 458889999999999999999 9999976 4555666666554322 233445788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ++.+||. +|.+||++.+|+.
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            9999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-26  Score=230.41  Aligned_cols=180  Identities=22%  Similarity=0.419  Sum_probs=155.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~-~~~~~~~   79 (502)
                      |..||+|-=..++..+++++.++.|...|..||.|||+.|  ||.||||.+|+|++.. |++||+|+|+++. +..+...
T Consensus       332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~gd~t  408 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPGDTT  408 (593)
T ss_pred             EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCCCccc
Confidence            5789999999999999999999999999999999999999  9999999999999987 8999999999986 4555667


Q ss_pred             ccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCC--C-----CChHHHHHHhhcCCCCCcccccccHHH
Q 010730           80 HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSE--C-----SNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~--~-----~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      .+++|||.|+|||++.+. |+..+|+|+|||+++||+.|+.||.-  .     ...+-+++.|...++  .+++..+-.+
T Consensus       409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprslsvka  486 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLSVKA  486 (593)
T ss_pred             ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceeehhh
Confidence            789999999999999864 99999999999999999999999942  2     233456777776655  3455567778


Q ss_pred             HHHHHHhhh-CcCCCCC------HHHHhcCCCCcCCCCCCC
Q 010730          152 RRFVGKCLE-NVSKRLP------AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpS------a~ELL~hPff~~~~~~~l  185 (502)
                      ..+++..|. ||.+|+.      ..++..|+||+...|..+
T Consensus       487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence            889999998 9999975      789999999998777553

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=1.9e-25  Score=216.40  Aligned_cols=168  Identities=20%  Similarity=0.365  Sum_probs=133.4

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.........
T Consensus        74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccc
Confidence            56799999999764 46899999999999999999999998  9999999999999876 78999999998754322111


Q ss_pred             ---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....++..|+|||.+. +.++.++|||||||++|+|++ |..||... ........+..+.. ...+...+..+.++
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  228 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRL  228 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHH
Confidence               1112345799999875 458899999999999999998 88998653 33444444444322 23445567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +.+||. +|.+||++.++++
T Consensus       229 i~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         229 MERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            999998 9999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=1.7e-25  Score=220.71  Aligned_cols=174  Identities=31%  Similarity=0.567  Sum_probs=143.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++.+ ..+++..+..++.||+.+|.|||..+  ++|+||||+||+++.+ +.++|+|||++..+.... ..
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchhhh
Confidence            5678999999975 46899999999999999999999988  9999999999999876 789999999987654322 12


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....|+..|+|||.+.. .++.++|+|||||++|+|++|..||.. .+...+...+..+..+ .+....+.++.++|.+|
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCCCC-CCCcccCHHHHHHHHHH
Confidence            34568999999998754 478899999999999999999999975 4445555555444332 34445678899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+||++.++++||||...
T Consensus       237 l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         237 LNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ccCChhhCcCHHHHHhCHHHhhh
Confidence            98 99999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-25  Score=219.25  Aligned_cols=170  Identities=24%  Similarity=0.402  Sum_probs=134.8

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--Ccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAH   80 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~~~   80 (502)
                      +++|.+++.+. ..+++..++.++.||+.||+|||.++  ++|+||||+||+++.+ +.+||+|||++.......  ...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccccc
Confidence            46899998765 57999999999999999999999998  9999999999999987 799999999998765432  123


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CC--CC--------------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KL--PG--------------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~--p~--------------  141 (502)
                      ...++..|+|||.+.+  .++.++||||||+++|+|++|..||..... ......+... ..  +.              
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            3567889999997653  478999999999999999999999976433 3333322210 00  00              


Q ss_pred             ------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          142 ------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       142 ------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                  .+....+..+.++|.+||. +|.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                        0111136788999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=3.3e-25  Score=218.03  Aligned_cols=169  Identities=20%  Similarity=0.355  Sum_probs=130.8

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++.+.    ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcc
Confidence            57899999999764    34677788999999999999999988  9999999999999876 78999999998643211


Q ss_pred             C---CcccccCCCcccCcccccc--------CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCC-C---C
Q 010730           77 Q---QAHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK-L---P  140 (502)
Q Consensus        77 ~---~~~s~vGTp~Y~APEvl~~--------~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~-~---p  140 (502)
                      .   ......|++.|+|||++..        .++.++|||||||++|+|++ |..||..... .+++.++..+. .   .
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~  231 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFK  231 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCC
Confidence            1   1234568899999998742        25678999999999999997 6778876443 34444433322 1   1


Q ss_pred             CcccccccHHHHHHHHHhhhCcCCCCCHHHHhc
Q 010730          141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL  173 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~dP~kRpSa~ELL~  173 (502)
                      ..+....++.+++++.+||.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 PQLELPYSERWYEVLQFCWLSPEKRATAEEVHR  264 (268)
T ss_pred             CccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence            223334578899999999999999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=2.4e-25  Score=224.24  Aligned_cols=169  Identities=28%  Similarity=0.511  Sum_probs=138.3

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++.. ...+++..++.++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++.....   ....
T Consensus        98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~---~~~~  171 (308)
T cd06634          98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---ANXF  171 (308)
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCcccceeecC---cccc
Confidence            4688887754 456999999999999999999999988  9999999999999876 7999999999876543   2345


Q ss_pred             cCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        83 vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .|++.|+|||++.    +.++.++|||||||++|+|++|..||........++. +..+..+.......+..++++|.+|
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-HhhcCCCCcCcccccHHHHHHHHHH
Confidence            7899999999863    3578899999999999999999999976443333443 3334344333445678899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |. +|.+||++.+++.|||+..
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             hhCCcccCCCHHHHhhCccccc
Confidence            98 9999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=9.7e-26  Score=238.32  Aligned_cols=168  Identities=26%  Similarity=0.413  Sum_probs=139.8

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      ||..|+|.+|++.  .+.++......|+.||++|++||++++  +|||||...||||+.+ ..+||+|||||+.+....-
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccccCCCce
Confidence            7899999999987  567999999999999999999999999  9999999999999987 6999999999995543322


Q ss_pred             ccc--ccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHS--VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s--~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ..+  .--..-|.|||.+. +.++.++|||||||+|+||+| |+.||.+..+ .++.+.+..|..- +.+..+++++.++
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~ev~~~le~GyRl-p~P~~CP~~vY~l  436 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EEVLELLERGYRL-PRPEGCPDEVYEL  436 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HHHHHHHhccCcC-CCCCCCCHHHHHH
Confidence            111  11245699999875 679999999999999999999 9999988655 5566667666432 3455678999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..||. +|.+|||++.+..
T Consensus       437 M~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHhhCCcccCCCHHHHHH
Confidence            999998 9999999886653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=245.42  Aligned_cols=169  Identities=33%  Similarity=0.515  Sum_probs=143.5

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec---cCC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL---RGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~---~~~   76 (502)
                      ++.|-+|..++.. ..+|++.+.+.|++||++|+.|||..+  |||||||..|||+..+ ++|||+||||+..-   ...
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccceeeeeeeccc
Confidence            4678899999964 356999999999999999999999999  9999999999999876 79999999998642   333


Q ss_pred             CCcccccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC---cccccccH
Q 010730           77 QQAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDA  149 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~---~~~~~~s~  149 (502)
                      .......|...|||||++..    .|+..+||||||+++|||+||.+||. ..+.++|.-.+..|.+-.   ........
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk  623 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPK  623 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHH
Confidence            44555678899999998852    48999999999999999999999998 588899888888884432   22333456


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ++++|+..||. ++++||...+||.
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHH
Confidence            89999999999 9999999999887

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=3.6e-25  Score=217.02  Aligned_cols=168  Identities=22%  Similarity=0.355  Sum_probs=136.6

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence            56889999999864  45899999999999999999999988  9999999999999876 7899999999976643322


Q ss_pred             c--ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~--~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .  ....++..|+|||++. ..++.++|||||||++|+|+| |..||.+ ....+++..+..+... ......+..+.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  235 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDL  235 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhcCCCC-CCccccCHHHHHH
Confidence            1  2344677899999775 558999999999999999999 8889876 4455666666554322 2233457889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=2.8e-25  Score=217.25  Aligned_cols=169  Identities=22%  Similarity=0.379  Sum_probs=138.2

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+.+|+|.+++... +.+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++....... .
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhcccccccc
Confidence            57899999999764 47999999999999999999999988  9999999999999886 789999999998764211 1


Q ss_pred             c--ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~--~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .  ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.... ..++.+.+..+... ..+...+..+.++
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~l  240 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRL-PPPMDCPSALYQL  240 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence            1  1233567899999876 458899999999999999998 999997643 45566666655332 2334557899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. +|.+||++.+++++
T Consensus       241 i~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         241 MLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHcCCCcccCcCHHHHHHH
Confidence            999998 99999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.6e-25  Score=214.98  Aligned_cols=167  Identities=23%  Similarity=0.379  Sum_probs=137.9

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+..  .+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEcccccccccccccc
Confidence            467899999998765  7999999999999999999999998  9999999999999876 7899999999987633221


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                        ...++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.++|.
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  233 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKVMK  233 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHHHH
Confidence              334566899999775 558889999999999999997 9999976 4556666666554332 233445789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. +|.+||++.++++.
T Consensus       234 ~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         234 DCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHhccChhhCcCHHHHHHH
Confidence            9998 99999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.8e-25  Score=227.98  Aligned_cols=172  Identities=29%  Similarity=0.408  Sum_probs=135.9

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +.|++|.++++. +.+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++.....  ....
T Consensus       103 ~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~~~--~~~~  176 (345)
T cd07877         103 LMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTDD--EMTG  176 (345)
T ss_pred             hcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEecccccccccc--cccc
Confidence            357899888865 46999999999999999999999998  9999999999999887 7999999999876432  2344


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC----------------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG----------------------  137 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g----------------------  137 (502)
                      ..|++.|+|||++.+  .++.++|||||||++|+|++|..||...... ..+..+...                      
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (345)
T cd07877         177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSESARNYIQ  255 (345)
T ss_pred             cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhcccHhHHHHHH
Confidence            678999999998754  4788999999999999999999999763332 222221110                      


Q ss_pred             ---CCC----CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          138 ---KLP----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       138 ---~~p----~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                         ..+    .......++.+++||.+||. +|.+|+++.++|.||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence               000    00111246789999999998 99999999999999999753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=8.6e-26  Score=255.20  Aligned_cols=173  Identities=34%  Similarity=0.588  Sum_probs=142.1

Q ss_pred             CCCCCcHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-----
Q 010730            1 MFTSGTLREYRKKYTRV-DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-----   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L-~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-----   74 (502)
                      ||..-+|++++..+... ....++.+++||++||.|+|++|  ||||||||.|||++.+ +.|||+|||+|+...     
T Consensus       677 yCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~  753 (1351)
T KOG1035|consen  677 YCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLES  753 (1351)
T ss_pred             hhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCC-CCeeecccccchhhhhhhhh
Confidence            45555677777665544 57789999999999999999999  9999999999999977 689999999997621     


Q ss_pred             --------------CCCCcccccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc
Q 010730           75 --------------GSQQAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS  136 (502)
Q Consensus        75 --------------~~~~~~s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~  136 (502)
                                    .....++.+||.-|+|||++.+    .|+.++||||||||++||+   +||........+...+..
T Consensus       754 ~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~  830 (1351)
T KOG1035|consen  754 IDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK  830 (1351)
T ss_pred             HhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc
Confidence                          0112356799999999999852    5999999999999999996   468766667788888888


Q ss_pred             CCCCCc--ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          137 GKLPGA--FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       137 g~~p~~--~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +.+|..  +....-+.-..+|..||. ||.+||||.|||++.||.+
T Consensus       831 g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  831 GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            888755  333345677889999999 9999999999999999863

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=3.9e-25  Score=218.53  Aligned_cols=168  Identities=24%  Similarity=0.392  Sum_probs=130.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+. .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+.....  
T Consensus        89 ~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~  164 (283)
T cd05080          89 YVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYY  164 (283)
T ss_pred             CCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccccccCCcchhh
Confidence            57889999999774 5999999999999999999999998  9999999999999876 7899999999986643222  


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh-H-------------HHHHHhhcCCCCC
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP-A-------------QIYKKVTSGKLPG  141 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~-~-------------ql~~kI~~g~~p~  141 (502)
                        .....++..|+|||++. ..++.++|||||||++|+|+||..||...... .             .+.+.+..+.. .
T Consensus       165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  243 (283)
T cd05080         165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR-L  243 (283)
T ss_pred             ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC-C
Confidence              12234567799999875 45889999999999999999999998542211 0             11111111111 1


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ..+...+..+++++.+||. +|.+|||+++++.
T Consensus       244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1233456899999999999 9999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.3e-25  Score=213.44  Aligned_cols=169  Identities=22%  Similarity=0.393  Sum_probs=135.5

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.|++|.+++.+ ...+++..+..++.|++.+|.|||+++  ++||||||+||+++.+ +.+||+|||++.........
T Consensus        73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcce
Confidence            5679999999966 456899999999999999999999998  9999999999999876 79999999999765421111


Q ss_pred             ---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....++..|+|||++. +.++.++|+|||||++|+|+| |..||... ........+..+.. ...+...+..+.++
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  227 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRL  227 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHH
Confidence               1123456799999775 458899999999999999999 88898763 44555555554422 22344557899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.|+|+.
T Consensus       228 i~~~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         228 MLQCWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             HHHHhccChhhCcCHHHHHHH
Confidence            999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=2.6e-25  Score=226.45  Aligned_cols=173  Identities=28%  Similarity=0.359  Sum_probs=136.3

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC------
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ------   77 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~------   77 (502)
                      .++|.+++.+. .+++..++.++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++..+....      
T Consensus        92 ~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~~~~~  167 (337)
T cd07852          92 ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENP  167 (337)
T ss_pred             ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhccccccccccCc
Confidence            46899999775 7899999999999999999999988  9999999999999887 799999999997654321      


Q ss_pred             CcccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC------------------
Q 010730           78 QAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG------------------  137 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g------------------  137 (502)
                      .....+||+.|+|||++.  ..++.++||||||+++|+|++|+.||..........+.+...                  
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (337)
T cd07852         168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAAT  247 (337)
T ss_pred             chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHH
Confidence            223467899999999774  347889999999999999999999997644433322111110                  


Q ss_pred             --------CCC--CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          138 --------KLP--GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       138 --------~~p--~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                              ...  .......+.++.++|.+||. +|.+|||+.++|.|||++.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         248 MLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                    000  01111246789999999999 99999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-25  Score=220.93  Aligned_cols=168  Identities=27%  Similarity=0.513  Sum_probs=136.2

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...  ..++...+..|+.||+.||.|||+.+  |+|++|++.|||++.+ +.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccc
Confidence            57889999999886  77999999999999999999999998  9999999999999987 6999999999987632221


Q ss_pred             ---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+...|+|||++.. .++.++||||||+++|||++ |..||.+. +..++..++..+..+ ..+...+..+.+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRL-PIPDNCPKDIYS  236 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEET-TSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc-eeccchhHHHHH
Confidence               233456788999998864 48999999999999999999 78999775 667777777666543 344556788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +|.+||. +|.+||++.+|++
T Consensus       237 li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            9999998 9999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=4.2e-25  Score=215.78  Aligned_cols=165  Identities=18%  Similarity=0.305  Sum_probs=129.2

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-------cEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-------QIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g-------~vKL~DFGlA~~   72 (502)
                      |+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+.+  |+||||||+||+++.+..       .+|++|||++..
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            578999999997654 5899999999999999999999998  999999999999976522       379999999865


Q ss_pred             ccCCCCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhcc-CCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           73 LRGSQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        73 ~~~~~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~-~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ...   .....+++.|+|||++.+  .++.++|||||||++|+|++|. .||.. ........... ...  .++...+.
T Consensus       158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~  230 (258)
T cd05078         158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYE-DRH--QLPAPKWT  230 (258)
T ss_pred             cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHH-ccc--cCCCCCcH
Confidence            432   233568899999998864  4788999999999999999984 66654 33322222221 111  22333457


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++.++|.+||. +|.+|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=5.5e-25  Score=222.47  Aligned_cols=171  Identities=29%  Similarity=0.486  Sum_probs=138.8

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++.. ..++++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.....   ....
T Consensus       108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---~~~~  181 (317)
T cd06635         108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASIASP---ANSF  181 (317)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCCCccccCC---cccc
Confidence            4688887754 456999999999999999999999998  9999999999999876 7999999999865432   2345


Q ss_pred             cCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        83 vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .|++.|+|||++.    +.++.++|||||||++|+|++|..||........ ...+..+..+.......+..++++|.+|
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            7899999999763    4588899999999999999999999977433333 3444444333333344577899999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. +|.+||++.+++.|+|+....
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhccC
Confidence            98 999999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=6.8e-26  Score=250.45  Aligned_cols=168  Identities=23%  Similarity=0.361  Sum_probs=137.9

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      ||.||.|.+|+.+  ..+|++.+|++|+.|+++|+.+||...+||||||||-||||++.+ |..||||||-|...-... 
T Consensus       123 yC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSatt~~~~~~  201 (738)
T KOG1989|consen  123 YCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSATTKILSPT  201 (738)
T ss_pred             hccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccccccccCCCc
Confidence            6788999999974  456999999999999999999999999999999999999999987 799999999986422111 


Q ss_pred             Cc---------ccccCCCcccCccccc---c-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc
Q 010730           78 QA---------HSVIGTPEFMAPELYE---E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH  144 (502)
Q Consensus        78 ~~---------~s~vGTp~Y~APEvl~---~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~  144 (502)
                      ..         -...-||.|.|||++.   + ..++|+|||+|||+||-|+....||.+...     -.|..+.+..+..
T Consensus       202 ~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----laIlng~Y~~P~~  276 (738)
T KOG1989|consen  202 SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----LAILNGNYSFPPF  276 (738)
T ss_pred             cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----eeEEeccccCCCC
Confidence            11         0123699999999874   2 379999999999999999999999976322     2455666644444


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ...+..+++||..||+ +|.+||.+-+++.+
T Consensus       277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            4568899999999999 99999999888864

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=3.9e-25  Score=219.61  Aligned_cols=169  Identities=23%  Similarity=0.371  Sum_probs=136.8

Q ss_pred             CCCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 010730            1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN   56 (502)
Q Consensus         1 ~~tgGsL~~yi~k~------------------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~   56 (502)
                      |+.+|+|.+|+...                        .++++..+..++.||+.||.|||+++  |+||||||+|||++
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~  161 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVA  161 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEc
Confidence            56789999998653                        34788999999999999999999988  99999999999998


Q ss_pred             CCCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHH
Q 010730           57 GHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY  131 (502)
Q Consensus        57 ~~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~  131 (502)
                      .+ +.+||+|||++..+.....   .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+ ..+.+++
T Consensus       162 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~  239 (290)
T cd05045         162 EG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPERLF  239 (290)
T ss_pred             CC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHH
Confidence            76 7999999999976532211   12234567899999765 458899999999999999999 9999976 5667777


Q ss_pred             HHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       132 ~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..+..+ ..+...+.++.+|+.+||. +|.+||++++++..
T Consensus       240 ~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~  282 (290)
T cd05045         240 NLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE  282 (290)
T ss_pred             HHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            766654332 2334457899999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=3.7e-25  Score=217.11  Aligned_cols=170  Identities=21%  Similarity=0.374  Sum_probs=140.1

Q ss_pred             CCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKYT---------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.+++....         .+++..+..++.||+.||+|||+.+  |+||||||+||+++.+ +.++++|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcEEEccccccc
Confidence            467899999998766         7999999999999999999999998  9999999999999876 789999999986


Q ss_pred             eccCC--CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccc
Q 010730           72 ILRGS--QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ  147 (502)
Q Consensus        72 ~~~~~--~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~  147 (502)
                      .....  .......+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .....++..+..+..+.......
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~  244 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-LSDEEVLNRLQAGKLELPVPEGC  244 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cchHHHHHHHHcCCcCCCCCCCC
Confidence            54321  1223456788899999765 457889999999999999999 8899965 34456666666665544444456


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +..+.++|.+||. +|.+||++.|++..
T Consensus       245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         245 PSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            7899999999998 99999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=6.7e-25  Score=215.09  Aligned_cols=169  Identities=24%  Similarity=0.428  Sum_probs=136.7

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++  ++||||||+||+++.+ +.+||+|||++.........
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceeeecccccce
Confidence            567999999998754 5899999999999999999999988  9999999999999886 79999999999876443221


Q ss_pred             --ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        ....+++.|+|||++. ..++.++|||||||++|+|++ |..||..... .+....+..+..+ ..+...+..++++|
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li  241 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPTLYSLM  241 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHHHHHHH
Confidence              1223456899999775 458899999999999999996 9999977544 4444555555433 23344578999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.+++..
T Consensus       242 ~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         242 TKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99998 99999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=5.9e-25  Score=213.60  Aligned_cols=167  Identities=22%  Similarity=0.381  Sum_probs=136.8

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++....  .+++..+..++.||+.||.|||+.+  ++||||||+||+++.+ +.+||+|||++......  
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceecccc--
Confidence            578999999997653  5899999999999999999999988  9999999999999876 78999999998764322  


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .....+...+..+..+. .....+..+.+++.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  231 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYVLMT  231 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHHHHH
Confidence            12234567899999775 458899999999999999998 9999976 44555666666554332 23445788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. +|.+||++++++..
T Consensus       232 ~~l~~~p~~Rp~~~~l~~~  250 (254)
T cd05083         232 SCWETEPKKRPSFHKLREK  250 (254)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9998 99999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.5e-25  Score=216.53  Aligned_cols=169  Identities=26%  Similarity=0.425  Sum_probs=139.3

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..+++..+..|+.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||+++.+......
T Consensus        89 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~  165 (279)
T cd05057          89 LMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKE  165 (279)
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCcccccccCcccc
Confidence            56899999999874 46999999999999999999999988  9999999999999876 68999999999876533221


Q ss_pred             c---cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 H---SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ~---s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .   ...++..|+|||.+. ..++.++|+||||+++|+|++ |..||.+ ....++.+.+..+... ..+...+..+.++
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  243 (279)
T cd05057         166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQPPICTIDVYMV  243 (279)
T ss_pred             eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence            1   122356899999775 568899999999999999999 9999976 4566777777765432 3344567889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. +|.+||++.+++.-
T Consensus       244 ~~~~l~~~p~~Rp~~~~l~~~  264 (279)
T cd05057         244 LVKCWMIDAESRPTFKELINE  264 (279)
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999998 99999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=4.8e-25  Score=221.25  Aligned_cols=169  Identities=26%  Similarity=0.463  Sum_probs=136.4

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++.+..... 
T Consensus        89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEccccccccccCcccc
Confidence            567899999997754 6899999999999999999999998  9999999999999876 6899999999986543222 


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++.+.+..+..+ ..+...+..+.++
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  243 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERL-PQPPICTIDVYMV  243 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence              12234577899999876 458899999999999999997 8999965 3344455545444332 2334567889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. +|.+||+++++++.
T Consensus       244 i~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         244 MVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999998 99999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.93  E-value=5.2e-25  Score=224.18  Aligned_cols=169  Identities=27%  Similarity=0.418  Sum_probs=137.6

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+..                .++...+..++.||+.||.|||.++  |+||||||+|||++.+ +.+||
T Consensus        99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~~-~~~kL  175 (334)
T cd05100          99 YASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKI  175 (334)
T ss_pred             cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEE
Confidence            567899999997642                3778889999999999999999998  9999999999999877 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.+.....   .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..++++.+..+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~  254 (334)
T cd05100         176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGHR  254 (334)
T ss_pred             CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC
Confidence            99999976543221   12233457899999875 458899999999999999998 8899976 456777777766544


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+.++.++|.+||. +|.+||++.|++.+
T Consensus       255 ~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         255 M-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             C-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3 2333456789999999998 99999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.93  E-value=5.8e-25  Score=216.66  Aligned_cols=168  Identities=24%  Similarity=0.347  Sum_probs=137.4

Q ss_pred             CCCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKY--------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.+|+|.+|+...        ..+++..+..++.||+.||+|||+++  ++||||||+||+++.+ +.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcEEECCCCCccc
Confidence            45689999999764        45889999999999999999999998  9999999999999876 7999999999976


Q ss_pred             ccCCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccc
Q 010730           73 LRGSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ  147 (502)
Q Consensus        73 ~~~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~  147 (502)
                      +.....   .....++..|+|||++.. .++.++|||||||++|+|++ |..||.. .++.++...+..+..+ ......
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~  244 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRL-AQPINC  244 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCC-CCCCcC
Confidence            533221   122345778999998754 48899999999999999999 9999976 4666777766655432 223345


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..+.+++.+||. +|.+|||+.+++.
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         245 PDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            7889999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=6.3e-25  Score=212.90  Aligned_cols=169  Identities=21%  Similarity=0.423  Sum_probs=138.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++... +.++++.++.++.||+.+|+|||+.+  ++||||||+||+++.+ +.+||+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccCccc
Confidence            57899999999764 56899999999999999999999998  9999999999999876 7899999999876533211 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+.+.+..+..+ ..+...+..+.+|+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  234 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYELM  234 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHH
Confidence             11233567899999876 458889999999999999998 9999976 4556667666655332 23345678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.++++.
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99998 99999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=4.6e-25  Score=225.81  Aligned_cols=169  Identities=31%  Similarity=0.422  Sum_probs=131.6

Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccC
Q 010730            5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG   84 (502)
Q Consensus         5 GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vG   84 (502)
                      ++|..++.  ..+++..++.++.||+.||+|||.++  |+||||||+||+++.+ +.+||+|||+++....  ......|
T Consensus       104 ~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~--~~~~~~~  176 (342)
T cd07879         104 TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYVV  176 (342)
T ss_pred             cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC--CCCCcee
Confidence            35666552  46899999999999999999999998  9999999999999986 7999999999875432  2234578


Q ss_pred             CCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC---------------------C
Q 010730           85 TPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL---------------------P  140 (502)
Q Consensus        85 Tp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~---------------------p  140 (502)
                      ++.|+|||++.+  .++.++|||||||++|+|++|+.||.+...... +..+.. ...                     +
T Consensus       177 ~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (342)
T cd07879         177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLP  255 (342)
T ss_pred             eecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhcccchHHHHhhcC
Confidence            999999998754  488899999999999999999999976432222 222211 000                     0


Q ss_pred             C----c---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          141 G----A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       141 ~----~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .    .   .....+..+.+||.+||. +|.+||++.++|.||||....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         256 KYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0    0   011245678999999998 999999999999999997643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=8.4e-25  Score=213.24  Aligned_cols=168  Identities=23%  Similarity=0.378  Sum_probs=136.9

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..++...+..++.||+.||+|||+++  ++||||||+||+++.+ +.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence            56799999998753  46899999999999999999999988  9999999999999876 7899999999977652221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. +..++.+.+..+..+ ..+...+.+++++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  235 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELYEL  235 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              12344677899999875 458889999999999999999 99999764 445556666554332 2334456789999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++++++.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            999998 9999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=5.1e-25  Score=219.02  Aligned_cols=170  Identities=27%  Similarity=0.441  Sum_probs=132.6

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--Ccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAH   80 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~~~   80 (502)
                      +|+|..++.+. ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++..+....  ...
T Consensus        99 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~  175 (302)
T cd07864          99 DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYT  175 (302)
T ss_pred             CccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcccccccccCCcccccc
Confidence            45777777653 56999999999999999999999998  9999999999999887 799999999997654322  112


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---CCCCCc-------------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GKLPGA-------------  142 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---g~~p~~-------------  142 (502)
                      ...+++.|+|||++.+  .++.++|||||||++|+|++|.+||........ +..+..   +..+..             
T Consensus       176 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T cd07864         176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSPCPAVWPDVIKLPYFNTM  254 (302)
T ss_pred             cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhccccccccccccc
Confidence            2456889999998753  378899999999999999999999976433222 222211   111111             


Q ss_pred             ------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          143 ------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       143 ------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                                  .....+..++++|.+||. +|.+||++.+++.||||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         255 KPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                        011246889999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.92  E-value=4.3e-25  Score=226.39  Aligned_cols=171  Identities=27%  Similarity=0.383  Sum_probs=136.2

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|++|.+++.. ..+++..++.++.||+.||+|||.++  |+||||||+||+++.+ +.+||+|||++.....  .....
T Consensus       102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~--~~~~~  175 (343)
T cd07880         102 MGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQTDS--EMTGY  175 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeccccccccc--Ccccc
Confidence            37889888864 57999999999999999999999998  9999999999999876 7899999999976533  22345


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC---------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---------------------  139 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~---------------------  139 (502)
                      .+++.|+|||++.+  .++.++|+|||||++|+|++|..||.+...... +.++.....                     
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (343)
T cd07880         176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQKLQSEDAKNYVKK  254 (343)
T ss_pred             ccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhcchhHHHHHHh
Confidence            68999999998764  478899999999999999999999976443322 222211000                     


Q ss_pred             -C-------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 -P-------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 -p-------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                       +       ..+....++.+.++|.+||. +|.+|||+.+++.||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         255 LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence             0       00112346778999999999 99999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=8.7e-25  Score=213.45  Aligned_cols=168  Identities=25%  Similarity=0.419  Sum_probs=135.1

Q ss_pred             CCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-----cEEEEecC
Q 010730            1 MFTSGTLREYRKKY-------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-----QIKIGDLG   68 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g-----~vKL~DFG   68 (502)
                      |+.+|+|.+++.+.       ..+++..+..++.||+.||.|||+.+  ++|+||||+||+++.+ +     .+||+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEECCcc
Confidence            56789999999743       34788999999999999999999988  9999999999999875 4     79999999


Q ss_pred             CceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcc
Q 010730           69 LAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAF  143 (502)
Q Consensus        69 lA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~  143 (502)
                      +++.+....   ......++..|+|||++. +.++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTAGGRL-QK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhcCCcc-CC
Confidence            987653221   112335678899999775 458999999999999999998 9999976 4445566666554332 23


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +...+..+.++|.+||. +|.+||++++++.
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            34457889999999998 9999999999876

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=2.8e-25  Score=222.32  Aligned_cols=177  Identities=33%  Similarity=0.492  Sum_probs=134.8

Q ss_pred             CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEEecCCceeccCC
Q 010730            5 GTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         5 GsL~~yi~k~-----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~---~g~vKL~DFGlA~~~~~~   76 (502)
                      -+|.+.|+-+     +.++...++.++.|||.|+.|||++.  |+||||||.|||+.++   .|.|||+|||+++.+...
T Consensus       112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p  189 (438)
T KOG0666|consen  112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP  189 (438)
T ss_pred             hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence            3566666533     35889999999999999999999999  9999999999999765   378999999999987643


Q ss_pred             C----CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCC------CCh---HHH---HHHhhc--
Q 010730           77 Q----QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSEC------SNP---AQI---YKKVTS--  136 (502)
Q Consensus        77 ~----~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~------~~~---~ql---~~kI~~--  136 (502)
                      .    ....++-|.+|.|||++.+  .|+.++||||+|||+.||+|-++.|.+.      .++   .|+   +..+..  
T Consensus       190 lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt  269 (438)
T KOG0666|consen  190 LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT  269 (438)
T ss_pred             ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc
Confidence            2    2345788999999998754  4999999999999999999999888542      111   121   111110  


Q ss_pred             -C------CCCCc----------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          137 -G------KLPGA----------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       137 -g------~~p~~----------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                       .      ++|..                      ...+.++.+.+|+.+||. ||.+|+|++++|+|+||..+...
T Consensus       270 ~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  270 DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence             0      01111                      011235558899999999 99999999999999999876543

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.92  E-value=7.9e-25  Score=224.45  Aligned_cols=155  Identities=23%  Similarity=0.368  Sum_probs=125.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APE   92 (502)
                      .++...+..|+.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++........   .....+++.|+|||
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  251 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  251 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence            3678888999999999999999998  9999999999999876 7999999999876532211   12234567899999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..++.++||||||+++|+|++ |..||.......++...+..+..+ ..+...++.+.+++..||. +|.+||++.
T Consensus       252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~~Rps~~  330 (343)
T cd05103         252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFS  330 (343)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            775 458999999999999999997 999998755555556555555433 2233457889999999998 999999999


Q ss_pred             HHhcC
Q 010730          170 ELLLD  174 (502)
Q Consensus       170 ELL~h  174 (502)
                      ||++|
T Consensus       331 eil~~  335 (343)
T cd05103         331 ELVEH  335 (343)
T ss_pred             HHHHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=1.2e-24  Score=210.16  Aligned_cols=169  Identities=21%  Similarity=0.363  Sum_probs=136.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++... ..+++..+..++.||+.+|.|||.++  ++||||||+||+++.+ +.+||+|||++.........
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccc
Confidence            57899999999753 46899999999999999999999998  9999999999999876 78999999998764332211


Q ss_pred             --ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 --~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        ....+++.|+|||++. +.++.++|||||||++|+|++ |..||... +.......+..+... ..+...+..+.+++
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  227 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVM  227 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence              1223467799999876 458889999999999999998 99999764 445555555544332 23334578999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.|+++.
T Consensus       228 ~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         228 QRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHHcccCcccCCCHHHHHHH
Confidence            99998 99999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=8.3e-25  Score=216.72  Aligned_cols=168  Identities=21%  Similarity=0.323  Sum_probs=136.3

Q ss_pred             CCCCCcHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 010730            1 MFTSGTLREYRKKYT----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH   58 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~   58 (502)
                      |+.+|+|.+++....                      .+++..+..++.||+.||+|||..+  ++||||||+||+++.+
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~~~  166 (288)
T cd05050          89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGEN  166 (288)
T ss_pred             cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEecCC
Confidence            567899999997532                      3778889999999999999999988  9999999999999876


Q ss_pred             CCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHH
Q 010730           59 LGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKK  133 (502)
Q Consensus        59 ~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~k  133 (502)
                       +.+||+|||++..+.....   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..++...
T Consensus       167 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~~~~~  244 (288)
T cd05050         167 -MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEEVIYY  244 (288)
T ss_pred             -CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence             7999999999876533211   12234567899999775 468999999999999999998 8889876 455667777


Q ss_pred             hhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       134 I~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..+.... .+...+..+.+||.+||. +|.+|||+.|+++
T Consensus       245 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         245 VRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77665542 233456889999999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=219.47  Aligned_cols=173  Identities=25%  Similarity=0.357  Sum_probs=136.8

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc--
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~--   74 (502)
                      |+..|+|.+++...    ..+++.++..|+.+|++||++||+..++.+||||||.|||+.+. +.++|+|||.+....  
T Consensus       104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS~~~a~i~  182 (302)
T KOG2345|consen  104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGSATQAPIQ  182 (302)
T ss_pred             hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccCccccceE
Confidence            57889999999643    36999999999999999999999999999999999999999886 799999999986542  


Q ss_pred             --CCCCc------ccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCC-CChHHHHHHhhcCCCCC
Q 010730           75 --GSQQA------HSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        75 --~~~~~------~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~-~~~~ql~~kI~~g~~p~  141 (502)
                        .....      ....+|..|.|||++.-+    .++++|||||||+||.|+.|..||.-. .....+--.+.++++..
T Consensus       183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~  262 (302)
T KOG2345|consen  183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI  262 (302)
T ss_pred             eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc
Confidence              11111      234579999999998633    688999999999999999999999421 01111122334445443


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +-....+..+.++|..||+ ||.+||++.+|+.+
T Consensus       263 P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  263 PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            4444468899999999999 99999999999864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=1.1e-24  Score=213.08  Aligned_cols=169  Identities=21%  Similarity=0.377  Sum_probs=136.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. +.+++..+..++.|++.||+|||+.+  |+||||||+||+++.+ +.+||+|||++.........
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccceeccccccc
Confidence            57889999999764 57899999999999999999999998  9999999999999876 78999999999765432211


Q ss_pred             --c--cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           80 --H--SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        80 --~--s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                        .  ....++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+.+.+..+... +.....+.++.+
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~  241 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRL-PAPMDCPSAVYQ  241 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence              1  122345799999875 458899999999999999998 9999976 3445666666654332 223345678999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++.+||. +|.+||++.++++.
T Consensus       242 li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         242 LMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.92  E-value=8.6e-25  Score=213.86  Aligned_cols=170  Identities=22%  Similarity=0.371  Sum_probs=139.5

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      |+.|++|.+++..    ...+++..++.++.||+.||.|||. .+  |+|+||||+||+++.+ +.+||+|||++.....
T Consensus        90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~  166 (269)
T cd08528          90 LIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTITDFGLAKQKQP  166 (269)
T ss_pred             cCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEecccceeeccc
Confidence            5678999998843    3569999999999999999999996 55  9999999999999876 7899999999987654


Q ss_pred             CCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           76 SQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ........|+..|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..........++.+.++
T Consensus       167 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  245 (269)
T cd08528         167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSEDVTDV  245 (269)
T ss_pred             ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcccCCHHHHHH
Confidence            444455678999999998764 488999999999999999999999965 444455555555544433333557899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.|+..+
T Consensus       246 i~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         246 ITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHCCCCCccCCCHHHHHHH
Confidence            999998 99999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=7.8e-25  Score=215.26  Aligned_cols=165  Identities=19%  Similarity=0.305  Sum_probs=129.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC------CcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL------GQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~------g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|..++.+ ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.+.      ..+|++|||++...
T Consensus        85 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~  162 (262)
T cd05077          85 FVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV  162 (262)
T ss_pred             cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence            5788999999975 456999999999999999999999988  99999999999997541      13899999998654


Q ss_pred             cCCCCcccccCCCcccCccccc--cCCCCcccchhHHHHHHHHh-hccCCCCCCCChHHHHHHhhcCCCCCcccccccHH
Q 010730           74 RGSQQAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLL-TG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ..   .....|++.|+|||++.  ..++.++|||||||++|+|+ +|..||... ...+.. ....+...  .......+
T Consensus       163 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~--~~~~~~~~  235 (262)
T cd05077         163 LS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM--LVTPSCKE  235 (262)
T ss_pred             cC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc--CCCCChHH
Confidence            32   23456889999999875  45889999999999999998 588888653 222222 22222221  11123467


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++++|.+||. +|.+||++.+||.+
T Consensus       236 ~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         236 LADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHh
Confidence            8999999999 99999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=9.7e-25  Score=212.21  Aligned_cols=168  Identities=24%  Similarity=0.385  Sum_probs=135.9

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||.|||.++  |+|+||||+||+++.+ +.+||+|||++..+.....
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence            56889999999764  36899999999999999999999998  9999999999999887 7999999999976643211


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+....++++..+... ..+...+.+++++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRM-PRPPNCPEELYDL  236 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              11223467899999876 458889999999999999999 9999976 4445566666554322 2233347789999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +.+||. +|.+||++++++.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            999998 9999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.92  E-value=2e-24  Score=210.91  Aligned_cols=168  Identities=21%  Similarity=0.389  Sum_probs=135.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||.|||+.+  ++||||||+||+++.. +.+||+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence            56789999999764  45788899999999999999999988  9999999999999876 7999999999976543221


Q ss_pred             --cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....++..|+|||++.. .++.++|+|||||++|+|+| |..||.. .+...+...+..+... ......+.++.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPENCPEELYNI  235 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCC-CCcccCCHHHHHH
Confidence              122345678999998764 47889999999999999999 9999976 3444555555554332 2234456789999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +.+||. +|.+||++.+++.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            999998 9999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=1.9e-24  Score=214.06  Aligned_cols=170  Identities=26%  Similarity=0.439  Sum_probs=132.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.||+|.+++.+. ..+++..+..++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++..+..... 
T Consensus        89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05079          89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEY  165 (284)
T ss_pred             ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCccccccccCccc
Confidence            56799999999765 46899999999999999999999998  9999999999999876 7899999999986643221 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC--------------CChHHHHHHhhcCCCC
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPAQIYKKVTSGKLP  140 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------------~~~~ql~~kI~~g~~p  140 (502)
                         .....|+..|+|||++. ..++.++|||||||++|+|+|+..|+...              .........+..+...
T Consensus       166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd05079         166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL  245 (284)
T ss_pred             eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC
Confidence               12355777899999765 45889999999999999999987664221              0111222222233222


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ..+...+..+.+||.+||. +|.+||+++++++.
T Consensus       246 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         246 -PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             2233457899999999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.1e-24  Score=211.42  Aligned_cols=169  Identities=20%  Similarity=0.356  Sum_probs=134.5

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccccccccCccc
Confidence            5678999999976 456899999999999999999999998  9999999999999876 68999999998765432211


Q ss_pred             c---ccc---CCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           80 H---SVI---GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        80 ~---s~v---GTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      .   ...   .+..|+|||++. ..++.++|||||||++|||++ |..||.. .+...+.+.+..... ...+...+..+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~-~~~~~~~~~~~  240 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYR-LPPPMDCPTAL  240 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCc-CCCcccCCHHH
Confidence            1   111   145799999876 458899999999999999887 9999976 444556666654322 22233456789


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+++.+||. +|.+||++.+++..
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         241 HQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.92  E-value=1.7e-24  Score=228.40  Aligned_cols=155  Identities=25%  Similarity=0.371  Sum_probs=126.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPE   92 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APE   92 (502)
                      .+++..+..++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||+++.+.....   .....+++.|+|||
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence            4788889999999999999999988  9999999999999987 6899999999986543221   23345788999999


Q ss_pred             ccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        93 vl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      ++. ..++.++|||||||++|+|++ |..||........++..+..+..+ ..+...+..++++|.+||. +|.+||++.
T Consensus       310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            875 458999999999999999997 999998755555666666665432 3344557889999999998 999999998


Q ss_pred             HHhcC
Q 010730          170 ELLLD  174 (502)
Q Consensus       170 ELL~h  174 (502)
                      +|.+.
T Consensus       389 ~l~~~  393 (400)
T cd05105         389 HLSDI  393 (400)
T ss_pred             HHHHH
Confidence            88763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=2.1e-24  Score=211.54  Aligned_cols=168  Identities=23%  Similarity=0.395  Sum_probs=136.2

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..+..++.||+.||.|||+++  ++||||||+||+++.+ +.+||+|||++..+..... 
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCcccccccccce
Confidence            56799999999765 56899999999999999999999998  9999999999999876 7899999999986543221 


Q ss_pred             c---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 A---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      .   ....++..|+|||++. ..++.++|+|||||++|+|++ |..||.+. ...++++.+..+..+ ......+..+++
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~  240 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPMDCPAALHQ  240 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCCCCCHHHHH
Confidence            1   1122356899999886 468999999999999999886 99999763 445566666655332 233345778999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ++.+||. +|.+||++.++++
T Consensus       241 li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         241 LMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHcccCchhCCCHHHHHH
Confidence            9999998 9999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=1.4e-24  Score=243.10  Aligned_cols=99  Identities=26%  Similarity=0.494  Sum_probs=79.6

Q ss_pred             cCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHHHhhh
Q 010730           83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        83 vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~kcL~  160 (502)
                      +||+.|+|||++. ..|+.++|||||||+||||++|..||.+ ....+++..+.....+. ......+..+.+++.+||.
T Consensus       541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~-~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~  619 (669)
T cd05610         541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT  619 (669)
T ss_pred             eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence            5799999999775 4589999999999999999999999976 56666777766544321 1122346789999999998


Q ss_pred             -CcCCCCCHHHHhcCCCCcCCCC
Q 010730          161 -NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~~~~~  182 (502)
                       +|.+||++.|+|.||||....+
T Consensus       620 ~dP~~R~ta~e~l~h~~~~~~~~  642 (669)
T cd05610         620 MDPTKRAGLKELKQHPLFHGVDW  642 (669)
T ss_pred             cChhHCcCHHHHHhCHhhcCCCH
Confidence             9999999999999999976433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=2.1e-24  Score=211.15  Aligned_cols=169  Identities=19%  Similarity=0.336  Sum_probs=135.0

Q ss_pred             CCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++...      ..++...++.++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++....
T Consensus        88 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~dfg~~~~~~  164 (273)
T cd05074          88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVADFGLSKKIY  164 (273)
T ss_pred             cCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEECccccccccc
Confidence            46789999987532      24789999999999999999999988  9999999999999876 789999999987654


Q ss_pred             CCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           75 GSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        75 ~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....   .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.+ .+...++..+..+.... .....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~  242 (273)
T cd05074         165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRLK-QPPDCLE  242 (273)
T ss_pred             CCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcCC-CCCCCCH
Confidence            3221   122345678999998754 47889999999999999999 8899865 45566676666554322 2234467


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.+++.+||. +|.+||++.+++..
T Consensus       243 ~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         243 DVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.6e-24  Score=214.53  Aligned_cols=169  Identities=23%  Similarity=0.367  Sum_probs=131.1

Q ss_pred             CCCCCcHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecC
Q 010730            1 MFTSGTLREYRKKYT------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG   68 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFG   68 (502)
                      |+.+|+|.+++....            .+++..+..++.||+.||+|||+++  ++||||||+||+++.+ +.+||+|||
T Consensus        98 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~dfg  174 (295)
T cd05097          98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNH-YTIKIADFG  174 (295)
T ss_pred             cCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEcCC-CcEEecccc
Confidence            578999999996532            3788899999999999999999998  9999999999999876 689999999


Q ss_pred             CceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh--ccCCCCCCCChHHHHHHhhc------
Q 010730           69 LAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTS------  136 (502)
Q Consensus        69 lA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT--G~~Pf~~~~~~~ql~~kI~~------  136 (502)
                      ++..+.....   .....+++.|+|||++. +.++.++|||||||++|+|++  |..||... +..++...+..      
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~  253 (295)
T cd05097         175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-SDEQVIENTGEFFRNQG  253 (295)
T ss_pred             cccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc-ChHHHHHHHHHhhhhcc
Confidence            9976533221   22345577899999764 568999999999999999988  67888663 33333333211      


Q ss_pred             CCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       137 g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .......+...+..+.+||.+||. +|.+||++.++++
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         254 RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            111112233456889999999999 9999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=3.5e-24  Score=213.74  Aligned_cols=169  Identities=22%  Similarity=0.350  Sum_probs=129.6

Q ss_pred             CCCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCC
Q 010730            1 MFTSGTLREYRKKYT-----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL   69 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGl   69 (502)
                      |+.+|+|.+++.+..           .+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~  176 (296)
T cd05095         100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKN-YTIKIADFGM  176 (296)
T ss_pred             eCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEcCC-CCEEeccCcc
Confidence            567899999997643           3667789999999999999999998  9999999999999876 7899999999


Q ss_pred             ceeccCCCC---cccccCCCcccCcccc-ccCCCCcccchhHHHHHHHHhh--ccCCCCCCCChHHHHHHhhc------C
Q 010730           70 AAILRGSQQ---AHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTS------G  137 (502)
Q Consensus        70 A~~~~~~~~---~~s~vGTp~Y~APEvl-~~~ys~~~DIWSLGviLyeLLT--G~~Pf~~~~~~~ql~~kI~~------g  137 (502)
                      +..+.....   .....+++.|+|||+. .+.++.++|||||||++|+|++  |..||... ...++...+..      .
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~  255 (296)
T cd05095         177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL-SDEQVIENTGEFFRDQGR  255 (296)
T ss_pred             cccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc-ChHHHHHHHHHHHhhccc
Confidence            976533221   1223456789999965 4568999999999999999998  77898653 33333332211      0


Q ss_pred             CCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ......+...+..+++|+.+||. +|.+||++.++++
T Consensus       256 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         256 QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            01111223346889999999999 9999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=3.6e-24  Score=211.45  Aligned_cols=170  Identities=27%  Similarity=0.410  Sum_probs=129.3

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++..+......
T Consensus        88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~  164 (284)
T cd05081          88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEY  164 (284)
T ss_pred             ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccccccCCCcc
Confidence            56799999999764 46899999999999999999999998  9999999999999876 78999999999876433221


Q ss_pred             ----ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCCh---------------HHHHHHhhcCCC
Q 010730           80 ----HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------------AQIYKKVTSGKL  139 (502)
Q Consensus        80 ----~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---------------~ql~~kI~~g~~  139 (502)
                          ....++..|+|||++.+ .++.++|||||||++|+|++|..|+......               ..+...+..+..
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd05081         165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR  244 (284)
T ss_pred             eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc
Confidence                11223456999998764 5889999999999999999987765321100               011112222211


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       .......+..+.+||.+||. +|.+|||+.|++..
T Consensus       245 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         245 -LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence             12233456789999999998 99999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=4.2e-24  Score=211.70  Aligned_cols=165  Identities=21%  Similarity=0.326  Sum_probs=128.8

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------CCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------LGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~------~g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|..++.+ .+.+++..+..++.||+.||+|||+.+  |+||||||+||+++..      ...+|++|||++...
T Consensus        97 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076          97 FVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence            6789999999976 567999999999999999999999988  9999999999999743      124899999987543


Q ss_pred             cCCCCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHh-hccCCCCCCCChHHHHHHhhcCCCCCcccccccHH
Q 010730           74 RGSQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLL-TG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ..   .....+++.|+|||++.+  .++.++|||||||++|+|+ +|..||.... ..+....+... .  ..+....+.
T Consensus       175 ~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~-~--~~~~~~~~~  247 (274)
T cd05076         175 LS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKERFYEKK-H--RLPEPSCKE  247 (274)
T ss_pred             cc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHHHHHHHhc-c--CCCCCCChH
Confidence            22   123467889999998754  4889999999999999984 6999997643 23222222211 1  112223568


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.++|.+||. +|.+||++.++|++
T Consensus       248 ~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         248 LATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHHHcccChhhCcCHHHHHHh
Confidence            9999999998 99999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5.5e-25  Score=224.99  Aligned_cols=172  Identities=22%  Similarity=0.411  Sum_probs=136.2

Q ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-------------------CCcE
Q 010730            4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-------------------LGQI   62 (502)
Q Consensus         4 gGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-------------------~g~v   62 (502)
                      |-++++|++++  .+++...|+.++.||+.+++|||+.+  ++|-||||||||+-..                   ...|
T Consensus       174 G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I  251 (415)
T KOG0671|consen  174 GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAI  251 (415)
T ss_pred             ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcce
Confidence            45899999864  56999999999999999999999999  9999999999998311                   1358


Q ss_pred             EEEecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHH--HHHhhcCCC
Q 010730           63 KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--YKKVTSGKL  139 (502)
Q Consensus        63 KL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql--~~kI~~g~~  139 (502)
                      |++|||-|....+.  -.+++.|..|.|||++.+ .++..+||||+||||+||.||...|+.-.|.+.+  .+.|.. ++
T Consensus       252 ~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~  328 (415)
T KOG0671|consen  252 KVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PI  328 (415)
T ss_pred             EEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CC
Confidence            99999999875443  367889999999997754 6999999999999999999999999886665543  233322 22


Q ss_pred             CCc-----------------ccc-------------------------cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCC
Q 010730          140 PGA-----------------FHR-------------------------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       140 p~~-----------------~~~-------------------------~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPf  176 (502)
                      |..                 |+.                         ....++-+||++||. ||.+|+|+.|+|.|||
T Consensus       329 P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  329 PSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF  408 (415)
T ss_pred             cHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence            210                 000                         012357789999999 9999999999999999


Q ss_pred             CcCC
Q 010730          177 LASD  180 (502)
Q Consensus       177 f~~~  180 (502)
                      |+..
T Consensus       409 F~~~  412 (415)
T KOG0671|consen  409 FARL  412 (415)
T ss_pred             hhcC
Confidence            9753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=203.30  Aligned_cols=174  Identities=24%  Similarity=0.449  Sum_probs=137.9

Q ss_pred             CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc-c
Q 010730            3 TSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-H   80 (502)
Q Consensus         3 tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~-~   80 (502)
                      +..+|..|... ++.++.+.++.++.|++.||.|||+++  |.||||||.|+|++.+ |.+|++|||+++-+.-.... .
T Consensus        83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEeee
Confidence            45678888865 578999999999999999999999999  9999999999999988 89999999999876543332 2


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhc-C-----CCCC----------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS-G-----KLPG----------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~-g-----~~p~----------  141 (502)
                      ..+-|.+|.+|.++-+  -|++..|+||.|||+.|+.. |.+.|++..-.+|+.+.... |     .+|.          
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            3567999999998854  39999999999999999987 88778886555555443321 1     1110          


Q ss_pred             -cccc---------cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          142 -AFHR---------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       142 -~~~~---------~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                       .++.         .....-++++.++|. +|.+|++|+++|+||||..
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence             0000         123457899999998 9999999999999999964

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.7e-24  Score=211.88  Aligned_cols=175  Identities=25%  Similarity=0.422  Sum_probs=137.8

Q ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-----
Q 010730            5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-----   78 (502)
Q Consensus         5 GsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-----   78 (502)
                      -+|+-.+.+. .+++...|+.++++++.||.|+|...  |+|||+|++|+|++++ |.+||+|||+++.+.....     
T Consensus       108 hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFGlar~fs~~~n~~kpr  184 (376)
T KOG0669|consen  108 HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFGLARAFSTSKNVVKPR  184 (376)
T ss_pred             hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeeccccccceecccccCCCC
Confidence            4566667654 57999999999999999999999999  9999999999999987 8999999999976543221     


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHH-----------------------HHH
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI-----------------------YKK  133 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql-----------------------~~k  133 (502)
                      ....+-|.+|.+||.+.+  .|+++.|||..|||+.+|+|+.+.+.+..+..++                       |+.
T Consensus       185 ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~s  264 (376)
T KOG0669|consen  185 YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQS  264 (376)
T ss_pred             cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHh
Confidence            234567999999997754  5999999999999999999999998775544443                       233


Q ss_pred             hhcCCCCCc---------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          134 VTSGKLPGA---------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       134 I~~g~~p~~---------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      +....+|..         -+...++++.+|+.++|. ||.+|+.++++|.|.||..++.
T Consensus       265 ie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  265 IELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             ccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            222211110         011235688899999999 9999999999999999976543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=9.3e-24  Score=229.07  Aligned_cols=176  Identities=24%  Similarity=0.351  Sum_probs=130.9

Q ss_pred             CCCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 010730            1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN   56 (502)
Q Consensus         1 ~~tgGsL~~yi~k~------------------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~   56 (502)
                      |+.+|+|.+++...                        ..+++..++.++.||+.+|.|||.++  |+||||||+|||++
T Consensus       266 y~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~  343 (507)
T PLN03224        266 FESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT  343 (507)
T ss_pred             cCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC
Confidence            56778888887532                        12456788999999999999999998  99999999999998


Q ss_pred             CCCCcEEEEecCCceeccCCCCccc--ccCCCcccCccccccC---------------------CC--CcccchhHHHHH
Q 010730           57 GHLGQIKIGDLGLAAILRGSQQAHS--VIGTPEFMAPELYEED---------------------YN--ELVDIYSFGMCV  111 (502)
Q Consensus        57 ~~~g~vKL~DFGlA~~~~~~~~~~s--~vGTp~Y~APEvl~~~---------------------ys--~~~DIWSLGviL  111 (502)
                      .+ +.+||+|||++...........  ..+||.|+|||++...                     |+  .+.||||+||++
T Consensus       344 ~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil  422 (507)
T PLN03224        344 VD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL  422 (507)
T ss_pred             CC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence            87 6899999999976543322222  2358999999976421                     11  347999999999


Q ss_pred             HHHhhccC-CCCCC----------CChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-Cc---CCCCCHHHHhcCCC
Q 010730          112 LEMLTSEY-PYSEC----------SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NV---SKRLPAKELLLDPF  176 (502)
Q Consensus       112 yeLLTG~~-Pf~~~----------~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP---~kRpSa~ELL~hPf  176 (502)
                      |+|++|.. ||.+.          .+....++.+.............+..+++|+.+||. +|   .+|+|++|+|.|||
T Consensus       423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            99999886 66432          112222334433443333344567899999999997 44   68999999999999


Q ss_pred             CcC
Q 010730          177 LAS  179 (502)
Q Consensus       177 f~~  179 (502)
                      |..
T Consensus       503 f~~  505 (507)
T PLN03224        503 FLP  505 (507)
T ss_pred             cCC
Confidence            964

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.91  E-value=4.1e-24  Score=243.36  Aligned_cols=170  Identities=28%  Similarity=0.386  Sum_probs=129.0

Q ss_pred             CCCCCcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCC
Q 010730            1 MFTSGTLREYRKKY-----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL   69 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-----------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGl   69 (502)
                      |+.||+|.+++...           ..++...+..++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEEEecCc
Confidence            57899999998642           23566778899999999999999998  9999999999999876 7999999999


Q ss_pred             ceeccCC-------------------CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH
Q 010730           70 AAILRGS-------------------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ  129 (502)
Q Consensus        70 A~~~~~~-------------------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q  129 (502)
                      ++.....                   ......+||+.|+|||++.+ .++.++|||||||++|+|+||..||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            9865210                   01123579999999998764 589999999999999999999999976333222


Q ss_pred             HHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          130 IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       130 l~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+................++.+.+++.+||. +|.+|++..+.|.
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2322221111111122356789999999999 9999987655553

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.91  E-value=8e-24  Score=223.53  Aligned_cols=154  Identities=26%  Similarity=0.399  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCccc
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---QAHSVIGTPEFMAPEL   93 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~~~s~vGTp~Y~APEv   93 (502)
                      +++..++.++.||+.||+|||+.+  |+||||||+|||++.+ +.+||+|||+++......   ......+++.|+|||+
T Consensus       236 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  312 (401)
T cd05107         236 LSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES  312 (401)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence            567778899999999999999987  9999999999999876 789999999998653221   1223467889999998


Q ss_pred             cc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHH
Q 010730           94 YE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE  170 (502)
Q Consensus        94 l~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~E  170 (502)
                      +. ..++.++|||||||++|||++ |..||........++..+..+..+ ..+...+.++.++|.+||. +|.+||++++
T Consensus       313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            75 458899999999999999998 899998765556666666655432 3344567899999999998 9999999999


Q ss_pred             HhcC
Q 010730          171 LLLD  174 (502)
Q Consensus       171 LL~h  174 (502)
                      |+..
T Consensus       392 ll~~  395 (401)
T cd05107         392 LVHL  395 (401)
T ss_pred             HHHH
Confidence            9874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=7.2e-24  Score=216.31  Aligned_cols=172  Identities=30%  Similarity=0.437  Sum_probs=133.7

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .+++|.++++. .++++..+..++.||+.||.|||+.+  |+||||||+||+++.+ +.+||+|||++.....  .....
T Consensus        92 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~--~~~~~  165 (328)
T cd07856          92 LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQDP--QMTGY  165 (328)
T ss_pred             hccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCccccccccCC--CcCCC
Confidence            36789988865 46889999999999999999999998  9999999999999876 7899999999875432  23445


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChH--------------HHHHHhhcC---------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA--------------QIYKKVTSG---------  137 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~--------------ql~~kI~~g---------  137 (502)
                      .+++.|+|||++.+  .++.++|||||||++|+|++|..||.......              ++.+.+..+         
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence            78999999998754  58899999999999999999999997532211              111111000         


Q ss_pred             CC--CCc---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          138 KL--PGA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       138 ~~--p~~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ..  +..   .....+..++++|.+||. +|.+||++.++|.||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            00  000   011246789999999998 99999999999999999643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=1.5e-23  Score=205.69  Aligned_cols=170  Identities=25%  Similarity=0.420  Sum_probs=132.0

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+.+ .+++..+..++.||+.||+|||+.+  |+||||||+||+++.+ +.+||+|||++.........
T Consensus        89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05038          89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDY  165 (284)
T ss_pred             cCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccccccccCCcc
Confidence            467899999998755 6999999999999999999999998  9999999999999887 79999999999876532211


Q ss_pred             ----ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC--------------hHHHHHHhhcCCCC
Q 010730           80 ----HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--------------PAQIYKKVTSGKLP  140 (502)
Q Consensus        80 ----~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--------------~~ql~~kI~~g~~p  140 (502)
                          ....++..|+|||.+. ..++.++||||||+++|+|++|..|+.....              ...+...+..+.. 
T Consensus       166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  244 (284)
T cd05038         166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER-  244 (284)
T ss_pred             eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc-
Confidence                1223456799999775 4588899999999999999999999864221              1112222222221 


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ...+...+.++.+++.+||. +|.+||++.|+++.
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            12233446789999999999 99999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-24  Score=234.85  Aligned_cols=176  Identities=27%  Similarity=0.472  Sum_probs=152.6

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      ||.||+.-+++++.  .++.|..+..+++.++.||.+||.+.  |||||||-.|||++.+ +.|||.|||++.++... .
T Consensus       102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEeeeeeeeeeecccc
Confidence            68899999999864  67999999999999999999999998  9999999999999988 89999999999887643 3


Q ss_pred             CcccccCCCcccCcccccc------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ...+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+.++.....+++...+.......+...+..+
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~F  258 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKF  258 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHH
Confidence            4578899999999999852      3788999999999999999999999887766777765554443333455668899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      -+||..||. |..+||+..++|+|||+..
T Consensus       259 ndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  259 NDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             HHHHHHHHhhccccCcchhhhccCCcccc
Confidence            999999998 9999999999999999973

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=217.70  Aligned_cols=180  Identities=25%  Similarity=0.453  Sum_probs=146.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-C-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-H-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~-~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.|.+|.=|++.++-+++++++.|+.||+.||.||....+||||-||||.|||+-. + .|.+||+||||++++.....
T Consensus       549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy  628 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY  628 (775)
T ss_pred             ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence            788999999999999999999999999999999999999999999999999998743 2 47899999999998864321


Q ss_pred             --------cccccCCCcccCccccc-c----CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHH--hhc-CCCCCc
Q 010730           79 --------AHSVIGTPEFMAPELYE-E----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK--VTS-GKLPGA  142 (502)
Q Consensus        79 --------~~s~vGTp~Y~APEvl~-~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~k--I~~-g~~p~~  142 (502)
                              .....||-+|++||.+- +    +.+.++||||+|||+|..+.|+-||........|.+.  |.. .....+
T Consensus       629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP  708 (775)
T KOG1151|consen  629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP  708 (775)
T ss_pred             CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence                    23357999999999652 2    3688999999999999999999999654333444332  211 111123


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ..++.+.++++||++||. .-..|..+.+|..||||.+.
T Consensus       709 ~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  709 PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            345668899999999998 88899999999999999764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=2.8e-24  Score=226.10  Aligned_cols=172  Identities=28%  Similarity=0.460  Sum_probs=138.1

Q ss_pred             CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            4 SGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         4 gGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      +-+|++.+++++.   |..++++.|+.||+.||..|-..|  |+|.||||+|||++.....+||||||.|...... ...
T Consensus       517 slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en-eit  593 (752)
T KOG0670|consen  517 SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASEN-EIT  593 (752)
T ss_pred             hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccc-ccc
Confidence            5689999999874   999999999999999999999998  9999999999999987778999999999766543 334


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHh--hcCCCCCc-----------c---
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV--TSGKLPGA-----------F---  143 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI--~~g~~p~~-----------~---  143 (502)
                      .+.-+..|.|||++.| .|+...|+||+||+||||+||+..|++..|..-+ +-.  ..|++|..           |   
T Consensus       594 PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~KGk~p~KmlRKgqF~dqHFD~d  672 (752)
T KOG0670|consen  594 PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELKGKFPNKMLRKGQFKDQHFDQD  672 (752)
T ss_pred             HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhcCCCcHHHhhhcchhhhhcccc
Confidence            4556778999997765 5999999999999999999999999986664433 211  12332210           0   


Q ss_pred             ------------------------------------------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          144 ------------------------------------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       144 ------------------------------------------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                                                                ....-..+++|+.+||. ||.+|+|..++|+||||..
T Consensus       673 ~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  673 LNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                                                      00012458899999999 9999999999999999964

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-24  Score=212.87  Aligned_cols=167  Identities=26%  Similarity=0.426  Sum_probs=139.6

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010730           13 KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE   92 (502)
Q Consensus        13 k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APE   92 (502)
                      +..+++|..+-.+..-.+.||+||-.. ..|||||+||+|||++.. |.|||||||++..+..+-....-.|...|||||
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPE  237 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPE  237 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecC-CCEeeecccchHhHHHHHHhhhccCCccccChh
Confidence            446799999999999999999999854 239999999999999988 899999999998776554444457899999999


Q ss_pred             ccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccc----cccHHHHHHHHHhhh-CcCC
Q 010730           93 LYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR----IQDAEARRFVGKCLE-NVSK  164 (502)
Q Consensus        93 vl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~----~~s~~l~~LI~kcL~-dP~k  164 (502)
                      -+.   ..|+.++|+||||++|||++||.+||.++.+.-+....+..|..|.-...    ..+..+..||..||. |-..
T Consensus       238 Ri~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~  317 (361)
T KOG1006|consen  238 RIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSD  317 (361)
T ss_pred             ccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhccccc
Confidence            875   34999999999999999999999999988776666667777776633222    246789999999998 9999


Q ss_pred             CCCHHHHhcCCCCcCCC
Q 010730          165 RLPAKELLLDPFLASDA  181 (502)
Q Consensus       165 RpSa~ELL~hPff~~~~  181 (502)
                      ||...+|+.+||++...
T Consensus       318 Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  318 RPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             CcchhhhhcCchhhhhh
Confidence            99999999999997653

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-23  Score=218.49  Aligned_cols=173  Identities=26%  Similarity=0.430  Sum_probs=131.2

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-C
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-S   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~   76 (502)
                      ||.+|+|.+++....  .+++....+|+.+++.||+|||.. .++|||||||+.|||+|.+ ...||+|||+|+.... .
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCccc
Confidence            789999999997654  899999999999999999999985 4589999999999999987 6999999999976654 3


Q ss_pred             CCcccc-cCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCC-----ChHHH-HHHhhcCCCCCccc----
Q 010730           77 QQAHSV-IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-----NPAQI-YKKVTSGKLPGAFH----  144 (502)
Q Consensus        77 ~~~~s~-vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-----~~~ql-~~kI~~g~~p~~~~----  144 (502)
                      ....+. .||.+|+|||.+. +..+.++|||||||+|+||+||+.|.....     +...+ ...+..+.+.....    
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            333333 8999999999775 679999999999999999999998876421     12222 22333333221111    


Q ss_pred             -cccc--HH---HHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          145 -RIQD--AE---ARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       145 -~~~s--~~---l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ....  ..   +..+..+|+. +|.+||++.|++..
T Consensus       312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence             1111  23   3445567998 99999999997653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=3.4e-23  Score=200.52  Aligned_cols=168  Identities=23%  Similarity=0.420  Sum_probs=138.1

Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC
Q 010730           11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMA   90 (502)
Q Consensus        11 i~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~A   90 (502)
                      .+=++.|+...++.++.|||.||.|||++|  |+|||+||.|++++....+++|+|.|+|.+...+....-.+.+..|--
T Consensus       123 k~ly~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKG  200 (338)
T KOG0668|consen  123 KQLYPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG  200 (338)
T ss_pred             HHHhhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCC
Confidence            334567888999999999999999999999  999999999999998777899999999999888777777788999999


Q ss_pred             ccccc--cCCCCcccchhHHHHHHHHhhccCCCC-CCCChHHHHHHhhc--------------CCCC-------------
Q 010730           91 PELYE--EDYNELVDIYSFGMCVLEMLTSEYPYS-ECSNPAQIYKKVTS--------------GKLP-------------  140 (502)
Q Consensus        91 PEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~-~~~~~~ql~~kI~~--------------g~~p-------------  140 (502)
                      ||++-  ..|+.+.|+|||||++..|+..+-||. +.+|.+|+.+...-              -.++             
T Consensus       201 PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk  280 (338)
T KOG0668|consen  201 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRK  280 (338)
T ss_pred             chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccc
Confidence            99875  458999999999999999999888875 45677776443210              0011             


Q ss_pred             -------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 -------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 -------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                             ..-....++++.+|+.++|. |..+|+||+|++.||||...
T Consensus       281 ~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  281 PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                   11122347899999999998 99999999999999999743

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=230.49  Aligned_cols=171  Identities=27%  Similarity=0.422  Sum_probs=130.3

Q ss_pred             CCCcHHHHHHhC-CCCCH---HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEEecCCceecc
Q 010730            3 TSGTLREYRKKY-TRVDI---RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQIKIGDLGLAAILR   74 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e---~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~----~g~vKL~DFGlA~~~~   74 (502)
                      +..+|.+|+... ..+..   -..+..+.|++.||++||+.+  ||||||||.||||...    ...++|.|||+++.+.
T Consensus       585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            456899999874 21111   345778999999999999988  9999999999999762    2468999999999886


Q ss_pred             CCCC----cccccCCCcccCccccccC-CCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCC-Ccccccc
Q 010730           75 GSQQ----AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQ  147 (502)
Q Consensus        75 ~~~~----~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~  147 (502)
                      .+..    .....||-+|+|||++... -..++||+||||++|+.++ |..||.+  +.+.-. .|..+... ..+....
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~-NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQA-NILTGNYTLVHLEPLP  739 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhh-hhhcCccceeeeccCc
Confidence            5432    3456799999999998653 5668999999999999999 5999954  222211 23333331 1222223


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      +.++++||.+||. +|..||+|.++|.||||=
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            3389999999999 999999999999999984

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.5e-23  Score=233.06  Aligned_cols=167  Identities=20%  Similarity=0.400  Sum_probs=140.6

Q ss_pred             CCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKY-------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      ||.||+|..||++.       ..+..+.+..++.||++|..||++++  +|||||-+.|+|++.. ..|||+|||+|+.+
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcccchhHhh
Confidence            79999999999876       34999999999999999999999998  9999999999999988 68999999999854


Q ss_pred             cCCCCccccc--C--CCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccc
Q 010730           74 RGSQQAHSVI--G--TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ  147 (502)
Q Consensus        74 ~~~~~~~s~v--G--Tp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~  147 (502)
                      .... .+..-  +  ...|||||.+. +.++.++|||||||+|||++| |..||.+..|.+-+..-...|++  ..+..+
T Consensus       853 y~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL--~~P~~C  929 (1025)
T KOG1095|consen  853 YDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL--DPPSYC  929 (1025)
T ss_pred             hhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc--CCCCCC
Confidence            3221 11111  1  24799999876 679999999999999999999 99999986666555556666766  445667


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..+.+++..||. +|.+||++..|++
T Consensus       930 P~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  930 PEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ChHHHHHHHHHccCChhhCccHHHHHh
Confidence            7888999999999 9999999999887

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.8e-23  Score=205.07  Aligned_cols=171  Identities=29%  Similarity=0.440  Sum_probs=133.7

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--Cccccc
Q 010730            6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--QAHSVI   83 (502)
Q Consensus         6 sL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~~~s~v   83 (502)
                      +|.+.|-.-..++...++-++.|||.||.|||+.+  |.||||||.|+|++.| -.+||+|||+++......  .+...+
T Consensus       142 DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hMTqEV  218 (449)
T KOG0664|consen  142 DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNMTHEV  218 (449)
T ss_pred             hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhhhhHHHH
Confidence            56666666678999999999999999999999998  9999999999999998 589999999998765433  344567


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh------------------------cC
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT------------------------SG  137 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~------------------------~g  137 (502)
                      -|-+|.|||++.+  .|+.++||||+|||+.|||..+..|.. .++.+..+.|.                        .+
T Consensus       219 VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~  297 (449)
T KOG0664|consen  219 VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG  297 (449)
T ss_pred             HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence            7999999998865  499999999999999999999999876 34433333222                        11


Q ss_pred             CCCCcccc---cc-----cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          138 KLPGAFHR---IQ-----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       138 ~~p~~~~~---~~-----s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ..++.++.   +.     ..+...++.++|. +|.+|++..+++.|+++...
T Consensus       298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            12222222   22     2456777788888 99999999999999998644

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.2e-23  Score=219.17  Aligned_cols=169  Identities=21%  Similarity=0.362  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~-L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+|+++.+. ++..+...++.+.+.||+|||+++  +|||||-..|+|+..+ +.+||+|||+++.-......
T Consensus       242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~~~~  318 (474)
T KOG0194|consen  242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQYVMK  318 (474)
T ss_pred             ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcceeec
Confidence            6889999999999874 999999999999999999999999  9999999999999886 57899999998754321111


Q ss_pred             ccc-cCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           80 HSV-IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        80 ~s~-vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ... .-...|+|||.+. +.|+.++|||||||++||+.+ |..||.+ ....++..+|....++...+...+..+..++.
T Consensus       319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~  397 (474)
T KOG0194|consen  319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELAKVMK  397 (474)
T ss_pred             cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHHHHHH
Confidence            111 2346799999886 569999999999999999999 8999988 55668888885555555666677889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhc
Q 010730          157 KCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~  173 (502)
                      +|+. +|.+|+++.++.+
T Consensus       398 ~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  398 QCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HhccCChhhccCHHHHHH
Confidence            9998 9999999988776

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.87  E-value=3.5e-22  Score=220.74  Aligned_cols=168  Identities=25%  Similarity=0.421  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 010730            1 MFTSGTLREYRKKYT--------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD   66 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~D   66 (502)
                      ||.-|+|.+|+.-..              +|+..+...++.||+.|++||-++.  +|||||-..|+||..+ -.|||+|
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~-l~VKIsD  646 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGEN-LVVKISD  646 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccc-eEEEecc
Confidence            788999999996432              2888999999999999999999998  9999999999999988 4899999


Q ss_pred             cCCceeccCCCCcc---cccCCCcccCcc-ccccCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCC
Q 010730           67 LGLAAILRGSQQAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        67 FGlA~~~~~~~~~~---s~vGTp~Y~APE-vl~~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~  141 (502)
                      ||+++.+....-.+   ...=...||+|| ++.++|++++||||+||+|||+++ |.-||.+..| .++.+.|.+|.. -
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~~g~l-L  724 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIRAGQL-L  724 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHHcCCc-c
Confidence            99998764321111   112246899999 567899999999999999999999 9999998666 566778888887 4


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .-+..++.++.+|+..||. +|.+||+++||-.
T Consensus       725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            5677788999999999999 9999999998753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.86  E-value=5.1e-22  Score=189.95  Aligned_cols=128  Identities=31%  Similarity=0.504  Sum_probs=110.8

Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC
Q 010730           11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMA   90 (502)
Q Consensus        11 i~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~A   90 (502)
                      +++.+.++|..+-+++..|+.||.|||++- .|||||+||+|||++.. |+||+||||++..+..+.....-.|.-.|||
T Consensus       139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiAkt~daGCkpYma  216 (282)
T KOG0984|consen  139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYD-GQVKICDFGISGYLVDSIAKTMDAGCKPYMA  216 (282)
T ss_pred             HhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccC-CcEEEcccccceeehhhhHHHHhcCCCccCC
Confidence            356678999999999999999999999872 49999999999999987 8999999999988766544333568889999


Q ss_pred             ccccc-----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC
Q 010730           91 PELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP  140 (502)
Q Consensus        91 PEvl~-----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p  140 (502)
                      ||.+.     ..|+.++||||||+++.||.++++||..+..+.+..+++.....|
T Consensus       217 PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  217 PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             hhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence            99874     259999999999999999999999999999998888888776544

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.86  E-value=6.6e-22  Score=214.77  Aligned_cols=121  Identities=31%  Similarity=0.513  Sum_probs=109.5

Q ss_pred             CCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCc--EEEEecCCceecc
Q 010730            1 MFTSGTLREYRKK---YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQ--IKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k---~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~-~~g~--vKL~DFGlA~~~~   74 (502)
                      |+.||+|+.++.+   ...|++.+++.++..+..||.|||.+|  |+||||||+||++-. ..|+  -||+|||.|+.+.
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            7899999999964   456999999999999999999999999  999999999998742 2233  5999999999999


Q ss_pred             CCCCcccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCC
Q 010730           75 GSQQAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSE  123 (502)
Q Consensus        75 ~~~~~~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~  123 (502)
                      ++....+++||+.|.+||+++  ..|+.-+|.|||||++|+.+||..||--
T Consensus       176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            888899999999999999998  5699999999999999999999999954

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=6.7e-21  Score=211.43  Aligned_cols=170  Identities=25%  Similarity=0.378  Sum_probs=142.6

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+..|+|.+|+++.+                .+....+..++.||+.|++||++..  +|||||-+.|||+..+ ..+||
T Consensus       383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~-~~~kI  459 (609)
T KOG0200|consen  383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKN-KVIKI  459 (609)
T ss_pred             eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCC-CEEEE
Confidence            577899999998765                3889999999999999999999988  9999999999999987 58999


Q ss_pred             EecCCceeccCCCCc--ccccCC--CcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCC
Q 010730           65 GDLGLAAILRGSQQA--HSVIGT--PEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK  138 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~--~s~vGT--p~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~  138 (502)
                      +|||+|+........  ....|+  ..|||||.+.. .|+.++||||||++|||+.| |..||++......+++.+..|.
T Consensus       460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~  539 (609)
T KOG0200|consen  460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN  539 (609)
T ss_pred             ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC
Confidence            999999865443222  112222  34999998764 69999999999999999999 9999998666778888888887


Q ss_pred             CCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .. ..+..++.++.+++..||. +|.+||+..++...
T Consensus       540 r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~  575 (609)
T KOG0200|consen  540 RM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF  575 (609)
T ss_pred             CC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            64 3445568999999999998 99999999888763

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.83  E-value=5.1e-21  Score=204.85  Aligned_cols=167  Identities=26%  Similarity=0.455  Sum_probs=138.5

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      +++-|.|+.|++..+ .|+...+..|+.||..+|.|||+..  +|||||...|||+... ..|||+|||+++.+....-.
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccccchh
Confidence            456799999998764 5999999999999999999999998  9999999999999987 58999999999988765433


Q ss_pred             ccccC--CCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 HSVIG--TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 ~s~vG--Tp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      +...|  ..-|||||-+. ..++.++|||-||||+||++. |.-||.+-.|.+-|. .+.+|..+ +.+..+++.+..++
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeRl-P~P~nCPp~LYslm  625 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGERL-PCPPNCPPALYSLM  625 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCCC-CCCCCCChHHHHHH
Confidence            33333  45699999776 679999999999999999988 999999866655443 44555443 45667789999999


Q ss_pred             HHhhh-CcCCCCCHHHHh
Q 010730          156 GKCLE-NVSKRLPAKELL  172 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL  172 (502)
                      .+||. +|.+||.+.||.
T Consensus       626 skcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  626 SKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHhccCcccCCcHHHHH
Confidence            99999 999999977654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.83  E-value=9.5e-21  Score=195.92  Aligned_cols=161  Identities=29%  Similarity=0.498  Sum_probs=122.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--------------CC---
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--------------QQ---   78 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--------------~~---   78 (502)
                      .++...++.|++.++.||.++|.+|  ||||||||.|+|.+...++-.|+|||+|......              ..   
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g  205 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMG  205 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcccc
Confidence            4778999999999999999999999  9999999999999988888999999999621100              00   


Q ss_pred             ----------------------------cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCCh-
Q 010730           79 ----------------------------AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNP-  127 (502)
Q Consensus        79 ----------------------------~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~-  127 (502)
                                                  .....|||+|.|||++..  ..++++||||.|||++-++++.+||....+. 
T Consensus       206 ~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~  285 (418)
T KOG1167|consen  206 KDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDA  285 (418)
T ss_pred             CcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCcccc
Confidence                                        012469999999998863  4788999999999999999999999643221 


Q ss_pred             ---HHHH--------HHh--hcCC-------------------------------C----CCcccccccHHHHHHHHHhh
Q 010730          128 ---AQIY--------KKV--TSGK-------------------------------L----PGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus       128 ---~ql~--------~kI--~~g~-------------------------------~----p~~~~~~~s~~l~~LI~kcL  159 (502)
                         .++.        ++.  ..|.                               .    ...+....+..+.+|+.+||
T Consensus       286 ~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~l  365 (418)
T KOG1167|consen  286 DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCL  365 (418)
T ss_pred             chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHc
Confidence               1110        000  0011                               0    00112223557899999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCc
Q 010730          160 E-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~  178 (502)
                      . ||.+|+||+++|+||||.
T Consensus       366 e~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  366 ELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             cCChhhcccHHHHhcCcCCc
Confidence            9 999999999999999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.83  E-value=1.7e-20  Score=216.94  Aligned_cols=166  Identities=22%  Similarity=0.356  Sum_probs=121.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++++   +++..+..++.||+.||+|||.+ .++|+||||||+||+++.+ +..++. ||.......   .
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~  835 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---D  835 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---C
Confidence            6889999999963   88999999999999999999954 3459999999999999876 466664 665543321   1


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC----ChHHHHHHhhc---------CCCCC--cc
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS----NPAQIYKKVTS---------GKLPG--AF  143 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~----~~~ql~~kI~~---------g~~p~--~~  143 (502)
                      ....||+.|+|||++.+ .|+.++|||||||++|||+||+.||....    ...++.+....         .....  ..
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            23478999999998764 59999999999999999999999985321    11122111110         00100  01


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ......++.+++.+||. +|.+||++.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11112356788899998 99999999999986

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.83  E-value=7.3e-21  Score=205.18  Aligned_cols=177  Identities=29%  Similarity=0.493  Sum_probs=149.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+-||+|.+.-.-.+++++.++...++..+.||+|||+++  -+|||||-.||+++.. |.+|++|||++..+... .+.
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccCchhhhhhhhhhh
Confidence            6778999998888899999999999999999999999998  8999999999999987 89999999999876543 345


Q ss_pred             ccccCCCcccCcccc----ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc--ccccHHHHH
Q 010730           80 HSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEARR  153 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl----~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~--~~~s~~l~~  153 (502)
                      ++++|||+|||||+-    .+.|+..+|||++|+...|+.--++|.........++-.-.++..|+.+.  ...++.+-+
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~  249 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN  249 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence            789999999999975    36799999999999999999999999776544455555555555443332  234788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |++.+|. +|++||+++.+|.|||+...
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccc
Confidence            9999998 99999999999999999654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.7e-20  Score=198.04  Aligned_cols=168  Identities=23%  Similarity=0.372  Sum_probs=140.7

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      ||+-|+|.+|+++..  .++.-.+..++.||.+|++||...+  +|||||-..|+|+..+ ..||++||||++.+....-
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhcCCce
Confidence            799999999998754  4777788899999999999999999  9999999999999887 5899999999998865432


Q ss_pred             c-c-cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 A-H-SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~-~-s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      . + ...-..-|.|||-+. ..++.++|||+|||+|||+.| |..||++ .+..++|..+..|-. ...+.-+++.+.+|
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyR-M~~PeGCPpkVYeL  498 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYR-MDGPEGCPPKVYEL  498 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccc-ccCCCCCCHHHHHH
Confidence            1 1 112245799999775 569999999999999999999 9999988 678889988776643 24455678899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..||+ .|..||+++|+-+
T Consensus       499 MraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  499 MRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHhcCCcccCccHHHHHH
Confidence            999999 9999999887654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4.6e-20  Score=193.56  Aligned_cols=118  Identities=27%  Similarity=0.396  Sum_probs=78.5

Q ss_pred             EEEecCCceeccCCCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC------CChH---HHHH
Q 010730           63 KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPA---QIYK  132 (502)
Q Consensus        63 KL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~------~~~~---ql~~  132 (502)
                      ||+|||-|.+...  ....-+.|..|.||||+- ..|++.+||||++|++|||+||.+.|.--      .+.+   .|..
T Consensus       394 KIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  394 KIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             EEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence            4444444444321  122345688999999775 56999999999999999999999998421      1111   2211


Q ss_pred             --------HhhcCCCCC----------------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCC
Q 010730          133 --------KVTSGKLPG----------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       133 --------kI~~g~~p~----------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hP  175 (502)
                              .+..|+...                            .|+.-...++.+|+.-||+ +|.+|+||.++|+||
T Consensus       472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence                    112222110                            1111234568899999999 999999999999999


Q ss_pred             CCcCCCC
Q 010730          176 FLASDAG  182 (502)
Q Consensus       176 ff~~~~~  182 (502)
                      ||.....
T Consensus       552 wLn~~~~  558 (590)
T KOG1290|consen  552 WLNPVAG  558 (590)
T ss_pred             cccCCCC
Confidence            9986544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.3e-20  Score=208.43  Aligned_cols=177  Identities=24%  Similarity=0.477  Sum_probs=141.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.+ +|+.++...+.+....+..+++||+.||+|+|.+|  |.||||||+|+++..+ |.+||+|||.+..+...    
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeeccCcchh
Confidence            4556 89999998888999999999999999999999999  9999999999999987 79999999999765422    


Q ss_pred             -CCcccccCCCcccCcccccc-CCCC-cccchhHHHHHHHHhhccCCCCCCCChHHHH-HHhhcCCC-----CCcccccc
Q 010730           77 -QQAHSVIGTPEFMAPELYEE-DYNE-LVDIYSFGMCVLEMLTSEYPYSECSNPAQIY-KKVTSGKL-----PGAFHRIQ  147 (502)
Q Consensus        77 -~~~~s~vGTp~Y~APEvl~~-~ys~-~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~-~kI~~g~~-----p~~~~~~~  147 (502)
                       .....++|+..|+|||++.+ .|.+ .+||||.|++++.|++|+.||.-....++.+ ......+.     +..+....
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence             22356789999999998864 4654 6899999999999999999996543333322 11111111     12334445


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +.+.+.+|.+||+ +|.+|.|+++||+++||+...
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            7788999999999 999999999999999998643

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=4.8e-20  Score=192.98  Aligned_cols=167  Identities=29%  Similarity=0.510  Sum_probs=127.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-------HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-------~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |...|+|-+|++.+ .++.....+++..|..||+|||.       ++|+|+|||||..|||+..+ ...-|+|||+|-.+
T Consensus       289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~~  366 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALRL  366 (534)
T ss_pred             eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEEe
Confidence            45789999999875 48999999999999999999994       56789999999999999877 79999999999887


Q ss_pred             cCCC---CcccccCCCcccCccccccCCC-------CcccchhHHHHHHHHhhccCC------------CCC----CCCh
Q 010730           74 RGSQ---QAHSVIGTPEFMAPELYEEDYN-------ELVDIYSFGMCVLEMLTSEYP------------YSE----CSNP  127 (502)
Q Consensus        74 ~~~~---~~~s~vGTp~Y~APEvl~~~ys-------~~~DIWSLGviLyeLLTG~~P------------f~~----~~~~  127 (502)
                      ....   .+...+||..|||||++++..+       ...||||+|.+||||++...-            |..    ....
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            6443   3455899999999999987532       258999999999999885422            210    1223


Q ss_pred             HHHHHHhhcCC----CCCccccc-ccHHHHHHHHHhhh-CcCCCCCHH
Q 010730          128 AQIYKKVTSGK----LPGAFHRI-QDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus       128 ~ql~~kI~~g~----~p~~~~~~-~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      +++...+...+    +|..|... -...+++.+.-||+ |+..|+||.
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            34444443332    23223222 23568899999999 999999964

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.81  E-value=3.1e-19  Score=163.35  Aligned_cols=139  Identities=34%  Similarity=0.618  Sum_probs=120.6

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      ++.|++|.+++... ..++...+..++.+++.+|.|||..+  ++|+||+|.||+++...+.++|+|||.+....... .
T Consensus        72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~  149 (215)
T cd00180          72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL  149 (215)
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcch
Confidence            35679999999876 57999999999999999999999998  99999999999999822689999999998764432 1


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      .....+...|++||.+..  .++.+.|+|++|+++++|                                  ..+.+++.
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~  195 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIR  195 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHH
Confidence            334568899999998865  678899999999999999                                  57899999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCC
Q 010730          157 KCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hP  175 (502)
                      +|+. +|.+||++.+++.++
T Consensus       196 ~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         196 KMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHhhCCcccCcCHHHHhhCC
Confidence            9998 999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-19  Score=197.58  Aligned_cols=169  Identities=27%  Similarity=0.456  Sum_probs=143.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      ||..|+|.+|++.+ ..+..+....|..||++|+.|||.+.  ++||||-..|||+... ..|||.|||+++.+......
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccCccccc
Confidence            68899999999875 46999999999999999999999998  9999999999999876 69999999999988655443


Q ss_pred             cccc---CCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 HSVI---GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ~s~v---GTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ....   -.+-|||-|.+. ..|..++|||||||++||++| |.-||.+ ...++|-+.+..|.. -..+.+.+.++..+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDVy~~  932 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDVYMV  932 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHHHHH
Confidence            3322   246789999664 679999999999999999999 9999987 455677666666654 45677888999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.+||. |+..||+++++...
T Consensus       933 mvkCwmid~~~rp~fkel~~~  953 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAEE  953 (1177)
T ss_pred             HHHHhccCcccCccHHHHHHH
Confidence            999998 99999999887753

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-19  Score=196.26  Aligned_cols=172  Identities=22%  Similarity=0.379  Sum_probs=144.5

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |++.|+|.+-+.+  ...|-...+..|+.||+.|+.||.+++  +|||||-..|||+... ..|||+||||.+-+.....
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeecccceeccCCCCc
Confidence            4678999999987  345888999999999999999999998  9999999999999875 5899999999998876655


Q ss_pred             ccccc----CCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 AHSVI----GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~v----GTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      .+..-    -...|.|||.+. ++++.++|+|++||++|||+| |+-||.+ -+..+|.++|..+..- ..+..++..+.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~iD~~erL-pRPk~csedIY  345 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNIDAGERL-PRPKYCSEDIY  345 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhccccccC-CCCCCChHHHH
Confidence            44322    245699999875 679999999999999999999 9999988 5678888888865442 34566789999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +++..||. +|.+|||+..|.++-++
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHH
Confidence            99999999 99999999888655443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.9e-19  Score=186.08  Aligned_cols=171  Identities=30%  Similarity=0.490  Sum_probs=129.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG------HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs------~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |-+.|+|++|+.+ ..++.+...+++..+++||++||.      .+|.|.|||||..|||+..+ +..-|+|+|||....
T Consensus       290 YHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD  367 (513)
T ss_pred             cccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeeceeeEEec
Confidence            5678999999988 669999999999999999999993      35679999999999999988 899999999997665


Q ss_pred             CCC-----CcccccCCCcccCccccccCCC-------CcccchhHHHHHHHHhhc----------cCCCCCC----CChH
Q 010730           75 GSQ-----QAHSVIGTPEFMAPELYEEDYN-------ELVDIYSFGMCVLEMLTS----------EYPYSEC----SNPA  128 (502)
Q Consensus        75 ~~~-----~~~s~vGTp~Y~APEvl~~~ys-------~~~DIWSLGviLyeLLTG----------~~Pf~~~----~~~~  128 (502)
                      ...     .....+||-.|||||++....+       ..+||||||.++||++..          ++||.+.    ...+
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e  447 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE  447 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence            432     2355799999999999975422       358999999999998752          4788663    3345


Q ss_pred             HHHHHhhcCCCCCccc--ccccHH---HHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          129 QIYKKVTSGKLPGAFH--RIQDAE---ARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       129 ql~~kI~~g~~p~~~~--~~~s~~---l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ++.+.+.-.++.+.++  ...++.   +..+++-||. +|.-|.||--+-+
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            5555444333322211  112333   4567888998 9999999755543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.80  E-value=4.9e-20  Score=201.47  Aligned_cols=168  Identities=26%  Similarity=0.491  Sum_probs=141.3

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      ||.+|+|..|++++ +.|..-++..+++-|+.|++||-.++  .|||||-..|||++.+. ..|+.|||+++.+.... .
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce-EEEeccccceeecccCCCc
Confidence            79999999999864 66999999999999999999999999  99999999999999984 88999999999886544 2


Q ss_pred             cccccC---CCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcC-CCCCcccccccHHHH
Q 010730           79 AHSVIG---TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG-KLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vG---Tp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g-~~p~~~~~~~s~~l~  152 (502)
                      ..+..|   ...|.|||.+. ++++.++||||+|++|||.++ |+.||.+++|.+-| +.|..| .+|+  +..++..+.
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-kaIe~gyRLPp--PmDCP~aL~  864 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KAIEQGYRLPP--PMDCPAALY  864 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-HHHHhccCCCC--CCCCcHHHH
Confidence            233332   36799999775 789999999999999999777 99999998886654 455444 4543  345678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|+..||+ |...||.+.||+..
T Consensus       865 qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  865 QLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999 99999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.79  E-value=1.1e-18  Score=164.21  Aligned_cols=137  Identities=31%  Similarity=0.522  Sum_probs=117.6

Q ss_pred             CCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~-L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+++|.+++..... +++..+..++.|++.+|.|||.++  ++|+||+|.||+++.+ +.++|+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence            4567899999988777 899999999999999999999998  9999999999999987 799999999998765432  


Q ss_pred             CcccccCCCcccCcccc-c-cCCCCcccchhHHHHHHHHhhccCCCCC-CCChHHHHHHhhcCCCC
Q 010730           78 QAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLTSEYPYSE-CSNPAQIYKKVTSGKLP  140 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl-~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~-~~~~~ql~~kI~~g~~p  140 (502)
                      ......++..|++||++ . ..++.++|+|+||+++++|++|+.||.. ..+..++++.+..+..+
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            33456788999999987 3 3467799999999999999999999977 56667888888887643

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.78  E-value=3.3e-19  Score=190.15  Aligned_cols=170  Identities=22%  Similarity=0.342  Sum_probs=134.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      ||..|+|.+|+.++  +.++.+....++.||++|++||.+.+  +|||||.+.|+|++++ .++||+|||+++-+..+..
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccCCc
Confidence            67889999999987  33456667779999999999999999  9999999999999998 6999999999986543221


Q ss_pred             ---cccccCCCcccCcc-ccccCCCCcccchhHHHHHHHHh--hccCCCCCCCChHHHHHHhhc---CCCC---Cccccc
Q 010730           79 ---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML--TSEYPYSECSNPAQIYKKVTS---GKLP---GAFHRI  146 (502)
Q Consensus        79 ---~~s~vGTp~Y~APE-vl~~~ys~~~DIWSLGviLyeLL--TG~~Pf~~~~~~~ql~~kI~~---g~~p---~~~~~~  146 (502)
                         ....+-...|||+| ++.+++++++|+|+||+++||++  |.+-||....+ +++.+....   ..-+   ...+..
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~~P~~  771 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLSRPPA  771 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceeccCCCc
Confidence               12334567899999 66799999999999999999975  58899987443 444433221   1111   234556


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++..+.+++.+||. +-.+||++++|..+
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            67889999999998 99999999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.77  E-value=7.3e-18  Score=160.88  Aligned_cols=176  Identities=29%  Similarity=0.399  Sum_probs=141.9

Q ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      ++.+++|.+++....   .+....+..++.||+.+|.|+|..+  ++||||||+||+++.....++++|||++.......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            467899998887765   7999999999999999999999999  99999999999999873379999999998654332


Q ss_pred             -------CcccccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCC-Cc
Q 010730           78 -------QAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLP-GA  142 (502)
Q Consensus        78 -------~~~s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p-~~  142 (502)
                             .....+||+.|+|||++.+    .+....|+||+|++++++++|..||.....   ..+....+.....+ ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                   2466789999999998864    588899999999999999999999876543   45666666555433 11


Q ss_pred             ccccc------cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          143 FHRIQ------DAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       143 ~~~~~------s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .....      ...+.+++.+++. +|..|.+..+...++|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence            11111      2578999999998 999999999988886654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.76  E-value=3.1e-19  Score=190.23  Aligned_cols=117  Identities=27%  Similarity=0.487  Sum_probs=106.9

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|-+|++||..+++++|.+++.+++||+.|+++||++|  |||||||-+|++++++ |.+||+|||.+..... .....+
T Consensus       653 ~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~~ks-gpfd~f  728 (772)
T KOG1152|consen  653 EGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAYTKS-GPFDVF  728 (772)
T ss_pred             CCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhhhcC-CCccee
Confidence            36799999999999999999999999999999999999  9999999999999998 8999999999987654 455778


Q ss_pred             cCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCC
Q 010730           83 IGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE  123 (502)
Q Consensus        83 vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~  123 (502)
                      +||..|.|||++.+.  -+..-|||++|++||.++..+.||++
T Consensus       729 ~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  729 VGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999999865  46788999999999999999999964

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=4e-18  Score=191.82  Aligned_cols=152  Identities=32%  Similarity=0.517  Sum_probs=125.3

Q ss_pred             HHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----------------CCcccccCCCcccCccc
Q 010730           30 LRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----------------QQAHSVIGTPEFMAPEL   93 (502)
Q Consensus        30 L~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----------------~~~~s~vGTp~Y~APEv   93 (502)
                      +.+++|||+.+  |+|||+||+|++|+.- |++|++|||+.+..-..                ..-+.++|||.|+|||+
T Consensus       153 vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            67899999988  9999999999999875 89999999998753211                01134789999999997


Q ss_pred             cc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHHHHhhh-CcCCCC---
Q 010730           94 YE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL---  166 (502)
Q Consensus        94 l~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI~kcL~-dP~kRp---  166 (502)
                      +. ..|+..+|+|++|+|+|+.+.|..||.+ +.+++++..+.....  |.. .....++++++|.++|. +|..|.   
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence            65 5699999999999999999999999987 788999988876433  333 33346899999999998 998886   


Q ss_pred             CHHHHhcCCCCcCCCCCCCC
Q 010730          167 PAKELLLDPFLASDAGEPLL  186 (502)
Q Consensus       167 Sa~ELL~hPff~~~~~~~l~  186 (502)
                      .+-++.+|+||+...+..+.
T Consensus       308 ga~evk~h~ff~~LDw~~ll  327 (1205)
T KOG0606|consen  308 GALEVKQHGFFQLLDWKSLL  327 (1205)
T ss_pred             hhhhhhhccceeecccchhh
Confidence            47889999999988887443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.73  E-value=2.1e-17  Score=170.05  Aligned_cols=165  Identities=22%  Similarity=0.326  Sum_probs=136.0

Q ss_pred             CCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            4 SGTLREYRKKY--------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         4 gGsL~~yi~k~--------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      =|+|+.|+...        +.+.-.++..++.||..|++|||.++  |||.||...|.++++. -+|||+|=.+++-+-+
T Consensus       372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqVkltDsaLSRDLFP  448 (563)
T KOG1024|consen  372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQVKLTDSALSRDLFP  448 (563)
T ss_pred             cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeEEeccchhccccCc
Confidence            48999999832        23666788889999999999999999  9999999999999987 4899999999876532


Q ss_pred             CC--Ccc-cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHH
Q 010730           76 SQ--QAH-SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        76 ~~--~~~-s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ..  .+. ..--...||+||.+. ..|+.++|+|||||+||||+| |+.||.+ .++.+++..+..|..- ..+-.++.+
T Consensus       449 ~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRl-aQP~NCPDe  526 (563)
T KOG1024|consen  449 GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRL-AQPFNCPDE  526 (563)
T ss_pred             ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcccee-cCCCCCcHH
Confidence            11  111 112245799999764 669999999999999999999 9999987 7889999888888653 455667889


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +..++.-||. .|.+||+.+|+..
T Consensus       527 Lf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  527 LFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999999 9999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=2.1e-18  Score=186.19  Aligned_cols=169  Identities=27%  Similarity=0.369  Sum_probs=145.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |..||.|...+.+...+++..++.+...++.+++.+|..+  |+|||+|++||+++.+ |++|+.|||+++..-..+.. 
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence            4578899998888889999999999999999999999998  9999999999999988 89999999999876443322 


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                        +||..|||||++. ....++|.||||+++++|+||..||..     ++.+.|...++  ..+...+..+++++..++.
T Consensus       154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~  223 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL--EMPRELSAEARSLFRQLFK  223 (612)
T ss_pred             --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc--CCchhhhHHHHHHHHHHHh
Confidence              9999999999998 667889999999999999999999976     55666665554  3455567899999999998


Q ss_pred             -CcCCCCC-----HHHHhcCCCCcCCCCC
Q 010730          161 -NVSKRLP-----AKELLLDPFLASDAGE  183 (502)
Q Consensus       161 -dP~kRpS-----a~ELL~hPff~~~~~~  183 (502)
                       +|..|..     +.|+++|+||+...+.
T Consensus       224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             hCHHHHhccCcchhHHHhccchheeeeHh
Confidence             9999976     6899999999876654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1e-17  Score=165.94  Aligned_cols=171  Identities=26%  Similarity=0.430  Sum_probs=124.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE-eCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl-~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.-|+|..-+.. ..+.|...+.++.|+++||.|+|+.+  +||||||.+|||+ +.+..+|||||||+......  ..
T Consensus       103 ~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV  177 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TV  177 (378)
T ss_pred             cCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc--ee
Confidence            4566888887755 45889999999999999999999999  9999999999997 45567899999999865432  22


Q ss_pred             ccccCCCcccCccccc----cC--CCCcccchhHHHHHHHHhhccCCCCCCCChH---HHHHHhhcCC---CCCcccccc
Q 010730           80 HSVIGTPEFMAPELYE----ED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPA---QIYKKVTSGK---LPGAFHRIQ  147 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~----~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~---ql~~kI~~g~---~p~~~~~~~  147 (502)
                      ...-.+..|.+||++.    +.  .++..|||.||+++|..+||.+||.......   --|.+...++   .|..|... 
T Consensus       178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f-  256 (378)
T KOG1345|consen  178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF-  256 (378)
T ss_pred             hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc-
Confidence            3334567799999764    22  5788999999999999999999997532222   2233333333   33334433 


Q ss_pred             cHHHHHHHHHhhh-CcCCC---CCHHHHhcCCCC
Q 010730          148 DAEARRFVGKCLE-NVSKR---LPAKELLLDPFL  177 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kR---pSa~ELL~hPff  177 (502)
                      ++.+..+.++-|. ++.+|   -+++.....-|.
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            5667777788887 77777   456666666665

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=6.5e-18  Score=179.40  Aligned_cols=166  Identities=28%  Similarity=0.471  Sum_probs=132.4

Q ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      +++.++|.+|+.+..   ..+...++.|+.||..|++|   ++  .+|||+||.||++..+ ..+||+|||+........
T Consensus       337 ~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl~ts~~~~~  410 (516)
T KOG1033|consen  337 LCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGLVTSQDKDE  410 (516)
T ss_pred             hhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhheeecccCC
Confidence            356789999997543   36677889999999999999   66  9999999999999876 589999999987765443


Q ss_pred             -------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCccccccc
Q 010730           78 -------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD  148 (502)
Q Consensus        78 -------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s  148 (502)
                             .....+||..||+||.+.+ .|+.++||||||+||+||+. -..++.    ....+..+..|.+|+.+... .
T Consensus       411 ~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~~d-~  485 (516)
T KOG1033|consen  411 TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFLQD-Y  485 (516)
T ss_pred             cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHhhc-C
Confidence                   3455789999999998875 59999999999999999988 333432    23345667788887554433 3


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      +.-..|+..+|. .|.+||++.+.-.|+|+
T Consensus       486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  486 PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            566789999998 99999988888888775

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.2e-14  Score=150.23  Aligned_cols=165  Identities=27%  Similarity=0.357  Sum_probs=119.4

Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEEecCCceeccCC-----
Q 010730            5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLGLAAILRGS-----   76 (502)
Q Consensus         5 GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~---~g~vKL~DFGlA~~~~~~-----   76 (502)
                      .||++|+-. ...+....+-++.|+|+|+.|||.||  |.|||||.+|||+.-+   ...+.++|||-+---...     
T Consensus       327 ~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp  403 (598)
T KOG4158|consen  327 QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP  403 (598)
T ss_pred             hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc
Confidence            478888855 34677788889999999999999999  9999999999998532   246899999976321110     


Q ss_pred             --CCcccccCCCcccCccccccC-------CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccc
Q 010730           77 --QQAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ  147 (502)
Q Consensus        77 --~~~~s~vGTp~Y~APEvl~~~-------ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~  147 (502)
                        ...-..-|.-.-||||+....       ...++|.|+.|.+.||+++...||+......--.+...+.++| .++...
T Consensus       404 y~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-alp~~v  482 (598)
T KOG4158|consen  404 YESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-ALPSRV  482 (598)
T ss_pred             cccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-CCcccC
Confidence              111123467788999988532       2358999999999999999999998722211112223334454 445556


Q ss_pred             cHHHHHHHHHhhh-CcCCCCC---HHHHhc
Q 010730          148 DAEARRFVGKCLE-NVSKRLP---AKELLL  173 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpS---a~ELL~  173 (502)
                      ++.+++++..+|+ ||+||++   |+.+|+
T Consensus       483 pp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  483 PPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            7899999999999 9999998   445554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.57  E-value=2.7e-15  Score=169.58  Aligned_cols=162  Identities=19%  Similarity=0.256  Sum_probs=118.1

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec--cCCCC--ccc
Q 010730            6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQ--AHS   81 (502)
Q Consensus         6 sL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~--~~~~~--~~s   81 (502)
                      +|.+.+.-.+-+..-+.+.++.|||.||..||..|  |+|+|||.||||++.= +.+.|+||.--|..  .....  ..-
T Consensus       106 nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPadf~f  182 (1431)
T KOG1240|consen  106 NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPADFTF  182 (1431)
T ss_pred             hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCCCCcccceE
Confidence            55565655566888889999999999999999998  9999999999999875 57999999876542  22111  111


Q ss_pred             cc----CCCcccCcccccc------------CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC--CCc
Q 010730           82 VI----GTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL--PGA  142 (502)
Q Consensus        82 ~v----GTp~Y~APEvl~~------------~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~--p~~  142 (502)
                      +.    --.+|+|||-+-.            ...++-||||+||+++||++ |++||.    ..|++.--..+..  ..-
T Consensus       183 FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  183 FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             EEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHH
Confidence            22    2347999996521            13567899999999999998 888883    2344322111111  112


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +..+.+..++++|..|++ ||.+|++|++.|+-
T Consensus       259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            344556789999999999 99999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.52  E-value=1.8e-13  Score=140.31  Aligned_cols=170  Identities=21%  Similarity=0.250  Sum_probs=120.7

Q ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC----CcEEEEecCCceecc-
Q 010730            2 FTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL----GQIKIGDLGLAAILR-   74 (502)
Q Consensus         2 ~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~----g~vKL~DFGlA~~~~-   74 (502)
                      +.|-+|.++++..  +.++...+..++.|++.+|++||+.|  +|||||||+|+++....    ..+.|+|||+++... 
T Consensus       102 l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~  179 (322)
T KOG1164|consen  102 LLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY  179 (322)
T ss_pred             ccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence            3578999998665  57999999999999999999999999  99999999999997542    369999999998321 


Q ss_pred             --CCC----C----cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH--HHHHhhcCCCCC
Q 010730           75 --GSQ----Q----AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--IYKKVTSGKLPG  141 (502)
Q Consensus        75 --~~~----~----~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q--l~~kI~~g~~p~  141 (502)
                        ...    .    .....||..|+++.+..+ ..+...|+||++.++.+|+.|..||........  -+.+........
T Consensus       180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~  259 (322)
T KOG1164|consen  180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD  259 (322)
T ss_pred             cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc
Confidence              111    0    123559999999997765 488999999999999999999999976443222  222222221111


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ........++..+...+-. +...+|....+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  260 RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            1222233455555544444 6677777655544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.51  E-value=1.2e-14  Score=147.56  Aligned_cols=131  Identities=19%  Similarity=0.267  Sum_probs=88.2

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcccccc------
Q 010730           23 KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE------   96 (502)
Q Consensus        23 ~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~------   96 (502)
                      ..+..|++..+++||.+|  |+|+||||+|+|++.+ |.++|+||+.......  .......+..|.+||+...      
T Consensus       148 l~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~  222 (288)
T PF14531_consen  148 LSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQD-GGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQ  222 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TT-S-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHH
T ss_pred             HHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCC-CCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCc
Confidence            455599999999999999  9999999999999987 8999999988755432  2222345688999997632      


Q ss_pred             ---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCC
Q 010730           97 ---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKR  165 (502)
Q Consensus        97 ---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kR  165 (502)
                         .++.+.|.|+||+++|.|+||..||............+..     ..  ..+..++.||..+|+ +|.+|
T Consensus       223 ~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f~~-----C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  223 NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDFSR-----CR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGGTT-----SS-----HHHHHHHHHHT-SSGGGS
T ss_pred             ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccchh-----cC--CcCHHHHHHHHHHccCCcccC
Confidence               3788999999999999999999999652111100001111     11  346789999999998 99877

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.43  E-value=5.1e-13  Score=143.75  Aligned_cols=171  Identities=26%  Similarity=0.387  Sum_probs=128.3

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---   76 (502)
                      |+.-|+|.+.+.+ .-.++..-...++++|+.||.|||..-. ..|+.|+..|.+++.. ..+||.|||+.......   
T Consensus        28 ~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~nClvd~~-w~lklt~~Gl~~~~~~~~~~  105 (484)
T KOG1023|consen   28 YCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSNCLVDSR-WVLKLTDFGLNSLLEETAEP  105 (484)
T ss_pred             eecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccccceeeee-EEEEechhhhcccccccccc
Confidence            5678999999987 4568888899999999999999997642 3999999999999988 69999999998765321   


Q ss_pred             CCcccccCCCcccCccccccC--------CCCcccchhHHHHHHHHhhccCCCCCC---CChHHHHHHhhcCCCCCcccc
Q 010730           77 QQAHSVIGTPEFMAPELYEED--------YNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~~--------ys~~~DIWSLGviLyeLLTG~~Pf~~~---~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      .......-...|.|||++...        ...+.||||||++++|+++...||...   ..+.++..++..+..+...+.
T Consensus       106 ~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~  185 (484)
T KOG1023|consen  106 EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPS  185 (484)
T ss_pred             cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcc
Confidence            111111223568999988643        456799999999999999999999763   233456666666222211111


Q ss_pred             -----cccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          146 -----IQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       146 -----~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                           ...+++..++..||. +|.+||+++++-.
T Consensus       186 i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  186 IELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             hhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence                 223468899999998 9999999888654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=9.8e-14  Score=153.98  Aligned_cols=176  Identities=30%  Similarity=0.425  Sum_probs=139.2

Q ss_pred             CCCCCcHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC-cEEEEecCCceeccC-
Q 010730            1 MFTSGTLREYR-KKYT-RVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRG-   75 (502)
Q Consensus         1 ~~tgGsL~~yi-~k~~-~L~e~~i~~i~~QIL~gL~YLH-s~g~~IIHRDLKPeNILl~~~~g-~vKL~DFGlA~~~~~-   75 (502)
                      |..||++++.+ .... ..+...+..++.|+..+|.|+| ..+  +.||||||+|.+++.+ + .+|+.|||+|..+.. 
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCchhhcccccc
Confidence            35678888888 5544 6777888999999999999999 777  9999999999999987 5 899999999987654 


Q ss_pred             CC---CcccccC-CCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC--CCCcccccc
Q 010730           76 SQ---QAHSVIG-TPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQ  147 (502)
Q Consensus        76 ~~---~~~s~vG-Tp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~--~p~~~~~~~  147 (502)
                      ..   .....+| ++.|+|||.+.+  ...+..|+||+|+++..|++|..|+.......+-|.......  .....+...
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            22   2344678 999999998876  467889999999999999999999865433333333333222  112334455


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +..+.+++.++|. +|..|.+.+++-.+||+..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccccccccc
Confidence            7788999999996 9999999999999999976

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=2.8e-13  Score=137.67  Aligned_cols=171  Identities=33%  Similarity=0.585  Sum_probs=121.4

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      ||.+|+|.+|+++-    +.+..+..++|+.||+.||.|||+..|+|+|+++.++.|++..+ |-||++--.... +...
T Consensus       153 ymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~n-gLIkig~~ap~s-~h~s  230 (458)
T KOG1266|consen  153 YMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHN-GLIKIGSVAPDS-THPS  230 (458)
T ss_pred             cccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCC-ceEEecccCccc-cchh
Confidence            78999999999753    46899999999999999999999999999999999999999865 677765322111 1110


Q ss_pred             CC------cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           77 QQ------AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        77 ~~------~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ..      .....+-++|.+||.=. .+...++|||+||++.++|..+..--.+.......-..+..     ..-.....
T Consensus       231 ~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~  305 (458)
T KOG1266|consen  231 VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENG  305 (458)
T ss_pred             hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCc
Confidence            00      11123678999998543 45677899999999999999887653332111111111111     11112233


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .-+.+|.+||+ .|..||+|.++|.||.+-
T Consensus       306 lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  306 LQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             cccCcCcccccCCCCCCcchhhhhcCceee
Confidence            45788999999 999999999999998763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.39  E-value=1.4e-12  Score=132.72  Aligned_cols=135  Identities=24%  Similarity=0.393  Sum_probs=110.4

Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEEecCCceeccCCC
Q 010730            3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~----~g~vKL~DFGlA~~~~~~~   77 (502)
                      .|-+|.++..-. .+|+.+.+.-++.|++.-++|+|++.  +|.|||||+|+||...    ...|.|+|||+|+......
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            466777777654 46999999999999999999999999  9999999999999532    2468999999999875432


Q ss_pred             C--------cccccCCCcccCccc-cccCCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCC
Q 010730           78 Q--------AHSVIGTPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKL  139 (502)
Q Consensus        78 ~--------~~s~vGTp~Y~APEv-l~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~  139 (502)
                      .        .++..||..||+--- +...-+..-|+=|||-++++.|-|.+||.+.  .+..+-|++|...+.
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            2        245679999999874 4456788899999999999999999999874  556778888876554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.35  E-value=1.5e-12  Score=127.82  Aligned_cols=155  Identities=23%  Similarity=0.352  Sum_probs=116.0

Q ss_pred             CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecCCceeccCCCC-
Q 010730            3 TSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         3 tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~--~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      .|-+|.++..- .+.++.+.+.-++-|++.-++|+|.++  +|||||||+|+|..  .+..++.|+|||+|+.+..... 
T Consensus        93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            35667776653 356999999999999999999999999  99999999999974  3445799999999987643211 


Q ss_pred             -------cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCCCcccccc-
Q 010730           79 -------AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAFHRIQ-  147 (502)
Q Consensus        79 -------~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p~~~~~~~-  147 (502)
                             -....||..|.+-...- ...+..-|+-|+|.+|.++.-|..||.+.  .+..|-|.+|..-+........+ 
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence                   13457999998877543 34677889999999999999999999874  34567788887766644333322 


Q ss_pred             --cHHHHHHHHHhh
Q 010730          148 --DAEARRFVGKCL  159 (502)
Q Consensus       148 --s~~l~~LI~kcL  159 (502)
                        +.++...+.-|-
T Consensus       251 G~P~EF~myl~Y~R  264 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCR  264 (341)
T ss_pred             CCcHHHHHHHHHHh
Confidence              445555555443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.32  E-value=2e-12  Score=146.45  Aligned_cols=182  Identities=25%  Similarity=0.411  Sum_probs=150.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc------
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR------   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~------   74 (502)
                      |+.||+|...+.+-+..+++.++.++..+..+++|||+..  ++|||+||.|+++... +..++.|||......      
T Consensus       885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccCcC
Confidence            3457888888888888999999999999999999999987  8999999999999876 789999998432210      


Q ss_pred             CC--------------------------CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCCh
Q 010730           75 GS--------------------------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP  127 (502)
Q Consensus        75 ~~--------------------------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~  127 (502)
                      ..                          ......+||+.|.+||.+.+ .-...+|+|++|+++++.++|.+||.. ..+
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cch
Confidence            00                          01234679999999997754 578889999999999999999999966 788


Q ss_pred             HHHHHHhhcCCCCCcc-cccccHHHHHHHHHhhh-CcCCCCCHH---HHhcCCCCcCCCCCCCC
Q 010730          128 AQIYKKVTSGKLPGAF-HRIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLASDAGEPLL  186 (502)
Q Consensus       128 ~ql~~kI~~g~~p~~~-~~~~s~~l~~LI~kcL~-dP~kRpSa~---ELL~hPff~~~~~~~l~  186 (502)
                      .++++.|..+..+.+. +...+.++++++.++|. ++.+|..+.   ++-.||||+..++..+.
T Consensus      1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            8999999888876433 33457899999999998 999999977   89999999988887654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.30  E-value=6.9e-12  Score=124.83  Aligned_cols=165  Identities=21%  Similarity=0.318  Sum_probs=123.2

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~-g~vKL~DFGlA~~~~~~~   77 (502)
                      ||.-|+|+..+.....  ++..++.+++.+|+.|++|||+..+-|.---|....++++.+. .++..+|--++-+     
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-----  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence            6788999999976543  7888999999999999999999986455556788889998763 3344455433321     


Q ss_pred             CcccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                       .......|.||+||.+..+    .-.++|+|||++++|||.|.+.||.+.++.+--.+....|-. ..+++..+..+-.
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ippgis~hm~k  420 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPPGISRHMNK  420 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCCCccHHHHH
Confidence             1223458999999988644    345799999999999999999999886665544444444433 3455566788899


Q ss_pred             HHHHhhh-CcCCCCCHHHHh
Q 010730          154 FVGKCLE-NVSKRLPAKELL  172 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL  172 (502)
                      |+.-|+. ||.+||.++.++
T Consensus       421 lm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHhcCCCCcCCCcceeh
Confidence            9999998 999999876543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.27  E-value=5.1e-12  Score=132.59  Aligned_cols=95  Identities=20%  Similarity=0.279  Sum_probs=71.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDL-KCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDL-KPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.|++|.. +..   ..   ...|+.||+.+|.|||++|  |+|||| ||+|||++.+ +.+||+|||+|+.+..... 
T Consensus        99 ~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~~~~~  168 (365)
T PRK09188         99 WTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFRRRGAL  168 (365)
T ss_pred             ccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECccceecccCcch
Confidence            578889963 211   11   2467899999999999998  999999 9999999766 7899999999987643321 


Q ss_pred             --------cccccCCCcccCccccccC-------CCCcccch
Q 010730           79 --------AHSVIGTPEFMAPELYEED-------YNELVDIY  105 (502)
Q Consensus        79 --------~~s~vGTp~Y~APEvl~~~-------ys~~~DIW  105 (502)
                              .....+++.|+|||.+...       .+...|-|
T Consensus       169 ~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        169 YRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             hhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence                    2456789999999988532       33446666

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.26  E-value=6.8e-12  Score=122.36  Aligned_cols=113  Identities=19%  Similarity=0.158  Sum_probs=84.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDL-KCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDL-KPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.|++|.+.+..       ....++.|++.+|.+||.+|  |+|||| ||+|||++.+ +.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchH
Confidence            4567788654321       12357899999999999999  999999 7999999865 78999999999865543321


Q ss_pred             --------------ccccCCCcccCccccc--cCCC-CcccchhHHHHHHHHhhccCCCCC
Q 010730           80 --------------HSVIGTPEFMAPELYE--EDYN-ELVDIYSFGMCVLEMLTSEYPYSE  123 (502)
Q Consensus        80 --------------~s~vGTp~Y~APEvl~--~~ys-~~~DIWSLGviLyeLLTG~~Pf~~  123 (502)
                                    ....+++.|+.|+.-.  ...+ ...+.++.|.-+|.++|+..|+.+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                          1123688999998332  2233 567889999999999999988754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=4.3e-11  Score=137.23  Aligned_cols=118  Identities=24%  Similarity=0.281  Sum_probs=102.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEEEEecCCceec-
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG------HLGQIKIGDLGLAAIL-   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~------~~g~vKL~DFGlA~~~-   73 (502)
                      |..-|||.+++...+.+++..+..+..|||..|+.||.++  |||+||||+|+|+..      +...++|+|||-+.-+ 
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            4566999999998889999999999999999999999999  999999999999842      1235999999998543 


Q ss_pred             --cCCCCcccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCC
Q 010730           74 --RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP  120 (502)
Q Consensus        74 --~~~~~~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~P  120 (502)
                        ........+++|-.+-.+|+..+. .+..+|.|.|+-+++.||.|++-
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence              444556678899999999999876 78899999999999999999853

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.15  E-value=5.2e-11  Score=113.78  Aligned_cols=69  Identities=16%  Similarity=0.194  Sum_probs=59.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYL-HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YL-Hs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.|++|...+.+.+.++++.+..++.||+.+|.|+ |..|  |+||||||+|||++.  +.++|+|||+|...
T Consensus        98 ~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~--~~v~LiDFG~a~~~  167 (190)
T cd05147          98 FIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD--GKLYIIDVSQSVEH  167 (190)
T ss_pred             EeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC--CcEEEEEccccccC
Confidence            456777776655567899999999999999999999 6888  999999999999984  58999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.11  E-value=1.6e-10  Score=109.75  Aligned_cols=71  Identities=20%  Similarity=0.188  Sum_probs=58.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      |+.|+++...+....+++...+..++.||+.+|.++|. .|  |+||||||+||+++ + +.++|+|||++..+..
T Consensus        98 ~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~-~~~~liDFG~a~~~~~  169 (190)
T cd05145          98 FIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D-GKPYIIDVSQAVELDH  169 (190)
T ss_pred             EecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C-CCEEEEEcccceecCC
Confidence            45666554443344678899999999999999999999 88  99999999999998 4 7899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.02  E-value=1.7e-10  Score=114.11  Aligned_cols=92  Identities=20%  Similarity=0.237  Sum_probs=68.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.|.+|.++.    .+++    ..+.+|+.+|..||..|  |+|||+||+||+++.+ | ++|+|||............
T Consensus       124 yi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i~liDfg~~~~~~e~~a~d  191 (232)
T PRK10359        124 YIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-LRIIDLSGKRCTAQRKAKD  191 (232)
T ss_pred             EECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-EEEEECCCcccccchhhHH
Confidence            45778888874    2333    24669999999999999  9999999999999876 6 9999999876543221111


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEM  114 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeL  114 (502)
                      .          =+++..|+.++|+|+||+++..+
T Consensus       192 ~----------~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        192 R----------IDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             H----------HHHHhHhcccccccceeEeehHH
Confidence            0          12345577899999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=6.7e-10  Score=120.29  Aligned_cols=173  Identities=23%  Similarity=0.293  Sum_probs=136.6

Q ss_pred             CCCCcHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            2 FTSGTLREYRKKYTR-VDIRAVKNWARQILR----GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~-L~e~~i~~i~~QIL~----gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      ++|.+|.+|...-.. ++...++..+.+.+.    ||..+|+.+  ++|-|+||+||+...+....+++|||+...+...
T Consensus       199 ~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~  276 (524)
T KOG0601|consen  199 LCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG  276 (524)
T ss_pred             cccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEccCC
Confidence            357788888876444 889999999999999    999999998  9999999999999877457899999999887654


Q ss_pred             CCc------ccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHH
Q 010730           77 QQA------HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        77 ~~~------~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      ...      ...-|...|++||+.++-+....|||++|.+..+..++..++....+  .-|..+..+.+|..+-...+.+
T Consensus       277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~~r~~~ip~e~~~~~s~~  354 (524)
T KOG0601|consen  277 NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQLRQGYIPLEFCEGGSSS  354 (524)
T ss_pred             ccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC--CCccccccccCchhhhcCcchh
Confidence            322      12257788999999999999999999999999999988877654311  1133344444444444444566


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      +...+..++. ++..|++++.++.++++.
T Consensus       355 l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  355 LRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             hhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            7778888888 999999999999999886

>PRK10345 hypothetical protein; Provisional

Probab=98.87  E-value=4.3e-09  Score=102.60  Aligned_cols=63  Identities=24%  Similarity=0.221  Sum_probs=51.1

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEEecCCc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGI-AYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLGLA   70 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL-~YLHs~g~~IIHRDLKPeNILl~~~---~g~vKL~DFGlA   70 (502)
                      .+|||.+++++. .+++.  ..++.|++.++ +|||+++  |+||||||+|||++..   .+.++|+||+.+
T Consensus        90 ~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         90 PSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             cchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            468999999774 56666  36688999888 9999999  9999999999999742   247999995544

>smart00090 RIO RIO-like kinase

Probab=98.78  E-value=7.3e-09  Score=102.52  Aligned_cols=71  Identities=23%  Similarity=0.230  Sum_probs=58.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.|++|..+......+....+..++.||+.+|.+||.+| +|+||||||+||+++ + +.++|+|||.+....
T Consensus       129 ~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~~~  199 (237)
T smart00090      129 FIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-D-GKVVIIDVSQSVELD  199 (237)
T ss_pred             EecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-C-CCEEEEEChhhhccC
Confidence            4567777776655556777788899999999999999876 499999999999998 4 689999999987543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.67  E-value=4.1e-08  Score=97.26  Aligned_cols=63  Identities=21%  Similarity=0.275  Sum_probs=52.8

Q ss_pred             CCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            2 FTS-GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         2 ~tg-GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      +.| ++|.+++.+ .++++..    +.||+.+|.+||..|  |+||||||+|||++.+ +.++|+|||.+..
T Consensus       128 l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LIDfg~~~~  191 (239)
T PRK01723        128 IEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLIDFDRGEL  191 (239)
T ss_pred             cCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEECCCccc
Confidence            455 689999865 3566543    578999999999999  9999999999999876 6899999998865

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.65  E-value=5.6e-08  Score=92.52  Aligned_cols=64  Identities=27%  Similarity=0.404  Sum_probs=56.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.|++|.+++.....    ....++.+|+.+|.++|..+  ++|||++|.|||++ + +.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            4679999999976443    77888999999999999998  99999999999998 3 6899999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.61  E-value=4.4e-08  Score=93.25  Aligned_cols=65  Identities=25%  Similarity=0.195  Sum_probs=52.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.|++|.+....      ..+..++.+|+.++.++|.++  |+||||||+||+++.+ +.++|+|||++....
T Consensus       112 ~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~-~~~~liDfg~~~~~~  176 (198)
T cd05144         112 YIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD-EKIYIIDWPQMVSTD  176 (198)
T ss_pred             EeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC-CcEEEEECCccccCC
Confidence            4567777665421      345678999999999999988  9999999999999875 799999999985543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=3.6e-08  Score=108.82  Aligned_cols=151  Identities=19%  Similarity=0.307  Sum_probs=107.3

Q ss_pred             HHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc----------ccccCCCcccCccccc
Q 010730           26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA----------HSVIGTPEFMAPELYE   95 (502)
Q Consensus        26 ~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~----------~s~vGTp~Y~APEvl~   95 (502)
                      +.++..||.|+|.+ +++||++|.|++|.++.+ +..||+.|+.+....+....          ....-...|.|||.+.
T Consensus       105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            45566899999977 469999999999999988 78999999988655432111          0112356799999776


Q ss_pred             c-CCCCcccchhHHHHHHHHh-hccCCCCCCCChHHHHHHhhcCCCC---CcccccccHHHHHHHHHhhh-CcCCCCCHH
Q 010730           96 E-DYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLP---GAFHRIQDAEARRFVGKCLE-NVSKRLPAK  169 (502)
Q Consensus        96 ~-~ys~~~DIWSLGviLyeLL-TG~~Pf~~~~~~~ql~~kI~~g~~p---~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~  169 (502)
                      . ....++|++|+||.+|.+. .|+.-+.. .+.. ++.....+...   .......+.++++=+.++|. +...||++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhc-cCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            5 4778999999999999998 46655533 2211 12222221111   11223446788999999998 999999999


Q ss_pred             HHhcCCCCcCC
Q 010730          170 ELLLDPFLASD  180 (502)
Q Consensus       170 ELL~hPff~~~  180 (502)
                      +++..|||...
T Consensus       261 ~l~~~~ff~D~  271 (700)
T KOG2137|consen  261 LLLSIPFFSDP  271 (700)
T ss_pred             hhhcccccCCc
Confidence            99999999754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.59  E-value=7.9e-08  Score=90.81  Aligned_cols=61  Identities=25%  Similarity=0.383  Sum_probs=52.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.|++|.+++.....       .++.||+.+|.+||+.+  ++|+|+||.||+++ + +.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            4678999998865332       77999999999999998  99999999999998 4 7899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.55  E-value=9.1e-08  Score=105.15  Aligned_cols=61  Identities=21%  Similarity=0.339  Sum_probs=53.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.|++|.+++.        ....++.||+.+|.|||+++  |+||||||+||+++ + +.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence            578999999886        35678999999999999998  99999999999994 3 68999999998653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.50  E-value=1e-06  Score=93.06  Aligned_cols=155  Identities=20%  Similarity=0.310  Sum_probs=112.8

Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCc
Q 010730           12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAP   91 (502)
Q Consensus        12 ~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~AP   91 (502)
                      +.++..+..-+.+.++.|+.+.+-||.+|  -+-+|+.++|+|+.+. +.|.|.|-.--.....+....+.+|.+.|.+|
T Consensus       109 qs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPP  185 (637)
T COG4248         109 QSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGTLHLCPVGVSEFTPP  185 (637)
T ss_pred             ccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-ceEEEEcccceeeccCCceEecccCccccCCH
Confidence            34566888899999999999999999999  8999999999999876 79999986543333344445667899999999


Q ss_pred             cccc-c-----CCCCcccchhHHHHHHHHhhc-cCCCCCC------CChHH--H------HHHh-hcCCCC---Cccccc
Q 010730           92 ELYE-E-----DYNELVDIYSFGMCVLEMLTS-EYPYSEC------SNPAQ--I------YKKV-TSGKLP---GAFHRI  146 (502)
Q Consensus        92 Evl~-~-----~ys~~~DIWSLGviLyeLLTG-~~Pf~~~------~~~~q--l------~~kI-~~g~~p---~~~~~~  146 (502)
                      |.-. +     .-....|.|.|||++++||.| +.||++.      .++.+  |      |.+- ..|..|   .+.+..
T Consensus       186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~  265 (637)
T COG4248         186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSM  265 (637)
T ss_pred             HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhh
Confidence            9654 2     246678999999999999885 9999763      12211  1      1111 112222   122334


Q ss_pred             ccHHHHHHHHHhhh---CcCCCCCHH
Q 010730          147 QDAEARRFVGKCLE---NVSKRLPAK  169 (502)
Q Consensus       147 ~s~~l~~LI~kcL~---dP~kRpSa~  169 (502)
                      ..+.++.+..+|+.   ++.-||+++
T Consensus       266 Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         266 LPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             cCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            57889999999997   356899954

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.47  E-value=2.2e-07  Score=86.73  Aligned_cols=51  Identities=27%  Similarity=0.307  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730           20 RAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus        20 ~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      ..++.++.+++.++.++|. ++  |+||||||+||+++ + +.++|+|||.+....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~-~~~~liDfg~a~~~~  165 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D-GKVYIIDVPQAVEID  165 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C-CcEEEEECccccccc
Confidence            6678899999999999999 87  99999999999999 4 789999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.36  E-value=2.5e-07  Score=100.55  Aligned_cols=167  Identities=22%  Similarity=0.209  Sum_probs=118.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|++...+.--..+++...+.+..|++.++.++|+..  ++|+|+||+||++..+.+..+++|||..+.+.-.  ..
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~  422 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SG  422 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee--cc
Confidence            4567777777755566889999999999999999999988  9999999999999875467899999988643211  11


Q ss_pred             cccCCCccc-Ccccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           81 SVIGTPEFM-APELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        81 s~vGTp~Y~-APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ...++-.++ ..|++..  .+..++|++|||..+.+.+++.. +..   ....+..|..+..+.....  ...++.+...
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~---~~~~~~~i~~~~~p~~~~~--~~~~q~~~kv  496 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSE---SGVQSLTIRSGDTPNLPGL--KLQLQVLLKV  496 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcc-cCc---ccccceeeecccccCCCch--HHhhhhhhhh
Confidence            122333444 3554433  37889999999999999999863 322   1222445666666532221  2456666677


Q ss_pred             hhh-CcCCCCCHHHHhcCCCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++. ++..|+.+.++..|+-|
T Consensus       497 ~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  497 MINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hcCCccccchhhhhhcccchh
Confidence            776 88999999998887654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.17  E-value=3e-06  Score=74.00  Aligned_cols=54  Identities=26%  Similarity=0.226  Sum_probs=45.7

Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           18 DIRAVKNWARQILRGIAYLHGHD-PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        18 ~e~~i~~i~~QIL~gL~YLHs~g-~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      +......++.+++.+|.++|... .+++|+||||.||+++.. +.++++|||.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            44667788999999999999752 349999999999999875 7899999998854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.91  E-value=2.5e-05  Score=75.64  Aligned_cols=55  Identities=20%  Similarity=0.252  Sum_probs=47.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730           16 RVDIRAVKNWARQILRGIAYL-HGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YL-Hs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      .++.+.+..++.|++.+|..| |..+  |||+||++.||++..  +.+.|+|||.+....
T Consensus       120 ~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~~--~~v~iIDF~qav~~~  175 (197)
T cd05146         120 KLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWHD--GKVWFIDVSQSVEPT  175 (197)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEC--CcEEEEECCCceeCC
Confidence            456667778899999999999 8888  999999999999974  579999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.73  E-value=3e-05  Score=70.79  Aligned_cols=47  Identities=21%  Similarity=0.242  Sum_probs=39.7

Q ss_pred             HHHHHHHHHHHHHHHhCCC---CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           23 KNWARQILRGIAYLHGHDP---PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        23 ~~i~~QIL~gL~YLHs~g~---~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      ..++.+|+.+|..||..+.   .++|+|++|.||++++  +.++++|||.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~--~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD--GRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC--CeEEEEeccccc
Confidence            4457899999999998762   2599999999999983  579999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.70  E-value=0.00011  Score=74.44  Aligned_cols=65  Identities=18%  Similarity=0.211  Sum_probs=54.8

Q ss_pred             cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEEEEecCCcee
Q 010730            6 TLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG------HLGQIKIGDLGLAAI   72 (502)
Q Consensus         6 sL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~------~~g~vKL~DFGlA~~   72 (502)
                      +|.+++..  ....+......++.+|...+.-||..|  |+|+||++.|||++.      ....+.|+||+.+..
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            78899864  345667788899999999999999999  999999999999974      235799999998753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.68  E-value=6.2e-05  Score=81.19  Aligned_cols=68  Identities=25%  Similarity=0.280  Sum_probs=50.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILR-GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~-gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.|++|.++.... ..++.   ..++.+++. .+..+|..|  ++|+|+||.||+++.+ +.++++|||++..+.
T Consensus       239 ~i~G~~L~~~~~~~~~~~~~---~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~  308 (437)
T TIGR01982       239 WIDGIPLSDIAALDEAGLDR---KALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS  308 (437)
T ss_pred             eECCcccccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence            56788888876532 12332   334555555 467889888  9999999999999876 799999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.66  E-value=0.0001  Score=71.32  Aligned_cols=67  Identities=25%  Similarity=0.316  Sum_probs=58.0

Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceec
Q 010730            5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAIL   73 (502)
Q Consensus         5 GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~   73 (502)
                      -+|.+++......+......++.+|...+.-||..|  |+|+|+++.|||++...  ..+.++||+.+...
T Consensus       103 ~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  103 QDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             ccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            479999987656788888999999999999999999  99999999999998762  26899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.59  E-value=0.00019  Score=83.96  Aligned_cols=166  Identities=23%  Similarity=0.360  Sum_probs=115.3

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC---cEEEeCCCCcEEEE--ecCCceeccCC
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCD---NIFVNGHLGQIKIG--DLGLAAILRGS   76 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPe---NILl~~~~g~vKL~--DFGlA~~~~~~   76 (502)
                      +++-++...+..-+.++...++.|..++++||.|+|++.  ..|.-|...   +.-.++. +.+.+.  ||+..+.+...
T Consensus       268 ~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  268 CSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             cCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCc
Confidence            456678888888889999999999999999999999875  555544433   2222332 355555  88877766555


Q ss_pred             CCcccccCCCcccCccccccC---CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~~---ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      .......-+..+.++|....+   .....|+|.+|..+..+..|..+-..    ......+        +.........+
T Consensus       345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~----~~~~~~~--------l~~~~~~~~~d  412 (1351)
T KOG1035|consen  345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK----SAVPVSL--------LDVLSTSELLD  412 (1351)
T ss_pred             ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc----ccchhhh--------hccccchhhhh
Confidence            545555667788899987654   33346999999999999888755321    1111111        11111125678


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ++.+|+. ++.+|+++.+++.|+|++....
T Consensus       413 ~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  413 ALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hhhhhcchhhhhccchhhhhhchhcccccc
Confidence            8889997 8999999999999999976543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.39  E-value=0.00019  Score=79.34  Aligned_cols=65  Identities=20%  Similarity=0.255  Sum_probs=48.8

Q ss_pred             CCCCCcHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEEecCCc
Q 010730            1 MFTSGTLREY--RKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----QIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~y--i~k~~----~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g----~vKL~DFGlA   70 (502)
                      |+.|+.|.++  +...+    .+.+..+..++.||+.       .|  ++|+|+||.||+++.+ +    .++++|||++
T Consensus       242 ~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~G--ffHaDpHPGNIlv~~~-g~~~~~i~llDFGiv  311 (537)
T PRK04750        242 RMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------DG--FFHADMHPGNIFVSYD-PPENPRYIALDFGIV  311 (537)
T ss_pred             eecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------CC--eeeCCCChHHeEEecC-CCCCCeEEEEecceE
Confidence            5688898774  33333    3555566667777753       56  9999999999999876 4    8999999999


Q ss_pred             eeccC
Q 010730           71 AILRG   75 (502)
Q Consensus        71 ~~~~~   75 (502)
                      ..+..
T Consensus       312 g~l~~  316 (537)
T PRK04750        312 GSLNK  316 (537)
T ss_pred             EECCH
Confidence            87643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=97.33  E-value=0.00075  Score=75.16  Aligned_cols=105  Identities=25%  Similarity=0.352  Sum_probs=72.9

Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-cccccCC
Q 010730            7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSVIGT   85 (502)
Q Consensus         7 L~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-~~s~vGT   85 (502)
                      |..|+++   +....+..-+.||+.||.|||..+ .++|++|.-+.|+++.. |..||++|.++........ .....--
T Consensus        94 l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~  168 (690)
T KOG1243|consen   94 LETVLKE---LGKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLI  168 (690)
T ss_pred             HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhh
Confidence            3445544   335677777999999999998542 39999999999999987 8999999998755433221 1111112


Q ss_pred             CcccCccccccCCCCcccchhHHHHHHHHhhc
Q 010730           86 PEFMAPELYEEDYNELVDIYSFGMCVLEMLTS  117 (502)
Q Consensus        86 p~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG  117 (502)
                      -.|..|+.+... .-..|.|-|||++++++.|
T Consensus       169 ~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  169 ESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence            234455433211 1357999999999999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.33  E-value=0.00045  Score=66.56  Aligned_cols=60  Identities=25%  Similarity=0.414  Sum_probs=46.8

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ..|-.|++++...   .    ..+++.|-.-+.-||..|  |+|+||.++||++.+.  .+.++||||+..
T Consensus        81 I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence            3456677777664   1    345666666677899998  9999999999999875  599999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.29  E-value=0.0006  Score=65.79  Aligned_cols=65  Identities=29%  Similarity=0.447  Sum_probs=52.5

Q ss_pred             cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE--EEEecCCcee
Q 010730            6 TLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI--KIGDLGLAAI   72 (502)
Q Consensus         6 sL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~v--KL~DFGlA~~   72 (502)
                      ++++|+...  .....+....++++|-+.|.-||..+  |||+||..+||++..+.+.+  .++|||++..
T Consensus        97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            889999764  23344444788999999999999999  99999999999997764444  8999999743

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=96.69  E-value=0.011  Score=64.61  Aligned_cols=132  Identities=16%  Similarity=0.259  Sum_probs=93.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcccc
Q 010730           15 TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY   94 (502)
Q Consensus        15 ~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl   94 (502)
                      ...++..+|.|+.||..||.++|+.|  +.=+-|.|.+|+++++. +++|...|+...+....      +       +-+
T Consensus       388 ~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~------~-------~~l  451 (655)
T KOG3741|consen  388 LKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP------T-------EPL  451 (655)
T ss_pred             CCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccceeeecCCC------C-------cch
Confidence            35788999999999999999999999  77799999999999884 89999888877664432      1       111


Q ss_pred             ccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHH-HHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHh
Q 010730           95 EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI-YKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL  172 (502)
Q Consensus        95 ~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql-~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL  172 (502)
                      ++  -.+-|.-.||.+++.|.||..--.......+. .+         .+....+.+++++|.-+.. ++.. -++.++|
T Consensus       452 e~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll  519 (655)
T KOG3741|consen  452 ES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLL  519 (655)
T ss_pred             hH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence            11  13458889999999999996331111112221 11         2234457788999988776 5654 6788887


Q ss_pred             cC
Q 010730          173 LD  174 (502)
Q Consensus       173 ~h  174 (502)
                      .+
T Consensus       520 p~  521 (655)
T KOG3741|consen  520 PM  521 (655)
T ss_pred             HH
Confidence            65

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.48  E-value=0.0036  Score=59.21  Aligned_cols=32  Identities=22%  Similarity=0.423  Sum_probs=26.1

Q ss_pred             CCeEecCCCCCcEEEeCC-CCcEEEEecCCcee
Q 010730           41 PPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAI   72 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~   72 (502)
                      ..++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            358999999999999873 25689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK09902 hypothetical protein; Provisional

Probab=96.44  E-value=0.0073  Score=59.42  Aligned_cols=65  Identities=11%  Similarity=0.114  Sum_probs=54.4

Q ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEEecCCcee
Q 010730            5 GTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAI   72 (502)
Q Consensus         5 GsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~--vKL~DFGlA~~   72 (502)
                      -+|.+++.+.  .+.+......++.+|...|.-||..|  +.|+|+-+.||+++.. +.  ++++||.-++.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence            5788888663  35677778899999999999999999  9999999999999754 45  99999986643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.42  E-value=0.0085  Score=57.67  Aligned_cols=51  Identities=31%  Similarity=0.382  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHHHHH-HHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730           20 RAVKNWARQILRGIAY-LHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus        20 ~~i~~i~~QIL~gL~Y-LHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      +....++.+++..+.. +|..|  |+|+||.+.||+++.+  .+.|+|||.+....
T Consensus       106 ~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~iIDf~qav~~~  157 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYIIDFGQAVDSS  157 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE--GTTEEETT
T ss_pred             hhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEEEecCcceecC
Confidence            4566778888885555 57877  9999999999999875  79999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress

Probab=96.39  E-value=0.0029  Score=45.15  Aligned_cols=32  Identities=41%  Similarity=0.580  Sum_probs=26.4

Q ss_pred             eEEEEEEEcCCC------CeeeeccCCCcccccHHHHH
Q 010730          234 IFLKVQITDKDG------QARNIYFPFDIFNDTATEVA  265 (502)
Q Consensus       234 i~L~l~i~d~~G------~~~~i~f~fd~~~Dt~~~VA  265 (502)
                      |.|+||+.|+.+      +...|+|.|++..|++.+||
T Consensus         1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA   38 (38)
T PF12202_consen    1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA   38 (38)
T ss_dssp             EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred             CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence            578999999988      78899999999999999997

This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.29  E-value=0.0009  Score=80.22  Aligned_cols=170  Identities=13%  Similarity=0.055  Sum_probs=115.1

Q ss_pred             CCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEEEecCCceec-
Q 010730            2 FTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGH---DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-   73 (502)
Q Consensus         2 ~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~---g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~-   73 (502)
                      +.+|.++..|-+.    ++++..-+....++.+.+..-+|++   |--.+|++||+-|.++..+ ..+|++++|+.++. 
T Consensus      1313 ~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIkn 1391 (2724)
T KOG1826|consen 1313 VEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKN 1391 (2724)
T ss_pred             HHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC-CcccccccccccccC
Confidence            3567888887543    4566666666666667777777743   2247899999999999988 58999999999943 


Q ss_pred             cCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC----CCccccccc
Q 010730           74 RGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----PGAFHRIQD  148 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~----p~~~~~~~s  148 (502)
                      ......+..++++.|+.|++... +++.+.|+|..|+-+|.+-.|..+|-.      ..+.+..|..    ....+...+
T Consensus      1392 p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~------flq~~Lkgiidn~tf~sIe~l~p 1465 (2724)
T KOG1826|consen 1392 PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF------FLQPALKGIIDNHTFFSIEKLKP 1465 (2724)
T ss_pred             chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH------HHHHHHcCcccccccccccccCC
Confidence            33334567789999999998864 577779999999999999888877632      2333333332    223333322


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .++..+...+|- +-..||.....+.-+.+.
T Consensus      1466 gdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1466 GDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             CcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            333333333333 566788888888766664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.11  E-value=0.0012  Score=73.33  Aligned_cols=149  Identities=21%  Similarity=0.283  Sum_probs=102.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCccccc-cCCC
Q 010730           21 AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN   99 (502)
Q Consensus        21 ~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~-~~ys   99 (502)
                      +.....+.-+.+|+|+|+.-  -+|||    ||+...  +.+|..+|+....+.......+..+|+.++|||+.. ..+.
T Consensus       337 ~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~  408 (829)
T KOG0576|consen  337 QFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTID  408 (829)
T ss_pred             hhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccCCcccCcccccccCCCCCCCCCchhhcccccc
Confidence            44455666677899999864  48888    777765  579999999998887666677889999999999664 5689


Q ss_pred             CcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccc--cccHH-HHHHHHHhhh-CcCCCCCHHHHhcCC
Q 010730          100 ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQDAE-ARRFVGKCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       100 ~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~--~~s~~-l~~LI~kcL~-dP~kRpSa~ELL~hP  175 (502)
                      ...|.|++|+-..+|.-|.+|-..   +......+..+.-...+..  ..++. -+++...|+. .|..|+....++.+.
T Consensus       409 ~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsK  485 (829)
T KOG0576|consen  409 GCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSK  485 (829)
T ss_pred             cCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHH
Confidence            999999999987888888877543   1111111111110000000  01111 1247778888 899999999999999


Q ss_pred             CCcCC
Q 010730          176 FLASD  180 (502)
Q Consensus       176 ff~~~  180 (502)
                      +|..-
T Consensus       486 vfngC  490 (829)
T KOG0576|consen  486 VFNGC  490 (829)
T ss_pred             HhccC
Confidence            98653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=94.70  E-value=0.051  Score=53.95  Aligned_cols=43  Identities=30%  Similarity=0.362  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        25 i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      +...|..++.-||..|  ++|+|..|.|++++.+  .++++||+..+
T Consensus       140 ~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEEEECcccc
Confidence            3466778899999999  9999999999999864  69999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=91.75  E-value=0.57  Score=47.32  Aligned_cols=32  Identities=22%  Similarity=0.253  Sum_probs=26.5

Q ss_pred             CCCeEecCCCCCcEEEeCC---CCcEEEEecCCce
Q 010730           40 DPPVIHRDLKCDNIFVNGH---LGQIKIGDLGLAA   71 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~---~g~vKL~DFGlA~   71 (502)
                      ...++|+|+.+.||+++.+   .+.+.++||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3458999999999999863   3579999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=91.09  E-value=0.36  Score=49.47  Aligned_cols=51  Identities=25%  Similarity=0.312  Sum_probs=39.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        18 ~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      +.+.+..++..|+.-+.-+-..|  |||+|+.+=||+++.+ |.+.++||--+.
T Consensus       200 ~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d-g~~~vIDwPQ~v  250 (304)
T COG0478         200 DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED-GDIVVIDWPQAV  250 (304)
T ss_pred             cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC-CCEEEEeCcccc
Confidence            35556666777777666555666  9999999999999987 789999997654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=90.30  E-value=0.61  Score=44.76  Aligned_cols=57  Identities=23%  Similarity=0.128  Sum_probs=47.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~g~-~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      .-++....+++.+++..+.+|+..-. .+.-.|++++|+-++.+ +.+|++|...+...
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~  112 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE  112 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence            35788999999999999999996311 28889999999999976 79999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=90.24  E-value=0.57  Score=44.10  Aligned_cols=33  Identities=39%  Similarity=0.459  Sum_probs=21.8

Q ss_pred             CCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           40 DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ...++|+|+.|.||+++...+.+-|+||+.+..
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccceE
Confidence            345999999999999994336678999987754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=89.25  E-value=0.75  Score=44.87  Aligned_cols=30  Identities=27%  Similarity=0.344  Sum_probs=24.3

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           41 PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      +.++|+|+.+.||++++. +..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDG-RLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECC-CEEEEEeCcccC
Confidence            348999999999999864 344699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=88.83  E-value=0.61  Score=45.10  Aligned_cols=30  Identities=30%  Similarity=0.329  Sum_probs=25.7

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .++|+|+.+.|||++++.+.+.|+||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            499999999999999733579999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=88.80  E-value=1.1  Score=44.12  Aligned_cols=31  Identities=26%  Similarity=0.417  Sum_probs=25.8

Q ss_pred             CCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           39 HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        39 ~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      ..+.++|+|+.|.||++++. + +.++||+.+.
T Consensus       151 ~~~~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~  181 (226)
T TIGR02172       151 DTSTCLHGDFQIGNLITSGK-G-TYWIDLGDFG  181 (226)
T ss_pred             CCCceEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence            34458899999999999875 4 9999999774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK05231 homoserine kinase; Provisional

Probab=88.53  E-value=0.9  Score=46.25  Aligned_cols=29  Identities=34%  Similarity=0.399  Sum_probs=24.3

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      ++||+|+.|.||+++++ ...-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence            59999999999999865 345799999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=87.97  E-value=1.2  Score=44.78  Aligned_cols=29  Identities=17%  Similarity=0.350  Sum_probs=24.7

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           41 PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .+++|+|+.+.||+++.  +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence            45999999999999986  468999999663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=87.65  E-value=1  Score=50.02  Aligned_cols=67  Identities=19%  Similarity=0.268  Sum_probs=42.6

Q ss_pred             CCCcHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            3 TSGTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         3 tgGsL~~y--i~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      .|-.+.+.  ++. ..++.+.+...+.++.-  .-+=..|  ++|.|..|.||+++.+ |++.+.|||+...+..
T Consensus       249 ~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         249 DGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            34444444  333 44565444433333321  1111246  9999999999999988 8999999999876643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=86.62  E-value=1.1  Score=45.53  Aligned_cols=30  Identities=33%  Similarity=0.417  Sum_probs=25.5

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           41 PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .+++|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence            459999999999999876 456899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=85.78  E-value=0.47  Score=52.97  Aligned_cols=53  Identities=26%  Similarity=0.425  Sum_probs=47.7

Q ss_pred             eeeeccCCCcccccHHHHHHHHHhcccCCCCCHHHHHHHHHHHHHhhCCCccc
Q 010730          247 ARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKE  299 (502)
Q Consensus       247 ~~~i~f~fd~~~Dt~~~VA~EMV~~l~l~~~d~~~ia~~Id~~i~~l~p~~~~  299 (502)
                      .+.|.|.|++.+|+..+||.|||++..+.+.|-..+|+.|...+.+|--....
T Consensus       336 ~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~  388 (632)
T KOG0584|consen  336 ANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND  388 (632)
T ss_pred             cccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence            45789999999999999999999999999999999999999999888866643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=84.73  E-value=2.5  Score=41.07  Aligned_cols=56  Identities=29%  Similarity=0.412  Sum_probs=38.5

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-C--cEEEEe
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-G--QIKIGD   66 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~-g--~vKL~D   66 (502)
                      +-||.+|+++ +.+++ .++..+.++   .+||-.++  |+.+||+|.||++.... +  .+.|+|
T Consensus       107 s~TL~~~l~~-~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  107 SPTLEDYLKE-GGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CccHHHHHHc-CCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEecCCCceEEEEEe
Confidence            4589999955 44666 444444444   45666667  99999999999996432 2  467777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02236 choline kinase

Probab=84.55  E-value=1.4  Score=46.15  Aligned_cols=30  Identities=30%  Similarity=0.405  Sum_probs=25.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .++|+|+++.||+++...+.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            489999999999998644679999998774

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=84.44  E-value=0.85  Score=44.50  Aligned_cols=31  Identities=32%  Similarity=0.223  Sum_probs=25.8

Q ss_pred             CCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           40 DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .+.++|+|+.|.|||+++. +.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPG-KFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCC-cEEEEEEccccc
Confidence            3459999999999999875 567899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=83.50  E-value=1.7  Score=43.62  Aligned_cols=29  Identities=34%  Similarity=0.440  Sum_probs=24.7

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      +++|+|+.|.||+++++ +.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGD-ELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence            49999999999999875 456899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=83.09  E-value=1.9  Score=43.77  Aligned_cols=54  Identities=19%  Similarity=0.260  Sum_probs=40.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      .+...++..+..+-.++.-++....-++|.|+.|+|++.++. +.++|+||.-|.
T Consensus       129 ~~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg  182 (269)
T COG0510         129 RDNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAG  182 (269)
T ss_pred             hhhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCC
Confidence            344455666666766776666541238999999999999985 689999998774

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=82.97  E-value=2.9  Score=42.47  Aligned_cols=52  Identities=21%  Similarity=0.289  Sum_probs=41.9

Q ss_pred             HHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730           19 IRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus        19 e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      .+.+..+..+++..+.-|-. .+  +||+||..=|||+..  +.+.|||||-|....
T Consensus       165 ~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~~--~~p~iID~~QaV~~~  217 (268)
T COG1718         165 LEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVHD--GEPYIIDVSQAVTID  217 (268)
T ss_pred             chhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEEC--CeEEEEECccccccC
Confidence            33677778888888877665 45  999999999999983  689999999886544

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=82.56  E-value=1  Score=43.23  Aligned_cols=30  Identities=33%  Similarity=0.517  Sum_probs=19.5

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           43 VIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        43 IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      +.|.||.|.||+++...+.++|+||..|..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            779999999999943447999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=81.76  E-value=3.6  Score=44.19  Aligned_cols=52  Identities=21%  Similarity=0.362  Sum_probs=41.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        18 ~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ..+++..++.+-+..|.-+.. +.+.-||+|...|||++ + |.|.|+||-+++.
T Consensus       319 ~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~-GnvtLIDfklsRl  370 (488)
T COG5072         319 RSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-E-GNVTLIDFKLSRL  370 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-c-CceEEEEeeeeec
Confidence            456777777777766655554 45689999999999999 4 8999999999984

>TIGR02721 ycfN_thiK thiamine kinase

Probab=81.43  E-value=1.2  Score=43.89  Aligned_cols=29  Identities=28%  Similarity=0.397  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      .++|+|+.|.||+++++ + +.|+||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~-~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQ-G-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCC-C-CEEEeccccCc
Confidence            48999999999999875 3 89999998743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=81.08  E-value=3.3  Score=39.57  Aligned_cols=31  Identities=26%  Similarity=0.331  Sum_probs=24.9

Q ss_pred             CeEecCCCCCcEEEeCCC-C---cEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHL-G---QIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~-g---~vKL~DFGlA~~   72 (502)
                      .++|+|+.+.||++..+. |   .+.++||..+..
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            489999999999997542 2   589999998743

subfamily of choline kinases

>PRK10271 thiK thiamine kinase; Provisional

Probab=80.25  E-value=1.7  Score=42.06  Aligned_cols=29  Identities=21%  Similarity=0.368  Sum_probs=24.6

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ..+|+|+.|.||+++++ + ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~-~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSAS-G-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECC-C-EEEEeCCcccC
Confidence            36899999999999875 4 99999998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	502
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-51
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-14
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-14
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-14
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-14
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-14
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-14
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-14
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-14
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-14
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-14
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-13
3soa_A	444	Full-Length Human Camkii Length = 444		8e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-04
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-04

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  201 bits (510), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 93/182 (51%), Positives = 124/182 (68%), Gaps = 2/182 (1%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           + TSGTL+ Y K++    I+ +++W RQIL+G+ +LH   PP+IHRDLKCDNIF+ G  G
Sbjct: 110 LXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
            +KIGDLGLA + R S  A +VIGTPEF APE YEE Y+E VD+Y+FG C LE  TSEYP
Sbjct: 170 SVKIGDLGLATLKRASF-AKAVIGTPEFXAPEXYEEKYDESVDVYAFGXCXLEXATSEYP 228
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLAS 179
           YSEC N AQIY++VTSG  P +F ++   E +  +  C+ +N  +R   K+LL   F   
Sbjct: 229 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
Query: 180 DA 181
           + 
Sbjct: 289 ET 290

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 88/163 (53%), Gaps = 7/163 (4%)
Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ- 78
           + +  + +QIL G+ YLH  D  ++HRD+K DN+ +N + G +KI D G +  L G    
Sbjct: 122 QTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 79  AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
             +  GT ++MAPE+ ++    Y +  DI+S G  ++EM T + P+ E   P     KV 
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 136 SGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
             K+         AEA+ F+ KC E +  KR  A +LL+D FL
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 88/163 (53%), Gaps = 7/163 (4%)
Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ- 78
           + +  + +QIL G+ YLH  D  ++HRD+K DN+ +N + G +KI D G +  L G    
Sbjct: 108 QTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 79  AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
             +  GT ++MAPE+ ++    Y +  DI+S G  ++EM T + P+ E   P     KV 
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 225
Query: 136 SGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
             K+         AEA+ F+ KC E +  KR  A +LL+D FL
Sbjct: 226 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 88/164 (53%), Gaps = 13/164 (7%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ +++ + + ARQ  RG+ YLH     +IHRDLK +NIF++     +KIGD GLA +  
Sbjct: 103 TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATVKS 159
Query: 73  -LRGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+        Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 160 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRLPA 168
            QI + V  G L     +++       +R + +CL+      P+
Sbjct: 220 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 263

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 88/164 (53%), Gaps = 13/164 (7%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---A 71
           T+ +++ + + ARQ  RG+ YLH     +IHRDLK +NIF++     +KIGD GLA   +
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATEKS 171
Query: 72  ILRGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+        Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRLPA 168
            QI + V  G L     +++       +R + +CL+      P+
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 88/164 (53%), Gaps = 13/164 (7%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---A 71
           T+ +++ + + ARQ  RG+ YLH     +IHRDLK +NIF++     +KIGD GLA   +
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATEKS 171
Query: 72  ILRGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+        Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRLPA 168
            QI + V  G L     +++       +R + +CL+      P+
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 16/190 (8%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
             + E  +  T   I+ V    +Q L  + YLH  D  +IHRDLK  NI      G IK+
Sbjct: 123 AVMLELERPLTESQIQVV---CKQTLDALNYLH--DNKIIHRDLKAGNILFTLD-GDIKL 176
Query: 65  GDLGLAAI-LRGSQQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLTS 117
            D G++A   R  Q+  S IGTP +MAPE+       +  Y+   D++S G+ ++EM   
Sbjct: 177 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236
Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDP 175
           E P+ E  NP ++  K+   + P      +  +  + F+ KCLE NV  R    +LL  P
Sbjct: 237 EPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295
Query: 176 FLASDAGEPL 185
           F+  D+ +P+
Sbjct: 296 FVTVDSNKPI 305

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
               + E  +  T   I+ V    +Q L  + YLH  D  +IHRDLK  NI      G I
Sbjct: 121 VDAVMLELERPLTESQIQVV---CKQTLDALNYLH--DNKIIHRDLKAGNILFTLD-GDI 174
Query: 63  KIGDLGLAAI-LRGSQQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEML 115
           K+ D G++A   R  Q+  S IGTP +MAPE+       +  Y+   D++S G+ ++EM 
Sbjct: 175 KLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLL 173
             E P+ E  NP ++  K+   + P      +  +  + F+ KCLE NV  R    +LL 
Sbjct: 235 EIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293
Query: 174 DPFLASDAGEPL 185
            PF+  D+ +P+
Sbjct: 294 HPFVTVDSNKPI 305

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 86/163 (52%), Gaps = 13/163 (7%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+  +  + + ARQ  +G+ YLH  +  +IHRD+K +NIF++  L  +KIGD GLA +  
Sbjct: 127 TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGL-TVKIGDFGLATVKS 183
Query: 73  -LRGSQQAHSVIGTPEFMAPELYE-EDYNELV---DIYSFGMCVLEMLTSEYPYSECSNP 127
              GSQQ     G+  +MAPE+   +D N      D+YS+G+ + E++T E PYS  +N 
Sbjct: 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRLP 167
            QI   V  G       ++        +R V  C++ V +  P
Sbjct: 244 DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP 286

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
               + E  +  T   I+ V    +Q L  + YLH  D  +IHRDLK  NI      G I
Sbjct: 121 VDAVMLELERPLTESQIQVV---CKQTLDALNYLH--DNKIIHRDLKAGNILFTLD-GDI 174
Query: 63  KIGDLGLAAI-LRGSQQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEML 115
           K+ D G++A   R  Q+    IGTP +MAPE+       +  Y+   D++S G+ ++EM 
Sbjct: 175 KLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLL 173
             E P+ E  NP ++  K+   + P      +  +  + F+ KCLE NV  R    +LL 
Sbjct: 235 EIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293
Query: 174 DPFLASDAGEPL 185
            PF+  D+ +P+
Sbjct: 294 HPFVTVDSNKPI 305

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 126 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 182
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 183 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 243 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 279

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 101 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 157
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 158 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 218 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 254

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 104 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 160
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 161 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 257

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 104 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 160
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 161 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 257

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 183
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 184 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 280

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 155
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-- 72
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA +  
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 155
Query: 73  -LRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/159 (37%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGT 179
Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CLE +V KR  AKELL   FL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 124 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGT 180
Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 235
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CLE +V KR  AKEL+   FL
Sbjct: 236 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CL+ +V KR  AKELL   FL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHRD+K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSEMVGT 179
Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CL+ +V KR  AKELL   FL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---A 71
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA   +
Sbjct: 119 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATEKS 175
Query: 72  ILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 176 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 236 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---A 71
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA   +
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATEKS 183
Query: 72  ILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 184 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 280

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA---A 71
           T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++  L  +KIGD GLA   +
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDL-TVKIGDFGLATEKS 155
Query: 72  ILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
              GS Q   + G+  +MAPE+     +  Y+   D+Y+FG+ + E++T + PYS  +N 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 128 AQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLEN 161
            QI   V  G L     +++       +R + +CL+ 
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/121 (37%), Positives = 72/121 (59%), Gaps = 4/121 (3%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG 75
           ++D R   + A  + +G+ YLH  +PP++HR+LK  N+ V+     +K+ D GL+ +   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLKAS 191
Query: 76  S-QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
           +   + S  GTPE+MAPE L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+   
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAA 250
Query: 134 V 134
           V
Sbjct: 251 V 251

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/122 (38%), Positives = 72/122 (59%), Gaps = 6/122 (4%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG 75
           ++D R   + A  + +G+ YLH  +PP++HRDLK  N+ V+     +K+ D GL+  L+ 
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSR-LKA 190
Query: 76  SQ--QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           S    +    GTPE+MAPE L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+  
Sbjct: 191 SXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVA 249
Query: 133 KV 134
            V
Sbjct: 250 AV 251

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VIGT 85
           R+ L+ + +LH +   VIHR++K DNI + G  G +K+ D G  A +   Q   S ++GT
Sbjct: 124 RECLQALEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 86  PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 235
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
            +Q+ E      R F+ +CLE +V KR  AKEL+   FL
Sbjct: 236 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
            S  L  ++K    V+I AV + A   L+G+AYLH H+  +IHRD+K  NI ++   G +
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLV 193
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSE 118
           K+GD G A+I+     A+  +GTP +MAPE+     E  Y+  VD++S G+  +E+   +
Sbjct: 194 KLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLL 173
            P    +  + +Y  +   + P           R FV  CL+ + +  P  E+LL
Sbjct: 251 PPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
            S  L  ++K    V+I AV + A   L+G+AYLH H+  +IHRD+K  NI ++   G +
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLV 154
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSE 118
           K+GD G A+I+     A+  +GTP +MAPE+     E  Y+  VD++S G+  +E+   +
Sbjct: 155 KLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLL 173
            P    +  + +Y  +   + P           R FV  CL+ + +  P  E+LL
Sbjct: 212 PPLFNMNAMSALYH-IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 8/168 (4%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   +    R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT 177
Query: 77  Q-QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           Q + ++ +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P ++   +
Sbjct: 178 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLI 236
Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
                P           + FV  CL +  S R  AKELL   F+  +A
Sbjct: 237 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 283

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 8/168 (4%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   +    R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT 157
Query: 77  Q-QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           Q + ++ +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P ++   +
Sbjct: 158 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLI 216
Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
                P           + FV  CL +  S R  AKELL   F+  +A
Sbjct: 217 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 263

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/116 (38%), Positives = 71/116 (61%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D GLA  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGLAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 8/168 (4%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   +    R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT 172
Query: 77  Q-QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           Q + +  +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P ++   +
Sbjct: 173 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLI 231
Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
                P           + FV  CL +  S R  AKELL   F+  +A
Sbjct: 232 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL-AAI 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 241 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 297
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 298 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 355
Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLI 187
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P  I
Sbjct: 356 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPPASI 413

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 8/168 (4%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   +    R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT 157
Query: 77  Q-QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           Q + +  +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P ++   +
Sbjct: 158 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLI 216
Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
                P           + FV  CL +  S R  AKELL   F+  +A
Sbjct: 217 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 263

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIKVADFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIKVADFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIKVADFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 10/187 (5%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +LR ++YLH     VIHRD+K D+I +    G+IK+ D G  A +
Sbjct: 135 HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQV 191
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPE+     Y   VDI+S G+ V+EM+  E PY     P Q  
Sbjct: 192 SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAM 250
Query: 132 KKVTSGKLPGA--FHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIP 188
           +++     P     H++     R F+   L    S+R  A+ELL  PFL        ++P
Sbjct: 251 RRIRDSLPPRVKDLHKVSSV-LRGFLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVP 309
Query: 189 QVPSFQN 195
            +  +++
Sbjct: 310 LMRQYRH 316

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIKVADFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQAHS 81
           N  +QIL GI YLH H+  ++HRD+K +NI +     L  IKI D GL++      +   
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 82  VIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
            +GT  ++APE+ ++ YNE  D++S G+ ++ +L   YP     N   I KKV  GK   
Sbjct: 208 RLGTAYYIAPEVLKKKYNEKCDVWSCGV-IMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 142 AFHRIQDA--EARRFVGKCLE-NVSKRLPAKELL 172
            F+  ++   EA+  +   L  + +KR  A+E L
Sbjct: 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDL 67
           +R K+  VD   +    +Q+L G+ YLH H+  ++HRDLK +N+ +        IKI D 
Sbjct: 129 HRMKFNEVDAAVI---IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
           GL+A+    ++    +GT  ++APE+  + Y+E  D++S G+ +L +L + YP       
Sbjct: 184 GLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGV-ILFILLAGYPPFGGQTD 242
Query: 128 AQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
            +I +KV  GK        ++    A+  + + L+ +  +R+ A++ L  P++     + 
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
Query: 185 LLIPQVPSFQNLNPN 199
               ++PS  N   N
Sbjct: 303 ESGIELPSLANAIEN 317

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 71/116 (61%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D GLA  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIQVTDFGLAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 13/174 (7%)
Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLG 68
           R+K++ VD   +    +Q+L G  YLH H+  ++HRDLK +N+ +        IKI D G
Sbjct: 98  RQKFSEVDAAVI---MKQVLSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           L+A      +    +GT  ++APE+  + Y+E  D++S G+ +L +L   YP        
Sbjct: 153 LSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQ 211
Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
           +I K+V  GK    P  + ++ D EA++ V   L    SKR+ A+E L  P++ 
Sbjct: 212 EILKRVEKGKFSFDPPDWTQVSD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G IK+ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           ++T G L +    RK+++ VD   +    RQ+L GI Y+H +   ++HRDLK +N+ +  
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITYMHKN--KIVHRDLKPENLLLES 161
Query: 58  HL--GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115
                 I+I D GL+     S++    IGT  ++APE+    Y+E  D++S G+ +L +L
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV-ILYIL 220
Query: 116 TSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV-SKRLPAKE 170
            S  P    +N   I KKV  GK    LP  + ++ ++ A+  + K L  V S R+ A++
Sbjct: 221 LSGCPPFNGANEYDILKKVEKGKYTFELP-QWKKVSES-AKDLIRKMLTYVPSMRISARD 278
Query: 171 LLLDPFLASDAGEPLLIPQVPSFQN 195
            L   ++ +   E + +  VPS  N
Sbjct: 279 ALDHEWIQTYTKEQISVD-VPSLDN 302

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 13/174 (7%)
Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLG 68
           R+K++ VD   +    +Q+L G  YLH H+  ++HRDLK +N+ +        IKI D G
Sbjct: 115 RQKFSEVDAAVI---MKQVLSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           L+A      +    +GT  ++APE+  + Y+E  D++S G+ +L +L   YP        
Sbjct: 170 LSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQ 228
Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
           +I K+V  GK    P  + ++ D EA++ V   L    SKR+ A+E L  P++ 
Sbjct: 229 EILKRVEKGKFSFDPPDWTQVSD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 98/189 (51%), Gaps = 15/189 (7%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 107 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 164
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP  
Sbjct: 165 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223
Query: 123 ECSNPAQIYKKVT------SGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDP 175
             S    I++ +         KLP     +   E + FV KCL +N ++R   K+L++  
Sbjct: 224 SGSGSMAIFELLDYIVNEPPPKLPSGVFSL---EFQDFVNKCLIKNPAERADLKQLMVHA 280
Query: 176 FLA-SDAGE 183
           F+  SDA E
Sbjct: 281 FIKRSDAEE 289

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 71/116 (61%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G+    ++ G
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGA--TWTLCG 221
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 71/116 (61%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +  ++ G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWTLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 71/116 (61%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +  ++ G
Sbjct: 132 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWTLCG 186
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 241

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 164 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 220
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 221 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 278
Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P
Sbjct: 279 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPP 333

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           ++T G L +    RK+++ VD   +    RQ+L GI Y+H +   ++HRDLK +N+ +  
Sbjct: 130 VYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITYMHKN--KIVHRDLKPENLLLES 184
Query: 58  HL--GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115
                 I+I D GL+     S++    IGT  ++APE+    Y+E  D++S G+ +L +L
Sbjct: 185 KSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV-ILYIL 243
Query: 116 TSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV-SKRLPAKE 170
            S  P    +N   I KKV  GK    LP  + ++ ++ A+  + K L  V S R+ A++
Sbjct: 244 LSGCPPFNGANEYDILKKVEKGKYTFELP-QWKKVSES-AKDLIRKMLTYVPSMRISARD 301
Query: 171 LLLDPFLASDAGEPLLIPQVPSFQN 195
            L   ++ +   E + +  VPS  N
Sbjct: 302 ALDHEWIQTYTKEQISVD-VPSLDN 325

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           ++T G L +    RK+++ VD   +    RQ+L GI Y+H +   ++HRDLK +N+ +  
Sbjct: 131 VYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITYMHKN--KIVHRDLKPENLLLES 185
Query: 58  HL--GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115
                 I+I D GL+     S++    IGT  ++APE+    Y+E  D++S G+ +L +L
Sbjct: 186 KSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV-ILYIL 244
Query: 116 TSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV-SKRLPAKE 170
            S  P    +N   I KKV  GK    LP  + ++ ++ A+  + K L  V S R+ A++
Sbjct: 245 LSGCPPFNGANEYDILKKVEKGKYTFELP-QWKKVSES-AKDLIRKMLTYVPSMRISARD 302
Query: 171 LLLDPFLASDAGEPLLIPQVPSFQN 195
            L   ++ +   E + +  VPS  N
Sbjct: 303 ALDHEWIQTYTKEQISVD-VPSLDN 326

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           ++T G L +   K  R          +Q+  GI Y+H H+  ++HRDLK +NI +     
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEK 159
Query: 61  Q--IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSE 118
              IKI D GL+   + + +    IGT  ++APE+    Y+E  D++S G+ +  +L+  
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGT 219
Query: 119 YPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
            P+    N   I K+V +GK    LP  +  I D +A+  + K L  + S R+ A + L 
Sbjct: 220 PPFY-GKNEYDILKRVETGKYAFDLP-QWRTISD-DAKDLIRKMLTFHPSLRITATQCLE 276
Query: 174 DPFLASDAGEPLLIPQVPSFQNLNPN 199
            P++   + E   I  +PS ++   N
Sbjct: 277 HPWIQKYSSETPTISDLPSLESAMTN 302

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-IL 73
            R++   +      +L+ +AYLH     VIHRD+K D+I +    G++K+ D G  A I 
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQIS 192
Query: 74  RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           +   +   ++GTP +MAPE+     Y   VDI+S G+ V+EM+  E PY    +P Q  K
Sbjct: 193 KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMK 251
Query: 133 KVTSGKLPGA--FHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQ 189
           ++     P     H++     R F+ + L  +  +R  A+ELL  PFL        L+P 
Sbjct: 252 RLRDSPPPKLKNSHKVSPV-LRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPL 310
Query: 190 VPSFQN 195
           +  ++ 
Sbjct: 311 IQLYRK 316

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 121 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 177
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 178 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 235
Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P
Sbjct: 236 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPP 290

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 119 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 175
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 176 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 233
Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P
Sbjct: 234 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPP 288

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLXG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLAG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 110 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 166
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 167 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 224
Query: 132 KKVTSGKLPGAFHRIQDAE--ARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P
Sbjct: 225 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPP 279

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           ++T G L +    RK+++ VD   +    RQ+L GI Y H +   ++HRDLK +N+ +  
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITYXHKN--KIVHRDLKPENLLLES 161
Query: 58  HL--GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115
                 I+I D GL+     S++    IGT  ++APE+    Y+E  D++S G+ +L +L
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV-ILYIL 220
Query: 116 TSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV-SKRLPAKE 170
            S  P    +N   I KKV  GK    LP  + ++ ++ A+  + K L  V S R+ A++
Sbjct: 221 LSGCPPFNGANEYDILKKVEKGKYTFELP-QWKKVSES-AKDLIRKXLTYVPSXRISARD 278
Query: 171 LLLDPFLASDAGEPLLIPQVPSFQN 195
            L   ++ +   E + +  VPS  N
Sbjct: 279 ALDHEWIQTYTKEQISVD-VPSLDN 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 139 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 193
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
            S  +R   K  T  +I  +    +  L+G+ YLH      IHRD+K  NI +N   G  
Sbjct: 111 VSDIIRLRNKTLTEDEIATI---LQSTLKGLEYLHFMRK--IHRDIKAGNILLNTE-GHA 164
Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYP 120
           K+ D G+A  L     + + VIGTP +MAPE+ +E  YN + DI+S G+  +EM   + P
Sbjct: 165 KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHR--IQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
           Y++      I+   T+   P  F +  +       FV +CL ++  +R  A +LL  PF+
Sbjct: 225 YADIHPMRAIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
Query: 178 ASDAGEPLL 186
            S  G  +L
Sbjct: 283 RSAKGVSIL 291

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-I 72
           +TR++   +      +L+ ++ LH     VIHRD+K D+I +  H G++K+ D G  A +
Sbjct: 114 HTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 170
Query: 73  LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            +   +   ++GTP +MAPEL     Y   VDI+S G+ V+EM+  E PY   + P    
Sbjct: 171 SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPLKA 228
Query: 132 KKVTSGKLPGAFHRIQDAE--ARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            K+    LP     +       + F+ + L  + ++R  A ELL  PFLA  AG P
Sbjct: 229 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPP 283

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 139 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 193
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 141 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 195
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 250

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADEPIQIYEKIVSGKV 255

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 201
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 133 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDEQ-GYIQVTDFGFAKRVKG--RTWXLCG 187
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 221
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLIIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 221
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           +L E  K+   V     + + RQ ++G+ YLH +   VIHRDLK  N+F+N  +  +KIG
Sbjct: 128 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIG 184
Query: 66  DLGLAAILR-GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-S 122
           D GLA  +    ++  ++ GTP ++APE L ++ ++  VDI+S G  +  +L  + P+ +
Sbjct: 185 DFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAG 182
            C     I  K     +P   + +  A  RR +     + + R    ELL D F  S   
Sbjct: 245 SCLKETYIRIKKNEYSVPRHINPVASALIRRMLH---ADPTLRPSVAELLTDEFFTSGYA 301
Query: 183 EPLLIP 188
            P+ +P
Sbjct: 302 -PMRLP 306

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++APE+   + YN+ VD ++ G+ + +M  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 6/159 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           S  ++ ++K+   +  R V  +  Q+   + ++H     V+HRD+K  N+F+    G +K
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVK 176
Query: 64  IGDLGLAAILRG-SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
           +GDLGL       +  AHS++GTP +M+PE ++E  YN   DI+S G  + EM   + P 
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159
           Y +  N   + KK+     P         E R+ V  C+
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           +L E  K+   V     + + RQ ++G+ YLH +   VIHRDLK  N+F+N  +  +KIG
Sbjct: 128 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIG 184
Query: 66  DLGLAAILR-GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-S 122
           D GLA  +    ++   + GTP ++APE L ++ ++  VDI+S G  +  +L  + P+ +
Sbjct: 185 DFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAG 182
            C     I  K     +P   + +  A  RR +     + + R    ELL D F  S   
Sbjct: 245 SCLKETYIRIKKNEYSVPRHINPVASALIRRMLH---ADPTLRPSVAELLTDEFFTSGYA 301
Query: 183 EPLLIP 188
            P+ +P
Sbjct: 302 -PMRLP 306

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           +L E  K+   V     + + RQ ++G+ YLH +   VIHRDLK  N+F+N  +  +KIG
Sbjct: 128 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIG 184
Query: 66  DLGLAAILR-GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-S 122
           D GLA  +    ++   + GTP ++APE L ++ ++  VDI+S G  +  +L  + P+ +
Sbjct: 185 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAG 182
            C     I  K     +P   + +  A  RR +     + + R    ELL D F  S   
Sbjct: 245 SCLKETYIRIKKNEYSVPRHINPVASALIRRMLH---ADPTLRPSVAELLTDEFFTSGYA 301
Query: 183 EPLLIP 188
            P+ +P
Sbjct: 302 -PMRLP 306

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 10/186 (5%)
Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           +L E  K+   V     + + RQ ++G+ YLH +   VIHRDLK  N+F+N  +  +KIG
Sbjct: 112 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIG 168
Query: 66  DLGLAAILR-GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-S 122
           D GLA  +    ++   + GTP ++APE L ++ ++  VDI+S G  +  +L  + P+ +
Sbjct: 169 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAG 182
            C     I  K     +P   + +  A  RR +     + + R    ELL D F  S   
Sbjct: 229 SCLKETYIRIKKNEYSVPRHINPVASALIRRMLH---ADPTLRPSVAELLTDEFFTSGYA 285
Query: 183 EPLLIP 188
            P+ +P
Sbjct: 286 -PMRLP 290

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE +APE+   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI+    YLH  D  +I+RDLK +N+ ++   G I++ D G A  ++G  +   + G
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTWXLCG 200
Query: 85  TPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           TPE++AP +   + YN+ VD ++ G+ + EM  + YP      P QIY+K+ SGK+
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVIGT 85
           RQ+L  + +LH     +IHRDLK  N+ +    G I++ D G++A  L+  Q+  S IGT
Sbjct: 124 RQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 86  PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P+ E  NP ++  K+     
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDP 239
Query: 140 PGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           P      +   E R F+   L+ N   R  A +LL  PF++S
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 7/171 (4%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAH 80
           + +W  QI   +A  H HD  ++HRD+K  NIF+    G +++GD G+A +L  + + A 
Sbjct: 127 ILDWFVQIC--LALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELAR 183
Query: 81  SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           + IGTP +++PE+ E + YN   DI++ G  + E+ T ++ +   S    + K ++    
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 140 PGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
           P + H   D   R  V +  +   +  P+   +L+    +   E  L PQ+
Sbjct: 244 PVSLHYSYD--LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVIGT 85
           RQ+L  + +LH     +IHRDLK  N+ +    G I++ D G++A  L+  Q+  S IGT
Sbjct: 116 RQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 86  PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P+ E  NP ++  K+     
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDP 231
Query: 140 PGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           P      +   E R F+   L+ N   R  A +LL  PF++S
Sbjct: 232 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A  I++ + +LH     VIHRD+K  N+ +N  LGQ+K+ D G++  L  S       G 
Sbjct: 159 AVSIVKALEHLHSK-LSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGC 216
Query: 86  PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
             +MAPE     L ++ Y+   DI+S G+ ++E+    +PY     P Q  K+V     P
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 276
Query: 141 GAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLA 178
                   AE   F  +CL+  SK  P   EL+  PF  
Sbjct: 277 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           TL EY + +  + +    N+  QIL GI   H HD  ++HRD+K  NI ++ +   +KI 
Sbjct: 97  TLSEYIESHGPLSVDTAINFTNQILDGIK--HAHDMRIVHRDIKPQNILIDSN-KTLKIF 153
Query: 66  DLGLAAILRGSQ--QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
           D G+A  L  +   Q + V+GT ++ +PE  + E  +E  DIYS G+ + EML  E P++
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKE 170
                  I  K     +P         + R+ + + L NV  R   K+
Sbjct: 214 -GETAVSIAIKHIQDSVPNV-----TTDVRKDIPQSLSNVILRATEKD 255

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           + T G L E    R+ Y+  D     +  +QIL  +  LH H   V+HRDLK +N+ +  
Sbjct: 102 LVTGGELFEDIVAREYYSEAD---ASHCIQQILEAV--LHCHQMGVVHRDLKPENLLLAS 156
Query: 58  HL--GQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
            L    +K+ D GLA  + G QQA     GTP +++PE+  +D Y + VD+++ G+ +L 
Sbjct: 157 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV-ILY 215
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + K L  N SKR+ A E
Sbjct: 216 ILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE 275
Query: 171 LLLDPFLA 178
            L  P+++
Sbjct: 276 ALKHPWIS 283

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 21/178 (11%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG- 75
           +D   +    R++L G+ YLH +    IHRD+K  NI + G  G ++I D G++A L   
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATG 174
Query: 76  -----SQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
                ++   + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY +   P 
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PM 233
Query: 129 QIYKKVTSGKLPGAFHRIQDAEA--------RRFVGKCLE-NVSKRLPAKELLLDPFL 177
           ++         P     +QD E         R+ +  CL+ +  KR  A ELL   F 
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 88/161 (54%), Gaps = 14/161 (8%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           ++IL+G+ YLH      IHRD+K  N+ ++   G +K+ D G+A  L  +Q + ++ +GT
Sbjct: 127 KEILKGLDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGT 183
Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---G 141
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P S+  +P ++   +     P   G
Sbjct: 184 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNNPPTLVG 242
Query: 142 AFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
            F +      + F+  CL ++ S R  AKELL   F+  ++
Sbjct: 243 DFTK----SFKEFIDACLNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           V    +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GLA I    
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 173
Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
               SV+ T  + APE L +  Y   VD++S G    EM   +  +   S+  Q+ K + 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 136 SGKLPG-------------AFHRIQDAEARRFVG-----------KCLE-NVSKRLPAKE 170
              LPG             AFH        +FV            KCL  N +KR+ A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 171 LLLDPFL 177
            L  P+ 
Sbjct: 294 ALSHPYF 300

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 18/182 (9%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           ++T G L +    RK+++ VD   +    RQ+L GI Y+H +   ++HRDLK +N+ +  
Sbjct: 113 VYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITYMHKN--KIVHRDLKPENLLLES 167
Query: 58  HL--GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115
                 I+I D GL+     S++    IGT  ++APE+    Y+E  D++S G+ +L +L
Sbjct: 168 KSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV-ILYIL 226
Query: 116 TSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV-SKRLPAKE 170
            S  P    +N   I KKV  GK    LP  + ++ ++ A+  + K L  V S R+ A++
Sbjct: 227 LSGCPPFNGANEYDILKKVEKGKYTFELP-QWKKVSES-AKDLIRKMLTYVPSMRISARD 284
Query: 171 LL 172
            L
Sbjct: 285 AL 286

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           V    +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GLA I    
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 173
Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
               SV+ T  + APE L +  Y   VD++S G    EM   +  +   S+  Q+ K + 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 136 SGKLPG-------------AFHRIQDAEARRFVG-----------KCLE-NVSKRLPAKE 170
              LPG             AFH        +FV            KCL  N +KR+ A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 171 LLLDPFL 177
            L  P+ 
Sbjct: 294 ALSHPYF 300

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 21/178 (11%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG- 75
           +D   +    R++L G+ YLH +    IHRD+K  NI + G  G ++I D G++A L   
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATG 169
Query: 76  -----SQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
                ++   + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY +   P 
Sbjct: 170 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PM 228
Query: 129 QIYKKVTSGKLPGAFHRIQDAEA--------RRFVGKCLE-NVSKRLPAKELLLDPFL 177
           ++         P     +QD E         R+ +  CL+ +  KR  A ELL   F 
Sbjct: 229 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           V    +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GLA I    
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 173
Query: 77  QQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
               SV+ T  + APE L +  Y   VD++S G    EM   +  +   S+  Q+ K + 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 136 SGKLPG-------------AFHRIQDAEARRFVG-----------KCLE-NVSKRLPAKE 170
              LPG             AFH        +FV            KCL  N +KR+ A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 171 LLLDPFL 177
            L  P+ 
Sbjct: 294 ALSHPYF 300

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 76/137 (55%), Gaps = 7/137 (5%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L    +K  R      K +A ++   + YLH  D  +I+RDLK +NI ++ + G IK
Sbjct: 90  GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIK 146
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
           I D G A  +      + + GTP+++APE+   + YN+ +D +SFG+ + EML    P+ 
Sbjct: 147 ITDFGFAKYV--PDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204
Query: 123 ECSNPAQIYKKVTSGKL 139
           + SN  + Y+K+ + +L
Sbjct: 205 D-SNTMKTYEKILNAEL 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 91  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 148
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
           + D G++  L   + A+  +GT  +M+PE L    Y+   DI+S G+ ++EM    YP  
Sbjct: 149 LCDFGVSGQLI-DEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRP 207
Query: 123 ECSNPAQIYKKVT------SGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDP 175
               P  I++ +         KLP A   +   E + FV KCL +N ++R   K+L++  
Sbjct: 208 ----PMAIFELLDYIVNEPPPKLPSAVFSL---EFQDFVNKCLIKNPAERADLKQLMVHA 260
Query: 176 FLA-SDAGE 183
           F+  SDA E
Sbjct: 261 FIKRSDAEE 269

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 21/195 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 88  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 145
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY- 121
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP  
Sbjct: 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 122 -----SECSNPAQIYKKV------TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAK 169
                 +   P  I++ +         KLP     +   E + FV KCL +N ++R   K
Sbjct: 205 PPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL---EFQDFVNKCLIKNPAERADLK 261
Query: 170 ELLLDPFLA-SDAGE 183
           +L++  F+  SDA E
Sbjct: 262 QLMVHAFIKRSDAEE 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           + T G L E    R+ Y+  D     +  +QIL  +  LH H   V+HR+LK +N+ +  
Sbjct: 91  LVTGGELFEDIVAREYYSEAD---ASHCIQQILEAV--LHCHQMGVVHRNLKPENLLLAS 145
Query: 58  HL--GQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
            L    +K+ D GLA  + G QQA     GTP +++PE+  +D Y + VD+++ G+ +L 
Sbjct: 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV-ILY 204
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + K L  N SKR+ A E
Sbjct: 205 ILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE 264
Query: 171 LLLDPFLA 178
            L  P+++
Sbjct: 265 ALKHPWIS 272

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           ++T G L +   K  R          +Q+  GI Y+H H+  ++HRDLK +NI +     
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEK 159
Query: 61  Q--IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSE 118
              IKI D GL+   + + +    IGT  ++APE+    Y+E  D++S G+ +L +L S 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGV-ILYILLSG 218
Query: 119 YPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
            P     N   I K+V +GK    LP  +  I D +A+  + K L  + S R+ A + L 
Sbjct: 219 TPPFYGKNEYDILKRVETGKYAFDLP-QWRTISD-DAKDLIRKMLTFHPSLRITATQCLE 276
Query: 174 DPFLASDAGE 183
            P++   + E
Sbjct: 277 HPWIQKYSSE 286

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 97/187 (51%), Gaps = 16/187 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           + T G L E    R+ Y+  D     +   QIL  + ++H HD  ++HRDLK +N+ +  
Sbjct: 111 LVTGGELFEDIVAREYYSEAD---ASHCIHQILESVNHIHQHD--IVHRDLKPENLLLAS 165
Query: 58  HL--GQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
                 +K+ D GLA  ++G QQA     GTP +++PE+  +D Y + VDI++ G+ +L 
Sbjct: 166 KCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGV-ILY 224
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + + L  N +KR+ A +
Sbjct: 225 ILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQ 284
Query: 171 LLLDPFL 177
            L  P++
Sbjct: 285 ALKHPWV 291

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A  I++ + +LH     VIHRD+K  N+ +N  LGQ+K+ D G++  L          G 
Sbjct: 115 AVSIVKALEHLHSK-LSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC 172
Query: 86  PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
             +MAPE     L ++ Y+   DI+S G+ ++E+    +PY     P Q  K+V     P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232
Query: 141 GAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLA 178
                   AE   F  +CL+  SK  P   EL+  PF  
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           ++T G L +   K  R          +Q+  GI Y+H H+  ++HRDLK +NI +     
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEK 159
Query: 61  Q--IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSE 118
              IKI D GL+   + + +    IGT  ++APE+    Y+E  D++S G+ +L +L S 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGV-ILYILLSG 218
Query: 119 YPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
            P     N   I K+V +GK    LP  +  I D +A+  + K L  + S R+ A + L 
Sbjct: 219 TPPFYGKNEYDILKRVETGKYAFDLP-QWRTISD-DAKDLIRKMLTFHPSLRITATQCLE 276
Query: 174 DPFLASDAGE 183
            P++   + E
Sbjct: 277 HPWIQKYSSE 286

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 67/121 (55%), Gaps = 5/121 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
             G L  + +   + D+     +A +I+ G+ +LH     +++RDLK DNI ++   G I
Sbjct: 102 NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHI 158
Query: 63  KIGDLGLAAI-LRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           KI D G+    + G  + +   GTP+++APE L  + YN  VD +SFG+ + EML  + P
Sbjct: 159 KIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218
Query: 121 Y 121
           +
Sbjct: 219 F 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 67/121 (55%), Gaps = 5/121 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
             G L  + +   + D+     +A +I+ G+ +LH     +++RDLK DNI ++   G I
Sbjct: 101 NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHI 157
Query: 63  KIGDLGLAAI-LRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           KI D G+    + G  + +   GTP+++APE L  + YN  VD +SFG+ + EML  + P
Sbjct: 158 KIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 121 Y 121
           +
Sbjct: 218 F 218

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 96/187 (51%), Gaps = 16/187 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           + T G L E    R+ Y+  D     +  +QIL  +  LH H   V+HRDLK +N+ +  
Sbjct: 84  LVTGGELFEDIVAREYYSEAD---ASHCIQQILEAV--LHCHQMGVVHRDLKPENLLLAS 138
Query: 58  HL--GQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLE 113
                 +K+ D GLA  ++G QQA     GTP +++PE L +E Y + VDI++ G+ +L 
Sbjct: 139 KCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGV-ILY 197
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + + L  N +KR+ A E
Sbjct: 198 ILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHE 257
Query: 171 LLLDPFL 177
            L  P++
Sbjct: 258 ALKHPWV 264

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 1   MFTSGTLREYRKKYTRVDI--RAVKNWARQILRGIAYL---HGHDPPVIHRDLKCDNIFV 55
           M   GT  E  KK  +  I  R +      I++ + YL   HG    VIHRD+K  NI +
Sbjct: 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILL 158
Query: 56  NGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE------DYNELVDIYSFGM 109
           +   GQIK+ D G++  L   +      G   +MAPE  +       DY+   D++S G+
Sbjct: 159 D-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 110 CVLEMLTSEYPYSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSKRL 166
            ++E+ T ++PY  C    ++  KV   +   LPG  H     + + FV  CL    ++ 
Sbjct: 218 SLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG--HMGFSGDFQSFVKDCLTKDHRKR 275
Query: 167 PAKELLLD 174
           P    LL+
Sbjct: 276 PKYNKLLE 283

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R+IL+G+ YLH      IHRD+K  N+ ++   G +K+ D G+A  L  +Q + +  +GT
Sbjct: 123 REILKGLDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNXFVGT 179
Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P S+  +P ++   +     P    
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLE 237
Query: 145 RIQDAEARRFVGKCLENVSKRLP-AKELLLDPFLA 178
                  + FV  CL    +  P AKELL   F+ 
Sbjct: 238 GQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 272

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGT 85
           R+ILRG+++LH H   VIHRD+K  N+ +  +  ++K+ D G++A L R   + ++ IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 86  PEFMAPELYEED------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE+   D      Y+   D++S G+  +EM     P  +  +P +    +     
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 251
Query: 140 PGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGE 183
           P    +    + + F+  CL +N S+R   ++L+  PF+     E
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAIL---RGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L       +A+S +GT ++++PEL  E+  ++  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 67/120 (55%), Gaps = 5/120 (4%)
Query: 24  NWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV 82
           +W  Q  +G+AYLH   P  +IHRDLK  N+ +      +KI D G A  ++     +  
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK- 165
Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA-QIYKKVTSGKLP 140
            G+  +MAPE++E  +Y+E  D++S+G+ + E++T   P+ E   PA +I   V +G  P
Sbjct: 166 -GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 224

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 99/182 (54%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++A ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 EP 184
           +P
Sbjct: 269 KP 270

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG- 84
           A  I++ + +LH     VIHRD+K  N+ +N  LGQ+K  D G++  L          G 
Sbjct: 142 AVSIVKALEHLHSK-LSVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC 199
Query: 85  ----TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
                PE + PEL ++ Y+   DI+S G+  +E+    +PY     P Q  K+V     P
Sbjct: 200 KPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSP 259
Query: 141 GAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLA 178
                   AE   F  +CL+  SK  P   EL   PF  
Sbjct: 260 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 67/120 (55%), Gaps = 5/120 (4%)
Query: 24  NWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV 82
           +W  Q  +G+AYLH   P  +IHRDLK  N+ +      +KI D G A  ++     +  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK- 164
Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA-QIYKKVTSGKLP 140
            G+  +MAPE++E  +Y+E  D++S+G+ + E++T   P+ E   PA +I   V +G  P
Sbjct: 165 -GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 119 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 175
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 176 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 233
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 234 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 291
Query: 183 EP 184
           +P
Sbjct: 292 KP 293

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 110 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 166
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 167 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 224
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 225 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 282
Query: 183 EP 184
           +P
Sbjct: 283 KP 284

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 111 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 164
Query: 67  LGLAA-ILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    ++  ++ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 165 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 225 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 99/182 (54%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++A ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 107 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 160
Query: 67  LGLAA-ILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    ++  ++ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 161 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 221 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 107 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 160
Query: 67  LGLAA-ILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    ++  ++ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 161 FGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 221 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 129 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 182
Query: 67  LGLAAILRGSQQAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    +   V+ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 183 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 243 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKK--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++A ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRA-ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +     YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQDTYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 131 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 184
Query: 67  LGLAAILRGSQQAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    +   V+ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 245 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 96/182 (52%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K +R D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 97  GTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSNGELKI 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L    P+ E
Sbjct: 154 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF-E 211
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
                + Y++++  ++   F       AR  + + L+ N S+RL   E+L  P++ +++ 
Sbjct: 212 AHTYQETYRRIS--RVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSS 269
Query: 183 EP 184
           +P
Sbjct: 270 KP 271

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L  + +K  R D    + +A +I+  + +LH  D  +I+RDLK DN+ ++ H G  K
Sbjct: 108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLD-HEGHCK 164
Query: 64  IGDLGLA--AILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
           + D G+    I  G   A +  GTP+++APE+ +E  Y   VD ++ G+ + EML    P
Sbjct: 165 LADFGMCKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 121 YSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGK 157
           + E  N   +++ + + ++  P   H       + F+ K
Sbjct: 224 F-EAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 173
Query: 64  IGDLGLAAIL---RGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L       +A+S +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 174 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 232
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 233 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 283

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 64/114 (56%), Gaps = 6/114 (5%)
Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           GTL ++  +++  ++D         QI +G+ Y+H     +IHRDLK  NIF+     Q+
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLV-DTKQV 175
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           KIGD GL   L+   +     GT  +M+PE +  +DY + VD+Y+ G+ + E+L
Sbjct: 176 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIF-VNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           + +QI  GI   H H   ++H DLK +NI  VN    QIKI D GLA   +  ++     
Sbjct: 192 FMKQICEGIR--HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 84  GTPEFMAPELYEEDYNEL-VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTPEF+APE+   D+     D++S G+    +L+   P+    N A+    + + +    
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDLE 308
Query: 143 FHRIQDA--EARRFVGKCL-ENVSKRLPAKELLLDPFLA 178
               QD   EA+ F+ K L +  S R+ A E L  P+L+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 71/137 (51%), Gaps = 6/137 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G L +Y  K  R+D +  +   +QIL G+ Y H H   V+HRDLK +N+ ++ H+   
Sbjct: 99  SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNA- 155
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEYP 120
           KI D GL+ ++   +      G+P + APE+          VDI+S G+ +  +L    P
Sbjct: 156 KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
Query: 121 YSECSNPAQIYKKVTSG 137
           + +   P  ++KK+  G
Sbjct: 216 FDDDHVPT-LFKKICDG 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 EP 184
           +P
Sbjct: 269 KP 270

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 61/99 (61%), Gaps = 5/99 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVI 83
           +  QI+ G+ +LH  +  +I+RDLK +N+ ++   G ++I DLGLA  L+  Q +     
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP FMAPE L  E+Y+  VD ++ G+ + EM+ +  P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 154
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 155 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 212
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 213 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 270
Query: 183 EP 184
           +P
Sbjct: 271 KP 272

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 74/153 (48%), Gaps = 31/153 (20%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +  S  L + R +Y R+         RQIL  ++Y+H     +IHRDLK  NIF++    
Sbjct: 105 LIHSENLNQQRDEYWRL--------FRQILEALSYIHSQG--IIHRDLKPMNIFIDES-R 153
Query: 61  QIKIGDLGLAA-------ILR--------GSQQAHSVIGTPEFMAPELYEED--YNELVD 103
            +KIGD GLA        IL+         S    S IGT  ++A E+ +    YNE +D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213
Query: 104 IYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
           +YS G+   EM+   YP+S       I KK+ S
Sbjct: 214 MYSLGIIFFEMI---YPFSTGMERVNILKKLRS 243

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 61/99 (61%), Gaps = 5/99 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVI 83
           +  QI+ G+ +LH  +  +I+RDLK +N+ ++   G ++I DLGLA  L+  Q +     
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP FMAPE L  E+Y+  VD ++ G+ + EM+ +  P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 154
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE  E   ++E VD++S G+   E L  + P+ E
Sbjct: 155 ADFGWSVHAPSSRRT-TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF-E 212
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 213 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSS 270
Query: 183 EP 184
           +P
Sbjct: 271 KP 272

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 61/99 (61%), Gaps = 5/99 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVI 83
           +  QI+ G+ +LH  +  +I+RDLK +N+ ++   G ++I DLGLA  L+  Q +     
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP FMAPE L  E+Y+  VD ++ G+ + EM+ +  P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 74/153 (48%), Gaps = 31/153 (20%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +  S  L + R +Y R+         RQIL  ++Y+H     +IHRDLK  NIF++    
Sbjct: 105 LIHSENLNQQRDEYWRL--------FRQILEALSYIHSQG--IIHRDLKPMNIFIDES-R 153
Query: 61  QIKIGDLGLAA-------ILR--------GSQQAHSVIGTPEFMAPELYEED--YNELVD 103
            +KIGD GLA        IL+         S    S IGT  ++A E+ +    YNE +D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213
Query: 104 IYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
           +YS G+   EM+   YP+S       I KK+ S
Sbjct: 214 MYSLGIIFFEMI---YPFSTGMERVNILKKLRS 243

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 119 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 175
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 176 ADFGW-SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 233
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 234 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 291
Query: 183 EP 184
           +P
Sbjct: 292 KP 293

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 24  NWARQILRGIAYLHGHD-PPVIHRDLKCDNIFV-----NGHLGQ--IKIGDLGLAAILRG 75
           NWA QI RG+ YLH     P+IHRDLK  NI +     NG L    +KI D GLA     
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 76  SQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           + +  S  G   +MAPE+     +++  D++S+G+ + E+LT E P+      A  Y
Sbjct: 169 TTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           V  + R  L  +A+LH     ++H D+K  NIF+ G  G+ K+GD GL   L  +     
Sbjct: 159 VWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEV 215
Query: 82  VIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
             G P +MAPEL +  Y    D++S G+ +LE+  +     E  +  + ++++  G LP 
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACN----MELPHGGEGWQQLRQGYLPP 271
Query: 142 AFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFL 177
            F     +E R  +   LE   K R  A+ LL  P L
Sbjct: 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 96/182 (52%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K +R D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 97  GTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSNGELKI 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +  ++ GT +++ PE+ E   ++E VD++S G+   E L    P+ E
Sbjct: 154 ADFGW-SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF-E 211
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
                + Y++++  ++   F       AR  + + L+ N S+RL   E+L  P++ +++ 
Sbjct: 212 AHTYQETYRRIS--RVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSS 269
Query: 183 EP 184
           +P
Sbjct: 270 KP 271

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 61/99 (61%), Gaps = 5/99 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVI 83
           +  QI+ G+ +LH  +  +I+RDLK +N+ ++   G ++I DLGLA  L+  Q +     
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP FMAPE L  E+Y+  VD ++ G+ + EM+ +  P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 15/175 (8%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 175
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 176 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 234
Query: 120 PYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   +   P AF      +AR  V K L  + +KRL  +E+
Sbjct: 235 PPFRAGNEYLIFQKIIKLEYDFPAAFF----PKARDLVEKLLVLDATKRLGCEEM 285

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 14/177 (7%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L + RK  T  + R    + RQI+ G  YLH +   VIHRDLK  N+F+N  L ++KIGD
Sbjct: 105 LHKRRKALTEPEARY---YLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL-EVKIGD 158
Query: 67  LGLAAILRGSQQAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-SE 123
            GLA  +    +   V+ GTP ++APE L ++ ++  VD++S G  +  +L  + P+ + 
Sbjct: 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           C     +  K     +P   + +    A   + K L+ + + R    ELL D F  S
Sbjct: 219 CLKETYLRIKKNEYSIPKHINPV----AASLIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 169
Query: 64  IGDLGLAAIL---RGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L       +A+S +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 170 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 228
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 229 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 279

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 150
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 151 ADFGW-SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 208
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 209 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266
Query: 183 EP 184
           +P
Sbjct: 267 KP 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRT-ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 150
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 151 ADFGWSCHAPSSRRT-TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 208
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 209 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266
Query: 183 EP 184
           +P
Sbjct: 267 KP 268

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I+ K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 92  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 148
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 149 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 206
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 207 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 264
Query: 183 EP 184
           +P
Sbjct: 265 KP 266

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 154
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 155 ADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 212
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 213 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 270
Query: 183 EP 184
           +P
Sbjct: 271 KP 272

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 95  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 151
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 152 ADFGW-SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 209
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 210 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 267
Query: 183 EP 184
           +P
Sbjct: 268 KP 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 97  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 154 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 211
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 212 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 269
Query: 183 EP 184
           +P
Sbjct: 270 KP 271

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 150
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 151 ADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 208
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 209 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266
Query: 183 EP 184
           +P
Sbjct: 267 KP 268

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  IAY H +   ++HR+LK +N+ +  
Sbjct: 86  LVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 140
Query: 56  NGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEM 114
                 +K+ D GLA  +  S+  H   GTP +++PE+ ++D Y++ VDI++ G+ +L +
Sbjct: 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYI 199
Query: 115 LTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           L   YP     +  ++Y ++ +G    P         EA+  +   L  N  KR+ A + 
Sbjct: 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 172 LLDPFL 177
           L  P++
Sbjct: 260 LKVPWI 265

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 170
Query: 64  IGDLGLAAIL---RGSQQAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L       +A++ +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 171 ITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 229
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 230 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  IAY H +   ++HR+LK +N+ +  
Sbjct: 85  LVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 139
Query: 56  NGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEM 114
                 +K+ D GLA  +  S+  H   GTP +++PE+ ++D Y++ VDI++ G+ +L +
Sbjct: 140 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYI 198
Query: 115 LTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           L   YP     +  ++Y ++ +G    P         EA+  +   L  N  KR+ A + 
Sbjct: 199 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 258
Query: 172 LLDPFL 177
           L  P++
Sbjct: 259 LKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  IAY H +   ++HR+LK +N+ +  
Sbjct: 86  LVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 140
Query: 56  NGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEM 114
                 +K+ D GLA  +  S+  H   GTP +++PE+ ++D Y++ VDI++ G+ +L +
Sbjct: 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYI 199
Query: 115 LTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           L   YP     +  ++Y ++ +G    P         EA+  +   L  N  KR+ A + 
Sbjct: 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 172 LLDPFL 177
           L  P++
Sbjct: 260 LKVPWI 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  K+  R+    +   +  +LRG+AYL      ++HRD+K  NI VN   G+IK
Sbjct: 98  GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSR-GEIK 155
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +MAPE L    Y+   DI+S G+ ++E+    YP
Sbjct: 156 LCDFGVSGQLIDSM-ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMAP 91
           +A  H H   +I+RDLK +NI +N H G +K+ D GL    +      H+  GT E+MAP
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 92  E-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           E L    +N  VD +S G  + +MLT   P++   N  +   K+   KL    +  Q  E
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCKLNLPPYLTQ--E 247
Query: 151 ARRFVGKCLE-NVSKRLP-----AKELLLDPFLASDAGEPLLIPQV-PSFQNL 196
           AR  + K L+ N + RL      A E+   PF      E LL  +V P F+ L
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL 300

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 353 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  +   H H   ++HRDLK +N+ +  
Sbjct: 84  LVTGGELFEDIVAREYYSEAD---ASHCIQQILESVN--HCHLNGIVHRDLKPENLLLAS 138
Query: 56  NGHLGQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
                 +K+ D GLA  ++G QQA     GTP +++PE+  +D Y + VD+++ G+ +L 
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV-ILY 197
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + K L  N +KR+ A E
Sbjct: 198 ILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASE 257
Query: 171 LLLDPFL 177
            L  P++
Sbjct: 258 ALKHPWI 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 15/186 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  IAY H +   ++HR+LK +N+ +  
Sbjct: 109 LVTGGELFEDIVAREFYSEAD---ASHCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 163
Query: 56  NGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEM 114
                 +K+ D GLA  +  S+  H   GTP +++PE+ ++D Y++ VDI++ G+ +L +
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYI 222
Query: 115 LTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           L   YP     +  ++Y ++ +G    P         EA+  +   L  N  KR+ A + 
Sbjct: 223 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282
Query: 172 LLDPFL 177
           L  P++
Sbjct: 283 LKVPWI 288

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH  +  +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 249 RLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 307 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 366
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 367 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 420

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 177
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 178 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 236
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 237 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 287

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 173
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 174 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 232
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 233 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 283

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I+ K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/108 (38%), Positives = 57/108 (52%), Gaps = 17/108 (15%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----IKIGDLGLAAILRGSQQAHSV- 82
           I  GI Y+   +PP++HRDL+  NIF+   L +      K+ D GL+      Q  HSV 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQS-LDENAPVCAKVADFGLS-----QQSVHSVS 184
Query: 83  --IGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
             +G  ++MAPE     EE Y E  D YSF M +  +LT E P+ E S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 170
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 171 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 229
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 230 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 170
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 171 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 229
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 230 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGWSVHAPSSRRT-XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 1   MFTSGTLRE---YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-- 55
           + T G L E    R+ Y+  D     +  +QIL  +   H H   ++HRDLK +N+ +  
Sbjct: 84  LVTGGELFEDIVAREYYSEAD---ASHCIQQILESVN--HCHLNGIVHRDLKPENLLLAS 138
Query: 56  NGHLGQIKIGDLGLAAILRGSQQA-HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
                 +K+ D GLA  ++G QQA     GTP +++PE+  +D Y + VD+++ G+ +L 
Sbjct: 139 KSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGV-ILY 197
Query: 114 MLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           +L   YP     +  ++Y+++ +G    P         EA+  + K L  N +KR+ A E
Sbjct: 198 ILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASE 257
Query: 171 LLLDPFL 177
            L  P++
Sbjct: 258 ALKHPWI 264

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 95  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 151
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            + G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 152 ANFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 209
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 210 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 267
Query: 183 EP 184
           +P
Sbjct: 268 KP 269

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 150
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 151 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 209
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 210 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 260

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 172
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 173 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 232 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 170
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 171 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 229
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 230 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 95/175 (54%), Gaps = 9/175 (5%)
Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA 71
           +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI D G + 
Sbjct: 105 QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV 161
Query: 72  ILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
               S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E +   + 
Sbjct: 162 HAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQET 219
Query: 131 YKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
           YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ +P
Sbjct: 220 YKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 109 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 167 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 226
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 227 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 280

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 149
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 150 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 208
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 209 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 259

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L    K R   +E L  P+L  +
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 147
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 148 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 206
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 207 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 257

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 169
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 170 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 228
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 229 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 154
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 155 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 213
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 214 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 264

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 83/173 (47%), Gaps = 13/173 (7%)
Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMAP 91
           +A  H H   +I+RDLK +NI +N H G +K+ D GL    +      H   GT E+MAP
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 92  E-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           E L    +N  VD +S G  + +MLT   P++   N  +   K+   KL    +  Q  E
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCKLNLPPYLTQ--E 247
Query: 151 ARRFVGKCLE-NVSKRLP-----AKELLLDPFLASDAGEPLLIPQV-PSFQNL 196
           AR  + K L+ N + RL      A E+   PF      E LL  +V P F+ L
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL 300

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAIL 73
           R+     K +  Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G + IL
Sbjct: 116 RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 173
Query: 74  RGSQQAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129
             +    ++ GTP ++APE+        YN  VD +S G+ +   L+   P+SE      
Sbjct: 174 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 233
Query: 130 IYKKVTSGK---LPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASD 180
           +  ++TSGK   +P  +  + + +A   V K L  +   R   +E L  P+L  +
Sbjct: 234 LKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 287

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 150 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 207
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 208 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L +Y +K    D    + +  +I+  + YLHG    +IHRDLK +NI +N  +  I+
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDM-HIQ 148
Query: 64  IGDLGLAAILR-GSQQAHS--VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEY 119
           I D G A +L   S+QA +   +GT ++++PEL  E+   +  D+++ G C++  L +  
Sbjct: 149 ITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGL 207
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171
           P     N   I++K+   KL   F      +AR  V K L  + +KRL  +E+
Sbjct: 208 PPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 149
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 150 ADFGW-SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 207
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 265
Query: 183 EP 184
           +P
Sbjct: 266 KP 267

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 97/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ADFGW-SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 EP 184
           +P
Sbjct: 269 KP 270

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 98/182 (53%), Gaps = 9/182 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            + G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ANFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 EP 184
           +P
Sbjct: 269 KP 270

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 172
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 173 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 7/125 (5%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G LR + ++        VK +  +++  + YL      +IHRD+K DNI ++ H G
Sbjct: 96  LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-G 152
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLT 116
            + I D  +AA+L    Q  ++ GT  +MAPE++       Y+  VD +S G+   E+L 
Sbjct: 153 HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 117 SEYPY 121
              PY
Sbjct: 213 GRRPY 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 111 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 273

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 229 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 274

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 162 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 216
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE+      YN  VDI+S G  + E+LT    +P ++  N  Q   ++T        
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVI 276
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            R+   EAR ++   L  + KR  A   +    LA D  E +L+
Sbjct: 277 SRMPSHEARNYIN-SLPQMPKRNFADVFIGANPLAVDLLEKMLV 319

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 88  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 145
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 31/166 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY----------- 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 132 --KKVTSGKL----------PGAFHRIQDAEARRFVGKCLENVSKR 165
             KK+ S  L          P A   I D +  R+  K L+  +KR
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 88  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 145
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 64/114 (56%), Gaps = 6/114 (5%)
Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           GTL ++  +++  ++D         QI +G+ Y+H     +I+RDLK  NIF+     Q+
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLV-DTKQV 161
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           KIGD GL   L+   +     GT  +M+PE +  +DY + VD+Y+ G+ + E+L
Sbjct: 162 KIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 94/175 (53%), Gaps = 9/175 (5%)
Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA 71
           +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI D G  +
Sbjct: 105 QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGW-S 160
Query: 72  ILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
           +   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E +   + 
Sbjct: 161 VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQET 219
Query: 131 YKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
           YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ +P
Sbjct: 220 YKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 88  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 145
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 4/118 (3%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK
Sbjct: 88  GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIK 145
Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 6/137 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G L +Y  K+ RV+    +   +QIL  + Y H H   V+HRDLK +N+ ++ H+   
Sbjct: 94  SGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNA- 150
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEYP 120
           KI D GL+ ++   +   +  G+P + APE+          VDI+S G+ +  +L    P
Sbjct: 151 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 121 YSECSNPAQIYKKVTSG 137
           + +   P  ++KK+  G
Sbjct: 211 FDDEHVPT-LFKKIRGG 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +    L +Y  +  ++  +  + + +QI+  + Y H H   ++HRDLK +N+ ++ HL  
Sbjct: 85  YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHL-N 141
Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+          VD++S G+ +  ML    
Sbjct: 142 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201
Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
           P+ + S P  ++K +++G   LP           +R +   + N   R+   E++ D + 
Sbjct: 202 PFDDESIPV-LFKNISNGVYTLPKFLSPGAAGLIKRML---IVNPLNRISIHEIMQDDWF 257
Query: 178 ASDAGEPLLIPQV 190
             D  E LL P +
Sbjct: 258 KVDLPEYLLPPDL 270

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +    L +Y  +  ++  +  + + +QI+  + Y H H   ++HRDLK +N+ ++ HL  
Sbjct: 89  YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHL-N 145
Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+          VD++S G+ +  ML    
Sbjct: 146 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205
Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
           P+ + S P  ++K +++G   LP           +R +   + N   R+   E++ D + 
Sbjct: 206 PFDDESIPV-LFKNISNGVYTLPKFLSPGAAGLIKRML---IVNPLNRISIHEIMQDDWF 261
Query: 178 ASDAGEPLLIPQV 190
             D  E LL P +
Sbjct: 262 KVDLPEYLLPPDL 274

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 62/111 (55%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q++ G++Y H     V HRDLK +N  ++G    ++KI D G +       Q  S +GT
Sbjct: 122 QQLISGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGT 179
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L +++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 56/108 (51%), Gaps = 17/108 (15%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----IKIGDLGLAAILRGSQQAHSV- 82
           I  GI Y+   +PP++HRDL+  NIF+   L +      K+ D G +      Q  HSV 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQS-LDENAPVCAKVADFGTS-----QQSVHSVS 184
Query: 83  --IGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
             +G  ++MAPE     EE Y E  D YSF M +  +LT E P+ E S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 70/137 (51%), Gaps = 6/137 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G L +Y  K+ RV+    +   +QIL  + Y H H   V+HRDLK +N+ ++ H+   
Sbjct: 94  SGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNA- 150
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEYP 120
           KI D GL+ ++   +      G+P + APE+          VDI+S G+ +  +L    P
Sbjct: 151 KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 121 YSECSNPAQIYKKVTSG 137
           + +   P  ++KK+  G
Sbjct: 211 FDDEHVPT-LFKKIRGG 226

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 97/181 (53%), Gaps = 9/181 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 E 183
           +
Sbjct: 269 K 269

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           I + + YLH     V+HRDLK  NI     +G+   I+I D G A  LR     + ++ T
Sbjct: 125 ITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMT 179
Query: 86  P----EFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGK 138
           P     F+APE+ E + Y+   DI+S G+ +  MLT   P++   +  P +I  ++ SGK
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 139 --LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
             L G +       A+  V K L  +  +RL A  +L  P++ 
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 56/108 (51%), Gaps = 17/108 (15%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----IKIGDLGLAAILRGSQQAHSV- 82
           I  GI Y+   +PP++HRDL+  NIF+   L +      K+ D  L+      Q  HSV 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQS-LDENAPVCAKVADFSLS-----QQSVHSVS 184
Query: 83  --IGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
             +G  ++MAPE     EE Y E  D YSF M +  +LT E P+ E S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 31/153 (20%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +  S  L + R +Y R+         RQIL  ++Y+H     +IHR+LK  NIF++    
Sbjct: 105 LIHSENLNQQRDEYWRL--------FRQILEALSYIHSQG--IIHRNLKPXNIFIDES-R 153
Query: 61  QIKIGDLGLAA-------ILR--------GSQQAHSVIGTPEFMAPELYEED--YNELVD 103
            +KIGD GLA        IL+         S    S IGT  ++A E+ +    YNE +D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKID 213
Query: 104 IYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
            YS G+   E +   YP+S       I KK+ S
Sbjct: 214 XYSLGIIFFEXI---YPFSTGXERVNILKKLRS 243

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 96/179 (53%), Gaps = 9/179 (5%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 90  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 146
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 147 ADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 204
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++
Sbjct: 205 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 261

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +    L +Y  +  ++  +  + + +QI+  + Y H H   ++HRDLK +N+ ++ HL  
Sbjct: 94  YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHL-N 150
Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+          VD++S G+ +  ML    
Sbjct: 151 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210
Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
           P+ + S P  ++K +++G   LP           +R +   + N   R+   E++ D + 
Sbjct: 211 PFDDESIPV-LFKNISNGVYTLPKFLSPGAAGLIKRML---IVNPLNRISIHEIMQDDWF 266
Query: 178 ASDAGEPLL 186
             D  E LL
Sbjct: 267 KVDLPEYLL 275

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +    L +Y  +  ++  +  + + +QI+  + Y H H   ++HRDLK +N+ ++ HL  
Sbjct: 95  YAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHL-N 151
Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+          VD++S G+ +  ML    
Sbjct: 152 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211
Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
           P+ + S P  ++K +++G   LP           +R +   + N   R+   E++ D + 
Sbjct: 212 PFDDESIPV-LFKNISNGVYTLPKFLSPGAAGLIKRML---IVNPLNRISIHEIMQDDWF 267
Query: 178 ASDAGEPLL 186
             D  E LL
Sbjct: 268 KVDLPEYLL 276

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 9/162 (5%)
Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH-S 81
           +++  QI+ G+ YLH H   ++HRDL   N+ +  ++  IKI D GLA  L+   + H +
Sbjct: 115 RHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYT 171
Query: 82  VIGTPEFMAPELYEEDYNEL-VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
           + GTP +++PE+     + L  D++S G     +L    P+   +    + K V +    
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231
Query: 141 GAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
            +F  I   EA+  + + L  N + RL    +L  PF++ ++
Sbjct: 232 PSFLSI---EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 38  GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPE-LYE 95
           GH   V+HRDLK  N+F++G    +K+GD GLA IL   +  A + +GTP +M+PE +  
Sbjct: 134 GH--TVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 96  EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155
             YNE  DI+S G C+L  L +  P     +  ++  K+  GK     +R  D E    +
Sbjct: 191 MSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD-ELNEII 248
Query: 156 GKCLENVSKRLPA-KELLLDPFL 177
            + L       P+ +E+L +P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---AHSVIG 84
           Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 85  TPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
           T  ++APEL +  E + E VD++S G+ +  ML  E P+ + S+  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 38  GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPE-LYE 95
           GH   V+HRDLK  N+F++G    +K+GD GLA IL   +  A + +GTP +M+PE +  
Sbjct: 134 GH--TVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 96  EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155
             YNE  DI+S G C+L  L +  P     +  ++  K+  GK     +R  D E    +
Sbjct: 191 MSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD-ELNEII 248
Query: 156 GKCLENVSKRLPA-KELLLDPFL 177
            + L       P+ +E+L +P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 38  GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSVIGTPEFMAPE-LYE 95
           GH   V+HRDLK  N+F++G    +K+GD GLA IL   +  A   +GTP +M+PE +  
Sbjct: 134 GH--TVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 96  EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155
             YNE  DI+S G C+L  L +  P     +  ++  K+  GK     +R  D E    +
Sbjct: 191 MSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD-ELNEII 248
Query: 156 GKCLENVSKRLPA-KELLLDPFL 177
            + L       P+ +E+L +P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 96/181 (53%), Gaps = 9/181 (4%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 152
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 153 ADFGW-SVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 210
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +   + YK+++  ++   F       AR  + + L+ N S+R   +E+L  P++ +++ 
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268
Query: 183 E 183
           +
Sbjct: 269 K 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++G +  I
Sbjct: 97  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKYIVHRDLKAENLLLDGDM-NI 153
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 154 KIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           + +  N  ++ ++V  GK    F+   D E
Sbjct: 214 F-DGQNLKELRERVLRGKYRIPFYMSTDCE 242

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 61/111 (54%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q+L G++Y H     + HRDLK +N  ++G    ++KI D G +       Q  S +GT
Sbjct: 123 QQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L  ++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 62/111 (55%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q++ G++Y H     V HRDLK +N  ++G    ++KI D G +       Q  S +GT
Sbjct: 122 QQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L +++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 62/111 (55%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q++ G++Y H     V HRDLK +N  ++G    ++KI D G +       Q  S +GT
Sbjct: 121 QQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 178
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L +++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 229

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+    + 
Sbjct: 113 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-TF 168
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/128 (24%), Positives = 69/128 (53%), Gaps = 10/128 (7%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G L +Y  +   +  +  ++  R +L  +++LH ++  ++HRDLK +NI ++ ++ 
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNM- 237
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLE 113
           QI++ D G +  L   ++   + GTP ++APE+ +         Y + VD+++ G+ +  
Sbjct: 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 114 MLTSEYPY 121
           +L    P+
Sbjct: 298 LLAGSPPF 305

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+    + 
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-TF 165
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+    + 
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-TF 165
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  ++  RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 94  SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADM-NI 150
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNE-LVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 151 KIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFLA 178
           + +  N  ++ ++V  GK    F+   D E   +RF+   + N  KR   ++++ D ++ 
Sbjct: 211 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMKDRWIN 266
Query: 179 SDAGEPLLIPQV 190
           +   E  L P V
Sbjct: 267 AGHEEDELKPFV 278

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQAHSVIG 84
           +QIL G+ YLH ++  ++H DLK  NI ++    LG IKI D G++  +  + +   ++G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 85  TPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
           TPE++APE+   D      D+++ G+    +LT   P+
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++      +  
Sbjct: 256 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 313
Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++      +  
Sbjct: 253 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 310
Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 31  RGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSVIGTPE 87
           RG+AYLH H DP +IHRD+K  NI ++     + +GD GLA ++  +      +V GT  
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            +APE L     +E  D++ +G+ +LE++T +  +
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 96  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL- 177
           + +  N  ++ ++V  GK    F+   D E   ++F+   + N SKR   ++++ D ++ 
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMN 268
Query: 178 ---ASDAGEPLLIPQVPSFQN 195
                D  +P + P +P +++
Sbjct: 269 VGHEDDELKPYVAP-LPDYKD 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ---IKIGDLGLAAILRGSQQAHSVIGT 85
           I + + YLH     V+HRDLK  NI      G    ++I D G A  LR     + ++ T
Sbjct: 130 IGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMT 184
Query: 86  P----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE--CSNPAQIYKKVTSGK 138
           P     F+APE L  + Y+E  DI+S G+ +  ML    P++      P +I  ++ SGK
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 139 --LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
             L G         A+  V K L  +  +RL AK++L  P++      P
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLP 293

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAILRGSQQA 79
           V    +Q++  +AY H     V+H+DLK +NI          IKI D GLA + +  + +
Sbjct: 126 VAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 80  HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
            +  GT  +MAPE+++ D     DI+S G+ +  +LT   P++  S
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 63/118 (53%), Gaps = 6/118 (5%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D + V+ +  QI+ GI + H H+  +IHRD+K +NI V+   G +K+ D G A  L   
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 177
Query: 77  QQAH-SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
            + +   + T  + APEL   D  Y + VD+++ G  V EM   E  +   S+  Q+Y
Sbjct: 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 18/163 (11%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           I + + YLH     V+HRDLK  NI     +G+   I+I D G A  LR     + ++ T
Sbjct: 125 ITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLXT 179
Query: 86  P----EFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGK 138
           P     F+APE+ E + Y+   DI+S G+ +   LT   P++   +  P +I  ++ SGK
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 139 --LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
             L G +       A+  V K L  +  +RL A  +L  P++ 
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ---IKIGDLGLAAILRGSQQAHSVIGT 85
           I + + YLH     V+HRDLK  NI      G    ++I D G A  LR     + ++ T
Sbjct: 130 IGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE---NGLLMT 184
Query: 86  P----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE--CSNPAQIYKKVTSGK 138
           P     F+APE L  + Y+E  DI+S G+ +  ML    P++      P +I  ++ SGK
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 139 --LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
             L G         A+  V K L  +  +RL AK++L  P++ 
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  ++  RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 97  SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADM-NI 153
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNE-LVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 154 KIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFLA 178
           + +  N  ++ ++V  GK    F+   D E   +RF+   + N  KR   ++++ D ++ 
Sbjct: 214 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMKDRWIN 269
Query: 179 SDAGEPLLIPQV 190
           +   E  L P V
Sbjct: 270 AGHEEDELKPFV 281

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 93/179 (51%), Gaps = 11/179 (6%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 96  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL 177
           + +  N  ++ ++V  GK    F+   D E   ++F+   + N SKR   ++++ D ++
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 93/179 (51%), Gaps = 11/179 (6%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 96  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL 177
           + +  N  ++ ++V  GK    F+   D E   ++F+   + N SKR   ++++ D ++
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 18  DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ 77
           + RAV  +A +I  G+  LH     +++RDLK +NI ++ H G I+I DLGLA  +   Q
Sbjct: 285 EARAV-FYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ 340
Query: 78  QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
                +GT  +MAPE+ + E Y    D ++ G  + EM+  + P+       Q  KK   
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKK--- 390
Query: 137 GKLPGAFHRIQDAEARRFVGKCLENVSKRL-PAKELLLDPFLASDAGEPL--------LI 187
                   +I+  E  R V +  E  S+R  P    L    L  D  E L         +
Sbjct: 391 --------KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442
Query: 188 PQVPSFQNLNPN--GAVMELVPKFAVDSDRRKSTDM-------TITGT-MNPEDDTIFLK 237
            + P F+ LN    GA M L P F  D       D+       T+ G  + P D   + K
Sbjct: 443 KEHPLFKKLNFKRLGAGM-LEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQK 501

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 250 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +I  G+  LH     +++RDLK +NI ++ H G I+I DLGLA  +   Q     +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 85  TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           T  +MAPE+ + E Y    D ++ G  + EM+  + P+       Q  KK          
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKK---------- 390
Query: 144 HRIQDAEARRFVGKCLENVSKRL-PAKELLLDPFLASDAGEPL--------LIPQVPSFQ 194
            +I+  E  R V +  E  S+R  P    L    L  D  E L         + + P F+
Sbjct: 391 -KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
Query: 195 NLNPN--GAVMELVPKFAVDSDRRKSTDM-------TITGT-MNPEDDTIFLK 237
            LN    GA M L P F  D       D+       T+ G  + P D   + K
Sbjct: 450 KLNFKRLGAGM-LEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQK 501

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 254 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-XF 165
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-XF 165
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-XF 165
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA--AILRGSQQAHSV 82
           +  +I+  + YLH  D  V++RD+K +N+ ++   G IKI D GL    I  G+      
Sbjct: 115 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-XF 170
Query: 83  IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
            GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA     + +    + T  
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMTGYVATRW 194
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 255 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA     + +    + T  
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMTGYVATRW 194
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 255 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 7   LREYRKKYTRVDIRA--VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           LR Y  K     + A  +K+  RQ LRG+ +LH +   ++HRDLK +NI V    G +K+
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKL 161
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            D GLA I         V+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 96  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +     G+P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL 177
           + +  N  ++ ++V  GK    F+   D E   ++F+   + N SKR   ++++ D ++
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LREY +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 101 GSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 215
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 216 YIEKSKSPPAEFMRMIGNDK 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA     + +    + T  
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMTGYVATRW 194
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 255 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R+  +  +   RQI+  + Y H     ++HRDLK +N+ ++  +  I
Sbjct: 96  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL 177
           + +  N  ++ ++V  GK    F+   D E   ++F+   + N SKR   ++++ D ++
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMTGYVATRW 192
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 253 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 144 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMTGYVATRW 198
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 258
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 259 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 301

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++         
Sbjct: 114 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFC 171
Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMTGYVATRW 192
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 253 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 7   LREYRKKYTRVDIRA--VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           LR Y  K     + A  +K+  RQ LRG+ +LH +   ++HRDLK +NI V    G +K+
Sbjct: 97  LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKL 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            D GLA I         V+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 154 ADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++         
Sbjct: 113 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFC 170
Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 156 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMXGYVATRW 210
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 270
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 271 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +  +I+  + YLH  +  V++RDLK +N+ ++   G IKI D GL    ++         
Sbjct: 115 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFC 172
Query: 84  GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
           GTPE++APE+ E+ DY   VD +  G+ + EM+    P+
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 7   LREYRKKYTRVDIRA--VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           LR Y  K     + A  +K+  RQ LRG+ +LH +   ++HRDLK +NI V    G +K+
Sbjct: 97  LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKL 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            D GLA I         V+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 154 ADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMAGFVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGXVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 86/162 (53%), Gaps = 13/162 (8%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQ-AH 80
           ++ RQIL  + Y H  D  +IHRD+K +N+ +    +   +K+GD G+A  L  S   A 
Sbjct: 134 HYMRQILEALRYCH--DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG 191
Query: 81  SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
             +GTP FMAPE+ + E Y + VD++  G+ +  +L+   P+       ++++ +  GK 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGKY 249
Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
              P  +  I ++ A+  V + L  + ++R+   E L  P+L
Sbjct: 250 KMNPRQWSHISES-AKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 7   LREYRKKYTRVDIRA--VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           LR Y  K     + A  +K+  RQ LRG+ +LH +   ++HRDLK +NI V    G +K+
Sbjct: 97  LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKL 153
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            D GLA I         V+ T  + APE L +  Y   VD++S G    EM 
Sbjct: 154 ADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 260 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 260 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE  L    YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/122 (37%), Positives = 63/122 (51%), Gaps = 12/122 (9%)
Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQIKIGDLG 68
           KK  ++    VK+   QIL GI YLH +   V+HRDLK  NI V G     G++KI D+G
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 69  LAAI----LRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            A +    L+       V+ T  + APEL      Y + +DI++ G    E+LTSE P  
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 236
Query: 123 EC 124
            C
Sbjct: 237 HC 238

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 199
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 260 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMXGXVATRW 207
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 268 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 310

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMAGFVATRW 183
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 244 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMAGFVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 250 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 250 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 131 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 185
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 245
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 246 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 288

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 144 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 198
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 258
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 259 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 301

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 183
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 244 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 183
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 244 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 189
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 250 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 194
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 255 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 130 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 184
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 244
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 245 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 152 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 206
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 266
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 267 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 309

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 130 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 184
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 244
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 245 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 192
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 253 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 143 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 197
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 257
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 258 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 300

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 70/137 (51%), Gaps = 6/137 (4%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +  G L +Y  +  R+     + + +QI+  I Y H H   ++HRDLK +N+ ++ +L  
Sbjct: 90  YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLN- 146
Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDY--NELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+          VD++S G+ +  ML    
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206
Query: 120 PYSECSNPAQIYKKVTS 136
           P+ +   P  ++KKV S
Sbjct: 207 PFDDEFIP-NLFKKVNS 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 254 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 192
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 253 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 207
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 268 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 310

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 132 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 186
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 246
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 247 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 289

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 156 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 210
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 270
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 271 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 183
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 244 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 207
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 268 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 310

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 152 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 206
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 266
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 267 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 309

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 254 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 254 KKISSESARNYI-QSLAQMPKMNFANVFIGANPLAVDLLEKMLV 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 32  GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMA 90
            +A  H H   +I+RDLK +NI ++   G IK+ D GL+   +   ++A+S  GT E+MA
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 91  PELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           PE+     + +  D +SFG+ + EMLT   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDYGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 31  RGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSVIGTPE 87
           RG+AYLH H DP +IHRD+K  NI ++     + +GD GLA ++  +      +V G   
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            +APE L     +E  D++ +G+ +LE++T +  +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q++ G++Y H     V HRDLK +N  ++G    ++KI   G +       Q  S +GT
Sbjct: 122 QQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGT 179
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L +++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDAGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 102 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 158
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 216
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 217 YIEKSKSPPAEFMRMIGNDK 236

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 103 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 217
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 218 YIEKSKSPPAEFMRMIGNDK 237

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 8/131 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L  + ++  ++     + ++ +I   + YLH  +  +I+RDLK DN+ ++   G IK
Sbjct: 137 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIK 193
Query: 64  IGDLGLAA-ILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           + D G+    LR      +  GTP ++APE+   EDY   VD ++ G+ + EM+    P+
Sbjct: 194 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 122 ---SECSNPAQ 129
                  NP Q
Sbjct: 254 DIVGSSDNPDQ 264

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 105 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENE-NRVK 161
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 219
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 220 YIEKSKSPPAEFMRMIGNDK 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 12/143 (8%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           V+ +  Q+LRG+ Y+H     VIHRDLK  N+ VN +  ++KIGD G+A  L  S   H 
Sbjct: 161 VRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQ 217
Query: 82  -----VIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYK 132
                 + T  + APEL     +Y + +D++S G    EML     +P     +  Q+  
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 277
Query: 133 KVTSGKLPGAFHRIQDAEARRFV 155
            V     P     +     R ++
Sbjct: 278 MVLGTPSPAVIQAVGAERVRAYI 300

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GL        +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLCR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 32  GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMA 90
            +A  H H   +I+RDLK +NI ++   G IK+ D GL+   +   ++A+S  GT E+MA
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 91  PELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           PE+     + +  D +SFG+ + EMLT   P+
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 32  GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAHSVIGTPEFMA 90
            +A  H H   +I+RDLK +NI ++   G IK+ D GL+   +   ++A+S  GT E+MA
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 91  PELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           PE+     + +  D +SFG+ + EMLT   P+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 10/137 (7%)
Query: 2   FTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           F S  L+++      T + +  +K++  Q+L+G+A+ H H   V+HRDLK +N+ +N   
Sbjct: 86  FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTE- 142
Query: 60  GQIKIGDLGLAAILRGSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML 115
           G IK+ D GLA       +   H V+ T  + APE+    + Y+  VDI+S G    EM+
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 116 TSEYPYSECSNPAQIYK 132
           T    +   S   Q+++
Sbjct: 202 TRRALFPGDSEIDQLFR 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 185
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 243
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 244 YIEKSKSPPAEFMRMIGNDK 263

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 97  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 153
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 211
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 212 YIEKSKSPPAEFMRMIGNDK 231

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 104 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 160
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 218
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 219 YIEKSKSPPAEFMRMIGNDK 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA-ILRGSQQAH 80
           VK +  ++  G+ +LH     +I+RDLK +NI ++   G IK+ D GL+   +   ++A+
Sbjct: 132 VKFYLAELALGLDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKEAIDHEKKAY 188
Query: 81  SVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           S  GT E+MAPE+   + ++   D +S+G+ + EMLT   P+
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 10/137 (7%)
Query: 2   FTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           F S  L+++      T + +  +K++  Q+L+G+A+ H H   V+HRDLK +N+ +N   
Sbjct: 84  FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTE- 140
Query: 60  GQIKIGDLGLAAILRGSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML 115
           G IK+ D GLA       +   H V+ T  + APE+    + Y+  VDI+S G    EM+
Sbjct: 141 GAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199
Query: 116 TSEYPYSECSNPAQIYK 132
           T    +   S   Q+++
Sbjct: 200 TRRALFPGDSEIDQLFR 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 101 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 215
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 216 YIEKSKSPPAEFMRMIGNDK 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDRGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 154
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 212
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 213 YIEKSKSPPAEFMRMIGNDK 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 64/112 (57%), Gaps = 9/112 (8%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL 73
           ++  D+R    +A +I+ G+   H H+  V++RDLK  NI ++ H G ++I DLGLA   
Sbjct: 288 FSEADMRF---YAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF 341
Query: 74  RGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
              ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ +
Sbjct: 342 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 392

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I   + YLH  +  +++RDLK +NI ++   G I + D GL    +  +    +  
Sbjct: 144 YAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTPE++APE L+++ Y+  VD +  G  + EML    P+    N A++Y  + +  L   
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKPLQLK 259
Query: 143 FHRIQDAEARRFVGKCLENVSKRLPAKE 170
              I ++      G   ++ +KRL AK+
Sbjct: 260 -PNITNSARHLLEGLLQKDRTKRLGAKD 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 154
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 212
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 213 YIEKSKSPPAEFMRMIGNDK 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 96  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 152
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 210
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 211 YIEKSKSPPAEFMRMIGNDK 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK +N+ +N   G IK+ D GLA    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTE-GAIKLADFGLARAFG 156
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 157 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 131 YK 132
           ++
Sbjct: 216 FR 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 161
Query: 75  GSQQ--AHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE  L  + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 162 VPVRTYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220
Query: 131 YK 132
           ++
Sbjct: 221 FR 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
           RQI+  + Y H     ++HRDLK +N+ ++  +  IKI D G +       +  +  G+P
Sbjct: 113 RQIVSAVQYCH--QKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSP 169
Query: 87  EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
            + APEL++ + Y+   VD++S G+ +  +++   P+ +  N  ++ ++V  GK    F+
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFY 228
Query: 145 RIQDAE--ARRFVGKCLENVSKRLPAKELLLDPFL 177
              D E   ++F+   + N SKR   ++++ D ++
Sbjct: 229 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 260

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK +N+ +N   G IK+ D GLA    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTE-GAIKLADFGLARAFG 155
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 156 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 131 YK 132
           ++
Sbjct: 215 FR 216

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 64/112 (57%), Gaps = 9/112 (8%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL 73
           ++  D+R    +A +I+ G+   H H+  V++RDLK  NI ++ H G ++I DLGLA   
Sbjct: 289 FSEADMRF---YAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF 342
Query: 74  RGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
              ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ +
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK +N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 116 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENE-NRVK 172
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 231 YIEKSKSPPAEFMRMIGNDK 250

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 64/112 (57%), Gaps = 9/112 (8%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL 73
           ++  D+R    +A +I+ G+   H H+  V++RDLK  NI ++ H G ++I DLGLA   
Sbjct: 289 FSEADMRF---YAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF 342
Query: 74  RGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
              ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ +
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 64/112 (57%), Gaps = 9/112 (8%)
Query: 14  YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL 73
           ++  D+R    +A +I+ G+   H H+  V++RDLK  NI ++ H G ++I DLGLA   
Sbjct: 289 FSEADMRF---YAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF 342
Query: 74  RGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
              ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ +
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQ--AHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE  L  + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 12/143 (8%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           V+ +  Q+LRG+ Y+H     VIHRDLK  N+ VN +  ++KIGD G+A  L  S   H 
Sbjct: 160 VRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQ 216
Query: 82  -----VIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYK 132
                 + T  + APEL     +Y + +D++S G    EML     +P     +  Q+  
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276
Query: 133 KVTSGKLPGAFHRIQDAEARRFV 155
            V     P     +     R ++
Sbjct: 277 MVLGTPSPAVIQAVGAERVRAYI 299

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 2   FTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           F S  L+++      T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   
Sbjct: 86  FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE- 142
Query: 60  GQIKIGDLGLAAILRGSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML 115
           G IK+ D GLA       +   H V+ T  + APE+    + Y+  VDI+S G    EM+
Sbjct: 143 GAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201
Query: 116 TSEYPYSECSNPAQIYK 132
           T    +   S   Q+++
Sbjct: 202 TRRALFPGDSEIDQLFR 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 18/148 (12%)
Query: 43  VIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-----ED 97
           +IHRD+K  NI ++   G IK+ D G++  L  S       G   +MAPE  +     + 
Sbjct: 147 IIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 98  YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR---- 153
           Y+   D++S G+ + E+ T  +PY + ++      +V  G  P    ++ ++E R     
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP----QLSNSEEREFSPS 261
Query: 154 ---FVGKCL-ENVSKRLPAKELLLDPFL 177
              FV  CL ++ SKR   KELL  PF+
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 116 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENE-NRVK 172
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 231 YIEKSKSPPAEFMRMIGNDK 250

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 4   SGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
            G LR+Y  ++     +    ++     I   + YLH +   +IHRDLK +NI +     
Sbjct: 103 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQ 160
Query: 61  QI--KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTS 117
           ++  KI DLG A  L   +     +GT +++APEL E+  Y   VD +SFG    E +T 
Sbjct: 161 RLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220
Query: 118 EYPYSECSNPAQIYKKV 134
             P+     P Q + KV
Sbjct: 221 FRPFLPNWQPVQWHGKV 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 4   SGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
            G LR+Y  ++     +    ++     I   + YLH +   +IHRDLK +NI +     
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQ 159
Query: 61  QI--KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTS 117
           ++  KI DLG A  L   +     +GT +++APEL E+  Y   VD +SFG    E +T 
Sbjct: 160 RLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219
Query: 118 EYPYSECSNPAQIYKKV 134
             P+     P Q + KV
Sbjct: 220 FRPFLPNWQPVQWHGKV 236

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           +   G L E  KK             R+++  ++  H HD  V+HRDLK +N+     N 
Sbjct: 87  LLNGGELFERIKKKKHFSETEASYIMRKLVSAVS--HMHDVGVVHRDLKPENLLFTDEND 144
Query: 58  HLGQIKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEML 115
           +L +IKI D G A +    +Q   +   T  + APEL  ++ Y+E  D++S G+ +  ML
Sbjct: 145 NL-EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203
Query: 116 TSEYPYSE------CSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFV-GKCLENVSKRL 166
           + + P+        C++  +I KK+  G     G   +    EA+  + G    + +KRL
Sbjct: 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
Query: 167 PAKELLLDPFLASD---AGEPLLIPQV 190
               L  + +L      +  PL+ P +
Sbjct: 264 KMSGLRYNEWLQDGSQLSSNPLMTPDI 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 2   FTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           F S  L+++      T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   
Sbjct: 85  FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE- 141
Query: 60  GQIKIGDLGLAAILRGSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML 115
           G IK+ D GLA       +   H V+ T  + APE+    + Y+  VDI+S G    EM+
Sbjct: 142 GAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200
Query: 116 TSEYPYSECSNPAQIYK 132
           T    +   S   Q+++
Sbjct: 201 TRRALFPGDSEIDQLFR 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDGGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 154
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 212
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 213 YIEKSKSPPAEFMRMIGNDK 232

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L  + ++  ++     + ++ +I   + YLH  +  +I+RDLK DN+ ++   G IK
Sbjct: 105 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIK 161
Query: 64  IGDLGLAAI-LRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           + D G+    LR         GTP ++APE+   EDY   VD ++ G+ + EM+    P+
Sbjct: 162 LTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221
Query: 122 ---SECSNPAQ 129
                  NP Q
Sbjct: 222 DIVGSSDNPDQ 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 10/128 (7%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G L +Y  +   +  +  +   R +L  I  LH  +  ++HRDLK +NI ++  + 
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM- 161
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLE 113
            IK+ D G +  L   ++  SV GTP ++APE+ E         Y + VD++S G+ +  
Sbjct: 162 NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 114 MLTSEYPY 121
           +L    P+
Sbjct: 222 LLAGSPPF 229

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 156
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 157 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 131 YK 132
           ++
Sbjct: 216 FR 217

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 161
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 162 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220
Query: 131 YK 132
           ++
Sbjct: 221 FR 222

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 157
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 158 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 131 YK 132
           ++
Sbjct: 217 FR 218

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 156
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 157 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 131 YK 132
           ++
Sbjct: 216 FR 217

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L  + ++  ++     + ++ +I   + YLH  +  +I+RDLK DN+ ++   G IK
Sbjct: 90  GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIK 146
Query: 64  IGDLGLAAI-LRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           + D G+    LR         GTP ++APE+   EDY   VD ++ G+ + EM+    P+
Sbjct: 147 LTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206
Query: 122 ---SECSNPAQ 129
                  NP Q
Sbjct: 207 DIVGSSDNPDQ 217

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 155
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 156 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 131 YK 132
           ++
Sbjct: 215 FR 216

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 155
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 156 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 131 YK 132
           ++
Sbjct: 215 FR 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            G L  + ++  ++     + ++ +I   + YLH  +  +I+RDLK DN+ ++   G IK
Sbjct: 94  GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIK 150
Query: 64  IGDLGLAA-ILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           + D G+    LR         GTP ++APE+   EDY   VD ++ G+ + EM+    P+
Sbjct: 151 LTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 122 ---SECSNPAQ 129
                  NP Q
Sbjct: 211 DIVGSSDNPDQ 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 27/188 (14%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L+G+ Y+H     +IHRDLK  N+ VN    ++KI D GLA   +   +    + T  
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNEDC-ELKILDFGLAR--QADSEMXGXVVTRW 190
Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--KVTSGKLPGAF 143
           + APE  L    Y + VDI+S G  + EM+T +  +    +  Q+ +  KVT G  P  F
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT-GTPPAEF 249
Query: 144 -HRIQDAEARRFVGKCLENVSKR---------------LPAKELLLDPFLASDAGEPLLI 187
             R+Q  EA+ ++ K L  + K+               L  K L+LD      AGE L  
Sbjct: 250 VQRLQSDEAKNYM-KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 188 PQVPSFQN 195
           P   S  +
Sbjct: 309 PYFESLHD 316

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 158
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 159 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217
Query: 131 YK 132
           ++
Sbjct: 218 FR 219

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 157
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 158 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 131 YK 132
           ++
Sbjct: 217 FR 218

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 157
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 158 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 131 YK 132
           ++
Sbjct: 217 FR 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 9/132 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H     +IHRDLK  N+ VN    +++I D GLA   +  ++    + T  
Sbjct: 139 QLLRGLKYIHSAG--IIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE+      YN+ VDI+S G  + E+L  +  +P S+  +  +   +V     P   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 253
Query: 144 HRIQDAEARRFV 155
            +I    AR ++
Sbjct: 254 AKISSEHARTYI 265

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 157
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 158 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 131 YK 132
           ++
Sbjct: 217 FR 218

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 158
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 159 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217
Query: 131 YK 132
           ++
Sbjct: 218 FR 219

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 154 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 131 YK 132
           ++
Sbjct: 213 FR 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 12/186 (6%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY-SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
           L+   P+  +            S      F       A+ F+ K L +   KRL  +E L
Sbjct: 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 173 LDPFLA 178
             P++ 
Sbjct: 272 RHPWIT 277

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 12/186 (6%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY-SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
           L+   P+  +            S      F       A+ F+ K L +   KRL  +E L
Sbjct: 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 173 LDPFLA 178
             P++ 
Sbjct: 272 RHPWIT 277

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 155
Query: 75  GSQQA--HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 156 VPVRTYXHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 131 YK 132
           ++
Sbjct: 215 FR 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 18/106 (16%)
Query: 26  ARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ 77
           A  + RG+AYLH        GH P + HRD+K  N+ +  +L    I D GLA      +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGK 185
Query: 78  QA---HSVIGTPEFMAPEL------YEEDYNELVDIYSFGMCVLEM 114
            A   H  +GT  +MAPE+      ++ D    +D+Y+ G+ + E+
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 9/132 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H     +IHRDLK  N+ VN    +++I D GLA   +  ++    + T  
Sbjct: 139 QLLRGLKYIHSAG--IIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE+      YN+ VDI+S G  + E+L  +  +P S+  +  +   +V     P   
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 253
Query: 144 HRIQDAEARRFV 155
            +I    AR ++
Sbjct: 254 AKISSEHARTYI 265

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 12/186 (6%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY-SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
           L+   P+  +            S      F       A+ F+ K L +   KRL  +E L
Sbjct: 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 173 LDPFLA 178
             P++ 
Sbjct: 272 RHPWIT 277

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K+  R+D   +  +  QI +G+ YL       IHR+L   NI V     ++K
Sbjct: 99  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRNLATRNILVENE-NRVK 155
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++ + V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 213
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 214 YIEKSKSPPAEFMRMIGNDK 233

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 12  KKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           K YT  + I+ +K   + +L   +Y+H ++  + HRD+K  NI ++ + G++K+ D G +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKN-GRVKLSDFGES 199
Query: 71  AILRGSQQAHSVIGTPEFMAPELY--EEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNP 127
             +   +   S  GT EFM PE +  E  YN   VDI+S G+C+  M  +  P+S   + 
Sbjct: 200 EYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 128 AQIYKKVTSGKLPGAFHR 145
            +++  + +  +     R
Sbjct: 259 VELFNNIRTKNIEYPLDR 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 5/111 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-QIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q++ G++Y H     V HRDLK +N  ++G    ++KI   G +       Q    +GT
Sbjct: 122 QQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGT 179
Query: 86  PEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
           P ++APE L +++Y+ ++ D++S G+ +  ML   YP+ +   P    K +
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
           G+L +Y +  T +D  +       I  G+A+LH         P + HRDLK  NI V  +
Sbjct: 120 GSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 178
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-----IGTPEFMAPELYEE-------DYNELVDIYS 106
            GQ  I DLGLA +   S     V     +GT  +MAPE+ +E       D  + VDI++
Sbjct: 179 -GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 237
Query: 107 FGMCVLEM 114
           FG+ + E+
Sbjct: 238 FGLVLWEV 245

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA--ILRGSQQAHSV 82
           +A +I  G+ +L      +I+RDLK DN+ ++   G IKI D G+    I  G       
Sbjct: 447 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVT-TKXF 502
Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
            GTP+++APE+   + Y + VD ++FG+ + EML  + P+
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 9/132 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H     +IHRDLK  N+ VN    +++I D GLA   +  ++    + T  
Sbjct: 131 QLLRGLKYIHSAG--IIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADEEMTGYVATRW 185
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
           + APE+      YN+ VDI+S G  + E+L  +  +P S+  +  +   +V     P   
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 245
Query: 144 HRIQDAEARRFV 155
            +I    AR ++
Sbjct: 246 AKISSEHARTYI 257

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y +  T +D  +       I  G+A+LH         P + HRDLK  NI V  +
Sbjct: 91  GSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-----IGTPEFMAPELYEE-------DYNELVDIYS 106
            GQ  I DLGLA +   S     V     +GT  +MAPE+ +E       D  + VDI++
Sbjct: 150 -GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208
Query: 107 FGMCVLEM 114
           FG+ + E+
Sbjct: 209 FGLVLWEV 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKE 170
           L+   P+   ++    A I     S      F       A+ F+ K L +   KRL  +E
Sbjct: 212 LSGASPFLGDTKQETLANITS--VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 171 LLLDPFLA 178
            L  P++ 
Sbjct: 270 ALRHPWIT 277

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIF-VNGHLGQ--IKIGDLGLAAILRGSQQAHSVI 83
           R ++ G+ +L   +  ++HR++K  NI  V G  GQ   K+ D G A  L   +Q  S+ 
Sbjct: 119 RDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 84  GTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIY 131
           GT E++ P++YE         + Y   VD++S G+      T   P+     P    ++ 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 132 KKVTSGKLPGAFHRIQDAE 150
            K+ +GK  GA   +Q AE
Sbjct: 237 YKIITGKPSGAISGVQKAE 255

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-VI 83
           + + +++GI YLH     +IHRD+K  N+ V G  G IKI D G++   +GS    S  +
Sbjct: 142 YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 84  GTPEFMAPELYEEDY----NELVDIYSFGMCVLEMLTSEYPYSE 123
           GTP FMAPE   E       + +D+++ G+ +   +  + P+ +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKE 170
           L+   P+   ++    A I     S      F       A+ F+ K L +   KRL  +E
Sbjct: 212 LSGASPFLGDTKQETLANITS--VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 171 LLLDPFLA 178
            L  P++ 
Sbjct: 270 ALRHPWIT 277

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y +  T +D  +       I  G+A+LH         P + HRDLK  NI V  +
Sbjct: 91  GSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-----IGTPEFMAPELYEE-------DYNELVDIYS 106
            GQ  I DLGLA +   S     V     +GT  +MAPE+ +E       D  + VDI++
Sbjct: 150 -GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208
Query: 107 FGMCVLEM 114
           FG+ + E+
Sbjct: 209 FGLVLWEV 216

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI   GLA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILGFGLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G + +Y   + R   +  +   RQI+  + Y H     ++HRDLK +N+ ++     I
Sbjct: 96  SGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH--QKFIVHRDLKAENLLLDADX-NI 152
Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D G +       +  +  G P + APEL++ + Y+   VD++S G+ +  +++   P
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150
           + +  N  ++ ++V  GK    F+   D E
Sbjct: 213 F-DGQNLKELRERVLRGKYRIPFYXSTDCE 241

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NG 57
           + + G L ++  +   +      ++ +QIL G+ YLH     + H DLK +NI +   N 
Sbjct: 96  LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNI 153
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEM 114
            +  IK+ D GLA  +    +  ++ GTPEF+APE+   +Y  L    D++S G+    +
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYIL 211
Query: 115 LTSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKE 170
           L+   P+   ++    A I     S      F       A+ F+ K L +   KRL  +E
Sbjct: 212 LSGASPFLGDTKQETLANITS--VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 171 LLLDPFLA 178
            L  P++ 
Sbjct: 270 ALRHPWIT 277

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 11/140 (7%)
Query: 5   GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y + +  R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 101 GSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTPE----FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E    + APE L E  ++   D++SFG+ + E+ T  
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 215
Query: 119 YPYSECSNPAQIYKKVTSGK 138
           Y     S PA+  + + + K
Sbjct: 216 YIEKSKSPPAEFMRMIGNDK 235

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T + +  +K++  Q+L+G+++ H H   V+HRDLK  N+ +N   G IK+ D GLA    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLSFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 154
Query: 75  GSQQ--AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
              +   H V+ T  + APE+    + Y+  VDI+S G    EM+T    +   S   Q+
Sbjct: 155 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 131 YK 132
           ++
Sbjct: 214 FR 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 133 HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             V K L +N   R      +    +    GEP   P+V
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQAHSVI 83
           +A +I  G+ +LH     +I+RDLK DN+ ++   G IKI D G+    +          
Sbjct: 125 YAAEISIGLFFLHKRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMMDGVTTREFC 181
Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           GTP+++APE+   + Y + VD +++G+ + EML  + P+
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 63/128 (49%), Gaps = 10/128 (7%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G L +Y  +   +  +  +   R +L  I  LH  +  ++HRDLK +NI ++  + 
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM- 161
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLE 113
            IK+ D G +  L   ++   V GTP ++APE+ E         Y + VD++S G+ +  
Sbjct: 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 114 MLTSEYPY 121
           +L    P+
Sbjct: 222 LLAGSPPF 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D  LA       +    + T  
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFYLAR--HTDDEMTGYVATRW 187
Query: 88  FMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE+      YN+ VDI+S G  + E+LT    +    +  Q+   +     PGA   
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLI 187
            +I    AR ++ + L  + K   A   +    LA D  E +L+
Sbjct: 248 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           Q+L  + YLH  D  ++HRDLK +N+         +I I D GL+ +        +  GT
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---PG 141
           P ++APE L ++ Y++ VD +S G+    +L    P+ +  N A++++++   +      
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSP 240
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +  I D+ A+ F+   +E +  KR   ++ L  P++A D  
Sbjct: 241 YWDDISDS-AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA--ILRGSQQAHSV 82
           +A +I  G+ +L      +I+RDLK DN+ ++   G IKI D G+    I  G       
Sbjct: 126 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVT-TKXF 181
Query: 83  IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
            GTP+++APE+   + Y + VD ++FG+ + EML  + P+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 10/108 (9%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLG--LAAILRGSQQAHSVIGTPEFMAPELYEE 96
           H    +HRD+K DNI ++ + G I++ D G  L  +  G+ Q+   +GTP++++PE+ + 
Sbjct: 192 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 97  ------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
                  Y    D +S G+C+ EML  E P+    +  + Y K+ + K
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHK 297

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 133 HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             V K L +N   R      +    +    GEP   P+V
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           Q+L  + YLH  D  ++HRDLK +N+         +I I D GL+ +        +  GT
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---PG 141
           P ++APE L ++ Y++ VD +S G+    +L    P+ +  N A++++++   +      
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSP 240
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +  I D+ A+ F+   +E +  KR   ++ L  P++A D  
Sbjct: 241 YWDDISDS-AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 133 HQNGIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             V K L +N   R      +    +    GEP   P+V
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 93/183 (50%), Gaps = 21/183 (11%)
Query: 33  IAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA--ILRGSQQAHSVIGTPEFMA 90
           +A  H H   +I+RD+K +NI ++ + G + + D GL+   +   +++A+   GT E+MA
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 91  PELY---EEDYNELVDIYSFGMCVLEMLTSEYPYS---ECSNPAQIYKKVTSGKLPGAFH 144
           P++    +  +++ VD +S G+ + E+LT   P++   E ++ A+I +++   + P  + 
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YP 286
Query: 145 RIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVME 204
           +   A A+  + + L     + P K L   P  A +  E L       FQ +N +    +
Sbjct: 287 QEMSALAKDLIQRLL----MKDPKKRLGCGPRDADEIKEHLF------FQKINWDDLAAK 336
Query: 205 LVP 207
            VP
Sbjct: 337 KVP 339

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 63/128 (49%), Gaps = 10/128 (7%)
Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           +   G L +Y  +   +  +  +   R +L  I  LH  +  ++HRDLK +NI ++  + 
Sbjct: 92  LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM- 148
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLE 113
            IK+ D G +  L   ++   V GTP ++APE+ E         Y + VD++S G+ +  
Sbjct: 149 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 208
Query: 114 MLTSEYPY 121
           +L    P+
Sbjct: 209 LLAGSPPF 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           Q+L  + YLH  D  ++HRDLK +N+         +I I D GL+ +        +  GT
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---PG 141
           P ++APE L ++ Y++ VD +S G+    +L    P+ +  N A++++++   +      
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSP 240
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +  I D+ A+ F+   +E +  KR   ++ L  P++A D  
Sbjct: 241 YWDDISDS-AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 2   FTSGTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---N 56
             + TL+EY  +K +  + +  +    +Q   G+A+LH  +  ++HRDLK  NI +   N
Sbjct: 99  LCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPN 155
Query: 57  GHLGQIK--IGDLGLAAILRGSQQAHS----VIGTPEFMAPELYEEDYNE----LVDIYS 106
            H G+IK  I D GL   L   + + S    V GT  ++APE+  ED  E     VDI+S
Sbjct: 156 AH-GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-----FH--RIQDAEARRFVGKCL 159
            G CV       Y  SE S+P     +  +  L GA      H  + +D  AR  + K +
Sbjct: 215 AG-CVF-----YYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268
Query: 160 E-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLN 197
             +  KR  AK +L  PF  S      L  Q+  FQ+++
Sbjct: 269 AMDPQKRPSAKHVLKHPFFWS------LEKQLQFFQDVS 301

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 133 HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             V K L +N   R      +    +    GEP   P+V
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 133 HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             V K L +N   R      +    +    GEP   P+V
Sbjct: 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 20/130 (15%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV----- 82
           QI   + +LH     ++HRDLK  NIF       +K+GD GL   +   ++  +V     
Sbjct: 126 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 83  --------IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
                   +GT  +M+PE ++   Y+  VDI+S G+ + E+L   YP+S      +    
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTD 239
Query: 134 VTSGKLPGAF 143
           V + K P  F
Sbjct: 240 VRNLKFPPLF 249

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 35/201 (17%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNG 57
           +G+L +Y K  T +D +++   A   + G+ +LH         P + HRDLK  NI V  
Sbjct: 119 NGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSV-----IGTPEFMAPELYEEDYNE-------LVDIY 105
           + G   I DLGLA           +     +GT  +M PE+ +E  N        + D+Y
Sbjct: 178 N-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236
Query: 106 SFGM--------CVLEMLTSEY--PYSEC--SNPA--QIYKKVTSGKLPGAF-HRIQDAE 150
           SFG+        CV   +  EY  PY +   S+P+   + + V   KL  +F +R    E
Sbjct: 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE 296
Query: 151 ARRFVGKCLENVSKRLPAKEL 171
             R +GK +       PA  L
Sbjct: 297 CLRQMGKLMTECWAHNPASRL 317

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 20/130 (15%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV----- 82
           QI   + +LH     ++HRDLK  NIF       +K+GD GL   +   ++  +V     
Sbjct: 172 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 83  --------IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
                   +GT  +M+PE ++  +Y+  VDI+S G+ + E+L   Y +S      +I   
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITD 285
Query: 134 VTSGKLPGAF 143
           V + K P  F
Sbjct: 286 VRNLKFPLLF 295

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIF-VNGHLGQ--IKIGDLGLAAILRGSQQAHSVI 83
           R ++ G+ +L   +  ++HR++K  NI  V G  GQ   K+ D G A  L   +Q   + 
Sbjct: 119 RDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY 176
Query: 84  GTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIY 131
           GT E++ P++YE         + Y   VD++S G+      T   P+     P    ++ 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 132 KKVTSGKLPGAFHRIQDAE 150
            K+ +GK  GA   +Q AE
Sbjct: 237 YKIITGKPSGAISGVQKAE 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           Q+L  + YLH  D  ++HRDLK +N+         +I I D GL+ +        +  GT
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---PG 141
           P ++APE L ++ Y++ VD +S G+    +L    P+ +  N A++++++   +      
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSP 240
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +  I D+ A+ F+   +E +  KR   ++ L  P++A D  
Sbjct: 241 YWDDISDS-AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 281

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 64/119 (53%), Gaps = 9/119 (7%)
Query: 4   SGTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           SG+L+EY  K   +++++    +A QI +G+ YL       +HRDL   N+ V     Q+
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQV 165
Query: 63  KIGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           KIGD GL   +   ++  +V     +P F  APE L +  +    D++SFG+ + E+LT
Sbjct: 166 KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 36/181 (19%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L+G+ Y+H     V+HRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRW 188
Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE  L    YN+ VDI+S G  + EMLT +  +       Q+ + +    +PG    
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 144 HRIQDAEARRFVG--------------------------KCLE-NVSKRLPAKELLLDPF 176
            ++ D  A+ ++                           K LE +V KRL A + L  PF
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 177 L 177
Sbjct: 309 F 309

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 125 GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 184 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 301 EALRVMAKIMRECWYANGAARLTA 324

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 36/181 (19%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L+G+ Y+H     V+HRDLK  N+ VN    ++KI D GLA       +    + T  
Sbjct: 152 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRW 206
Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--F 143
           + APE  L    YN+ VDI+S G  + EMLT +  +       Q+ + +    +PG    
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266
Query: 144 HRIQDAEARRFVG--------------------------KCLE-NVSKRLPAKELLLDPF 176
            ++ D  A+ ++                           K LE +V KRL A + L  PF
Sbjct: 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326
Query: 177 L 177
Sbjct: 327 F 327

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 64/119 (53%), Gaps = 9/119 (7%)
Query: 4   SGTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           SG+L+EY  K   +++++    +A QI +G+ YL       +HRDL   N+ V     Q+
Sbjct: 97  SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQV 153
Query: 63  KIGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           KIGD GL   +   ++  +V     +P F  APE L +  +    D++SFG+ + E+LT
Sbjct: 154 KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 112 GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 170
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 171 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 227
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 228 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 287
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 288 EALRVMAKIMRECWYANGAARLTA 311

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQAHSVIGTPEFMAPELY 94
           H   +IHRD+K  NI ++     +K+ D G+A  +  S     Q  +VIGT ++++PE  
Sbjct: 150 HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 95  EED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEAR 152
             D  +   D+YS G  + E+LT E P++  S  +  Y+ V    + P A H    A+  
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 268
Query: 153 RFVGKCL 159
             V K L
Sbjct: 269 AVVLKAL 275

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 87  GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 145
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 146 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 202
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 203 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 262
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 263 EALRVMAKIMRECWYANGAARLTA 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 92  GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 150
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 151 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 207
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 208 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 267
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 268 EALRVMAKIMRECWYANGAARLTA 291

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 13/93 (13%)
Query: 39  HDPPVIHRDLKCDNIF--VNGHLGQIKIGDLGLAAILR--GSQQAHSVIGTPEFMAPELY 94
           H    +HRD+K DN+   VNGH   I++ D G    +   G+ Q+   +GTP++++PE+ 
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 95  E--ED----YNELVDIYSFGMCVLEMLTSEYPY 121
           +  ED    Y    D +S G+C+ EML  E P+
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 2/115 (1%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +K +  Q++R I  LH     V HRD+K  N+ VN   G +K+ D G A  L  S+   +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 82  VIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            I +  + APEL    + Y   VDI+S G    EM+  E  +   ++  Q+++ V
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 86  GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 145 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 262 EALRVMAKIMRECWYANGAARLTA 285

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y K    + +  +K +  Q+LR +AY+H     + HRD+K  N+ ++   G +K+ D 
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A IL   +   S I +  + APEL     +Y   +DI+S G  + E++  +
Sbjct: 187 GSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 13/93 (13%)
Query: 39  HDPPVIHRDLKCDNIF--VNGHLGQIKIGDLGLAAILR--GSQQAHSVIGTPEFMAPELY 94
           H    +HRD+K DN+   VNGH   I++ D G    +   G+ Q+   +GTP++++PE+ 
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGH---IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 95  E--ED----YNELVDIYSFGMCVLEMLTSEYPY 121
           +  ED    Y    D +S G+C+ EML  E P+
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 19/108 (17%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ------ 77
           ++A+ I  G+AYLH  +  +IHRDL   N  V  +   + + D GLA ++   +      
Sbjct: 112 SFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGL 168
Query: 78  ---------QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEML 115
                    + ++V+G P +MAPE+     Y+E VD++SFG+ + E++
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 176 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 176 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 89  GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 147
Query: 59  LGQIKIGDLGLAAILRGSQQAHSV-------IGTPEFMAPELYEEDYN-------ELVDI 104
            G   I DLGLA  +R      ++       +GT  +MAPE+ ++  N       +  DI
Sbjct: 148 -GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 204
Query: 105 YSFGMCVLEMLTS----------EYPYSEC--SNPA--QIYKKVTSGKL-PGAFHRIQDA 149
           Y+ G+   E+             + PY +   S+P+  ++ K V   KL P   +R Q  
Sbjct: 205 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 264
Query: 150 EARRFVGKCLE-----NVSKRLPA 168
           EA R + K +      N + RL A
Sbjct: 265 EALRVMAKIMRECWYANGAARLTA 288

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI--FVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           RQ+L  + YLH     ++HRDLK +N+  +      +I I D GL+ +        +  G
Sbjct: 127 RQVLDAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---P 140
           TP ++APE L ++ Y++ VD +S G+    +L    P+ +  N +++++++   +     
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDSKLFEQILKAEYEFDS 243
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
             +  I D+ A+ F+   +E + +KR   ++    P++A D  
Sbjct: 244 PYWDDISDS-AKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTA 285

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSV 82
           +  Q+LRG+ Y+H  +  V+HRDLK  N+F+N     +KIGD GLA I+    S + H  
Sbjct: 125 FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 83  IG--TPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
            G  T  + +P L     +Y + +D+++ G    EMLT +  ++      Q+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 66/118 (55%), Gaps = 11/118 (9%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  +++ + +  +  +A+QI  G+AYLH      IHRDL   N+ + N  L  +K
Sbjct: 120 GSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRL--VK 174
Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           IGD GLA  +    + + V     +P F  APE L E  +    D++SFG+ + E+LT
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 6/117 (5%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRG 75
           +++  VK +  Q+L+G+A+ H  +  ++HRDLK  N+ +N   GQ+K+GD GLA A    
Sbjct: 105 LELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIP 161
Query: 76  SQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI 130
                S + T  + AP++      Y+  +DI+S G  + EM+T +  +   ++  Q+
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 62/115 (53%), Gaps = 8/115 (6%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--LRGSQQA 79
           +K +  Q+LRG+A+ H H   ++HRDLK  N+ +N   G +K+ D GLA    +      
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYT 177
Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           H V+ T  + AP++    + Y+  VDI+S G    EM+T +  +   ++  Q+ K
Sbjct: 178 HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 62/115 (53%), Gaps = 8/115 (6%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--LRGSQQA 79
           +K +  Q+LRG+A+ H H   ++HRDLK  N+ +N   G +K+ D GLA    +      
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYT 177
Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
           H V+ T  + AP++    + Y+  VDI+S G    EM+T +  +   ++  Q+ K
Sbjct: 178 HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 5/118 (4%)
Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRGSQ 77
           R   +  +QIL  +AYLH +   ++HRDLK +N+          +KI D GL+ I+    
Sbjct: 148 RDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 78  QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
              +V GTP + APE+     Y   VD++S G+    +L    P+ +      +++++
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 8/119 (6%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLK--CDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AH 80
           ++ RQIL  + Y H  D  +IHRD+K  C  +    +   +K+G  G+A  L  S   A 
Sbjct: 136 HYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 193
Query: 81  SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
             +GTP FMAPE+ + E Y + VD++  G+ +  +L+   P+       ++++ +  GK
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGK 250

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 13/162 (8%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLK--CDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AH 80
           ++ RQIL  + Y H  D  +IHRD+K  C  +    +   +K+G  G+A  L  S   A 
Sbjct: 134 HYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 81  SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
             +GTP FMAPE+ + E Y + VD++  G+ +  +L+   P+       ++++ +  GK 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGKY 249
Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
              P  +  I ++ A+  V + L  + ++R+   E L  P+L
Sbjct: 250 KMNPRQWSHISES-AKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 26  ARQILRGIAYLH---------GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           A  + RG++YLH         GH P + HRD K  N+ +   L  + + D GLA      
Sbjct: 118 AETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPG 176
Query: 77  Q---QAHSVIGTPEFMAPEL------YEEDYNELVDIYSFGMCVLEMLT 116
           +     H  +GT  +MAPE+      ++ D    +D+Y+ G+ + E+++
Sbjct: 177 KPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 202 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 138 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 195
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 196 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 146 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 203
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 204 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  +K+ R D +    +  ++   + Y H  +  VIHRD+K +N+ + G+ G++KI
Sbjct: 100 GELYKELQKHGRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLM-GYKGELKI 156
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E + ++E VD++  G+   E L    P+  
Sbjct: 157 ADFGW-SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
            S+  + ++++ +  L   F       ++  + K L  +  +RLP K ++  P++ +++
Sbjct: 216 PSH-TETHRRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 271

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 148 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 205
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 206 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH--SVIGTPEFMAPELYEE 96
           H   +IHRD+K DN+ ++ H G +K+ D G    +  +   H  + +GTP++++PE+ + 
Sbjct: 191 HSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE- 150
                 Y    D +S G+ + EML  + P+    +    Y K+   K    F   +DAE 
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDHKNSLCFP--EDAEI 306
Query: 151 ---ARRFVGKCLENVSKRL---PAKELLLDPFLASD 180
              A+  +   L +   RL     +E+   PF  +D
Sbjct: 307 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 342

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 189 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 246
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 247 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  +K+ R D +    +  ++   + Y H  +  VIHRD+K +N+ + G+ G++KI
Sbjct: 99  GELYKELQKHGRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLM-GYKGELKI 155
Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G  ++   S +   + GT +++ PE+ E + ++E VD++  G+   E L    P+  
Sbjct: 156 ADFGW-SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
            S+  + ++++ +  L   F       ++  + K L  +  +RLP K ++  P++ +++
Sbjct: 215 PSH-TETHRRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 115 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 172
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 173 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 118 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 175
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 176 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 122 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 179
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 180 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 129 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 186
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 187 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 122 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 179
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 180 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 123 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 180
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 181 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IK+ D G+A  +    +  +
Sbjct: 120 FLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IK+ D G+A  +    +  +
Sbjct: 113 FLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 171 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 111 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 168
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 169 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--LRGSQQAH 80
           K++  Q+L GIAY H  D  V+HRDLK  N+ +N   G++KI D GLA    +   +  H
Sbjct: 103 KSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTH 159
Query: 81  SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
            V+ T  + AP++    + Y+  +DI+S G    EM+     +   S   Q+ +
Sbjct: 160 EVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--LRGSQQAH 80
           K++  Q+L GIAY H  D  V+HRDLK  N+ +N   G++KI D GLA    +   +  H
Sbjct: 103 KSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTH 159
Query: 81  SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
            V+ T  + AP++    + Y+  +DI+S G    EM+     +   S   Q+ +
Sbjct: 160 EVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMR 212

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 64/121 (52%), Gaps = 8/121 (6%)
Query: 1   MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           +   G L EY  ++   +  + + NW  QI +G+ YL   +  ++HRDL   N+ V    
Sbjct: 97  LMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSP- 153
Query: 60  GQIKIGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
             +KI D GLA +L G ++ ++  G     ++MA E ++   +    D++S+G+ + E++
Sbjct: 154 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 213
Query: 116 T 116
           T
Sbjct: 214 T 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 8   REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL 67
           R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D 
Sbjct: 114 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 171
Query: 68  GLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +
Sbjct: 172 GSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IK+ D G+A  +    +  +
Sbjct: 134 FLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTPEF+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 192 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           + RQ+ +G+ ++H ++   +H DLK +NI F      ++K+ D GL A L   Q      
Sbjct: 154 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211
Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--- 139
           GT EF APE+ E +      D++S G+    +L+   P+    N  +  + V S      
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD 270
Query: 140 PGAFHRIQDAEARRFVGK-CLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPS 192
             AF  I + + + F+ K  L + + R+   + L  P+L +    P    Q+PS
Sbjct: 271 DSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWL-TPGNAPGRDSQIPS 322

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 10/103 (9%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQQAHS 81
           + +QIL G+ YLH     + H DLK +NI +   N    +IKI D GLA  +    +  +
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 82  VIGTPEFMAPELYEEDYNEL---VDIYSFGMCVLEMLTSEYPY 121
           + GTP F+APE+   +Y  L    D++S G+    +L+   P+
Sbjct: 177 IFGTPAFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 63/121 (52%), Gaps = 8/121 (6%)
Query: 1   MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           +   G L EY  ++   +  + + NW  QI +G+ YL      ++HRDL   N+ V    
Sbjct: 120 LMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP- 176
Query: 60  GQIKIGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
             +KI D GLA +L G ++ ++  G     ++MA E ++   +    D++S+G+ + E++
Sbjct: 177 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236
Query: 116 T 116
           T
Sbjct: 237 T 237

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI--LRGSQQAH 80
           K++  Q+L GIAY H  D  V+HRDLK  N+ +N   G++KI D GLA    +   +  H
Sbjct: 103 KSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTH 159
Query: 81  SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
            ++ T  + AP++    + Y+  +DI+S G    EM+     +   S   Q+ +
Sbjct: 160 EIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           + RQ+ +G+ ++H ++   +H DLK +NI F      ++K+ D GL A L   Q      
Sbjct: 260 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--- 139
           GT EF APE+ E +      D++S G+    +L+   P+    N  +  + V S      
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD 376
Query: 140 PGAFHRIQDAEARRFVGK-CLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPS 192
             AF  I + + + F+ K  L + + R+   + L  P+L +    P    Q+PS
Sbjct: 377 DSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWL-TPGNAPGRDSQIPS 428

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 11/118 (9%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  +++ + +  +  +A+QI  G+AYLH      IHR+L   N+ + N  L  +K
Sbjct: 103 GSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRNLAARNVLLDNDRL--VK 157
Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           IGD GLA  +    + + V     +P F  APE L E  +    D++SFG+ + E+LT
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 26/138 (18%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-------HDPPVIHRDLKCDNIF 54
           + +G+L +Y   +T   + + +  A  + RG+AYLH        + P + HRDL   N+ 
Sbjct: 94  YPNGSLXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 55  VNGHLGQIKIGDLGLAAILRGSQ---------QAHSVIGTPEFMAPELYEEDYN------ 99
           V    G   I D GL+  L G++          A S +GT  +MAPE+ E   N      
Sbjct: 153 VKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 100 --ELVDIYSFGMCVLEML 115
             + VD+Y+ G+   E+ 
Sbjct: 212 ALKQVDMYALGLIYWEIF 229

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 11/118 (9%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  +++ + +  +  +A+QI  G+AYLH      IHR+L   N+ + N  L  +K
Sbjct: 103 GSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQH--YIHRNLAARNVLLDNDRL--VK 157
Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           IGD GLA  +    + + V     +P F  APE L E  +    D++SFG+ + E+LT
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 12/97 (12%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ------A 79
           A+    GI +LH +    IHRD+K  NI ++      KI D GLA   R S++       
Sbjct: 139 AQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLA---RASEKFAQTVMX 192
Query: 80  HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT 116
             ++GT  +MAPE    +     DIYSFG+ +LE++T
Sbjct: 193 SRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI--FVNGHLGQIKIGDLG 68
           R  YT  D   V    +Q+L  + YLH  +  ++HRDLK +N+         +I I D G
Sbjct: 100 RGVYTEKDASLV---IQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 69  LAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
           L+ + +    + +  GTP ++APE L ++ Y++ VD +S G+    +L    P+ E    
Sbjct: 155 LSKMEQNGIMS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETE 212
Query: 128 AQIYKKVTSG 137
           +++++K+  G
Sbjct: 213 SKLFEKIKEG 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 12/97 (12%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ------A 79
           A+    GI +LH +    IHRD+K  NI ++      KI D GLA   R S++       
Sbjct: 139 AQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLA---RASEKFAQTVMX 192
Query: 80  HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT 116
             ++GT  +MAPE    +     DIYSFG+ +LE++T
Sbjct: 193 XRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA I    +  H+      
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLINTTC-DLKICDFGLARI-ADPEHDHTGFLTEX 207
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAAILRGSQQAH 80
           V N+ RQ   G+ ++H H   ++H D+K +NI         +KI D GLA  L   +   
Sbjct: 151 VINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 81  SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS--ECSNPAQIYKKVTSG 137
               T EF APE+ + E      D+++ G+    +L+   P++  +     Q  K+    
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 268
Query: 138 KLPGAFHRIQDAEARRFVGKCLENV-SKRLPAKELLLDPFLASDAGEPLLIPQVPS 192
               AF  +   EA+ F+   L+    KRL   + L  P+L  D     L  ++PS
Sbjct: 269 FDEDAFSSVS-PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN--LTSRIPS 321

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 12/97 (12%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ------A 79
           A+    GI +LH +    IHRD+K  NI ++      KI D GLA   R S++       
Sbjct: 133 AQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLA---RASEKFAQXVMX 186
Query: 80  HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT 116
             ++GT  +MAPE    +     DIYSFG+ +LE++T
Sbjct: 187 XRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 223

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAAILRG 75
           V +   + +A+Q+   + +L   +  +IH DLK +NI + N     IKI D G +  L  
Sbjct: 135 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-- 192
Query: 76  SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            Q+ +  I +  + +PE L    Y+  +D++S G  ++EM T E  +S  +   Q+ K V
Sbjct: 193 GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252
Query: 135 TSGKLPGAFHRIQDAEARRFVGK 157
               +P A    Q  +AR+F  K
Sbjct: 253 EVLGIPPAHILDQAPKARKFFEK 275

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 107 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 163
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 164 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAAILRG 75
           V +   + +A+Q+   + +L   +  +IH DLK +NI + N     IKI D G +  L  
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-- 211
Query: 76  SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            Q+ +  I +  + +PE L    Y+  +D++S G  ++EM T E  +S  +   Q+ K V
Sbjct: 212 GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271
Query: 135 TSGKLPGAFHRIQDAEARRFVGK 157
               +P A    Q  +AR+F  K
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEK 294

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 126 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 182
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 183 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 102 GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 158
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 159 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 108 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 164
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 165 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 103 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 160 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 111 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 167
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 168 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 108 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 164
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 165 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 102 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 158
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 159 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 95  GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 151
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 108 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 164
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 165 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 104 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 160
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 161 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 103 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 160 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 104 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 160
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 161 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 105 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 161
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 162 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 104 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 160
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 161 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 104 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 160
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 161 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 64/118 (54%), Gaps = 11/118 (9%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  ++  V +  +  +A+QI  G+AYLH      IHR L   N+ + N  L  +K
Sbjct: 98  GSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQH--YIHRALAARNVLLDNDRL--VK 152
Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           IGD GLA  +    + + V     +P F  APE L E  +    D++SFG+ + E+LT
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 135 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 191
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 192 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/118 (35%), Positives = 64/118 (54%), Gaps = 11/118 (9%)
Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIK 63
           G+LR+Y  ++  V +  +  +A+QI  G+AYLH      IHR L   N+ + N  L  +K
Sbjct: 97  GSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQH--YIHRALAARNVLLDNDRL--VK 151
Query: 64  IGDLGLAAILRGSQQAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           IGD GLA  +    + + V     +P F  APE L E  +    D++SFG+ + E+LT
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L   R+   R+  + + NW  QI +G++YL   D  ++HRDL   N+ V      +KI D
Sbjct: 106 LDHVRENRGRLGSQDLLNWCMQIAKGMSYL--EDVRLVHRDLAARNVLVKSP-NHVKITD 162
Query: 67  LGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
            GLA +L   +  +   G     ++MA E +    +    D++S+G+ V E++T
Sbjct: 163 FGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQIKIGDLGLAAILRG 75
           V +   + +A+Q+   + +L   +  +IH DLK +NI + N     IKI D G +  L  
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL-- 211
Query: 76  SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
            Q+ +  I +  + +PE L    Y+  +D++S G  ++EM T E  +S  +   Q+ K V
Sbjct: 212 GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271
Query: 135 TSGKLPGAFHRIQDAEARRFVGK 157
               +P A    Q  +AR+F  K
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEK 294

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
           R + ++  Q+   + +LH H+  + H D++ +NI +       IKI + G A  L+    
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 79  AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
              +   PE+ APE+++ D  +   D++S G  V  +L+   P+   +N  QI + + + 
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNA 218
Query: 138 KLP---GAFHRIQDAEARRFVGKCLENVSK-RLPAKELLLDPFL 177
           +      AF  I   EA  FV + L    K R+ A E L  P+L
Sbjct: 219 EYTFDEEAFKEI-SIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQAH 80
           VK+   Q L+ + + H H+   IHRD+K +NI +  H   IK+ D G A +L G S    
Sbjct: 104 VKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYD 160
Query: 81  SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
             + T  + +PEL   D  Y   VD+++ G    E+L+    +   S+  Q+Y
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TSDLKICDFGLARV-ADPDHDHTGFLTEY 189
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKIXDFGLARV-ADPDHDHTGFLTEY 187
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKICDFGLARV-ADPDHDHTGFLTEY 187
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 14/141 (9%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           LR++  ++T + +  +    R I  G+ YL   D   +HRDL   NI +N +L   K+ D
Sbjct: 137 LRKHDAQFTVIQLVGM---LRGIASGMKYLS--DMGAVHRDLAARNILINSNL-VCKVSD 190
Query: 67  LGLAAILRGS-QQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYP 120
            GL+ +L    + A++  G      + +PE +    +    D++S+G+ + E+++  E P
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 121 YSECSNPAQIYKKVTSG-KLP 140
           Y E SN   + K V  G +LP
Sbjct: 251 YWEMSN-QDVIKAVDEGYRLP 270

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKICDFGLARV-ADPDHDHTGFLTEY 187
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI  G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 98  GCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 154
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D GLA +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 155 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIF--VNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           + +L  +AY H  +  V HRDLK +N     +     +K+ D GLAA  +  +   + +G
Sbjct: 113 KDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 85  TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           TP +++P++ E  Y    D +S G+ +  +L    P+S  ++  ++  K+  G
Sbjct: 171 TPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREG 222

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKICDFGLARV-ADPDHDHTGFLTEY 191
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ----AHSVI 83
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 84  GTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
            T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ----AHSVI 83
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +              +
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 84  GTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
            T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKICDFGLARV-ADPDHDHTGFLTEY 191
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 12/97 (12%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ------A 79
           A+    GI +LH +    IHRD+K  NI ++      KI D GLA   R S++       
Sbjct: 130 AQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLA---RASEKFAQXVXX 183
Query: 80  HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT 116
             ++GT  + APE    +     DIYSFG+ +LE++T
Sbjct: 184 SRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 187
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRG 75
           +++  VK +  Q+LRG+AY H     V+HRDLK  N+ +N   G++K+ D GLA A    
Sbjct: 97  INMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIP 153
Query: 76  SQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           ++   + + T  +  P+  L   DY+  +D++  G    EM T 
Sbjct: 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TXDLKICDFGLARV-ADPDHDHTGFLTEY 207
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIF--VNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           + +L  +AY H  +  V HRDLK +N     +     +K+ D GLAA  +  +   + +G
Sbjct: 130 KDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 187
Query: 85  TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           TP +++P++ E  Y    D +S G+ +  +L    P+S  ++  ++  K+  G
Sbjct: 188 TPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREG 239

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 189
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSVIGTPEFMAPELYEE 96
           H    IHRD+K DN+ ++   G +K+ D G    +   G  +  + +GTP++++PE+ + 
Sbjct: 185 HSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--A 149
                 Y    D +S G+ + EML  + P+    +    Y K+ + K    F    D   
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDISK 302
Query: 150 EARRFVGKCLENVSKRL 166
           EA+  +   L +   RL
Sbjct: 303 EAKNLICAFLTDREVRL 319

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 189
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 38/198 (19%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG------SQQAHS 81
           Q  R + ++H   PP+IHRDLK +N+ ++   G IK+ D G A  +        S Q  +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 82  VI-------GTPEFMAPELYEEDYN----ELVDIYSFGMCVLEMLT-SEYPYSECSNPAQ 129
           ++        TP +  PE+ +   N    E  DI++ G C+L +L   ++P+ + +    
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFEDGAK--- 258
Query: 130 IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
              ++ +GK     H  Q       +   L+ N  +RL   E++              + 
Sbjct: 259 --LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ------------LQ 304
Query: 189 QVPSFQNLNPNGAVMELV 206
           ++ + +N+NP   + EL+
Sbjct: 305 EIAAARNVNPKSPITELL 322

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 191
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 191
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 192
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 138 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 193
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 129 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 184
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 191
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSVIGTPEFMAPELYEE 96
           H    IHRD+K DN+ ++   G +K+ D G    +   G  +  + +GTP++++PE+ + 
Sbjct: 190 HSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--A 149
                 Y    D +S G+ + EML  + P+    +    Y K+ + K    F    D   
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 150 EARRFVGKCLENVSKRL 166
           EA+  +   L +   RL
Sbjct: 308 EAKNLICAFLTDREVRL 324

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 185
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 140 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 195
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 187
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 39  HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHSVIGTPEFMAPELYEE 96
           H    IHRD+K DN+ ++   G +K+ D G    +   G  +  + +GTP++++PE+ + 
Sbjct: 190 HSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 97  D-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--A 149
                 Y    D +S G+ + EML  + P+    +    Y K+ + K    F    D   
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 150 EARRFVGKCLENVSKRL 166
           EA+  +   L +   RL
Sbjct: 308 EAKNLICAFLTDREVRL 324

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 207
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS-----V 82
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA +       H+      
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARV-ADPDHDHTGFLTEY 185
Query: 83  IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
           + T  + APE  L  + Y + +DI+S G  + EML++
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSV 82
           +++ QI  G+A++   +   IHRDL+  NI V+  L   KI D GLA ++  ++  A   
Sbjct: 115 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG 171
Query: 83  IGTP-EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
              P ++ APE      +    D++SFG+ ++E++T    PY   SNP  I
Sbjct: 172 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
           +K +    L+G+ YLH H   ++HRDLK +N+ ++ + G +K+ D GLA       +A  
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYX 170
Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           H V+ T  + APEL      Y   VD+++ G C+L  L    P+
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVG-CILAELLLRVPF 212

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 69/138 (50%), Gaps = 20/138 (14%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL---AAIL 73
           +D+   +  A++I++G+ YLH     ++H+DLK  N+F +   G++ I D GL   + +L
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN--GKVVITDFGLFSISGVL 182
Query: 74  RGSQQAHSVI---GTPEFMAPELY-------EED---YNELVDIYSFGMCVLEMLTSEYP 120
           +  ++   +    G    +APE+        EED   +++  D+++ G    E+   E+P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 121 YSECSNPAQIYKKVTSGK 138
           +      A I++  T  K
Sbjct: 243 FKTQPAEAIIWQMGTGMK 260

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G+ + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G+ + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSV 82
           +++ QI  G+A++   +   IHRDL+  NI V+  L   KI D GLA ++  ++  A   
Sbjct: 288 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG 344
Query: 83  IGTP-EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
              P ++ APE      +    D++SFG+ ++E++T    PY   SNP  I
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHS 81
           NW  QI +G+ YL  H   ++HR+L   N+ +     Q+++ D G+A +L     Q  +S
Sbjct: 137 NWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYS 193
Query: 82  VIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYS 122
              TP ++MA E ++   Y    D++S+G+ V E++T    PY+
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 103 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 160 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 103 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 160 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL--RGSQQAHS 81
           NW  QI +G+ YL  H   ++HR+L   N+ +     Q+++ D G+A +L     Q  +S
Sbjct: 119 NWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYS 175
Query: 82  VIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYS 122
              TP ++MA E ++   Y    D++S+G+ V E++T    PY+
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 157
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 158 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 103 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 159
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 160 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 105 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 161
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 162 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL   D  ++HRDL   N+ V      +K
Sbjct: 108 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP-QHVK 164
Query: 64  IGDLGLAAILRGSQQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G A +L   ++ +   G     ++MA E +    Y    D++S+G+ V E++T
Sbjct: 165 ITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 41/207 (19%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA----- 71
           +  + V+ +   + + +  +H     ++HRD+K  N   N  L +  + D GLA      
Sbjct: 114 LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 72  ------------------------ILRGSQQAHSVIGTPEFMAPELYEEDYNEL--VDIY 105
                                    L   QQ     GTP F APE+  +  N+   +D++
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 106 SFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKR 165
           S G+  L +L+  YP+ + S+      ++ +  + G+   IQ A+     GK +   SK 
Sbjct: 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMT--IRGSRETIQAAKT---FGKSIL-CSKE 285
Query: 166 LPAKEL--LLDPFLASDAGEPLLIPQV 190
           +PA++L  L +     D+  P L   +
Sbjct: 286 VPAQDLRKLCERLRGMDSSTPKLTSDI 312

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 17/112 (15%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----- 76
           ++ +  Q LR +  LHG +  VIHRDLK  N+ +N +   +K+ D GLA I+  S     
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNS 170
Query: 77  ----QQAHSV--IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
               QQ+  V  + T  + APE  L    Y+  +D++S G C+L  L    P
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 91  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 147
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 148 CKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 205
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 206 HGRIPYPGMTNPEVI 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 5/125 (4%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L  +  ++ R+D        RQ++  + YL   D  +IHRD+K +NI +      IK+ D
Sbjct: 117 LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDF-TIKLID 173
Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSEC 124
            G AA L   +  ++  GT E+ APE+   +      ++++S G+ +  ++  E P+ E 
Sbjct: 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233
Query: 125 SNPAQ 129
               +
Sbjct: 234 EETVE 238

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 100 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 156
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 157 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 214
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 215 HGRIPYPGMTNPEVI 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 4   SGTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           +G+L  + RK   R  +  +    R I  G+ YL   D   +HRDL   NI VN +L   
Sbjct: 114 NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS--DMSAVHRDLAARNILVNSNL-VC 170
Query: 63  KIGDLGLAAILRGS-QQAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           K+ D G++ +L    + A++  G      + APE +    +    D++S+G+ + E+++ 
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 230
Query: 117 SEYPYSECSNPAQIYKKVTSG-KLP 140
            E PY + SN   + K +  G +LP
Sbjct: 231 GERPYWDMSN-QDVIKAIEEGYRLP 254

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 19/101 (18%)
Query: 32  GIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV--- 82
           G+A+LH         P + HRD K  N+ V  +L Q  I DLGLA +         +   
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 83  --IGTPEFMAPELYEEDYN-------ELVDIYSFGMCVLEM 114
             +GT  +MAPE+ +E          +  DI++FG+ + E+
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 99  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 155
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 156 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 213
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 214 HGRIPYPGMTNPEVI 228

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 97  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 153
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 154 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 211
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 212 HGRIPYPGMTNPEVI 226

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 22/181 (12%)
Query: 2   FTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLH--GHDPPVIHRDLKCDNIFVNGH 58
           +  G L     K+  R+     + +  +I+  I  +H  G+    +HRD+K DNI ++  
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLD-R 197
Query: 59  LGQIKIGDLGLAAILR--GSQQAHSVIGTPEFMAPELYEEDYNEL--------VDIYSFG 108
            G I++ D G    LR  G+ ++   +GTP++++PE+ +               D ++ G
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA---EARRFVGKCLENVSKR 165
           +   EM   + P+   S  A+ Y K+   K   +   + +    EAR F+ + L     R
Sbjct: 258 VFAYEMFYGQTPFYADST-AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETR 316
Query: 166 L 166
           L
Sbjct: 317 L 317

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 93  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 149
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 150 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 207
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 208 HGRIPYPGMTNPEVI 222

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 101 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 157
Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 158 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 215
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 216 HGRIPYPGMTNPEVI 230

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 96  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 152
Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 153 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 210
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 211 HGRIPYPGMTNPEVI 225

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 97  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 153
Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 154 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 211
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 212 HGRIPYPGMTNPEVI 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 91  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 147
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 148 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 205
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 206 HGRIPYPGMTNPEVI 220

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 92  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 148
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 149 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 206
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 207 HGRIPYPGMTNPEVI 221

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 91  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 147
Query: 62  IKIGDLGLAAILRGSQQ-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 148 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 205
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 206 HGRIPYPGMTNPEVI 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 13/120 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L     K+T  +I+ V    + +L G+ Y+H +   ++HRD+K  N+ +    G +K
Sbjct: 112 AGLLSNVLVKFTLSEIKRV---MQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLK 165
Query: 64  IGDLGLA---AILRGSQ--QAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
           + D GLA   ++ + SQ  +  + + T  +  PEL   E DY   +D++  G  + EM T
Sbjct: 166 LADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/139 (23%), Positives = 66/139 (47%), Gaps = 8/139 (5%)
Query: 2   FTSGTLREYRKKYTR----VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
           +   TL +  K + R    + +  +  +  Q+ R + ++H     + HRD+K  N+ VN 
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNS 176
Query: 58  HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEML 115
               +K+ D G A  L  S+ + + I +  + APEL     +Y   +D++S G    E++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 116 TSEYPYSECSNPAQIYKKV 134
             +  +S  ++  Q+ + +
Sbjct: 237 LGKPLFSGETSIDQLVRII 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 7/150 (4%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A ++ H   VIHRD+K +N+ +    G++KI D G  ++   S +  ++ GT +++ PE+
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGL-KGELKIADFGW-SVHAPSLRRKTMCGTLDYLPPEM 192
Query: 94  YE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152
            E   +NE VD++  G+   E+L    P+   S+  + Y+++    L   F       A+
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH-NETYRRIVKVDL--KFPASVPTGAQ 249
Query: 153 RFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
             + K L  N S+RLP  ++   P++ +++
Sbjct: 250 DLISKLLRHNPSERLPLAQVSAHPWVRANS 279

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   VK++  Q+L+G+ + H  +  V+HRDLK  N+ +N + G++K+ D GLA      
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIP 154
Query: 77  QQAHSV-IGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYP 120
            + +S  + T  +  P++    + Y+  +D++S G    E+  +  P
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 86  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 142
Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 143 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 200
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 201 HGRIPYPGMTNPEVI 215

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 17/112 (15%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  Q LR +  LHG +  VIHRDLK  N+ +N +   +K+ D GLA I+  S   +S
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNS 170
Query: 82  -----------VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
                       + T  + APE  L    Y+  +D++S G C+L  L    P
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 4   SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +G+L ++ K  +  ++ I  + + A QI  G+A++   +   IHRDL+  NI V+  L  
Sbjct: 91  NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS- 147
Query: 62  IKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
            KI D GLA ++  ++  A      P ++ APE    +Y       D++SFG+ + E++T
Sbjct: 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 205
Query: 117 -SEYPYSECSNPAQI 130
               PY   +NP  I
Sbjct: 206 HGRIPYPGMTNPEVI 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 121 TLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 176
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 177 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 90  TLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 145
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 146 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 64/120 (53%), Gaps = 9/120 (7%)
Query: 1   MFTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
           + T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +
Sbjct: 93  LCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN 149
Query: 59  LGQIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
              +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 150 -DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 98  TLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 153
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 154 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 17/112 (15%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  Q LR +  LHG +  VIHRDLK  N+ +N +   +K+ D GLA I+  S   +S
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNS 170
Query: 82  -----------VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
                       + T  + APE  L    Y+  +D++S G C+L  L    P
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 93  TLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 148
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 149 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 64/120 (53%), Gaps = 9/120 (7%)
Query: 1   MFTSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
           + T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +
Sbjct: 94  LCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN 150
Query: 59  LGQIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
              +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 151 -DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 127 QMLXGIKHLHSAG--IIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +KY+ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 93  TLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 148
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 149 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 129 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 186
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 187 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 128 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 13/120 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L     K+T  +I+ V    + +L G+ Y+H +   ++HRD+K  N+ +    G +K
Sbjct: 111 AGLLSNVLVKFTLSEIKRV---MQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLK 164
Query: 64  IGDLGLA---AILRGSQ--QAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
           + D GLA   ++ + SQ  +  + + T  +  PEL   E DY   +D++  G  + EM T
Sbjct: 165 LADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 128 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 13/120 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L     K+T  +I+ V    + +L G+ Y+H +   ++HRD+K  N+ +    G +K
Sbjct: 112 AGLLSNVLVKFTLSEIKRV---MQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLK 165
Query: 64  IGDLGLA---AILRGSQ--QAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
           + D GLA   ++ + SQ  +  + + T  +  PEL   E DY   +D++  G  + EM T
Sbjct: 166 LADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 13/120 (10%)
Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +G L     K+T  +I+ V    + +L G+ Y+H +   ++HRD+K  N+ +    G +K
Sbjct: 112 AGLLSNVLVKFTLSEIKRV---MQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLK 165
Query: 64  IGDLGLA---AILRGSQ--QAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
           + D GLA   ++ + SQ  +  + + T  +  PEL   E DY   +D++  G  + EM T
Sbjct: 166 LADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +K++ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 93  TLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 148
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 149 CVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 148 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 205
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 206 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +  ++L+ + Y H     ++HRD+K  N+ ++  L ++++ D GLA      ++ + 
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 82  VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPY 121
            + +  F  PEL    +DY+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/117 (24%), Positives = 59/117 (50%), Gaps = 7/117 (5%)
Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            ++ R+  T  DIR    +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D
Sbjct: 121 FKQLRQTLTDYDIRF---YMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLID 175
Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
            GLA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 176 WGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 12/122 (9%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR---GSQQAHSVIG 84
           Q++ G+ YLH     ++H+D+K  N+ +    G +KI  LG+A  L          +  G
Sbjct: 117 QLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 85  TPEFMAPELYE--EDYNEL-VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--L 139
           +P F  PE+    + ++   VDI+S G+ +  + T  YP+ E  N  ++++ +  G   +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAI 232
Query: 140 PG 141
           PG
Sbjct: 233 PG 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 136 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRY 192
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 133 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 189
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 127 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HL 59
              G++  + +K    + R      R +   + +LH     + HRDLK +NI       +
Sbjct: 93  LQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG--IAHRDLKPENILCESPEKV 150
Query: 60  GQIKIGDLGLAAILRGSQQAHSVI--------GTPEFMAPELYE------EDYNELVDIY 105
             +KI D  L + ++ +     +         G+ E+MAPE+ E        Y++  D++
Sbjct: 151 SPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLW 210
Query: 106 SFGMCVLEMLTSEYPY-----SECSNPAQIYKKVTSGKLPGAFHRIQD------------ 148
           S G+ +  ML+   P+     ++C        +V   KL   F  IQ+            
Sbjct: 211 SLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL---FESIQEGKYEFPDKDWAH 267
Query: 149 --AEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGE 183
             +EA+  + K L  +  +RL A ++L  P++   A E
Sbjct: 268 ISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPE 305

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VDI+S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           +++ QI  G+A++   +   IHRDL+  NI V+  L   KI D GLA +  G++      
Sbjct: 282 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARV--GAK------ 330
Query: 84  GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
              ++ APE      +    D++SFG+ ++E++T    PY   SNP  I
Sbjct: 331 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 379

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 63/118 (53%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +K++ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +  
Sbjct: 473 TLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-D 528
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 529 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI---- 83
           Q L G+ YLH     ++H D+K DN+ ++    +  + D G A  L+      S++    
Sbjct: 158 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 84  --GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE------CSNPAQ----- 129
             GT   MAPE +  +  +  VDI+S    +L ML   +P+++      C   A      
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275
Query: 130 ----------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVS 163
                       + +  G      HR    E RR VGK L+ V 
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L  +   H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  
Sbjct: 165 QVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRV 221
Query: 88  FMAPEL--YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           +  PE   Y   +     ++S G+ + +M+  + P+
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 62/118 (52%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +K++ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+    
Sbjct: 93  TLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSAT-D 148
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 149 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI---- 83
           Q L G+ YLH     ++H D+K DN+ ++    +  + D G A  L+      S++    
Sbjct: 174 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 84  --GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE------CSNPAQ----- 129
             GT   MAPE +  +  +  VDI+S    +L ML   +P+++      C   A      
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 291
Query: 130 ----------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVS 163
                       + +  G      HR    E RR VGK L+ V 
Sbjct: 292 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 335

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 199
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 212
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 200
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI---- 83
           Q L G+ YLH     ++H D+K DN+ ++    +  + D G A  L+      S++    
Sbjct: 172 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 84  --GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE------CSNPAQ----- 129
             GT   MAPE +  +  +  VDI+S    +L ML   +P+++      C   A      
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 289
Query: 130 ----------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVS 163
                       + +  G      HR    E RR VGK L+ V 
Sbjct: 290 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 333

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 62/118 (52%), Gaps = 9/118 (7%)
Query: 3   TSGTLREYR--KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           T G LR +   +K++ +D+ ++  +A Q+   +AYL       +HRD+   N+ V+    
Sbjct: 473 TLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSA-TD 528
Query: 61  QIKIGDLGLAAILRGSQQAHSVIGT--PEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
            +K+GD GL+  +  S    +  G    ++MAPE +    +    D++ FG+C+ E+L
Sbjct: 529 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS 76
           +D   VK++  Q+L+G+ + H  +  V+HRDLK  N+ +N + G++K+ + GLA      
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIP 154
Query: 77  QQAHSV-IGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYP 120
            + +S  + T  +  P++    + Y+  +D++S G    E+  +  P
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 199
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 213
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 227
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 184
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 200
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 212
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 213
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 213
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 185
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 184
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 212
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 200
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 183
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 185
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 232
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 185
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 213
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 212
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 227
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVLIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 176
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 59/115 (51%), Gaps = 11/115 (9%)
Query: 17  VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQIKIGDLGLAAILRG 75
           VD      +A  + RG+A+LH  +P +    L   ++ ++  +  +I + D+      + 
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV------KF 161
Query: 76  SQQAHSVIGTPEFMAPELYE---EDYNEL-VDIYSFGMCVLEMLTSEYPYSECSN 126
           S Q+   +  P ++APE  +   ED N    D++SF + + E++T E P+++ SN
Sbjct: 162 SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 139 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 195
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VD++S G  + EM+
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 219
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFV--------NGHLG----QIKIGDLGLAAILR 74
           RQI  G+A+LH     +IHRDLK  NI V        +   G    +I I D GL   L 
Sbjct: 122 RQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 75  GSQQAHSV-----IGTPEFMAPELYEEDYN--------ELVDIYSFGMCVLEMLTS--EY 119
             Q +         GT  + APEL EE  N          +DI+S G CV   + S  ++
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKH 238
Query: 120 PYSE-CSNPAQIYKKVTSGKLPGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           P+ +  S  + I + + S       H R   AEA   + + ++ +  KR  A ++L  P 
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 177 LASDAGEPLLIPQVPS---FQNLNPNGAVMELVPKFAVDSD 214
               + +   + +V      +N +P  A   L+ KF   SD
Sbjct: 299 FWPKSKKLEFLLKVSDRLEIENRDPPSA---LLMKFDAGSD 336

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 176
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/109 (24%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T  DIR    +  ++L+ + Y H     ++HRD+K  N+ ++    ++++ D GLA    
Sbjct: 130 TDFDIRF---YMYELLKALDYCHS--KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH 184
Query: 75  GSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
            +Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+    P+
Sbjct: 185 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 182
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 183 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 175
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 182
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 183 AKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 243 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 278

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VD++S G  + EM+
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     S      + T  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
           + APE +    Y E VD++S G  + EM+
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPEL 93
           A  H H+  V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT  +  PE 
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 207
Query: 94  --YEEDYNELVDIYSFGMCVLEMLTSEYPY 121
             Y   +     ++S G+ + +M+  + P+
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/115 (21%), Positives = 59/115 (51%), Gaps = 4/115 (3%)
Query: 9   EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLG 68
           ++++ Y  +    ++ +  +IL+ + Y H     ++HRD+K  N+ ++    ++++ D G
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWG 177
Query: 69  LAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           LA      Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 178 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 35/182 (19%)
Query: 39  HDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILR--------GSQQAHSVIGTPEF 88
           H+  + HRDLK +NI       +  +KI D GL + ++         + +  +  G+ E+
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 89  MAPELYE------EDYNELVDIYSFGMCVLEMLTSEYP------YSEC------SNPA-- 128
           MAPE+ E        Y++  D++S G+ +L +L S YP       S+C      + PA  
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 129 -QIYKKVTSGK--LPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
             +++ +  GK   P          A+  + K L  +  +RL A ++L  P++   A E 
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306
Query: 185 LL 186
            L
Sbjct: 307 TL 308

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/109 (24%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 15  TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR 74
           T  DIR    +  ++L+ + Y H     ++HRD+K  N+ ++    ++++ D GLA    
Sbjct: 135 TDFDIRF---YMYELLKALDYCHS--KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH 189
Query: 75  GSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
            +Q+ +  + +  F  PEL    + Y+  +D++S G  +  M+    P+
Sbjct: 190 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG--- 84
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 211 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 182
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 183 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 243 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 278

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 112 VCEGMAYLE--EASVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 182
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 183 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 242
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 243 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 278

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 181
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 242 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 277

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 181
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 242 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 277

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 139 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 196
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 197 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 257 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 292

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 116 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 173
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 174 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 233
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 234 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 269

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 139 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 196
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 197 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 257 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 292

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 131 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 188
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 189 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 248
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 249 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 284

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 141 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 198
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 199 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 258
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 259 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 294

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 139 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 196
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 197 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 256
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 257 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 292

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +       +      
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 152 QLARGMEYLASQK--CIHRDLTARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 209 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 248

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 151 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 208
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R S  ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 209 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 268
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 269 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 304

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 157 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 214 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 253

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 113 VCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFV--------NGHLG----QIKIGDLGLAAILR 74
           RQI  G+A+LH     +IHRDLK  NI V        +   G    +I I D GL   L 
Sbjct: 140 RQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 75  GSQ-----QAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTS--EYPYSE 123
             Q       ++  GT  + APEL EE         +DI+S G CV   + S  ++P+ +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256
Query: 124 -CSNPAQIYKKVTSGKLPGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
             S  + I + + S       H R   AEA   + + ++ +  KR  A ++L  P     
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 316
Query: 181 AGEPLLIPQVP---SFQNLNPNGAVMELVPKFAVDSD 214
           + +   + +V      +N +P  A   L+ KF   SD
Sbjct: 317 SKKLEFLLKVSDRLEIENRDPPSA---LLMKFDAGSD 350

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 154 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 211 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 250

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFV--------NGHLG----QIKIGDLGLAAILR 74
           RQI  G+A+LH     +IHRDLK  NI V        +   G    +I I D GL   L 
Sbjct: 140 RQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 75  GSQ-----QAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTS--EYPYSE 123
             Q       ++  GT  + APEL EE         +DI+S G CV   + S  ++P+ +
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256
Query: 124 -CSNPAQIYKKVTSGKLPGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
             S  + I + + S       H R   AEA   + + ++ +  KR  A ++L  P     
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 316
Query: 181 AGEPLLIPQVP---SFQNLNPNGAVMELVPKFAVDSD 214
           + +   + +V      +N +P  A   L+ KF   SD
Sbjct: 317 SKKLEFLLKVSDRLEIENRDPPSA---LLMKFDAGSD 350

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 34  AYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE- 92
           A  H H   V+HRD+K +NI ++   G  K+ D G  A+L   +      GT  +  PE 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEW 209
Query: 93  LYEEDYNEL-VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151
           +    Y+ L   ++S G+ + +M+  + P+          +++   +L    H   D  A
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELHFPAHVSPDCCA 262
Query: 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
              + +CL    S R   +E+LLDP++ + A
Sbjct: 263 --LIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 31  RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH---SVIGTPE 87
           RG+ YLH     +IHRD+K  NI ++ +    KI D G++       Q H    V GT  
Sbjct: 150 RGLHYLHTR--AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 88  FMAPELY-EEDYNELVDIYSFGMCVLEMLTS 117
           ++ PE + +    E  D+YSFG+ + E+L +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 115 VCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 170
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 39/221 (17%)
Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFV--------NGHLG----QIKIGDLGLAAILR 74
           RQI  G+A+LH     +IHRDLK  NI V        +   G    +I I D GL   L 
Sbjct: 122 RQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 75  GSQ-----QAHSVIGTPEFMAPELYEEDYN--------ELVDIYSFGMCVLEMLTS--EY 119
             Q       ++  GT  + APEL EE  N          +DI+S G CV   + S  ++
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKH 238
Query: 120 PYSE-CSNPAQIYKKVTSGKLPGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           P+ +  S  + I + + S       H R   AEA   + + ++ +  KR  A ++L  P 
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 177 LASDAGEPLLIPQVPS---FQNLNPNGAVMELVPKFAVDSD 214
               + +   + +V      +N +P  A   L+ KF   SD
Sbjct: 299 FWPKSKKLEFLLKVSDRLEIENRDPPSA---LLMKFDAGSD 336

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 145 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 243

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 4/116 (3%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA     +      + T  
Sbjct: 132 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRY 188
Query: 88  FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           + APE +    Y E VDI+S G  + E++     +    +  Q  K +     P A
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 244

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI---- 83
           Q L G+ YLH     ++H D+K DN+ ++       + D G A  L+      S++    
Sbjct: 193 QALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 84  --GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
             GT   MAPE +     +  VD++S    +L ML   +P+++
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 149 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 141 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 112 VCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 220

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 110 VCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 165
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 218

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 148 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 31  RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH---SVIGTPE 87
           RG+ YLH     +IHRD+K  NI ++ +    KI D G++       Q H    V GT  
Sbjct: 150 RGLHYLHTR--AIIHRDVKSINILLDENFVP-KITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 88  FMAPELY-EEDYNELVDIYSFGMCVLEMLTS 117
           ++ PE + +    E  D+YSFG+ + E+L +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           R K  ++ +     +  +IL  ++YLH     +++ DLK +NI +     Q+K+ DLG  
Sbjct: 173 RSKGQKLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLG-- 226
Query: 71  AILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           A+ R +   + + GTP F APE+         DIY+ G   L  LT + P
Sbjct: 227 AVSRINSFGY-LYGTPGFQAPEIVRTGPTVATDIYTVGRT-LAALTLDLP 274

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA  +            
Sbjct: 197 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 86  ---PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
               ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 10/114 (8%)
Query: 29  ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP-- 86
           +  G+AYL   +  VIHRDL   N  V G    IK+ D G+   +   Q   S  GT   
Sbjct: 132 VCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 187
Query: 87  -EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            ++ +PE++    Y+   D++SFG+ + E+ +  + PY   SN +++ + +++G
Sbjct: 188 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 240

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R    ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 283 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 318

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT-- 85
           Q+ RG+ YL       IHRDL   N+ V  +   ++I D GLA  +              
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 86  -PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
             ++MAPE L++  Y    D++SFG+ + E+ T   S YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 7   LREYRKKYTRVDIRAVKNW---ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQ 61
           LRE R + ++    A+ +    AR I  G  YL  +    IHRD+   N  +   G    
Sbjct: 142 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 199
Query: 62  IKIGDLGLAA-ILRGS--QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            KIGD G+A  I R    ++    +   ++M PE + E  +    D +SFG+ + E+ + 
Sbjct: 200 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 259
Query: 118 EY-PYSECSNPAQIYKKVTSG-------KLPGAFHRI 146
            Y PY   SN  ++ + VTSG         PG  +RI
Sbjct: 260 GYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRI 295

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 11/132 (8%)
Query: 2   FTSGTLREYRKKYTRVDIR--AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
            + G+L ++ K  T   +R   + + A QI  G+AY+   +   +HRDL+  NI V  +L
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL 400
Query: 60  GQIKIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
              K+ D GLA ++  ++  A      P ++ APE  LY   +    D++SFG+ + E+ 
Sbjct: 401 -VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELT 458
Query: 116 T-SEYPYSECSN 126
           T    PY    N
Sbjct: 459 TKGRVPYPGMVN 470

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 18/178 (10%)
Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG 75
           +V +  + +++ QI  G+AY+   +   IHRDL+  N+ V+  L   KI D GLA ++  
Sbjct: 106 KVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESL-MCKIADFGLARVIED 162
Query: 76  SQ-QAHSVIGTP-EFMAPELYEED-YNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131
           ++  A      P ++ APE      +    D++SFG+ + E++T  + PY   +N A + 
Sbjct: 163 NEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTN-ADVM 221
Query: 132 KKVTSG-KLPGAFHRIQDA--EARRFVGKCLENVSKRLPAKELL---LDPFLASDAGE 183
             ++ G ++P    R+++   E    +  C +  ++  P  + L   LD F  +  G+
Sbjct: 222 TALSQGYRMP----RVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQ 275

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	502
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-38
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-27
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-13
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-12
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-12
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-12
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-09
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-08
2lru_A	98	Serine/threonine-protein kinase WNK1; autoinhibito	1e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  292 bits (749), Expect = 3e-96
 Identities = 96/180 (53%), Positives = 128/180 (71%), Gaps = 2/180 (1%)

Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
            TSGTL+ Y K++  + I+ +++W RQIL+G+ +LH   PP+IHRDLKCDNIF+ G  G 
Sbjct: 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170

Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           +KIGDLGLA + R S  A +VIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYPY
Sbjct: 171 VKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPY 229

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
           SEC N AQIY++VTSG  P +F ++   E +  +  C+  N  +R   K+LL   F   +
Sbjct: 230 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  160 bits (407), Expect = 1e-45
 Identities = 58/178 (32%), Positives = 91/178 (51%), Gaps = 15/178 (8%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAH 80
           +  + +QIL G+ YLH +   ++HRD+K DN+ +N + G +KI D G +  L G      
Sbjct: 124 IGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181

Query: 81  SVIGTPEFMAPE---LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
           +  GT ++MAPE        Y +  DI+S G  ++EM T + P+ E   P     KV   
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241

Query: 138 K----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
           K    +P +      AEA+ F+ KC E +  KR  A +LL+D FL   + +    P++
Sbjct: 242 KVHPEIPESM----SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  159 bits (404), Expect = 4e-45
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 9/175 (5%)

Query: 5   GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            +L+++ + +   +    V  + R  L  +A+LH     ++H D+K  NIF+    G+ K
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCK 197

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
           +GD GL   L  +       G P +MAPEL +  Y    D++S G+ +LE+  +      
Sbjct: 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG 257

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                Q+ +     +          +E R  +   LE +   R  A+ LL  P L
Sbjct: 258 GEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (375), Expect = 3e-41
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 14/177 (7%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           GTL ++  +++  ++D         QI +G+ Y+H     +I+RDLK  NIF+     Q+
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQV 161

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
           KIGD GL   L+   +     GT  +M+PE      Y + VD+Y+ G+ + E+L      
Sbjct: 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            E S     +  +  G +   F    D + +  + K L      R    E+L    +
Sbjct: 222 FETSK---FFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  146 bits (369), Expect = 8e-40
 Identities = 43/207 (20%), Positives = 75/207 (36%), Gaps = 18/207 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  K+   +       +  Q L G+ YLH     ++H D+K DN+ ++    +  +
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAAL 192

Query: 65  GDLGLAAILRGSQ------QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
            D G A  L+             + GT   MAPE+      +  VDI+S    +L ML  
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

Query: 118 EYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
            +P+++        K  +       +P +          + + + L      R  A EL 
Sbjct: 253 CHPWTQYFRGPLCLKIASEPPPIREIPPSC----APLTAQAIQEGLRKEPVHRASAMELR 308

Query: 173 LDPFLASDAGEPLLIPQVPSFQNLNPN 199
                A      L  P    ++    N
Sbjct: 309 RKVGKALQEVGGLKSPWKGEYKEPRGN 335

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  144 bits (366), Expect = 1e-39
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           GTL +    +             RQIL  ++Y+H     +IHRDLK  NIF++     +K
Sbjct: 100 GTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVK 156

Query: 64  IGDLGLAAIL---------------RGSQQAHSVIGTPEFMAPELYEE--DYNELVDIYS 106
           IGD GLA  +                 S    S IGT  ++A E+ +    YNE +D+YS
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216

Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVS 163
            G+   EM+   YP+S       I KK+ S     P  F   +    ++ +   ++ + +
Sbjct: 217 LGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273

Query: 164 KRLPAKELLLDPFLASDAGEPLL 186
           KR  A+ LL   +L     + ++
Sbjct: 274 KRPGARTLLNSGWLPVKHQDEVI 296

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  142 bits (359), Expect = 1e-38
 Identities = 44/193 (22%), Positives = 81/193 (41%), Gaps = 25/193 (12%)

Query: 5   GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
             L+++   R      +     +   QI   + +LH     ++HRDLK  NIF       
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DV 202

Query: 62  IKIGDLGLAAILRGSQQAHSV-------------IGTPEFMAPELYEED-YNELVDIYSF 107
           +K+GD GL   +   ++  +V             +GT  +M+PE    + Y+  VDI+S 
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262

Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL 166
           G+ + E+L   Y +S      +I   V + K P  F +    +    V   L  + ++R 
Sbjct: 263 GLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERP 318

Query: 167 PAKELLLDPFLAS 179
            A +++ +    +
Sbjct: 319 EATDIIENAIFEN 331

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  140 bits (355), Expect = 4e-38
 Identities = 48/140 (34%), Positives = 74/140 (52%), Gaps = 7/140 (5%)

Query: 5   GTLREY-RKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           G+L     K   R  +D R   + A  + +G+ YLH  +PP++HR+LK  N+ V+     
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YT 177

Query: 62  IKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
           +K+ D GL+ +       + S  GTPE+MAPE+   E  NE  D+YSFG+ + E+ T + 
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

Query: 120 PYSECSNPAQIYKKVTSGKL 139
           P+    NPAQ+   V     
Sbjct: 238 PWGNL-NPAQVVAAVGFKCK 256

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  138 bits (350), Expect = 2e-37
 Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 25/193 (12%)

Query: 5   GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
             L+++   R      +     +   QI   + +LH     ++HRDLK  NIF       
Sbjct: 100 ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DV 156

Query: 62  IKIGDLGLAAILRGSQQAHSV-------------IGTPEFMAPELYEE-DYNELVDIYSF 107
           +K+GD GL   +   ++  +V             +GT  +M+PE      Y+  VDI+S 
Sbjct: 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216

Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
           G+ + E+L   YP+S      +    V + K P  F +         V   L  +  +R 
Sbjct: 217 GLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQK-YPCEYVMVQDMLSPSPMERP 272

Query: 167 PAKELLLDPFLAS 179
            A  ++ +     
Sbjct: 273 EAINIIENAVFED 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  139 bits (351), Expect = 2e-37
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 8/142 (5%)

Query: 5   GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLG 60
           G+L       +           +W  Q  +G+AYLH   P  +IHRDLK  N+ +     
Sbjct: 84  GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
            +KI D G A  +       +  G+  +MAPE++E  +Y+E  D++S+G+ + E++T   
Sbjct: 144 VLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201

Query: 120 PYSECSNPAQ-IYKKVTSGKLP 140
           P+ E   PA  I   V +G  P
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRP 223

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (349), Expect = 6e-37
 Identities = 46/183 (25%), Positives = 85/183 (46%), Gaps = 16/183 (8%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G L +    +K        + +W  QI   + ++H     ++HRD+K  NIF+    G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTV 164

Query: 63  KIGDLGLAAIL-RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
           ++GD G+A +L    + A + IGTP +++PE+ E   YN   DI++ G  + E+ T ++ 
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

Query: 121 YSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           + E  +   +  K+ SG    +   +      + R  V +  + N   R     +L   F
Sbjct: 225 F-EAGSMKNLVLKIISGSFPPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279

Query: 177 LAS 179
           +A 
Sbjct: 280 IAK 282

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (345), Expect = 1e-36
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 7/190 (3%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           ++ ++K+   +  R V  +  Q+   + ++H     V+HRD+K  N+F+    G +K+GD
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGD 179

Query: 67  LGLAAILRGS-QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY-SE 123
           LGL          AHS++GTP +M+PE   E+ YN   DI+S G  + EM   + P+  +
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
             N   + KK+     P         E R+ V  C+  +  KR     +           
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299

Query: 183 EPLLIPQVPS 192
              L      
Sbjct: 300 ASSLEHHHHH 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (343), Expect = 1e-36
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 17/181 (9%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLH---GHDPPVIHRDLKCDNIFVNGHLGQIK 63
           + +  K+   +D   V     Q+   +   H        V+HRDLK  N+F++G    +K
Sbjct: 98  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVK 156

Query: 64  IGDLGLAAIL-RGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVL-EMLTSEYP 120
           +GD GLA IL   +  A + +GTP +M+PE      YNE  DI+S G C+L E+     P
Sbjct: 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPP 215

Query: 121 YSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           +    +  ++  K+  GK   +P  +      E    + + L      R   +E+L +P 
Sbjct: 216 F-TAFSQKELAGKIREGKFRRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPL 270

Query: 177 L 177
           +
Sbjct: 271 I 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  133 bits (336), Expect = 1e-35
 Identities = 41/144 (28%), Positives = 59/144 (40%), Gaps = 11/144 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-- 61
           G L      K   +           I  GI Y+   +PP++HRDL+  NIF+        
Sbjct: 106 GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165

Query: 62  --IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLT 116
              K+ D GL+           ++G  ++MAPE     EE Y E  D YSF M +  +LT
Sbjct: 166 VCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223

Query: 117 SEYPYSECSN-PAQIYKKVTSGKL 139
            E P+ E S    +    +    L
Sbjct: 224 GEGPFDEYSYGKIKFINMIREEGL 247

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  132 bits (333), Expect = 4e-35
 Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 11/152 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            +L  +     T+ +++ + + ARQ  RG+ YLH     +IHRDLK +NIF++     +K
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHED-NTVK 160

Query: 64  IGDLGLAAILR---GSQQAHSVIGTPEFMAPEL--YEED--YNELVDIYSFGMCVLEMLT 116
           IGD GLA       GS Q   + G+  +MAPE+   ++   Y+   D+Y+FG+ + E++T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD 148
            + PYS  +N  QI + V  G L     +++ 
Sbjct: 221 GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (335), Expect = 5e-35
 Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 30/252 (11%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIK 63
             L  + KK   +D    K++ + +L  +  +H H   ++H DLK  N   V+G    +K
Sbjct: 93  IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 147

Query: 64  IGDLGLAAILRG---SQQAHSVIGTPEFMAPEL------------YEEDYNELVDIYSFG 108
           + D G+A  ++    S    S +GT  +M PE              +   +   D++S G
Sbjct: 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207

Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
             +  M   + P+ +  N       +        F  I + + +  +  CL+ +  +R+ 
Sbjct: 208 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 267

Query: 168 AKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTM 227
             ELL  P++             P  Q        M+ V    V  +   S         
Sbjct: 268 IPELLAHPYVQIQT--------HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLY 319

Query: 228 NPEDDTIFLKVQ 239
                       
Sbjct: 320 EHYSGGESHNSS 331

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (333), Expect = 6e-35
 Identities = 41/193 (21%), Positives = 79/193 (40%), Gaps = 22/193 (11%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIK 63
             L  + KK   +D    K++ + +L  +  +H H   ++H DLK  N   V+G    +K
Sbjct: 112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 166

Query: 64  IGDLGLAAILRG---SQQAHSVIGTPEFMAPELYEED------------YNELVDIYSFG 108
           + D G+A  ++    S    S +GT  +M PE  ++              +   D++S G
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
             +  M   + P+ +  N       +        F  I + + +  +  CL+ +  +R+ 
Sbjct: 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286

Query: 168 AKELLLDPFLASD 180
             ELL  P++   
Sbjct: 287 IPELLAHPYVQIQ 299

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (325), Expect = 5e-34
 Identities = 39/197 (19%), Positives = 73/197 (37%), Gaps = 37/197 (18%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---------- 56
           + E  +  +      +K+   Q+ RG+ Y+H     ++H D+K  NIF++          
Sbjct: 102 ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASE 159

Query: 57  --------GHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYS 106
                    +    KIGDLG    +          G   F+A E+ +E+  +    DI++
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFA 216

Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NV 162
             + V+    +E            + ++  G+LP    RI      E    +   +  + 
Sbjct: 217 LALTVVCAAGAEPLPRN----GDQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDP 268

Query: 163 SKRLPAKELLLDPFLAS 179
            +R  A  L+    L S
Sbjct: 269 ERRPSAMALVKHSVLLS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  128 bits (323), Expect = 5e-34
 Identities = 31/142 (21%), Positives = 60/142 (42%), Gaps = 11/142 (7%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L           VD      +A  + RG+A+LH  +P +    L   ++ ++  +   
Sbjct: 94  GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TA 152

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSE 118
           +I    +      S Q+   +  P ++APE  +    +      D++SF + + E++T E
Sbjct: 153 RISMADVKF----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
            P+++ SN     K    G  P
Sbjct: 209 VPFADLSNMEIGMKVALEGLRP 230

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 1e-33
 Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 22/153 (14%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            TL    R     +D+   +  A++I++G+ YLH     ++H+DLK  N+F +    ++ 
Sbjct: 114 RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNG--KVV 169

Query: 64  IGDLGLAAILRGSQQAH------SVIGTPEFMAPEL----------YEEDYNELVDIYSF 107
           I D GL +I    Q            G    +APE+           +  +++  D+++ 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229

Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
           G    E+   E+P+        I  ++ +G  P
Sbjct: 230 GTIWYELHAREWPFKT-QPAEAIIWQMGTGMKP 261

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (326), Expect = 2e-33
 Identities = 40/193 (20%), Positives = 78/193 (40%), Gaps = 22/193 (11%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIK 63
             L  + KK   +D    K++ + +L  +  +H H   ++H DLK  N   V+G    +K
Sbjct: 140 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 194

Query: 64  IGDLGLAAILRG---SQQAHSVIGTPEFMAPELYEED------------YNELVDIYSFG 108
           + D G+A  ++    S    S +G   +M PE  ++              +   D++S G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254

Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
             +  M   + P+ +  N       +        F  I + + +  +  CL+ +  +R+ 
Sbjct: 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314

Query: 168 AKELLLDPFLASD 180
             ELL  P++   
Sbjct: 315 IPELLAHPYVQIQ 327

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (318), Expect = 3e-33
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 13/146 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQ- 61
           G L      K  R+    + NWA QI RG+ YLH     P+IHRDLK  NI +   +   
Sbjct: 91  GPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148

Query: 62  ------IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEM 114
                 +KI D GLA     + +  S  G   +MAPE+     +++  D++S+G+ + E+
Sbjct: 149 DLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207

Query: 115 LTSEYPYSECSNPAQIYKKVTSGKLP 140
           LT E P+      A  Y    +    
Sbjct: 208 LTGEVPFRGIDGLAVAYGVAMNKLAL 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (307), Expect = 2e-31
 Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 8/158 (5%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A  I++ + +LH     VIHRD+K  N+ +N  LGQ+K+ D G++  L          G 
Sbjct: 115 AVSIVKALEHLH-SKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGC 172

Query: 86  PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
             +MAPE     L ++ Y+   DI+S G+ ++E+    +PY     P Q  K+V     P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                   AE   F  +CL+ N  +R    EL+  PF 
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (307), Expect = 2e-31
 Identities = 59/170 (34%), Positives = 88/170 (51%), Gaps = 16/170 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R+ L+ + +LH +   VIHRD+K DNI +    G +K+ D G  A +   Q +  +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 86  PEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY    NP +    + +   P    
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
            +Q+ E      R F+ +CLE +V KR  AKELL   FL        L P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (302), Expect = 9e-31
 Identities = 54/164 (32%), Positives = 92/164 (56%), Gaps = 14/164 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           R+IL+G+ YLH      IHRD+K  N+ ++ H G++K+ D G+A  L  +Q + ++ +GT
Sbjct: 126 REILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGT 182

Query: 86  PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ-IYKKVTSG--KLPG 141
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P+SE  +P + ++    +    L G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 241

Query: 142 AFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
            + +      + FV  CL +  S R  AKELL   F+  +A + 
Sbjct: 242 NYSK----PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (303), Expect = 9e-31
 Identities = 55/170 (32%), Positives = 88/170 (51%), Gaps = 16/170 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
             +L+ +AYLH     VIHRD+K D+I +    G++K+ D G  A +     +  S++GT
Sbjct: 148 EAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGT 204

Query: 86  PEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE+     Y   VDI+S G+ V+EM+  E PY    +P Q  K++     P    
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP---- 259

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
           +++++       R F+ + L  +  +R  A+ELL  PFL        L+P
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (300), Expect = 2e-30
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 27/171 (15%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA------H 80
           R++L G+ YLH +    IHRD+K  NI +    G ++I D G++A L             
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 81  SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSEC-----------SNP 127
           + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY +            ++P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244

Query: 128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
             +   V   ++   + +      R+ +  CL ++  KR  A ELL   F 
Sbjct: 245 PSLETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (301), Expect = 2e-30
 Identities = 55/172 (31%), Positives = 87/172 (50%), Gaps = 16/172 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QAHSVIGT 85
           +  L+G+ YLH      IHRD+K  NI +N   G  K+ D G+A  L  +  + ++VIGT
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGT 188

Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           P +MAPE + E  YN + DI+S G+  +EM   + PY++  +P +    + +   P    
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPP---- 243

Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
             +  E        FV +CL  +  +R  A +LL  PF+ S  G  +L   +
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (299), Expect = 4e-30
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
               ++ + +L   +  +IHRD+K  NI ++   G IK+ D G++  L  S       G 
Sbjct: 131 TLATVKALNHLK-ENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188

Query: 86  PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--- 137
             +MAPE        + Y+   D++S G+ + E+ T  +PY + ++      +V  G   
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248

Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           +L  +  R        FV  CL  + SKR   KELL  PF+
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  120 bits (301), Expect = 4e-30
 Identities = 24/188 (12%), Positives = 56/188 (29%), Gaps = 30/188 (15%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
             L  +   +  +   A      Q++R +A LH +   ++H  L+  +I ++   G + +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 247

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPEL------------YEEDYNELVDIYSFGMCVL 112
                               +  F  PEL                     D ++ G+ + 
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 113 EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAK 169
            +  ++ P ++        + +        F   ++     R  +   L      RL   
Sbjct: 305 WIWCADLPITK-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 170 ELLLDPFL 177
           + +  P  
Sbjct: 356 QAMETPEY 363

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (297), Expect = 5e-30
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 24/195 (12%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           + E  +  T   I+ V    RQ+L  + +LH     +IHRDLK  N+ +    G I++ D
Sbjct: 107 MLELDRGLTEPQIQVV---CRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLAD 160

Query: 67  LGLAAILRGSQQ-AHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEY 119
            G++A    + Q   S IGTP +MAPE      + +  Y+   DI+S G+ ++EM   E 
Sbjct: 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

Query: 120 PYSECSNPAQ-IYKKVTSG----KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
           P+ E  NP + + K   S       P  +      E R F+   L+ N   R  A +LL 
Sbjct: 221 PHHEL-NPMRVLLKIAKSDPPTLLTPSKWSV----EFRDFLKIALDKNPETRPSAAQLLE 275

Query: 174 DPFLASDAGEPLLIP 188
            PF++S      L  
Sbjct: 276 HPFVSSITSNKALRE 290

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 9e-30
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 10/182 (5%)

Query: 4   SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           +   +  ++    +  R +      I++ + YL      VIHRD+K  NI ++   GQIK
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLD-ERGQIK 165

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTS 117
           + D G++  L   +      G   +MAPE        + DY+   D++S G+ ++E+ T 
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDP 175
           ++PY  C    ++  KV   + P     +    + + FV  CL  +  KR    +LL   
Sbjct: 226 QFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285

Query: 176 FL 177
           F+
Sbjct: 286 FI 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 1e-29
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 20/176 (11%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSVIGT 85
           R+ILRG+++LH H   VIHRD+K  N+ +  +  ++K+ D G++A L  +    ++ IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 192

Query: 86  PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
           P +MAPE        +  Y+   D++S G+  +EM     P  +  +P +    +     
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 251

Query: 140 PGAFHRIQD----AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
           P    R++      + + F+  CL  N S+R   ++L+  PF+     E  +  Q+
Sbjct: 252 P----RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (294), Expect = 3e-29
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 20/171 (11%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
              L+G+AYLH H+  +IHRD+K  NI ++   G +K+GD G A+I+     A+S +GTP
Sbjct: 161 HGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM---APANSFVGTP 214

Query: 87  EFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
            +MAPE    + E  Y+  VD++S G+  +E+   + P     N       +   + P  
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP-- 271

Query: 143 FHRIQD----AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
              +Q        R FV  CL+     R  ++ LL   F+  +    +++ 
Sbjct: 272 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  118 bits (298), Expect = 5e-29
 Identities = 58/247 (23%), Positives = 113/247 (45%), Gaps = 25/247 (10%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R K+  VD   +    +Q+L G+ YLH H+  ++HRDLK +N+   +      IKI D G
Sbjct: 130 RMKFNEVDAAVI---IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFG 184

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           L+A+    ++    +GT  ++APE+  + Y+E  D++S G+ +  +L    P+       
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQ 243

Query: 129 QIYKKVTSGKLPGAFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183
           +I +KV  GK    F   +       A+  + + L+ +  +R+ A++ L  P++     +
Sbjct: 244 EILRKVEKGKYT--FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

Query: 184 PLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI--- 240
                ++PS          +E + KF       ++  + +   +  +++T  L       
Sbjct: 302 KESGIELPSLA------NAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHI 355

Query: 241 -TDKDGQ 246
             + DGQ
Sbjct: 356 DKNGDGQ 362

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  117 bits (296), Expect = 1e-28
 Identities = 63/246 (25%), Positives = 114/246 (46%), Gaps = 23/246 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLG 68
           RK+++  D   +    +Q+  GI Y+H H+  ++HRDLK +NI   +      IKI D G
Sbjct: 115 RKRFSEHDAARI---IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG 169

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           L+   + + +    IGT  ++APE+    Y+E  D++S G+ +  +L+   P+    N  
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEY 228

Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
            I K+V +GK       +  I D +A+  + K L  + S R+ A + L  P++   + E 
Sbjct: 229 DILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

Query: 185 LLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI---- 240
             I  +PS        + M  + +F  +    ++  + +   +   D+T  L        
Sbjct: 288 PTISDLPS------LESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLD 341

Query: 241 TDKDGQ 246
           T+ DG 
Sbjct: 342 TNNDGM 347

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  116 bits (293), Expect = 1e-28
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 21/194 (10%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGH 58
            TL+EY  +K +  + +       +Q   G+A+LH  +  ++HRDLK  NI +       
Sbjct: 102 ATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHG 158

Query: 59  LGQIKIGDLGLAAILRGSQQA----HSVIGTPEFMAPELYEED----YNELVDIYSFGMC 110
             +  I D GL   L   + +      V GT  ++APE+  ED        VDI+S G  
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218

Query: 111 VLEMLTSEY-PYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLP 167
              +++    P+ + S   Q    + +  L      + +D  AR  + K +  +  KR  
Sbjct: 219 FYYVISEGSHPFGK-SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277

Query: 168 AKELLLDPFLASDA 181
           AK +L  PF  S  
Sbjct: 278 AKHVLKHPFFWSLE 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (285), Expect = 2e-28
 Identities = 47/189 (24%), Positives = 96/189 (50%), Gaps = 13/189 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ + G  G++KI
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 150

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S++   + GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 151 ADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 208

Query: 124 CSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
            +   + YK+++  +   P          AR  + + L+ N S+R   +E+L  P++ ++
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

Query: 181 AGEPLLIPQ 189
           + +P     
Sbjct: 265 SSKPSNCQN 273

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  114 bits (287), Expect = 2e-28
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 20/138 (14%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
           G+L +Y K  T +D +++   A   + G+ +LH         P + HRDLK  NI V  +
Sbjct: 120 GSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178

Query: 59  LGQIKIGDLGLAAILRGSQQ-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
            G   I DLGLA              ++ +GT  +M PE+ +E           + D+YS
Sbjct: 179 -GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237

Query: 107 FGMCVLEMLTSEYPYSEC 124
           FG+ + E+          
Sbjct: 238 FGLILWEVARRCVSGGIV 255

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (285), Expect = 2e-28
 Identities = 42/138 (30%), Positives = 63/138 (45%), Gaps = 20/138 (14%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
           G+L +Y +  T +D  +       I  G+A+LH         P + HRDLK  NI V  +
Sbjct: 91  GSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149

Query: 59  LGQIKIGDLGLAAILRGSQQ-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
            GQ  I DLGLA +   S        +  +GT  +MAPE+ +E       D  + VDI++
Sbjct: 150 -GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208

Query: 107 FGMCVLEMLTSEYPYSEC 124
           FG+ + E+          
Sbjct: 209 FGLVLWEVARRMVSNGIV 226

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (281), Expect = 6e-28
 Identities = 44/195 (22%), Positives = 96/195 (49%), Gaps = 14/195 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  +K+ R D +    +  ++   + Y H     VIHRD+K +N+ +    G++KI
Sbjct: 99  GELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKI 155

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +      ++  ++ GT +++ PE+ E + ++E VD++  G+   E L    P+ +
Sbjct: 156 ADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-D 213

Query: 124 CSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
             +  + ++++ +  L  P          ++  + K L  +  +RLP K ++  P++ ++
Sbjct: 214 SPSHTETHRRIVNVDLKFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

Query: 181 AGEPLLIPQVPSFQN 195
           +   +L P   S Q+
Sbjct: 270 S-RRVLPPVYQSTQS 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 2e-27
 Identities = 58/246 (23%), Positives = 114/246 (46%), Gaps = 24/246 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           RK+++ VD   +    RQ+L GI Y+H +   ++HRDLK +N+   +      I+I D G
Sbjct: 120 RKRFSEVDAARI---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 174

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           L+     S++    IGT  ++APE+    Y+E  D++S G+ +  +L+   P++  +N  
Sbjct: 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEY 233

Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
            I KKV  GK       + ++ +  A+  + K L    S R+ A++ L   ++ +   E 
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292

Query: 185 LLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI---- 240
           + +       ++      +  + +F       ++  + +   +  +D+T  L        
Sbjct: 293 ISV-------DVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMD 345

Query: 241 TDKDGQ 246
            + DGQ
Sbjct: 346 KNGDGQ 351

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  111 bits (280), Expect = 2e-27
 Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 20/146 (13%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +YT V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 125 GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183

Query: 59  LGQIKIGDLGLAAILRGSQQ-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
            G   I DLGLA     +        +  +GT  +MAPE+ ++       +  +  DIY+
Sbjct: 184 -GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242

Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYK 132
            G+   E+           +    Y 
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYY 268

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (280), Expect = 3e-27
 Identities = 28/183 (15%), Positives = 61/183 (33%), Gaps = 15/183 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
            TL           I A+     Q++R  A L      ++H     DN+F+    G++ +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLML 235

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLTSEYPY 121
           GD+      +   +  +      +   E        +   ++ +  G+ +  +     P+
Sbjct: 236 GDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD------AEARRFVGKCLE-NVSKRLPAKELLLD 174
              +   +   K  S ++PG                +  +G+ L  +  +RL   E +  
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353

Query: 175 PFL 177
           P  
Sbjct: 354 PEF 356

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (277), Expect = 3e-27
 Identities = 38/182 (20%), Positives = 60/182 (32%), Gaps = 20/182 (10%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           +   + K   +    +      I RG+  +H       HRDLK  NI +    GQ  + D
Sbjct: 121 IERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDE-GQPVLMD 177

Query: 67  LGLAAILRGS----------QQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVL 112
           LG                  Q   +   T  + APEL+        +E  D++S G CVL
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVL 236

Query: 113 -EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKE 170
             M+  E PY                +L         +   + +   +  +  +R     
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296

Query: 171 LL 172
           LL
Sbjct: 297 LL 298

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (280), Expect = 4e-27
 Identities = 26/201 (12%), Positives = 61/201 (30%), Gaps = 25/201 (12%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
             L  +   +  +   A      Q++R +A LH +   ++H  L+  +I ++   G + +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 252

Query: 65  GDLGLAAIL--RGSQQAHSVIGTPEFMAPELYEED------YNELVDIYSFGMCVLEMLT 116
                                  PE  A  +               D ++ G+ +  +  
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLL 173
           ++ P ++        + +        F   ++     R  +   L      RL   + + 
Sbjct: 313 ADLPNTD-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363

Query: 174 DPFLASDAGEPLLIPQVPSFQ 194
            P    +     L   +P +Q
Sbjct: 364 TPEY--EQLRTELSAALPLYQ 382

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 5e-27
 Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 28/248 (11%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R K+   D   +    +QIL GI YLH H+  ++HRD+K +NI   N +    IKI D G
Sbjct: 140 RHKFDECDAANI---MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNP 127
           L++      +    +GT  ++APE+ ++ YNE  D++S G+ +  +L    P   +  N 
Sbjct: 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ--ND 252

Query: 128 AQIYKKVTSGKLPGAFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
             I KKV  GK    F          EA+  +   L  + +KR  A+E L   ++   A 
Sbjct: 253 QDIIKKVEKGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA- 309

Query: 183 EPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI-- 240
                    +  +       +  + KF       ++  + I   +   ++   L      
Sbjct: 310 ------NNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKK 363

Query: 241 --TDKDGQ 246
              + DGQ
Sbjct: 364 LDKNGDGQ 371

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  110 bits (278), Expect = 7e-27
 Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 21/187 (11%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQI 62
           G LR + ++        VK +  +++  + YL      +IHRD+K DNI +  +GH   +
Sbjct: 100 GDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGH---V 154

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSE 118
            I D  +AA+L    Q  ++ GT  +MAPE++       Y+  VD +S G+   E+L   
Sbjct: 155 HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

Query: 119 YPYSECS--NPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL-PAKELL 172
            PY   S  +  +I     +  +  P A+ +    E    + K LE N  +R     ++ 
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ----EMVSLLKKLLEPNPDQRFSQLSDVQ 270

Query: 173 LDPFLAS 179
             P++  
Sbjct: 271 NFPYMND 277

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (272), Expect = 2e-26
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 19/192 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDL 67
           ++  +  +  +     +QIL G+ YLH     + H DLK +NI +   N  +  IK+ D 
Sbjct: 109 KESLSEEEATSF---IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 68  GLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
           GLA  +    +  ++ GTPEF+APE +  E      D++S G  +  +L S       + 
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 221

Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
               +    +TS         F    +  A+ F+ K L     KRL  +E L  P++   
Sbjct: 222 -TKQETLANITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

Query: 181 AGEPLLIPQVPS 192
             +  ++ +   
Sbjct: 280 DNQQAMVRRESV 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (268), Expect = 4e-26
 Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 16/192 (8%)

Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
              +L E  K+   +     + + RQI+ G  YLH +   VIHRDLK  N+F+N    ++
Sbjct: 98  RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEV 154

Query: 63  KIGDLGLAAILRGSQQAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEY 119
           KIGD GLA  +    +   V+ GTP ++APE L ++ ++  VD++S G C++  +L  + 
Sbjct: 155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKP 213

Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           P+ E S   + Y ++      +P   +      A   + K L+ + + R    ELL D F
Sbjct: 214 PF-ETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEF 268

Query: 177 LASDAGEPLLIP 188
             S    P  +P
Sbjct: 269 FTSGY-IPARLP 279

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (270), Expect = 5e-26
 Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 21/193 (10%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           +  Y+  D        +QIL  +AYLH +   ++HRDLK +N+ +        +KI D G
Sbjct: 142 KGYYSERDAADA---VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFG 196

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
           L+ I+       +V GTP + APE L    Y   VD++S G  +  +L   +   Y E  
Sbjct: 197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG-IITYILLCGFEPFYDE-R 254

Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
               +++++ + +    F       +    A+  V K +  +  KRL   + L  P++  
Sbjct: 255 GDQFMFRRILNCEY--YFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

Query: 180 DAGEPLLIPQVPS 192
            A   + +     
Sbjct: 312 KAANFVHMDTAQK 324

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (268), Expect = 6e-26
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDL 67
           ++  T  +        +QIL G+ YLH     + H DLK +NI +   N    +IKI D 
Sbjct: 108 KESLTEEEATEF---LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

Query: 68  GLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
           GLA  +    +  ++ GTPEF+APE +  E      D++S G  +  +L S       + 
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 220

Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
               +    V++         F       A+ F+ + L  +  KR+  ++ L  P++   
Sbjct: 221 -TKQETLANVSAVNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

Query: 181 AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKSTDMTITG 225
             +  L        +   +   ME   KFA    R+KS + +  G
Sbjct: 279 DTQQAL--------SRKASAVNMEKFKKFAA---RKKSNNGSGGG 312

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (271), Expect = 7e-26
 Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 14/173 (8%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
             V N+ RQ   G+ ++H H   ++H D+K +NI         +KI D GLA  L   + 
Sbjct: 149 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206

Query: 79  AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
                 T EF APE +  E      D+++ G  +  +L S       E  +  +  + V 
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVK 263

Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
                    AF  +   EA+ F+   L+    KRL   + L  P+L  D    
Sbjct: 264 RCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (266), Expect = 7e-26
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 22/197 (11%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R+ Y+  D        +QIL  IAY H +   ++HR+LK +N+   +   G  +K+ D G
Sbjct: 99  REFYSEADASHC---IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG 153

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
           LA  +  S+  H   GTP +++PE L ++ Y++ VDI++ G  +L +L   YP  + E  
Sbjct: 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE-- 210

Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           +  ++Y ++ +G     +       +   EA+  +   L  N  KR+ A + L  P++ +
Sbjct: 211 DQHRLYAQIKAGAY--DYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICN 267

Query: 180 DAGEPLLIPQVPSFQNL 196
                  I +  +   L
Sbjct: 268 RERVASAIHRQDTVDCL 284

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (268), Expect = 8e-26
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 16/190 (8%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
            +L E  K+   +     + + RQI+ G  YLH +   VIHRDLK  N+F+N    ++KI
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKI 182

Query: 65  GDLGLAAILRGSQQAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPY 121
           GD GLA  +    +   V+ GTP ++APE L ++ ++  VD++S G C++  +L  + P+
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPF 241

Query: 122 SECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
            E S   + Y ++      +P   +      A   + K L+ + + R    ELL D F  
Sbjct: 242 -ETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFT 296

Query: 179 SDAGEPLLIP 188
           S    P  +P
Sbjct: 297 SGY-IPARLP 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  106 bits (266), Expect = 1e-25
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVN 56
           G+L ++ K    V    + + A  + RG+AYLH        GH P + HRD+K  N+ + 
Sbjct: 107 GSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165

Query: 57  GHLGQIKIGDLGLAAILRGSQQA---HSVIGTPEFMAPEL------YEEDYNELVDIYSF 107
            +     I D GLA      + A   H  +GT  +MAPE+      ++ D    +D+Y+ 
Sbjct: 166 NN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224

Query: 108 GMCVLEMLTSEYPYSECSNPAQI 130
           G+ + E+ +         +   +
Sbjct: 225 GLVLWELASRCTAADGPVDEYML 247

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (264), Expect = 1e-25
 Identities = 39/158 (24%), Positives = 73/158 (46%), Gaps = 13/158 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +Q++  +AY H     V+H+DLK +NI F +      IKI D GLA + +  + + +  G
Sbjct: 131 KQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188

Query: 85  TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGKL--P 140
           T  +MAPE+++ D     DI+S G  V+  L +          +  ++ +K T  +    
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYA 245

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                +   +A   + + L  +  +R  A ++L   + 
Sbjct: 246 VECRPLTP-QAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  104 bits (263), Expect = 1e-25
 Identities = 37/182 (20%), Positives = 78/182 (42%), Gaps = 17/182 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           ++ +   D   +    + +L  +AY H  +  V HRDLK +N  F+       +K+ D G
Sbjct: 100 KRVFRESDAARI---MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFG 154

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN 126
           LAA  +  +   + +GTP +++P++ E  Y    D +S G  ++ +L   YP   +    
Sbjct: 155 LAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--T 211

Query: 127 PAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
            +++  K+  G        +  +   +A   + + L  +  +R+ + + L   +      
Sbjct: 212 DSEVMLKIREGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270

Query: 183 EP 184
             
Sbjct: 271 SS 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  106 bits (267), Expect = 1e-25
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 19/192 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDL 67
           ++  +  +  +     +QIL G+ YLH     + H DLK +NI +   N  +  IK+ D 
Sbjct: 109 KESLSEEEATSF---IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 68  GLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
           GLA  +    +  ++ GTPEF+APE +  E      D++S G  +  +L S       + 
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 221

Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
               +    +T+         F +  +  A+ F+ K L     KRL  +E L  P++   
Sbjct: 222 -TKQETLANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

Query: 181 AGEPLLIPQVPS 192
             +  ++ +   
Sbjct: 280 DTQQAMVRRESV 291

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (263), Expect = 2e-25
 Identities = 41/185 (22%), Positives = 78/185 (42%), Gaps = 19/185 (10%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDL 67
           ++  T  +        +QIL G+ YLH     + H DLK +NI +   N    +IK+ D 
Sbjct: 102 KESLTEDEATQF---LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDF 156

Query: 68  GLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
           G+A  +    +  ++ GTPEF+APE +  E      D++S G  +  +L S       E 
Sbjct: 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE- 214

Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
               +    +++         F    +  A+ F+ + L  +  +R+   + L   ++ + 
Sbjct: 215 -TKQETLTNISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

Query: 181 AGEPL 185
               +
Sbjct: 273 RRRNV 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 2e-25
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 46/216 (21%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVN-SRGEIKL 173

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP   
Sbjct: 174 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQD----------------------------------- 148
                         +   A    +                                    
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292

Query: 149 ------AEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
                  E + FV KCL +N ++R   K+L++  F+
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (263), Expect = 2e-25
 Identities = 55/181 (30%), Positives = 92/181 (50%), Gaps = 17/181 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLG 68
           RK+++  D   +    +Q+  GI Y+H H+  ++HRDLK +NI   +      IKI D G
Sbjct: 115 RKRFSEHDAARI---IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG 169

Query: 69  LAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN 126
           L+   + + +    IGT  ++APE+    Y+E  D++S G  +L +L S  P  Y +  N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--N 226

Query: 127 PAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
              I K+V +GK       +  I D +A+  + K L  + S R+ A + L  P++   + 
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

Query: 183 E 183
           E
Sbjct: 286 E 286

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  106 bits (266), Expect = 2e-25
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 22/197 (11%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R+ Y+  D        +QIL  IAY H +   ++HR+LK +N+   +   G  +K+ D G
Sbjct: 122 REFYSEADASHC---IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG 176

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
           LA  +  S+  H   GTP +++PE L ++ Y++ VDI++ G  +L +L   YP  + E  
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE-- 233

Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           +  ++Y ++ +G     +       +   EA+  +   L  N  KR+ A + L  P++ +
Sbjct: 234 DQHRLYAQIKAGAY--DYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICN 290

Query: 180 DAGEPLLIPQVPSFQNL 196
                  I +  +   L
Sbjct: 291 RERVASAIHRQDTVDCL 307

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (272), Expect = 2e-25
 Identities = 49/186 (26%), Positives = 71/186 (38%), Gaps = 17/186 (9%)

Query: 5   GTLREYRKKYTRVDI---RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI--FVNGHL 59
           G LR+Y  ++          ++     I   + YLH +   +IHRDLK +NI        
Sbjct: 103 GDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQR 160

Query: 60  GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE 118
              KI DLG A  L   +     +GT +++APEL E + Y   VD +SFG    E +T  
Sbjct: 161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

Query: 119 YPYSECSNPAQIYKKVTSG---------KLPGAFHRIQDAEARRFVGKCLENVSKRLPAK 169
            P+     P Q + KV             L GA            +   L    +R    
Sbjct: 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280

Query: 170 ELLLDP 175
            L+   
Sbjct: 281 MLMWHQ 286

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (263), Expect = 3e-25
 Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 16/188 (8%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
           R + ++  Q+   + +LH H+  + H D++ +NI +       IKI + G A  L+    
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

Query: 79  AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
              +   PE+ APE    +  +   D++S G  ++ +L S      +E     QI + + 
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIM 216

Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD--AGEPLLIPQ 189
           + +      AF  I   EA  FV + L      R+ A E L  P+L          +I  
Sbjct: 217 NAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275

Query: 190 VPSFQNLN 197
           +   +  +
Sbjct: 276 LKHRRYYH 283

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (263), Expect = 3e-25
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 15/182 (8%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLGLAAILRGSQ 77
             V    +QIL G+ YLH ++  ++H DLK  NI   +   LG IKI D G++  +  + 
Sbjct: 131 NDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 78  QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKV 134
           +   ++GTPE++APE L  +      D+++ G+ +  ML +       E  +  + Y  +
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNI 245

Query: 135 TSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQV 190
           +   +      F  +    A  F+   L  N  KR  A+  L   +L     E L  P+ 
Sbjct: 246 SQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304

Query: 191 PS 192
            S
Sbjct: 305 TS 306

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (264), Expect = 5e-25
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 14/186 (7%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
                + +QI  GI ++H     ++H DLK +NI  VN    QIKI D GLA   +  ++
Sbjct: 187 LDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244

Query: 79  AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
                GTPEF+APE +  +  +   D++S G+ +  ML S       +  N A+    + 
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNIL 301

Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVP 191
           + +       F  I + EA+ F+ K L    S R+ A E L  P+L+       L  Q  
Sbjct: 302 ACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360

Query: 192 SFQNLN 197
             +  +
Sbjct: 361 KNRGSD 366

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (262), Expect = 5e-25
 Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 31/229 (13%)

Query: 2   FTSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
              G L E+    +    +    V     Q  R + ++H   PP+IHRDLK +N+ ++  
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174

Query: 59  LGQIKIGDLGLAAILRGS-------------QQAHSVIGTPEFMAPELYE----EDYNEL 101
            G IK+ D G A  +                ++  +   TP +  PE+ +        E 
Sbjct: 175 -GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233

Query: 102 VDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL- 159
            DI++ G C+L  +   ++P+ E     +I     +GK     H  Q       +   L 
Sbjct: 234 QDIWALG-CILYLLCFRQHPF-EDGAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQ 287

Query: 160 ENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPK 208
            N  +RL   E++        A    + P+ P  + L  NG        
Sbjct: 288 VNPEERLSIAEVVHQLQEI--AAARNVNPKSPITELLEQNGGYGSATLS 334

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (260), Expect = 6e-25
 Identities = 38/170 (22%), Positives = 66/170 (38%), Gaps = 20/170 (11%)

Query: 3   TSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-- 57
             G+L            +         R ++ G+ +L  +   ++HR++K  NI      
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGE 149

Query: 58  -HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE---------EDYNELVDIYSF 107
                 K+ D G A  L   +Q  S+ GT E++ P++YE         + Y   VD++S 
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 108 GMCVLEMLTSE---YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
           G+      T      P+       ++  K+ +GK  GA   +Q AE    
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (260), Expect = 7e-25
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 19/164 (11%)

Query: 12  KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGL 69
           +K    D    + +  +I+  + YLHG    +IHRDLK +NI +  + H   I+I D G 
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMH---IQITDFGT 176

Query: 70  AAILRGSQQ---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
           A +L    +   A+S +GT ++++PE L E+   +  D+++ G  + +++    P+    
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG 235

Query: 126 NPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL 166
           N   I++K+   +   P  F      +AR  V K L  + +KRL
Sbjct: 236 NEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRL 275

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (263), Expect = 7e-25
 Identities = 35/206 (16%), Positives = 65/206 (31%), Gaps = 58/206 (28%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-------- 78
           + +L+ + Y+H      +HR +K  +I ++   G++ +  L     +    Q        
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 79  AHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSE------------ 123
               +    +++PE+ +++   Y+   DIYS G+   E+     P+ +            
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 124 ------------------------CSNPAQIYKKVTSGKLPGAFHRIQDAEARR------ 153
                                    +N        TS   P           R       
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 154 -FVGKCLE-NVSKRLPAKELLLDPFL 177
            FV +CL+ N   R  A  LL   F 
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFF 337

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (260), Expect = 7e-25
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 18/198 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
            K+      +       Q+L  + YLH +   +IHRDLK +N+   +      IKI D G
Sbjct: 108 NKRLKEATCKLY---FYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEY-PYSE 123
            + IL  +    ++ GTP ++APE    +    YN  VD +S G  +L +  S Y P+SE
Sbjct: 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSE 221

Query: 124 CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
                 +  ++TSGK    P  +  + + +A   V K L  +   R   +E L  P+L  
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

Query: 180 DAGEPLLIPQVPSFQNLN 197
           +  +      +       
Sbjct: 281 EDMKRKFQDLLSEENEST 298

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  104 bits (261), Expect = 7e-25
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 19/186 (10%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN--GHLGQIKIGDL 67
           +K ++  +  AV      I + + YLH     V+HRDLK  NI +V+  G+   I+I D 
Sbjct: 110 QKFFSEREASAV---LFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF 164

Query: 68  GLAAILRGSQQA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSE 123
           G A  LR       +   T  F+APE L  + Y+   DI+S G  +L  + + Y    + 
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANG 223

Query: 124 CS-NPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
               P +I  ++ SGK     G ++ + D  A+  V K L  +  +RL A  +L  P++ 
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

Query: 179 SDAGEP 184
                P
Sbjct: 283 HWDQLP 288

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (263), Expect = 1e-24
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 18/182 (9%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLG 68
            K+      +       Q+L  + YLH +   +IHRDLK +N+ ++       IKI D G
Sbjct: 233 NKRLKEATCKLY---FYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEY-PYSE 123
            + IL  +    ++ GTP ++APE    +    YN  VD +S G  +L +  S Y P+SE
Sbjct: 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSE 346

Query: 124 CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
                 +  ++TSGK    P  +  + + +A   V K L  +   R   +E L  P+L  
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

Query: 180 DA 181
           + 
Sbjct: 406 ED 407

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  103 bits (258), Expect = 2e-24
 Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 26/212 (12%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
             L +       + I+ +K   + +L   +Y+H     + HRD+K  NI ++ + G++K+
Sbjct: 138 FVLDKNYTC--FIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKL 193

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPY 121
            D G +  +   +      GT EFM PE +          VDI+S G+C+  M  +  P+
Sbjct: 194 SDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

Query: 122 SECSNPAQIYKKVTSGKL--PGAFHRIQDA---------------EARRFVGKCLE-NVS 163
           S   +  +++  + +  +  P   +                    E   F+   L  N +
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312

Query: 164 KRLPAKELLLDPFLASDAGEPLLIPQVPSFQN 195
           +R+ +++ L   +LA    E L       ++ 
Sbjct: 313 ERITSEDALKHEWLADTNIEDLREFSKELYKK 344

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  102 bits (256), Expect = 2e-24
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 23/182 (12%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R  YT  D   V    +Q+L  + YLH +   ++HRDLK +N+ ++      +I I D G
Sbjct: 100 RGVYTEKDASLV---IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFG 154

Query: 69  LAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
           L+ + +      +  GTP ++APE L ++ Y++ VD +S G  +  +L   YP  Y E  
Sbjct: 155 LSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE-- 210

Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
             +++++K+  G     F       I +  A+ F+   LE + ++R   ++ L  P++  
Sbjct: 211 TESKLFEKIKEGYY--EFESPFWDDISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

Query: 180 DA 181
           + 
Sbjct: 268 NT 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (257), Expect = 2e-24
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 19/176 (10%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
           + + N  RQI   + YLH     + HRD+K +N  F      +IK+ D GL+        
Sbjct: 168 KLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225

Query: 79  A-----HSVIGTPEFMAPEL---YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQ 129
                  +  GTP F+APE+     E Y    D +S G+ +  +L    P      N A 
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV--NDAD 283

Query: 130 IYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
              +V + KL      ++ +    AR  +   L  NV +R  A   L  P+++  +
Sbjct: 284 TISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  102 bits (255), Expect = 3e-24
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 37/198 (18%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           GTLR   +   ++       ++A+ I  G+AYLH  +  +IHRDL   N  V  +   + 
Sbjct: 92  GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVV 148

Query: 64  IGDLGLAAILRGSQ---------------QAHSVIGTPEFMAPE-LYEEDYNELVDIYSF 107
           + D GLA ++   +               + ++V+G P +MAPE +    Y+E VD++SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208

Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--------PGAFHRI------QDAEAR- 152
           G+ + E++       +       +     G L        P +F  I       D E R 
Sbjct: 209 GIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268

Query: 153 RF--VGKCLENVSKRLPA 168
            F  +   LE +   L  
Sbjct: 269 SFVKLEHWLETLRMHLAG 286

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  103 bits (259), Expect = 3e-24
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 20/170 (11%)

Query: 3   TSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-- 57
             G+L            +         R ++ G+ +L  +   ++HR++K  NI      
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGE 149

Query: 58  -HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED---------YNELVDIYSF 107
                 K+ D G A  L   +Q  S+ GT E++ P++YE           Y   VD++S 
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 108 GMCVLEMLTSE---YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
           G+      T      P+       ++  K+ +GK  GA   +Q AE    
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (254), Expect = 3e-24
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 23/188 (12%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           +   +  + R +    R +L  I  LH  +  ++HRDLK +NI ++  +  IK+ D G +
Sbjct: 118 KVTLSEKETRKI---MRALLEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFS 171

Query: 71  AILRGSQQAHSVIGTPEFMAPE-------LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
             L   ++   V GTP ++APE            Y + VD++S G  ++  L +  P  +
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFW 230

Query: 122 SECSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
                   + + + SG        +    D   +  V + L     KR  A+E L  PF 
Sbjct: 231 HR--KQMLMLRMIMSGNYQFGSPEWDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

Query: 178 ASDAGEPL 185
                E +
Sbjct: 288 QQYVVEEV 295

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  104 bits (262), Expect = 4e-24
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 14/181 (7%)

Query: 20  RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIKIGDLGLAAILRGSQQ 78
                + RQ+ +G+ ++H ++   +H DLK +NI F      ++K+ D GL A L   Q 
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

Query: 79  AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
                GT EF APE    +      D++S G  +  +L S       E  N  +  + V 
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVK 369

Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVP 191
           S        AF  I + + + F+ K L  + + R+   + L  P+L              
Sbjct: 370 SCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 428

Query: 192 S 192
           S
Sbjct: 429 S 429

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 5e-24
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 23/198 (11%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLG 68
           R+ Y+  D        +QIL  + + H     V+HR+LK +N+   +   G  +K+ D G
Sbjct: 104 REYYSEADASHC---IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFG 158

Query: 69  LAAILRGSQQA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
           LA  + G QQA     GTP +++PE L ++ Y + VD+++ G  +L +L   YP  + E 
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPPFWDE- 216

Query: 125 SNPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
            +  ++Y+++ +G     F       +   EA+  + K L  N SKR+ A E L  P+++
Sbjct: 217 -DQHRLYQQIKAGAY--DFPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWIS 272

Query: 179 SDAGEPLLIPQVPSFQNL 196
             +     + +  +   L
Sbjct: 273 HRSTVASCMHRQETVDCL 290

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (257), Expect = 6e-24
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)

Query: 24  NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAA--ILRG 75
            WAR    +++  +  +H      IHRD+K DN+ +  +GH   +K+ D G        G
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKEG 222

Query: 76  SQQAHSVIGTPEFMAPEL-----YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQ 129
             +  + +GTP++++PE+      +  Y    D +S G+ + EML  + P Y++  +   
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVG 280

Query: 130 IYKKVTSGKLPGAFHRIQD--AEARRFVGKCLENVSKRL 166
            Y K+ + K    F    D   EA+  +   L +   RL
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (253), Expect = 7e-24
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 25/203 (12%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLG 68
           +K ++  +   +    R+++  ++++H     V+HRDLK +N+ F +     +IKI D G
Sbjct: 100 KKHFSETEASYI---MRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFG 154

Query: 69  LAAILRGSQQA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSE- 123
            A +     Q   +   T  + APE L +  Y+E  D++S G  +L  + S      S  
Sbjct: 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHD 213

Query: 124 ----CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
               C++  +I KK+  G       A+  +   EA+  +   L  + +KRL    L  + 
Sbjct: 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNE 272

Query: 176 FLASDAG---EPLLIPQVPSFQN 195
           +L   +     PL+ P +     
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSG 295

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (256), Expect = 1e-23
 Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 34/206 (16%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---- 60
               E  K     +  ++    RQI  G+A+LH     +IHRDLK  NI V+        
Sbjct: 103 NVSDENLKLQKEYNPISL---LRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTAD 157

Query: 61  --------QIKIGDLGLAAILRGSQQA-----HSVIGTPEFMAPELYEED--------YN 99
                   +I I D GL   L   Q +     ++  GT  + APEL EE           
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217

Query: 100 ELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGK-LPGAFHRIQDAEARRFVG 156
             +DI+S G     +L+        + S  + I + + S   +     R   AEA   + 
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277

Query: 157 KCLE-NVSKRLPAKELLLDPFLASDA 181
           + ++ +  KR  A ++L  P     +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKS 303

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  101 bits (254), Expect = 1e-23
 Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 27/163 (16%)

Query: 24  NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAA--ILRG 75
             AR    +I+  I  +H      +HRD+K DNI +   GH   I++ D G        G
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGH---IRLADFGSCLKLRADG 216

Query: 76  SQQAHSVIGTPEFMAPEL--------YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSN 126
           + ++   +GTP++++PE+            Y    D ++ G+   EM   + P Y++  +
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--S 274

Query: 127 PAQIYKKVTSGKLPGAFHRIQDA---EARRFVGKCLENVSKRL 166
            A+ Y K+   K   +   + +    EAR F+ + L     RL
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 2e-23
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 17/180 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLGLAAILRGSQQA-HSVI 83
           RQIL  + Y H ++  +IHRD+K   +   +      +K+G  G+A  L  S       +
Sbjct: 137 RQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGKL- 139
           GTP FMAPE +  E Y + VD++  G  +L +L S     Y       ++++ +  GK  
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYK 250

Query: 140 --PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNL 196
             P  +  I +  A+  V + L  + ++R+   E L  P+L         I    + + L
Sbjct: 251 MNPRQWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 46/145 (31%), Positives = 81/145 (55%), Gaps = 14/145 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           A ++   + YLH  D  +I+RDLK +NI +  NGH   IKI D G A         +++ 
Sbjct: 112 AAEVCLALEYLHSKD--IIYRDLKPENILLDKNGH---IKITDFGFAK--YVPDVTYTLC 164

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTP+++APE +  + YN+ +D +SFG+ + EML    P+   SN  + Y+K+ + +L   
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAEL--R 221

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
           F    + + +  + + +  ++S+RL
Sbjct: 222 FPPFFNEDVKDLLSRLITRDLSQRL 246

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 47/145 (32%), Positives = 68/145 (46%), Gaps = 15/145 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           +I   + +LH     +I+RDLK +NI +   GH   +K+ D GL    +      H+  G
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCG 183

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
           T E+MAPE L    +N  VD +S G  + +MLT   P   E  N  +   K+   KL   
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLN-- 239

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
                  EAR  + K L+ N + RL
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRL 264

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL-RGSQQAHSVIGT 85
            QI+ G+ YLH H   ++HRDL   N+ +  +   IKI D GLA  L    ++ +++ GT
Sbjct: 119 HQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGT 175

Query: 86  PEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSG--KLPG 141
           P +++PE      +    D++S G C+   +L    P+ +         KV     ++P 
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPS 233

Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
                   EA+  + + L  N + RL    +L  PF
Sbjct: 234 FLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 99.3 bits (247), Expect = 7e-23
 Identities = 36/193 (18%), Positives = 63/193 (32%), Gaps = 31/193 (16%)

Query: 5   GTLREYRKKYTRVDIRA-----VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           GTL      Y     +      V ++A ++L  I  +H  +  +IH D+K DN  +    
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209

Query: 60  ----------GQIKIGDLGLAAILRG---SQQAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
                       + + DLG +  ++         +   T  F   E L  + +N  +D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 106 SFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA-RRFVGKCL-ENVS 163
                V  ML   Y   +        + +        F R+   +    F    L     
Sbjct: 270 GVAATVYCMLFGTYMKVKNEGGECKPEGL--------FRRLPHLDMWNEFFHVMLNIPDC 321

Query: 164 KRLPAKELLLDPF 176
             LP+ +LL    
Sbjct: 322 HHLPSLDLLRQKL 334

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.0 bits (245), Expect = 8e-23
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 15/145 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           ++   + +LH     +I+RDLK +NI +   GH   IK+ D GL+   +   ++A+S  G
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCG 188

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
           T E+MAPE +    + +  D +SFG+ + EMLT   P   +  +  +    +   KL   
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLG-- 244

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
             +    EA+  +    + N + RL
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRL 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 15/169 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           + I   I YLH  +  + HRD+K +N+ + +      +K+ D G A          +   
Sbjct: 168 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQ--IYKKVTSGKL 139
           TP ++APE L  E Y++  D++S G  ++ +L   YP  YS         +  ++  G+ 
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284

Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
                 +  + + E +  +   L+   ++R+   E +  P++      P
Sbjct: 285 EFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 13/150 (8%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSV 82
           A +I   + YLH  +  +++RDLK +NI +   GH   I + D GL    +  +    + 
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTF 199

Query: 83  IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
            GTPE++APE L+++ Y+  VD +  G  + EML    P+    N A++Y  + +  L  
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQ- 257

Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
                    AR  +   L+ + +KRL AK+
Sbjct: 258 -LKPNITNSARHLLEGLLQKDRTKRLGAKD 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 26/136 (19%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH-------GHDPPVIHRDLKCDNIFVNG 57
           G+L +Y   +T  D  +    A  + RG+AYLH        + P + HRDL   N+ V  
Sbjct: 97  GSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155

Query: 58  HLGQIKIGDLGLAAILRGSQQA---------HSVIGTPEFMAPELYE--------EDYNE 100
             G   I D GL+  L G++            S +GT  +MAPE+ E        E   +
Sbjct: 156 D-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214

Query: 101 LVDIYSFGMCVLEMLT 116
            VD+Y+ G+   E+  
Sbjct: 215 QVDMYALGLIYWEIFM 230

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 11/166 (6%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           +    +            +  QI+ G+ +LH  +  +I+RDLK +N+ ++   G ++I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISD 332

Query: 67  LGLA-AILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY--- 121
           LGLA  +  G  +     GTP FMAPE L  E+Y+  VD ++ G+ + EM+ +  P+   
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
            E     ++ ++V    +   +       ++ F    L+ +  KRL
Sbjct: 393 GEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRL 436

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 40/160 (25%), Positives = 79/160 (49%), Gaps = 10/160 (6%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-AHSV 82
            + + +++GI YLH     +IHRD+K  N+ V    G IKI D G++   +GS     + 
Sbjct: 141 FYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNT 197

Query: 83  IGTPEFMAPEL---YEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
           +GTP FMAPE      + ++ + +D+++ G+ +   +  + P+ +      ++ K+ S  
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQA 256

Query: 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           L          + +  + + L+ N   R+   E+ L P++
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 39/182 (21%), Positives = 83/182 (45%), Gaps = 27/182 (14%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA 70
           +   +  + R++    R +L  +++LH ++  ++HRDLK +NI ++ ++ QI++ D G +
Sbjct: 194 KVALSEKETRSI---MRSLLEAVSFLHANN--IVHRDLKPENILLDDNM-QIRLSDFGFS 247

Query: 71  AILRGSQQAHSVIGTPEFMAPE-------LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
             L   ++   + GTP ++APE            Y + VD+++ G  +L  L +  P  +
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFW 306

Query: 122 SECSNPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
                   + + +  G+    F             +  + + L+ +   RL A++ L  P
Sbjct: 307 HR--RQILMLRMIMEGQY--QFSSPEWDDRSS-TVKDLISRLLQVDPEARLTAEQALQHP 361

Query: 176 FL 177
           F 
Sbjct: 362 FF 363

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 41/197 (20%), Positives = 89/197 (45%), Gaps = 22/197 (11%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           R I   I +LH H+  + HRD+K +N+ + +      +K+ D G A          +   
Sbjct: 135 RDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCY 191

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN--PAQIYKKVTSGKL 139
           TP ++APE L  E Y++  D++S G  ++ +L   +P  YS         + +++  G+ 
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250

Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVP--SF 193
                 +  + + +A++ +   L+ + ++RL   + +  P++        ++PQ P  + 
Sbjct: 251 GFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSM----VVPQTPLHTA 305

Query: 194 QNLNPNGAVMELVPKFA 210
           + L  +    + V +  
Sbjct: 306 RVLQEDKDHWDEVKEEM 322

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 98.3 bits (245), Expect = 3e-22
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 25/161 (15%)

Query: 24  NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAA--ILRG 75
             AR    +++  I  +H      +HRD+K DNI +  NGH   I++ D G     +  G
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDG 229

Query: 76  SQQAHSVIGTPEFMAPEL------YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPA 128
           + Q+   +GTP++++PE+       +  Y    D +S G+C+ EML  E P Y+E  +  
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLV 287

Query: 129 QIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRL 166
           + Y K+ + K    F          A+  + + + +   RL
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRL 328

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 46/145 (31%), Positives = 78/145 (53%), Gaps = 14/145 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           A QI+    YLH  D  +I+RDLK +N+ +   G+   I++ D G A   R   +  ++ 
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGY---IQVTDFGFAK--RVKGRTWTLC 199

Query: 84  GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
           GTPE +APE +  + YN+ VD ++ G+ + EM     P+     P QIY+K+ SGK+   
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKV--R 256

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
           F     ++ +  +   L+ +++KR 
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRF 281

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 40/150 (26%), Positives = 81/150 (54%), Gaps = 18/150 (12%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA--AILRGSQQAHSVI 83
           +I+  + +LH     +I+RD+K +NI +  NGH   + + D GL+   +   +++A+   
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFC 221

Query: 84  GTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPY---SECSNPAQIYKKVTSG 137
           GT E+MAP++       +++ VD +S G+ + E+LT   P+    E ++ A+I +++   
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281

Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
           + P  + +   A A+  + + L  +  KRL
Sbjct: 282 EPP--YPQEMSALAKDLIQRLLMKDPKKRL 309

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 26/178 (14%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSV 82
             +I+  + YLH  D  V++RD+K +N+ +  +GH   IKI D GL    +       + 
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTF 165

Query: 83  IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLP 140
            GTPE++APE L + DY   VD +  G+ + EM+    P Y++  +  ++++ +   ++ 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR 223

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLN 197
             F R    EA+  +   L+ +  +RL            SDA E   + +   F ++N
Sbjct: 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGP--------SDAKE---VMEHRFFLSIN 268

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.9 bits (241), Expect = 2e-21
 Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           ++ +A +I+ G+ ++H     V++RDLK  NI ++ H G ++I DLGLA      ++ H+
Sbjct: 294 MRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSK-KKPHA 349

Query: 82  VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY--SECSNPAQIYKKVTSG 137
            +GT  +MAPE       Y+   D +S G  + ++L    P+   +  +  +I +   + 
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
            +          E R  +   L+ +V++RL
Sbjct: 410 AVE--LPDSFSPELRSLLEGLLQRDVNRRL 437

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.4 bits (240), Expect = 2e-21
 Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 10/151 (6%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A +I  G+  LH     +++RDLK +NI ++ H G I+I DLGLA  +   Q     +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY---SECSNPAQIYKKVTSGKLP 140
           T  +MAPE +  E Y    D ++ G  + EM+  + P+    +     ++ + V      
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407

Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
             +      +AR    + L  + ++RL  + 
Sbjct: 408 --YSERFSPQARSLCSQLLCKDPAERLGCRG 436

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 44/149 (29%), Positives = 78/149 (52%), Gaps = 15/149 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           +I+ G+ +LH     +++RDLK DNI +  +GH   IKI D G+    + G  + ++  G
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFCG 180

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
           TP+++APE L  + YN  VD +SFG+ + EML  + P + +  +  +++  +        
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF-- 236

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
           + R  + EA+  + K       KRL  + 
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 265

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 14/178 (7%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           TL EY + +  + +    N+  QIL GI + H     ++HRD+K  NI ++ +   +KI 
Sbjct: 97  TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIF 153

Query: 66  DLGLAAILRGSQ--QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPY 121
           D G+A  L  +   Q + V+GT ++ +PE  + E  +E  DIYS G  VL EML  E P+
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG-IVLYEMLVGEPPF 212

Query: 122 SECSNPAQI-YKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-AKELLLD 174
           +       I  K +      +     +         + +  E + + R    +E+  D
Sbjct: 213 NG-ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 9/146 (6%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQQAHSVIGTP 86
           +I+  + +LH     +I+RDLK DN+ ++   G  K+ D G+    +       +  GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 87  EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR 145
           +++APE L E  Y   VD ++ G+ + EML    P+ E  N   +++ + + ++   +  
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVV--YPT 245

Query: 146 IQDAEARRFVGKCLE-NVSKRLPAKE 170
               +A   +   +  N + RL +  
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLT 271

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 41/215 (19%)

Query: 11  RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQIKIGDLG 68
           R+ +  ++   V    + +   + +LH     + HRDLK +NI   +   +  +KI D  
Sbjct: 105 RRHFNELEASVV---VQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD 159

Query: 69  LAAILR--------GSQQAHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEM 114
           L + ++         + +  +  G+ E+MAPE           Y++  D++S G  +L +
Sbjct: 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYI 218

Query: 115 LTSEYP--YSEC-SNPAQIYKKVTSGKLPGAFHRIQDA--------------EARRFVGK 157
           L S YP     C S+      +         F  IQ+                A+  + K
Sbjct: 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278

Query: 158 CLE-NVSKRLPAKELLLDPFLASDAGE-PLLIPQV 190
            L  +  +RL A ++L  P++   A E  L  P V
Sbjct: 279 LLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 13/144 (9%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           +I  G+ +L      +I+RDLK DN+ +   GH   IKI D G+    +       +  G
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCG 183

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TP+++APE +  + Y + VD ++FG+ + EML  + P+ E  +  ++++ +    +   +
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA--Y 240

Query: 144 HRIQDAEARRFVGKCLE-NVSKRL 166
            +    EA       +  +  KRL
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRL 264

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 41/192 (21%), Positives = 88/192 (45%), Gaps = 10/192 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
           RQI+  + Y H     ++HRDLK +N+ ++     IKI D G +       +  +  G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAP 177

Query: 87  EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
            + APEL++ + Y+   VD++S G+ +  +++   P+   +   ++ ++V  GK    F+
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVLRGKYRIPFY 236

Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVM 203
                +    + + L  N  KR   ++++ D ++ +   E  L P V   +    +   +
Sbjct: 237 --MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP-ELDISDQKRI 293

Query: 204 ELVPKFAVDSDR 215
           +++       + 
Sbjct: 294 DIMVGMGYSQEE 305

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.2 bits (234), Expect = 1e-20
 Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 11/119 (9%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
            +L+  + +  ++ +     +  +IL  ++YLH     +++ DLK +NI +     Q+K+
Sbjct: 169 QSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTE--EQLKL 222

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVL-EMLTSEYPYS 122
            DLG             + GTP F APE+         DIY+ G   L  +       +
Sbjct: 223 IDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 42/192 (21%), Positives = 79/192 (41%), Gaps = 17/192 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVI 83
            Q++ G+ YLH     ++H+D+K  N+ +    G +KI  LG+A  L          +  
Sbjct: 116 CQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 84  GTPEFMAPELY--EEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-- 138
           G+P F  PE+    + ++   VDI+S G+ +  + T  YP+ E  N  ++++ +  G   
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYA 231

Query: 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLN 197
           +PG             +   LE   +KR   +++    +             +P   +  
Sbjct: 232 IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287

Query: 198 PNGAVMELVPKF 209
                M +VP  
Sbjct: 288 DRWRSMTVVPYL 299

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 20/154 (12%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSV 82
           + +I   + YLH     +I+RDLK DN+ +   GH   IK+ D G+    LR      + 
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 170

Query: 83  IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS--------NPAQIYKK 133
            GTP ++APE L  EDY   VD ++ G+ + EM+    P+                +++ 
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230

Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
           +   ++     R    +A   +   L  +  +RL
Sbjct: 231 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERL 262

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQAHSVIGT 85
           +Q+L G++Y H     + HRDLK +N  ++G    ++KI D G +       Q  S +GT
Sbjct: 123 QQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180

Query: 86  PEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK----VTSGK- 138
           P ++APE+   ++Y+ ++ D++S G+ +  ML   YP+ E     + Y+K    + S K 
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKY 239

Query: 139 -LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNL 196
            +P         E    + +    + + R+   E+    +   +    L+       Q  
Sbjct: 240 SIPDDIRI--SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQ 297

Query: 197 NPNGAVMELVPKFAVDSDRRKSTDMT 222
            P   +  L     + S+        
Sbjct: 298 EPEQPMQSLDTIMQIISEATIPAVRN 323

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 15/173 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
            Q++  I + H     V+HRD+K +NI ++   G  K+ D G  A+L          GT 
Sbjct: 146 GQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202

Query: 87  EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
            +  PE      Y+     ++S G+ + +M+  + P+          +++   +L    H
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELHFPAH 255

Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNL 196
                +    + +CL    S R   +E+LLDP++ + A +  L P       L
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPL 306

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 27/209 (12%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           TLR+       +  +          + + + H +   +IHRD+K  NI ++     +K+ 
Sbjct: 102 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVM 158

Query: 66  DLGLAAILRGSQ----QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEY 119
           D G+A  +  S     Q  +VIGT ++++PE    +  +   D+YS G CVL E+LT E 
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG-CVLYEVLTGEP 217

Query: 120 PYSECSNPAQI-YKKVTSG-KLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-AKELLLD- 174
           P++   +P  + Y+ V      P A H    A+    V K L  N   R   A E+  D 
Sbjct: 218 PFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

Query: 175 -----------PFLASDAGEPLLIPQVPS 192
                      P + +DA    L+     
Sbjct: 277 VRVHNGEPPEAPKVLTDAERTSLLSSAAG 305

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 14/219 (6%)

Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           +  G L +Y  +  R+     + + +QI+  I Y H H   ++HRDLK +N+ ++ +   
Sbjct: 90  YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LN 146

Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEY 119
           +KI D GL+ I+       +  G+P + APE+   + Y    VD++S G+ +  ML    
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206

Query: 120 PYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
           P+ +      ++KKV S    +P          A+  + + +  +  +R+  +E+  DP+
Sbjct: 207 PFDD-EFIPNLFKKVNSCVYVMPDFLSP----GAQSLIRRMIVADPMQRITIQEIRRDPW 261

Query: 177 LASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDR 215
              +  + L   +       +    V +L        D 
Sbjct: 262 FNVNLPDYLRPMEEVQGSYADSR-IVSKLGEAMGFSEDY 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.1 bits (224), Expect = 9e-20
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 20/154 (12%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSV 82
           + +I   + YLH     +I+RDLK DN+ +   GH   IK+ D G+    LR      + 
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 213

Query: 83  IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS--------NPAQIYKK 133
            GTP ++APE L  EDY   VD ++ G+ + EM+    P+                +++ 
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
           +   ++     R    +A   +   L  +  +RL
Sbjct: 274 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERL 305

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.6 bits (227), Expect = 9e-20
 Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 9/144 (6%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           A +I  G+ +L      +I+RDLK DN+ ++   G IKI D G+    +       +  G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TP+++APE +  + Y + VD ++FG+ + EML  + P+ E  +  ++++ +    +   +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA--Y 561

Query: 144 HRIQDAEARRFVGKCLE-NVSKRL 166
            +    EA       +  +  KRL
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRL 585

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 17/162 (10%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLA-AILRGSQQAHSVIG 84
           +I+  + YLH     V++RDLK +N+ +  +GH   IKI D GL    ++      +  G
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCG 311

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
           TPE++APE L + DY   VD +  G+ + EM+    P+    +  ++++ +   ++   F
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR--F 368

Query: 144 HRIQDAEARRFVGKCLE-NVSKRL-----PAKELLLDPFLAS 179
            R    EA+  +   L+ +  +RL      AKE++   F A 
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 9/168 (5%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVI 83
            Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + 
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168

Query: 84  GTPEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
           GT  ++APE L   +++ E VD++S G+ +  ML  E P+ + S+  Q Y      K   
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
              +  D+     + K L  N S R+   ++  D +      +    P
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 17/190 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA---HSVI 83
            Q++ G+ YLHG    + HRD+K +N+ ++     +KI D GLA + R + +    + + 
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168

Query: 84  GTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
           GT  ++APEL +  +++ E VD++S G+ +  ML  E P+ + S+  Q Y      K   
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--- 225

Query: 142 AFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNL 196
             +       D+     + K L  N S R+   ++  D +      +    P+V S    
Sbjct: 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVS 284

Query: 197 NPNGAVMELV 206
                  + +
Sbjct: 285 ESPSGFSKHI 294

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 50/190 (26%), Positives = 88/190 (46%), Gaps = 14/190 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y  K+ RV+    +   +QIL  + Y H H   V+HRDLK +N+ ++ H    KI
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKI 152

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYS 122
            D GL+ ++   +   +  G+P + APE+     Y    VDI+S G+ +  +L    P+ 
Sbjct: 153 ADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

Query: 123 ECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           +  +   ++KK+  G   +P   +R         +   L+ +  KR   K++    +   
Sbjct: 213 D-EHVPTLFKKIRGGVFYIPEYLNR----SVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

Query: 180 DAGEPLLIPQ 189
           D    L  P+
Sbjct: 268 DLPSYLF-PE 276

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 33/121 (27%), Positives = 49/121 (40%), Gaps = 8/121 (6%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
            L    ++   +         RQI   +   H       HRD+K +NI V+       + 
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLV 176

Query: 66  DLGLAAILRGSQ--QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPY 121
           D G+A+     +  Q  + +GT  +MAPE +         DIY+   CVL E LT   PY
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY 235

Query: 122 S 122
            
Sbjct: 236 Q 236

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 39/206 (18%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            R Y K    + +  +K +  Q+LR +AY+H     + HRD+K  N+ ++   G +K+ D
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLID 185

Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT------- 116
            G A IL   +   S I +  + APEL     +Y   +DI+S G CV+ E++        
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPG 244

Query: 117 -SEY------------PYSE---CSNPAQI------YKKVTSGKLPGAFHRIQDAEARRF 154
            S              P  E     NP  +       +     K+   F      +A   
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV---FRPRTPPDAIDL 301

Query: 155 VGKCLE-NVSKRLPAKELLLDPFLAS 179
           + + LE   S RL A E L  PF   
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFFDE 327

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 46/207 (22%), Positives = 73/207 (35%), Gaps = 38/207 (18%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            R Y ++        +K +  Q++R I  LH     V HRD+K  N+ VN   G +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175

Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE----- 118
            G A  L  S+   + I +  + APEL    + Y   VDI+S G C+  EM+  E     
Sbjct: 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRG 234

Query: 119 --------------------------YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152
                                       +++            S        +    EA 
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLY-NSKGIPWSNVFSDHSLKD-AKEAY 292

Query: 153 RFVGKCLE-NVSKRLPAKELLLDPFLA 178
             +   L+    +R+   E L  P+  
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFD 319

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 42/236 (17%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L+ + +    + +  +  +  Q+ R + ++H     + HRD+K  N+ VN     +K+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EML-------- 115
            G A  L  S+ + + I +  + APEL     +Y   +D++S G CV  E++        
Sbjct: 186 FGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFSG 244

Query: 116 -----------------TSEYPYSECSNPAQIYKKVTSGK-LPGAFHRIQDAEARRFVGK 157
                            T E       +  ++       K           + A   + +
Sbjct: 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304

Query: 158 CLE-NVSKRLPAKELLLDPFLAS---DAGEPLLIPQVPSFQNLNPNGAVMELVPKF 209
            L      R+   E +  PF           +            P+G    +   F
Sbjct: 305 ILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSN------FPHGVNQNIPQLF 354

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)

Query: 6   TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           T+     +Y R V    VK+   Q L+ + + H H+   IHRD+K +NI +  H   IK+
Sbjct: 87  TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKL 143

Query: 65  GDLGLAAILRGSQQA--HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE- 118
            D G A +L G        V  T  + +PEL   +  Y   VD+++ G CV  E+L+   
Sbjct: 144 CDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGVP 201

Query: 119 -YPYSECSNPAQIYK--KV----TSGKLPG-----AFHRIQ-----------------DA 149
            +P    S+  Q+Y   K                  F  ++                   
Sbjct: 202 LWPGK--SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISY 259

Query: 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLAS--DAGEPLLIPQVPS 192
            A   +  CL  + ++RL  ++LL  P+  +  +  +       P+
Sbjct: 260 PALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPA 305

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 35/176 (19%), Positives = 75/176 (42%), Gaps = 15/176 (8%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
            Q+L  + + H     V+HRD+K +NI ++ + G++K+ D G  A+L+ +       GT 
Sbjct: 156 WQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTR 212

Query: 87  EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
            +  PE      Y+     ++S G+ + +M+  + P+          +++  G++   F 
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQV--FFR 263

Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPN 199
           +   +E +  +  CL    S R   +E+   P++                 +  P+
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 6e-18
 Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 33/203 (16%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ D
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD 200

Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE--YPY 121
            G A  L   +   S I +  + APEL     DY   +D++S G CVL E+L  +  +P 
Sbjct: 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPG 259

Query: 122 SECSN------------PAQIYKKVTSGKLPGAFHRIQ------------DAEARRFVGK 157
               +              +  +++        F +I+              EA     +
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319

Query: 158 CLE-NVSKRLPAKELLLDPFLAS 179
            LE   + RL   E     F   
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDE 342

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 50/193 (25%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           Q+LRG+ Y+H  +  V+HRDLK  N+F+N     +KIGD GLA   R     +S      
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA---RIMDPHYS---HKG 179

Query: 88  FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
            +          +P   L   +Y + +D+++ G C+  EMLT                  
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLIL 238

Query: 117 ------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRL 166
                  E    E  +   +Y +    +      ++      EA  F+ + L  +   RL
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298

Query: 167 PAKELLLDPFLAS 179
            A+E L  P+++ 
Sbjct: 299 TAEEALSHPYMSI 311

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 13/218 (5%)

Query: 3   TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           + G L +Y  K  R+D +  +   +QIL G+ Y H H   V+HRDLK +N+ ++ H    
Sbjct: 99  SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNA 155

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
           KI D GL+ ++   +   +  G+P + APE+     Y    VDI+S G+ +  +L    P
Sbjct: 156 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

Query: 121 YSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           + +  +   ++KK+  G    P   +          +   L+ +  KR   K++    + 
Sbjct: 216 FDD-DHVPTLFKKICDGIFYTPQYLNP----SVISLLKHMLQVDPMKRATIKDIREHEWF 270

Query: 178 ASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDR 215
             D  + L          +  + A+ E+  KF    + 
Sbjct: 271 KQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEE 308

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 44/208 (21%), Positives = 86/208 (41%), Gaps = 19/208 (9%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTP 86
           RQ++  + YL   D  +IHRD+K +NI +      IK+ D G AA L   +  ++  GT 
Sbjct: 137 RQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTI 193

Query: 87  EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
           E+ APE+     Y    ++++S G+  L  L  E       NP    ++     +   + 
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCELEETVEAAIHPPYL 246

Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVM 203
                E    V   L+    +R   ++L+ DP++     +P+ +      +    N    
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT----QPVNLADYTWEEVFRVNKPES 300

Query: 204 ELVPKFAVDSDRRKSTDMTITGTMNPED 231
            ++   +++   R  +D+     +   +
Sbjct: 301 GVLSAASLEMGNRSLSDVAQAQELCGGE 328

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 48/237 (20%), Positives = 86/237 (36%), Gaps = 58/237 (24%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           +K   + +L G+ Y+H +   ++HRD+K  N+ +    G +K+ D GLA     ++ +  
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182

Query: 82  VIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVL-EMLT----------------- 116
              T       +  PEL   E DY   +D++  G C++ EM T                 
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLALI 241

Query: 117 ---------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE- 160
                            Y   E     +  K+    +L      ++D  A   + K L  
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLLVL 298

Query: 161 NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRK 217
           + ++R+ + + L   F  SD   P+  P            ++ E +        RRK
Sbjct: 299 DPAQRIDSDDALNHDFFWSD---PM--PSDLKGMLSTHLTSMFEYLAP-----PRRK 345

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 46/209 (22%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GSQQA 79
           +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GLA   R    Q A
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA---RIYSFQMA 175

Query: 80  --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSE--YPYSECSNPAQIYK- 132
               V+ T  + APE L +  Y   VD++S G C+  EM   +  +  S  S+  Q+ K 
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFRRKPLFRGS--SDVDQLGKI 231

Query: 133 ------------------------KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
                                     ++  +      I D   +  + KCL  N +KR+ 
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-DELGKDLLLKCLTFNPAKRIS 290

Query: 168 AKELLLDPFLAS-DAGEPLLIPQVPSFQN 195
           A   L  P+    +  +  L   +P  QN
Sbjct: 291 AYSALSHPYFQDLERCKENLDSHLPPSQN 319

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 50/215 (23%)

Query: 6   TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           T+ +  + +   +D + V+ +  QI+ GI + H H+  +IHRD+K +NI V+   G +K+
Sbjct: 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKL 165

Query: 65  GDLGLAAILRGSQQA--HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT--- 116
            D G A  L    +     V  T  + APEL   +  Y + VD+++ G C++ EM     
Sbjct: 166 CDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGEP 223

Query: 117 -----------------------------SEYP-YSECSNPAQIYKKVTSGKLPGAFHRI 146
                                        ++ P ++    P    ++    + P      
Sbjct: 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL---- 279

Query: 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
                     KCL  +  KR    ELL   F   D
Sbjct: 280 -SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.9 bits (198), Expect = 8e-17
 Identities = 29/105 (27%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
           VK++  Q+L+G+ + H  +  V+HRDLK  N+ +N   G++K+ + GLA       +   
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159

Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSEYPY 121
             V+ T  +  P++    + Y+  +D++S G C+  E+  +  P 
Sbjct: 160 AEVV-TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 51/215 (23%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GSQQA 79
           VK +  Q+L+G+A+ H +   ++HRDLK  N+ +N   GQ+K+GD GLA   R  G    
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA---RAFGIPVN 163

Query: 80  ---HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT----------------- 116
                V+ T  + AP++      Y+  +DI+S G C+L EM+T                 
Sbjct: 164 TFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMITGKPLFPGTNDEEQLKLI 221

Query: 117 ---------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE- 160
                          ++ P    +   +  + +    L        D     F+   L+ 
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQ-VLQPHTKEPLDGNLMDFLHGLLQL 280

Query: 161 NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQN 195
           N   RL AK+ L  P+  ++      +    S  +
Sbjct: 281 NPDMRLSAKQALHHPWF-AEYYHHASMGGSRSHHH 314

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 47/218 (21%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN----GHLGQI 62
           L++Y  K   V +R +K++  Q++ G+ + H      +HRDLK  N+ ++         +
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL 176

Query: 63  KIGDLGLAAILR--GSQQA---HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EM 114
           KIGD GLA   R  G       H +I T  +  PE+      Y+  VDI+S   C+  EM
Sbjct: 177 KIGDFGLA---RAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEM 231

Query: 115 LT--------SE------------------YP-YSECSNPAQIYKKVTSGKLPGAFHRIQ 147
           L         SE                  +P  +   +  Q + K     L      + 
Sbjct: 232 LMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALL 291

Query: 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
           D E    +   LE +  KR+ AK  L  P+ + +  +P
Sbjct: 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 43/107 (40%), Positives = 59/107 (55%), Gaps = 13/107 (12%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQIKIGDLGLA----AILR 74
           VK+   QIL GI YLH +   V+HRDLK  NI V G     G++KI D+G A    + L+
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 75  GSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
                  V+ T  + APEL      Y + +DI++ G C+  E+LTSE
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTSE 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 50/202 (24%), Positives = 75/202 (37%), Gaps = 55/202 (27%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR--GSQQA 79
           +K+  RQ LRG+ +LH +   ++HRDLK +NI V    G +K+ D GLA   R    Q A
Sbjct: 122 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLA---RIYSYQMA 175

Query: 80  --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------- 116
               V+ T  + APE L +  Y   VD++S G C+  EM                     
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFRRKPLFCGNSEADQLGKIFD 233

Query: 117 -------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NV 162
                           P          +       +      + +    + + + L  N 
Sbjct: 234 LIGLPPEDDWPRDVSLPRGA-------FPPRGPRPVQSVVPEM-EESGAQLLLEMLTFNP 285

Query: 163 SKRLPAKELLLDPFLASDAGEP 184
            KR+ A   L   +L  D G P
Sbjct: 286 HKRISAFRALQHSYLHKDEGNP 307

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 51/213 (23%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGSQQAHSVIGTP 86
           Q LR +  LHG +  VIHRDLK  N+ +N +   +K+ D GLA  I   +       G  
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 87  EFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLTSE--------------- 118
             M          APE  L    Y+  +D++S G C+L E+                   
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLI 235

Query: 119 -----YPYSE------CSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVS 163
                 P+S+       S  A+ Y K           ++    + +    + + L  + +
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295

Query: 164 KRLPAKELLLDPFLAS---DAGEPLLIPQVPSF 193
           KR+ AKE L  P+L +      EP   P  PSF
Sbjct: 296 KRITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 10/100 (10%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
           +K +  Q+LRG+A+ H H   ++HRDLK  N+ +N   G +K+ D GLA       ++  
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYT 177

Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
           H V+ T  + AP++    + Y+  VDI+S G C+  EM+T
Sbjct: 178 HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 42/218 (19%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
           VK +  Q+LRG+AY H     V+HRDLK  N+ +N   G++K+ D GLA       +   
Sbjct: 102 VKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYD 158

Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSEYPY----SE--------- 123
           + V+ T  +  P++     DY+  +D++  G C+  EM T   P     +          
Sbjct: 159 NEVV-TLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMATGR-PLFPGSTVEEQLHFIFR 215

Query: 124 -------------CSNP---AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
                         SN       Y K  +  L     R+ D++    + K L+     R+
Sbjct: 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL-DSDGADLLTKLLQFEGRNRI 274

Query: 167 PAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAVME 204
            A++ +  PF  S       +P   S   L       E
Sbjct: 275 SAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE 312

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 10/139 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL      ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVK 157

Query: 64  IGDLGLAAILRGSQQAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           I D GLA +L   ++ +   G   P ++MA E +    Y    D++S+G+ V E++T   
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY      ++I   +  G
Sbjct: 218 KPYDGIPA-SEISSILEKG 235

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 77.2 bits (191), Expect = 9e-16
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 23/112 (20%)

Query: 15  TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL 73
            R  I      A    RG+AYLH H DP +IHRD+K  NI ++    +  +GD GLA  L
Sbjct: 132 KRQRI------ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK-L 183

Query: 74  RGSQQAH---SVIGTPEFMAPELYEEDY------NELVDIYSFGMCVLEMLT 116
              +  H   +V GT   +APE     Y      +E  D++ +G+ +LE++T
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.8 bits (190), Expect = 9e-16
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 10/100 (10%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
            K++  Q+L GIAY H     V+HRDLK  N+ +N   G++KI D GLA       +   
Sbjct: 102 AKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYT 158

Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
           H ++ T  + AP++    + Y+  +DI+S G C+  EM+ 
Sbjct: 159 HEIV-TLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 31  RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH---SVIGTPE 87
            GI +LH  +   IHRD+K  NI ++      KI D GLA       Q      ++GT  
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTA 200

Query: 88  FMAPELYEEDYNELVDIYSFGMCVLEMLT 116
           +MAPE    +     DIYSFG+ +LE++T
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 52/194 (26%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  +  V+HRDLK  N+ +N     +KI D GLA   R +   H       
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLA---RVADPDH---DHTG 186

Query: 88  FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
           F+          APE  L  + Y + +DI+S G C+L EML+                  
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHIL 245

Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKR 165
                   E      +  A+ Y      K    ++R+    D++A   + K L  N  KR
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305

Query: 166 LPAKELLLDPFLAS 179
           +  ++ L  P+L  
Sbjct: 306 IEVEQALAHPYLEQ 319

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 74.5 bits (184), Expect = 6e-15
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 31  RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH---SVIGTPE 87
           RG+ YLH     +IHRD+K  NI ++ +    KI D G++       Q H    V GT  
Sbjct: 150 RGLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLG 206

Query: 88  FMAPELYEEDY-NELVDIYSFGMCVLEMLT 116
           ++ PE + +    E  D+YSFG+ + E+L 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 36/191 (18%), Positives = 72/191 (37%), Gaps = 42/191 (21%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           +IL+ + Y H     ++HRD+K  N+ ++    ++++ D GLA      Q+ +  + +  
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 88  FMAPE--LYEEDYNELVDIYSFGMCVL-EMLT---------------------------S 117
           F  PE  +  + Y+  +D++S G C+L  M+                             
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254

Query: 118 EYPYSECSNPAQIY--------KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPA 168
           +Y           +        +K     +      +   EA  F+ K L  +   RL A
Sbjct: 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314

Query: 169 KELLLDPFLAS 179
           +E +  P+  +
Sbjct: 315 REAMEHPYFYT 325

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 50/233 (21%), Positives = 84/233 (36%), Gaps = 42/233 (18%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-- 79
           +K +    L+G+ YLH H   ++HRDLK +N+ ++   G +K+ D GLA       +A  
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 170

Query: 80  HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSEYPY----SE--------- 123
           H V+ T  + APEL      Y   VD+++ G C+L E+L    P+    S+         
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVG-CILAELLLRV-PFLPGDSDLDQLTRIFE 227

Query: 124 -------------CSNP-AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPA 168
                        CS P    +K      L   F      +    +      N   R+ A
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA-GDDLLDLIQGLFLFNPCARITA 286

Query: 169 KELLLDPFLASD--AGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKST 219
            + L   + ++         +P+           +   L  K        +  
Sbjct: 287 TQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGG 339

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 46/195 (23%), Positives = 69/195 (35%), Gaps = 57/195 (29%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
            IL G+  LH     V+HRDL   NI +  +   I I D  LA   R             
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA---RE-------DTADA 188

Query: 88  FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
                       APE  +  + + +LVD++S G CV+ EM                    
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYNQLNKIV 247

Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPG-AFHRI---QDAEARRFVGKCLE-NVSK 164
                   E      S  A+ Y + +   +P  A+  +    D  A   + K LE N  +
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307

Query: 165 RLPAKELLLDPFLAS 179
           R+  ++ L  P+  S
Sbjct: 308 RISTEQALRHPYFES 322

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 32/168 (19%), Positives = 65/168 (38%), Gaps = 34/168 (20%)

Query: 27  RQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QIKIGDLGLAAILRGSQQAHSVIG 84
           + I   I YLH  +  + HRD+K +N+ + +      +K+ D G                
Sbjct: 124 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 85  TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQ--IYKKVTSGKL- 139
                A E   E Y++  D++S G  ++ +L   YP  YS         +  ++  G+  
Sbjct: 167 -----AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220

Query: 140 --PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
                +  + + E +  +   L+   ++R+   E +  P++      P
Sbjct: 221 FPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 43/204 (21%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV-IGTP 86
           Q+L+G+ Y+H     +IHRDLK  N+ VN    ++KI D GLA   R +    +  + T 
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA---RQADSEMTGYVVTR 189

Query: 87  EFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT-------------------------SE 118
            + APE  L    Y + VDI+S G C++ EM+T                         +E
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKELLLD 174
           +     S+ A+ Y K         F  I       A   + K L  +  +R+ A E L  
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308

Query: 175 PFLAS---DAGEPLLIPQVPSFQN 195
           P+  S      EP +     SF +
Sbjct: 309 PYFESLHDTEDEPQVQKYDDSFDD 332

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 10/139 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R+    +  + + NW  QI +G+ YL      ++HRDL   N+ V      +K
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVK 157

Query: 64  IGDLGLAAILRGSQQAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           I D GLA +L   ++ +   G   P ++MA E +    Y    D++S+G+ V E++T   
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY      ++I   +  G
Sbjct: 218 KPYDGIPA-SEISSILEKG 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 40/185 (21%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV-IGTP 86
           Q+L+G+ Y+H     V+HRDLK  N+ VN    ++KI D GLA   R +    +  + T 
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTR 187

Query: 87  EFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT-------------------------SE 118
            + APE  L    YN+ VDI+S G C++ EMLT                         +E
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKELLLD 174
           +        A+ Y +         F ++      +A   + K LE +V KRL A + L  
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 175 PFLAS 179
           PF   
Sbjct: 307 PFFEP 311

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 74.1 bits (181), Expect = 4e-14
 Identities = 66/496 (13%), Positives = 138/496 (27%), Gaps = 156/496 (31%)

Query: 12  KKY--TRVD-IRAVKNWARQILRGIAY--LHG--------------HDPPVIHRDLKCDN 52
            KY  +R+     ++    + LR      + G                  V  +      
Sbjct: 127 AKYNVSRLQPYLKLRQALLE-LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK--MDFK 183

Query: 53  IF-VNGHLGQIKIGDLGLAAILR--------GSQQAHSVIGTP-----------EFMAPE 92
           IF +N  L      +  L  + +         + ++                    +  +
Sbjct: 184 IFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 93  LYEEDYNELV--DIYS------FGM-C-VLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
            YE     LV  ++ +      F + C +L  LT+ +        A     ++       
Sbjct: 242 PYENCL--LVLLNVQNAKAWNAFNLSCKIL--LTTRFKQVTDFLSAATTTHISLDHHSMT 297

Query: 143 FHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNLNPNGAV 202
                  E +  + K L+   + LP + L  +P   S   E  +   + ++ N       
Sbjct: 298 LT---PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDGLATWDNWK----- 348

Query: 203 MELVPKFAVDSDRRKST-DMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPFDIFNDTA 261
                   V+ D+  +  + ++   + P +                R ++    +F  +A
Sbjct: 349 -------HVNCDKLTTIIESSLN-VLEPAEY---------------RKMFDRLSVFPPSA 385

Query: 262 --TEVALEMVKELEITDWEPL--EIAEMIEQEI--SSLVPNW----------------KE 299
               + L ++       W  +      ++  ++   SLV                    +
Sbjct: 386 HIPTILLSLI-------WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438

Query: 300 CGSPQFCHQ---------HSFSYEDEDDDNDDDGIY-HPFY--SNSSHSSSHASLPAFFT 347
             +    H+          +F  +D      D   Y H  +   N  H          F 
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498

Query: 348 NNANSPPSWLQQEDLLGNDDASSNGSVSSF-------KYSSWDYHSGNEDDSE------- 393
           +       +L+Q+  + +D  + N S S          Y    Y   N+   E       
Sbjct: 499 DF-----RFLEQK--IRHDSTAWNASGSILNTLQQLKFYK--PYICDNDPKYERLVNAIL 549

Query: 394 -FSHRAGEPLCIARAT 408
            F  +  E L  ++ T
Sbjct: 550 DFLPKIEENLICSKYT 565

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 7e-07
 Identities = 81/569 (14%), Positives = 157/569 (27%), Gaps = 199/569 (34%)

Query: 7   LREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           L  +   +    D + V++  + IL                  + D+I ++        G
Sbjct: 22  LSVFEDAFVDNFDCKDVQDMPKSILS---------------KEEIDHIIMSKDAVS---G 63

Query: 66  DLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY--SE 123
            L L   L  S+Q   V    +F+  E+   +Y  L+           M+T  Y      
Sbjct: 64  TLRLFWTLL-SKQEEMV---QKFVE-EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118

Query: 124 CSNPAQIYKK--VTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD------- 174
             N  Q++ K  V+         R+Q     R   + L  +    PAK +L+D       
Sbjct: 119 LYNDNQVFAKYNVS---------RLQPYLKLR---QALLELR---PAKNVLIDGVLGSGK 163

Query: 175 PFLASDAGEPLLIPQVPSFQ-------NLNPNGAVMELVPKF--AVDSDRRKSTDMTITG 225
            ++A D      +     F+       N N    V+E++ K    +D +    +D +   
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 226 TMNPEDDTIFLKVQITDKDGQA-----RNIYFP-----FDI-----------------FN 258
            +        L+  +  K  +       N+        F++                   
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283

Query: 259 DTATEVALEM---------------------VKEL--EITDWEPLE---IAEMIEQEISS 292
            T T ++L+                       ++L  E+    P     IAE I   +++
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343

Query: 293 LVPNWKECGSPQFCHQHSFSYEDEDDDNDDDGIYHPFYSNSSHSSSHASLPAFFTNNANS 352
              NWK     +       S    +   +   ++                 + F  +A+ 
Sbjct: 344 W-DNWKHVNCDKLTTIIESSLNVLEPA-EYRKMFDRL--------------SVFPPSAHI 387

Query: 353 PPSWLQQEDLLGNDDASSNGSVSSFKYSSWDYHSGNEDDSEFSHRAGEPLCIARATQKST 412
           P   L    L+                  W      +                       
Sbjct: 388 PTILLS---LI------------------W-----FDVIKS------------------- 402

Query: 413 RFCPEAAMNNDRCNSEDVNSRKACRSNSNNHRKLSRIRSL-VDVRSQL-----LHRSLVE 466
                  +N      +                    I S+ ++++ +L     LHRS+V+
Sbjct: 403 --DVMVVVN------KLHKYSLV---EKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451

Query: 467 EIHKRRLFKTVGAVEN---------IGFH 486
             +  + F +   +           IG H
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 10/139 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L ++ R+    +  + + NW  QI +G+ YL  H   ++HR+L   N+ +     Q++
Sbjct: 99  GSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQ 155

Query: 64  IGDLGLAAILRGSQQAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           + D G+A +L    +         P ++MA E ++   Y    D++S+G+ V E++T   
Sbjct: 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY+     A++   +  G
Sbjct: 216 EPYAGLRL-AEVPDLLEKG 233

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 50/214 (23%), Positives = 79/214 (36%), Gaps = 55/214 (25%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV---IG 84
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA   R +  +  +   + 
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA---RTAGTSFMMTPYVV 188

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------------SE 118
           T  + APE +    Y E VDI+S G C++ EM+                           
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247

Query: 119 YPYSECSNPAQIY--------KKVTSGKLPGAFH-------RIQDAEARRFVGKCLE-NV 162
               +     + Y                P           +++ ++AR  + K L  + 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307

Query: 163 SKRLPAKELLLDPFLAS---DAGEPLLIPQVPSF 193
           SKR+   E L  P++      +      P++P  
Sbjct: 308 SKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 13/142 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K   R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVK 154

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++   V    E      APE L E  ++   D++SFG+ + E+ T  
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 212

Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
             Y E S           G   
Sbjct: 213 --YIEKSKSPPAEFMRMIGNDK 232

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 57/225 (25%)

Query: 7   LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-----NGHL 59
           L    KK  +  + +  VK  ++Q+L G+ Y+H     +IH D+K +N+ +       +L
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENL 174

Query: 60  GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
            QIKI DLG A      +   + I T E+ +PE L    +    DI+S    + E++T +
Sbjct: 175 IQIKIADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

Query: 119 Y------PYSECSNPAQI------------------------------YKKVTSGKLPG- 141
           +       +S   +   I                               + ++  K    
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292

Query: 142 -----AFHRIQDAEARRF---VGKCLE-NVSKRLPAKELLLDPFL 177
                  ++    EA+     +   L+ +  KR  A  L+  P+L
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 54/194 (27%), Positives = 77/194 (39%), Gaps = 58/194 (29%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPE 87
           QILRG+ Y+H  D  +IHRDLK  N+ VN    ++KI D GLA   R          T +
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA---R---------HTAD 184

Query: 88  FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
            M          APE  L    YN+ VDI+S G C++ E+LT                  
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLIL 243

Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKR 165
                  +E      S  A+ Y +  +      F  +    +  A   + K L  +  KR
Sbjct: 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303

Query: 166 LPAKELLLDPFLAS 179
           + A + L   + A 
Sbjct: 304 ITAAQALAHAYFAQ 317

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 37/140 (26%), Positives = 55/140 (39%), Gaps = 12/140 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G    + R +  R+ ++ +         G+ YL       IHRDL   N  V      +K
Sbjct: 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKN-VLK 253

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
           I D G++        A S  G  +      APE L    Y+   D++SFG+ + E  +  
Sbjct: 254 ISDFGMSREEADGVYAASG-GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312

Query: 118 EYPYSECSNPAQIYKKVTSG 137
             PY   SN  Q  + V  G
Sbjct: 313 ASPYPNLSN-QQTREFVEKG 331

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV---IG 84
           Q+L GI +LH     +IHRDLK  NI V      +KI D GLA   R +  +  +   + 
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA---RTAGTSFMMTPYVV 225

Query: 85  TPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------------SE 118
           T  + APE +    Y E VDI+S G C++ EM+                           
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284

Query: 119 YPYSECSNPAQIY--------KKVTSGKLPGAFH-------RIQDAEARRFVGKCLE-NV 162
               +     + Y                P +         +++ ++AR  + K L  + 
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344

Query: 163 SKRLPAKELLLDPFLAS 179
           +KR+   + L  P++  
Sbjct: 345 AKRISVDDALQHPYINV 361

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 13/142 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+LR+Y +K   R+D   +  +  QI +G+ YL       IHRDL   NI V     ++K
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVK 185

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL  +L   ++ + V    E      APE L E  ++   D++SFG+ + E+ T  
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 243

Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
             Y E S           G   
Sbjct: 244 --YIEKSKSPPAEFMRMIGNDK 263

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K  T   +R  +  + A QI  G+AY+   +   +HRDL+  NI V  +L   
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VC 319

Query: 63  KIGDLGLA-AILRGSQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           K+ D GLA  I      A      P ++ APE      +    D++SFG+ + E+ T   
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY    N  ++  +V  G
Sbjct: 380 VPYPGMVNR-EVLDQVERG 397

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 45/225 (20%), Positives = 77/225 (34%), Gaps = 80/225 (35%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA------------AILRG 75
           Q+++ I YLH     ++HRD+K  NI +N     +K+ D GL+              L  
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 76  SQQAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------ 116
           ++   +       +          APE  L    Y + +D++S G C+L E+L       
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIFP 232

Query: 117 ---------------------------SEY--------------PYSECSNPAQIYKKVT 135
                                      S +                S   +    +K + 
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292

Query: 136 SGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
               P A     + EA   + K L+ N +KR+ A + L  PF++ 
Sbjct: 293 LKINPKAD---CNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K  T   +R  +  + A QI  G+AY+   +   +HRDL+  NI V  +L   
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VC 402

Query: 63  KIGDLGLA-AILRGSQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           K+ D GLA  I      A      P ++ APE      +    D++SFG+ + E+ T   
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY    N  ++  +V  G
Sbjct: 463 VPYPGMVNR-EVLDQVERG 480

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 31/139 (22%), Positives = 59/139 (42%), Gaps = 10/139 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y ++   V  + +     Q+  G+ YL   +   +HRDL   N+ +       KI
Sbjct: 102 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQH-YAKI 158

Query: 65  GDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS-E 118
            D GL+  LR  +  +      ++     APE +    ++   D++SFG+ + E  +  +
Sbjct: 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY       ++   +  G
Sbjct: 219 KPYRGMKGS-EVTAMLEKG 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 35/138 (25%), Positives = 69/138 (50%), Gaps = 9/138 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR + + +   +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +   +K
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVK 531

Query: 64  IGDLGLAAILRGSQQAHSVIG-TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEY 119
           +GD GL+  +  S    +  G  P ++MAPE +    +    D++ FG+C+ E+L     
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591

Query: 120 PYSECSNPAQIYKKVTSG 137
           P+    N   +  ++ +G
Sbjct: 592 PFQGVKNN-DVIGRIENG 608

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR++ ++   R+D   +  ++ QI +G+ YL       +HRDL   NI V      +K
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEA-HVK 167

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           I D GLA +L   +  + V    +      APE L +  ++   D++SFG+ + E+ T  
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           +   S  +   ++       
Sbjct: 228 DKSCSPSAEFLRMMGCERDV 247

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 6/114 (5%)

Query: 7   LREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIK 63
           L +  +      V +   + +A+Q+   + +L   +  +IH DLK +NI   N     IK
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           I D G +  L   Q+ +  I +  + +PE L    Y+  +D++S G  ++EM T
Sbjct: 202 IVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 10/139 (7%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G L +Y ++  R ++ AV     A QI   + YL   +   IHR+L   N  V  +   +
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENH-LV 357

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
           K+ D GL+ ++ G    AH+    P ++ APE L    ++   D+++FG+ + E+ T   
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 417

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY      +Q+Y+ +   
Sbjct: 418 SPYPGIDL-SQVYELLEKD 435

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 26/158 (16%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L+EY  K   +++++    +A QI +G+ YL       +HRDL   N+ V     Q+K
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVK 166

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-- 116
           IGD GL   +   ++ ++V    +      APE L +  +    D++SFG+ + E+LT  
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 117 -------------SEYPYSECSNPAQIYKKVTSGK-LP 140
                            + + +   ++   +  GK LP
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTV-TRLVNTLKEGKRLP 263

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 30/140 (21%), Positives = 59/140 (42%), Gaps = 11/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++   K   + +  V     Q+  G+ YL   +   +HRDL   N+ +       K
Sbjct: 94  GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-YAK 150

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           I D GL+  L      ++     ++     APE +    ++   D++S+G+ + E L+  
Sbjct: 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           + PY +     ++   +  G
Sbjct: 211 QKPYKKMKG-PEVMAFIEQG 229

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 30/127 (23%), Positives = 45/127 (35%), Gaps = 35/127 (27%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA----------------- 70
            +L G+ Y+H     ++HRDLK  N  VN     +K+ D GLA                 
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 71  -AILRGSQQAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT 116
                              +          APE  L +E+Y E +D++S G C+  E+L 
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279

Query: 117 SEYPYSE 123
                  
Sbjct: 280 MIKENVA 286

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 11/137 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L +  RK      +  +  +A Q+  G+ YL       IHRDL   N+ +      +K
Sbjct: 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVK 161

Query: 64  IGDLGLA-AILRGSQQAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           IGD GL  A+ +             P  + APE L    ++   D + FG+ + EM T  
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221

Query: 118 EYPYSECSNPAQIYKKV 134
           + P+   +  +QI  K+
Sbjct: 222 QEPWIGLNG-SQILHKI 237

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 26/157 (16%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+LR+Y  ++  + +  +  +A+QI  G+AYLH      IHRDL   N+ ++     +KI
Sbjct: 120 GSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDR-LVKI 175

Query: 65  GDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT--- 116
           GD GLA  +    + + V    +      APE L E  +    D++SFG+ + E+LT   
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD 235

Query: 117 ------------SEYPYSECSNPAQIYKKVTSGK-LP 140
                             + +   ++ + +  G+ LP
Sbjct: 236 SSQSPPTKFLELIGIAQGQMTV-LRLTELLERGERLP 271

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 34/140 (24%), Positives = 67/140 (47%), Gaps = 13/140 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR + + +   +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ +   +K
Sbjct: 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVK 156

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           +GD GL+  +  S    +  G  +     MAPE +    +    D++ FG+C+ E+L   
Sbjct: 157 LGDFGLSRYMEDSTYYKASKG--KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214

Query: 118 EYPYSECSNPAQIYKKVTSG 137
             P+    N   +  ++ +G
Sbjct: 215 VKPFQGVKN-NDVIGRIENG 233

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 30/140 (21%), Positives = 60/140 (42%), Gaps = 13/140 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y  +    + +  +  ++ QI + +AYL   +   +HRD+   NI V      +K
Sbjct: 97  GELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPE-CVK 153

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           +GD GL+  +       + +         M+PE +    +    D++ F +C+ E+L+  
Sbjct: 154 LGDFGLSRYIEDEDYYKASVT--RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           + P+    N   +   +  G
Sbjct: 212 KQPFFWLEN-KDVIGVLEKG 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 29/122 (23%), Positives = 48/122 (39%), Gaps = 30/122 (24%)

Query: 28  QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-------------AILR 74
            +L G  ++H     +IHRDLK  N  +N     +K+ D GLA              +  
Sbjct: 137 NLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 75  GSQQAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLTSEYPY 121
             +         + +          APE  L +E+Y + +DI+S G C+  E+L     +
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSH 252

Query: 122 SE 123
             
Sbjct: 253 IN 254

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 28/144 (19%), Positives = 58/144 (40%), Gaps = 17/144 (11%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN------- 56
           G+L  Y +K    ++I      A+Q+   + +L  +   +IH ++   NI +        
Sbjct: 97  GSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKT 154

Query: 57  GHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
           G+   IK+ D G++  +         I    ++ PE     ++ N   D +SFG  + E+
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI---PWVPPECIENPKNLNLATDKWSFGTTLWEI 211

Query: 115 LTS-EYPYSECSNPAQIYKKVTSG 137
            +  + P S   +  +  +     
Sbjct: 212 CSGGDKPLSALDS-QRKLQFYEDR 234

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 11/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L  + R    +  I  +    R +  G+ YL       +HRDL   N+ V+ +L   K
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCK 191

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           + D GL+ +L     A       +      APE +    ++   D++SFG+ + E+L   
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           E PY   +N   +   V  G
Sbjct: 252 ERPYWNMTN-RDVISSVEEG 270

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 31/144 (21%), Positives = 62/144 (43%), Gaps = 12/144 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++   K   + +  V     Q+  G+ YL   +   +HR+L   N+ +       K
Sbjct: 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRH-YAK 476

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           I D GL+  L      ++     ++     APE +    ++   D++S+G+ + E L+  
Sbjct: 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536

Query: 118 EYPYSECSNPAQIYKKVTSGK-LP 140
           + PY +   P ++   +  GK + 
Sbjct: 537 QKPYKKMKGP-EVMAFIEQGKRME 559

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 11/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L  + RK   +  +  +    R I  G+ YL       +HRDL   NI +N +L   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCK 187

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           + D GL  +L    +A       +      +PE +    +    D++S+G+ + E+++  
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           E PY E SN   + K V  G
Sbjct: 248 ERPYWEMSN-QDVIKAVDEG 266

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 13/140 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y R     ++   +      +  G+A+L  H    IHRDL   N  V+  L  +K
Sbjct: 88  GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDL-CVK 144

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
           + D G+   +   Q   SV    +F     APE  +   Y+   D+++FG+ + E+ +  
Sbjct: 145 VSDFGMTRYVLDDQYVSSVGT--KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           + PY   +N +++  KV+ G
Sbjct: 203 KMPYDLYTN-SEVVLKVSQG 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 35/138 (25%), Positives = 64/138 (46%), Gaps = 9/138 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R +        +      +  G+AYL      VIHRDL   N  V  +   IK
Sbjct: 88  GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQ-VIK 144

Query: 64  IGDLGLAAILRGSQ-QAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EY 119
           + D G+   +   Q  + +    P ++ +PE      Y+   D++SFG+ + E+ +  + 
Sbjct: 145 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

Query: 120 PYSECSNPAQIYKKVTSG 137
           PY   SN +++ + +++G
Sbjct: 205 PYENRSN-SEVVEDISTG 221

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++ R+K     +  +    R I  G+ YL   +   +HRDL   NI VN +L   K
Sbjct: 131 GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNL-VCK 187

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
           + D GL+ +L    +A       +      APE +    +    D++SFG+ + E++T  
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           E PY E SN  ++ K +  G
Sbjct: 248 ERPYWELSN-HEVMKAINDG 266

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 29/119 (24%), Positives = 54/119 (45%), Gaps = 8/119 (6%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
            ++ Q+ +G+ +L       IHRDL   NI ++     +KI D GLA  +          
Sbjct: 197 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253

Query: 84  GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSG 137
                 ++MAPE +++  Y    D++SFG+ + E+ +    PY       +  +++  G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 38/139 (27%), Positives = 74/139 (53%), Gaps = 10/139 (7%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++    + ++  +  + +++ QI  G+A++   +   IHRDL+  NI V+  L   
Sbjct: 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VC 323

Query: 63  KIGDLGLAAILRGSQ-QAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-E 118
           KI D GLA ++  ++  A      P ++ APE +    +    D++SFG+ ++E++T   
Sbjct: 324 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY   SNP ++ + +  G
Sbjct: 384 IPYPGMSNP-EVIRALERG 401

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 34/141 (24%), Positives = 63/141 (44%), Gaps = 12/141 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR + R +     ++ +  +  Q+ +G+ YL       +HRDL   N  ++     +K
Sbjct: 112 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVK 168

Query: 64  IGDLGLA-AILRG---SQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           + D GLA  +      S    +    P ++MA E L  + +    D++SFG+ + E++T 
Sbjct: 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228

Query: 117 SEYPYSECSNPAQIYKKVTSG 137
              PY + +    I   +  G
Sbjct: 229 GAPPYPDVNT-FDITVYLLQG 248

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 33/140 (23%), Positives = 60/140 (42%), Gaps = 13/140 (9%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y R+   R   + +    + +   + YL       +HRDL   N  VN     +K
Sbjct: 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQG-VVK 160

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
           + D GL+  +   +   SV    +F      PE L    ++   DI++FG+ + E+ +  
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218

Query: 118 EYPYSECSNPAQIYKKVTSG 137
           + PY   +N ++  + +  G
Sbjct: 219 KMPYERFTN-SETAEHIAQG 237

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 37/141 (26%), Positives = 63/141 (44%), Gaps = 14/141 (9%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G L +Y ++  R ++ AV     A QI   + YL   +   IHRDL   N  V  +   +
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LV 150

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           K+ D GL+ ++ G           +F     APE L    ++   D+++FG+ + E+ T 
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208

Query: 118 -EYPYSECSNPAQIYKKVTSG 137
              PY      +Q+Y+ +   
Sbjct: 209 GMSPYPGIDL-SQVYELLEKD 228

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 14/141 (9%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L ++ K  + + +   K  + A QI  G+A++   +   IHRDL+  NI V+  L   
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SC 148

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           KI D GLA ++  ++         +F     APE +    +    D++SFG+ + E++T 
Sbjct: 149 KIADFGLARLIEDNEYTAREGA--KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206

Query: 117 SEYPYSECSNPAQIYKKVTSG 137
              PY   +NP ++ + +  G
Sbjct: 207 GRIPYPGMTNP-EVIQNLERG 226

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 8/114 (7%)

Query: 7   LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQIK 63
           L E  KK  +    +  V+ +A  IL+ +  LH +   +IH DLK +NI         IK
Sbjct: 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIK 242

Query: 64  IGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
           + D G +      Q+ ++ I +  + APE +    Y   +D++S G  + E+LT
Sbjct: 243 VIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 59.9 bits (146), Expect = 4e-10
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 11/118 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A QI  G+ YL       +HRDL   N  V  +L  +KIGD G++  +  S   + V G 
Sbjct: 139 ASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVY-STDYYRVGGH 194

Query: 86  PEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
                  M PE +    +    D++SFG+ + E+ T  + P+ + SN  ++ + +T G
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQG 251

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 12/141 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR + R +     ++ +  +  Q+ +G+ +L       +HRDL   N  ++     +K
Sbjct: 176 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVK 232

Query: 64  IGDLGLA-AILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           + D GLA  +      +       +     MA E L  + +    D++SFG+ + E++T 
Sbjct: 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292

Query: 117 SEYPYSECSNPAQIYKKVTSG 137
              PY + +    I   +  G
Sbjct: 293 GAPPYPDVNT-FDITVYLLQG 312

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 12/141 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++ R       ++ + ++  Q+ RG+ YL       +HRDL   N  ++     +K
Sbjct: 108 GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVK 164

Query: 64  IGDLGLA-AILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
           + D GLA  IL     +              A E L    +    D++SFG+ + E+LT 
Sbjct: 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224

Query: 117 SEYPYSECSNPAQIYKKVTSG 137
              PY        +   +  G
Sbjct: 225 GAPPYRHIDP-FDLTHFLAQG 244

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 55/273 (20%), Positives = 82/273 (30%), Gaps = 104/273 (38%)

Query: 6   TLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-------- 55
            L ++  K  Y  + +  VK   +Q+L+G+ YLH     +IH D+K +NI +        
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIR 188

Query: 56  ----------------------------------------NGHLGQIKIGDLGLAAILRG 75
                                                   N    ++KI DLG A     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WV 246

Query: 76  SQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP------- 127
            +     I T ++ + E L    YN   DI+S      E+ T +Y +   S         
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306

Query: 128 --AQIYKKVTSGKLPGAF-----------------------------------HRIQDAE 150
             A I +    GK+P                                      +     E
Sbjct: 307 HIALIIE--LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364

Query: 151 AR---RFVGKCLE-NVSKRLPAKELLLDPFLAS 179
           A     F+   LE    KR  A E L  P+L S
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 36/120 (30%), Positives = 56/120 (46%), Gaps = 11/120 (9%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
             A +I  G+AYL+ +    +HRDL   N  V      +KIGD G+   +      +   
Sbjct: 142 QMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIY-ETDYYRKG 197

Query: 84  GTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
           G        M+PE L +  +    D++SFG+ + E+ T +E PY   SN  Q+ + V  G
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEG 256

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 15/120 (12%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG--SQQAHSVI 83
           A Q+  G+ YL G     +HRDL   N  V   L  +KIGD G++   R   S   + V 
Sbjct: 164 ASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMS---RDIYSTDYYRVG 217

Query: 84  GTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
           G        M PE +    +    D++SFG+ + E+ T  + P+ + SN  +    +T G
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 12/138 (8%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L +Y +   R  +       ++  +   + YL G++   +HRDL   N+ V+      
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VA 156

Query: 63  KIGDLGLAAILRGSQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EY 119
           K+ D GL    + +         P ++ APE L E+ ++   D++SFG+ + E+ +    
Sbjct: 157 KVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

Query: 120 PYSECSNPAQIYKKVTSG 137
           PY        +  +V  G
Sbjct: 214 PYPRIPL-KDVVPRVEKG 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 13/119 (10%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ----QAHS 81
             QI  G+ YL  H   V+H+DL   N+ V   L  +KI DLGL   +  +       +S
Sbjct: 134 VAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNS 190

Query: 82  VIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
           ++  P  +MAPE +    ++   DI+S+G+ + E+ +    PY   SN   + + + + 
Sbjct: 191 LL--PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIRNR 246

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 32/139 (23%), Positives = 58/139 (41%), Gaps = 13/139 (9%)

Query: 7   LREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           L   R      ++       +   I  G+ YL   +   IHRDL   N  +   +  + +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCV 178

Query: 65  GDLGLAAILRGSQQAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
            D GL+  +  S   +      +     +A E L +  Y    D+++FG+ + E++T  +
Sbjct: 179 ADFGLSRKIY-SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

Query: 119 YPYSECSNPAQIYKKVTSG 137
            PY+   N A+IY  +  G
Sbjct: 238 TPYAGIEN-AEIYNYLIGG 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 30/121 (24%), Positives = 56/121 (46%), Gaps = 14/121 (11%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           ++ Q+ +G+ +L       IHRDL   NI ++     +KI D GLA   R   +    + 
Sbjct: 153 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGLA---RDIYKDPDYVR 206

Query: 85  TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
             +      +MAPE +++  Y    D++SFG+ + E+ +    PY       +  +++  
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266

Query: 137 G 137
           G
Sbjct: 267 G 267

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 33/122 (27%), Positives = 58/122 (47%), Gaps = 14/122 (11%)

Query: 24  NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI 83
           +++ Q+ +G+A+L   +   IHRDL   NI +  H    KI D GLA   R  +   + +
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGLA---RDIKNDSNYV 202

Query: 84  GTPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVT 135
                     +MAPE ++   Y    D++S+G+ + E+ +    PY      ++ YK + 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 136 SG 137
            G
Sbjct: 263 EG 264

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 12/138 (8%)

Query: 5   GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L +Y +   R  +       ++  +   + YL G++   +HRDL   N+ V+      
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VA 328

Query: 63  KIGDLGLAAILRGSQQAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EY 119
           K+ D GL    + +         P ++ APE L E+ ++   D++SFG+ + E+ +    
Sbjct: 329 KVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

Query: 120 PYSECSNPAQIYKKVTSG 137
           PY        +  +V  G
Sbjct: 386 PYPRIPL-KDVVPRVEKG 402

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 26/127 (20%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A Q+ +G+ +L       +HRDL   N+ V      +KI D GL         A  ++ 
Sbjct: 177 FAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL---------ARDIMS 224

Query: 85  TPEF------------MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
              +            MAPE L+E  Y    D++S+G+ + E+ +    PY      A  
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284

Query: 131 YKKVTSG 137
           YK + +G
Sbjct: 285 YKLIQNG 291

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 27/118 (22%), Positives = 49/118 (41%), Gaps = 11/118 (9%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
              I  G+ YL   +   +HRDL   N  +   +  + + D GL+  +  S   +     
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGLSKKIY-SGDYYRQGRI 208

Query: 86  PEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            +     +A E L +  Y    D+++FG+ + E+ T    PY    N  ++Y  +  G
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHG 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 32/119 (26%), Positives = 55/119 (46%), Gaps = 13/119 (10%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA-AILRGS---QQAHS 81
           ARQ+  G+AYL       +HRDL   N  V  ++  +KI D GL+  I          + 
Sbjct: 180 ARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGND 236

Query: 82  VIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
            I  P  +M PE ++   Y    D++++G+ + E+ +    PY   ++  ++   V  G
Sbjct: 237 AI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292

>2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98

 Score = 51.5 bits (123), Expect = 1e-08
 Identities = 21/77 (27%), Positives = 36/77 (46%), Gaps = 10/77 (12%)

Query: 228 NPEDDTIFLKVQITD--------KDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEP 279
           + E   I L ++I D        KD +A  I F FD+  D   +VA EMV+   + + + 
Sbjct: 20  DGEKIAIKLWLRIEDIKKLKGKYKDNEA--IEFSFDLERDVPEDVAQEMVESGYVCEGDH 77

Query: 280 LEIAEMIEQEISSLVPN 296
             +A+ I+  +S +   
Sbjct: 78  KTMAKAIKDRVSLIKRK 94

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 12/117 (10%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGT 85
           A  + RG+ YL       IHRDL   NI V  +    KI D GL+   RG +        
Sbjct: 148 AADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS---RGQEVYVKKTMG 201

Query: 86  --P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
             P  +MA E L    Y    D++S+G+ + E+++    PY   +  A++Y+K+  G
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 36/122 (29%), Positives = 50/122 (40%), Gaps = 16/122 (13%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAILRG--SQQAHS 81
           AR I  G  YL  +    IHRD+   N  +         KIGD G+A   R       + 
Sbjct: 146 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRASYYR 200

Query: 82  VIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVT 135
             G        M PE   E  +    D +SFG+ + E+ +    PY   SN  ++ + VT
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVT 259

Query: 136 SG 137
           SG
Sbjct: 260 SG 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 27/127 (21%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
           +A QI +G+ YL      ++HRDL   NI V     ++KI D GL         +  V  
Sbjct: 155 FAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL---------SRDVYE 202

Query: 85  TPEF------------MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
              +            MA E L++  Y    D++SFG+ + E++T    PY       ++
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERL 261

Query: 131 YKKVTSG 137
           +  + +G
Sbjct: 262 FNLLKTG 268

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 15/121 (12%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
              Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA   R          
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---RDINNIDYYKK 215

Query: 85  TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
           T        +MAPE L++  Y    D++SFG+ + E+ T    PY       +++K +  
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKE 274

Query: 137 G 137
           G
Sbjct: 275 G 275

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 15/121 (12%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
              Q+ RG+ YL       IHRDL   N+ V  +   +KI D GLA   R          
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---RDINNIDYYKK 261

Query: 85  TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
           T        +MAPE L++  Y    D++SFG+ + E+ T    PY       +++K +  
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKE 320

Query: 137 G 137
           G
Sbjct: 321 G 321

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 37/121 (30%), Positives = 56/121 (46%), Gaps = 14/121 (11%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLA-AILRGS---QQA 79
           AR I  G  YL  +    IHRD+   N  +         KIGD G+A  I R     +  
Sbjct: 187 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244

Query: 80  HSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
            +++  P ++M PE   E  +    D +SFG+ + E+ +    PY   SN  ++ + VTS
Sbjct: 245 CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTS 301

Query: 137 G 137
           G
Sbjct: 302 G 302

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 53.4 bits (129), Expect = 7e-08
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 36/155 (23%)

Query: 7   LREYRKKYTRVDIRAVKN----------WARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56
           LR   +        A+ N          ++ Q+ +G+A+L   +   IHRD+   N+ + 
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT 198

Query: 57  GHLGQIKIGDLGLAAILRGSQQAHSVIGTPEF------------MAPE-LYEEDYNELVD 103
                 KIGD GL         A  ++    +            MAPE +++  Y    D
Sbjct: 199 NGH-VAKIGDFGL---------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248

Query: 104 IYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
           ++S+G+ + E+ +    PY      ++ YK V  G
Sbjct: 249 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 15/121 (12%)

Query: 25  WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG 84
            A Q+ RG+ YL       IHRDL   N+ V      +KI D GLA   R          
Sbjct: 196 CAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA---RDIHHIDYYKK 249

Query: 85  TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
           T        +MAPE L++  Y    D++SFG+ + E+ T    PY       +++K +  
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKE 308

Query: 137 G 137
           G
Sbjct: 309 G 309

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 29/132 (21%), Positives = 56/132 (42%), Gaps = 27/132 (20%)

Query: 7   LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQ-- 61
             ++ K+  +    +  ++  A QI + + +LH +   + H DLK +NI FV     +  
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAY 160

Query: 62  ---------------IKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
                          IK+ D G A      +   +++ T  + APE +    +++  D++
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVW 218

Query: 106 SFGMCVL-EMLT 116
           S G C+L E   
Sbjct: 219 SIG-CILIEYYL 229

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 27/132 (20%), Positives = 53/132 (40%), Gaps = 27/132 (20%)

Query: 7   LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--- 61
             E+ K+  +    +  V++ A Q+   + +LH +   + H DLK +NI       +   
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLY 165

Query: 62  ---------------IKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
                          I++ D G A      +   +++ T  +  PE + E  + +  D++
Sbjct: 166 NEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVW 223

Query: 106 SFGMCVL-EMLT 116
           S G C+L E   
Sbjct: 224 SIG-CILFEYYR 234

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 23/172 (13%), Positives = 42/172 (24%), Gaps = 46/172 (26%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L+E     T           + +       H     V         + V+   G + +
Sbjct: 116 GSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVL 170

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVL-EMLTSEYPYSE 123
                                P  M     ++D      I   G   L  +L + +P  E
Sbjct: 171 AY-------------------PATMPDANPQDD------IRGIG-ASLYALLVNRWPLPE 204

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQD-----AEARRFVGKCLENVSKRLPAKE 170
               +          L  A           A+  R +   +  V+ R    +
Sbjct: 205 AGVRSG---------LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 36/138 (26%), Positives = 56/138 (40%), Gaps = 33/138 (23%)

Query: 7   LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG--- 60
           L E   +  Y    I  +K +  +IL+ + YL      + H DLK +NI   + +     
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSL 179

Query: 61  --------------------QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYN 99
                                IK+ D G A     S    S+I T ++ APE +    ++
Sbjct: 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWD 237

Query: 100 ELVDIYSFGMCVL-EMLT 116
              D++SFG CVL E+ T
Sbjct: 238 VSSDMWSFG-CVLAELYT 254

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 16/73 (21%), Positives = 31/73 (42%), Gaps = 11/73 (15%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQIKIGDLGLAAILRGSQQ------ 78
           A ++L  + +LH ++   +H ++  +NIFV+     Q+ +   G A     S +      
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 79  --AHSVIGTPEFM 89
                  G  EF+
Sbjct: 223 GSRSPHEGDLEFI 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 19/73 (26%), Positives = 31/73 (42%), Gaps = 11/73 (15%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQIKIGDLGLAAILR-GSQQAH--- 80
           + +IL  + Y+H H+   +H D+K  N+ +N  +  Q+ + D GLA              
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 81  ----SVIGTPEFM 89
                  GT EF 
Sbjct: 216 DPKRCHDGTIEFT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 11/92 (11%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQIKIG 65
           L++   +        V     ++L  + Y+H ++   +H D+K  N+ +   +  Q+ + 
Sbjct: 138 LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLA 195

Query: 66  DLGLAAILRGSQQ--------AHSVIGTPEFM 89
           D GL+     +               GT EF 
Sbjct: 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 12/90 (13%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDL 67
           +     +  ++ V   A Q++  I Y+H  +   IHRD+K DN  +        + I D 
Sbjct: 95  FNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF 152

Query: 68  GLAAILRGSQ--------QAHSVIGTPEFM 89
           GLA   R ++        +  ++ GT  + 
Sbjct: 153 GLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.3 bits (106), Expect = 3e-05
 Identities = 34/200 (17%), Positives = 61/200 (30%), Gaps = 32/200 (16%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
            F    L + R K +   +   K+   Q+   +A          HRDL   N+ +     
Sbjct: 144 EFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSL 200

Query: 61  -------------------QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNEL 101
                              Q+ I D  L+ + R       V+     M  +L+  D +  
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQ 256

Query: 102 VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLEN 161
            DIY   +   E       Y   SN   ++           F    +  A + + + ++ 
Sbjct: 257 FDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314

Query: 162 VSKRLP----AKELLLDPFL 177
             + +     A +LL    L
Sbjct: 315 FHRTMLNFSSATDLLCQHSL 334

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 14/76 (18%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQIKIGDLGLAAILRGSQ---- 77
           A Q++  + Y+H  +  +I+RD+K +N  +    N     I I D  LA      +    
Sbjct: 111 AIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168

Query: 78  ----QAHSVIGTPEFM 89
               +  S+ GT  +M
Sbjct: 169 IPYREHKSLTGTARYM 184

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 12/74 (16%)

Query: 26  ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQIKIGDLGLAAILRGSQ------ 77
           A Q++  + ++H      +HRD+K DN  +       Q+ I D GLA   R +       
Sbjct: 109 ADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166

Query: 78  --QAHSVIGTPEFM 89
             +  ++ GT  + 
Sbjct: 167 YRENKNLTGTARYA 180

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 15/96 (15%)

Query: 7   LREYRKKYTRV-DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----Q 61
           L +      R   ++ V   A+Q+L  +  +H     +++RD+K DN  +          
Sbjct: 92  LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANM 149

Query: 62  IKIGDLGLAAILRGSQ--------QAHSVIGTPEFM 89
           I + D G+    R           +  ++ GT  +M
Sbjct: 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	502
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.98
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.98
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.98
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.98
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.98
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.98
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.98
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.98
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.98
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.87
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.87
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.62
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.28
2lru_A	98	Serine/threonine-protein kinase WNK1; autoinhibito	98.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.86
2v3s_A	96	Serine/threonine-protein kinase OSR1; ATP-binding,	98.52
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.43
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	96.93
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.74
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	96.72
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	96.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	94.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	92.34
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	90.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	85.83
3ats_A	357	Putative uncharacterized protein; hypothetical pro	85.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	85.35
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	84.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	83.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	82.07

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-44  Score=361.79  Aligned_cols=178  Identities=53%  Similarity=1.029  Sum_probs=164.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++++.+.+++..++.|++||+.||+|||+++++||||||||+|||+++..+.+||+|||+|+... .....
T Consensus       110 y~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~  188 (290)
T 3fpq_A          110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAK  188 (290)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBE
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CCccC
Confidence            78999999999999999999999999999999999999988899999999999998655899999999997543 34556


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      +.+|||.|||||++.+.|+.++|||||||++|||+||.+||.+..+..++++.+..+..|..++...++++++||.+||.
T Consensus       189 ~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~  268 (290)
T 3fpq_A          189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred             CcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence            78999999999999989999999999999999999999999988888999999999988877788888999999999998


Q ss_pred             -CcCCCCCHHHHhcCCCCcC
Q 010730          161 -NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~~  179 (502)
                       ||.+|||++|+|+||||+.
T Consensus       269 ~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          269 QNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SSGGGSCCHHHHHTSGGGC-
T ss_pred             CChhHCcCHHHHhcCccccC
Confidence             9999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-42  Score=349.52  Aligned_cols=179  Identities=31%  Similarity=0.512  Sum_probs=160.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.||+|.+++++.+.+++..++.|++||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.+...   .
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCCcc
Confidence            7899999999999999999999999999999999999999  9999999999999887 79999999999987532   2


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...+.+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++++|..+.+.  ++...++++++||.
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~dli~  266 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEYD--FPEKFFPKARDLVE  266 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTCCHHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCcccCHHHHHHHH
Confidence            3567899999999999865 599999999999999999999999976 6788899999888763  45567899999999


Q ss_pred             Hhhh-CcCCCCCHHH------HhcCCCCcCCCCCCC
Q 010730          157 KCLE-NVSKRLPAKE------LLLDPFLASDAGEPL  185 (502)
Q Consensus       157 kcL~-dP~kRpSa~E------LL~hPff~~~~~~~l  185 (502)
                      +||. ||.+|+|++|      |++||||+.-++..+
T Consensus       267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            9999 9999999988      589999998777654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-41  Score=338.70  Aligned_cols=172  Identities=24%  Similarity=0.527  Sum_probs=144.4

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .+|+|.+++.+.+++++..++.|++||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.........+.
T Consensus        95 ~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~~~~~  171 (275)
T 3hyh_A           95 AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNFLKTS  171 (275)
T ss_dssp             CCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC------------
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecCCCCccCCe
Confidence            38999999999999999999999999999999999999  9999999999999887 79999999999887666666788


Q ss_pred             cCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           83 IGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        83 vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      +|||.|||||++.+. | +.++|||||||++|+|+||++||.+ .+..++++.+..+..+  ++...++++++||.+||.
T Consensus       172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAAGLIKRMLI  248 (275)
T ss_dssp             ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHHHHHHSC
T ss_pred             eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHcc
Confidence            999999999998754 4 6899999999999999999999976 6788899999888763  455678999999999999


Q ss_pred             -CcCCCCCHHHHhcCCCCcCC
Q 010730          161 -NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~~~  180 (502)
                       ||.+|||++|+|+||||+.+
T Consensus       249 ~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          249 VNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SSGGGSCCHHHHHHCHHHHTT
T ss_pred             CChhHCcCHHHHHcCcccccC
Confidence             99999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.7e-41  Score=341.35  Aligned_cols=176  Identities=27%  Similarity=0.406  Sum_probs=156.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.||+|.+++++.+.+++..++.|++||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+.... ....
T Consensus       107 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~  183 (304)
T 3ubd_A          107 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKA  183 (304)
T ss_dssp             CCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC-----CCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceeccCCCccc
Confidence            7899999999999999999999999999999999999999  9999999999999987 7999999999986543 3445


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++.+|..+.++  ++...++++++||.+|
T Consensus       184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~  260 (304)
T 3ubd_A          184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRML  260 (304)
T ss_dssp             CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred             cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHH
Confidence            67899999999998864 599999999999999999999999976 6778888888887663  4556789999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. ||.+|||     ++|+|+||||+..++
T Consensus       261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             TCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             cccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence            99 9999998     589999999987654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-40  Score=344.34  Aligned_cols=175  Identities=31%  Similarity=0.550  Sum_probs=154.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.+++.+ +++++..++.|++||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+.+... ...
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCB
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCceecCCCCCcc
Confidence            7899999999977 56999999999999999999999999  9999999999999877 89999999999987543 345


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l~~LI~k  157 (502)
                      .+.+|||.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..++++.|..+..+ ...+...++++++||.+
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            67899999999998865 599999999999999999999999987 6777778887766443 23344568999999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. ||.+|||++|+|+||||+..
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCC
Confidence            999 99999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-40  Score=343.31  Aligned_cols=175  Identities=26%  Similarity=0.484  Sum_probs=154.4

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.||+|.+++...  ..+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccceeecCCcc
Confidence            78999999999754  35799999999999999999999999  9999999999999887 899999999998765332 


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++.++..+.++. .+...++++++||.
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~  258 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence            2356789999999999875 599999999999999999999999976 67788888888887763 34456889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +||. ||.+|||++|+|+||||+..
T Consensus       259 ~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999 99999999999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=344.86  Aligned_cols=175  Identities=31%  Similarity=0.550  Sum_probs=153.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.++++. +++++..++.|++||+.||+|||+++  ||||||||+|||++.+ |.|||+|||+|+.+... ...
T Consensus       229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCB
T ss_pred             CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccceECCCCCccc
Confidence            7899999999976 56999999999999999999999999  9999999999999887 89999999999987543 445


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l~~LI~k  157 (502)
                      .+.+||+.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..+++..|..+..+ ...+...++++++||.+
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            67899999999998865 599999999999999999999999977 6677777777766443 22334568999999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. ||.+|+||.|||+||||+..
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCC
Confidence            999 99999999999999999754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-39  Score=333.23  Aligned_cols=176  Identities=24%  Similarity=0.343  Sum_probs=148.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.||+|.+++++.+++++..++.|+.||+.||+|||+++  ||||||||+|||++.+...+||+|||+|+.+.....  
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            7899999999999999999999999999999999999998  999999999999987633699999999987654321  


Q ss_pred             ----cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHHH
Q 010730           79 ----AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEAR  152 (502)
Q Consensus        79 ----~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l~  152 (502)
                          ...++|||.|||||++.+ .|+.++|||||||++|||+||.+||.+ .+..+++.+|..+..+ ..++...++.++
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ-YFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT-TCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                234689999999998865 499999999999999999999999976 4445556666666543 234556789999


Q ss_pred             HHHHHhhh-CcCCCCCHHHH-------------hcCCCCcC
Q 010730          153 RFVGKCLE-NVSKRLPAKEL-------------LLDPFLAS  179 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~EL-------------L~hPff~~  179 (502)
                      +||.+||. ||.+|||+.||             |+|||+..
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence            99999998 99999999998             56888854

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.7e-38  Score=325.60  Aligned_cols=174  Identities=24%  Similarity=0.453  Sum_probs=140.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.++++   .+++..++.|++||+.||+|||++|  ||||||||+|||++.+.+.+||+|||+|+......   
T Consensus       101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred             CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence            688999999994   5999999999999999999999999  99999999999999876799999999998653321   


Q ss_pred             --------------------------CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHH
Q 010730           78 --------------------------QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ  129 (502)
Q Consensus        78 --------------------------~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q  129 (502)
                                                ...+.+|||.|||||++.+  .|+.++||||+|||+|+|+||+.||....+..+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence                                      2345689999999998864  489999999999999999999999976555443


Q ss_pred             HHHHhhc--C-------------------CC-------------------------------CCcccccccHHHHHHHHH
Q 010730          130 IYKKVTS--G-------------------KL-------------------------------PGAFHRIQDAEARRFVGK  157 (502)
Q Consensus       130 l~~kI~~--g-------------------~~-------------------------------p~~~~~~~s~~l~~LI~k  157 (502)
                      ....|..  |                   ..                               ....+...++++++||.+
T Consensus       256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~  335 (361)
T 4f9c_A          256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK  335 (361)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence            3322211  0                   00                               001223457899999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ||. ||.+|+||+|+|+||||+.
T Consensus       336 lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          336 LLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HCcCChhHCcCHHHHhcCcccCC
Confidence            999 9999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.8e-37  Score=342.49  Aligned_cols=178  Identities=26%  Similarity=0.449  Sum_probs=157.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+|||++.+ |.|||+|||+|+.+.. ....
T Consensus       273 y~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~-~~~~  348 (689)
T 3v5w_A          273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSK-KKPH  348 (689)
T ss_dssp             CCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS-CCCC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeecCC-CCCC
Confidence            7899999999999999999999999999999999999999  9999999999999987 8999999999988754 3456


Q ss_pred             cccCCCcccCccccc-c-CCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      +.+|||.|||||++. + .|+.++|||||||++|+|++|.+||.+.  .+..++++.+.....  .++...++++++||.
T Consensus       349 t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--~~p~~~S~~a~dLI~  426 (689)
T 3v5w_A          349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSPELRSLLE  426 (689)
T ss_dssp             SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred             CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--CCCccCCHHHHHHHH
Confidence            789999999999985 3 5999999999999999999999999753  345677777776655  345567899999999


Q ss_pred             Hhhh-CcCCCCC-----HHHHhcCCCCcCCCCCC
Q 010730          157 KCLE-NVSKRLP-----AKELLLDPFLASDAGEP  184 (502)
Q Consensus       157 kcL~-dP~kRpS-----a~ELL~hPff~~~~~~~  184 (502)
                      +||. ||.+|++     |+||++||||+..+|..
T Consensus       427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             HHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             HHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence            9999 9999998     89999999999877643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=324.80  Aligned_cols=175  Identities=29%  Similarity=0.454  Sum_probs=144.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-----   75 (502)
                      |+ +|+|.+++.+.+++++..++.|++||+.||+|||++|  ||||||||+|||++.+ +.+||+|||+|+.+..     
T Consensus       140 ~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~~~~~~~  215 (398)
T 4b99_A          140 LM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMARGLCTSPAEH  215 (398)
T ss_dssp             CC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCBCC-------
T ss_pred             CC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecceeeecccCcccc
Confidence            44 6889999999999999999999999999999999999  9999999999999987 8999999999987643     


Q ss_pred             CCCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCCC----------
Q 010730           76 SQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG----------  141 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p~----------  141 (502)
                      .....+.+||+.|||||++.+  .|+.++||||+|||+|||++|.+||.+ .+....+.+|..  +..+.          
T Consensus       216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g-~~~~~~l~~I~~~~g~p~~~~~~~~~~~~  294 (398)
T 4b99_A          216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG-KNYVHQLQLIMMVLGTPSPAVIQAVGAER  294 (398)
T ss_dssp             CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC-SSHHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred             ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC-CCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence            223457899999999998754  479999999999999999999999987 444444444432  11110          


Q ss_pred             --------------cc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          142 --------------AF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       142 --------------~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                    .+   ....++++++||.+||. ||.+|+||+|+|+||||+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                          00   11247889999999999 99999999999999999754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-37  Score=313.13  Aligned_cols=173  Identities=24%  Similarity=0.404  Sum_probs=136.8

Q ss_pred             CCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+...   .++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.+....
T Consensus        96 ~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~DFGla~~~~~~~  172 (299)
T 4g31_A           96 LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDE  172 (299)
T ss_dssp             CCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCCCC-------
T ss_pred             cCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEccCccceecCCCc
Confidence            6889999999987654   455678999999999999999999  9999999999999987 799999999998765322


Q ss_pred             -------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc
Q 010730           78 -------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF  143 (502)
Q Consensus        78 -------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~  143 (502)
                                   ...+.+|||.|||||++.+ .|+.++|||||||++|||++   ||....+.......+....+|..+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~  249 (299)
T 4g31_A          173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLF  249 (299)
T ss_dssp             -------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHH
T ss_pred             cccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCC
Confidence                         1234689999999998875 59999999999999999996   886533334455666667666433


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      . ..++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus       250 ~-~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          250 T-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             H-HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             c-ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            3 335678899999999 99999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=308.79  Aligned_cols=171  Identities=30%  Similarity=0.494  Sum_probs=143.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC---C
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG---S   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~---~   76 (502)
                      |+.||+|.+++... +++++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+....   .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceecccCCcc
Confidence            78999999999764 57999999999999999999999998  9999999999999987 7999999999987543   2


Q ss_pred             CCcccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC---cccccccH
Q 010730           77 QQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDA  149 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~---~~~~~~s~  149 (502)
                      ....+.+||+.|||||++.    +.|+.++|||||||+||||+||+.||.+..+...+...+..+..++   ..+...++
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence            2345678999999999884    2489999999999999999999999988777777777777665432   23445678


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++++||.+||. +|.+|||+.|++.+
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999998 99999999987643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-36  Score=333.17  Aligned_cols=179  Identities=24%  Similarity=0.394  Sum_probs=158.1

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+ .+.+++..++.|++||+.||+|||+++  |+||||||+|||++.+ .+.+||+|||+|+.+.....
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            6889999999964 568999999999999999999999999  9999999999999853 37899999999999877777


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~LI  155 (502)
                      ..+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++.+|..+..  +...+...+.++++||
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            778899999999998875 499999999999999999999999987 677788888877654  3344455689999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .+||. ||.+|||+.|+|+||||+....
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999 9999999999999999986543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9e-36  Score=301.39  Aligned_cols=171  Identities=22%  Similarity=0.378  Sum_probs=147.6

Q ss_pred             CCCCCcHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 010730            1 MFTSGTLREYRKKY-------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDL   67 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DF   67 (502)
                      |+.+|+|.+|+.+.             ..+++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~-~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC-CcEEECCc
Confidence            78999999999865             36999999999999999999999998  9999999999999987 79999999


Q ss_pred             CCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           68 GLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        68 GlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      |+|+.......   ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+ .+..+++..+..+..+ .
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~  250 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGRVL-Q  250 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTCCC-C
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCC-C
Confidence            99986643322   23457999999999886 569999999999999999999 9999987 5677888888888764 3


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+...++++++||.+||. ||.+|||++|++.  ||+
T Consensus       251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~  285 (299)
T 4asz_A          251 RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQ  285 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             CCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHH
Confidence            445678899999999998 9999999999954  554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.8e-36  Score=309.53  Aligned_cols=170  Identities=22%  Similarity=0.361  Sum_probs=148.5

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+++.                ..+++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||
T Consensus       150 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~-~~vKi  226 (353)
T 4ase_A          150 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI  226 (353)
T ss_dssp             CCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCC-CCEEE
Confidence            78999999999763                34899999999999999999999998  9999999999999987 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+|+.+.....   ..+.+||+.|||||++. +.|+.++|||||||+||||+| |..||.+......+.+.+..+..
T Consensus       227 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~  306 (353)
T 4ase_A          227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR  306 (353)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred             CcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            99999987654322   34568999999999875 569999999999999999998 99999887777778888887765


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...++++.++|.+||. ||.+|||+.||++|
T Consensus       307 ~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          307 M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4 3445568899999999998 99999999999987

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=301.06  Aligned_cols=169  Identities=21%  Similarity=0.366  Sum_probs=139.6

Q ss_pred             CCCCCcHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 010730            1 MFTSGTLREYRKKY---------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG   65 (502)
Q Consensus         1 ~~tgGsL~~yi~k~---------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~   65 (502)
                      |+.+|+|.+|+.+.               +++++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~-~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG-LVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC-CcEEEc
Confidence            78999999999764               35899999999999999999999998  9999999999999987 799999


Q ss_pred             ecCCceeccCCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCC
Q 010730           66 DLGLAAILRGSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP  140 (502)
Q Consensus        66 DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p  140 (502)
                      |||+++.+....   .....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+ .+..+++..+..+..+
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~g~~~  279 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCITQGREL  279 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHHHHTCCC
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence            999998764332   2245689999999998864 59999999999999999999 9999987 4567778888877644


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ..+...++++++||.+||. ||.+|||++||+.+
T Consensus       280 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          280 -ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             -CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             -CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence             3455678999999999998 99999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.8e-35  Score=297.92  Aligned_cols=169  Identities=22%  Similarity=0.327  Sum_probs=146.9

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+...                ..+++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||
T Consensus       110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~-~~~Ki  186 (308)
T 4gt4_A          110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKI  186 (308)
T ss_dssp             CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred             cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCC-CCEEE
Confidence            78999999999753                35899999999999999999999998  9999999999999987 79999


Q ss_pred             EecCCceeccCC---CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGS---QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~---~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.+...   ......+||+.|||||++. +.|+.++|||||||+||||+| |..||.+ .+..++...+..+..
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~~~~~  265 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIRNRQV  265 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHHTTCC
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence            999999876432   2345578999999999875 569999999999999999999 8999987 566788888888766


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++ .+...++.+.+||.+||. ||.+|||++||+.+
T Consensus       266 ~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          266 LP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43 445568899999999998 99999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-34  Score=293.32  Aligned_cols=175  Identities=23%  Similarity=0.470  Sum_probs=156.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..........
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCGGG
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCccc
Confidence            5789999999999899999999999999999999999998  9999999999999887 799999999998776666667


Q ss_pred             cccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ..+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+..++..++..+..+  ++...++++.+||.+|
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~  248 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRF  248 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHH
Confidence            78999999999988654 4 4789999999999999999999976 6778888888887764  3345688999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. ||.+|||++|+|+||||+...
T Consensus       249 L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          249 LVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             CCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCCChhHCcCHHHHhcCHhhcCCC
Confidence            99 999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-34  Score=282.78  Aligned_cols=179  Identities=53%  Similarity=1.027  Sum_probs=161.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++...+.+||+|||++..... ....
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~  188 (290)
T 1t4h_A          110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAK  188 (290)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBE
T ss_pred             ecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-cccc
Confidence            578999999999988999999999999999999999998877999999999999985557999999999965433 3345


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      ...||+.|+|||++.+.++.++|||||||++|+|++|..||....+..+++..+..+..+..++...++.+.+||.+||.
T Consensus       189 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  268 (290)
T 1t4h_A          189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred             cccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence            57899999999999988999999999999999999999999988888999999988888777777788999999999999


Q ss_pred             -CcCCCCCHHHHhcCCCCcCC
Q 010730          161 -NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~~~  180 (502)
                       +|.+|||+.|+|+||||+..
T Consensus       269 ~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          269 QNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             SSGGGSCCHHHHHTSGGGC--
T ss_pred             CChhhCCCHHHHhhCcccccC
Confidence             99999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=296.70  Aligned_cols=177  Identities=24%  Similarity=0.462  Sum_probs=151.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus       105 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~  181 (353)
T 3txo_A          105 FVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTT  181 (353)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-----
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeecccCCccc
Confidence            6789999999999899999999999999999999999998  9999999999999887 799999999998643 33345


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..++++++..+...  ++...+..+++||.+|
T Consensus       182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~l  258 (353)
T 3txo_A          182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLHEDATGILKSF  258 (353)
T ss_dssp             ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred             cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence            66789999999998864 499999999999999999999999976 6778888888887653  3445688999999999


Q ss_pred             hh-CcCCCCCH------HHHhcCCCCcCCCCC
Q 010730          159 LE-NVSKRLPA------KELLLDPFLASDAGE  183 (502)
Q Consensus       159 L~-dP~kRpSa------~ELL~hPff~~~~~~  183 (502)
                      |. +|.+||++      .|+++||||+...+.
T Consensus       259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             hhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            99 99999998      899999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.5e-34  Score=290.14  Aligned_cols=176  Identities=27%  Similarity=0.486  Sum_probs=155.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCB
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhcccCCCcc
Confidence            6789999999999889999999999999999999999998  9999999999999887 799999999998643 33445


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..++++.+..+..  .++...++++++||.+|
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l  239 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL  239 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            67889999999998864 589999999999999999999999976 667788888877655  34456689999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. ||.+||     +++|+++||||+...+
T Consensus       240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             hhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence            98 999999     8999999999987654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5e-34  Score=294.25  Aligned_cols=177  Identities=26%  Similarity=0.443  Sum_probs=156.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---cEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---QIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g---~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++.+.+   .+||+|||+++.+....
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~  173 (361)
T 2yab_A           96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV  173 (361)
T ss_dssp             CCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence            5789999999998889999999999999999999999998  999999999999976532   79999999999877666


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+...  ..++...+..+++|
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  252 (361)
T 2yab_A          174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDF  252 (361)
T ss_dssp             CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred             ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence            6677889999999998865 599999999999999999999999976 6677788888777653  23345568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. ||.+|||+.|+|+||||+..
T Consensus       253 i~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          253 IRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999 99999999999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-33  Score=291.01  Aligned_cols=176  Identities=23%  Similarity=0.440  Sum_probs=155.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus       102 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~  178 (353)
T 2i0e_A          102 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTT  178 (353)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCcccccccCCccc
Confidence            6789999999998889999999999999999999999998  9999999999999887 799999999998643 33345


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..++++++..+...  ++...+.++++||.+|
T Consensus       179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~l  255 (353)
T 2i0e_A          179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAICKGL  255 (353)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred             ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHH
Confidence            6788999999999886 4589999999999999999999999976 6778888888877653  4456789999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. +|.+||+     ++++++||||+...+
T Consensus       256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             TCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence            98 9999994     799999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-33  Score=296.01  Aligned_cols=178  Identities=23%  Similarity=0.454  Sum_probs=154.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI-LRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~-~~~~~~~   79 (502)
                      |+.||+|..++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++. .......
T Consensus       134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~  210 (396)
T 4dc2_A          134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT  210 (396)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeecccCCCcc
Confidence            6789999999999899999999999999999999999998  9999999999999987 7999999999986 3344456


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--------CChHHHHHHhhcCCCCCcccccccHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...        .....+++.+.....  .++...+++
T Consensus       211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~  288 (396)
T 4dc2_A          211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK  288 (396)
T ss_dssp             CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred             ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCcCCHH
Confidence            67899999999998865 5999999999999999999999999632        234457777777655  344557889


Q ss_pred             HHHHHHHhhh-CcCCCCCH------HHHhcCCCCcCCCCC
Q 010730          151 ARRFVGKCLE-NVSKRLPA------KELLLDPFLASDAGE  183 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa------~ELL~hPff~~~~~~  183 (502)
                      +++||.+||. ||.+||++      +|+++||||+..++.
T Consensus       289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            9999999999 99999985      899999999876553

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-33  Score=278.96  Aligned_cols=176  Identities=34%  Similarity=0.554  Sum_probs=150.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.||+|.+++.+. .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCceecCCccccc
Confidence            67899999999875 6999999999999999999999998  9999999999999877 799999999998765433 34


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......++.....+......+...+..+++||.+|
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            55789999999998854 58999999999999999999999998754444555444444444444556788999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. ||.+|||+.|+|+||||+..
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCChhHCcCHHHHhhChhhccc
Confidence            99 99999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-33  Score=284.67  Aligned_cols=174  Identities=29%  Similarity=0.548  Sum_probs=154.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ |.+||+|||+++....  ...
T Consensus        87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--~~~  161 (318)
T 1fot_A           87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--VTY  161 (318)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS--CBC
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC--ccc
Confidence            6789999999999999999999999999999999999998  9999999999999877 7999999999987643  345


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++.++..+..  .++...+.+++++|.+||
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHh
Confidence            6789999999998864 589999999999999999999999976 567778888877665  344556889999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      . +|.+|+     +++|+++||||+...+
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence            8 999999     8999999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9e-34  Score=290.66  Aligned_cols=177  Identities=27%  Similarity=0.521  Sum_probs=156.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus        99 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~  175 (345)
T 1xjd_A           99 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKT  175 (345)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhcccCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999887 799999999998643 23345


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++.++..+..  .++...+.++++||.+|
T Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l  252 (345)
T 1xjd_A          176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKL  252 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHHH
Confidence            67889999999998864 589999999999999999999999976 677788888877654  34455688999999999


Q ss_pred             hh-CcCCCCCHH-HHhcCCCCcCCCCC
Q 010730          159 LE-NVSKRLPAK-ELLLDPFLASDAGE  183 (502)
Q Consensus       159 L~-dP~kRpSa~-ELL~hPff~~~~~~  183 (502)
                      |. +|.+||++. ++++||||+...+.
T Consensus       253 L~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          253 FVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             hcCCHhHcCCChHHHHcCccccCCCHH
Confidence            98 999999998 99999999876543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-33  Score=286.61  Aligned_cols=174  Identities=28%  Similarity=0.522  Sum_probs=155.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.....  ..
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~--~~  196 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TW  196 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceeccCC--cc
Confidence            5789999999999889999999999999999999999999  9999999999999877 79999999999876432  34


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++.++..+..+  ++...+..++++|.+||
T Consensus       197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHHHS
T ss_pred             cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence            6789999999998764 589999999999999999999999976 6778888888887653  44556889999999999


Q ss_pred             h-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      . ||.+||+     ++|+++||||+...+
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             hcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            8 9999998     999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-33  Score=285.68  Aligned_cols=177  Identities=22%  Similarity=0.423  Sum_probs=152.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus        91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~~~~  167 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT  167 (345)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTTCCB
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEeccccccccCCCCcc
Confidence            6789999999999889999999999999999999999998  9999999999999877 799999999998643 33445


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--------CChHHHHHHhhcCCCCCcccccccHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--------~~~~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...        .....+++.+..+..  .++...+..
T Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~  245 (345)
T 3a8x_A          168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK  245 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred             cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCCCHH
Confidence            66789999999998864 5899999999999999999999999642        234556777776654  344556889


Q ss_pred             HHHHHHHhhh-CcCCCCCH------HHHhcCCCCcCCCC
Q 010730          151 ARRFVGKCLE-NVSKRLPA------KELLLDPFLASDAG  182 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa------~ELL~hPff~~~~~  182 (502)
                      +++||.+||. ||.+||++      .|++.||||+...+
T Consensus       246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            9999999999 99999995      89999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-33  Score=284.11  Aligned_cols=172  Identities=27%  Similarity=0.394  Sum_probs=134.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~------g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++++. +++++.+..++.||+.||+|||++      .++||||||||+|||++.+ +.+||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCcccc
Confidence            78999999999874 589999999999999999999986      3359999999999999987 799999999998765


Q ss_pred             CCCC-----cccccCCCcccCcccccc-------CCCCcccchhHHHHHHHHhhccCCCCC----------C----CChH
Q 010730           75 GSQQ-----AHSVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSE----------C----SNPA  128 (502)
Q Consensus        75 ~~~~-----~~s~vGTp~Y~APEvl~~-------~ys~~~DIWSLGviLyeLLTG~~Pf~~----------~----~~~~  128 (502)
                      ....     ....+||+.|||||++.+       .|+.++|||||||+||||+||.+||..          .    ....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            4322     234689999999998864       367799999999999999999776532          1    1234


Q ss_pred             HHHHHhhcCCCCCccccc-----ccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          129 QIYKKVTSGKLPGAFHRI-----QDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       129 ql~~kI~~g~~p~~~~~~-----~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++.+.+....+.+.++..     ....+.+|+.+||. ||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            556666555443333221     12467899999998 99999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-33  Score=280.42  Aligned_cols=177  Identities=25%  Similarity=0.450  Sum_probs=152.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~---g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+.   ..+||+|||++..+....
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~  172 (326)
T 2y0a_A           95 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  172 (326)
T ss_dssp             CCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence            5789999999998889999999999999999999999998  99999999999998652   279999999998876555


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ ....+++..+......  .......+..+++|
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  251 (326)
T 2y0a_A          173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDF  251 (326)
T ss_dssp             CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccccccCCHHHHHH
Confidence            566778999999999886 4589999999999999999999999976 4556666666554432  22334567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. ||.+|||+.|+|+||||+..
T Consensus       252 i~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          252 IRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999998 99999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.8e-33  Score=288.34  Aligned_cols=177  Identities=26%  Similarity=0.421  Sum_probs=156.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus       120 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~~~~~~  196 (373)
T 2r5t_A          120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTT  196 (373)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGBCCCCCC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccccCCCcc
Confidence            6789999999999889999999999999999999999999  9999999999999887 799999999998643 33445


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..++++++..+..  .++...+..+++||.+|
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~l  273 (373)
T 2r5t_A          197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGL  273 (373)
T ss_dssp             CSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCC--CCCSSSCHHHHHHHHHH
T ss_pred             ccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccc--CCCCCCCHHHHHHHHHH
Confidence            67899999999998865 589999999999999999999999976 677888888887754  34455688999999999


Q ss_pred             hh-CcCCCCCH----HHHhcCCCCcCCCCC
Q 010730          159 LE-NVSKRLPA----KELLLDPFLASDAGE  183 (502)
Q Consensus       159 L~-dP~kRpSa----~ELL~hPff~~~~~~  183 (502)
                      |. ||.+|+++    .+++.||||+...+.
T Consensus       274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             TCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             cccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            98 99999986    699999999876553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=276.28  Aligned_cols=175  Identities=30%  Similarity=0.440  Sum_probs=142.4

Q ss_pred             CCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            3 TSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         3 tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      .+|+|.+++.+...  +++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.........
T Consensus       101 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~  177 (308)
T 3g33_A          101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALT  177 (308)
T ss_dssp             CCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEECSCSCTTTSTTCCCSG
T ss_pred             hhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEeeCccccccCCCcccC
Confidence            35799999988654  999999999999999999999999  9999999999999877 799999999998776555566


Q ss_pred             cccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCC-Cc--------------
Q 010730           81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP-GA--------------  142 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p-~~--------------  142 (502)
                      ..+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ......++..  +..+ ..              
T Consensus       178 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  256 (308)
T 3g33_A          178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPP  256 (308)
T ss_dssp             GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCC
T ss_pred             CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhccchhhccccccCC
Confidence            788999999999875 569999999999999999999999998744 4443333322  1111 00              


Q ss_pred             --------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          143 --------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       143 --------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                              .....+..+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          257 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                    112346889999999999 999999999999999998653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.9e-33  Score=292.03  Aligned_cols=176  Identities=27%  Similarity=0.486  Sum_probs=152.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+ ++  ||||||||+|||++.+ +.+||+|||+++... ....
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceeccCCCcc
Confidence            67899999999998999999999999999999999998 88  9999999999999887 799999999997643 2334


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+......  ++...++++++||.+
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~  382 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIR--FPRTLGPEAKSLLSG  382 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHH
T ss_pred             cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHHHHH
Confidence            56688999999999886 4599999999999999999999999976 5667777777766553  445568899999999


Q ss_pred             hhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          158 CLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       158 cL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      ||. ||.+||     +++|+|+||||+...+
T Consensus       383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence            999 999999     9999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-33  Score=296.86  Aligned_cols=180  Identities=22%  Similarity=0.440  Sum_probs=153.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.||+|.+++.+ .+.+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++....... 
T Consensus       155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCE
T ss_pred             cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhcccCCCc
Confidence            6789999999987 578999999999999999999999998  9999999999999987 7999999999987654332 


Q ss_pred             -cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC----CCCCcccccc
Q 010730           79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG----KLPGAFHRIQ  147 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g----~~p~~~~~~~  147 (502)
                       ....+||+.|+|||++.      +.|+.++|||||||++|||++|..||.+ .+..+++.++...    .+|.. ....
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~-~~~~  309 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQ-VTDV  309 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSS-CCCS
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcc-cccC
Confidence             23468999999999875      3589999999999999999999999976 6677777777643    23322 2335


Q ss_pred             cHHHHHHHHHhhh-CcCC--CCCHHHHhcCCCCcCCCCCCC
Q 010730          148 DAEARRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGEPL  185 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~k--RpSa~ELL~hPff~~~~~~~l  185 (502)
                      ++++++||.+||. +|.+  |++++|+++||||+..++..+
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            8899999999998 6766  999999999999998777654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.8e-33  Score=291.71  Aligned_cols=179  Identities=22%  Similarity=0.417  Sum_probs=152.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.||+|.+++++. .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....  .
T Consensus       150 ~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          150 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSEEE
T ss_pred             CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEeeccCCccc
Confidence            67899999999774 6999999999999999999999998  9999999999999887 799999999998765443  2


Q ss_pred             cccccCCCcccCccccccC-----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC--CCCcccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~-----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~--~p~~~~~~~s~~l  151 (502)
                      ..+.+||+.|+|||++.+.     |+.++|||||||++|+|++|..||.+ .+...++.++..+.  +..+.....+.++
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccHHH
Confidence            3467899999999988532     78899999999999999999999976 67778888887643  2222233568899


Q ss_pred             HHHHHHhhh-CcCC--CCCHHHHhcCCCCcCCCCCC
Q 010730          152 RRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGEP  184 (502)
Q Consensus       152 ~~LI~kcL~-dP~k--RpSa~ELL~hPff~~~~~~~  184 (502)
                      ++||.+||. +|.+  |++++|+++||||+...+..
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence            999999998 7777  99999999999999876643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.7e-33  Score=286.84  Aligned_cols=176  Identities=26%  Similarity=0.472  Sum_probs=154.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+  .+.+||+|||++........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            5789999999998889999999999999999999999998  9999999999999754  24699999999988766555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+...  ...+...++++++||
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  265 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI  265 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            667889999999998865 599999999999999999999999976 5667788888777653  333445688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      .+||. ||.+|||+.|+|+||||..
T Consensus       266 ~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          266 DSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHcCCChhhCcCHHHHhcCcccCC
Confidence            99998 9999999999999999964

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.4e-33  Score=308.88  Aligned_cols=178  Identities=24%  Similarity=0.445  Sum_probs=158.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR-GSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~-~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++... .....
T Consensus       423 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~  499 (674)
T 3pfq_A          423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTT  499 (674)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECCCTTCCB
T ss_pred             CcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeeccccCCccc
Confidence            6889999999999899999999999999999999999998  9999999999999987 799999999998643 33445


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..+++++|..+..  .++...++++++||.+|
T Consensus       500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            6789999999999886 4599999999999999999999999977 678889999988765  34556789999999999


Q ss_pred             hh-CcCCCCCH-----HHHhcCCCCcCCCCCC
Q 010730          159 LE-NVSKRLPA-----KELLLDPFLASDAGEP  184 (502)
Q Consensus       159 L~-dP~kRpSa-----~ELL~hPff~~~~~~~  184 (502)
                      |. ||.+|+++     +||++||||+..++..
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence            99 99999997     9999999998766543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.6e-33  Score=293.04  Aligned_cols=176  Identities=26%  Similarity=0.456  Sum_probs=154.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.||+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+  .+.+||+|||++....... 
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            6789999999999999999999999999999999999998  9999999999999842  3689999999998765433 


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+...  ...+...++++++|
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  247 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL  247 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence            2356789999999998875 599999999999999999999999976 6677888888877653  33344568999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |.+||. ||.+|||+.|+|+||||+.
T Consensus       248 i~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          248 INKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHcCCChhHCCCHHHHhcCccccC
Confidence            999999 9999999999999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-33  Score=292.83  Aligned_cols=180  Identities=26%  Similarity=0.469  Sum_probs=152.3

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.||+|.+++.+. ..+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus       142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCE
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheeccCCCcc
Confidence            67899999999875 47999999999999999999999998  9999999999999987 7999999999987754433 


Q ss_pred             -cccccCCCcccCccccc--------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC----CCCcccc
Q 010730           79 -AHSVIGTPEFMAPELYE--------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK----LPGAFHR  145 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~--------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~----~p~~~~~  145 (502)
                       ....+||+.|+|||++.        ..|+.++|||||||++|||++|..||.+ .+..+++.++....    +| ....
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p-~~~~  296 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLP-LVDE  296 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC-----
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCC-cccc
Confidence             23568999999999885        3589999999999999999999999976 66777777776532    22 2234


Q ss_pred             cccHHHHHHHHHhhhCcCCC---CCHHHHhcCCCCcCCCCCCC
Q 010730          146 IQDAEARRFVGKCLENVSKR---LPAKELLLDPFLASDAGEPL  185 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~dP~kR---pSa~ELL~hPff~~~~~~~l  185 (502)
                      ..++++++||.+||.+|.+|   ++++|+++||||+...+..+
T Consensus       297 ~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          297 GVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             CCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            56889999999999988887   58999999999998777654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-33  Score=277.50  Aligned_cols=170  Identities=28%  Similarity=0.436  Sum_probs=145.6

Q ss_pred             CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         3 tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      .+|+|.+++... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++...........
T Consensus       139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~  215 (311)
T 3p1a_A          139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEV  215 (311)
T ss_dssp             CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC------C
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecccCCCCcc
Confidence            378999998764 46999999999999999999999998  9999999999999877 7999999999988765555556


Q ss_pred             ccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-
Q 010730           82 VIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-  160 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-  160 (502)
                      ..||+.|+|||++.+.++.++|||||||++|+|++|..|+..    ...+..+..+..+..++...+.++++||.+||. 
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             CCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred             cCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence            789999999999988999999999999999999999777654    344566667766666666778999999999999 


Q ss_pred             CcCCCCCHHHHhcCCCCcC
Q 010730          161 NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       161 dP~kRpSa~ELL~hPff~~  179 (502)
                      +|.+|||+.|+|+||||+.
T Consensus       292 dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          292 DPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             STTTSCCHHHHHTSGGGSC
T ss_pred             ChhhCcCHHHHHhCccccC
Confidence            9999999999999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.8e-32  Score=283.16  Aligned_cols=178  Identities=26%  Similarity=0.467  Sum_probs=155.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||.|||++|  |+||||||+|||++.+ +.+||+|||+++.+.......
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~  172 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQIT  172 (384)
T ss_dssp             CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTCCBC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeeccCCCcee
Confidence            6789999999999989999999999999999999999998  9999999999999887 799999999999887666677


Q ss_pred             cccCCCcccCcccccc----CCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           81 SVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~----~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      +.+||+.|+|||++..    .|+.++|||||||++|+|++|..||...  ....+++..+.....  .++...+..+.+|
T Consensus       173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~~~l  250 (384)
T 4fr4_A          173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQEMVSL  250 (384)
T ss_dssp             CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred             ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcCCHHHHHH
Confidence            8899999999998852    4899999999999999999999999742  345666666665544  3344568899999


Q ss_pred             HHHhhh-CcCCCCC-HHHHhcCCCCcCCCCC
Q 010730          155 VGKCLE-NVSKRLP-AKELLLDPFLASDAGE  183 (502)
Q Consensus       155 I~kcL~-dP~kRpS-a~ELL~hPff~~~~~~  183 (502)
                      |.+||. +|.+||+ +.+++.||||+...+.
T Consensus       251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             HHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             HHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            999999 9999998 9999999999876553

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-33  Score=282.80  Aligned_cols=177  Identities=23%  Similarity=0.381  Sum_probs=153.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ .+.+||+|||++..+.....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            67899999999765 47999999999999999999999998  9999999999999863 37899999999998766555


Q ss_pred             cccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc--ccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~--~~~~~s~~l~~LI  155 (502)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+..+++..+..+.....  .+...+.++++||
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence            5667899999999988755 79999999999999999999999977 566777777777665422  2334678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. ||.+|||+.|+|+||||+..
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99998 99999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-32  Score=269.00  Aligned_cols=176  Identities=22%  Similarity=0.359  Sum_probs=154.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl---~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||++   +.+ +.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence            5789999999999889999999999999999999999998  9999999999999   444 789999999998877666


Q ss_pred             CcccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc--cccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~--~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++.+.++.++||||||+++|+|++|..||.. ....++...+..+..+...  +...++.+++||
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence            6667789999999999988899999999999999999999999976 5566677777766553222  224578999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. +|.+|||+.++|+||||+..
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999 99999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-33  Score=288.31  Aligned_cols=171  Identities=26%  Similarity=0.516  Sum_probs=148.5

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++.+.+++++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++............+
T Consensus        92 ~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~~~~~~~  168 (336)
T 3h4j_B           92 GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSC  168 (336)
T ss_dssp             CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSBTTCCCT
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceeccCCccccccc
Confidence            8999999998899999999999999999999999998  9999999999999987 799999999998877666667789


Q ss_pred             CCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-
Q 010730           84 GTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-  160 (502)
Q Consensus        84 GTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-  160 (502)
                      ||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .....+++++..+..  .++...++.+++||.+||. 
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~  245 (336)
T 3h4j_B          169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVY--VMPDFLSPGAQSLIRRMIVA  245 (336)
T ss_dssp             TSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC-SSSTTCBCCCCSSCC--CCCTTSCHHHHHHHHTTSCS
T ss_pred             CCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCC--CCcccCCHHHHHHHHHHcCC
Confidence            99999999998754 3 7899999999999999999999976 333344444444433  3345568899999999999 


Q ss_pred             CcCCCCCHHHHhcCCCCcCC
Q 010730          161 NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       161 dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||.+|||++|+++||||+..
T Consensus       246 dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          246 DPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             SGGGSCCHHHHTTCHHHHTT
T ss_pred             ChhHCcCHHHHHhChhhccC
Confidence            99999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=281.30  Aligned_cols=179  Identities=26%  Similarity=0.430  Sum_probs=144.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~--~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  ..+.+||+|||+++.......
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            5789999999998888999999999999999999999998  999999999999974  237899999999987765555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+++.+..+...  ..++...+..+++||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            566789999999998865 58999999999999999999999998877767678887776543  233445688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .+||. ||.+|||+.|+|+||||....
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999 999999999999999997543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.4e-33  Score=294.33  Aligned_cols=178  Identities=29%  Similarity=0.499  Sum_probs=155.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++..  .+.+||+|||+++.......
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            6789999999998889999999999999999999999998  9999999999999643  35799999999987766666


Q ss_pred             cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--cccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~~~~~~s~~l~~LI~  156 (502)
                      ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+..++++.+..+..+.  ..+...++++++||.
T Consensus       180 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  258 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (486)
T ss_dssp             --CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence            667889999999999998999999999999999999999999977 66777888888776543  333456889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +||. +|.+|||+.|+|+||||+...
T Consensus       259 ~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          259 KMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHcCCChhhCcCHHHHhcCHhhccCc
Confidence            9999 999999999999999997644

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.1e-33  Score=280.05  Aligned_cols=179  Identities=26%  Similarity=0.416  Sum_probs=151.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.||+|.+++...+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+...   .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeeccceeccCCccc
Confidence            5789999999988888999999999999999999999998  9999999999999887 79999999999865422   2


Q ss_pred             CcccccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      .....+||+.|+|||++.+.  ++.++|||||||++|+|++|..||.........+............+...+..+.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence            23457899999999988643  4778999999999999999999998765555555555554443334455688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .+||. ||.+|||+.|+|+||||+....
T Consensus       243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          243 HKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHccCChhhCcCHHHHhhChhhccccc
Confidence            99999 9999999999999999976543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.3e-33  Score=282.06  Aligned_cols=177  Identities=29%  Similarity=0.462  Sum_probs=153.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEecCCceeccCC-
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGDLGLAAILRGS-   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~---g~vKL~DFGlA~~~~~~-   76 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||+....   +.+||+|||+++.+... 
T Consensus        97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            5789999999999999999999999999999999999998  99999999999985432   35999999999876543 


Q ss_pred             CCcccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCCC--cccccccHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPG--AFHRIQDAEA  151 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p~--~~~~~~s~~l  151 (502)
                      ....+.+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.  ....+++..+..+.++.  ..+...+.++
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  254 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA  254 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence            334567899999999988654 899999999999999999999999753  46678888888877642  3345568999


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ++||.+||. ||.+|||+.|+|+||||..
T Consensus       255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999998 9999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.98  E-value=9.9e-33  Score=286.37  Aligned_cols=175  Identities=22%  Similarity=0.407  Sum_probs=148.6

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---C
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---Q   78 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~   78 (502)
                      +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  +.+||+|||+++.+....   .
T Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~~~~~  212 (390)
T 2zmd_A          137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV  212 (390)
T ss_dssp             CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEESS--SCEEECCCSSSCCC--------
T ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEEC--CeEEEEecCccccccCCCcccc
Confidence            357899999999999999999999999999999999998  999999999999953  689999999998764332   2


Q ss_pred             cccccCCCcccCcccccc------------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           79 AHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~------------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      ....+||+.|+|||++.+            .|+.++|||||||++|+|++|..||....+....+..+........++..
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  292 (390)
T 2zmd_A          213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  292 (390)
T ss_dssp             -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCC
T ss_pred             CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCcc
Confidence            345789999999998854            58899999999999999999999998766666666666666555556666


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+..+++||.+||. ||.+|||+.|+|+||||+..
T Consensus       293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            68899999999999 99999999999999999743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.98  E-value=1.5e-32  Score=292.95  Aligned_cols=176  Identities=26%  Similarity=0.510  Sum_probs=157.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++..  .+.+||+|||++..+.....
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            6789999999998889999999999999999999999998  9999999999999753  35699999999998876666


Q ss_pred             cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI~  156 (502)
                      ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+..+++..+..+..+  ...+...++.+++||.
T Consensus       195 ~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  273 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK  273 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence            677889999999999988899999999999999999999999976 6677788888877654  2334456889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +||. +|.+|||+.|+|+||||+.
T Consensus       274 ~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          274 QMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHCCCChhhCccHHHHhcCccccc
Confidence            9999 9999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.98  E-value=5e-33  Score=294.85  Aligned_cols=179  Identities=28%  Similarity=0.459  Sum_probs=158.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~--~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  ..+.+||+|||+++.+.....
T Consensus       107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  184 (484)
T 3nyv_A          107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK  184 (484)
T ss_dssp             CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence            5789999999999999999999999999999999999998  999999999999952  237899999999988766666


Q ss_pred             cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--cccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~~~~~~s~~l~~LI~  156 (502)
                      ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+..+++..+..+....  ..+...++.+++||.
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  263 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR  263 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence            667889999999999988999999999999999999999999976 66777888888776543  333456899999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      +||. +|.+|||+.|+|+||||+....
T Consensus       264 ~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          264 KMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHCCCChhHCcCHHHHhhChhhccccc
Confidence            9999 9999999999999999976443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.98  E-value=1.6e-32  Score=277.14  Aligned_cols=176  Identities=29%  Similarity=0.397  Sum_probs=148.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~  178 (327)
T 3a62_A          102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVT  178 (327)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC----------
T ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCcccccccCCccc
Confidence            5789999999998889999999999999999999999998  9999999999999877 7999999999976432 2334


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+..+++.++..+...  ++...+..+++||.+|
T Consensus       179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~  255 (327)
T 3a62_A          179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLN--LPPYLTQEARDLLKKL  255 (327)
T ss_dssp             CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHHHHHH
T ss_pred             cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHH
Confidence            5678999999999875 4589999999999999999999999976 5666777777766553  3445688999999999


Q ss_pred             hh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      |. +|.+||     ++.|+|+||||+...+
T Consensus       256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          256 LKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             SCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            98 999999     8999999999986544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=279.00  Aligned_cols=175  Identities=22%  Similarity=0.406  Sum_probs=146.6

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---C
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---Q   78 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~   78 (502)
                      +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  +.+||+|||+++.+....   .
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~~~~~~~  165 (343)
T 3dbq_A           90 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV  165 (343)
T ss_dssp             CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSCCC--------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC--CcEEEeecccccccCccccccc
Confidence            468899999999999999999999999999999999998  999999999999974  689999999998764332   2


Q ss_pred             cccccCCCcccCccccc------------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           79 AHSVIGTPEFMAPELYE------------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      ....+||+.|+|||++.            ..|+.++|||||||++|+|++|..||....+....+..+........++..
T Consensus       166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T 3dbq_A          166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  245 (343)
T ss_dssp             ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred             CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCccc
Confidence            34568999999999874            458889999999999999999999998766665656666655555566667


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+..+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus       246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            78899999999999 99999999999999999743

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.98  E-value=1.6e-32  Score=286.06  Aligned_cols=178  Identities=20%  Similarity=0.369  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+.+  .+++..++.|+.||+.||.|||+++  |+||||||+|||++..  .+.+||+|||+++.....
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            678999999998754  5999999999999999999999998  9999999999999863  378999999999887655


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh---HHHHHHhhcCCC--CCcccccccHH
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL--PGAFHRIQDAE  150 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---~ql~~kI~~g~~--p~~~~~~~s~~  150 (502)
                      ....+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+....   ..+...+..+.+  +...+...+.+
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  297 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE  297 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHH
Confidence            5566788999999999886 45999999999999999999999999763321   123445555543  22333456889


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +++||.+||. ||.+|||+.|+|+||||...
T Consensus       298 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            9999999998 99999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.98  E-value=4.2e-32  Score=265.26  Aligned_cols=179  Identities=26%  Similarity=0.462  Sum_probs=154.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+  .+.+||+|||++........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            5789999999998889999999999999999999999998  9999999999999754  23499999999988766555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .+...++..+..+...  .......++.+++||
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI  242 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence            566789999999998865 489999999999999999999999977 5667777777766543  233345688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .+||. +|.+|||+.|+|+||||+....
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          243 DSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999 9999999999999999976543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.98  E-value=1.7e-32  Score=272.54  Aligned_cols=179  Identities=22%  Similarity=0.376  Sum_probs=142.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceeccCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRGS--   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~~~~--   76 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+.  ..+||+|||++..+...  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            5789999999998889999999999999999999999998  99999999999998652  23999999998765321  


Q ss_pred             ------CCcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCC--------------hHHH
Q 010730           77 ------QQAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--------------PAQI  130 (502)
Q Consensus        77 ------~~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--------------~~ql  130 (502)
                            ......+||+.|+|||++.      ..++.++|||||||++|+|++|..||.+...              ...+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                  1123457999999999885      3489999999999999999999999976432              2456


Q ss_pred             HHHhhcCCCCCc--ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          131 YKKVTSGKLPGA--FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       131 ~~kI~~g~~p~~--~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +..+..+.....  .+...+..+++||.+||. ||.+|||+.|+|+||||+...
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            677776655322  123457899999999999 999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.98  E-value=2.4e-32  Score=269.19  Aligned_cols=176  Identities=26%  Similarity=0.400  Sum_probs=141.9

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++..    .+.+++..++.++.||+.||+|||+++  |+||||||+||+++..  .+.+||+|||++..+.
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            5789999999954    377999999999999999999999998  9999999999999542  3689999999998766


Q ss_pred             CCCCcccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc-ccccccHHHHH
Q 010730           75 GSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-FHRIQDAEARR  153 (502)
Q Consensus        75 ~~~~~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~-~~~~~s~~l~~  153 (502)
                      .........||+.|+|||++.+.++.++|||||||++|+|++|..||.+ ....++...+........ .....++.+.+
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPLTPQAVD  257 (285)
T ss_dssp             --------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred             CcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence            5555566789999999999988899999999999999999999999976 455555555554433211 12235789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ||.+||. ||.+|||+.|+|+||||+.
T Consensus       258 li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          258 LLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999 9999999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=1.4e-32  Score=283.19  Aligned_cols=172  Identities=24%  Similarity=0.371  Sum_probs=137.8

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC--------
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG--------   75 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~--------   75 (502)
                      +|+|.+++.. +.+++..++.++.||+.||+|||++|  |+||||||+|||++.+ +.+||+|||+++.+..        
T Consensus        94 ~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~  169 (388)
T 3oz6_A           94 ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNI  169 (388)
T ss_dssp             SEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCCCCCG
T ss_pred             CcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCcccccccccccccccc
Confidence            4799999977 57999999999999999999999998  9999999999999987 7999999999986532        


Q ss_pred             --------------CCCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC
Q 010730           76 --------------SQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        76 --------------~~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                                    .......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.....++.+.+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  249 (388)
T 3oz6_A          170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF  249 (388)
T ss_dssp             GGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence                          112345689999999998854  5899999999999999999999999875444443332211111


Q ss_pred             CCc--------------------------------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGA--------------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~--------------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |..                                            .....++++.+||.+||. ||.+|||++|+|+|
T Consensus       250 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            100                                            011347789999999999 99999999999999


Q ss_pred             CCCcC
Q 010730          175 PFLAS  179 (502)
Q Consensus       175 Pff~~  179 (502)
                      |||+.
T Consensus       330 p~~~~  334 (388)
T 3oz6_A          330 PFVSI  334 (388)
T ss_dssp             TTTTT
T ss_pred             HHHHH
Confidence            99974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.98  E-value=2e-32  Score=276.51  Aligned_cols=179  Identities=26%  Similarity=0.414  Sum_probs=135.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+.  ..+||+|||+++..... .
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            5789999999999999999999999999999999999998  99999999999997642  27999999999876433 3


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC------CChHHHHHHhhcCCCCCc--cccccc
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPAQIYKKVTSGKLPGA--FHRIQD  148 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~------~~~~ql~~kI~~g~~p~~--~~~~~s  148 (502)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...      ....++++++..+..+..  .+...+
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            3456789999999998864 5899999999999999999999999753      334677888887765422  233468


Q ss_pred             HHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       149 ~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +++++||.+||. ||.+|||+.|+|+||||+...
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            899999999999 999999999999999998643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.98  E-value=2.6e-32  Score=291.75  Aligned_cols=178  Identities=31%  Similarity=0.471  Sum_probs=158.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+.  ..+||+|||++..+.....
T Consensus       127 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  204 (504)
T 3q5i_A          127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK  204 (504)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc
Confidence            6789999999998889999999999999999999999998  99999999999998652  2699999999998876666


Q ss_pred             cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc--ccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~--~~~~~s~~l~~LI~  156 (502)
                      ....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..+++..+..+.+...  .+...++++++||.
T Consensus       205 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  283 (504)
T 3q5i_A          205 LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIK  283 (504)
T ss_dssp             BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHH
Confidence            677889999999999998899999999999999999999999976 677788888888776432  23456889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +||. +|.+|||+.|+|+||||+...
T Consensus       284 ~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          284 LMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHcCCChhHCCCHHHHhcCHhhhhch
Confidence            9999 999999999999999997543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.98  E-value=3.6e-32  Score=279.23  Aligned_cols=174  Identities=22%  Similarity=0.512  Sum_probs=152.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++.+ +.+||+|||++..+.......
T Consensus       181 ~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~~~~~~~  257 (365)
T 2y7j_A          181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLR  257 (365)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCcccccCCCcccc
Confidence            5789999999998889999999999999999999999998  9999999999999877 799999999998877666666


Q ss_pred             cccCCCcccCcccccc-------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc--ccccccHHH
Q 010730           81 SVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEA  151 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~--~~~~~s~~l  151 (502)
                      ..+||+.|+|||++.+       .++.++|||||||++|+|++|..||.+ .+...++..+..+.....  .+...+..+
T Consensus       258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  336 (365)
T 2y7j_A          258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSSTV  336 (365)
T ss_dssp             CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHSSSCHHH
T ss_pred             cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence            7889999999998752       488899999999999999999999976 556667777777665422  223457889


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+||.+||. ||.+|||+.|+|+||||+
T Consensus       337 ~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          337 KDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            999999998 999999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=2.5e-32  Score=292.27  Aligned_cols=174  Identities=27%  Similarity=0.509  Sum_probs=155.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..........
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCTTCCBC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhcccccccc
Confidence            5789999999998889999999999999999999999998  9999999999999887 799999999999876666667


Q ss_pred             cccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      +.+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...++.++..+...  .+...++.+++||.+|
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~  250 (476)
T 2y94_A          174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISLLKHM  250 (476)
T ss_dssp             CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHHHHHH
T ss_pred             ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHHHHHH
Confidence            78999999999988754 3 6899999999999999999999976 5667788888877653  3345678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. ||.+|||+.|+++||||+..
T Consensus       251 L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          251 LQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             cCCCchhCcCHHHHHhCHHhhhc
Confidence            99 99999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=2.4e-32  Score=280.35  Aligned_cols=178  Identities=23%  Similarity=0.409  Sum_probs=137.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~-g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||+|||+++  |+||||||+|||++.+. +.+||+|||+++........
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            6789999999998889999999999999999999999999  99999999999998652 35999999999865444445


Q ss_pred             ccccCCCcccCcccccc-CCCCc-ccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNEL-VDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~-~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ...+||+.|+|||++.+ .+..+ +|||||||++|+|++|..||.+..   ....+.+.+.............++.+++|
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  254 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL  254 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence            66789999999998754 45544 899999999999999999997643   23455566665555433344568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. +|.+|||+.|+|+||||...
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          255 ISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999 99999999999999999643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=5.1e-32  Score=271.33  Aligned_cols=177  Identities=27%  Similarity=0.445  Sum_probs=152.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---cEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---QIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g---~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+..   .+||+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~  173 (321)
T 2a2a_A           96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV  173 (321)
T ss_dssp             CCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence            5779999999999889999999999999999999999998  999999999999987622   79999999998876655


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++...+..+...  .......+..+++|
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  252 (321)
T 2a2a_A          174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKDF  252 (321)
T ss_dssp             CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred             cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcccCHHHHHH
Confidence            5566789999999998864 589999999999999999999999976 5566667777665543  22234567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. ||.+|||+.|+|+||||...
T Consensus       253 i~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          253 IRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHcCCChhhCcCHHHHhcCccccCC
Confidence            999998 99999999999999999743

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.97  E-value=7.1e-32  Score=265.96  Aligned_cols=173  Identities=23%  Similarity=0.398  Sum_probs=140.0

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +|+|.+++.. .+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSCCCS
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCCccccccC
Confidence            4566666654 678999999999999999999999998  9999999999999987 79999999999876533 23455


Q ss_pred             ccCCCcccCcccccc-C-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--CCC-C---------------
Q 010730           82 VIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP-G---------------  141 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~-~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--~~p-~---------------  141 (502)
                      .+||+.|+|||++.+ . ++.++|||||||++|+|++|..||....+.......+...  ..+ .               
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            689999999998754 3 8999999999999999999888876656665555554321  100 0               


Q ss_pred             ---------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          142 ---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       142 ---------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                               ......+..+++||.+||. ||.+|||++|+|+||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence                     0112356889999999999 9999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.1e-32  Score=270.54  Aligned_cols=173  Identities=25%  Similarity=0.489  Sum_probs=147.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++. .+++++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+.... ..
T Consensus       119 ~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  194 (298)
T 2zv2_A          119 LVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALL  194 (298)
T ss_dssp             CCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECSSSSCEE
T ss_pred             cCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CCEEEecCCCccccccccccc
Confidence            567889888754 467999999999999999999999998  9999999999999877 799999999998765432 23


Q ss_pred             ccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ...+||+.|+|||++.+.    ++.++|||||||++|+|++|..||.+ .+...+...+.....+.......++.+++||
T Consensus       195 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  273 (298)
T 2zv2_A          195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLI  273 (298)
T ss_dssp             CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHH
T ss_pred             cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHHhcccCCCCCccccCHHHHHHH
Confidence            456899999999988653    37789999999999999999999976 5566677777666554444445678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+||. ||.+|||+.|+|+||||+
T Consensus       274 ~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          274 TRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHhhcChhhCCCHHHHhcCcccc
Confidence            99999 999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=5.4e-32  Score=281.77  Aligned_cols=179  Identities=24%  Similarity=0.398  Sum_probs=152.5

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++...+ .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ .+.+||+|||+++.+.....
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            578999999997654 7999999999999999999999998  9999999999999743 36799999999998766555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+.+..+..+...  .......++++++||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            566789999999998864 589999999999999999999999977 5556666666665432  233345688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .+||. ||.+|||+.|+|+||||+....
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            99999 9999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=3.6e-32  Score=273.89  Aligned_cols=183  Identities=26%  Similarity=0.410  Sum_probs=147.9

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~--~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++...  +.+++..++.++.||+.||+|||+++  |+||||||+|||++.  ..+.+||+|||++......
T Consensus       110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            67899999998653  67999999999999999999999998  999999999999986  2378999999999887665


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l~~  153 (502)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+.....  +.......+..+++
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            5556678999999999886 4589999999999999999999999977 455555555554433  33334456789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCCCCCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLL  186 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~~l~  186 (502)
                      ||.+||. +|.+|||++|+|+||||+........
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             HHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence            9999999 99999999999999999876665543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=5.1e-32  Score=278.68  Aligned_cols=177  Identities=20%  Similarity=0.426  Sum_probs=141.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--   76 (502)
                      |+.+|+|.+++...  +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++......  
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCGGGCEECEETTE
T ss_pred             ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccccceeeccccc
Confidence            67899999999876  77999999999999999999999998  9999999999999877 79999999998654221  


Q ss_pred             ------CCcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-------
Q 010730           77 ------QQAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-------  140 (502)
Q Consensus        77 ------~~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-------  140 (502)
                            ......+||+.|+|||++.+   .|+.++|||||||++|+|++|..||.+......+...+. +..+       
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~  262 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTST  262 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCccccccc
Confidence                  11233579999999998865   589999999999999999999999987554444433221 1111       


Q ss_pred             -------------------------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          141 -------------------------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       141 -------------------------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                                           ..++...++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                                                 11233457889999999999 999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=4.6e-32  Score=265.18  Aligned_cols=174  Identities=25%  Similarity=0.500  Sum_probs=147.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus        90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~-~~~  165 (279)
T 3fdn_A           90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-RRT  165 (279)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC-------
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCcc-ccc
Confidence            5778999999999889999999999999999999999998  9999999999999877 79999999998654332 234


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+.++.+.....  .++...+..+++||.+||
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  242 (279)
T 3fdn_A          166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLL  242 (279)
T ss_dssp             --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHC
T ss_pred             ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHh
Confidence            5689999999998865 478899999999999999999999976 566677777766554  344556789999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCcCCC
Q 010730          160 E-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      . +|.+|||+.|+|+||||+...
T Consensus       243 ~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          243 KHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ccChhhCCCHHHHhhCccccCCc
Confidence            8 999999999999999997644

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.6e-31  Score=262.84  Aligned_cols=177  Identities=26%  Similarity=0.459  Sum_probs=153.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+.......
T Consensus       105 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  181 (298)
T 1phk_A          105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLR  181 (298)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEecccchhhcCCCcccc
Confidence            5778999999998889999999999999999999999998  9999999999999877 799999999998876655566


Q ss_pred             cccCCCcccCccccc-------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--cccccccHHH
Q 010730           81 SVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEA  151 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~~~~~~s~~l  151 (502)
                      ...||+.|+|||++.       ..++.++||||||+++|+|++|..||.. .+...+...+..+....  ......+..+
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  260 (298)
T 1phk_A          182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV  260 (298)
T ss_dssp             CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred             cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccCcccccccCHHH
Confidence            778999999999874       3478899999999999999999999976 55666677776665432  2223467899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +++|.+||. +|.+|||+.|+|+||||+...
T Consensus       261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             HHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            999999999 999999999999999997543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=4.6e-32  Score=273.31  Aligned_cols=178  Identities=28%  Similarity=0.424  Sum_probs=138.7

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEEecCCceeccCC-CC
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~----~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      +|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+    .+.+||+|||++..+... ..
T Consensus       116 ~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  193 (329)
T 3gbz_A          116 ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ  193 (329)
T ss_dssp             SEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----
T ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc
Confidence            4799999999999999999999999999999999998  9999999999999532    246999999999876432 23


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--c------------
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--A------------  142 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~------------  142 (502)
                      ....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+.+.+.....+.  .            
T Consensus       194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (329)
T 3gbz_A          194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ  273 (329)
T ss_dssp             ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence            345678999999998864  489999999999999999999999987555444444332211110  0            


Q ss_pred             -------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          143 -------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       143 -------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                                   +....+.++++||.+||. ||.+|||++|+|+||||+...+.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence                         011256889999999999 99999999999999999876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=6.6e-32  Score=275.50  Aligned_cols=176  Identities=25%  Similarity=0.430  Sum_probs=148.3

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~   74 (502)
                      |+.||+|.+++.+.    ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+  .+.+||+|||++....
T Consensus       107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            67899999988643    35899999999999999999999998  9999999999999754  2359999999998775


Q ss_pred             CCCC-cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc--ccccccHH
Q 010730           75 GSQQ-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAE  150 (502)
Q Consensus        75 ~~~~-~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~--~~~~~s~~  150 (502)
                      .... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+  ...+++..+..+.....  .+...+..
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~  262 (351)
T 3c0i_A          185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHISES  262 (351)
T ss_dssp             TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccccccCCHH
Confidence            4433 345789999999998864 589999999999999999999999976  45667777777665322  22346789


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +++||.+||. ||.+|||+.|+|+||||+..
T Consensus       263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          263 AKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            9999999998 99999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=5.4e-32  Score=262.99  Aligned_cols=177  Identities=26%  Similarity=0.425  Sum_probs=148.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.+|+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+...   .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCCCcchh
Confidence            5678999999988888999999999999999999999998  9999999999999876 79999999999865422   1


Q ss_pred             CcccccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++.+.  ++.++|||||||++|+|++|..||.........+..+.............+..++++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            23456799999999988653  3678999999999999999999998755554555555544333233345688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. +|.+|||+.|+++||||+..
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccCh
Confidence            99998 99999999999999999754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.1e-31  Score=263.19  Aligned_cols=175  Identities=23%  Similarity=0.455  Sum_probs=150.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..... ....
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~-~~~~  170 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAPS-LRRR  170 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECSS-SCBC
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCcc-cccc
Confidence            5678999999998889999999999999999999999998  9999999999999876 7999999999976543 2334


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+.....  .++...+..++++|.+||
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  247 (284)
T 2vgo_A          171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDLISKLL  247 (284)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHS
T ss_pred             cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHh
Confidence            5689999999998865 589999999999999999999999976 455666666666544  234456789999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      . +|.+||++.++|+||||+....
T Consensus       248 ~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          248 RYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             hcCHhhCCCHHHHhhCHHHHhhcc
Confidence            8 9999999999999999986543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=1.6e-31  Score=277.39  Aligned_cols=168  Identities=28%  Similarity=0.414  Sum_probs=138.9

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010730           13 KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE   92 (502)
Q Consensus        13 k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APE   92 (502)
                      ..+.+++..++.|+.||+.||+|||+++  |+||||||+|||++...+.+||+|||+++.+.........+||+.|+|||
T Consensus       134 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE  211 (394)
T 4e7w_A          134 LKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE  211 (394)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHH
Confidence            4678999999999999999999999998  99999999999999544899999999999876666666788999999999


Q ss_pred             cccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc------------------CCCCC--------ccc
Q 010730           93 LYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS------------------GKLPG--------AFH  144 (502)
Q Consensus        93 vl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~------------------g~~p~--------~~~  144 (502)
                      ++.+  .|+.++|||||||++|+|++|..||.+.....++...+..                  ..++.        .++
T Consensus       212 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (394)
T 4e7w_A          212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFR  291 (394)
T ss_dssp             HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSC
T ss_pred             HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhcc
Confidence            8754  4899999999999999999999999875544444433321                  11110        122


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ...++++.+||.+||. ||.+|||+.|+|+||||+....
T Consensus       292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          292 PRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             ccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            2357899999999999 9999999999999999986544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=1.1e-31  Score=272.16  Aligned_cols=170  Identities=25%  Similarity=0.373  Sum_probs=137.7

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------------------------
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG------------------------   57 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~------------------------   57 (502)
                      +|+|.+++.+.+  .+++..++.++.||+.||+|||+++  |+||||||+|||++.                        
T Consensus       119 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (360)
T 3llt_A          119 GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT  196 (360)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEE
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhccccccccccccc
Confidence            899999998754  5999999999999999999999998  999999999999974                        


Q ss_pred             CCCcEEEEecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc
Q 010730           58 HLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS  136 (502)
Q Consensus        58 ~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~  136 (502)
                      ..+.+||+|||++.....  .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... +..+....+..
T Consensus       197 ~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~~~~  273 (360)
T 3llt_A          197 KSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH-EHMEHLAMMES  273 (360)
T ss_dssp             SCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHH
T ss_pred             CCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC-cHHHHHHHHHH
Confidence            247899999999986543  2346789999999998764 5999999999999999999999999763 33443333322


Q ss_pred             C--CCCC------------------------------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHH
Q 010730          137 G--KLPG------------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKEL  171 (502)
Q Consensus       137 g--~~p~------------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~EL  171 (502)
                      .  ..|.                                          ......++.+.+||.+||. ||.+|||++|+
T Consensus       274 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~el  353 (360)
T 3llt_A          274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAEL  353 (360)
T ss_dssp             HTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             hcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHH
Confidence            1  1110                                          0011123678899999999 99999999999


Q ss_pred             hcCCCCc
Q 010730          172 LLDPFLA  178 (502)
Q Consensus       172 L~hPff~  178 (502)
                      |+||||+
T Consensus       354 L~hp~f~  360 (360)
T 3llt_A          354 LKHKFLE  360 (360)
T ss_dssp             TTSGGGC
T ss_pred             hcCcccC
Confidence            9999995

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=1.7e-31  Score=267.50  Aligned_cols=175  Identities=25%  Similarity=0.389  Sum_probs=139.5

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      .|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus       102 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          102 EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             SEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEETTSCCC---C
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcCceecCCCcccccC
Confidence            46888888765 45999999999999999999999998  9999999999999887 79999999999876533 23345


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh--cCCCCCcc--------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT--SGKLPGAF--------------  143 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~--~g~~p~~~--------------  143 (502)
                      .+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+......+.+.+.  ....+..+              
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            689999999998754  489999999999999999999999987554443332221  11111111              


Q ss_pred             -----------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          144 -----------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       144 -----------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                 ....++++.+||.+||. ||.+|||++|+|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                       11235789999999999 999999999999999998643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1.9e-31  Score=279.38  Aligned_cols=176  Identities=25%  Similarity=0.359  Sum_probs=142.6

Q ss_pred             CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            4 SGTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         4 gGsL~~yi~----k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      .|+|.+++.    ....+++..++.++.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||+++.+......
T Consensus       136 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~  213 (420)
T 1j1b_A          136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN  213 (420)
T ss_dssp             CEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             cccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc
Confidence            356666554    3577999999999999999999999998  9999999999999976567899999999987655555


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC------------------CC
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG------------------KL  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g------------------~~  139 (502)
                      ...+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+.....++.+.+...                  .+
T Consensus       214 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~  293 (420)
T 1j1b_A          214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF  293 (420)
T ss_dssp             CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCC
T ss_pred             eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcc
Confidence            67789999999998753  58999999999999999999999998755445544433210                  11


Q ss_pred             CC--------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          140 PG--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       140 p~--------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |.        .+....++++++||.+||. ||.+|||+.|+|+||||+...
T Consensus       294 p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            10        0122347899999999999 999999999999999997543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.1e-31  Score=268.23  Aligned_cols=175  Identities=32%  Similarity=0.573  Sum_probs=149.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.||+|.+++.+ .++++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+.... ..
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCB
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcccc
Confidence            6789999999865 56999999999999999999999998  9999999999999877 799999999998765432 33


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~LI~k  157 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+....+.....+. ......++.++++|.+
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            55789999999998864 589999999999999999999999976 55666666666654432 2233457899999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. ||.+|||+.|+|+||||...
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HccCChhhCcCHHHHhcChhhccC
Confidence            999 99999999999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=2.4e-32  Score=286.05  Aligned_cols=177  Identities=29%  Similarity=0.456  Sum_probs=144.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+  ...+||+|||+++.......
T Consensus       220 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  297 (419)
T 3i6u_A          220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL  297 (419)
T ss_dssp             CCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCCCcc
Confidence            6789999999998899999999999999999999999998  9999999999999754  24599999999988766555


Q ss_pred             cccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--cccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~~~~~~s~~l~  152 (502)
                      ....+||+.|+|||++.    ..|+.++|||||||++|+|++|..||.+......+...+..+..+.  ..+...+..++
T Consensus       298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  377 (419)
T 3i6u_A          298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL  377 (419)
T ss_dssp             -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHH
Confidence            66788999999999874    4578899999999999999999999987655556666776665532  22334578999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +||.+||. ||.+|||++|+|+||||+.
T Consensus       378 ~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          378 DLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            99999999 9999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=1e-31  Score=294.15  Aligned_cols=178  Identities=25%  Similarity=0.399  Sum_probs=155.0

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+.  +++..++.++.||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+++.+.....
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCTTCC
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccceecccCcc
Confidence            6789999999987654  999999999999999999999998  9999999999999877 7999999999998766555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....   ...++++.+.....  .++...++++++|
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~s~~~~dL  419 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERFSPQARSL  419 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence            666799999999998865 59999999999999999999999997642   45667777765543  3455678999999


Q ss_pred             HHHhhh-CcCCCC-----CHHHHhcCCCCcCCCCC
Q 010730          155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGE  183 (502)
Q Consensus       155 I~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~~  183 (502)
                      |.+||. ||.+||     +++|+++||||+...+.
T Consensus       420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            999999 999999     79999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=271.82  Aligned_cols=167  Identities=26%  Similarity=0.417  Sum_probs=143.3

Q ss_pred             CCCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSG-TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgG-sL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+| +|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+......
T Consensus       110 ~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~  186 (335)
T 3dls_A          110 KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLF  186 (335)
T ss_dssp             CCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTCCB
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecccceECCCCCce
Confidence            34455 99999999999999999999999999999999998  9999999999999887 79999999999987766666


Q ss_pred             ccccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      ...+||+.|+|||++.+. + +.++|||||||++|+|++|..||...       ........  ..+...+.++++||.+
T Consensus       187 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~--~~~~~~~~~l~~li~~  257 (335)
T 3dls_A          187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL-------EETVEAAI--HPPYLVSKELMSLVSG  257 (335)
T ss_dssp             CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG-------GGGTTTCC--CCSSCCCHHHHHHHHH
T ss_pred             eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH-------HHHHhhcc--CCCcccCHHHHHHHHH
Confidence            678899999999988654 4 78999999999999999999999652       11222222  2233467899999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ||. +|.+|||+.|+|+||||+.
T Consensus       258 ~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          258 LLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             HTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             HccCChhhCcCHHHHhcCccccC
Confidence            999 9999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=2e-31  Score=267.23  Aligned_cols=175  Identities=29%  Similarity=0.450  Sum_probs=141.3

Q ss_pred             CCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-
Q 010730            4 SGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-   76 (502)
Q Consensus         4 gGsL~~yi~k~------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-   76 (502)
                      .|+|.+++...      ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++..... 
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           86 DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCSSCEETTSCC
T ss_pred             CCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCccceecCCCc
Confidence            47999999754      35999999999999999999999998  9999999999999887 79999999999876532 


Q ss_pred             CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCCC-----------
Q 010730           77 QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG-----------  141 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p~-----------  141 (502)
                      ......+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+. +..+....+..  +..+.           
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT-NDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            23345689999999998864  4899999999999999999999999874 43443333321  11000           


Q ss_pred             -------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          142 -------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       142 -------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                                         ......+.++++||.+||. ||.+|||++|+|+||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                               0111346789999999999 9999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=6.1e-32  Score=264.46  Aligned_cols=173  Identities=28%  Similarity=0.473  Sum_probs=135.4

Q ss_pred             CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            4 SGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         4 gGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      +|+|.+++..    .+.+++..++.++.||+.||.|||++ +  |+||||||+||+++.+ +.+||+|||++........
T Consensus        89 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  165 (290)
T 3fme_A           89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVA  165 (290)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-----------
T ss_pred             ccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecCCccccccccc
Confidence            4688777753    57899999999999999999999997 8  9999999999999886 7999999999987765555


Q ss_pred             cccccCCCcccCccccc-----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      .....||+.|+|||++.     ..++.++|||||||++|+|++|..||............+.....+.......++.+.+
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (290)
T 3fme_A          166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD  245 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred             ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence            55568999999999862     3488899999999999999999999987666655555555555444444556889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +|.+||. +|.+|||+.|+|+||||+.
T Consensus       246 li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          246 FTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHhhcChhhCcCHHHHHhCccccc
Confidence            9999999 9999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=2.1e-31  Score=266.29  Aligned_cols=175  Identities=19%  Similarity=0.377  Sum_probs=143.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.++++.   +++..++.++.||+.||+|||+++  |+||||||+|||++.+...+||+|||+++.........
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence            5788999999854   899999999999999999999998  99999999999999764589999999998876666666


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHH-------------hhcCCC------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK-------------VTSGKL------  139 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~k-------------I~~g~~------  139 (502)
                      ..+||+.|+|||++.+  .++.++|||||||++|+|++|..||....+.......             +.....      
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            7789999999998754  5899999999999999999999999654443222211             111111      


Q ss_pred             ----------------CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 ----------------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 ----------------p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                      +.......++++++||.+||. ||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                            011122357899999999999 99999999999999999754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=8.2e-32  Score=278.15  Aligned_cols=176  Identities=27%  Similarity=0.359  Sum_probs=149.5

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~-~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++  |+||||||+|||+.. ..+.+||+|||+++.+.....
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            67899999999764 46999999999999999999999998  999999999999842 336899999999998766655


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+.+..+..+..+  .......++++++||
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            666789999999998864 588999999999999999999999987 4555666666655432  222344688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      .+||. +|.+|||+.|+|+||||+.
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcCC
Confidence            99999 9999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.4e-31  Score=275.55  Aligned_cols=174  Identities=22%  Similarity=0.344  Sum_probs=142.7

Q ss_pred             CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            4 SGTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         4 gGsL~~yi~----k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      +|+|.+++.    ..+.+++..++.++.||+.||.|||++|  |+||||||+|||++...+.+||+|||+++.+......
T Consensus       121 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  198 (383)
T 3eb0_A          121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS  198 (383)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC
T ss_pred             CccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC
Confidence            367666654    4678999999999999999999999998  9999999999999865579999999999987666666


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC------------------C
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------L  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~------------------~  139 (502)
                      ...+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+.....++.+.+....                  +
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~  278 (383)
T 3eb0_A          199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF  278 (383)
T ss_dssp             CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCC
T ss_pred             cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccC
Confidence            67889999999998754  489999999999999999999999987555554444332111                  1


Q ss_pred             CC--------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          140 PG--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       140 p~--------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +.        .++...++++.+||.+||. +|.+|||+.|+|+||||+.
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            10        1223357889999999999 9999999999999999964

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=267.10  Aligned_cols=178  Identities=24%  Similarity=0.398  Sum_probs=137.2

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      +|+|.+++.+. +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC---------
T ss_pred             ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCcccccccCCcccccc
Confidence            47999999875 45999999999999999999999998  9999999999999887 79999999999765432 23345


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc---CCCCCccc------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GKLPGAFH------------  144 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~---g~~p~~~~------------  144 (502)
                      .+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+. +..+....+..   ...+..++            
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            689999999998754  4899999999999999999999999874 43333333321   11111111            


Q ss_pred             -------------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCCCCC
Q 010730          145 -------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPL  185 (502)
Q Consensus       145 -------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~~~l  185 (502)
                                   ...++++++||.+||. ||.+|||++|+|+||||........
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence                         1246789999999999 9999999999999999986654443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=274.32  Aligned_cols=177  Identities=24%  Similarity=0.403  Sum_probs=148.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+...  ..
T Consensus       140 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~  216 (355)
T 1vzo_A          140 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETER  216 (355)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGG
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCeecccCCCCc
Confidence            6789999999998889999999999999999999999998  9999999999999887 79999999999865322  22


Q ss_pred             cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCC---CChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~---~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ....+||+.|+|||++.+   .++.++|||||||++|+|++|..||...   .....+.+.+.....  .++...+..++
T Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  294 (355)
T 1vzo_A          217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK  294 (355)
T ss_dssp             GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred             ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccCHHHH
Confidence            345689999999998864   3788999999999999999999999642   234556666555443  23445678999


Q ss_pred             HHHHHhhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       153 ~LI~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      +||.+||. ||.+||     +++|+++||||+...+
T Consensus       295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            99999998 999999     9999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=1.2e-31  Score=264.22  Aligned_cols=173  Identities=27%  Similarity=0.424  Sum_probs=136.3

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      .|+|.+++... +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-------
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccCcccccccc
Confidence            46999999874 67999999999999999999999998  9999999999999877 79999999999766432 22345


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC-C----------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP-G----------------  141 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p-~----------------  141 (502)
                      .+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+.+.+.. +..+ .                
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence            679999999998854  4899999999999999999999999875444433332211 0000 0                


Q ss_pred             --------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          142 --------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       142 --------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                              .+....+.++++||.+||. ||.+|||++|+|+||||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                    0112357889999999999 9999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=7.2e-32  Score=269.95  Aligned_cols=178  Identities=29%  Similarity=0.461  Sum_probs=150.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+.  +.+||+|||++........
T Consensus        95 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  172 (322)
T 2ycf_A           95 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL  172 (322)
T ss_dssp             CCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc
Confidence            5778999999998889999999999999999999999998  99999999999998652  3599999999987755444


Q ss_pred             cccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--cccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~~~~~~s~~l~  152 (502)
                      .....||+.|+|||++.    ..++.++|||||||++|+|++|..||........+...+..+..+.  ..+...+..+.
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (322)
T 2ycf_A          173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL  252 (322)
T ss_dssp             HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHH
Confidence            45578999999999873    4588999999999999999999999987555545556666555432  22334578999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +||.+||. ||.+||++.++|+||||+..
T Consensus       253 ~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          253 DLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            99999999 99999999999999999753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=9.8e-32  Score=261.59  Aligned_cols=174  Identities=26%  Similarity=0.493  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..........
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-----
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCCCccee
Confidence            5678999999998889999999999999999999999998  9999999999999877 799999999998765544455


Q ss_pred             cccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .+..++++.+..+..+  ++...+..+.++|.+|
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~  245 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHM  245 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHH
Confidence            67899999999998764 3 5799999999999999999999976 5667777777776542  3345578999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+|||+.|+|+||||+..
T Consensus       246 l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          246 LQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             TCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccCChhhCCCHHHHHhChhhccC
Confidence            99 99999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=1.4e-31  Score=265.86  Aligned_cols=172  Identities=24%  Similarity=0.418  Sum_probs=141.2

Q ss_pred             CCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+...   .++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++......
T Consensus       142 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~  218 (332)
T 3qd2_B          142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDE  218 (332)
T ss_dssp             CCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC-
T ss_pred             ecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccch
Confidence            5789999999987644   566678999999999999999998  9999999999999877 799999999998765432


Q ss_pred             -------------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc
Q 010730           78 -------------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF  143 (502)
Q Consensus        78 -------------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~  143 (502)
                                   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..|+.   ....+...+..+..+..+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~  295 (332)
T 3qd2_B          219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLF  295 (332)
T ss_dssp             -------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHH
T ss_pred             hhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCccc
Confidence                         2234679999999998864 58999999999999999999877752   334555566666655333


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      . ..++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus       296 ~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          296 T-QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             H-HHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             c-cCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            2 335778999999999 9999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=1.2e-31  Score=282.43  Aligned_cols=176  Identities=26%  Similarity=0.387  Sum_probs=134.2

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-----   77 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-----   77 (502)
                      .+|+|.+++...+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+....     
T Consensus       139 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~~  215 (458)
T 3rp9_A          139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQ  215 (458)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCBCTTSCTTCCCC
T ss_pred             cccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccchhccCccccccc
Confidence            57899999999889999999999999999999999998  9999999999999987 799999999998754211     


Q ss_pred             -----------------------CcccccCCCcccCcccc-c-cCCCCcccchhHHHHHHHHhh-----------ccCCC
Q 010730           78 -----------------------QAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLT-----------SEYPY  121 (502)
Q Consensus        78 -----------------------~~~s~vGTp~Y~APEvl-~-~~ys~~~DIWSLGviLyeLLT-----------G~~Pf  121 (502)
                                             .....+||+.|+|||++ . ..|+.++||||||||+|||++           |.++|
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f  295 (458)
T 3rp9_A          216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF  295 (458)
T ss_dssp             CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSC
T ss_pred             cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccC
Confidence                                   23456899999999975 3 459999999999999999999           67777


Q ss_pred             CCCCC--------------------hHHHHHHhh-cCCC--------------------C-------CcccccccHHHHH
Q 010730          122 SECSN--------------------PAQIYKKVT-SGKL--------------------P-------GAFHRIQDAEARR  153 (502)
Q Consensus       122 ~~~~~--------------------~~ql~~kI~-~g~~--------------------p-------~~~~~~~s~~l~~  153 (502)
                      .+...                    ..++...+. -|..                    +       .......++++.+
T Consensus       296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  375 (458)
T 3rp9_A          296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIH  375 (458)
T ss_dssp             C--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHH
T ss_pred             CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHH
Confidence            55321                    111110000 0000                    0       0111234789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      ||.+||. ||.+|||++|+|+||||+...
T Consensus       376 Ll~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          376 LLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            9999999 999999999999999998643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=3.1e-31  Score=288.45  Aligned_cols=178  Identities=26%  Similarity=0.460  Sum_probs=152.9

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+.    ..+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ |.+||+|||+++.+...
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeecceeeeccCC
Confidence            67899999999874    36999999999999999999999998  9999999999999987 79999999999887544


Q ss_pred             CC-cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC---ChHHHHHHhhcCCCCCcccccccHHH
Q 010730           77 QQ-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        77 ~~-~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~---~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      .. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....   ...++++.+..+..  .++...++.+
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~~  420 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSPAS  420 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCHHH
Confidence            33 345689999999998865 59999999999999999999999997642   45677887776654  3445568899


Q ss_pred             HHHHHHhhh-CcCCCCC-----HHHHhcCCCCcCCCCC
Q 010730          152 RRFVGKCLE-NVSKRLP-----AKELLLDPFLASDAGE  183 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpS-----a~ELL~hPff~~~~~~  183 (502)
                      ++||.+||. ||.+||+     +++++.||||+...+.
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            999999999 9999996     5899999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=9.2e-32  Score=286.09  Aligned_cols=171  Identities=29%  Similarity=0.381  Sum_probs=131.4

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++..  .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++...........+
T Consensus       150 ~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~  224 (464)
T 3ttj_A          150 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  224 (464)
T ss_dssp             SEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC-----CCCC----
T ss_pred             CCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeeeecCCCcccCCCc
Confidence            4567777753  5999999999999999999999998  9999999999999987 799999999998876655567789


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC---------------------
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP---------------------  140 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p---------------------  140 (502)
                      ||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.....++.+.+.. |..+                     
T Consensus       225 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~  304 (464)
T 3ttj_A          225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY  304 (464)
T ss_dssp             CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCC
T ss_pred             ccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccccc
Confidence            9999999998764 5999999999999999999999999875443333322211 1000                     


Q ss_pred             ------Ccccc-----------cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          141 ------GAFHR-----------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       141 ------~~~~~-----------~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                            ..++.           ..++++++||.+||. ||.+|||++|+|+||||+.
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                  00000           015679999999999 9999999999999999973

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=5.4e-31  Score=276.55  Aligned_cols=177  Identities=25%  Similarity=0.325  Sum_probs=134.8

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-----   77 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-----   77 (502)
                      .+|+|.++++....+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++......     
T Consensus       112 ~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~  188 (432)
T 3n9x_A          112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIV  188 (432)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEEC---------
T ss_pred             CCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC-CCEEEccCCCccccccccccccc
Confidence            46799999999888999999999999999999999998  9999999999999887 799999999998764321     


Q ss_pred             ------------------CcccccCCCcccCcccc-c-cCCCCcccchhHHHHHHHHhhcc-----------CCCCCCCC
Q 010730           78 ------------------QAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLTSE-----------YPYSECSN  126 (502)
Q Consensus        78 ------------------~~~s~vGTp~Y~APEvl-~-~~ys~~~DIWSLGviLyeLLTG~-----------~Pf~~~~~  126 (502)
                                        .....+||+.|+|||++ . ..|+.++||||||||+|+|++|.           ++|.+...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~  268 (432)
T 3n9x_A          189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC  268 (432)
T ss_dssp             ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCS
T ss_pred             ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccc
Confidence                              23567899999999975 3 45999999999999999999843           33333210


Q ss_pred             -----------------hHHH-----------------------HHHhhcCCC--CCc---ccccccHHHHHHHHHhhh-
Q 010730          127 -----------------PAQI-----------------------YKKVTSGKL--PGA---FHRIQDAEARRFVGKCLE-  160 (502)
Q Consensus       127 -----------------~~ql-----------------------~~kI~~g~~--p~~---~~~~~s~~l~~LI~kcL~-  160 (502)
                                       ..++                       .+.+.....  +..   .....++++.+||.+||. 
T Consensus       269 ~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  348 (432)
T 3n9x_A          269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKF  348 (432)
T ss_dssp             CC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred             cccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcC
Confidence                             1111                       111111111  000   112357899999999999 


Q ss_pred             CcCCCCCHHHHhcCCCCcCCCC
Q 010730          161 NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       161 dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      ||.+|||++|+|+||||+...+
T Consensus       349 dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          349 NPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             STTTSCCHHHHHTCGGGTTTCC
T ss_pred             CcccCCCHHHHhcChhhhhccC
Confidence            9999999999999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=3.2e-31  Score=257.27  Aligned_cols=170  Identities=22%  Similarity=0.364  Sum_probs=140.1

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------------------
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------   58 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~------------------   58 (502)
                      |+.||+|.+++.+.    +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+                  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            57799999999765    67999999999999999999999998  9999999999999732                  


Q ss_pred             CCcEEEEecCCceeccCCCCcccccCCCcccCccccccC--CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc
Q 010730           59 LGQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS  136 (502)
Q Consensus        59 ~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~~--ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~  136 (502)
                      ...+||+|||++......   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+|+...    ..+..+..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~  242 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQ  242 (289)
T ss_dssp             CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHT
T ss_pred             ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHc
Confidence            247999999999876542   234699999999988654  557999999999999999999877542    33555566


Q ss_pred             CCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       137 g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +..+ .++...+..++++|.+||. ||.+|||+.|+|+||||+..
T Consensus       243 ~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            6554 3445568899999999999 99999999999999999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=2e-31  Score=274.23  Aligned_cols=174  Identities=22%  Similarity=0.339  Sum_probs=137.5

Q ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEEecCCceeccCCCCcc
Q 010730            4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         4 gGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~-~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      +|+|.+++...  +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|||+++....  ...
T Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~  216 (382)
T 2vx3_A          139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIY  216 (382)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCC
T ss_pred             CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccc
Confidence            57999999875  4699999999999999999999975455999999999999953 236899999999987643  345


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCCC----------------
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG----------------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p~----------------  141 (502)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+. +..+.+.++..  +..+.                
T Consensus       217 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  295 (382)
T 2vx3_A          217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA-NEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL  295 (382)
T ss_dssp             SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEEC
T ss_pred             cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhc
Confidence            6789999999998865 5899999999999999999999999874 33333333322  11100                


Q ss_pred             --ccc------------------------------------------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCC
Q 010730          142 --AFH------------------------------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF  176 (502)
Q Consensus       142 --~~~------------------------------------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPf  176 (502)
                        ..+                                          ....+++++||.+||. ||.+|||++|+|+|||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~  375 (382)
T 2vx3_A          296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF  375 (382)
T ss_dssp             TTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcc
Confidence              000                                          0001478999999999 9999999999999999


Q ss_pred             CcCC
Q 010730          177 LASD  180 (502)
Q Consensus       177 f~~~  180 (502)
                      |+..
T Consensus       376 f~~~  379 (382)
T 2vx3_A          376 FKKT  379 (382)
T ss_dssp             GCC-
T ss_pred             cccC
Confidence            9754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.6e-31  Score=272.28  Aligned_cols=171  Identities=27%  Similarity=0.408  Sum_probs=140.9

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +++|.++++. +.+++..++.++.||+.||+|||++|  |+||||||+|||++.+ +.+||+|||+++....  .....+
T Consensus       113 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~--~~~~~~  186 (367)
T 1cm8_A          113 GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADS--EMTGYV  186 (367)
T ss_dssp             SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCS--SCCSSC
T ss_pred             CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeeeccccccc--ccCcCc
Confidence            8899999987 57999999999999999999999998  9999999999999987 7999999999987543  345678


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC--------------------
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP--------------------  140 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p--------------------  140 (502)
                      ||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+.....++...+.. +..+                    
T Consensus       187 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  266 (367)
T 1cm8_A          187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP  266 (367)
T ss_dssp             SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred             CCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCC
Confidence            9999999998754  5899999999999999999999999874443333222211 1111                    


Q ss_pred             ----C---cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 ----G---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 ----~---~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          .   ......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                0   1112347889999999999 99999999999999999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=3.2e-31  Score=278.61  Aligned_cols=173  Identities=27%  Similarity=0.380  Sum_probs=138.6

Q ss_pred             CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEEecCCceeccCCCC
Q 010730            3 TSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--IKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         3 tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~--vKL~DFGlA~~~~~~~~   78 (502)
                      .+|+|.+++...+  .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.  +||+|||++.....  .
T Consensus       181 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~~~~--~  255 (429)
T 3kvw_A          181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVIDFGSSCYEHQ--R  255 (429)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEECCCTTCEETTC--C
T ss_pred             cCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEeecccceecCC--c
Confidence            3689999998754  4999999999999999999999998  9999999999999876 45  99999999976543  3


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC----------------
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG----------------  141 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~----------------  141 (502)
                      ..+.+||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+......+...+.....|.                
T Consensus       256 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~  335 (429)
T 3kvw_A          256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSS  335 (429)
T ss_dssp             CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCT
T ss_pred             ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCC
Confidence            456789999999998764 599999999999999999999999987544333322221100000                


Q ss_pred             ----------------------------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          142 ----------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       142 ----------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                                              .+....++.+.+||.+||. ||.+|||++|+|+||||+..
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             TSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             CCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence                                                    0111236789999999999 99999999999999999854

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=259.23  Aligned_cols=174  Identities=26%  Similarity=0.494  Sum_probs=123.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+.+|+|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEECC-----
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceeeccCCCCc
Confidence            57789999999875 67999999999999999999999998  9999999999999877 79999999999876432 22


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ......+.....  ..+...+.+++++|.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-KNTLNKVVLADY--EMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-C-----CCSSCC--CCCTTSCHHHHHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH-HHHHHHHhhccc--CCccccCHHHHHHHHH
Confidence            345679999999998864 488899999999999999999999976433 333334333322  2344567899999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          158 CLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ||. ||.+|||+.++|+||||...
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HcccCHhhCCCHHHHhcCccccCC
Confidence            998 99999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=3.1e-31  Score=262.87  Aligned_cols=175  Identities=24%  Similarity=0.465  Sum_probs=150.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl---~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||++   +.+ +.+||+|||++..... .
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~  162 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G  162 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence            5679999999998889999999999999999999999998  9999999999999   444 7899999999976433 2


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+..+  ...+...+..+++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence            3345679999999998865 589999999999999999999999976 5667777777776543  33345568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |.+||. ||.+|||+.|+|+||||+..
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCC
Confidence            999999 99999999999999999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=2.5e-31  Score=259.66  Aligned_cols=176  Identities=22%  Similarity=0.435  Sum_probs=146.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~---g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+.   ..+||+|||++.......
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~  166 (283)
T 3bhy_A           89 LVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN  166 (283)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence            5679999999998888999999999999999999999998  99999999999997652   279999999998776555


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+..+....+......  .......+..+++|
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (283)
T 3bhy_A          167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKDF  245 (283)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred             cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCCHHHHHH
Confidence            555678999999999886 4589999999999999999999999976 4556666666655442  22234457889999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |.+||. +|.+|||+.|+|+||||+.
T Consensus       246 i~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          246 IRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            999998 9999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=3e-31  Score=263.99  Aligned_cols=175  Identities=22%  Similarity=0.414  Sum_probs=144.9

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC---
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ---   78 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~---   78 (502)
                      +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.  +.+||+|||++..+.....   
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~~~~~~  184 (313)
T 3cek_A          109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV  184 (313)
T ss_dssp             CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSCC---------
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC--CeEEEeeccccccccCcccccc
Confidence            357899999999999999999999999999999999998  999999999999974  6899999999987643221   


Q ss_pred             cccccCCCcccCcccccc------------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           79 AHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~------------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      .....||+.|+|||++.+            .++.++|||||||++|+|++|..||....+.......+........++..
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  264 (313)
T 3cek_A          185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI  264 (313)
T ss_dssp             -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred             ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCccc
Confidence            234679999999998754            58889999999999999999999998766665556666555544455566


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+..++++|.+||. +|.+||++.|+|+||||+..
T Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             chHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            68899999999999 99999999999999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=3.5e-31  Score=259.63  Aligned_cols=179  Identities=32%  Similarity=0.558  Sum_probs=143.9

Q ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+||+++...+.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            567899999998752   4679999999999999999999998  99999999999999744799999999998764322


Q ss_pred             -CcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                       ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.....................++...+.++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence             2345679999999998854   378999999999999999999999976544443332322222223445556889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +|.+||. +|.+||++.++|+||||+...
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999 999999999999999997543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=5.9e-31  Score=266.41  Aligned_cols=174  Identities=22%  Similarity=0.391  Sum_probs=139.7

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-----C
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-----Q   77 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-----~   77 (502)
                      +|+|.+++... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+...     .
T Consensus       107 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~  183 (351)
T 3mi9_A          107 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN  183 (351)
T ss_dssp             SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCCCSSSSCC
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEccchhccccccccccccc
Confidence            46888888764 67999999999999999999999998  9999999999999877 79999999999876422     2


Q ss_pred             CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCCC-ccccc------
Q 010730           78 QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG-AFHRI------  146 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p~-~~~~~------  146 (502)
                      .....+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+. +.......+..  +..+. .++..      
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  262 (351)
T 3mi9_A          184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWPNVDNYELY  262 (351)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGCGGG
T ss_pred             ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhhccccccchhh
Confidence            2345689999999998854  4899999999999999999999999874 43333333322  22221 11111      


Q ss_pred             ---------------------ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          147 ---------------------QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       147 ---------------------~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                           .++.+++||.+||. ||.+|||++|+|+||||....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence                                 26779999999999 999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.6e-31  Score=262.82  Aligned_cols=177  Identities=29%  Similarity=0.507  Sum_probs=154.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+  .+.+||+|||++........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            5679999999988889999999999999999999999998  9999999999999754  24799999999987665555


Q ss_pred             cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc--cccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~--~~~~s~~l~~LI~  156 (502)
                      .....||+.|+|||++.+.++.++||||||+++|+|++|..||.+ .+..++.+.+..+..+...  ....+.+++++|.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            556679999999999988899999999999999999999999976 5667777777777654332  2346789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +||. +|.+|||+.|+|+||||+..
T Consensus       259 ~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          259 KMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999 99999999999999999743

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.6e-31  Score=263.37  Aligned_cols=178  Identities=26%  Similarity=0.423  Sum_probs=138.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccccc
Confidence            5778999999998889999999999999999999999998  9999999999999877 79999999999876533 233


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh--cC------------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT--SG------------------  137 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~--~g------------------  137 (502)
                      ...+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+.....  ..                  
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            45689999999998854  589999999999999999999999987544433322111  00                  


Q ss_pred             CCCCc--------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          138 KLPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       138 ~~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      ..+..        .....+..+.+||.+||. ||.+|||++|+|+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            01100        002346789999999999 999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=7.2e-31  Score=258.60  Aligned_cols=175  Identities=29%  Similarity=0.494  Sum_probs=151.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus        96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCceecccCcccc
Confidence            5778999999998889999999999999999999999998  9999999999999977 79999999999876532 234


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ....+.+..+..+..  .++...+..+.++|.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM  249 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHHHHHHHHHH
Confidence            45679999999998865 488999999999999999999999976 555666666666554  23445678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. +|.+|||+.|+|+||||....
T Consensus       250 l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          250 LQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             cccChhhCcCHHHHhhChheecCC
Confidence            99 999999999999999997543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=5.4e-31  Score=266.33  Aligned_cols=175  Identities=26%  Similarity=0.333  Sum_probs=138.6

Q ss_pred             CcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            5 GTLREYR----KKYTRVDIRAVKNWARQILRGIAYLH--GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         5 GsL~~yi----~k~~~L~e~~i~~i~~QIL~gL~YLH--s~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+|...+    .....+++..++.++.||+.||.|||  +++  |+||||||+|||++...+.+||+|||++..+.....
T Consensus       110 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~  187 (360)
T 3e3p_A          110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP  187 (360)
T ss_dssp             CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC
T ss_pred             ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC
Confidence            4554444    35677999999999999999999999  666  999999999999997447999999999988766555


Q ss_pred             cccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC---------------
Q 010730           79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP---------------  140 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p---------------  140 (502)
                      ....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.. ....+..+.. ...+               
T Consensus       188 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3e3p_A          188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQLHEIVRVLGCPSREVLRKLNPSHTDV  266 (360)
T ss_dssp             CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCTTCCCG
T ss_pred             cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-hHHHHHHHHHHcCCCCHHHHHhcccchhhc
Confidence            666789999999998753  38999999999999999999999998744 3333333321 0000               


Q ss_pred             --------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          141 --------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       141 --------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                                    .......+.++++||.+||. ||.+|||+.|+|+||||+....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          267 DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                          00111135789999999999 9999999999999999986543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=263.79  Aligned_cols=176  Identities=27%  Similarity=0.514  Sum_probs=141.4

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~   77 (502)
                      |+.+|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++...... .
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~  184 (326)
T 2x7f_A          108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG  184 (326)
T ss_dssp             CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEECCCTTTC-------
T ss_pred             cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEEeeCcCceecCcCcc
Confidence            56789999999875  57999999999999999999999998  9999999999999876 79999999999765432 2


Q ss_pred             CcccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           78 QAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+. +.......+.....+.......+..+
T Consensus       185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  263 (326)
T 2x7f_A          185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWSKKF  263 (326)
T ss_dssp             ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCSCHHH
T ss_pred             ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCccccCHHH
Confidence            234567999999999874      35889999999999999999999999774 44444445555554444455568899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++||.+||. +|.+||++.++|+||||+..
T Consensus       264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          264 QSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            999999998 99999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=6.6e-31  Score=265.46  Aligned_cols=175  Identities=29%  Similarity=0.494  Sum_probs=151.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus       122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred             cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCceecccCcccc
Confidence            5788999999998889999999999999999999999998  9999999999999987 79999999999876532 234


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+..+..  .++...+..+++||.+|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHH
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHH
Confidence            45679999999998864 488999999999999999999999976 555666666666554  23445678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      |. ||.+|||+.|+|+||||....
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ccCChhHCcCHHHHhcCccccCCC
Confidence            99 999999999999999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=7e-31  Score=261.10  Aligned_cols=172  Identities=22%  Similarity=0.355  Sum_probs=138.2

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------------------CCcEE
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------LGQIK   63 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~------------------~g~vK   63 (502)
                      +|+|.+++...+  ++++..++.++.||+.||+|||+++  |+||||||+|||++..                  .+.+|
T Consensus       100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~k  177 (339)
T 1z57_A          100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK  177 (339)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEE
T ss_pred             CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCce
Confidence            899999998765  6899999999999999999999998  9999999999999762                  25799


Q ss_pred             EEecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCC
Q 010730           64 IGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP  140 (502)
Q Consensus        64 L~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p  140 (502)
                      |+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+....+..  +..|
T Consensus       178 l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~p  254 (339)
T 1z57_A          178 VVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-SKEHLAMMERILGPLP  254 (339)
T ss_dssp             ECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-HHHHHHHHHHHHCSCC
T ss_pred             EeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Confidence            999999987543  2345689999999998864 58999999999999999999999997743 3332222211  1111


Q ss_pred             Cc----------------------------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          141 GA----------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       141 ~~----------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ..                                        .....+..+.+||.+||. ||.+|||+.|+|+||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            10                                        011224678999999999 9999999999999999975


Q ss_pred             C
Q 010730          180 D  180 (502)
Q Consensus       180 ~  180 (502)
                      .
T Consensus       335 ~  335 (339)
T 1z57_A          335 L  335 (339)
T ss_dssp             G
T ss_pred             H
Confidence            3

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=4.2e-32  Score=278.86  Aligned_cols=163  Identities=15%  Similarity=0.171  Sum_probs=133.5

Q ss_pred             CCcHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            4 SGTLREYRKKYTRVDI-------RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e-------~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      +|+|.+++.+.+.+++       ..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.... 
T Consensus       183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~-  258 (377)
T 3byv_A          183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA-  258 (377)
T ss_dssp             SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCGGGCEETTC-
T ss_pred             CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEEechhheecCC-
Confidence            7999999987666666       788889999999999999998  9999999999999977 7999999999986432 


Q ss_pred             CCcccccCCCcccCcccccc------------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc
Q 010730           77 QQAHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH  144 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~------------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~  144 (502)
                       .....+| +.|+|||++.+            .|+.++|||||||++|+|++|..||.+. +....+..+...      .
T Consensus       259 -~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~~------~  329 (377)
T 3byv_A          259 -RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD-AALGGSEWIFRS------C  329 (377)
T ss_dssp             -EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGGSS------C
T ss_pred             -cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccc-ccccchhhhhhh------c
Confidence             3456678 99999998864            5899999999999999999999999763 222222222221      1


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ...++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus       330 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            3457899999999999 9999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=1.8e-31  Score=271.10  Aligned_cols=176  Identities=29%  Similarity=0.528  Sum_probs=143.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+. +  |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~  187 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  187 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-C-
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCcccccc-cc
Confidence            578999999999988999999999999999999999985 7  9999999999999987 79999999999765322 23


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHH----------------------------
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI----------------------------  130 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql----------------------------  130 (502)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||... +..++                            
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC-----------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            45689999999998864 5899999999999999999999999753 32222                            


Q ss_pred             --------------HHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          131 --------------YKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       131 --------------~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                    .+.+.....+.......+.++++||.+||. ||.+|||++|+|+||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                          222333333333334457899999999999 999999999999999997543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=1.2e-31  Score=267.34  Aligned_cols=180  Identities=26%  Similarity=0.391  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---   77 (502)
                      |+.||+|.+++...+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+....   
T Consensus        97 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~  173 (311)
T 3ork_A           97 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSV  173 (311)
T ss_dssp             CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC----------
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCccccccccccc
Confidence            5779999999998889999999999999999999999998  9999999999999987 799999999998664322   


Q ss_pred             -CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRF  154 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l~~L  154 (502)
                       .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......++.+.....+. ......+.++.++
T Consensus       174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (311)
T 3ork_A          174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV  253 (311)
T ss_dssp             --------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHH
T ss_pred             ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHH
Confidence             2234679999999998864 589999999999999999999999987444444454444443332 2233467899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      |.+||. ||.+||++.++|.|+|++.....
T Consensus       254 i~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          254 VLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             HHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            999998 99999999999999999754433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=258.50  Aligned_cols=177  Identities=29%  Similarity=0.524  Sum_probs=146.8

Q ss_pred             CCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010730            1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~-k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~   78 (502)
                      |+.+|+|.+++. ....+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++....... .
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSC
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccchhhhhhccc
Confidence            567899999997 4678999999999999999999999998  9999999999999877 799999999998765432 2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~~~~~~~s~~l~~LI~  156 (502)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........++ .+..... ....+...+..+.+||.
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCCcccCCcccCCHHHHHHHH
Confidence            345679999999998764 58999999999999999999999998744333333 3333322 22234456789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +||. +|.+|||+.++|+||||+...
T Consensus       261 ~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHccCChhhCcCHHHHHhCHHHhcCC
Confidence            9998 999999999999999997643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.4e-31  Score=267.35  Aligned_cols=162  Identities=28%  Similarity=0.433  Sum_probs=130.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecCCceeccCCC-----CcccccCCCcccC
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQIKIGDLGLAAILRGSQ-----QAHSVIGTPEFMA   90 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~-g~vKL~DFGlA~~~~~~~-----~~~s~vGTp~Y~A   90 (502)
                      +++..++.++.||+.||+|||+++  |+||||||+|||++.+. +.+||+|||++..+....     ......||+.|+|
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            467889999999999999999998  99999999999997652 379999999998763311     2345689999999


Q ss_pred             ccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHHHHhhh-CcCC
Q 010730           91 PELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFVGKCLE-NVSK  164 (502)
Q Consensus        91 PEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI~kcL~-dP~k  164 (502)
                      ||++.   ..++.++|||||||++|+|++|..||.+. +..+....+..+...  .......++.+++||.+||. +|.+
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV-NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-ChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            99885   45889999999999999999999999874 444555555554432  22333468899999999999 9999


Q ss_pred             CCCHHHHhcCCCCcCCC
Q 010730          165 RLPAKELLLDPFLASDA  181 (502)
Q Consensus       165 RpSa~ELL~hPff~~~~  181 (502)
                      ||++.|+|+||||+...
T Consensus       322 Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          322 RFDAMRALQHPWISQFS  338 (345)
T ss_dssp             SCCHHHHHHSHHHHTTS
T ss_pred             CCCHHHHhcChhhccCh
Confidence            99999999999997643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.4e-30  Score=259.40  Aligned_cols=174  Identities=33%  Similarity=0.486  Sum_probs=142.6

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +|+|.+++.+..  .+++..++.++.||+.||.|||++|  |+||||||+||+++.+ +.+||+|||++...........
T Consensus       102 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~  178 (326)
T 1blx_A          102 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS  178 (326)
T ss_dssp             SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCC
T ss_pred             CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEEecCcccccccCCCCccc
Confidence            479999998754  4999999999999999999999998  9999999999999877 7999999999987654444556


Q ss_pred             ccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC-CCC-------------------
Q 010730           82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP-------------------  140 (502)
Q Consensus        82 ~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g-~~p-------------------  140 (502)
                      ..||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ...+..+... ..+                   
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 1blx_A          179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK  257 (326)
T ss_dssp             CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC
T ss_pred             cccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCcccCccccccchhhhccc
Confidence            78999999999875 4589999999999999999999999987443 3333333210 000                   


Q ss_pred             -----CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          141 -----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       141 -----~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                           ..+....+..+++||.+||. ||.+|||+.|+|+||||+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                 01223457889999999999 999999999999999997543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=255.79  Aligned_cols=172  Identities=22%  Similarity=0.411  Sum_probs=145.8

Q ss_pred             CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---CCc
Q 010730            5 GTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---QQA   79 (502)
Q Consensus         5 GsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~~~   79 (502)
                      |+|.+++..  .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++......   ...
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~  168 (305)
T 2wtk_C           92 CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTC  168 (305)
T ss_dssp             EEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCSSCEE
T ss_pred             CCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeeccccccccCcccccccc
Confidence            448888876  456999999999999999999999998  9999999999999877 79999999999876432   223


Q ss_pred             ccccCCCcccCccccccC---CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           80 HSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~---ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ....||+.|+|||++.+.   ++.++|||||||++|+|++|..||.+ .+..+++..+..+..+  ++...++.+.+||.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~  245 (305)
T 2wtk_C          169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYA--IPGDCGPPLSDLLK  245 (305)
T ss_dssp             CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCC--CCSSSCHHHHHHHH
T ss_pred             ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCCC--CCCccCHHHHHHHH
Confidence            456799999999988642   47799999999999999999999976 6677778887776553  34456789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      +||. ||.+|||+.|+++||||+....
T Consensus       246 ~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          246 GMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHccCChhhCCCHHHHhcCcccccCCC
Confidence            9999 9999999999999999986544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=1.8e-30  Score=260.23  Aligned_cols=171  Identities=21%  Similarity=0.378  Sum_probs=136.2

Q ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE-------------------eCCCCcE
Q 010730            4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-------------------NGHLGQI   62 (502)
Q Consensus         4 gGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl-------------------~~~~g~v   62 (502)
                      +|+|.+++....  .+++..++.++.||+.||+|||+++  |+||||||+|||+                   +.+ +.+
T Consensus       105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~-~~~  181 (355)
T 2eu9_A          105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN-TSI  181 (355)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC-CCE
T ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCC-CcE
Confidence            788888887653  7999999999999999999999998  9999999999999                   333 789


Q ss_pred             EEEecCCceeccCCCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCC
Q 010730           63 KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL  139 (502)
Q Consensus        63 KL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~  139 (502)
                      ||+|||+++....  .....+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+..  +..
T Consensus       182 kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~  258 (355)
T 2eu9_A          182 RVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-LVMMEKILGPI  258 (355)
T ss_dssp             EECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred             EEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCC
Confidence            9999999986543  234568999999999875 4689999999999999999999999987443322 222111  121


Q ss_pred             CCc----------------------------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          140 PGA----------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       140 p~~----------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      |..                                        .....+..+.+||.+||. ||.+|||+.|+|+||||+
T Consensus       259 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA  338 (355)
T ss_dssp             CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred             cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            110                                        001124578899999999 999999999999999998


Q ss_pred             CC
Q 010730          179 SD  180 (502)
Q Consensus       179 ~~  180 (502)
                      ..
T Consensus       339 ~~  340 (355)
T 2eu9_A          339 GL  340 (355)
T ss_dssp             GC
T ss_pred             CC
Confidence            54

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.5e-31  Score=273.91  Aligned_cols=173  Identities=14%  Similarity=0.213  Sum_probs=134.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAV------KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i------~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+. |+|.+++... ..+....+      ..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++..
T Consensus       169 ~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DFG~a~~~  244 (371)
T 3q60_A          169 AAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLGDVSALWKV  244 (371)
T ss_dssp             CCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTT-SCEEECCGGGEEET
T ss_pred             CCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCC-CCEEEEecceeeec
Confidence            344 8999999864 33444444      566799999999999999  9999999999999987 79999999999876


Q ss_pred             cCCCCcccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCCCCh-HHHHHH---hh--cCCCCCccc
Q 010730           74 RGSQQAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNP-AQIYKK---VT--SGKLPGAFH  144 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~-~ql~~k---I~--~g~~p~~~~  144 (502)
                      ..  ......||+.|+|||++.+   .|+.++|||||||++|+|+||..||.+.... ...+..   ..  .........
T Consensus       245 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (371)
T 3q60_A          245 GT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC  322 (371)
T ss_dssp             TC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTS
T ss_pred             CC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhc
Confidence            43  2225667899999998864   5899999999999999999999999764211 111111   01  111111222


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ...++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus       323 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            3568899999999998 9999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=7.6e-31  Score=267.38  Aligned_cols=171  Identities=28%  Similarity=0.398  Sum_probs=134.5

Q ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCC---------------------
Q 010730            4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHL---------------------   59 (502)
Q Consensus         4 gGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~---------------------   59 (502)
                      +|+|.+++.+.  +.+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.                     
T Consensus       128 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~  205 (397)
T 1wak_A          128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP  205 (397)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred             CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence            77888888664  5699999999999999999999998 8  99999999999998652                     


Q ss_pred             ---------------------------CcEEEEecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHH
Q 010730           60 ---------------------------GQIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV  111 (502)
Q Consensus        60 ---------------------------g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviL  111 (502)
                                                 ..+||+|||++.....  .....+||+.|+|||++.+ .|+.++|||||||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  283 (397)
T 1wak_A          206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA  283 (397)
T ss_dssp             -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred             CCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHH
Confidence                                       2799999999987643  2445689999999998864 499999999999999


Q ss_pred             HHHhhccCCCCCCCC-----hHHHHHHhh--cCCCCC--------------------------------------ccccc
Q 010730          112 LEMLTSEYPYSECSN-----PAQIYKKVT--SGKLPG--------------------------------------AFHRI  146 (502)
Q Consensus       112 yeLLTG~~Pf~~~~~-----~~ql~~kI~--~g~~p~--------------------------------------~~~~~  146 (502)
                      |+|+||..||.....     .......+.  .+..|.                                      .+...
T Consensus       284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (397)
T 1wak_A          284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE  363 (397)
T ss_dssp             HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHH
T ss_pred             HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchh
Confidence            999999999975332     111111111  011110                                      01122


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+..+++||.+||. ||.+|||++|+|+||||+
T Consensus       364 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          364 EAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence            34678899999999 999999999999999996

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=1.3e-30  Score=266.56  Aligned_cols=170  Identities=29%  Similarity=0.521  Sum_probs=143.9

Q ss_pred             CCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~-k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|+|.+++. ..+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++.....   ....
T Consensus       137 ~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~---~~~~  210 (348)
T 1u5q_A          137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---ANSF  210 (348)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---BCCC
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCceecCC---CCcc
Confidence            478888885 4567999999999999999999999998  9999999999999987 7999999999976543   3456


Q ss_pred             cCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        83 vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      +||+.|+|||++.    +.++.++|||||||++|+|++|..||.+......++ .+..+..+.......+..+++||.+|
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            8999999999873    468999999999999999999999998754444444 44445444444556688999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+|||+.++|+||||...
T Consensus       290 l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             cccChhhCcCHHHHhhChhhhcc
Confidence            99 99999999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=4.3e-31  Score=271.13  Aligned_cols=170  Identities=30%  Similarity=0.419  Sum_probs=127.8

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++.  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++...........+
T Consensus       113 ~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~  187 (371)
T 2xrw_A          113 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  187 (371)
T ss_dssp             SEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC--------------
T ss_pred             CCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecccccccccccCCce
Confidence            578999986  46999999999999999999999998  9999999999999987 799999999998765544455678


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CC-------------------c
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PG-------------------A  142 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~-------------------~  142 (502)
                      ||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ..+.+.++..... +.                   .
T Consensus       188 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (371)
T 2xrw_A          188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK  266 (371)
T ss_dssp             --CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred             ecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence            9999999998764 58999999999999999999999998744 4344444432211 00                   0


Q ss_pred             ---------c-----------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          143 ---------F-----------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       143 ---------~-----------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                               +           ....+..+++||.+||. ||.+|||++|+|+||||+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                     0           00115679999999999 9999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=7.3e-31  Score=272.13  Aligned_cols=177  Identities=30%  Similarity=0.422  Sum_probs=129.6

Q ss_pred             CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEEecCCc
Q 010730            3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---GHLGQIKIGDLGLA   70 (502)
Q Consensus         3 tgGsL~~yi~k~---------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~---~~~g~vKL~DFGlA   70 (502)
                      .+|+|.+++...         ..+++..++.++.||+.||.|||+++  |+||||||+|||+.   ...+.+||+|||++
T Consensus       102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            457888888632         24999999999999999999999999  99999999999993   22378999999999


Q ss_pred             eeccCC----CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCC---------hHHHHHHhh
Q 010730           71 AILRGS----QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSN---------PAQIYKKVT  135 (502)
Q Consensus        71 ~~~~~~----~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---------~~ql~~kI~  135 (502)
                      +.+...    ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.....         ..++...+.
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            876432    22355789999999998864  489999999999999999999999965322         122222221


Q ss_pred             c-CCCC-Ccccc---------------------------------cccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          136 S-GKLP-GAFHR---------------------------------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       136 ~-g~~p-~~~~~---------------------------------~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      . +..+ ..+..                                 ..+..+.+||.+||. ||.+|||++|+|+||||..
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~  339 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE  339 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence            1 1111 11110                                 115688999999999 9999999999999999986


Q ss_pred             CC
Q 010730          180 DA  181 (502)
Q Consensus       180 ~~  181 (502)
                      ..
T Consensus       340 ~~  341 (405)
T 3rgf_A          340 DP  341 (405)
T ss_dssp             SS
T ss_pred             CC
Confidence            53

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=1.6e-30  Score=260.82  Aligned_cols=171  Identities=29%  Similarity=0.489  Sum_probs=136.7

Q ss_pred             CCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++.+.+.   +++..++.++.||+.||+|||+++++|+||||||+|||++.+ +.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCccccccc
Confidence            6789999999987654   999999999999999999999998789999999999999887 799999999997654322


Q ss_pred             -CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++...+........++...++.+.+||
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  272 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAII  272 (309)
T ss_dssp             --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence             2345689999999998865 489999999999999999999999976 5566666666544444455566789999999


Q ss_pred             HHhhh-CcCCCCCHHHHhc
Q 010730          156 GKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+||. +|.+|||+.++++
T Consensus       273 ~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          273 EGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            99999 9999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=5.8e-31  Score=263.02  Aligned_cols=172  Identities=23%  Similarity=0.406  Sum_probs=140.9

Q ss_pred             CCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl----~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|.+++.....   +++..++.++.||+.||+|||+++  |+||||||+|||+    +.+ +.+||+|||+++..
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAREL  166 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEEccCCCceec
Confidence            5789999999986543   999999999999999999999998  9999999999998    444 57999999999987


Q ss_pred             cCCCCcccccCCCcccCccccc---------cCCCCcccchhHHHHHHHHhhccCCCCCCCC---hHHHHHHhhcCCCCC
Q 010730           74 RGSQQAHSVIGTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPG  141 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~---------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---~~ql~~kI~~g~~p~  141 (502)
                      .........+||+.|+|||++.         ..++.++|||||||++|+|++|..||.....   ..++..++..+..+.
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  246 (319)
T 4euu_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG  246 (319)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred             CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence            7666666778999999999874         4689999999999999999999999964332   234444444433221


Q ss_pred             -----------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCC
Q 010730          142 -----------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       142 -----------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hP  175 (502)
                                             .+....+..+.+||.+||. ||.+|||++|+|+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                                   1122335678999999999 999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-30  Score=263.70  Aligned_cols=174  Identities=22%  Similarity=0.314  Sum_probs=140.4

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~~s   81 (502)
                      .|+|.+++... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+... .....
T Consensus        95 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~  171 (346)
T 1ua2_A           95 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTH  171 (346)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCC
T ss_pred             CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEecccceeccCCcccCCc
Confidence            46899998765 46999999999999999999999999  9999999999999887 79999999999876432 23455


Q ss_pred             ccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCC-Ccc-------------
Q 010730           82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP-GAF-------------  143 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p-~~~-------------  143 (502)
                      .+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.. ..+.+..+..  +..+ ..+             
T Consensus       172 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T 1ua2_A          172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  250 (346)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence            789999999998853  48899999999999999999999997744 3333333322  1111 111             


Q ss_pred             ----------cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          144 ----------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       144 ----------~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                ....+..+++||.+||. ||.+|||+.|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                      12346789999999999 999999999999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=1.2e-30  Score=257.14  Aligned_cols=176  Identities=31%  Similarity=0.481  Sum_probs=142.6

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~   78 (502)
                      |+.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..... ...
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHHHHC
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCCCccccccccc
Confidence            5789999999876 567999999999999999999999998  9999999999999876 7999999998754321 112


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC-cccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~s~~l  151 (502)
                      .....||+.|+|||++.      ..++.++|||||||++|+|++|..||.. .+.......+..+..+. ..+...+..+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  252 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSDPPTLLTPSKWSVEF  252 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHhccCCcccCCccccCHHH
Confidence            23467999999999872      4588999999999999999999999977 44445555555444332 2344567899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .++|.+||. +|.+|||+.++|+||||+..
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            999999998 99999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=8.6e-31  Score=263.66  Aligned_cols=176  Identities=24%  Similarity=0.504  Sum_probs=150.0

Q ss_pred             CCCCCcHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730            1 MFTSGTLREY------RKK--YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~y------i~k--~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.++      +.+  ...+++..++.++.||+.||.|||+ ++  |+||||||+||+++.+ +.+||+|||++.
T Consensus       124 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~  200 (348)
T 2pml_X          124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN-GRVKLSDFGESE  200 (348)
T ss_dssp             CCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             ccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCC-CcEEEecccccc
Confidence            5778999998      665  5779999999999999999999999 88  9999999999999877 799999999998


Q ss_pred             eccCCCCcccccCCCcccCccccccC--CCC-cccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc----
Q 010730           72 ILRGSQQAHSVIGTPEFMAPELYEED--YNE-LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH----  144 (502)
Q Consensus        72 ~~~~~~~~~s~vGTp~Y~APEvl~~~--ys~-~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~----  144 (502)
                      ..... ......||+.|+|||++.+.  ++. ++|||||||++|+|++|..||.......+++..+..+..+....    
T Consensus       201 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (348)
T 2pml_X          201 YMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF  279 (348)
T ss_dssp             ECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSS
T ss_pred             ccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhh
Confidence            76543 34557899999999988654  555 89999999999999999999988666578888887765532211    


Q ss_pred             -------------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          145 -------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       145 -------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                   ...+..+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                         4467899999999999 99999999999999999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=2e-30  Score=262.93  Aligned_cols=175  Identities=27%  Similarity=0.435  Sum_probs=135.6

Q ss_pred             CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCC-----CCcEEEEecCCceecc
Q 010730            3 TSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGH-----LGQIKIGDLGLAAILR   74 (502)
Q Consensus         3 tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~-----~g~vKL~DFGlA~~~~   74 (502)
                      .+|+|.+++.+.  +.+++..++.++.||+.||+|||++ +  |+||||||+|||++..     .+.+||+|||++....
T Consensus       112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~  189 (373)
T 1q8y_A          112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD  189 (373)
T ss_dssp             CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccC
Confidence            389999999874  4599999999999999999999998 8  9999999999999532     2479999999998764


Q ss_pred             CCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC-----hHHHHHHhhc--CCCCC-----
Q 010730           75 GSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-----PAQIYKKVTS--GKLPG-----  141 (502)
Q Consensus        75 ~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~-----~~ql~~kI~~--g~~p~-----  141 (502)
                      .  .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.....     .......+..  +..|.     
T Consensus       190 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  267 (373)
T 1q8y_A          190 E--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN  267 (373)
T ss_dssp             B--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             C--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhc
Confidence            3  2345689999999998865 589999999999999999999999975321     1111111110  11111     


Q ss_pred             ---------------------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          142 ---------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       142 ---------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                                       .++...+.++++||.+||. ||.+|||++|+|+||||+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             cchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence                                             1122335788999999999 999999999999999998643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2e-30  Score=260.42  Aligned_cols=164  Identities=21%  Similarity=0.413  Sum_probs=139.1

Q ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccC
Q 010730            5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIG   84 (502)
Q Consensus         5 GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vG   84 (502)
                      |+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||++...... ......|
T Consensus       134 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~g  210 (320)
T 3a99_A          134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDG  210 (320)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCS
T ss_pred             ccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCC
Confidence            899999998889999999999999999999999998  9999999999999955579999999999876543 3445679


Q ss_pred             CCcccCcccccc-C-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-C
Q 010730           85 TPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-N  161 (502)
Q Consensus        85 Tp~Y~APEvl~~-~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-d  161 (502)
                      |+.|+|||++.+ . ++.++|||||||++|+|++|..||..   ...    +..+..  .+....+.++++||.+||. +
T Consensus       211 t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~~~--~~~~~~~~~~~~li~~~l~~d  281 (320)
T 3a99_A          211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQV--FFRQRVSSECQHLIRWCLALR  281 (320)
T ss_dssp             CGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCCC--CCSSCCCHHHHHHHHHHTCSS
T ss_pred             CccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhcccc--cccccCCHHHHHHHHHHccCC
Confidence            999999998864 3 46789999999999999999999965   222    222222  2334567899999999998 9


Q ss_pred             cCCCCCHHHHhcCCCCcCC
Q 010730          162 VSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       162 P~kRpSa~ELL~hPff~~~  180 (502)
                      |.+|||+.|+++||||+..
T Consensus       282 p~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          282 PSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             GGGSCCHHHHHTSGGGSSC
T ss_pred             hhhCcCHHHHhcCHhhcCc
Confidence            9999999999999999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=5.1e-31  Score=265.11  Aligned_cols=177  Identities=29%  Similarity=0.460  Sum_probs=139.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.+++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+... ...
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceeecCCcccc
Confidence            5678899999888888999999999999999999999998  9999999999999877 79999999999765432 233


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CC------------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK------------------  138 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~------------------  138 (502)
                      ...+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......++..+.. +.                  
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            45689999999998865  5889999999999999999999999875554444433221 10                  


Q ss_pred             -CCCc--------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          139 -LPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       139 -~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                       .+..        .....+..+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             0100        011347889999999999 99999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=2e-30  Score=254.85  Aligned_cols=178  Identities=28%  Similarity=0.525  Sum_probs=138.5

Q ss_pred             CCCCCcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKK--------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k--------~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.||+|.+++..        .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEEEeccchhe
Confidence            5779999999974        456999999999999999999999998  9999999999999877 7999999999876


Q ss_pred             ccCCC------CcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC----
Q 010730           73 LRGSQ------QAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP----  140 (502)
Q Consensus        73 ~~~~~------~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p----  140 (502)
                      .....      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||........+...+......    
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG  250 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence            54321      1234679999999998863  58999999999999999999999998755444443333322111    


Q ss_pred             ---CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          141 ---GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       141 ---~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                         .......+..++++|.+||. ||.+||++.|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence               11223457889999999999 999999999999999997543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=2.2e-30  Score=264.48  Aligned_cols=174  Identities=27%  Similarity=0.403  Sum_probs=139.3

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC----C
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ----Q   78 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~----~   78 (502)
                      .+|+|.++++. +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++.......    .
T Consensus       112 ~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~  187 (364)
T 3qyz_A          112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGF  187 (364)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCT
T ss_pred             cCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCcceEecCCCCCcccc
Confidence            45799999976 46999999999999999999999998  9999999999999887 799999999998764322    2


Q ss_pred             cccccCCCcccCccccc-c-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC---------------
Q 010730           79 AHSVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP---------------  140 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p---------------  140 (502)
                      ....+||+.|+|||++. . .++.++|||||||++|+|++|..||.+......+...+.. +..+               
T Consensus       188 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  267 (364)
T 3qyz_A          188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY  267 (364)
T ss_dssp             TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred             ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence            34568999999999764 3 4899999999999999999999999875443333222110 0000               


Q ss_pred             ---------C---cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 ---------G---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 ---------~---~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                               .   ......++++.+||.+||. ||.+|||+.|+|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                     0   0112347889999999999 99999999999999999754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=9.9e-31  Score=269.52  Aligned_cols=172  Identities=30%  Similarity=0.411  Sum_probs=125.6

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .+++|.++++. +.+++..++.++.||+.||.|||++|  |+||||||+|||++.+ +.+||+|||+++....  .....
T Consensus       116 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~  189 (367)
T 2fst_X          116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTAD--EMTGY  189 (367)
T ss_dssp             CCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC----------------
T ss_pred             cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeeccccccccc--cCCCc
Confidence            47899999876 67999999999999999999999998  9999999999999987 7999999999976543  23457


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC--------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL--------------------  139 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~--------------------  139 (502)
                      +||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+.....++...+.. +..                    
T Consensus       190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~  269 (367)
T 2fst_X          190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL  269 (367)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred             CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence            89999999998764  5899999999999999999999999875443333222111 110                    


Q ss_pred             ---C-Ccc---cccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 ---P-GAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 ---p-~~~---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                         + ..+   ....++.+.+||.+||. ||.+|||+.|+|.||||+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence               0 000   11246789999999999 99999999999999999754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.8e-30  Score=252.80  Aligned_cols=173  Identities=32%  Similarity=0.512  Sum_probs=138.1

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---   76 (502)
                      |+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++......   
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~  172 (303)
T 1zy4_A           96 YCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDI  172 (303)
T ss_dssp             CCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCCCSCTTC----
T ss_pred             cCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEEEeeCcchhhcccccch
Confidence            567899999998654 5889999999999999999999998  9999999999999877 79999999999765421   


Q ss_pred             ------------CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCC--CC
Q 010730           77 ------------QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LP  140 (502)
Q Consensus        77 ------------~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~--~p  140 (502)
                                  .......||+.|+|||++.+  .++.++|||||||++|+|++   ||....+..++...+....  +|
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 1zy4_A          173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP  249 (303)
T ss_dssp             ---------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCC
T ss_pred             hccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccC
Confidence                        12345679999999998864  58999999999999999998   6654344455666665543  34


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ..+....+..++++|.+||. ||.+|||+.++|+||||+.
T Consensus       250 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            44555567789999999999 9999999999999999964

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=4.2e-30  Score=254.23  Aligned_cols=174  Identities=31%  Similarity=0.577  Sum_probs=148.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.+|+|.+++.+ +++++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++..+.... ..
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCCB
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeecccceecCcccccc
Confidence            5778999999965 57999999999999999999999998  9999999999999877 799999999998765433 23


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++...+..+..+ .+....+..+++||.+|
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~  254 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEAC  254 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCC-CCCSSCCHHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCCC-CCccccCHHHHHHHHHH
Confidence            45689999999998864 588999999999999999999999976 4555555555555443 34455678999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcCC
Q 010730          159 LE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      |. +|.+|||+.|+|+||||...
T Consensus       255 l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          255 LNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             CCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             cCCChhhCcCHHHHhhChhhhcC
Confidence            98 99999999999999999643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=4.8e-30  Score=258.68  Aligned_cols=174  Identities=25%  Similarity=0.393  Sum_probs=137.7

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC------
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ------   77 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~------   77 (502)
                      +|+|.+++.. +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++..+....      
T Consensus        97 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~  172 (353)
T 2b9h_A           97 QTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEP  172 (353)
T ss_dssp             SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECC---------
T ss_pred             CccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEecccccccccccccccCc
Confidence            4799999987 57999999999999999999999998  9999999999999887 799999999998764321      


Q ss_pred             -----CcccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC----------
Q 010730           78 -----QAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL----------  139 (502)
Q Consensus        78 -----~~~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~----------  139 (502)
                           .....+||+.|+|||++.  ..++.++|||||||++|+|++|..||.+......+...... +..          
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
T 2b9h_A          173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE  252 (353)
T ss_dssp             -------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCC
T ss_pred             cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccc
Confidence                 123457999999999874  45899999999999999999999999874433332221110 000          


Q ss_pred             --------------CC----cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          140 --------------PG----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       140 --------------p~----~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                    +.    ......++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                          00    0112457889999999999 999999999999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=1.3e-30  Score=264.13  Aligned_cols=177  Identities=21%  Similarity=0.405  Sum_probs=122.7

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+.+  .+++..++.++.||+.||.|||+++  |+||||||+|||++.+  .+.+||+|||++..... 
T Consensus       107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-  183 (336)
T 3fhr_A          107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-  183 (336)
T ss_dssp             CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence            578999999998764  6999999999999999999999998  9999999999999753  35699999999987643 


Q ss_pred             CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChH---HHHHHhhcCC--CCCcccccccHH
Q 010730           77 QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA---QIYKKVTSGK--LPGAFHRIQDAE  150 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~---ql~~kI~~g~--~p~~~~~~~s~~  150 (502)
                      ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.......   .+...+..+.  .+...+...+..
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED  263 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred             cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence            2345578999999999885 458899999999999999999999996532211   1122222222  223333456889


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +++||.+||. ||.+|||+.|+|+||||+..
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          264 AKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            9999999998 99999999999999999753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.7e-30  Score=255.65  Aligned_cols=168  Identities=24%  Similarity=0.441  Sum_probs=140.6

Q ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         2 ~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++...+.+||+|||++...... ....
T Consensus       121 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~  197 (312)
T 2iwi_A          121 LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTD  197 (312)
T ss_dssp             SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCC
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccc
Confidence            578999999998888999999999999999999999998  9999999999999944479999999999876543 3455


Q ss_pred             ccCCCcccCcccccc-CC-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           82 VIGTPEFMAPELYEE-DY-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        82 ~vGTp~Y~APEvl~~-~y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ..||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..   ..++    .....  .++...+..++++|.+||
T Consensus       198 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~----~~~~~--~~~~~~~~~~~~li~~~l  268 (312)
T 2iwi_A          198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEI----LEAEL--HFPAHVSPDCCALIRRCL  268 (312)
T ss_dssp             CCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHTCC--CCCTTSCHHHHHHHHHHT
T ss_pred             cCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC---hHHH----hhhcc--CCcccCCHHHHHHHHHHc
Confidence            679999999998854 34 4589999999999999999999965   2222    22222  233456789999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCcCCC
Q 010730          160 E-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      . +|.+|||+.|+|+||||+...
T Consensus       269 ~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          269 APKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             CSSTTTSCCHHHHHHSTTTCC--
T ss_pred             cCChhhCcCHHHHhcChhhcCch
Confidence            8 999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=1.3e-30  Score=254.03  Aligned_cols=176  Identities=28%  Similarity=0.450  Sum_probs=146.2

Q ss_pred             CCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHD---PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----~~L~e~~i~~i~~QIL~gL~YLHs~g---~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|.+++.+.    ..+++..++.++.||+.||.|||+++   .+|+||||||+||+++.+ +.+||+|||++...
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARIL  166 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCHHHHC
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCchheee
Confidence            56789999999754    34999999999999999999999876   349999999999999877 79999999999765


Q ss_pred             cCCCC-cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           74 RGSQQ-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        74 ~~~~~-~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..++...+..+..+ .++...+.++
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l  244 (279)
T 2w5a_A          167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDEL  244 (279)
T ss_dssp             ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred             ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCcccCHHH
Confidence            43222 234679999999998864 588999999999999999999999976 5567777788777664 3344567899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +++|.+||. +|.+||++.|+|+|+|+..
T Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          245 NEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             HHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            999999999 9999999999999999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=3.1e-30  Score=257.45  Aligned_cols=180  Identities=20%  Similarity=0.350  Sum_probs=134.3

Q ss_pred             CCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYT------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++....      .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++...
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~-~~~kl~Dfg~a~~~~  188 (323)
T 3qup_A          112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLSRKIY  188 (323)
T ss_dssp             CCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred             eccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-CCEEEeecccccccc
Confidence            578999999996543      5999999999999999999999998  9999999999999887 799999999998764


Q ss_pred             CCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           75 GSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        75 ~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+..+++..+..+..+ ..+...+.
T Consensus       189 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  266 (323)
T 3qup_A          189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYLIGGNRL-KQPPECME  266 (323)
T ss_dssp             ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred             ccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-cChHHHHHHHhcCCCC-CCCCccCH
Confidence            3322   123457889999998864 58999999999999999999 9999977 4555666666665543 23345578


Q ss_pred             HHHHHHHHhhh-CcCCCCC-------HHHHhcCCCCcCCCCCCC
Q 010730          150 EARRFVGKCLE-NVSKRLP-------AKELLLDPFLASDAGEPL  185 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpS-------a~ELL~hPff~~~~~~~l  185 (502)
                      .+++||.+||. ||.+|||       +++++.|||+......++
T Consensus       267 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          267 EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence            99999999999 9999999       778889999976554443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=3.8e-30  Score=261.09  Aligned_cols=173  Identities=24%  Similarity=0.363  Sum_probs=130.8

Q ss_pred             CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         4 gGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      +|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++............
T Consensus       117 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~  193 (362)
T 3pg1_A          117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHY  193 (362)
T ss_dssp             SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCTTC-------------
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCEEEEecCccccccccccccee
Confidence            47899998764 46999999999999999999999998  9999999999999876 79999999999866555555567


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CC---------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK---------------------  138 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~---------------------  138 (502)
                      +||+.|+|||++.+  .++.++|||||||++|+|++|..||.+. +.......+.. ..                     
T Consensus       194 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (362)
T 3pg1_A          194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS-TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRN  272 (362)
T ss_dssp             --CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTT
T ss_pred             cccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHh
Confidence            89999999998764  5899999999999999999999999874 33333333321 00                     


Q ss_pred             ----CCC----cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          139 ----LPG----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       139 ----~p~----~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          .+.    ......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          273 SLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                000    0112346789999999999 99999999999999999754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=3.4e-30  Score=260.40  Aligned_cols=154  Identities=23%  Similarity=0.374  Sum_probs=131.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCccc
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ---QAHSVIGTPEFMAPEL   93 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~---~~~s~vGTp~Y~APEv   93 (502)
                      +++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+....   ......||+.|+|||+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence            899999999999999999999998  9999999999999876 789999999998664322   2234678999999998


Q ss_pred             cc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHH
Q 010730           94 YE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE  170 (502)
Q Consensus        94 l~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~E  170 (502)
                      +. ..++.++|||||||++|+|+| |..||.+......+...+..+..+ ..+...++++.++|.+||. +|.+|||+.|
T Consensus       267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  345 (359)
T 3vhe_A          267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  345 (359)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            75 558999999999999999998 999998866667777776665543 3445568899999999999 9999999999


Q ss_pred             HhcC
Q 010730          171 LLLD  174 (502)
Q Consensus       171 LL~h  174 (502)
                      +++|
T Consensus       346 ll~~  349 (359)
T 3vhe_A          346 LVEH  349 (359)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=1.1e-29  Score=261.57  Aligned_cols=169  Identities=27%  Similarity=0.427  Sum_probs=143.5

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.+                .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||
T Consensus       168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kl  244 (370)
T 2psq_A          168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI  244 (370)
T ss_dssp             CCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEE
T ss_pred             cCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEECCC-CCEEE
Confidence            678999999998754                4899999999999999999999998  9999999999999877 79999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++.+....   ......||+.|+|||++.+ .|+.++|||||||++|+|+| |..||.+ ....+++..+..+..
T Consensus       245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~  323 (370)
T 2psq_A          245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR  323 (370)
T ss_dssp             CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCC
T ss_pred             ccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCC
Confidence            9999998765432   2234567899999998754 58999999999999999999 9999977 456667777776654


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+..+.++|.+||. +|.+||++.|++++
T Consensus       324 ~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          324 M-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 3344567899999999998 99999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=6.3e-30  Score=253.39  Aligned_cols=173  Identities=28%  Similarity=0.502  Sum_probs=135.7

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS   81 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s   81 (502)
                      ++.+..++.. .+.+++..++.++.||+.||.|||+. +  |+||||||+||+++.+ +.+||+|||++..+........
T Consensus       107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  183 (318)
T 2dyl_A          107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDR  183 (318)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC-----------
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchhccCCccccc
Confidence            5566666654 57899999999999999999999984 8  9999999999999877 7999999999987655444556


Q ss_pred             ccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc-ccccccHHHHHH
Q 010730           82 VIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-FHRIQDAEARRF  154 (502)
Q Consensus        82 ~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~-~~~~~s~~l~~L  154 (502)
                      ..||+.|+|||++.      ..++.++|||||||++|+|++|..||.......++...+..+..+.. .....+..+.+|
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  263 (318)
T 2dyl_A          184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF  263 (318)
T ss_dssp             ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred             cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence            78999999999873      34889999999999999999999999887777777777766554322 223457899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |.+||. ||.+||++.++|+||||+.
T Consensus       264 i~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          264 VKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhhCHHHHh
Confidence            999998 9999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=4.3e-30  Score=253.89  Aligned_cols=173  Identities=25%  Similarity=0.375  Sum_probs=138.2

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----CCc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----QQA   79 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----~~~   79 (502)
                      +|+|.+++.+ +++++..++.++.||+.||+|||+++  |+||||||+|||++...+.+||+|||++......    ...
T Consensus       105 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  181 (320)
T 2i6l_A          105 ETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL  181 (320)
T ss_dssp             SEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CC
T ss_pred             CCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccc
Confidence            4799999965 67999999999999999999999998  9999999999999865578999999999865422    223


Q ss_pred             ccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-----------------
Q 010730           80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-----------------  140 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-----------------  140 (502)
                      ....||+.|+|||++.  ..++.++|||||||++|+|++|..||.+.. ..+.+..+......                 
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (320)
T 2i6l_A          182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILESIPVVHEEDRQELLSVIPVYI  260 (320)
T ss_dssp             CGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHH
T ss_pred             ccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCchhhhhhhhhcCcccc
Confidence            4467899999999774  458999999999999999999999998743 33333333221100                 


Q ss_pred             -----------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 -----------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 -----------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                 .......+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          261 RNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             cccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                       00112357889999999999 99999999999999999754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=1e-29  Score=249.56  Aligned_cols=171  Identities=16%  Similarity=0.233  Sum_probs=138.3

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC----CcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL----GQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~----g~vKL~DFGlA~~~~~   75 (502)
                      |+ +|+|.+++...+ ++++..++.++.||+.||+|||+++  |+||||||+|||++.+.    +.+||+|||++.....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            45 999999998754 5999999999999999999999998  99999999999997651    2399999999987654


Q ss_pred             CCC--------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCC---
Q 010730           76 SQQ--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPG---  141 (502)
Q Consensus        76 ~~~--------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~---  141 (502)
                      ...        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..  ...+.+..+.....+.   
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  243 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence            321        345679999999998865 58999999999999999999999997642  3445555554332211   


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ......+..++++|.+||. +|.+||++++|++.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1222457899999999999 99999999998874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=4.5e-30  Score=257.06  Aligned_cols=174  Identities=27%  Similarity=0.447  Sum_probs=122.6

Q ss_pred             CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            4 SGTLREYRKK-----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         4 gGsL~~yi~k-----~~~L~e~~i~~i~~QIL~gL~YLHs~-g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      .|+|.+++..     ...+++..++.++.||+.||.|||+. +  |+||||||+|||++.+ +.+||+|||++..+....
T Consensus       104 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             SEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEECCCSSSCC-----
T ss_pred             CCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEccCCCceeccccc
Confidence            4688888864     57799999999999999999999998 8  9999999999999987 799999999998765544


Q ss_pred             CcccccCCCcccCccccc-----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC---CcccccccH
Q 010730           78 QAHSVIGTPEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---GAFHRIQDA  149 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p---~~~~~~~s~  149 (502)
                      ......||+.|+|||++.     ..++.++|||||||++|+|++|..||.......+....+..+..+   .......++
T Consensus       181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3aln_A          181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP  260 (327)
T ss_dssp             -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCH
T ss_pred             ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCH
Confidence            444558999999999873     348999999999999999999999997754433444444444332   122234678


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+.+||.+||. ||.+|||+.++|+||||...
T Consensus       261 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          261 SFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            99999999999 99999999999999999643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=1.2e-29  Score=260.30  Aligned_cols=170  Identities=29%  Similarity=0.425  Sum_probs=133.3

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++.  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++....  .....+
T Consensus       130 ~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~--~~~~~~  202 (371)
T 4exu_A          130 QTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYV  202 (371)
T ss_dssp             CEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC----------CTT
T ss_pred             cccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccccccc--CcCCcc
Confidence            478888874  35999999999999999999999998  9999999999999987 7999999999976543  234568


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC---------------------
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---------------------  140 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p---------------------  140 (502)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+...+.....+                     
T Consensus       203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (371)
T 4exu_A          203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP  282 (371)
T ss_dssp             CCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSC
T ss_pred             cCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccC
Confidence            9999999998764  58999999999999999999999998744333332222111110                     


Q ss_pred             ----C---cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 ----G---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 ----~---~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          .   ......++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                0   0112347899999999999 99999999999999999754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=3.8e-29  Score=245.10  Aligned_cols=171  Identities=25%  Similarity=0.418  Sum_probs=142.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----IKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~-----vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++++|+||||||+|||++.+ +.     +||+|||+++...
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~Dfg~~~~~~  180 (287)
T 4f0f_A          102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVADFGLSQQSV  180 (287)
T ss_dssp             CCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEECCCTTCBCCS
T ss_pred             ecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeCCCCcccccc
Confidence            57889999998764 47999999999999999999999998779999999999999765 34     9999999997543


Q ss_pred             CCCCcccccCCCcccCccccc---cCCCCcccchhHHHHHHHHhhccCCCCCCCCh-HHHHHHhhcCCCCCcccccccHH
Q 010730           75 GSQQAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP-AQIYKKVTSGKLPGAFHRIQDAE  150 (502)
Q Consensus        75 ~~~~~~s~vGTp~Y~APEvl~---~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~-~ql~~kI~~g~~p~~~~~~~s~~  150 (502)
                      .  ......||+.|+|||++.   ..++.++|||||||++|+|++|..||...... ......+.....+..++...++.
T Consensus       181 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (287)
T 4f0f_A          181 H--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR  258 (287)
T ss_dssp             S--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             c--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHH
Confidence            2  344578999999999883   34788999999999999999999999765433 33344555555555566667899


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +.++|.+||. ||.+|||+.|+++.
T Consensus       259 l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          259 LRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999 99999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.9e-29  Score=253.92  Aligned_cols=170  Identities=23%  Similarity=0.323  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 010730            1 MFTSGTLREYRKKYT-----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG   57 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~   57 (502)
                      |+.+|+|.+++....                       .+++..++.++.||+.||+|||+++  |+||||||+|||++.
T Consensus       130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~  207 (344)
T 1rjb_A          130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH  207 (344)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred             cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcC
Confidence            578999999998753                       3799999999999999999999998  999999999999998


Q ss_pred             CCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHH
Q 010730           58 HLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYK  132 (502)
Q Consensus        58 ~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~  132 (502)
                      + +.+||+|||++..+.....   .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+..
T Consensus       208 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  286 (344)
T 1rjb_A          208 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK  286 (344)
T ss_dssp             T-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             C-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHH
Confidence            7 7999999999987643322   23456789999999875 568999999999999999998 9999988666666666


Q ss_pred             HhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       133 kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus       287 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          287 LIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            66655332 3445568899999999999 99999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=7.6e-30  Score=253.17  Aligned_cols=173  Identities=26%  Similarity=0.437  Sum_probs=134.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++.......  .
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCccccccccccc
Confidence            5789999999999899999999999999999999999998  9999999999999887 799999999997654332  2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC---cccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~---~~~~~~s~~l~~L  154 (502)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+........+.+ ....+.   ......+..+.++
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l  247 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSLSNV  247 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SSCCCCHHHHSCTTSCHHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hccCCCcchhcccCCCHHHHHH
Confidence            344679999999998865 48899999999999999999999998744333334433 333332   2334467899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      |.+||. +|.+||+..+.+.+.|.
T Consensus       248 i~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          248 ILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhcCCHhHccccHHHHHHHHH
Confidence            999999 99999954444444443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=2.3e-29  Score=248.88  Aligned_cols=169  Identities=24%  Similarity=0.390  Sum_probs=143.0

Q ss_pred             CCCCCcHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 010730            1 MFTSGTLREYRKKYTR------------------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN   56 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~------------------------L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~   56 (502)
                      |+.+|+|.+++.+.+.                        +++..++.++.||+.||.|||+++  |+||||||+|||++
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~  184 (314)
T 2ivs_A          107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA  184 (314)
T ss_dssp             CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE
T ss_pred             ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEc
Confidence            5779999999987644                        899999999999999999999998  99999999999999


Q ss_pred             CCCCcEEEEecCCceeccCCCC---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHH
Q 010730           57 GHLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY  131 (502)
Q Consensus        57 ~~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~  131 (502)
                      .+ +.+||+|||++........   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ ....+++
T Consensus       185 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~  262 (314)
T 2ivs_A          185 EG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPPERLF  262 (314)
T ss_dssp             TT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHH
T ss_pred             CC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence            76 7999999999987643322   233567899999998764 58999999999999999999 9999976 4556677


Q ss_pred             HHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       132 ~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus       263 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          263 NLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777666543 3444567899999999998 99999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=1.6e-29  Score=249.15  Aligned_cols=171  Identities=32%  Similarity=0.554  Sum_probs=136.3

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC---C
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG---S   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~---~   76 (502)
                      |+.+|+|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.....   .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceecccccccccc
Confidence            5788999999964 456999999999999999999999998  9999999999999987 7999999999976532   2


Q ss_pred             CCcccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc---cccccH
Q 010730           77 QQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF---HRIQDA  149 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~---~~~~s~  149 (502)
                      .......||+.|+|||++.    ..++.++|||||||++|+|++|..||.+..+...+...+..+..+..+   ....++
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK  256 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence            2234567999999999874    347889999999999999999999999878888888887777654433   334578


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+++||.+||. +|.+|||+.++++.
T Consensus       257 ~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHH
Confidence            99999999999 99999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=1.4e-29  Score=248.29  Aligned_cols=171  Identities=19%  Similarity=0.300  Sum_probs=136.5

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~--~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+ +|+|.+++.. .+.+++..++.++.||+.||+|||+++  |+||||||+|||++  ...+.+||+|||++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            45 8999999984 467999999999999999999999998  99999999999995  233789999999998765432


Q ss_pred             C--------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC--hHHHHHHhhcCCCCC---cc
Q 010730           78 Q--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPG---AF  143 (502)
Q Consensus        78 ~--------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--~~ql~~kI~~g~~p~---~~  143 (502)
                      .        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...  ..+.+..+.....+.   ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence            2        245689999999998865 589999999999999999999999976322  223333333222211   12


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ....++.+.++|.+||. +|.+|||+.++++.
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            23457889999999999 99999999998874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=2.1e-29  Score=245.23  Aligned_cols=168  Identities=29%  Similarity=0.480  Sum_probs=144.3

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  177 (284)
T 2a19_B          101 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGK  177 (284)
T ss_dssp             CCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEESSCCSC
T ss_pred             ccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-CCEEECcchhheecccccc
Confidence            56789999999764  67999999999999999999999998  9999999999999977 7999999999988766555


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK  157 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~k  157 (502)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+..   ....+..+..+..+    ...+..++++|.+
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~li~~  250 (284)
T 2a19_B          178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIIS----DIFDKKEKTLLQK  250 (284)
T ss_dssp             CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCCC----TTSCHHHHHHHHH
T ss_pred             ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccccc----ccCCHHHHHHHHH
Confidence            566789999999998864 589999999999999999999998743   34555566555443    3457889999999


Q ss_pred             hhh-CcCCCCCHHHHhcCCCCc
Q 010730          158 CLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       158 cL~-dP~kRpSa~ELL~hPff~  178 (502)
                      ||. ||.+|||+.|++++.+.-
T Consensus       251 ~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          251 LLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHHHHHH
Confidence            998 999999999999997653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=2.2e-29  Score=252.44  Aligned_cols=169  Identities=24%  Similarity=0.351  Sum_probs=142.0

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.+                .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC-CeEEE
Confidence            567999999998764                7999999999999999999999998  9999999999999876 79999


Q ss_pred             EecCCceeccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           65 GDLGLAAILRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      +|||+++............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+..+++..+..+..+ .
T Consensus       184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~-~  261 (327)
T 1fvr_A          184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E  261 (327)
T ss_dssp             CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCC-C
T ss_pred             cccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCCCC-C
Confidence            99999975433333344567899999998864 48999999999999999998 9999976 5667778887776443 2


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...+..++++|.+||. +|.+|||+.|++++
T Consensus       262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            334567899999999999 99999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=3.2e-29  Score=241.89  Aligned_cols=168  Identities=20%  Similarity=0.319  Sum_probs=139.5

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.+  .+++..++.++.||+.||.|||+++++|+||||||+||+++.+ +.++|+|||++...    .
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~----~  164 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF----Q  164 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT----S
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee----c
Confidence            578999999998765  4999999999999999999999988889999999999999876 78999999887543    2


Q ss_pred             cccccCCCcccCccccccC-C---CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEED-Y---NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~~-y---s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                      .....||+.|+|||++.+. +   +.++|||||||++|+|++|..||.+. +...+...+........++...++.+.++
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (271)
T 3kmu_A          165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGISPHVSKL  243 (271)
T ss_dssp             CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-CHHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred             ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-ChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            2346789999999988643 3   33799999999999999999999874 44444444444444445556678999999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.++++.
T Consensus       244 i~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          244 MKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999 99999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=1.8e-29  Score=253.63  Aligned_cols=170  Identities=24%  Similarity=0.376  Sum_probs=136.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH----------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~----------g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+++++. .+++..++.++.||+.||+|||+.          +  |+||||||+|||++.+ +.+||+|||++
T Consensus       103 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~~kL~DFg~a  178 (322)
T 3soc_A          103 FHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LTACIADFGLA  178 (322)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred             cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-CeEEEccCCcc
Confidence            57899999999774 599999999999999999999998          7  9999999999999887 79999999999


Q ss_pred             eeccCCCC---cccccCCCcccCcccccc------CCCCcccchhHHHHHHHHhhccCCCCCCC---------------C
Q 010730           71 AILRGSQQ---AHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECS---------------N  126 (502)
Q Consensus        71 ~~~~~~~~---~~s~vGTp~Y~APEvl~~------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~---------------~  126 (502)
                      +.+.....   ....+||+.|+|||++.+      .++.++|||||||++|+|+||..||.+..               .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            87654322   344689999999998864      35678899999999999999999996532               2


Q ss_pred             hHHHHHHhhcCCCCCcccc-----cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          127 PAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       127 ~~ql~~kI~~g~~p~~~~~-----~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ...+...+........+..     ..+.++.+||.+||. ||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3344444444433322222     123569999999999 99999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=3.6e-29  Score=242.86  Aligned_cols=169  Identities=21%  Similarity=0.386  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ 
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence            578999999998754 5999999999999999999999998  9999999999999887 7999999999987654322 


Q ss_pred             -cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....||+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .........+..+... ..+...++.+.++|
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  238 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLASDTIYQIM  238 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcChHHHHHHH
Confidence             223456778999998865 58999999999999999999 9999976 4555666666655433 33445678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.|++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999 99999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=5.5e-30  Score=254.54  Aligned_cols=166  Identities=25%  Similarity=0.410  Sum_probs=132.9

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.++++. .+.+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++........ 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceeccccccc
Confidence            6789999999987 567999999999999999999999999  9999999999999887 7999999999987643221 


Q ss_pred             --------------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH----HHHHhhcCCC
Q 010730           79 --------------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ----IYKKVTSGKL  139 (502)
Q Consensus        79 --------------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q----l~~kI~~g~~  139 (502)
                                    ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........    ........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence                          125689999999998865 589999999999999999999999865321100    01111111  


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                        ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus       243 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 --YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             --TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              1123346789999999999 9999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=257.64  Aligned_cols=169  Identities=27%  Similarity=0.420  Sum_probs=144.7

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++...+                .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||
T Consensus       156 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL  232 (382)
T 3tt0_A          156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI  232 (382)
T ss_dssp             CCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEE
T ss_pred             ecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEcCC-CcEEE
Confidence            578999999998754                4999999999999999999999998  9999999999999877 79999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ ....++.+.+..+..
T Consensus       233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~  311 (382)
T 3tt0_A          233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR  311 (382)
T ss_dssp             CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCC
T ss_pred             cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence            9999998764322   2334567899999998754 58999999999999999999 9999976 567778888777654


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+.++.+||.+||. +|.+|||++|++++
T Consensus       312 ~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          312 M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             C-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4 3344567899999999999 99999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=2.6e-29  Score=247.08  Aligned_cols=170  Identities=29%  Similarity=0.425  Sum_probs=133.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLH--------s~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.+|+|.+++++ ..+++..++.++.||+.||+|||        +++  |+||||||+|||++.+ +.+||+|||+++.
T Consensus        87 ~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~  162 (301)
T 3q4u_A           87 YHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQCCIADLGLAVM  162 (301)
T ss_dssp             CCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             hccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CCEEEeeCCCeee
Confidence            5789999999954 57999999999999999999999        777  9999999999999977 7999999999987


Q ss_pred             ccCCCC-----cccccCCCcccCccccccC-------CCCcccchhHHHHHHHHhhc----------cCCCCCCC----C
Q 010730           73 LRGSQQ-----AHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTS----------EYPYSECS----N  126 (502)
Q Consensus        73 ~~~~~~-----~~s~vGTp~Y~APEvl~~~-------ys~~~DIWSLGviLyeLLTG----------~~Pf~~~~----~  126 (502)
                      ......     ....+||+.|+|||++.+.       ++.++|||||||++|+|+||          ..||.+..    .
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~  242 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS  242 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence            654322     2345899999999988653       44689999999999999999          88886532    2


Q ss_pred             hHHHHHHhhcCCCCCccc-----ccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          127 PAQIYKKVTSGKLPGAFH-----RIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       127 ~~ql~~kI~~g~~p~~~~-----~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ...+.+.+........++     ...+..+.+||.+||. ||.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            233333333222221221     2235789999999998 99999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=1.8e-29  Score=247.16  Aligned_cols=169  Identities=19%  Similarity=0.317  Sum_probs=135.3

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE---eCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl---~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++  |+||||||+|||+   +.+ +.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEecCccceeccCc
Confidence            34 9999999985 467999999999999999999999999  9999999999999   444 78999999999876543


Q ss_pred             CC--------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC--hHHHHHHhhcCCCCCc---
Q 010730           77 QQ--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGA---  142 (502)
Q Consensus        77 ~~--------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--~~ql~~kI~~g~~p~~---  142 (502)
                      ..        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...  ..+.+..+.....+..   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            22        235689999999998865 589999999999999999999999976432  1222333322222111   


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .....+..+.++|.+||. +|.+|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            123347899999999999 9999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=1.8e-29  Score=254.09  Aligned_cols=169  Identities=26%  Similarity=0.456  Sum_probs=141.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTHHHHHTTTCC-
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEccCcceeEccCCccc
Confidence            5789999999987 457999999999999999999999998  9999999999999887 7999999999987654332 


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+ .+..++...+..+... ..+...+..+.++
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  251 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI  251 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHHHHH
T ss_pred             ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence              22345788999999875 458999999999999999999 9999976 4555566666655433 3344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.|++++
T Consensus       252 i~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          252 MVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999 99999999999976

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=1.6e-29  Score=250.29  Aligned_cols=170  Identities=22%  Similarity=0.368  Sum_probs=144.4

Q ss_pred             CCCCCcHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYTR----------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~----------------L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.....                +++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl  189 (316)
T 2xir_A          113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI  189 (316)
T ss_dssp             CCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred             cCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEE
Confidence            5778999999987654                899999999999999999999998  9999999999999876 78999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||++..+.....   .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+...+..+..
T Consensus       190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  269 (316)
T 2xir_A          190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR  269 (316)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred             CCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc
Confidence            99999987643322   23456899999999875 458999999999999999998 99999886666677777666554


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...++.+.++|.+||. +|.+|||+.|+++|
T Consensus       270 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          270 M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 3344567899999999999 99999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=2.9e-29  Score=252.26  Aligned_cols=168  Identities=18%  Similarity=0.266  Sum_probs=137.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----IKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~-----vKL~DFGlA~~~~   74 (502)
                      |+ +|+|.+++... +.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEcccceeee
Confidence            45 99999999874 67999999999999999999999998  9999999999999876 45     9999999998764


Q ss_pred             CCCC--------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCCCcc
Q 010730           75 GSQQ--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAF  143 (502)
Q Consensus        75 ~~~~--------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p~~~  143 (502)
                      ....        ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.  ....+.+..+.....+...
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            3322        246789999999998865 4899999999999999999999999764  3445556666443322111


Q ss_pred             ---cccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          144 ---HRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       144 ---~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                         .... +++.++|..||. +|.+||++.+|++
T Consensus       242 ~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 EVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence               1112 389999999999 9999999888775

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=1e-29  Score=255.34  Aligned_cols=169  Identities=24%  Similarity=0.411  Sum_probs=140.1

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+. +.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....  
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCSGGGGSCCCTTC
T ss_pred             eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCCcccccCccccc
Confidence            67899999999875 57999999999999999999999998  9999999999999876 799999999998764332  


Q ss_pred             -CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                       ......||+.|+|||++. +.++.++|||||||++|+|+| |..||.+ ....++...+..+..+ ..+...+..+.++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  249 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG-LRLAEVPDLLEKGERL-AQPQICTIDVYMV  249 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCTTHHHHHHHTTCBC-CCCTTBCTTTTHH
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCCC-CCCCcCcHHHHHH
Confidence             224456888999999886 569999999999999999999 9999976 4445566666655433 3334456789999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.+++++
T Consensus       250 i~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          250 MVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999 99999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=2.4e-29  Score=251.89  Aligned_cols=178  Identities=26%  Similarity=0.402  Sum_probs=133.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH---------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~---------g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.++++..+ +++..++.++.||+.||.|||++         +  |+||||||+|||++.+ +.+||+|||+++
T Consensus        93 ~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~kL~DFG~a~  168 (336)
T 3g2f_A           93 YYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-GTCVISDFGLSM  168 (336)
T ss_dssp             CCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             cCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-CcEEEeecccee
Confidence            578999999997754 58999999999999999999998         7  9999999999999987 799999999998


Q ss_pred             eccCCC---------CcccccCCCcccCcccccc--------CCCCcccchhHHHHHHHHhhccCCCCCCCC--------
Q 010730           72 ILRGSQ---------QAHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLTSEYPYSECSN--------  126 (502)
Q Consensus        72 ~~~~~~---------~~~s~vGTp~Y~APEvl~~--------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--------  126 (502)
                      .+....         .....+||+.|+|||++.+        .++.++|||||||++|+|++|..||.....        
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  248 (336)
T 3g2f_A          169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF  248 (336)
T ss_dssp             ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred             ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence            764321         1234679999999998864        366789999999999999999777643211        


Q ss_pred             ---------hHHHHHHhhcCCCCCcccc------cccHHHHHHHHHhhh-CcCCCCCHHHHh------cCCCCcCCCC
Q 010730          127 ---------PAQIYKKVTSGKLPGAFHR------IQDAEARRFVGKCLE-NVSKRLPAKELL------LDPFLASDAG  182 (502)
Q Consensus       127 ---------~~ql~~kI~~g~~p~~~~~------~~s~~l~~LI~kcL~-dP~kRpSa~ELL------~hPff~~~~~  182 (502)
                               ...+...+........++.      ..+..+.+||.+||. ||.+|||++|++      .++|.+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred             hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence                     1122222222222112221      134579999999999 999999999994      5677765443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=2.3e-29  Score=252.30  Aligned_cols=169  Identities=21%  Similarity=0.315  Sum_probs=142.7

Q ss_pred             CCCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 010730            1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN   56 (502)
Q Consensus         1 ~~tgGsL~~yi~k~------------------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~   56 (502)
                      |+.+|+|.+++.+.                        ..+++..++.++.||+.||.|||+++  |+||||||+|||++
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~  208 (343)
T 1luf_A          131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG  208 (343)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEC
Confidence            57899999999874                        57999999999999999999999998  99999999999998


Q ss_pred             CCCCcEEEEecCCceeccCC---CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHH
Q 010730           57 GHLGQIKIGDLGLAAILRGS---QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY  131 (502)
Q Consensus        57 ~~~g~vKL~DFGlA~~~~~~---~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~  131 (502)
                      .+ +.+||+|||+++.+...   .......||+.|+|||++. ..++.++|||||||++|+|+| |..||.+ ....++.
T Consensus       209 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~  286 (343)
T 1luf_A          209 EN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVI  286 (343)
T ss_dssp             GG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHH
T ss_pred             CC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-CChHHHH
Confidence            76 79999999999765332   1223457899999999875 468999999999999999999 9999976 5566777


Q ss_pred             HHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       132 ~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..+..+ ..+...+..+.++|.+||. +|.+||++.+++++
T Consensus       287 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          287 YYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            777777654 2344567899999999998 99999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=2.5e-29  Score=246.41  Aligned_cols=169  Identities=24%  Similarity=0.438  Sum_probs=131.6

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-------------
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECccccccccCccccc
Confidence            578899999998654 6999999999999999999999998  9999999999999976 7999999999987644322 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+. ...++...+..+..+ ..+...++.+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  250 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPPTLYSLM  250 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence             23345788999999886 458999999999999999997 99999774 445556666665443 34455688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.|++++
T Consensus       251 ~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          251 TKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99998 99999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=3.8e-29  Score=242.69  Aligned_cols=171  Identities=28%  Similarity=0.440  Sum_probs=135.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeCC-------CCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGH-------LGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~-~IIHRDLKPeNILl~~~-------~g~vKL~DFGlA~~   72 (502)
                      |+.+|+|.+++. .+++++..++.++.||+.||.|||+++. +|+||||||+||+++..       .+.+||+|||++..
T Consensus        87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            578999999985 4679999999999999999999999873 38899999999999751       36899999999986


Q ss_pred             ccCCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           73 LRGSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        73 ~~~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      ..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. +.......+.........+...+..+
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (271)
T 3dtc_A          166 WHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTCPEPF  243 (271)
T ss_dssp             -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             ccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcccCHHH
Confidence            64432 235679999999998864 5899999999999999999999999874 44444445555555445566678899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .++|.+||. +|.+|||+.|++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          244 AKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCcccCcCHHHHHHH
Confidence            999999999 99999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=1.3e-29  Score=258.94  Aligned_cols=169  Identities=18%  Similarity=0.280  Sum_probs=133.6

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~--~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+ ||+|.+++... +.+++..++.|+.||+.||+|||+++  |+||||||+|||++  .+ +.+||+|||+++.+....
T Consensus       133 ~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~-~~~kl~DFG~a~~~~~~~  208 (364)
T 3op5_A          133 RF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNP-DQVYLVDYGLAYRYCPEG  208 (364)
T ss_dssp             CE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCT-TCEEECCCTTCEESSGGG
T ss_pred             CC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCC-CeEEEEECCcceecccCC
Confidence            45 89999999876 67999999999999999999999998  99999999999998  54 799999999998764321


Q ss_pred             --------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC---CCCC----
Q 010730           78 --------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---KLPG----  141 (502)
Q Consensus        78 --------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g---~~p~----  141 (502)
                              .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..............   .++.    
T Consensus       209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (364)
T 3op5_A          209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK  288 (364)
T ss_dssp             CCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHH
T ss_pred             cccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHH
Confidence                    1234569999999998865 48999999999999999999999997533322222111110   0000    


Q ss_pred             c-ccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 A-FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~-~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      . .....+.++.++|..||. +|.+||++.+|++
T Consensus       289 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          289 CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            0 012346789999999999 9999999999886

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=3.3e-29  Score=247.65  Aligned_cols=170  Identities=24%  Similarity=0.379  Sum_probs=143.1

Q ss_pred             CCCCCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 010730            1 MFTSGTLREYRKKYT------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI   62 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~v   62 (502)
                      |+.+|+|.+++....                  .+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~  184 (313)
T 1t46_A          108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RIT  184 (313)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETT-TEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCC-CCE
Confidence            577899999998754                  4899999999999999999999998  9999999999999887 799


Q ss_pred             EEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcC
Q 010730           63 KIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG  137 (502)
Q Consensus        63 KL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g  137 (502)
                      ||+|||++........   .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+.+.+..+
T Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  264 (313)
T 1t46_A          185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG  264 (313)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred             EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence            9999999987654332   23456788999999775 568999999999999999999 999998866666666666555


Q ss_pred             CCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+ ..+...+..+.++|.+||. +|.+|||+.|++++
T Consensus       265 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          265 FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            432 3344567899999999999 99999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=265.27  Aligned_cols=174  Identities=28%  Similarity=0.359  Sum_probs=131.6

Q ss_pred             CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEEecCCceeccCC-
Q 010730            3 TSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQIKIGDLGLAAILRGS-   76 (502)
Q Consensus         3 tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~----~g~vKL~DFGlA~~~~~~-   76 (502)
                      .+|+|.+++.+.. .+.+..++.++.||+.||.|||+++  |+||||||+|||++.+    ...+||+|||+++.+... 
T Consensus       100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            4689999998754 4566677899999999999999998  9999999999999532    136889999999876533 


Q ss_pred             ---CCcccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCC-cccccc
Q 010730           77 ---QQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQ  147 (502)
Q Consensus        77 ---~~~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~-~~~~~~  147 (502)
                         ......+||+.|+|||++.    ..++.++|||||||++|+|+| |..||.. ....+....+.....+. ......
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-SLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS-TTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch-hhHHHHHHHhccCCccccCccccc
Confidence               2234578999999999885    346779999999999999999 9999965 33333333332222221 112233


Q ss_pred             cHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       148 s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      +..+++||.+||. ||.+|||+.|+|+||||..
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            5678999999999 9999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=259.81  Aligned_cols=174  Identities=21%  Similarity=0.343  Sum_probs=145.7

Q ss_pred             CCCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~   71 (502)
                      |+.||+|.+++...+       .+++..++.++.||+.||+|||+++  |+||||||+|||++.+  ...+||+|||+++
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~  232 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  232 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence            578999999998653       5999999999999999999999998  9999999999999843  2359999999997


Q ss_pred             eccC---CCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           72 ILRG---SQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        72 ~~~~---~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      .+..   ........||+.|+|||++. ..++.++|||||||++|+|+| |..||.. ....+++..+..+..+ ..+..
T Consensus       233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~-~~~~~  310 (367)
T 3l9p_A          233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-DPPKN  310 (367)
T ss_dssp             HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred             ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence            5422   22334567899999999875 569999999999999999998 9999976 5667777777776543 23445


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+..+.+||.+||. +|.+||++.+++++.++.
T Consensus       311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            67889999999999 999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=6.7e-29  Score=250.38  Aligned_cols=169  Identities=20%  Similarity=0.340  Sum_probs=140.2

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.||+|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECC----C
T ss_pred             CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCcccccccCccc
Confidence            57899999999765 57999999999999999999999998  9999999999999877 7999999999987654321 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.+
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  285 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPHALHQ  285 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCHHHHH
Confidence               12235688999999886 458999999999999999999 9999977 5566677777666433 334456789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+|||+.++++.
T Consensus       286 li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999998 99999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=3.9e-29  Score=243.17  Aligned_cols=169  Identities=21%  Similarity=0.421  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++... +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......  
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence            57899999999764 56999999999999999999999998  9999999999999876 789999999997654321  


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. ....++...+..+..+ ..+...+..+.++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  240 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIM  240 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHHHH
Confidence            223456788999999886 568999999999999999999 9999976 5667777777766433 34455688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.+++++
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999 99999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=3.6e-29  Score=253.79  Aligned_cols=169  Identities=29%  Similarity=0.420  Sum_probs=132.4

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|+|.+++.  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.....  .....+
T Consensus       112 ~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~--~~~~~~  184 (353)
T 3coi_A          112 QTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYV  184 (353)
T ss_dssp             SEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCTTC----------C
T ss_pred             cCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeecccccCCCC--Cccccc
Confidence            467877774  35999999999999999999999998  9999999999999977 7999999999976533  234568


Q ss_pred             CCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CC---------------------
Q 010730           84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GK---------------------  138 (502)
Q Consensus        84 GTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~---------------------  138 (502)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+... .+.+..+..  +.                     
T Consensus       185 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (353)
T 3coi_A          185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL  263 (353)
T ss_dssp             CSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS
T ss_pred             cCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC
Confidence            9999999998764  589999999999999999999999977433 332222211  00                     


Q ss_pred             ----CC--CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          139 ----LP--GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       139 ----~p--~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          .+  .......++.+++||.+||. ||.+|||++|+|+||||+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             CBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             cCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                00  01122457899999999999 99999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=7.5e-29  Score=244.21  Aligned_cols=168  Identities=22%  Similarity=0.361  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc-
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA-   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~-   79 (502)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++......... 
T Consensus        98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A           98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred             eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCcceeeccCCCcc
Confidence            5778999999999889999999999999999999999998  9999999999999977 79999999999876543221 


Q ss_pred             ---ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.++
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  252 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL  252 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence               22456789999998864 58899999999999999999 9999976 5667777777776544 3344568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++.++++
T Consensus       253 i~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          253 MNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            999998 9999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=4e-30  Score=268.71  Aligned_cols=164  Identities=16%  Similarity=0.181  Sum_probs=134.4

Q ss_pred             CCCcHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC
Q 010730            3 TSGTLREYRKK-------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG   75 (502)
Q Consensus         3 tgGsL~~yi~k-------~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~   75 (502)
                      .+|+|.++++.       .+.+++..+..++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++....
T Consensus       187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCGGGCEETTE
T ss_pred             hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecC-CeEEEEeccceeecCC
Confidence            56899999852       234778899999999999999999998  9999999999999987 7899999999987543


Q ss_pred             CCCcccccCCCcccCcccc----------cc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCccc
Q 010730           76 SQQAHSVIGTPEFMAPELY----------EE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH  144 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl----------~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~  144 (502)
                      .  ....+| +.|+|||++          .. .|+.++|||||||++|+|+||..||... +..+++..+....      
T Consensus       264 ~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~~~~~~~~~~------  333 (413)
T 3dzo_A          264 S--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD-AALGGSEWIFRSC------  333 (413)
T ss_dssp             E--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT-GGGSCSGGGGSSC------
T ss_pred             c--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc-chhhhHHHHHhhc------
Confidence            2  455678 999999987          22 3788999999999999999999999763 3333333332221      


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ...+..+++||.+||. +|.+||++.++|+||||+.
T Consensus       334 ~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          334 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            2346889999999999 9999999999999999964

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=257.85  Aligned_cols=171  Identities=17%  Similarity=0.248  Sum_probs=135.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~-g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+ ||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+. +.+||+|||+++.+....  
T Consensus       133 ~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~  209 (345)
T 2v62_A          133 RL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH  209 (345)
T ss_dssp             CE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC
T ss_pred             cc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccccc
Confidence            45 8999999988889999999999999999999999998  99999999999998651 389999999998764221  


Q ss_pred             ------CcccccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCC-CChHHHHHHh--hcCCCCCcc----
Q 010730           78 ------QAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKV--TSGKLPGAF----  143 (502)
Q Consensus        78 ------~~~s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~-~~~~ql~~kI--~~g~~p~~~----  143 (502)
                            ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. .+...+....  .....+...    
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (345)
T 2v62_A          210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWA  289 (345)
T ss_dssp             CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHS
T ss_pred             ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhc
Confidence                  12456899999999988654 899999999999999999999999543 2322222111  111222111    


Q ss_pred             -cccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          144 -HRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       144 -~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ....+.+++++|.+||. +|.+||++.+|++.
T Consensus       290 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          290 PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence             11457799999999999 99999999999885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=4.7e-29  Score=248.33  Aligned_cols=169  Identities=24%  Similarity=0.397  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKY----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+++.+.          ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++
T Consensus       109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~-~~~kl~Dfg~~  185 (322)
T 1p4o_A          109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT  185 (322)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CCEEECCTTCC
T ss_pred             eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC-CeEEECcCccc
Confidence            57799999999753          45799999999999999999999998  9999999999999977 79999999999


Q ss_pred             eeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           71 AILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        71 ~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      ........   .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..++...+..+..+. .+.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~  263 (322)
T 1p4o_A          186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD-KPD  263 (322)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC-CCT
T ss_pred             cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcCC-CCC
Confidence            76543221   23456789999999886 458999999999999999999 8999976 56677777777766542 334


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+..++++|.+||. +|.+|||+.|++++
T Consensus       264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          264 NCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            567889999999999 99999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=5e-29  Score=243.71  Aligned_cols=169  Identities=20%  Similarity=0.393  Sum_probs=142.6

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......  
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence            5789999999987 567999999999999999999999998  9999999999999877 799999999997654321  


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+..+....+..+..+ ..+...++.+.++|
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  254 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTIM  254 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCHHHHHHH
Confidence            123345788999999886 568999999999999999998 9999976 4566667777665433 33455678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+++++++
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999 99999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=8.6e-29  Score=242.18  Aligned_cols=170  Identities=22%  Similarity=0.315  Sum_probs=141.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ 
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  177 (291)
T 1u46_A          101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDH  177 (291)
T ss_dssp             CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCE
T ss_pred             cccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEccccccccccccccc
Confidence            56789999999764 57999999999999999999999998  9999999999999876 7999999999987654322 


Q ss_pred             ---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+..++...+.............+..+.+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  256 (291)
T 1u46_A          178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYN  256 (291)
T ss_dssp             EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred             hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCcCcCHHHHH
Confidence               233567889999998864 48899999999999999999 9999976 55667777776654444455566889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+|||+.+++++
T Consensus       257 li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          257 VMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999999 99999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.4e-28  Score=245.59  Aligned_cols=172  Identities=28%  Similarity=0.487  Sum_probs=132.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~------g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++++. .+++..++.++.||+.||.|||++      .++|+||||||+|||++.+ +.+||+|||++..+.
T Consensus       116 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          116 YHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFI  193 (337)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCceeec
Confidence            57899999999764 699999999999999999999988      1139999999999999877 799999999997764


Q ss_pred             CCCC-----cccccCCCcccCccccccC-CCC------cccchhHHHHHHHHhhc----------cCCCCCCC----ChH
Q 010730           75 GSQQ-----AHSVIGTPEFMAPELYEED-YNE------LVDIYSFGMCVLEMLTS----------EYPYSECS----NPA  128 (502)
Q Consensus        75 ~~~~-----~~s~vGTp~Y~APEvl~~~-ys~------~~DIWSLGviLyeLLTG----------~~Pf~~~~----~~~  128 (502)
                      ....     ....+||+.|+|||++.+. +..      ++|||||||++|+|+||          ..||....    ...
T Consensus       194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  273 (337)
T 3mdy_A          194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE  273 (337)
T ss_dssp             ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             cccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence            3222     2356899999999988654 333      38999999999999999          77775432    223


Q ss_pred             HHHHHhhcCCCCCcccc-----cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          129 QIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       129 ql~~kI~~g~~p~~~~~-----~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...+........++.     ..+..+.+||.+||. ||.+|||+.|++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            33333333333222222     335679999999999 99999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=7.2e-29  Score=250.36  Aligned_cols=169  Identities=26%  Similarity=0.460  Sum_probs=135.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTC----------
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEEccCcceeEccCcccc
Confidence            57899999999874 57999999999999999999999998  9999999999999876 7999999999987643322 


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ ....++...+..+... ..+...+..+.++
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  251 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI  251 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHHHHH
T ss_pred             ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence              23345788999999875 458999999999999999999 9999976 4555666666655433 3344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+||++.|+++.
T Consensus       252 i~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          252 MRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999 99999999999974

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=5.9e-29  Score=243.35  Aligned_cols=169  Identities=21%  Similarity=0.408  Sum_probs=137.8

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ 
T Consensus        93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCGGGCC------
T ss_pred             cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCCCccccccccc
Confidence            57899999999765 45999999999999999999999998  9999999999999876 7999999999976543321 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||... ....+...+..+..+ ..+...++.+.++|
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  247 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDRL-PKPDLCPPVLYTLM  247 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCCC-CCCTTCCHHHHHHH
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence             23356788999999886 458999999999999999998 99999763 334445555554432 23445678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.|++++
T Consensus       248 ~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          248 TRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCchhCcCHHHHHHH
Confidence            99998 99999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-28  Score=242.23  Aligned_cols=170  Identities=20%  Similarity=0.331  Sum_probs=143.4

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ 
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCE
T ss_pred             eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccceeeeccCcce
Confidence            57889999999754 56999999999999999999999998  9999999999999976 7999999999987653322 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....||+.|+|||++. ..++.++|||||||++|+|+| |..||... ...++...+..+..+ .++...++.+.+
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~  244 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYA  244 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCCcCHHHHH
Confidence               22345789999999886 458999999999999999998 99999774 455666777666543 344556889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcCC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLDP  175 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~hP  175 (502)
                      +|.+||. +|.+||++.+++++.
T Consensus       245 li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          245 LMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999 999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=1.7e-28  Score=247.08  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=143.3

Q ss_pred             CCCCCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++...+                .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||
T Consensus       122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL  198 (334)
T 2pvf_A          122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI  198 (334)
T ss_dssp             CCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEE
T ss_pred             CCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEcCC-CCEEE
Confidence            577999999998754                3899999999999999999999998  9999999999999876 79999


Q ss_pred             EecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||++........   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....+++..+..+..
T Consensus       199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~  277 (334)
T 2pvf_A          199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR  277 (334)
T ss_dssp             CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCC
T ss_pred             ccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHHHHhcCCC
Confidence            99999987654322   23346788999999875 458999999999999999999 9999976 566777777776654


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...+..+.++|.+||. +|.+||++.|++++
T Consensus       278 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          278 M-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3 3344567899999999998 99999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.8e-28  Score=240.64  Aligned_cols=170  Identities=21%  Similarity=0.341  Sum_probs=141.7

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---   76 (502)
                      |+.+|+|.+++.. ...+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++..+...   
T Consensus       104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGGGG
T ss_pred             cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCcccccCCccc
Confidence            5789999999987 467999999999999999999999998  9999999999999877 79999999999765322   


Q ss_pred             --CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 --QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 --~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                        .......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....+...+...+..+..+ ..+...+..+.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  259 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPDSLYQ  259 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchHHHHH
Confidence              22234568899999998865 58999999999999999999666655556667777777666543 334456789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+|||+.++++.
T Consensus       260 li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999 99999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=9.3e-29  Score=251.03  Aligned_cols=170  Identities=20%  Similarity=0.329  Sum_probs=137.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG--QIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g--~vKL~DFGlA~~~~~~   76 (502)
                      |+ +|+|.+++.+.  +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +  .+||+|||+++.+...
T Consensus       139 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          139 SL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             CC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETT-EEEEEEECCGGGCBCSSGG
T ss_pred             CC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCC-CCceEEEecCcceeeccCC
Confidence            45 99999999986  78999999999999999999999998  9999999999999976 5  8999999999765422


Q ss_pred             C--------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC-ChHHHHHHhh---cCCCC---
Q 010730           77 Q--------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVT---SGKLP---  140 (502)
Q Consensus        77 ~--------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-~~~ql~~kI~---~g~~p---  140 (502)
                      .        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... +...+.....   ....+   
T Consensus       215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (352)
T 2jii_A          215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG  294 (352)
T ss_dssp             GCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC
T ss_pred             CccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh
Confidence            1        1234589999999998865 58999999999999999999999997754 4444433332   11111   


Q ss_pred             -CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 -GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 -~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ...+...+..+.+||.+||. +|.+||++.++++.
T Consensus       295 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence             01112347899999999999 99999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=9.1e-29  Score=245.70  Aligned_cols=169  Identities=20%  Similarity=0.320  Sum_probs=135.5

Q ss_pred             CCCCCcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKK------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k------~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++..      .+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++..+.
T Consensus       122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~  198 (313)
T 3brb_A          122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLSKKIY  198 (313)
T ss_dssp             CCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT-SCEEECSCSCC----
T ss_pred             cccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEEeecCcceecc
Confidence            5778999999953      356999999999999999999999998  9999999999999887 799999999998664


Q ss_pred             CCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           75 GSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        75 ~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ...   ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. ....+++..+..+..+ ..+...+.
T Consensus       199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  276 (313)
T 3brb_A          199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLHGHRL-KQPEDCLD  276 (313)
T ss_dssp             ------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCBTTCCH
T ss_pred             cccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHHcCCCC-CCCccccH
Confidence            332   1233467889999998864 58999999999999999999 8999976 4555666666666543 33445678


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.++|.+||. +|.+|||+.+++.+
T Consensus       277 ~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          277 ELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999998 99999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.4e-28  Score=237.79  Aligned_cols=169  Identities=21%  Similarity=0.421  Sum_probs=142.5

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......  
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence            56789999999875 56999999999999999999999998  9999999999999876 789999999997653321  


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++...+..+..+ ..+...+..+.++|
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  238 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIM  238 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHHHH
Confidence            123356788999999886 458999999999999999999 8999976 5666777777766443 33445688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+||++.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999 99999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=1e-28  Score=259.66  Aligned_cols=172  Identities=28%  Similarity=0.395  Sum_probs=127.2

Q ss_pred             CCCcHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------------CCcEE
Q 010730            3 TSGTLREYRKKYTRVD-------IRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------LGQIK   63 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~-------e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~------------~g~vK   63 (502)
                      .+|+|.+++...+...       +..++.++.||+.||+|||+++  |+||||||+|||++..            .+.+|
T Consensus        91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            3689999998765432       2245679999999999999998  9999999999999743            24799


Q ss_pred             EEecCCceeccCCCC-----cccccCCCcccCcccccc--------CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHH
Q 010730           64 IGDLGLAAILRGSQQ-----AHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQ  129 (502)
Q Consensus        64 L~DFGlA~~~~~~~~-----~~s~vGTp~Y~APEvl~~--------~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~q  129 (502)
                      |+|||+++.+.....     ....+||+.|+|||++.+        .++.++|||||||++|+|+| |..||.+..... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            999999987654321     234689999999998853        48899999999999999999 999997643322 


Q ss_pred             HHHHhhcCCCC-----CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          130 IYKKVTSGKLP-----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       130 l~~kI~~g~~p-----~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                        ..+..+...     .......++++++||.+||. ||.+|||+.|+|+||||..
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              122222221     11112235789999999999 9999999999999999964

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=244.76  Aligned_cols=169  Identities=22%  Similarity=0.394  Sum_probs=139.7

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC----
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG----   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~----   75 (502)
                      |+.||+|.+++.+.+ .+++..++.++.||+.||+|||+++  |+||||||+|||++.  +.+||+|||++.....    
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~~--~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC--------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEeC--CCEEEeecCCcccccccccc
Confidence            567899999998755 6999999999999999999999998  999999999999973  6899999999875431    


Q ss_pred             --CCCcccccCCCcccCcccccc----------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcc
Q 010730           76 --SQQAHSVIGTPEFMAPELYEE----------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF  143 (502)
Q Consensus        76 --~~~~~s~vGTp~Y~APEvl~~----------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~  143 (502)
                        ........||+.|+|||++..          .++.++|||||||++|+|++|..||.. .....+...+..+..+...
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~  264 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLS  264 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCC
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCC
Confidence              122334569999999998753          378899999999999999999999976 5566677777777665544


Q ss_pred             cccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       144 ~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ....+.++.++|.+||. +|.+|||+.++++.
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            44567889999999999 99999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.95  E-value=6.5e-29  Score=247.14  Aligned_cols=166  Identities=26%  Similarity=0.413  Sum_probs=117.8

Q ss_pred             CCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            3 TSGTLREYRKK---YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         3 tgGsL~~yi~k---~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      .+|+|.+++..   .+.+++..++.++.||+.||.|||+++++|+||||||+|||++.+ +.+||+|||++........ 
T Consensus       116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~  194 (337)
T 3ll6_A          116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDY  194 (337)
T ss_dssp             CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCTTCBCCSSCC--
T ss_pred             cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCccceeccccCcc
Confidence            46899999875   567999999999999999999999988789999999999999987 7999999999987643221 


Q ss_pred             ------------cccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc
Q 010730           79 ------------AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        79 ------------~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                                  .....||+.|+|||++.    ..++.++|||||||++|+|++|..||..... ..+    ..+.....
T Consensus       195 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~----~~~~~~~~  269 (337)
T 3ll6_A          195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-LRI----VNGKYSIP  269 (337)
T ss_dssp             -----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCC
T ss_pred             cccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-HHh----hcCcccCC
Confidence                        12456999999999873    3478899999999999999999999976322 222    22222223


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .....+..+++||.+||. +|.+|||+.|++++
T Consensus       270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            334446678999999999 99999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=1.3e-28  Score=246.69  Aligned_cols=170  Identities=22%  Similarity=0.360  Sum_probs=141.5

Q ss_pred             CCCCCcHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 010730            1 MFTSGTLREYRKKY--------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD   66 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~D   66 (502)
                      |+.+|+|.+++.+.              ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~D  207 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG-HVAKIGD  207 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGG-GEEEBCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCC-CeEEECc
Confidence            57889999999753              45899999999999999999999998  9999999999999877 7999999


Q ss_pred             cCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCC
Q 010730           67 LGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        67 FGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~  141 (502)
                      ||++........   .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+...+..+..+ 
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-  286 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM-  286 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC-
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC-
Confidence            999986543322   23456788999999875 468999999999999999999 999998766666666555554332 


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..+...+..+.++|.+||. +|.+|||+.|++++
T Consensus       287 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            3444567899999999999 99999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=242.86  Aligned_cols=169  Identities=26%  Similarity=0.448  Sum_probs=132.5

Q ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHG---HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---~L~e~~i~~i~~QIL~gL~YLHs---~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.||+|.+++.+.+   .+++..+..++.||+.||+|||+   ++  |+||||||+|||++.+...+||+|||++....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            578999999998765   37899999999999999999999   56  99999999999998763348999999997654


Q ss_pred             CCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC-hHHHHHHhhcCCCCCcccccccHHHH
Q 010730           75 GSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-PAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        75 ~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~-~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+...+..+..+ ......+..++
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~  234 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIE  234 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHH
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHH
Confidence            32  234579999999998865 589999999999999999999999976433 33444455555444 33445678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++|.+||. +|.+|||+.+++++
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999 99999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.95  E-value=6.5e-29  Score=248.15  Aligned_cols=171  Identities=24%  Similarity=0.397  Sum_probs=133.8

Q ss_pred             CCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGH---DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----~L~e~~i~~i~~QIL~gL~YLHs~---g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|.+++....    .+++..++.++.||+.||+|||++   +  |+||||||+|||++.+ +.+||+|||++...
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAVVGDFGLAKLM  184 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEEECCCSSCEEC
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEEeccCcccccc
Confidence            578999999998654    499999999999999999999998   7  9999999999999987 79999999999876


Q ss_pred             cCCCC--cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCC-------CChHHHHHHhhcC-C----
Q 010730           74 RGSQQ--AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC-------SNPAQIYKKVTSG-K----  138 (502)
Q Consensus        74 ~~~~~--~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~-------~~~~ql~~kI~~g-~----  138 (502)
                      .....  .....||+.|+|||++. ..++.++|||||||++|+|++|..||...       ............. .    
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL  264 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred             CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence            43222  34456999999999885 45899999999999999999999999520       1111111111111 1    


Q ss_pred             ----CCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          139 ----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       139 ----~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                          ....+....+..+.+++.+||. +|.+|||+.|++++
T Consensus       265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  305 (326)
T 3uim_A          265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM  305 (326)
T ss_dssp             SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence                1111222234678999999999 99999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=2.5e-28  Score=238.34  Aligned_cols=168  Identities=23%  Similarity=0.387  Sum_probs=141.3

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++....  .+++..+..++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence            577999999997543  6999999999999999999999998  9999999999999876 7999999999987654321


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.++
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  242 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCPEELYQL  242 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccccHHHHHH
Confidence              23345788999999886 458999999999999999999 9999976 4556677777665433 3344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+|||+.+++.
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            999998 9999999999886

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=2.4e-28  Score=240.64  Aligned_cols=169  Identities=21%  Similarity=0.371  Sum_probs=137.0

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......  
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEECcccccccccccchh
Confidence            5788999999986 456999999999999999999999998  9999999999999877 799999999997654322  


Q ss_pred             ---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           78 ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        78 ---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                         ......||+.|+|||++. ..++.++|||||||++|+|++ |.+||.. .+..++...+..+..+ ..+...+..+.
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~  262 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPDPLY  262 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCHHHH
Confidence               123456789999999886 458999999999999999999 5666655 4444555555555443 23344578899


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++|.+||. +|.+|||+.|+++.
T Consensus       263 ~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999 99999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=9.7e-29  Score=241.98  Aligned_cols=165  Identities=19%  Similarity=0.308  Sum_probs=133.5

Q ss_pred             CCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--------EEEEecCCce
Q 010730            1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--------IKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~-L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~--------vKL~DFGlA~   71 (502)
                      |+.||+|.+++.+.+. +++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.        +||+|||++.
T Consensus        93 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl~Dfg~~~  169 (289)
T 4fvq_A           93 FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPFIKLSDPGISI  169 (289)
T ss_dssp             CCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCEEEECCCCSCT
T ss_pred             CCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-CcccccccceeeeccCcccc
Confidence            5789999999988655 999999999999999999999999  9999999999999876 44        9999999986


Q ss_pred             eccCCCCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccH
Q 010730           72 ILRGSQQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA  149 (502)
Q Consensus        72 ~~~~~~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~  149 (502)
                      ....   .....||+.|+|||++.+  .++.++|||||||++|+|++|..|+....+............   .++...+.
T Consensus       170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  243 (289)
T 4fvq_A          170 TVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH---QLPAPKAA  243 (289)
T ss_dssp             TTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCCSSC
T ss_pred             cccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC---CCCCCCCH
Confidence            5432   234568999999998864  489999999999999999996555444455444444433322   22233466


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .++++|.+||. +|.+|||+.|++++
T Consensus       244 ~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          244 ELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            78999999999 99999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=2.9e-28  Score=257.35  Aligned_cols=166  Identities=19%  Similarity=0.362  Sum_probs=138.6

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+|+.+.+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--
Confidence            6789999999987544  799999999999999999999998  9999999999999877 79999999999865332  


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||.+. ...++...+..+..+ ..+...++.+.++|.
T Consensus       343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYDVMK  420 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred             ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHH
Confidence            22346789999999885 459999999999999999998 99999874 344566666666433 344556889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhc
Q 010730          157 KCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~  173 (502)
                      +||. +|.+|||+.+++.
T Consensus       421 ~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            9998 9999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=1.8e-28  Score=241.55  Aligned_cols=170  Identities=25%  Similarity=0.398  Sum_probs=132.4

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+.+ ++++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++........ 
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  170 (295)
T 3ugc_A           94 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEF  170 (295)
T ss_dssp             CCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCSCC--------
T ss_pred             eCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccCcccccccCCcce
Confidence            578999999998764 4999999999999999999999998  9999999999999987 7999999999987643321 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC---------------hHHHHHHhhcCCC
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---------------PAQIYKKVTSGKL  139 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~---------------~~ql~~kI~~g~~  139 (502)
                         .....||+.|+|||++. ..++.++|||||||++|+|+||..||.....               ...+...+..+..
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (295)
T 3ugc_A          171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR  250 (295)
T ss_dssp             -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred             eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc
Confidence               22345778899999876 4589999999999999999999999853110               0022223333322


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      . ..+...++++.++|.+||. +|.+|||+.|+++.
T Consensus       251 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          251 L-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             C-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             C-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2 3344567899999999999 99999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=4.8e-28  Score=240.17  Aligned_cols=171  Identities=29%  Similarity=0.463  Sum_probs=134.2

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++..    ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++......
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccceeeecCC
Confidence            5778999999974    466999999999999999999999998  9999999999999876 79999999999765433


Q ss_pred             C-CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC-CChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           77 Q-QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        77 ~-~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~-~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                      . ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .+...+.+.+..+..+.......+.++++
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  269 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  269 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence            2 2345679999999998764 5899999999999999999999999753 34556777777777665544566889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. ||.+|||+.++++.
T Consensus       270 li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          270 LVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCCCHHHHHHH
Confidence            9999998 99999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=1.9e-28  Score=252.18  Aligned_cols=169  Identities=20%  Similarity=0.345  Sum_probs=139.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceecCCCcee
Confidence            57899999999865 46999999999999999999999998  9999999999999877 79999999999865432111


Q ss_pred             ---ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        80 ---~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         ....+++.|+|||++. +.++.++|||||||++|||+| |..||.+ ....++...+..+... ..+...+..+.++
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  347 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCPDAVFRL  347 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence               1223577899999886 558999999999999999998 9999987 4455666666655432 3345567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.++++.
T Consensus       348 i~~cl~~dP~~Rps~~~i~~~  368 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQE  368 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHHH
Confidence            999999 99999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=2.9e-28  Score=243.07  Aligned_cols=170  Identities=21%  Similarity=0.282  Sum_probs=131.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--Q   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++.......  .
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC-----------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCcccccccccc
Confidence            5678999999998889999999999999999999999998  9999999999999877 799999999997654322  2


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC-CCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~-p~~~~~~~s~~l~~LI~  156 (502)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..... +...+...+..++++|.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  270 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA  270 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence            345679999999998864 588999999999999999999999976 333444444443332 22334456789999999


Q ss_pred             Hhhh-CcCCCC-CHHHHhcC
Q 010730          157 KCLE-NVSKRL-PAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRp-Sa~ELL~h  174 (502)
                      +||. +|.+|| ++++++..
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~  290 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAA  290 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHH
T ss_pred             HhccCCHHHHHHhHHHHHHH
Confidence            9999 999999 88888864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.95  E-value=1.9e-28  Score=239.47  Aligned_cols=167  Identities=19%  Similarity=0.359  Sum_probs=134.5

Q ss_pred             CCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~--L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.+.  +++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeecccccccccc--
Confidence            5678999999987543  899999999999999999999998  9999999999999876 79999999999765432  


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      .....+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .+..++...+..+..+ ..+...++.+.++|.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  248 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPAVYEVMK  248 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCC-CCCTTCCHHHHHHHH
T ss_pred             ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCcccCCHHHHHHHH
Confidence            23446899999999885 458999999999999999998 9999976 4455666666665433 344556889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. +|.+||++.|+++.
T Consensus       249 ~~l~~~p~~Rps~~~l~~~  267 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQLREQ  267 (278)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHHH
Confidence            9998 99999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=1.5e-28  Score=246.29  Aligned_cols=174  Identities=21%  Similarity=0.346  Sum_probs=144.4

Q ss_pred             CCCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCce
Q 010730            1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAA   71 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~   71 (502)
                      |+.+|+|.+++.+..       .+++..++.++.||+.||.|||+++  |+||||||+|||++.+  ...+||+|||++.
T Consensus       114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~  191 (327)
T 2yfx_A          114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  191 (327)
T ss_dssp             CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECcccccc
Confidence            567999999998763       4999999999999999999999998  9999999999999843  2469999999997


Q ss_pred             eccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCccccc
Q 010730           72 ILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI  146 (502)
Q Consensus        72 ~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~  146 (502)
                      ......   ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .+..++...+..+..+ ..+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~  269 (327)
T 2yfx_A          192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-DPPKN  269 (327)
T ss_dssp             HHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred             ccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCC-CCCCC
Confidence            653322   223467899999999875 568999999999999999998 9999976 5666777777766543 23445


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                      .+..+.++|.+||. +|.+||++.+++++.|+.
T Consensus       270 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            67899999999999 999999999999997764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=3.6e-28  Score=239.40  Aligned_cols=169  Identities=27%  Similarity=0.433  Sum_probs=137.5

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+ ...+++..++.++.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||++..+..... 
T Consensus       106 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  182 (302)
T 4e5w_A          106 FLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEY  182 (302)
T ss_dssp             CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCCE
T ss_pred             eCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEECcccccccccCCCcc
Confidence            5789999999954 567999999999999999999999998  9999999999999887 7999999999987754432 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCC--------------CCChHHHHHHhhcCCCC
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE--------------CSNPAQIYKKVTSGKLP  140 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~--------------~~~~~ql~~kI~~g~~p  140 (502)
                         .....||+.|+|||++. ..++.++|||||||++|+|+||..|+..              ......+...+..+...
T Consensus       183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (302)
T 4e5w_A          183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL  262 (302)
T ss_dssp             EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC
T ss_pred             eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC
Confidence               23456889999999875 4588999999999999999999987632              11223334444444332


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                       ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus       263 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          263 -PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence             3444567899999999999 9999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=9.3e-29  Score=245.67  Aligned_cols=170  Identities=22%  Similarity=0.265  Sum_probs=134.0

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++.+    ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEecCcchhcccc
Confidence            5788999999976    467999999999999999999999998  9999999999999876 79999999998764321


Q ss_pred             CC----------cccccCCCcccCccccccC----CCCcccchhHHHHHHHHhhccCCCCCCC-ChHHHHHHhhcCCCCC
Q 010730           77 QQ----------AHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPG  141 (502)
Q Consensus        77 ~~----------~~s~vGTp~Y~APEvl~~~----ys~~~DIWSLGviLyeLLTG~~Pf~~~~-~~~ql~~kI~~g~~p~  141 (502)
                      ..          .....||+.|+|||++.+.    ++.++|||||||++|+|++|..||.... ....+...+.. ....
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~  266 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSI  266 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--C
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCCC
Confidence            10          1234689999999988542    6899999999999999999999995310 00112222222 2222


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ......+..+.++|.+||. +|.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2334457899999999999 99999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=2.5e-28  Score=238.96  Aligned_cols=169  Identities=23%  Similarity=0.367  Sum_probs=141.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence            57789999999874  45999999999999999999999998  9999999999999876 7899999999976643322


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++...+.....+ ..+...++.+.+|
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  244 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYEL  244 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCHHHHHH
Confidence              23356788999999886 568999999999999999999 9999976 4555666666555333 3344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.++++.
T Consensus       245 i~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHHH
Confidence            999999 99999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=3.2e-28  Score=243.94  Aligned_cols=170  Identities=24%  Similarity=0.383  Sum_probs=138.7

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+ ...+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||++........ 
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~  183 (327)
T 3lxl_A          107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDY  183 (327)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGGGCEECCTTCSE
T ss_pred             ecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEcccccceecccCCcc
Confidence            5779999999987 456999999999999999999999998  9999999999999877 7999999999987654332 


Q ss_pred             ---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC--------------ChHHHHHHhhcCCCC
Q 010730           79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--------------NPAQIYKKVTSGKLP  140 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--------------~~~ql~~kI~~g~~p  140 (502)
                         .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....              ....+...+..+..+
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (327)
T 3lxl_A          184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL  263 (327)
T ss_dssp             EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC
T ss_pred             ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC
Confidence               234568899999998864 48899999999999999999999985421              112334444444332


Q ss_pred             CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                       ..+...++.+.+||.+||. +|.+|||+.|++++
T Consensus       264 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          264 -PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             3445568899999999999 99999999999765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=255.77  Aligned_cols=171  Identities=23%  Similarity=0.410  Sum_probs=139.0

Q ss_pred             CCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~---L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl----~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.+|+|.+++.+...   +++..++.++.||+.||+|||+++  |+||||||+|||+    +++ +.+||+|||+++..
T Consensus        90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~~~  166 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAREL  166 (396)
T ss_dssp             CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEECCGGGCEEC
T ss_pred             cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEEecCCCceEc
Confidence            5789999999976433   999999999999999999999998  9999999999998    444 57999999999887


Q ss_pred             cCCCCcccccCCCcccCccccc---------cCCCCcccchhHHHHHHHHhhccCCCCCC---CChHHHHHHhhcCCCCC
Q 010730           74 RGSQQAHSVIGTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        74 ~~~~~~~s~vGTp~Y~APEvl~---------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~---~~~~ql~~kI~~g~~p~  141 (502)
                      .........+||+.|+|||++.         ..++.++|||||||++|+|++|..||...   ....++..++..+..+.
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~  246 (396)
T 4eut_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG  246 (396)
T ss_dssp             CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred             cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence            6655556678999999999875         35788999999999999999999999642   22344455555444321


Q ss_pred             c-----------------------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          142 A-----------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       142 ~-----------------------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .                       +....+..+.++|.+||. ||.+|++++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            1                       112235678999999999 99999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=7.1e-28  Score=238.25  Aligned_cols=171  Identities=26%  Similarity=0.368  Sum_probs=137.0

Q ss_pred             CCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKK---YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k---~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.+|+|.+++..   ...+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++.......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSCS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeeccccccccccc
Confidence            5679999999974   356999999999999999999999998  9999999999999876 799999999998764322


Q ss_pred             C---cccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCCh---HHHHHHhhcCCC---------CCc
Q 010730           78 Q---AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL---------PGA  142 (502)
Q Consensus        78 ~---~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---~ql~~kI~~g~~---------p~~  142 (502)
                      .   .....||+.|+|||++.+.++.++|||||||++|+|++|..||......   ..+.+.+.....         ...
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence            2   2346799999999999888999999999999999999999999764322   222232222111         011


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .....+..+.++|.+||. +|.+|||+.+++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            222335678999999999 99999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=7.1e-28  Score=241.39  Aligned_cols=170  Identities=28%  Similarity=0.438  Sum_probs=137.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLH--------s~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      |+.+|+|.+++.+. .+++..++.++.||+.||.|||        +++  |+||||||+|||++.+ +.+||+|||++..
T Consensus       121 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIADLGLAVR  196 (342)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred             ecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCEEEEECCCcee
Confidence            57889999999874 6999999999999999999999        777  9999999999999877 7999999999987


Q ss_pred             ccCCC-----CcccccCCCcccCccccccC-------CCCcccchhHHHHHHHHhhc----------cCCCCCC----CC
Q 010730           73 LRGSQ-----QAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTS----------EYPYSEC----SN  126 (502)
Q Consensus        73 ~~~~~-----~~~s~vGTp~Y~APEvl~~~-------ys~~~DIWSLGviLyeLLTG----------~~Pf~~~----~~  126 (502)
                      .....     ......||+.|+|||++.+.       ++.++|||||||++|+|+||          ..||...    ..
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  276 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  276 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence            65443     23456899999999988653       23689999999999999999          7888653    23


Q ss_pred             hHHHHHHhhcCCCCCcccc-----cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          127 PAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       127 ~~ql~~kI~~g~~p~~~~~-----~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ...+.+.+........++.     .....+.++|.+||. +|.+|||+.|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            4556666655444333322     223578999999998 99999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.95  E-value=6.9e-29  Score=248.20  Aligned_cols=171  Identities=23%  Similarity=0.323  Sum_probs=134.3

Q ss_pred             CCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~----~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.+|+|.+++....    .+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||+++.....
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeecccccccccc
Confidence            578999999996543    5999999999999999999999998  9999999999999876 79999999999865422


Q ss_pred             ---CCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCC-----hHHH-HHHhhcCCCC------
Q 010730           77 ---QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN-----PAQI-YKKVTSGKLP------  140 (502)
Q Consensus        77 ---~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~-----~~ql-~~kI~~g~~p------  140 (502)
                         .......||+.|+|||++. +.++.++|||||||++|+|+||..||.....     .... ......+.+.      
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence               1223456999999999875 5699999999999999999999999965321     1111 1111222221      


Q ss_pred             --CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          141 --GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       141 --~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                        .......+..+.+++.+||. +|.+|||+.|++++
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              11222335678999999999 99999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=8.6e-28  Score=242.77  Aligned_cols=169  Identities=22%  Similarity=0.381  Sum_probs=136.3

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++........ 
T Consensus       127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC----------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCCcchhhcccccc
Confidence            57789999999865 67999999999999999999999998  9999999999999876 7999999999987643221 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.+
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  281 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRL-PTPMDCPSAIYQ  281 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTCBHHHHH
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcC-CCcccCCHHHHH
Confidence               12235688999999886 458999999999999999999 9999976 4556777777766433 233456789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+||++.+++++
T Consensus       282 li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          282 LMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999998 99999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.6e-28  Score=251.13  Aligned_cols=169  Identities=21%  Similarity=0.367  Sum_probs=130.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++++. ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+....  
T Consensus       172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred             CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeeccccccccccccc
Confidence            67899999999865 45899999999999999999999998  9999999999999877 799999999998654321  


Q ss_pred             ---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           78 ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        78 ---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                         ......+|+.|+|||++. ..++.++|||||||++|+|+| |.+||.+. +..++...+..+..+ ..+...+..+.
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~-~~p~~~~~~l~  326 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-LQPEYCPDPLY  326 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence               123346788999999885 458999999999999999999 77788663 334445555555543 23345678999


Q ss_pred             HHHHHhhh-CcCCCCCHHHHhcC
Q 010730          153 RFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       153 ~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++|.+||. +|.+|||+.|++++
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999998 99999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=3.7e-28  Score=256.55  Aligned_cols=168  Identities=21%  Similarity=0.399  Sum_probs=140.6

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|.+++.+.  ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+.... 
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce
Confidence            67899999999754  36899999999999999999999998  9999999999999887 799999999998654321 


Q ss_pred             -CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                       ......+|+.|+|||++. +.++.++|||||||++|||+| |..||.+ ....++...+..+... ..+...+.++.++
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l  417 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPENCPEELYNI  417 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence             122345688999999886 569999999999999999999 9999987 4556666777665432 2344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+|||+.+|+.
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            999998 9999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=250.39  Aligned_cols=163  Identities=21%  Similarity=0.254  Sum_probs=127.6

Q ss_pred             CCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----------CCcEEEE
Q 010730            1 MFTSGTLREYRKK-----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----------LGQIKIG   65 (502)
Q Consensus         1 ~~tgGsL~~yi~k-----~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~----------~g~vKL~   65 (502)
                      |+.+|+|.+++..     .+.+++..++.|+.||+.||+|||+++  ||||||||+|||++..          .+.+||+
T Consensus       148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~  225 (365)
T 3e7e_A          148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI  225 (365)
T ss_dssp             CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred             ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence            6789999999974     467999999999999999999999998  9999999999999861          3789999


Q ss_pred             ecCCceecc---CCCCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC
Q 010730           66 DLGLAAILR---GSQQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG  141 (502)
Q Consensus        66 DFGlA~~~~---~~~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~  141 (502)
                      |||+++.+.   ........+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.......  +.  ....++.
T Consensus       226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~--~~~~~~~  301 (365)
T 3e7e_A          226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--CK--PEGLFRR  301 (365)
T ss_dssp             CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--EE--ECSCCTT
T ss_pred             eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--ee--echhccc
Confidence            999997654   2233456789999999998865 48999999999999999999999995422110  00  0111111


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHh
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELL  172 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL  172 (502)
                      .   ..+..+.+++.+||. +|.+|++..+.|
T Consensus       302 ~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          302 L---PHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             C---SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             c---CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            1   235678999999999 888886543333

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=7.5e-28  Score=248.27  Aligned_cols=169  Identities=21%  Similarity=0.372  Sum_probs=130.0

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus       127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCccccccccCCcc
Confidence            578999999998754 6999999999999999999999998  9999999999999887 7999999999987643221 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++.+.+..+... ..+...+..+.+
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~  281 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRL-PPPMDCPAALYQ  281 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEEC-CCCTTCBHHHHH
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHHHH
Confidence               11234578899999886 568999999999999999998 9999977 4556667776655332 223345788999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      +|.+||. +|.+||++.++++.
T Consensus       282 li~~cl~~dp~~RPs~~~i~~~  303 (373)
T 2qol_A          282 LMLDCWQKDRNNRPKFEQIVSI  303 (373)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCcChhhCcCHHHHHHH
Confidence            9999998 99999999998863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=9.4e-28  Score=257.32  Aligned_cols=168  Identities=20%  Similarity=0.330  Sum_probs=136.5

Q ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecCCceeccCCCC--
Q 010730            4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         4 gGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~--~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      +|+|.+++.. .+.+++..++.|+.||+.||+|||+++  ||||||||+|||++  ...+.+||+|||+++.+.....  
T Consensus        86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            9999999986 567999999999999999999999998  99999999999994  2337899999999987654322  


Q ss_pred             ------cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCC---ccccc
Q 010730           79 ------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPG---AFHRI  146 (502)
Q Consensus        79 ------~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~---~~~~~  146 (502)
                            ....+||+.|+|||++.+ .++.++|||||||+||+|++|..||.+..  ...+.+.++.......   .+...
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~  243 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG  243 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTT
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcC
Confidence                  225789999999998764 58999999999999999999999997643  3344555544332211   12234


Q ss_pred             ccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          147 QDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       147 ~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+.++.+||.+||. +|.+||++.+|++
T Consensus       244 ~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          244 YPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             SCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            57899999999999 9999999988764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=6.2e-28  Score=266.58  Aligned_cols=168  Identities=22%  Similarity=0.365  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+.....  
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-----
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCccccccCcccc
Confidence            6789999999999999999999999999999999999998  9999999999999987 7999999999987643321  


Q ss_pred             --cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+ .+..++...+..+..+ ..+...+.++.+|
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l  604 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL  604 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              223457889999998864 69999999999999999998 9999977 5666777777776643 3444567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+||++.+|++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            999999 9999999999886

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=1.2e-27  Score=255.86  Aligned_cols=169  Identities=22%  Similarity=0.362  Sum_probs=141.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+|+.+.  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence            67899999999874  45999999999999999999999998  9999999999999876 7999999999987643221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....+|+.|+|||++. ..|+.++|||||||++|+|+| |..||.+ .+..++++.+..+... ..+...+..+.+|
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  451 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYEL  451 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              22345678999999886 458999999999999999999 9999987 4455667766655432 3345567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.+|++.
T Consensus       452 i~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHHH
Confidence            999999 99999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=1.3e-27  Score=236.87  Aligned_cols=158  Identities=20%  Similarity=0.371  Sum_probs=124.9

Q ss_pred             CCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~--~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+.+  .+++..++.++.||+.||.|||+++  |+||||||+|||++..  .+.+||+|||++..... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-  172 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-  172 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccccccccc-
Confidence            578999999998864  6999999999999999999999998  9999999999999873  37899999999865432 


Q ss_pred             CCcccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHH----HhhcCCCC--CcccccccHH
Q 010730           77 QQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK----KVTSGKLP--GAFHRIQDAE  150 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~----kI~~g~~p--~~~~~~~s~~  150 (502)
                                         ..|+.++|||||||++|+|++|..||.+... ..+..    .+..+..+  ...+...+.+
T Consensus       173 -------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (299)
T 3m2w_A          173 -------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFPNPEWSEVSEE  232 (299)
T ss_dssp             -------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred             -------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCCchhcccCCHH
Confidence                               3467899999999999999999999976322 22211    11111111  1111345789


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      +++||.+||. ||.+|||+.|+|+||||+...
T Consensus       233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            9999999999 999999999999999997543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=1.1e-27  Score=252.96  Aligned_cols=168  Identities=22%  Similarity=0.350  Sum_probs=136.6

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+  .+.+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence            6789999999964  356999999999999999999999998  9999999999999876 7999999999987643221


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+ ....++...+..+... ..+...+..+.++
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l  413 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDL  413 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              22345788999999875 569999999999999999999 9999987 4556677777666432 2344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+|||+++|+.
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            999999 9999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.3e-27  Score=239.40  Aligned_cols=168  Identities=26%  Similarity=0.406  Sum_probs=135.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+. .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++........  
T Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~  191 (318)
T 3lxp_A          116 YVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYY  191 (318)
T ss_dssp             CCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECCTTCSEE
T ss_pred             cccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCcccccccccccccc
Confidence            57789999999775 4999999999999999999999998  9999999999999887 7999999999987754332  


Q ss_pred             --cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCC--------------hHHHHHHhhcCCCCC
Q 010730           79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--------------PAQIYKKVTSGKLPG  141 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~--------------~~ql~~kI~~g~~p~  141 (502)
                        .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.....              ...+...+..+.. .
T Consensus       192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  270 (318)
T 3lxp_A          192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER-L  270 (318)
T ss_dssp             EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC-C
T ss_pred             ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC-C
Confidence              234568899999998864 588999999999999999999999864211              0112233333332 2


Q ss_pred             cccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       142 ~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ..+...+..+.+||.+||. +|.+|||+.|+++
T Consensus       271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3445567899999999999 9999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=2.6e-27  Score=260.39  Aligned_cols=168  Identities=20%  Similarity=0.335  Sum_probs=138.2

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTTCC-----
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCce
Confidence            67899999999754 56999999999999999999999998  9999999999999977 7999999999986543221 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.+. +..+++..+..+... ..+...++++.+
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~  570 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYA  570 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence               12234678999999886 569999999999999999998 99999874 456677777776543 344556789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +|.+||. +|.+||++.+|++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            9999998 9999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.94  E-value=1.6e-27  Score=264.89  Aligned_cols=177  Identities=28%  Similarity=0.401  Sum_probs=140.6

Q ss_pred             CCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCCceeccC
Q 010730            1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQIKIGDLGLAAILRG   75 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~---~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~--g~vKL~DFGlA~~~~~   75 (502)
                      |+.||+|.+++...+   .+++..++.++.||+.||+|||+++  |+||||||+||+++.+.  ..+||+|||++.....
T Consensus        99 y~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~  176 (676)
T 3qa8_A           99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ  176 (676)
T ss_dssp             CCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred             eCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence            577999999998754   6999999999999999999999998  99999999999998652  2489999999988766


Q ss_pred             CCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhh-------------cCC---
Q 010730           76 SQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-------------SGK---  138 (502)
Q Consensus        76 ~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~-------------~g~---  138 (502)
                      .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.....+.++...+.             .+.   
T Consensus       177 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~  256 (676)
T 3qa8_A          177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF  256 (676)
T ss_dssp             CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCC
T ss_pred             ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccc
Confidence            55566778999999999886 4589999999999999999999999976433322211110             111   


Q ss_pred             -----CCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          139 -----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       139 -----~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                           .+..+....+..+.+||.+||. ||.+|||+.|+|.||||+.
T Consensus       257 ~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          257 SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                 0112233356889999999999 9999999999999999964

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=2e-28  Score=246.66  Aligned_cols=165  Identities=19%  Similarity=0.188  Sum_probs=130.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC-------------------
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLG-------------------   60 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLH-s~g~~IIHRDLKPeNILl~~~~g-------------------   60 (502)
                      |+.+|+|.+++.+ +.+++..++.++.||+.||+||| +++  |+||||||+|||++.+ +                   
T Consensus       143 ~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~  218 (336)
T 2vuw_A          143 FEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCG  218 (336)
T ss_dssp             EECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTT
T ss_pred             ecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCC
Confidence            3568877776644 67899999999999999999999 888  9999999999999876 4                   


Q ss_pred             -cEEEEecCCceeccCCCCcccccCCCcccCccccccCCCCcccchhHHHH-HHHHhhccCCCCCCCChHHHHHHhhcC-
Q 010730           61 -QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMC-VLEMLTSEYPYSECSNPAQIYKKVTSG-  137 (502)
Q Consensus        61 -~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~~~ys~~~DIWSLGvi-LyeLLTG~~Pf~~~~~~~ql~~kI~~g-  137 (502)
                       .+||+|||+|+.....    ..+||+.|+|||++.+..+.++||||||++ .+++++|..||.+......+...+... 
T Consensus       219 ~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~  294 (336)
T 2vuw_A          219 LQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM  294 (336)
T ss_dssp             EEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC
T ss_pred             ceEEEeeccccEecCCC----cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh
Confidence             8999999999876542    458999999999998877889999998777 778999999985421112233333311 


Q ss_pred             CC----CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHh-cCCCCc
Q 010730          138 KL----PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL-LDPFLA  178 (502)
Q Consensus       138 ~~----p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL-~hPff~  178 (502)
                      ..    +...+...++++++||.+||. |     ||+|+| +||||+
T Consensus       295 ~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          295 TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            11    122233457889999999998 4     999999 999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=3.6e-27  Score=236.59  Aligned_cols=169  Identities=26%  Similarity=0.410  Sum_probs=135.4

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++  |+||||||+||+++.+ +.+||+|||++........ 
T Consensus       125 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~~~~~~  201 (326)
T 2w1i_A          125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEY  201 (326)
T ss_dssp             CCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCSSCSE
T ss_pred             CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCcchhhccccccc
Confidence            56789999999876 46999999999999999999999998  9999999999999876 7999999999987654322 


Q ss_pred             ---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCC-----------C----hHHHHHHhhcCCC
Q 010730           79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-----------N----PAQIYKKVTSGKL  139 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~-----------~----~~ql~~kI~~g~~  139 (502)
                         .....+|+.|+|||++.+ .++.++|||||||++|+|+||..||....           .    ...+...+..+..
T Consensus       202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (326)
T 2w1i_A          202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR  281 (326)
T ss_dssp             EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred             cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC
Confidence               223457888999998864 48899999999999999999999885310           0    0112233333322


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      + ..+...+.++.++|.+||. +|.+|||+.|+++
T Consensus       282 ~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          282 L-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             C-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2 2344567899999999998 9999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=4.1e-27  Score=254.34  Aligned_cols=169  Identities=22%  Similarity=0.342  Sum_probs=140.9

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|.+|+.+  .+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+.... 
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce
Confidence            6789999999974  356999999999999999999999998  9999999999999876 789999999997654321 


Q ss_pred             -CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                       ......+++.|+|||++. +.++.++|||||||+||+|++ |..||.+ ....++...+..+... ..+...+..+.+|
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l  496 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDL  496 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence             122345788999999775 569999999999999999999 9999987 4556677777666432 2344567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.+|+..
T Consensus       497 i~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999 99999999999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=9e-27  Score=258.19  Aligned_cols=169  Identities=24%  Similarity=0.436  Sum_probs=139.9

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.++++..+ .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCCeecCCCcce
Confidence            678999999998654 6999999999999999999999998  9999999999999977 7999999999987644322 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..++...+..+..+ ..+...++.+.++|
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  625 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYSLM  625 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHH
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHHHHHH
Confidence             22345788999999885 458999999999999999997 9999977 4556667777666543 24445678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.++++.
T Consensus       626 ~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          626 TKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH
Confidence            99998 99999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=3.9e-26  Score=253.06  Aligned_cols=160  Identities=19%  Similarity=0.300  Sum_probs=129.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++..  ++++..++.|+.||+.||.|||+++  ||||||||+|||++.+  .+||+|||+++.....   .
T Consensus       165 ~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~---~  235 (681)
T 2pzi_A          165 YVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF---G  235 (681)
T ss_dssp             CCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--CEEECCCTTCEETTCC---S
T ss_pred             eCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--cEEEEecccchhcccC---C
Confidence            6789999998865  7999999999999999999999998  9999999999999864  7999999999876543   4


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      ..+||+.|+|||++.+.++.++|||||||++|+|++|..||.+..         ..+..........++.+.++|.+||.
T Consensus       236 ~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~  306 (681)
T 2pzi_A          236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLPEDDPVLKTYDSYGRLLRRAID  306 (681)
T ss_dssp             CCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEE---------CSSCCTTCHHHHHCHHHHHHHHHHTC
T ss_pred             ccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccc---------cccccccccccccCHHHHHHHhhhcc
Confidence            568999999999998888999999999999999999998886411         01111111111235689999999999


Q ss_pred             -CcCCCCCHHHHhcCCCCc
Q 010730          161 -NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~  178 (502)
                       ||.+||+..+.|.++|+.
T Consensus       307 ~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          307 PDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             SSGGGSCSSHHHHHHHHHH
T ss_pred             CChhhCCCHHHHHHHHHHH
Confidence             999999988888888874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.87  E-value=3.7e-23  Score=205.54  Aligned_cols=143  Identities=15%  Similarity=0.140  Sum_probs=110.9

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++++.  .....+..++.||+.||+|||++|  |+||||||+|||++.+ +.+||+++             
T Consensus       112 ~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~-------------  173 (286)
T 3uqc_A          112 WIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYP-------------  173 (286)
T ss_dssp             CCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSC-------------
T ss_pred             ecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEec-------------
Confidence            57899999999543  466678899999999999999998  9999999999999977 78988733             


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHH--HHhhcCCCC--CcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY--KKVTSGKLP--GAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~--~kI~~g~~p--~~~~~~~s~~l~~LI~  156 (502)
                            .|++|      ++.++|||||||++|+|+||..||.+......+.  .+...+..+  .......++.++++|.
T Consensus       174 ------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  241 (286)
T 3uqc_A          174 ------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA  241 (286)
T ss_dssp             ------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred             ------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence                  34443      7889999999999999999999997643322110  011112111  1223346788999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. ||.+| |+.|+++.
T Consensus       242 ~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          242 RSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHCTTSSCC-CHHHHHHH
T ss_pred             HHcccCCccC-CHHHHHHH
Confidence            9999 99999 99999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.87  E-value=5.9e-24  Score=232.13  Aligned_cols=115  Identities=14%  Similarity=0.119  Sum_probs=85.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.++|++.+++++..   +++||+.||+|||++|  ||||||||+|||++.+ |.|||+|||+|+..... ...
T Consensus       323 yv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          323 KLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             CCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCS
T ss_pred             cCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCCCCCccc
Confidence            789999999999999998764   6899999999999999  9999999999999887 89999999999876543 345


Q ss_pred             ccccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCC
Q 010730           80 HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY  121 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf  121 (502)
                      .+.+||+.|||||++.+.+..++|+||+|+++++|+++..|+
T Consensus       397 ~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             cCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            678999999999999999999999999999998887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.62  E-value=5.5e-17  Score=176.01  Aligned_cols=109  Identities=21%  Similarity=0.299  Sum_probs=94.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.||+|.+++.+        +..|+.||+.||+|||+++  |+||||||+|||++.   .+||+|||+++.......  
T Consensus       420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred             CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence            6789999999976        6689999999999999999  999999999999986   799999999998754321  


Q ss_pred             ------cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCC
Q 010730           79 ------AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYS  122 (502)
Q Consensus        79 ------~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~  122 (502)
                            ..+.+||+.|||||++..   .|+..+|+|+..+-..+.+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  236789999999999864   48889999999998888888877774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.28  E-value=6.8e-13  Score=132.00  Aligned_cols=72  Identities=21%  Similarity=0.203  Sum_probs=60.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+ +.      ...+..++.||+.||.|||++|  |+||||||+|||++ + +.+||+|||++..        
T Consensus       181 ~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~vkl~DFG~a~~--------  241 (282)
T 1zar_A          181 LIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIIDFPQSVE--------  241 (282)
T ss_dssp             CCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECCCTTCEE--------
T ss_pred             ecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-CcEEEEECCCCeE--------
Confidence            578899988 42      1235578999999999999999  99999999999999 5 8999999999863        


Q ss_pred             cccCCCcccCccccc
Q 010730           81 SVIGTPEFMAPELYE   95 (502)
Q Consensus        81 s~vGTp~Y~APEvl~   95 (502)
                          +..++|||++.
T Consensus       242 ----~~~~~a~e~l~  252 (282)
T 1zar_A          242 ----VGEEGWREILE  252 (282)
T ss_dssp             ----TTSTTHHHHHH
T ss_pred             ----CCCCCHHHHHH
Confidence                45578999875

>2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus}

Probab=98.79  E-value=2.6e-12  Score=107.78  Aligned_cols=65  Identities=28%  Similarity=0.361  Sum_probs=60.2

Q ss_pred             CCceEEEEEEEcCC---CCee---eeccCCCcccccHHHHHHHHHhcccCCCCCHHHHHHHHHHHHHhhCC
Q 010730          231 DDTIFLKVQITDKD---GQAR---NIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVP  295 (502)
Q Consensus       231 ~~~i~L~l~i~d~~---G~~~---~i~f~fd~~~Dt~~~VA~EMV~~l~l~~~d~~~ia~~Id~~i~~l~p  295 (502)
                      ...++|+||+.|++   |+.|   +|+|+||+.+|++.+||+|||+++.+.++|...||+||+..|..+-.
T Consensus        23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~r   93 (98)
T 2lru_A           23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKR   93 (98)
Confidence            45899999999994   8888   99999999999999999999999999999999999999999887753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.86  E-value=1.4e-09  Score=106.26  Aligned_cols=60  Identities=23%  Similarity=0.313  Sum_probs=51.1

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         6 sL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLH-s~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      +|.++...   .++..+..++.||+.+|.||| .++  |+||||||+|||++.   .++|+|||+|...
T Consensus       159 ~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          159 TLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             BHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             cHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            77776543   234567889999999999999 888  999999999999986   7999999999764

>2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens}

Probab=98.52  E-value=1.6e-07  Score=78.14  Aligned_cols=59  Identities=19%  Similarity=0.269  Sum_probs=56.8

Q ss_pred             ceEEEEEEEcCCCCeeeeccCCCcccccHHHHHHHHHhcccCCCCCHHHHHHHHHHHHH
Q 010730          233 TIFLKVQITDKDGQARNIYFPFDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEIS  291 (502)
Q Consensus       233 ~i~L~l~i~d~~G~~~~i~f~fd~~~Dt~~~VA~EMV~~l~l~~~d~~~ia~~Id~~i~  291 (502)
                      .+.|.||++|.+.++.+|.|.|-..+||+.+||+|||....|+..|..++|.+|++.|.
T Consensus         2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~   60 (96)
T 2v3s_A            2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE   60 (96)
T ss_dssp             CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred             CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence            46899999999999999999999999999999999999999999999999999999997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.24  E-value=3.5e-07  Score=95.81  Aligned_cols=64  Identities=16%  Similarity=0.173  Sum_probs=49.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----------cEEEEecCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----------QIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g----------~vKL~DFGlA   70 (502)
                      |+.|++|.+++      +...+..++.||+.+|.|||.+|  ||||||||.|||++.+ +          .+.||||+-+
T Consensus       192 ~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-gd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          192 LVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-KDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             CCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-ECSSCTTSEEEEEEECCCTTC
T ss_pred             ecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-CCcccccccccceEEEEeCCc
Confidence            45566665432      22345678899999999999998  9999999999999765 3          3899999977


Q ss_pred             eec
Q 010730           71 AIL   73 (502)
Q Consensus        71 ~~~   73 (502)
                      ...
T Consensus       263 V~~  265 (397)
T 4gyi_A          263 VSM  265 (397)
T ss_dssp             EET
T ss_pred             ccC
Confidence            543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.43  E-value=4.7e-05  Score=75.22  Aligned_cols=77  Identities=22%  Similarity=0.219  Sum_probs=50.1

Q ss_pred             CeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCCcccccCCCcc---cCccccc---cCCCC------------cc
Q 010730           42 PVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQAHSVIGTPEF---MAPELYE---EDYNE------------LV  102 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y---~APEvl~---~~ys~------------~~  102 (502)
                      .++|+|++|.||+++.+ .+.+.|+||+.+.........   .....+   ..|+...   ..|..            ..
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~  268 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKE  268 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHH
Confidence            48999999999999874 246789999998754321111   111111   2333221   11221            25


Q ss_pred             cchhHHHHHHHHhhccCCC
Q 010730          103 DIYSFGMCVLEMLTSEYPY  121 (502)
Q Consensus       103 DIWSLGviLyeLLTG~~Pf  121 (502)
                      +.|++|.++|.+.+|..+|
T Consensus       269 ~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          269 KYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHcCCHHH
Confidence            7899999999999999876

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=96.93  E-value=0.00075  Score=64.50  Aligned_cols=30  Identities=33%  Similarity=0.306  Sum_probs=24.4

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      .++|+|++|.||++++. +.+.|+||+.+..
T Consensus       184 ~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             eEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence            48999999999999864 3457999997743

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.74  E-value=0.013  Score=56.58  Aligned_cols=120  Identities=15%  Similarity=0.103  Sum_probs=77.2

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            6 TLREYRKK-YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         6 sL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      +|.+.++. ..++++++++.++.|.+..|.-+-. ..  -..+=+-|..|++..+ |.|.+.+ +.+.           .
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~   98 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A   98 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence            68898875 5789999999999999998876521 11  1133344678888876 6776653 1110           1


Q ss_pred             CCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           84 GTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        84 GTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      ....+.|||........+.-|||||+++|.-+-=..|                    ...+...++.+..||..|..
T Consensus        99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A           99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTT
T ss_pred             cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHh
Confidence            2334668887755566778899999999987653222                    23445568889999988875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=96.72  E-value=0.0013  Score=66.14  Aligned_cols=58  Identities=17%  Similarity=0.205  Sum_probs=47.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------------
Q 010730           16 RVDIRAVKNWARQILRGIAYLHGH--------------------------------------------------------   39 (502)
Q Consensus        16 ~L~e~~i~~i~~QIL~gL~YLHs~--------------------------------------------------------   39 (502)
                      .++......++.++...|..||..                                                        
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            467888888999999999999973                                                        


Q ss_pred             CCCeEecCCCCCcEEEeCCCCc-EEEEecCCceec
Q 010730           40 DPPVIHRDLKCDNIFVNGHLGQ-IKIGDLGLAAIL   73 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~~g~-vKL~DFGlA~~~   73 (502)
                      .+.++|+|+++.||+++.+... +.|+||+.+..-
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence            1459999999999999865323 689999998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=96.41  E-value=0.0019  Score=60.78  Aligned_cols=29  Identities=28%  Similarity=0.220  Sum_probs=24.6

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           43 VIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        43 IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ++|+|++|.||+++++ +.+.|+|||.+..
T Consensus       186 l~HgDl~~~Nil~~~~-~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENG-RFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence            9999999999999865 4567999998754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.77  E-value=0.035  Score=54.35  Aligned_cols=45  Identities=24%  Similarity=0.265  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHh-----------CCCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           27 RQILRGIAYLHG-----------HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        27 ~QIL~gL~YLHs-----------~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      .++..++++|+.           ....++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus       197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~  252 (346)
T 2q83_A          197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence            344456666653           23459999999999999765 5799999997743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=92.34  E-value=0.16  Score=50.11  Aligned_cols=34  Identities=38%  Similarity=0.429  Sum_probs=26.1

Q ss_pred             CCCeEecCCCCCcEEEeCC--CCc-EEEEecCCceec
Q 010730           40 DPPVIHRDLKCDNIFVNGH--LGQ-IKIGDLGLAAIL   73 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~--~g~-vKL~DFGlA~~~   73 (502)
                      .+.++|+|++|.||+++.+  .+. +.|+||+.+..-
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            3458999999999999871  234 489999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=90.19  E-value=0.22  Score=51.20  Aligned_cols=31  Identities=19%  Similarity=0.324  Sum_probs=26.4

Q ss_pred             CCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           40 DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      .+.++|+|++|.|||++.+ + ++++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence            3459999999999999875 3 99999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=85.83  E-value=0.86  Score=44.50  Aligned_cols=29  Identities=24%  Similarity=0.123  Sum_probs=24.5

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           41 PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ..++|+|+++.||+++ +  .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            3488999999999998 3  699999987754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=85.46  E-value=0.55  Score=46.59  Aligned_cols=31  Identities=16%  Similarity=0.372  Sum_probs=25.4

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           41 PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      +.++|+|+.+.||++++. +.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~-~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDF-QPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETT-EEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCC-cEEEEEccccccc
Confidence            459999999999999853 3578999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=85.35  E-value=0.45  Score=45.05  Aligned_cols=29  Identities=31%  Similarity=0.410  Sum_probs=24.3

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           43 VIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        43 IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ++|+|+.+.||++++. +.+-|+||+.+..
T Consensus       195 l~HGDl~~~Nil~~~~-~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEG-KLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence            7899999999999865 4556999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=83.63  E-value=0.48  Score=46.23  Aligned_cols=30  Identities=37%  Similarity=0.387  Sum_probs=24.7

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      .++|+|+.+.||+++++ +.+.|+||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGD-ELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence            59999999999999875 3457999997743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=82.07  E-value=1.3  Score=43.61  Aligned_cols=33  Identities=21%  Similarity=0.293  Sum_probs=27.0

Q ss_pred             CCeEecCCCCCcEEEeCC---CCcEEEEecCCceec
Q 010730           41 PPVIHRDLKCDNIFVNGH---LGQIKIGDLGLAAIL   73 (502)
Q Consensus        41 ~~IIHRDLKPeNILl~~~---~g~vKL~DFGlA~~~   73 (502)
                      +.++|+|+.+.||+++.+   .+.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999763   147899999988653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	502
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-37
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-34
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-33
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-26
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-26
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-25
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-25
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-24
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-23
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-22
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-21
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-20
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-08

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-54
 Identities = 94/174 (54%), Positives = 125/174 (71%), Gaps = 2/174 (1%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GTL+ Y K++  + I+ +++W RQIL+G+ +LH   PP+IHRDLKCDNIF+ G  G +KI
Sbjct: 97  GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
           GDLGLA + R S  A +VIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYPYSEC
Sbjct: 157 GDLGLATLKRASF-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 215

Query: 125 SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            N AQIY++VTSG  P +F ++   E +  +  C+  N  +R   K+LL   F 
Sbjct: 216 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-39
 Identities = 45/179 (25%), Positives = 93/179 (51%), Gaps = 9/179 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT+    +K ++ D +    +  ++   ++Y H     VIHRD+K +N+ +    G++KI
Sbjct: 91  GTVYRELQKLSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSA-GELKI 147

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSE 123
            D G +     S +  ++ GT +++ PE+ E   ++E VD++S G+   E L  + P+ E
Sbjct: 148 ADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 205

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
            +   + YK+++  +    F       AR  + + L+ N S+R   +E+L  P++ +++
Sbjct: 206 ANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-37
 Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 13/183 (7%)

Query: 5   GTLREYRKKYTR----VDIRAVKNWARQILRGIAYLH---GHDPPVIHRDLKCDNIFVNG 57
           G L     K T+    +D   V     Q+   +   H        V+HRDLK  N+F++G
Sbjct: 90  GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149

Query: 58  HLGQIKIGDLGLAAIL-RGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEML 115
               +K+GD GLA IL   +  A + +GTP +M+PE      YNE  DI+S G  + E+ 
Sbjct: 150 K-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208

Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
               P+    +  ++  K+  GK     +R    E    + + L      R   +E+L +
Sbjct: 209 ALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDELNEIITRMLNLKDYHRPSVEEILEN 266

Query: 175 PFL 177
           P +
Sbjct: 267 PLI 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 4e-37
 Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 15/180 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
            +L  +     T+ ++  + + ARQ  +G+ YLH     +IHRDLK +NIF++     +K
Sbjct: 88  SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHED-LTVK 144

Query: 64  IGDLGLAAIL---RGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLT 116
           IGD GLA +     GS Q   + G+  +MAPE+        Y+   D+Y+FG+ + E++T
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELL 172
            + PYS  +N  QI   V  G L     +++       +R + +CL+    +R    ++L
Sbjct: 205 GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-36
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 5   GTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G +     +  R +    ++   +Q L  + YLH +   +IHRDLK  NI      G IK
Sbjct: 94  GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIK 150

Query: 64  IGDLGLAAIL-RGSQQAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLT 116
           + D G++A   R  Q+  S IGTP +MAPE+       +  Y+   D++S G+ ++EM  
Sbjct: 151 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
            E P+ E  NP ++  K+   + P  A      +  + F+ KCLE NV  R    +LL  
Sbjct: 211 IEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269

Query: 175 PFLASDAGEPL--LIPQ 189
           PF+  D+ +P+  LI +
Sbjct: 270 PFVTVDSNKPIRELIAE 286

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 9/179 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +  +    +     + +  Q++ G+ YLHG    + HRD+K +N+ ++     +KI
Sbjct: 88  GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKI 144

Query: 65  GDLGLAAILRGSQQAH---SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEY 119
            D GLA + R + +      + GT  ++APEL    E + E VD++S G+ +  ML  E 
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           P+ + S+  Q Y      K      +  D+     + K L  N S R+   ++  D + 
Sbjct: 205 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-35
 Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 7/191 (3%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +   + T +D   +    R+ L+ + +LH +   VIHRD+K DNI +    G +K+
Sbjct: 102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMD-GSVKL 157

Query: 65  GDLGLAAILRGSQ-QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D G  A +   Q +  +++GTP +MAPE +  + Y   VDI+S G+  +EM+  E PY 
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
             +    +Y   T+G           A  R F+ +CL+ +V KR  AKELL   FL    
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

Query: 182 GEPLLIPQVPS 192
               L P + +
Sbjct: 278 PLSSLTPLIAA 288

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  129 bits (325), Expect = 8e-35
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 14/183 (7%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y  +   +  +  +   R +L  I  LH  +  ++HRDLK +NI ++     IK+
Sbjct: 95  GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKL 151

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTS 117
            D G +  L   ++   V GTP ++APE+ E         Y + VD++S G+ +  +L  
Sbjct: 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211

Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLD 174
             P+        + + + SG          D     +  V + L     KR  A+E L  
Sbjct: 212 SPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270

Query: 175 PFL 177
           PF 
Sbjct: 271 PFF 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 2e-34
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 12/196 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
                       +    +       L+G+AYLH H   +IHRD+K  NI ++   G +K+
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKL 156

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYP 120
           GD G A+I+     A+S +GTP +MAPE+        Y+  VD++S G+  +E+   + P
Sbjct: 157 GDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
               +  + +Y  +   + P           R FV  CL+     R  ++ LL   F+  
Sbjct: 214 LFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272

Query: 180 DAGEPLLIPQVPSFQN 195
           +    +++  +   ++
Sbjct: 273 ERPPTVIMDLIQRTKD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-34
 Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 47/237 (19%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G+L +  KK  R+  + +   +  +++G+ YL      ++HRD+K  NI VN   G+IK+
Sbjct: 89  GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKL 146

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS- 122
            D G++  L  S  A+S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP   
Sbjct: 147 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

Query: 123 ----------------------------------------ECSNPAQIYKKVTSGKLPGA 142
                                                         ++   + +   P  
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265

Query: 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQ-VPSFQNLN 197
              +   E + FV KCL  N ++R   K+L++  F+     E +     + S   LN
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 322

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  127 bits (319), Expect = 3e-33
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 10/196 (5%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQI 62
           G L E    ++ ++       + RQ+ +G+ ++H ++   +H DLK +NI        ++
Sbjct: 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL 165

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           K+ D GL A L   Q      GT EF APE+ E +      D++S G+    +L+   P+
Sbjct: 166 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
               N  +  + V S               + + F+ K L  + + R+   + L  P+L 
Sbjct: 226 GG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL- 283

Query: 179 SDAGEPLLIPQVPSFQ 194
           +    P    Q+PS +
Sbjct: 284 TPGNAPGRDSQIPSSR 299

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 8e-33
 Identities = 47/191 (24%), Positives = 85/191 (44%), Gaps = 9/191 (4%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQI 62
           G L +   +      R       Q+L  + YLH  D  ++HRDLK +N+         +I
Sbjct: 92  GELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKI 149

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            I D GL+ +        +  GTP ++AP  L ++ Y++ VD +S G+    +L    P+
Sbjct: 150 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
            +  N A++++++   +         D    A+ F+   +E +  KR   ++ L  P++A
Sbjct: 210 YD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

Query: 179 SDAGEPLLIPQ 189
            D      I Q
Sbjct: 269 GDTALDKNIHQ 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  125 bits (315), Expect = 1e-32
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 11/194 (5%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQI 62
           G L +    +  ++    V N+ RQ   G+ ++H H   ++H D+K +NI         +
Sbjct: 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSV 168

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
           KI D GLA  L   +       T EF APE+ + E      D+++ G+    +L+   P+
Sbjct: 169 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
           +   +  +  + V                 EA+ F+   L+    KRL   + L  P+L 
Sbjct: 229 AG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

Query: 179 SDAGEPLLIPQVPS 192
            D     L  ++PS
Sbjct: 288 GD--HSNLTSRIPS 299

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 2e-32
 Identities = 44/221 (19%), Positives = 88/221 (39%), Gaps = 10/221 (4%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQI 62
             + E        ++ R + ++  Q+   + +LH H   + H D++ +NI         I
Sbjct: 86  LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTI 143

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
           KI + G A  L+       +   PE+ APE+++ D  +   D++S G  V  +L+   P+
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
                  QI + + + +        ++   EA  FV + L      R+ A E L  P+L 
Sbjct: 204 -LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL- 261

Query: 179 SDAGEPLLIPQVPSFQNLNPNGAVMELVPKFAVDSDRRKST 219
               E +    + + ++      +++      V + R    
Sbjct: 262 KQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG 302

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 6e-31
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y +K    D    + +  +I+  + YLH     +IHRDLK +NI +N     I+I
Sbjct: 93  GELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNED-MHIQI 149

Query: 65  GDLGLAAILRGSQQ---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
            D G A +L    +   A+S +GT ++++PE L E+   +  D+++ G  + +++    P
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE------LLL 173
           +    N   I++K+   +    F      +AR  V K L  + +KRL  +E      L  
Sbjct: 210 F-RAGNEYLIFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

Query: 174 DPFLASDAGEPLL---IPQVPS 192
            PF  S   E L     P++ +
Sbjct: 267 HPFFESVTWENLHQQTPPKLTA 288

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 38/200 (19%), Positives = 86/200 (43%), Gaps = 20/200 (10%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
                 L ++  +   +     +++  Q+L  + + H     V+HRD+K +NI ++ + G
Sbjct: 91  PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRG 148

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           ++K+ D G  A+L+ +       GT  +  PE       +     ++S G+ + +M+  +
Sbjct: 149 ELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            P+            +  G++   F +   +E +  +  CL    S R   +E+   P++
Sbjct: 208 IPFEHDEE-------IIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

Query: 178 ASDAGEPLLIPQVPSFQNLN 197
                  +L+PQ  +  +L+
Sbjct: 259 QD-----VLLPQETAEIHLH 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-28
 Identities = 40/198 (20%), Positives = 76/198 (38%), Gaps = 17/198 (8%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--G 60
           G L      +       R      + I   I YLH  +  + HRD+K +N+         
Sbjct: 94  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 151

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
            +K+ D G A          +   TP ++APE+   E Y++  D++S G+ +  +L    
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211

Query: 120 PYSECSNPA---QIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
           P+      A    +  ++  G+   P         E +  +   L+   ++R+   E + 
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

Query: 174 DPFLASDAGEPLLIPQVP 191
            P++     +   +PQ P
Sbjct: 272 HPWIM----QSTKVPQTP 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 45/220 (20%), Positives = 78/220 (35%), Gaps = 31/220 (14%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
             R Y +    + +  VK +  Q+ R +AY+H     + HRD+K  N+ ++     +K+ 
Sbjct: 108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLC 165

Query: 66  DLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
           D G A  L   +   S I +  + APEL     DY   +D++S G  + E+L  +  +  
Sbjct: 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

Query: 124 CSNPAQIYK--------------------------KVTSGKLPGAFHRIQDAEARRFVGK 157
            S   Q+ +                          ++ +      F      EA     +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285

Query: 158 CLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQNL 196
            LE   + RL   E     F        + +P       L
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPAL 325

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 8e-28
 Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 14/187 (7%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
               G L  +  +         + +  +I+  +   + H   V++RD+K +N+ ++   G
Sbjct: 86  YANGGELFFHLSRERVFTEERARFYGAEIVSALE--YLHSRDVVYRDIKLENLMLDKD-G 142

Query: 61  QIKIGDLGLAAILRGS-QQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE 118
            IKI D GL            +  GTPE++APE+ E  DY   VD +  G+ + EM+   
Sbjct: 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELL 172
            P+    +  ++++ +   ++   F R    EA+  +   L+ +  +RL      AKE++
Sbjct: 203 LPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259

Query: 173 LDPFLAS 179
              F  S
Sbjct: 260 EHRFFLS 266

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 12/199 (6%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQ 61
           G L ++  +   +       + +QIL G+   + H   + H DLK +NI +   N    +
Sbjct: 98  GELFDFLAEKESLTEEEATEFLKQILNGVY--YLHSLQIAHFDLKPENIMLLDRNVPKPR 155

Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
           IKI D GLA  +    +  ++ GTPEF+APE+   +      D++S G+    +L+   P
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

Query: 121 YSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           +       +    V++        +     A A+ F+ + L  +  KR+  ++ L  P++
Sbjct: 216 F-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

Query: 178 ASDAGEPLLIPQV--PSFQ 194
                +  L      P F+
Sbjct: 275 KPKDTQQALSSAWSHPQFE 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-27
 Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 9/173 (5%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L +Y R +        +      +  G+AYL   +  VIHRDL   N  V  +   IK
Sbjct: 85  GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGEN-QVIK 141

Query: 64  IGDLGLAAILRGSQ--QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           + D G+   +   Q   +       ++ +PE      Y+   D++SFG+ + E+ +    
Sbjct: 142 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
             E  + +++ + +++G       R+      + +  C  E    R     LL
Sbjct: 202 PYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-27
 Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 12/189 (6%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
                +    + +  + + A QI  G+AY+       +HRDL+  NI V  +    K+ D
Sbjct: 100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGEN-LVCKVAD 156

Query: 67  LGLAAILRGSQ--QAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
            GLA ++  ++           ++ APE      +    D++SFG+ + E+ T       
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216

Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LDPFLASD 180
                ++  +V  G                 + +C      +R   + L   L+ +  S 
Sbjct: 217 GMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

Query: 181 AGEPLLIPQ 189
             EP   P 
Sbjct: 276 --EPQYQPG 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-27
 Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 10/191 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  + +   + D+     +A +I+ G+ +LH     +++RDLK DNI ++   G IKI
Sbjct: 88  GDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKI 144

Query: 65  GDLGLAAILR-GSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D G+      G  + ++  GTP+++APE L  + YN  VD +SFG+ + EML  + P+ 
Sbjct: 145 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF- 203

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK-ELLLDPFLASD 180
              +  +++  +        + R  + EA+  + K       KRL  + ++   P     
Sbjct: 204 HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

Query: 181 AGEPLLIPQVP 191
             E L   ++ 
Sbjct: 262 NWEELERKEID 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 9/203 (4%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           M     L   R+    +  + + NW  QI +G+ YL      ++HRDL   N+ V     
Sbjct: 92  MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTP-Q 148

Query: 61  QIKIGDLGLAAILRGSQQAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
            +KI D GLA +L   ++ +         ++MA E +    Y    D++S+G+ V E++T
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
                 +    ++I   +  G+       I   +    + KC   +   R   +EL+++ 
Sbjct: 209 FGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

Query: 176 FLASDAGEPLLIPQVPSFQNLNP 198
              +   +  L+ Q     +L  
Sbjct: 268 SKMARDPQRYLVIQGDERMHLPS 290

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 60/196 (30%), Positives = 83/196 (42%), Gaps = 29/196 (14%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
            +     V    +K+   Q+LRG+ +LH H   V+HRDLK  NI V    GQIK+ D GL
Sbjct: 106 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGL 162

Query: 70  AAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           A I        SV+ T  + APE L +  Y   VD++S G    EM   +  +   S+  
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222

Query: 129 QIYKKVTSGKLPG-------------AFHRIQ-----------DAEARRFVGKCLE-NVS 163
           Q+ K +    LPG             AFH              D   +  + KCL  N +
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282

Query: 164 KRLPAKELLLDPFLAS 179
           KR+ A   L  P+   
Sbjct: 283 KRISAYSALSHPYFQD 298

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 10/176 (5%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
                 ++ I  + + A QI  G+A++       IHRDL+  NI V+      KI D GL
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDT-LSCKIADFGL 155

Query: 70  AAILRGSQQAH--SVIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN 126
           A ++  ++           ++ AP  +    +    D++SFG+ + E++T          
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

Query: 127 PAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL--LDPFLAS 179
             ++ + +  G            E  + +  C  E    R     L   L+ F  +
Sbjct: 216 NPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 51/192 (26%), Positives = 97/192 (50%), Gaps = 15/192 (7%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
           L    +K  R      K +A ++   + YLH     +I+RDLK +NI ++ + G IKI D
Sbjct: 91  LFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKN-GHIKITD 147

Query: 67  LGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
            G A  +      +++ GTP+++APE +  + YN+ +D +SFG+ + EML    P+ + S
Sbjct: 148 FGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-S 204

Query: 126 NPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELLLDPFLAS 179
           N  + Y+K+ + +L   F    + + +  + + +  ++S+RL       +++   P+   
Sbjct: 205 NTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

Query: 180 DAGEPLLIPQVP 191
              E LL   + 
Sbjct: 263 VVWEKLLSRNIE 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 10/172 (5%)

Query: 5   GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI 62
           G+L +Y   +  + +    +  ++  +   + YL G+    +HRDL   N+ V+      
Sbjct: 86  GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSED-NVA 142

Query: 63  KIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           K+ D GL      S    +     ++ APE L E+ ++   D++SFG+ + E+ +     
Sbjct: 143 KVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                   +  +V  G    A            +  C   + + R    +L 
Sbjct: 201 YPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLR 251

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 3e-26
 Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 10/174 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L +Y ++   V  + +     Q+  G+ YL       +HRDL   N+ +       KI
Sbjct: 92  GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQ-HYAKI 148

Query: 65  GDLGLAAILRGSQQAHS----VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
            D GL+  LR  +  +          ++ APE +    ++   D++SFG+ + E  +   
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                   +++   +  G+  G        E    +  C   +V  R     + 
Sbjct: 209 KPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPGFAAVE 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  107 bits (267), Expect = 4e-26
 Identities = 59/276 (21%), Positives = 116/276 (42%), Gaps = 38/276 (13%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           G L  +  ++       ++ +A +I+ G+ ++H  +  V++RDLK  NI ++ H G ++I
Sbjct: 92  GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH-GHVRI 148

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYS 122
            DLGLA      ++ H+ +GT  +MAPE+ ++   Y+   D +S G  + ++L    P+ 
Sbjct: 149 SDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL-----PAKELLLDPF 176
           +     +      +  +          E R  +   L+ +V++RL      A+E+   PF
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

Query: 177 LASDAGEPLLI-----PQVPSFQNLNPNGAV-------------------MELVPKFAVD 212
             S   + + +     P +P    +N   A                     EL   F + 
Sbjct: 268 FRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLT 327

Query: 213 SDRRKSTDM--TITGTMNPEDDTIFLKVQITDKDGQ 246
              R   ++  T+  T+N E D +  + +  +K   
Sbjct: 328 ISERWQQEVAETVFDTINAETDRLEARKKTKNKQLG 363

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 38/177 (21%), Positives = 76/177 (42%), Gaps = 9/177 (5%)

Query: 1   MFTSGTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
           + T G LR +   +   +D+ ++  +A Q+   +AYL       +HRD+   N+ V+ + 
Sbjct: 88  LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSN- 144

Query: 60  GQIKIGDLGLAAILRGSQQAHS--VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
             +K+GD GL+  +  S    +       ++MAPE +    +    D++ FG+C+ E+L 
Sbjct: 145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                 +      +  ++ +G+                + KC   + S+R    EL 
Sbjct: 205 HGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRRPRFTELK 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 10/180 (5%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
            TLR+       +  +          + + + H +   +IHRD+K  NI ++     +K+
Sbjct: 96  VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISAT-NAVKV 152

Query: 65  GDLGLAAILRGSQ----QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
            D G+A  +  S     Q  +VIGT ++++PE    +  +   D+YS G  + E+LT E 
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

Query: 120 PYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
           P++  S  +  Y+ V    + P A H    A+    V K L  N   R      +    +
Sbjct: 213 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 6/174 (3%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           + T           + +  + + ++A  + RG+ YL       IHRDL   NI V  +  
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN-Y 164

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
             KI D GL+       +         +MA E L    Y    D++S+G+ + E+++   
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                   A++Y+K+  G          D E    + +C      +R    ++L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 3e-25
 Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 10/177 (5%)

Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           + +    E  +    +    +  +A Q+ +G+ +L       +HRDL   N+ V      
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KV 202

Query: 62  IKIGDLGLAAILRGSQQAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           +KI D GLA  +          +     ++MAPE L+E  Y    D++S+G+ + E+ + 
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 118 -EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
              PY      A  YK + +G            E    +  C   +  KR     L 
Sbjct: 263 GVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 3e-25
 Identities = 32/175 (18%), Positives = 61/175 (34%), Gaps = 11/175 (6%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L ++   K   + +  V     Q+  G+ YL       +HRDL   N+ +       K
Sbjct: 93  GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNR-HYAK 149

Query: 64  IGDLGLAAILRGSQQAH----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           I D GL+  L      +    +     ++ APE +    ++   D++S+G+ + E L+  
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
               +     ++   +  GK           E    +  C       R     + 
Sbjct: 210 QKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWEDRPDFLTVE 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 6e-25
 Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 9/173 (5%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G L  Y R+   R   + +    + +   + YL       +HRDL   N  VN   G +K
Sbjct: 84  GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQ-GVVK 140

Query: 64  IGDLGLAAILRGSQQAHS--VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP 120
           + D GL+  +   +   S        +  PE+     ++   DI++FG+ + E+ +    
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200

Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
             E    ++  + +  G        +   +    +  C  E   +R   K LL
Sbjct: 201 PYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKILL 252

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 32/171 (18%), Positives = 60/171 (35%), Gaps = 9/171 (5%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            R        +        ARQ+  G+AYL       +HRDL   N  V  +   +KI D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIAD 183

Query: 67  LGLAAILRGSQQAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            GL+  +  +       +      +M PE ++   Y    D++++G+ + E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
                 ++   V  G +  A       E    +  C  +  + R     + 
Sbjct: 244 YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 32/186 (17%), Positives = 68/186 (36%), Gaps = 15/186 (8%)

Query: 5   GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L  + R+   +  +  +    R I  G+ YL       +HRDL   NI VN +    K
Sbjct: 112 GSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSN-LVCK 168

Query: 64  IGDLGLAAILRGSQQAHSV------IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT 116
           + D GL+  L       +            + APE  +   +    D++S+G+ + E+++
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--L 173
                        +   +              +   + +  C + + + R    +++  L
Sbjct: 229 YGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 174 DPFLAS 179
           D  + +
Sbjct: 288 DKMIRN 293

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 15/186 (8%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
               G +  + ++  R      + +A QI+    YLH  D  +I+RDLK +N+ ++   G
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-G 178

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
            I++ D G A   R   +  ++ GTPE +APE +  + YN+ VD ++ G+ + EM     
Sbjct: 179 YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELLL 173
           P+     P QIY+K+ SGK+   F     ++ +  +   L+ +++KR         ++  
Sbjct: 237 PF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293

Query: 174 DPFLAS 179
             + A+
Sbjct: 294 HKWFAT 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 4e-24
 Identities = 35/181 (19%), Positives = 72/181 (39%), Gaps = 12/181 (6%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
            +  R+K     +  +    R I  G+ Y    +   +HRDL   NI VN +    K+ D
Sbjct: 97  DKFLREKDGEFSVLQLVGMLRGIAAGMKY--LANMNYVHRDLAARNILVNSN-LVCKVSD 153

Query: 67  LGLAAILRGSQQAHSVI----GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
            GL+ +L    +A            + APE +    +    D++SFG+ + E++T     
Sbjct: 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL--LDPFLA 178
               +  ++ K +  G           +   + + +C  +  ++R    +++  LD  + 
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

Query: 179 S 179
           +
Sbjct: 273 A 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 5e-24
 Identities = 40/213 (18%), Positives = 77/213 (36%), Gaps = 40/213 (18%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
                      +  +  +K   + +L G+ Y+H     ++HRD+K  N+ +    G +K+
Sbjct: 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD-GVLKL 158

Query: 65  GDLGLAAILRGSQQAH-----SVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
            D GLA     ++ +      + + T  +  PE  L E DY   +D++  G  + EM T 
Sbjct: 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218

Query: 118 EYPYSECSNPAQIYK--------------KVTSGKLPGAFHRIQ---------------D 148
                  +   Q+                 V + +L      ++               D
Sbjct: 219 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278

Query: 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
             A   + K L  + ++R+ + + L   F  SD
Sbjct: 279 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 6e-24
 Identities = 39/202 (19%), Positives = 76/202 (37%), Gaps = 15/202 (7%)

Query: 5   GTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G LR + +  T    ++ +  +  Q+ +G+          +HRDL   N  ++     +K
Sbjct: 114 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEK-FTVK 170

Query: 64  IGDLGLAAILRGSQQAH-----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
           + D GLA  +   +              ++MA E L  + +    D++SFG+ + E++T 
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230

Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LD 174
             P     N   I   +  G+         D      + KC       R    EL+  + 
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRIS 289

Query: 175 PFLASDAGEPLLIPQVPSFQNL 196
              ++  GE   +    ++ N+
Sbjct: 290 AIFSTFIGEH-YVHVNATYVNV 310

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 6e-24
 Identities = 38/175 (21%), Positives = 61/175 (34%), Gaps = 10/175 (5%)

Query: 5   GTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIK 63
           G+L +   K      +  +  +A Q+  G+ YL       IHRDL   N+ +      +K
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATR-DLVK 151

Query: 64  IGDLGLAAILRGSQQAH----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
           IGD GL   L  +   +           + APE L    ++   D + FG+ + EM T  
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211

Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                  N +QI  K+               +    + +C       R     L 
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.8 bits (245), Expect = 2e-23
 Identities = 38/213 (17%), Positives = 79/213 (37%), Gaps = 43/213 (20%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
              ++  +  T  DIR    +  +IL+ + Y H     ++HRD+K  N+ ++    ++++
Sbjct: 117 TDFKQLYQTLTDYDIR---FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRL 171

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYS 122
            D GLA      Q+ +  + +  F  PEL  +   Y+  +D++S G  +  M+  + P+ 
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

Query: 123 ECSNPAQIYKKVT-----------------------------------SGKLPGAFHRIQ 147
              +      ++                                       +      + 
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291

Query: 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
             EA  F+ K L  +   RL A+E +  P+  +
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 2e-23
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 11/180 (6%)

Query: 6   TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIG 65
           +         ++  + + + A Q+ RG+ YL       IHRDL   N+ V      +KI 
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTED-NVMKIA 177

Query: 66  DLGLAAILRGSQQ---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
           D GLA  +          +     ++MAPE L++  Y    D++SFG+ + E+ T     
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LDPFLA 178
                  +++K +  G          + E    +  C     S+R   K+L+  LD  +A
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 3e-23
 Identities = 43/214 (20%), Positives = 79/214 (36%), Gaps = 33/214 (15%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGD 66
               +     +    +K +    L+G+ YLH H   ++HRDLK +N+ ++ + G +K+ D
Sbjct: 87  EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDEN-GVLKLAD 143

Query: 67  LGLAAILRGSQQAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
            GLA       +A++  + T  + APEL      Y   VD+++ G  + E+L        
Sbjct: 144 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203

Query: 124 CSNPAQIYK-------------------------KVTSGKLPGAFHRIQDAEARRFVGKC 158
            S+  Q+ +                         K   G            +    +   
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263

Query: 159 LE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVP 191
              N   R+ A + L   + ++  G P    Q+P
Sbjct: 264 FLFNPCARITATQALKMKYFSNRPG-PTPGCQLP 296

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 6e-23
 Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 33/200 (16%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
                T + +  +K++  Q+L+G+A+ H H   V+HRDLK  N+ +N   G IK+ D GL
Sbjct: 92  DASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTE-GAIKLADFGL 148

Query: 70  AAIL-RGSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSN 126
           A       +     + T  + APE+      Y+  VDI+S G    EM+T    +   S 
Sbjct: 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208

Query: 127 PAQIYKKVTSGKLPGAFHRIQ--------------------------DAEARRFVGKCLE 160
             Q+++   +   P                                 D + R  + + L 
Sbjct: 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268

Query: 161 -NVSKRLPAKELLLDPFLAS 179
            + +KR+ AK  L  PF   
Sbjct: 269 YDPNKRISAKAALAHPFFQD 288

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 96.1 bits (238), Expect = 9e-23
 Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 33/207 (15%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
                  +        ++    K++  Q+L GIAY H  D  V+HRDLK  N+ +N   G
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINRE-G 137

Query: 61  QIKIGDLGLAAILR-GSQQAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTS 117
           ++KI D GLA       ++    I T  + AP++      Y+  +DI+S G    EM+  
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

Query: 118 EYPYSECSNPAQIYK--------------------------KVTSGKLPGAFHRIQDAEA 151
              +   S   Q+ +                           V       +F +  D   
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257

Query: 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177
              + K L+ + ++R+ AK+ L   + 
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 1e-22
 Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
           G+L +Y  +Y  V +  +   A     G+A+LH         P + HRDLK  NI V  +
Sbjct: 86  GSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144

Query: 59  LGQIKIGDLGLAAILRGSQQ-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
            G   I DLGLA     +        +  +GT  +MAPE+ ++       +  +  DIY+
Sbjct: 145 -GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203

Query: 107 FGMCVLEMLTSEYPYSECS--------------NPAQIYKKVTSGKL-PGAFHRIQDAEA 151
            G+   E+                         +  ++ K V   KL P   +R Q  EA
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263

Query: 152 ----RRFVGKCL-ENVSKRLPAKELL 172
                + + +C   N + RL A  + 
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIK 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 95.6 bits (237), Expect = 1e-22
 Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 8/167 (4%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
                  V    +   A QI   + YL       IHRDL   N  V  +   +K+ D GL
Sbjct: 105 RECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGEN-HLVKVADFGL 161

Query: 70  AAILRGSQQAHS--VIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN 126
           + ++ G             ++ AP  L    ++   D+++FG+ + E+ T         +
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221

Query: 127 PAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
            +Q+Y+ +               +    +  C + N S R    E+ 
Sbjct: 222 LSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 1e-22
 Identities = 48/205 (23%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
               G L  +  +  R     V+ +  +I+  + +LH     +I+RD+K +NI ++ + G
Sbjct: 110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSN-G 166

Query: 61  QIKIGDLGLAAILRG--SQQAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEML 115
            + + D GL+       +++A+   GT E+MAP++    +  +++ VD +S G+ + E+L
Sbjct: 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226

Query: 116 TSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP---- 167
           T   P+    E ++ A+I +++   + P  + +   A A+  + + L  +  KRL     
Sbjct: 227 TGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284

Query: 168 -AKELLLDPFLASDAGEPLLIPQVP 191
            A E+    F      + L   +VP
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVP 309

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 38/188 (20%), Positives = 73/188 (38%), Gaps = 12/188 (6%)

Query: 2   FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
           F    +         + +  +  ++ Q+ +G+ +L       IHRDL   NI ++     
Sbjct: 116 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NV 172

Query: 62  IKIGDLGLAAILRGSQQAH---SVIGTPEFMA-PELYEEDYNELVDIYSFGMCVLEMLT- 116
           +KI D GLA  +                ++MA   +++  Y    D++SFG+ + E+ + 
Sbjct: 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--L 173
              PY       +  +++  G    A       E  + +  C     S+R    EL+  L
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 174 DPFLASDA 181
              L ++A
Sbjct: 292 GNLLQANA 299

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 95.7 bits (237), Expect = 2e-22
 Identities = 31/192 (16%), Positives = 71/192 (36%), Gaps = 22/192 (11%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQI 62
                +     +  ++ V   A Q++  I Y+H  +   IHRD+K DN  +        +
Sbjct: 88  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLV 145

Query: 63  KIGDLGLAAILRGSQ--------QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLE 113
            I D GLA   R ++        +  ++ GT  + +   +   + +   D+ S G  ++ 
Sbjct: 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 205

Query: 114 MLT--SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLP 167
                  +   + +   Q Y++++  K+      +     +E   ++  C       +  
Sbjct: 206 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 168 A---KELLLDPF 176
               ++L  + F
Sbjct: 266 YSYLRQLFRNLF 277

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 5e-22
 Identities = 34/162 (20%), Positives = 67/162 (41%), Gaps = 8/162 (4%)

Query: 16  RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG 75
            +D+  + +++ Q+ +G+A+L   +   IHRDL   NI +       KI D GLA  ++ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKN 197

Query: 76  SQQAHS---VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
                         ++MAPE ++   Y    D++S+G+ + E+ +              +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
            K+              AE    +  C + +  KR   K+++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 3e-21
 Identities = 47/212 (22%), Positives = 77/212 (36%), Gaps = 38/212 (17%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
               G       K   +    +  +  QILRG+ Y+H     V+HRDLK  N+ +N    
Sbjct: 90  THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTT-C 146

Query: 61  QIKIGDLGLAAILRGSQQAH----SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEM 114
            +KI D GLA +              + T  + APE+    + Y + +DI+S G  + EM
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206

Query: 115 LTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ--------------------------- 147
           L++   +       Q+   +     P                                  
Sbjct: 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 266

Query: 148 -DAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
            D++A   + K L  N  KR+  ++ L  P+L
Sbjct: 267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 4e-21
 Identities = 36/177 (20%), Positives = 67/177 (37%), Gaps = 9/177 (5%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
           + +               +  +   A +I  G+AYL+ +    +HRDL   N  V     
Sbjct: 114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-F 170

Query: 61  QIKIGDLGLAAILRGSQQAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
            +KIGD G+   +  +         +    +M+PE L +  +    D++SFG+ + E+ T
Sbjct: 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 230

Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
                 +  +  Q+ + V  G L        D      +  C + N   R    E++
Sbjct: 231 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEII 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 90.6 bits (224), Expect = 6e-21
 Identities = 24/178 (13%), Positives = 62/178 (34%), Gaps = 20/178 (11%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---- 56
           +              +  ++ V   A+Q+L  +  +H     +++RD+K DN  +     
Sbjct: 82  LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNS 139

Query: 57  GHLGQIKIGDLGLAAILRGS--------QQAHSVIGTPEFMAPELYE-EDYNELVDIYSF 107
            +   I + D G+    R          ++  ++ GT  +M+   +   + +   D+ + 
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199

Query: 108 GMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE 160
           G   +  L     +   + +   Q Y+++   K       +      E  +++     
Sbjct: 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN 257

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.6 bits (221), Expect = 2e-20
 Identities = 38/188 (20%), Positives = 78/188 (41%), Gaps = 34/188 (18%)

Query: 22  VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHS 81
           VK++  Q+L+G+ + H     V+HRDLK  N+ +N + G++K+ + GLA       + +S
Sbjct: 103 VKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYS 159

Query: 82  -VIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
             + T  +  P++    + Y+  +D++S G    E+  +  P    ++     K++    
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 139 LPGAFHRIQ---------------------------DAEARRFVGKCLE-NVSKRLPAKE 170
                 +                             +A  R  +   L+ N  +R+ A+E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279

Query: 171 LLLDPFLA 178
            L  P+ +
Sbjct: 280 ALQHPYFS 287

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 9e-20
 Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 37/222 (16%)

Query: 5   GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI 64
           GT      K+ ++    ++    Q+L+G+ Y+H       HRDLK  N+ VN    ++KI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNED-CELKI 162

Query: 65  GDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
            D GLA       +    + T  + APE+      Y + VDI+S G  + EM+T +  + 
Sbjct: 163 LDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220

Query: 123 ECSNPAQIYKKV-TSGKLPGAFHRIQ---------------------------DAEARRF 154
              +  Q+ + +  +G  P  F +                                A   
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280

Query: 155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPQVPSFQN 195
           + K L  +  +R+ A E L  P+      +    PQV  + +
Sbjct: 281 LEKMLVLDAEQRVTAGEALAHPYF-ESLHDTEDEPQVQKYDD 321

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.4 bits (210), Expect = 8e-19
 Identities = 51/229 (22%), Positives = 80/229 (34%), Gaps = 47/229 (20%)

Query: 10  YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGL 69
            +     +D   +     Q+L GI +LH      IHRDLK  NI V      +KI D GL
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGL 165

Query: 70  AAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
           A     S      + T  + APE +    Y E VDI+S G  + EM+  +  +       
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Query: 129 QIYKKVTSGKLP---------------------------------------GAFHRIQDA 149
           Q  K +     P                                          ++++ +
Sbjct: 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285

Query: 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASD---AGEPLLIPQVPSFQ 194
           +AR  + K L  + +KR+   + L  P++      A      PQ+   Q
Sbjct: 286 QARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 334

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 2e-17
 Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 39/229 (17%)

Query: 1   MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
               G       K  ++    V+    QILRG+ Y+H  D  +IHRDLK  N+ VN    
Sbjct: 102 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-C 158

Query: 61  QIKIGDLGLAAILRGSQQAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
           ++KI D GLA       +    + T  + APE+      YN+ VDI+S G  + E+LT  
Sbjct: 159 ELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

Query: 119 YPYSECSN--------------PAQIYKKVTSGKLPGAFHRIQ--------------DAE 150
             +    +               A++ KK++S         +               +  
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276

Query: 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLA---SDAGEPLLIPQVPSFQN 195
           A   + K L  +  KR+ A + L   + A       EP+  P   SF++
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFES 325

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 75.1 bits (183), Expect = 2e-15
 Identities = 47/242 (19%), Positives = 90/242 (37%), Gaps = 56/242 (23%)

Query: 7   LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-----GHLGQ 61
               + ++  + +  VK  ++Q+L G+ Y+H     +IH D+K +N+ +       +L Q
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQ 170

Query: 62  IKIGDLGLAAILRGSQQAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
           IKI DLG A      +   + I T E+ +PE L    +    DI+S    + E++T ++ 
Sbjct: 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

Query: 121 YSECS------------------------------------NPAQIYKKVTSGKLPG--- 141
           +                                        N   + + ++  K      
Sbjct: 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 288

Query: 142 ------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG-EPLLIPQVPSF 193
                  F + +  E   F+   L+ +  KR  A  L+  P+L    G E + +P    +
Sbjct: 289 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348

Query: 194 QN 195
            +
Sbjct: 349 GS 350

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 50.6 bits (120), Expect = 6e-08
 Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 27/102 (26%)

Query: 23  KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV 82
                 IL  +A  +     ++H DL   N+ V+     I I D   +            
Sbjct: 106 DEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE--GIWIIDFPQS------------ 149

Query: 83  IGTPEFMAPELYEED-----------YNELVDIYSFGMCVLE 113
           +   E    E+ E D           Y    DI S    +L+
Sbjct: 150 VEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	502
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.98
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.98
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.98
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	88.61
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	84.81
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	82.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	81.77
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	80.23

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=341.13  Aligned_cols=177  Identities=54%  Similarity=1.033  Sum_probs=163.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++++||||||||+|||+++..+.+||+|||+|+.... ....
T Consensus        93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~  171 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAK  171 (270)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBE
T ss_pred             CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccC
Confidence            688999999999989999999999999999999999999888999999999999986557999999999975433 3456


Q ss_pred             cccCCCcccCccccccCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhhh
Q 010730           81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE  160 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~  160 (502)
                      +.+|||.|||||++.+.|+.++|||||||++|+|++|+.||.+..+..++++++..+..|..++...++++++||.+||.
T Consensus       172 ~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~  251 (270)
T d1t4ha_         172 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR  251 (270)
T ss_dssp             ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred             CcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHcc
Confidence            78999999999999999999999999999999999999999988889999999999888877888888999999999999


Q ss_pred             -CcCCCCCHHHHhcCCCCc
Q 010730          161 -NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       161 -dP~kRpSa~ELL~hPff~  178 (502)
                       ||.+|||++|+|+||||+
T Consensus       252 ~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         252 QNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             SSGGGSCCHHHHHTSGGGC
T ss_pred             CCHhHCcCHHHHhCCcccC
Confidence             999999999999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-40  Score=323.86  Aligned_cols=172  Identities=26%  Similarity=0.505  Sum_probs=155.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+++++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+..... ...
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~-~~~  162 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-RRT  162 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC-CCE
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCCC-ccc
Confidence            6889999999999999999999999999999999999999  9999999999999887 79999999999876543 345


Q ss_pred             cccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      ..+||+.|||||++.+. |+.++|||||||++|+|++|+.||.+ .+..++++++..+..+  ++...++++++||.+||
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARDLISRLL  239 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHHHHHHHT
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCccCCHHHHHHHHHHc
Confidence            67899999999998764 89999999999999999999999976 6778888888877653  45567899999999999


Q ss_pred             h-CcCCCCCHHHHhcCCCCcC
Q 010730          160 E-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       160 ~-dP~kRpSa~ELL~hPff~~  179 (502)
                      . ||.+|||++|+|+||||+.
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            9 9999999999999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=326.07  Aligned_cols=176  Identities=26%  Similarity=0.442  Sum_probs=152.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.||+|.+++.+.+.+++..++.+++||+.||+|||++|  ||||||||+|||++.+ +.+||+|||+|+.+...   .
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeeccCCccc
Confidence            6889999999988889999999999999999999999999  9999999999999877 79999999999876432   2


Q ss_pred             CcccccCCCcccCccccccC-C-CCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~~-y-s~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ...+.+||+.|||||++.+. | +.++|||||||++|+|+||++||....+....+..+.........+...++++++||
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  240 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence            24567899999999988653 4 678999999999999999999998766666666666665554444455688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      .+||. ||.+|||++|+|+||||+.
T Consensus       241 ~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         241 HKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhCc
Confidence            99998 9999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=324.31  Aligned_cols=175  Identities=33%  Similarity=0.560  Sum_probs=153.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.+++.+ +++++..++.|++||+.||+|||++|  ||||||||+|||++.+ +.+||+|||+|+.+... ...
T Consensus        98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhheeeccccccc
Confidence            7899999999876 46999999999999999999999999  9999999999999876 79999999999887543 334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+......++..+..+..+...+...++++++||.+|
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  253 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence            56789999999998865 48999999999999999999999998755556666666666555555666789999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |. ||.+|||++|+|+||||+.
T Consensus       254 L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         254 LDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             TCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ccCChhHCcCHHHHhcCHhhCC
Confidence            99 9999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-39  Score=321.80  Aligned_cols=179  Identities=31%  Similarity=0.511  Sum_probs=155.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---Q   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.+...   .
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCCccc
Confidence            6889999999999999999999999999999999999999  9999999999999987 79999999999887532   2


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..++++++..+.+  .++...++++++||.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHH
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence            3456789999999998865 599999999999999999999999976 678888999888765  344566899999999


Q ss_pred             Hhhh-CcCCCCCHHH------HhcCCCCcCCCCCCC
Q 010730          157 KCLE-NVSKRLPAKE------LLLDPFLASDAGEPL  185 (502)
Q Consensus       157 kcL~-dP~kRpSa~E------LL~hPff~~~~~~~l  185 (502)
                      +||. ||.+|||++|      +++||||+.-++..+
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            9999 9999999988      588999987766544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=323.58  Aligned_cols=176  Identities=27%  Similarity=0.485  Sum_probs=158.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRG-SQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~-~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+.... ....
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCB
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccCCccc
Confidence            7899999999999999999999999999999999999999  9999999999999987 8999999999987643 3455


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      .+.+|||.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+..++++++..+.+  .++...++++++||.+|
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~  239 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL  239 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHhh
Confidence            67899999999999864 599999999999999999999999987 778889999988876  35566789999999999


Q ss_pred             hh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          159 LE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       159 L~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      |. ||.+|++     +.|+++||||+...+
T Consensus       240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ccCCchhhcccccccHHHHHcCcccccCCH
Confidence            99 9999994     999999999987543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-38  Score=321.02  Aligned_cols=177  Identities=24%  Similarity=0.454  Sum_probs=142.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~--~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  ||||||||+|||+..  ..+.+||+|||+++.......
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            6889999999999999999999999999999999999998  999999999999963  347899999999988766666


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ..+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+..+  ...+...++++++||
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  244 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI  244 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence            677899999999998865 499999999999999999999999977 5677788888776653  334455689999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. ||.+|||++|+|+||||+..
T Consensus       245 ~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         245 RHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999 99999999999999999754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=314.95  Aligned_cols=174  Identities=28%  Similarity=0.455  Sum_probs=141.7

Q ss_pred             CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEEecCCceec
Q 010730            1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHD---PPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAIL   73 (502)
Q Consensus         1 ~~tgGsL~~yi~k----~~~L~e~~i~~i~~QIL~gL~YLHs~g---~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~   73 (502)
                      |+.||+|.+++.+    .+.+++..++.|+.||+.||+|||+++   .+||||||||+|||++.+ +.+||+|||+|+.+
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~~~  164 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARIL  164 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHHHC
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccceeec
Confidence            6889999999864    467999999999999999999999864   249999999999999987 79999999999876


Q ss_pred             cCCC-CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           74 RGSQ-QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        74 ~~~~-~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                      .... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++.++..+..+ .++...++++
T Consensus       165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~l  242 (269)
T d2java1         165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDEL  242 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred             ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHH
Confidence            5433 3456889999999998865 599999999999999999999999976 6778888898888775 3445568899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFL  177 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff  177 (502)
                      ++||.+||. ||.+|||++|||+|||+
T Consensus       243 ~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         243 NEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999 99999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=316.77  Aligned_cols=176  Identities=32%  Similarity=0.536  Sum_probs=149.7

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~   78 (502)
                      |+.||+|.+++.+ .+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+|+..... ..
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHHH
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechhhhccCCCccc
Confidence            6899999999765 567999999999999999999999999  9999999999999987 79999999999765422 22


Q ss_pred             cccccCCCcccCccccc------cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHH
Q 010730           79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA  151 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~------~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l  151 (502)
                      ..+.+||+.|||||++.      ..|+.++|||||||++|+|+||.+||.+ .+..+++.++..+..+ ...+...++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT-SCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            34678999999999873      3488999999999999999999999987 4555566666665543 23445668999


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      ++||.+||. ||.+|||++|+|+||||+..
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999 99999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=321.80  Aligned_cols=176  Identities=29%  Similarity=0.524  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++  |+||||||+|||++.+ +.+||+|||+|+.+.. ...
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~-~~~  160 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-SMA  160 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH-HTC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCccccCC-Ccc
Confidence            68999999999998999999999999999999999997 57  9999999999999877 7999999999987643 234


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHH-----------------------------
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ-----------------------------  129 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~q-----------------------------  129 (502)
                      .+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||........                             
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            56799999999998865 599999999999999999999999976332211                             


Q ss_pred             ------------HHHHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          130 ------------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       130 ------------l~~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                  ....+.....+.......+.++++||.+||. ||.+||||+|+|+||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                        1111112222222223457899999999999 99999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-38  Score=313.34  Aligned_cols=180  Identities=24%  Similarity=0.431  Sum_probs=156.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQIKIGDLGLAAILRGSQ   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~---g~vKL~DFGlA~~~~~~~   77 (502)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+.   ..+||+|||+++.+....
T Consensus        94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~  171 (293)
T d1jksa_          94 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  171 (293)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred             cCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence            6899999999999889999999999999999999999999  99999999999997652   259999999999887666


Q ss_pred             CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF  154 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~L  154 (502)
                      ...+..||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+..+  ...+...++.+++|
T Consensus       172 ~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (293)
T d1jksa_         172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDF  250 (293)
T ss_dssp             BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence            6777899999999999875 599999999999999999999999976 6777788888877653  23334568899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcCCCCcCCCCC
Q 010730          155 VGKCLE-NVSKRLPAKELLLDPFLASDAGE  183 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~hPff~~~~~~  183 (502)
                      |.+||. ||.+|||++|+|+||||+.....
T Consensus       251 i~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence            999999 99999999999999999865443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-38  Score=319.75  Aligned_cols=174  Identities=28%  Similarity=0.525  Sum_probs=155.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++  ||||||||+|||++.+ |.+||+|||+|+.+..  ...
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~--~~~  196 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--RTW  196 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS--CBC
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeeccc--ccc
Confidence            6789999999999999999999999999999999999999  9999999999999887 7999999999998754  345


Q ss_pred             cccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++.++..+..+  ++...++++++||.+||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHHh
Confidence            6789999999998865 499999999999999999999999976 6788888888887653  34456889999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      . ||.+|+     |++|||+||||+..++
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             hhCHHhccccccccHHHHHcCccccCCCH
Confidence            8 999995     8999999999987654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.8e-38  Score=320.24  Aligned_cols=179  Identities=24%  Similarity=0.395  Sum_probs=156.4

Q ss_pred             CCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~-k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++. +.+++++..++.|+.||+.||+|||++|  ||||||||+|||++.+ .+.+||+|||+++.+.....
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            689999999995 4567999999999999999999999999  9999999999999642 37899999999998877666


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ..+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+...  .......++++++||
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  260 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  260 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            677899999999998875 489999999999999999999999976 6777888888776543  233345688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDAG  182 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~~  182 (502)
                      .+||. ||.+|||++|+|+||||+....
T Consensus       261 ~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         261 RKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            99999 9999999999999999986543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-38  Score=316.46  Aligned_cols=173  Identities=28%  Similarity=0.468  Sum_probs=151.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|..++...+++++..++.|++||+.||.|||++|  ||||||||+|||++.+ +.+||+|||+|+....   ..
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---~~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---AN  169 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---BC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeecccccccCC---CC
Confidence            6789999999888899999999999999999999999999  9999999999999987 7999999999986543   34


Q ss_pred             cccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ..+||+.|||||++.    +.|+.++|||||||++|+|++|..||.+ .+..+.+.++..+..+...+...++++++||.
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  248 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            578999999999874    3489999999999999999999999987 44555566666666655555667899999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          157 KCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +||. ||.+|||++|+|+||||...
T Consensus       249 ~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         249 SCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999 99999999999999999753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-37  Score=312.03  Aligned_cols=175  Identities=29%  Similarity=0.554  Sum_probs=156.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|..++.....+++..++.++.||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+....  ...
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--~~~  159 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--VTY  159 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS--CBC
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEecc--ccc
Confidence            6889999999999999999999999999999999999998  9999999999999987 7999999999988654  345


Q ss_pred             cccCCCcccCccccccC-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHhh
Q 010730           81 SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL  159 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kcL  159 (502)
                      +.+||+.|||||++.+. |+.++|||||||++|+|+||..||.+ .+..+++.++..+..  .++...+++++++|.+||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence            67899999999998764 99999999999999999999999976 677888888887765  344556889999999999


Q ss_pred             h-CcCCCC-----CHHHHhcCCCCcCCCCC
Q 010730          160 E-NVSKRL-----PAKELLLDPFLASDAGE  183 (502)
Q Consensus       160 ~-dP~kRp-----Sa~ELL~hPff~~~~~~  183 (502)
                      . ||.+|+     |++++|+||||+...+.
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             hhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            8 999996     89999999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-37  Score=319.23  Aligned_cols=176  Identities=26%  Similarity=0.453  Sum_probs=151.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ |.+||+|||+|+.+... ...
T Consensus        88 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~~-~~~  163 (364)
T d1omwa3          88 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH  163 (364)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEECSSS-CCC
T ss_pred             ecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeecCCC-ccc
Confidence            6889999999999999999999999999999999999999  9999999999999876 79999999999877543 345


Q ss_pred             cccCCCcccCccccc-c-CCCCcccchhHHHHHHHHhhccCCCCCCC--ChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           81 SVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        81 s~vGTp~Y~APEvl~-~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~--~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      ..+||+.|||||++. + .|+.++|||||||++|+|+||..||.+..  +...+.+.+.....  .++...++++++||.
T Consensus       164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~  241 (364)
T d1omwa3         164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSPELRSLLE  241 (364)
T ss_dssp             SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC--CCCSSSCHHHHHHHH
T ss_pred             ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC--CCCCCCCHHHHHHHH
Confidence            678999999999885 3 48999999999999999999999997643  33445555444333  445567899999999


Q ss_pred             Hhhh-CcCCCCC-----HHHHhcCCCCcCCCC
Q 010730          157 KCLE-NVSKRLP-----AKELLLDPFLASDAG  182 (502)
Q Consensus       157 kcL~-dP~kRpS-----a~ELL~hPff~~~~~  182 (502)
                      +||. ||.+|||     |+|+|+||||+..++
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            9999 9999999     899999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-37  Score=318.56  Aligned_cols=178  Identities=24%  Similarity=0.396  Sum_probs=155.7

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~-~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+. .++++..++.|+.||+.||+|||++|  ||||||||+|||++. ..+.+||+|||+|+.+.....
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            68999999988664 46999999999999999999999998  999999999999974 347899999999998877666


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ..+..||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++..+..+..+  .......++++++||
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            777899999999998865 499999999999999999999999976 5666777777766543  334455689999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                      .+||. ||.+|||++|+|+||||+...
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            99999 999999999999999998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.8e-37  Score=305.20  Aligned_cols=175  Identities=26%  Similarity=0.472  Sum_probs=155.5

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.++++..+++++..++.|+.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+.......
T Consensus        91 ~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~  167 (277)
T d1phka_          91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLR  167 (277)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred             cCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchheeEccCCCcee
Confidence            6889999999999899999999999999999999999998  9999999999999877 799999999999887666667


Q ss_pred             cccCCCcccCcccccc-------CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC--CCcccccccHHH
Q 010730           81 SVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEA  151 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-------~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~--p~~~~~~~s~~l  151 (502)
                      ..+||+.|+|||++.+       .|+.++||||+||++|+|+||..||.+ .+...+++.+..+..  +.......++++
T Consensus       168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  246 (277)
T d1phka_         168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV  246 (277)
T ss_dssp             CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred             eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence            7889999999998742       378899999999999999999999987 566777777777654  333344578999


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                      ++||.+||. +|.+|||++|+|+||||+.
T Consensus       247 ~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            999999999 9999999999999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=315.53  Aligned_cols=178  Identities=20%  Similarity=0.364  Sum_probs=148.5

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEecCCceeccCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~--~g~vKL~DFGlA~~~~~~   76 (502)
                      |+.||+|.+++.+.  .++++..++.|+.||+.||+|||+++  |+||||||+|||++.+  .+.+||+|||+|+.....
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCC
Confidence            68899999999874  46999999999999999999999999  9999999999999853  367999999999988776


Q ss_pred             CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCCh---HHHHHHhhcCCC--CCcccccccHH
Q 010730           77 QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL--PGAFHRIQDAE  150 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~---~ql~~kI~~g~~--p~~~~~~~s~~  150 (502)
                      ......+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+....   ..+...+..+..  |...+...+++
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  247 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE  247 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHH
T ss_pred             CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHH
Confidence            66777899999999999875 4999999999999999999999999764322   234444444443  22233346889


Q ss_pred             HHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       151 l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      +++||.+||. ||.+|||+.|+|+||||...
T Consensus       248 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            9999999999 99999999999999999643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-37  Score=310.89  Aligned_cols=175  Identities=26%  Similarity=0.507  Sum_probs=155.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||+|.+++.+.+++++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++..... ...
T Consensus        84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred             ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhcccccccc
Confidence            6899999999999999999999999999999999999999  9999999999999977 79999999999876433 334


Q ss_pred             ccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+..  .++...++++++||.+|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~  237 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKL  237 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHh
Confidence            55789999999998865 599999999999999999999999976 678888888887765  34556789999999999


Q ss_pred             hh-CcCCCCCHH-HHhcCCCCcCCC
Q 010730          159 LE-NVSKRLPAK-ELLLDPFLASDA  181 (502)
Q Consensus       159 L~-dP~kRpSa~-ELL~hPff~~~~  181 (502)
                      |. ||.+|||+. |+++||||+...
T Consensus       238 L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         238 FVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             cccCCCCCcCHHHHHHhCchhccCC
Confidence            99 999999995 899999998653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-37  Score=301.14  Aligned_cols=166  Identities=20%  Similarity=0.403  Sum_probs=142.0

Q ss_pred             CCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            2 FTS-GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         2 ~tg-GsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      +.+ ++|.+++.+.+.+++..++.|+.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||+|+.... ....
T Consensus        91 ~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~  167 (273)
T d1xwsa_          91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYT  167 (273)
T ss_dssp             CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCS-SCBC
T ss_pred             ccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccc-cccc
Confidence            444 789999998899999999999999999999999999  999999999999997667999999999987543 3445


Q ss_pred             cccCCCcccCcccccc-C-CCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHHHh
Q 010730           81 SVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC  158 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~-~-ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~kc  158 (502)
                      +.+||+.|+|||++.+ . ++.++|||||||++|+|+||..||..   ..    .+..+..  .++...++++++||.+|
T Consensus       168 ~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~~--~~~~~~s~~~~~li~~~  238 (273)
T d1xwsa_         168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQV--FFRQRVSSECQHLIRWC  238 (273)
T ss_dssp             CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCCC--CCSSCCCHHHHHHHHHH
T ss_pred             ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---ch----HHhhccc--CCCCCCCHHHHHHHHHH
Confidence            6889999999998864 3 46789999999999999999999965   22    3333433  34455689999999999


Q ss_pred             hh-CcCCCCCHHHHhcCCCCcC
Q 010730          159 LE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       159 L~-dP~kRpSa~ELL~hPff~~  179 (502)
                      |. ||.+|||++|+|+||||+.
T Consensus       239 L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         239 LALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ccCCHhHCcCHHHHhcCHhhCC
Confidence            99 9999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-37  Score=303.20  Aligned_cols=178  Identities=22%  Similarity=0.333  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      |+.||++..++...+.+++..++.|++||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence            5677777777777788999999999999999999999999  9999999999999977 79999999999876443 334


Q ss_pred             ccccCCCcccCccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC-----C-----------
Q 010730           80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-----P-----------  140 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~-----p-----------  140 (502)
                      .+.+||+.|+|||++.  ..|+.++|||||||++|+|+||.+||.+..+.+.+.+.... +..     +           
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            5678999999999875  34899999999999999999999999875444433332211 000     0           


Q ss_pred             ----C----cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          141 ----G----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       141 ----~----~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                          .    ......++++++||.+||. ||.+||||+|+|+||||+..+
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                0    0011346889999999999 999999999999999998543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-36  Score=296.53  Aligned_cols=176  Identities=31%  Similarity=0.422  Sum_probs=142.2

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|.+..+... .+.+++..++.++.||+.||+|||+++  ||||||||+|||++.. +.+||+|||+++........
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~dfg~~~~~~~~~~~  172 (305)
T d1blxa_          96 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMAL  172 (305)
T ss_dssp             CCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGG
T ss_pred             eccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecchhhhhhhcccccC
Confidence            3556666544443 456999999999999999999999999  9999999999999887 79999999999876655556


Q ss_pred             ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCC-----------------
Q 010730           80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL-----------------  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~-----------------  139 (502)
                      ...+||+.|+|||++. ..|+.++|||||||++|||+||.+||.+. +..+.+.++..  +..                 
T Consensus       173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  251 (305)
T d1blxa_         173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH  251 (305)
T ss_dssp             CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred             CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhcccccccchhhhhc
Confidence            7789999999999875 55999999999999999999999999874 44444333321  000                 


Q ss_pred             ------CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 ------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 ------p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                            ...+....++.+++||.+||. ||.+||||+|+|+||||+.-
T Consensus       252 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                  011223357889999999999 99999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-36  Score=306.31  Aligned_cols=177  Identities=23%  Similarity=0.381  Sum_probs=154.9

Q ss_pred             CCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~-~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.||+|.+++.+.+ ++++..++.|+.||+.||+|||++|  |+||||||+|||++.+ ...+||+|||+++.......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            688999999998765 7999999999999999999999999  9999999999999753 35899999999998766666


Q ss_pred             cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC--CcccccccHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV  155 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p--~~~~~~~s~~l~~LI  155 (502)
                      ..+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++.+|..+.+.  ...+...++++++||
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            677889999999998764 489999999999999999999999976 6777888888877653  223334688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .+||. ||.+|||++|+|+||||+..
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999 99999999999999999743

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-36  Score=295.36  Aligned_cols=171  Identities=30%  Similarity=0.506  Sum_probs=144.4

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC---
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS---   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~---   76 (502)
                      |+.||+|.+++... .++++..+..++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.....   
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeeccccCCc
Confidence            68899999999764 56999999999999999999999998  9999999999999987 79999999999876432   


Q ss_pred             CCcccccCCCcccCccccc----cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCc---ccccccH
Q 010730           77 QQAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDA  149 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~----~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~---~~~~~s~  149 (502)
                      ....+..||+.|||||++.    +.|+.++|||||||++|||+||+.||.+..+..++...+..+..++.   .+...++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence            2345678999999999885    24889999999999999999999999987777888888777765433   3344578


Q ss_pred             HHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          150 EARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       150 ~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++++||.+||. +|.+|||++|++++
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999998 99999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-35  Score=297.54  Aligned_cols=170  Identities=23%  Similarity=0.321  Sum_probs=145.5

Q ss_pred             CCCCCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 010730            1 MFTSGTLREYRKKYT-----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG   57 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~-----------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~   57 (502)
                      |+.||+|.+++++.+                       .+++..++.++.||+.||+|||+++  ||||||||+|||++.
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~  199 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH  199 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhcccccc
Confidence            688999999997642                       4899999999999999999999998  999999999999998


Q ss_pred             CCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHH
Q 010730           58 HLGQIKIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYK  132 (502)
Q Consensus        58 ~~g~vKL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~  132 (502)
                      + +.+||+|||+|+.......   ..+..||+.|||||++. +.|+.++|||||||++|||+| |..||.+......+++
T Consensus       200 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~  278 (325)
T d1rjba_         200 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK  278 (325)
T ss_dssp             T-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             C-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            7 7999999999987654332   23567899999999775 569999999999999999998 8999988666666776


Q ss_pred             HhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       133 kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+..+.. ...+...++++++||.+||. +|.+|||++||++|
T Consensus       279 ~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         279 LIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6665543 34555678999999999999 99999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-35  Score=291.22  Aligned_cols=172  Identities=22%  Similarity=0.366  Sum_probs=147.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ--   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~--   78 (502)
                      |+.+|+|.+++.+.+.+++..+..|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+.....  
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhcccccccc
Confidence            6889999999999999999999999999999999999998  9999999999999987 7999999999987654322  


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+...++++++|
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~l  242 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL  242 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence              23457999999999885 458999999999999999998 8999987 5667888888887654 3445568899999


Q ss_pred             HHHhhh-CcCCCCCHHHH---hcCCCC
Q 010730          155 VGKCLE-NVSKRLPAKEL---LLDPFL  177 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~EL---L~hPff  177 (502)
                      |.+||. ||.+|||++++   |+|+|+
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999998 99999999998   456665

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=294.55  Aligned_cols=168  Identities=26%  Similarity=0.375  Sum_probs=138.5

Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC
Q 010730           11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMA   90 (502)
Q Consensus        11 i~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~A   90 (502)
                      ......+++..++.|++||+.||+|||++|  |+||||||+|||++.+...+||+|||+++.+.......+.+||+.|+|
T Consensus       113 ~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~a  190 (350)
T d1q5ka_         113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA  190 (350)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccC
Confidence            345667999999999999999999999998  999999999999987755899999999998876666777899999999


Q ss_pred             ccccc--cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc------------------CCCCC--------c
Q 010730           91 PELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS------------------GKLPG--------A  142 (502)
Q Consensus        91 PEvl~--~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~------------------g~~p~--------~  142 (502)
                      ||++.  ..|+.++|||||||++|||++|.+||.......++.+.+..                  ..++.        .
T Consensus       191 PE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (350)
T d1q5ka_         191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV  270 (350)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGT
T ss_pred             hHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhh
Confidence            99764  35899999999999999999999999875544444332210                  01110        1


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .....++++.+||.+||. ||.+||||.|+|+||||+..
T Consensus       271 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            122357899999999999 99999999999999999754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-35  Score=291.24  Aligned_cols=170  Identities=22%  Similarity=0.358  Sum_probs=139.9

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+|+...                ..+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||
T Consensus        99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~-~~~Kl  175 (299)
T d1ywna1          99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI  175 (299)
T ss_dssp             CCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEE
T ss_pred             ecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCC-CcEEE
Confidence            68899999999754                24899999999999999999999998  9999999999999877 79999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhc-cCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG-~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+|+......   ...+.+||+.|||||++. +.|+.++|||||||++|||+|| .+||.+......+.+.+..+..
T Consensus       176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~  255 (299)
T d1ywna1         176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR  255 (299)
T ss_dssp             CC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred             ccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999998754332   234568999999999876 4599999999999999999986 5688776667777777777765


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...++++++||.+||. ||.+|||++|+++|
T Consensus       256 ~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         256 M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5 3445568899999999998 99999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-34  Score=288.77  Aligned_cols=176  Identities=19%  Similarity=0.371  Sum_probs=144.0

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.+|+|.++.   +.+++..++.+++||+.||+|||++|  ||||||||+|||++.+.+.+||+|||+|+.........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~  187 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  187 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence            57888987764   57999999999999999999999999  99999999999998765679999999999887666677


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-------------CC-------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-------------GK-------  138 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-------------g~-------  138 (502)
                      ..+||+.|+|||++.+  .|+.++||||+||++|+|++|..||....+.......+..             ..       
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  267 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  267 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence            7899999999998754  4899999999999999999999999775544332222110             00       


Q ss_pred             ---------------CCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCCC
Q 010730          139 ---------------LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA  181 (502)
Q Consensus       139 ---------------~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~~  181 (502)
                                     .+.......++++++||.+||. ||.+||||+|+|+||||+.-.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                           0111223357899999999999 999999999999999998643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-34  Score=291.08  Aligned_cols=176  Identities=26%  Similarity=0.375  Sum_probs=141.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      ++.||+|.++++.. ++++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.....    
T Consensus        91 ~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          91 HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBC
T ss_pred             eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccCceeeccCCCccc
Confidence            46799999999764 6999999999999999999999998  9999999999999876 79999999999875432    


Q ss_pred             CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC---------------
Q 010730           77 QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---------------  139 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~---------------  139 (502)
                      ......+||+.|+|||++..  .|+.++||||+||++|+|++|..||.+..........+.....               
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  246 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence            22455789999999998743  4789999999999999999999999764433333222211000               


Q ss_pred             ----------CCc---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 ----------PGA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 ----------p~~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                +..   .....++++++||.+||. ||.+||||+|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                      000   112346789999999999 99999999999999999743

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-34  Score=285.09  Aligned_cols=175  Identities=26%  Similarity=0.388  Sum_probs=136.6

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.++.|..+.+..+.+++..++.+++||+.||+|||+++  ||||||||+|||++.+ +.+||+|||++....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceecccCcccc
Confidence            3455666666666888999999999999999999999998  9999999999999887 799999999998765332 34


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCCC----------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP----------------  140 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~p----------------  140 (502)
                      ...+|++.|+|||++.+  .++.++|||||||++|+|++|++||.+.....++.+.... +..+                
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            55679999999998753  4789999999999999999999999875444443332210 0000                


Q ss_pred             ---------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCc
Q 010730          141 ---------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA  178 (502)
Q Consensus       141 ---------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~  178 (502)
                               ..+....++.+++||.+||. ||.+||||+|+|+||||+
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                     01122347889999999999 999999999999999997

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=280.09  Aligned_cols=170  Identities=21%  Similarity=0.366  Sum_probs=135.8

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence            68899999998765 56899999999999999999999998  9999999999999987 7999999999987654322 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                       .....||+.|+|||++. ..|+.++|||||||++|||+|+..|+....+..++++.+..+..+ ..+...++++.+||.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMN  236 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHH
Confidence             23467999999999886 459999999999999999999544444557778888888877554 345567889999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. ||.+|||++|+|++
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999 99999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-34  Score=283.63  Aligned_cols=175  Identities=29%  Similarity=0.463  Sum_probs=140.0

Q ss_pred             CCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010730            3 TSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS-QQA   79 (502)
Q Consensus         3 tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~-~~~   79 (502)
                      .+|++.+++..  .+.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+..... ...
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSBCT
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccCCcccc
Confidence            35666666643  467999999999999999999999999  9999999999999877 79999999999876533 344


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCC--c-------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--A-------------  142 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~--~-------------  142 (502)
                      ...+||+.|+|||++..  .++.++|||||||++|+|++|+.||.+......+++.+.....+.  .             
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            56789999999997653  368899999999999999999999987555555554432211100  0             


Q ss_pred             -----------ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          143 -----------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       143 -----------~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                 .....+.++++||.+||. ||.+|||++|||+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                       011236789999999999 99999999999999999753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=283.98  Aligned_cols=174  Identities=22%  Similarity=0.341  Sum_probs=148.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|.+++...  .++++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+.+.... 
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence            68899999988543  36999999999999999999999998  9999999999999987 799999999999875432 


Q ss_pred             -CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       ......||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++++.+..+..+ ..+...++++++||
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li  243 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPEELYQLM  243 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCcccChHHHHHHH
Confidence             234567999999999886 559999999999999999999666655557788888888877554 34455678999999


Q ss_pred             HHhhh-CcCCCCCHHHHhc--CCCCc
Q 010730          156 GKCLE-NVSKRLPAKELLL--DPFLA  178 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~--hPff~  178 (502)
                      .+||. +|.+|||++|+++  ++||.
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99998 9999999999987  67774

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=285.25  Aligned_cols=173  Identities=20%  Similarity=0.344  Sum_probs=147.9

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+|+... +.+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus        89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCE
T ss_pred             eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhcccccccc
Confidence            68999999998654 67999999999999999999999998  9999999999999987 7999999999988754322 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+. +..+++..+..+..+. .+...++++.+
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~l~~  243 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPECPPELYA  243 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCcCCHHHHH
Confidence               23457899999999886 569999999999999999998 99999874 4567788888877653 44556889999


Q ss_pred             HHHHhhh-CcCCCCCHHHH---hcCCCCc
Q 010730          154 FVGKCLE-NVSKRLPAKEL---LLDPFLA  178 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~EL---L~hPff~  178 (502)
                      ||.+||. +|.+|||+.++   |+++|+.
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999 99999998887   5677764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-34  Score=283.11  Aligned_cols=176  Identities=21%  Similarity=0.373  Sum_probs=138.7

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.+|.+..+......+++..++.+++||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+...    
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~dfg~~~~~~~~~~~~  174 (318)
T d3blha1          98 FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQ  174 (318)
T ss_dssp             CCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCC-----
T ss_pred             ccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEeeecceeeecccccccc
Confidence            3455666666666788999999999999999999999998  9999999999999987 79999999999876432    


Q ss_pred             -CCcccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc--CCCC-Cccc------
Q 010730           77 -QQAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP-GAFH------  144 (502)
Q Consensus        77 -~~~~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~--g~~p-~~~~------  144 (502)
                       ....+.+||+.|+|||++.+  .|+.++|||||||++|+|++|++||.+. +.......+..  +..+ ....      
T Consensus       175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  253 (318)
T d3blha1         175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWPNVDNYE  253 (318)
T ss_dssp             CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred             cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCChhhccccchhh
Confidence             22345689999999998753  5899999999999999999999999763 43333332221  1111 1000      


Q ss_pred             ---------------------ccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          145 ---------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       145 ---------------------~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                           ...++.+.+||.+||. ||.+||||+|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence                                 1136678899999999 99999999999999999853

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-34  Score=283.04  Aligned_cols=174  Identities=26%  Similarity=0.408  Sum_probs=136.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC----
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS----   76 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~----   76 (502)
                      |+.||+|.+++...+++++..++.++.||+.||+|||++|  ||||||||+|||++.+ +.++++|||.++.....    
T Consensus        92 ~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~~~~~~  168 (277)
T d1o6ya_          92 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSV  168 (277)
T ss_dssp             CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEECC------
T ss_pred             CCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhhhccccccc
Confidence            6889999999999999999999999999999999999998  9999999999999987 78999999998765432    


Q ss_pred             CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCC-CcccccccHHHHHH
Q 010730           77 QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRF  154 (502)
Q Consensus        77 ~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p-~~~~~~~s~~l~~L  154 (502)
                      ....+.+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+......+++.+.....+ .......++++++|
T Consensus       169 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l  248 (277)
T d1o6ya_         169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV  248 (277)
T ss_dssp             ----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHH
T ss_pred             cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence            23455789999999998875 49999999999999999999999998743334444444444433 23345568999999


Q ss_pred             HHHhhh-CcCCCC-CHHHHhcCCCCc
Q 010730          155 VGKCLE-NVSKRL-PAKELLLDPFLA  178 (502)
Q Consensus       155 I~kcL~-dP~kRp-Sa~ELL~hPff~  178 (502)
                      |.+||. ||.+|| |+++++ |+|++
T Consensus       249 i~~~L~~dp~~R~~sa~~l~-~~l~r  273 (277)
T d1o6ya_         249 VLKALAKNPENRYQTAAEMR-ADLVR  273 (277)
T ss_dssp             HHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred             HHHHccCCHhHCHhHHHHHH-HHHHH
Confidence            999999 999999 566654 45543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-34  Score=284.40  Aligned_cols=169  Identities=19%  Similarity=0.346  Sum_probs=135.0

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~   79 (502)
                      |+.+|+|.+++.+. +.+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+......
T Consensus       108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred             ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccceEccCCCCc
Confidence            78999999999874 56999999999999999999999998  9999999999999987 79999999999876543221


Q ss_pred             ------ccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHH
Q 010730           80 ------HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA  151 (502)
Q Consensus        80 ------~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l  151 (502)
                            ....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ ....++...+..+..+. .+...+..+
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l  262 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDCPSAL  262 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCCHHH
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHH
Confidence                  2245799999999886 569999999999999999998 8999987 55677788887765443 344567899


Q ss_pred             HHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          152 RRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       152 ~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ++||.+||. +|.+|||+.|+++.
T Consensus       263 ~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         263 HQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999998 99999999998875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-34  Score=287.74  Aligned_cols=177  Identities=24%  Similarity=0.403  Sum_probs=148.8

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGS--QQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~--~~   78 (502)
                      |+.+|+|.+++...+.+.+..++.+++||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+...  ..
T Consensus       110 ~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~~~~~~~~  186 (322)
T d1vzoa_         110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETER  186 (322)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGG
T ss_pred             cccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchhhhccccccc
Confidence            6889999999999999999999999999999999999999  9999999999999987 79999999999876432  23


Q ss_pred             cccccCCCcccCcccccc---CCCCcccchhHHHHHHHHhhccCCCCCC---CChHHHHHHhhcCCCCCcccccccHHHH
Q 010730           79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHRIQDAEAR  152 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~~---~ys~~~DIWSLGviLyeLLTG~~Pf~~~---~~~~ql~~kI~~g~~p~~~~~~~s~~l~  152 (502)
                      ..+..||+.|+|||++.+   .++.++|||||||+||+|+||..||...   ....++.+.......  .++...+++++
T Consensus       187 ~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~~  264 (322)
T d1vzoa_         187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK  264 (322)
T ss_dssp             GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred             ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCCHHHH
Confidence            456789999999998753   4788999999999999999999999664   233455555544443  34455789999


Q ss_pred             HHHHHhhh-CcCCCC-----CHHHHhcCCCCcCCCC
Q 010730          153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAG  182 (502)
Q Consensus       153 ~LI~kcL~-dP~kRp-----Sa~ELL~hPff~~~~~  182 (502)
                      +||.+||. ||.+|+     ||+|+|+||||+...+
T Consensus       265 ~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            99999999 999999     5899999999986543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=276.10  Aligned_cols=176  Identities=22%  Similarity=0.336  Sum_probs=147.3

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-QA   79 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-~~   79 (502)
                      |+.|++|..++...+.+++..++.+++||+.||+|||+++  ||||||||+|||++.+ +.+||+|||.++...... ..
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccCCCccc
Confidence            5678899999999999999999999999999999999998  9999999999999987 799999999998875433 33


Q ss_pred             ccccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCC------------------
Q 010730           80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL------------------  139 (502)
Q Consensus        80 ~s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~------------------  139 (502)
                      ....+++.|+|||++..  .++.++|||||||++|+|++|..||....+..+.+.++.....                  
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            44568899999998754  3689999999999999999999998777777776666532110                  


Q ss_pred             ---------CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcC
Q 010730          140 ---------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS  179 (502)
Q Consensus       140 ---------p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~  179 (502)
                               ........++.+++||.+||. ||.+||||+|+|+||||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                     011122346789999999999 9999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-33  Score=281.06  Aligned_cols=169  Identities=22%  Similarity=0.325  Sum_probs=145.8

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+++.+.  ..+++..++.++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence            68899999999764  56899999999999999999999998  9999999999999987 7999999999987654332


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                        .....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+ ..+...++++++||
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  249 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKVYELM  249 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHHHHHH
Confidence              23346899999999875 569999999999999999999877776667888888888776544 44556688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhc
Q 010730          156 GKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~  173 (502)
                      .+||. ||.+|||++|+++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            99999 9999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=277.55  Aligned_cols=169  Identities=24%  Similarity=0.438  Sum_probs=135.9

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ--   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~--   77 (502)
                      |+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++  ||||||||+||+++.+ +.+||+|||+++.+....  
T Consensus        88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-------------
T ss_pred             eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhheeccCCcce
Confidence            6889999999765 457999999999999999999999999  9999999999999987 799999999998765332  


Q ss_pred             CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 ~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                      ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..+++.++..+..+ .++...++.+++||
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li  242 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYSLM  242 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence            234567899999999886 569999999999999999998 8999976 5667788888887655 34556688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. ||.+|||+.||+++
T Consensus       243 ~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         243 TKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999 99999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-33  Score=280.26  Aligned_cols=172  Identities=27%  Similarity=0.389  Sum_probs=138.9

Q ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010730            3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSV   82 (502)
Q Consensus         3 tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~   82 (502)
                      .|++|..++++ +++++..++.+++||+.||+|||++|  ||||||||+|||++.+ +.+||+|||+|+....  .....
T Consensus       105 ~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~~--~~~~~  178 (346)
T d1cm8a_         105 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADS--EMTGY  178 (346)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCS--SCCSS
T ss_pred             ccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccccceeccCC--ccccc
Confidence            36777777654 67999999999999999999999999  9999999999999987 7999999999987643  34567


Q ss_pred             cCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc-CCC--------------------
Q 010730           83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL--------------------  139 (502)
Q Consensus        83 vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~-g~~--------------------  139 (502)
                      +||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+...... +..                    
T Consensus       179 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (346)
T d1cm8a_         179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL  258 (346)
T ss_dssp             CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred             cccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccC
Confidence            89999999998754  4789999999999999999999999875433333221110 100                    


Q ss_pred             ----CC---cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          140 ----PG---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       140 ----p~---~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                          ..   ......++.+.+||.+||. ||.+||||+|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                00   1112347889999999999 99999999999999999754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.1e-33  Score=273.98  Aligned_cols=169  Identities=20%  Similarity=0.313  Sum_probs=138.8

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.+. +.+++..+..++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus        90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC----------
T ss_pred             ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEcccchhhcccCCCcc
Confidence            57899999988764 67999999999999999999999998  9999999999999987 7999999999987643221 


Q ss_pred             ---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                         .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++++.+..+..+. .+...+..+++|
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~l  245 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIYQL  245 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHHHHHH
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHHHHHH
Confidence               22356899999999876 4699999999999999999997667666678888999988876543 444567899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhc
Q 010730          155 VGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~  173 (502)
                      |.+||. +|.+|||+.|+++
T Consensus       246 i~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         246 MMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHCcCCHhHCcCHHHHHH
Confidence            999998 9999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.1e-33  Score=281.39  Aligned_cols=173  Identities=28%  Similarity=0.376  Sum_probs=137.1

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAH   80 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~   80 (502)
                      |+.||+|.+++.. +++++..++.+++||+.||+|||++|  |+||||||+|||++.+ +.+|++|||++....  ....
T Consensus       103 ~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~--~~~~  176 (348)
T d2gfsa1         103 HLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTD--DEMT  176 (348)
T ss_dssp             ECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----CCT--GGGS
T ss_pred             eecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhcccC--cccc
Confidence            4679999999954 57999999999999999999999999  9999999999999987 799999999997543  3345


Q ss_pred             cccCCCcccCcccccc--CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcC--CCCC---------------
Q 010730           81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLPG---------------  141 (502)
Q Consensus        81 s~vGTp~Y~APEvl~~--~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g--~~p~---------------  141 (502)
                      +..||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+. +.......+...  ..+.               
T Consensus       177 ~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  255 (348)
T d2gfsa1         177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSESARNYI  255 (348)
T ss_dssp             SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred             cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence            6789999999997654  3688999999999999999999999874 333333333211  0000               


Q ss_pred             ---------c---ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          142 ---------A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       142 ---------~---~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                               .   .....++++++||.+||. ||.+||||+|+|+||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                     0   012357889999999999 99999999999999999753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.4e-33  Score=279.74  Aligned_cols=169  Identities=26%  Similarity=0.456  Sum_probs=142.7

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus        91 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~~~~  167 (317)
T d1xkka_          91 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE  167 (317)
T ss_dssp             CCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHHHHTTTTCC-
T ss_pred             eccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccceeccccccc
Confidence            5789999998876 467999999999999999999999998  9999999999999987 7999999999987654322 


Q ss_pred             --cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHH
Q 010730           79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF  154 (502)
Q Consensus        79 --~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~L  154 (502)
                        .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+ ..+...++.+++|
T Consensus       168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~l  245 (317)
T d1xkka_         168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI  245 (317)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCC-CCCTTBCHHHHHH
T ss_pred             ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence              23457899999999775 569999999999999999999 7888876 5566778888777654 3445668899999


Q ss_pred             HHHhhh-CcCCCCCHHHHhcC
Q 010730          155 VGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       155 I~kcL~-dP~kRpSa~ELL~h  174 (502)
                      |.+||. +|.+|||+.|++.|
T Consensus       246 i~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         246 MVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCChhhCcCHHHHHHH
Confidence            999998 99999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1e-32  Score=270.24  Aligned_cols=169  Identities=20%  Similarity=0.389  Sum_probs=146.4

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++  |+||||||+||+++.+ +.+||+|||+++.+..... 
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccCCCce
Confidence            6789999999765 467999999999999999999999998  9999999999999976 7999999999987654322 


Q ss_pred             -cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        79 -~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+ .+..++..++..+..+ ..+...++++++||
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li  234 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHHHHHH
Confidence             23467899999999876 569999999999999999998 8999977 4567888888887544 45566788999999


Q ss_pred             HHhhh-CcCCCCCHHHHhcC
Q 010730          156 GKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+||. +|.+|||+.|+|.|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999 99999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-32  Score=272.50  Aligned_cols=176  Identities=20%  Similarity=0.309  Sum_probs=144.5

Q ss_pred             CCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010730            1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         1 ~~tgGsL~~yi~k--~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      |+.+|+|..++..  .+.+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.+.... 
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhccCCCc
Confidence            6889999999854  457999999999999999999999998  9999999999999877 799999999998764332 


Q ss_pred             -CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHH
Q 010730           78 -QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV  155 (502)
Q Consensus        78 -~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI  155 (502)
                       ......||+.|+|||++. +.++.++|||||||++|||+||..||.......+++..+..+..+ ..+...++++++||
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li  247 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPESLHDLM  247 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccCHHHHHHH
Confidence             233467999999999875 569999999999999999999776766667888888888776544 34556688999999


Q ss_pred             HHhhh-CcCCCCCHHHHhc--CCCCcCC
Q 010730          156 GKCLE-NVSKRLPAKELLL--DPFLASD  180 (502)
Q Consensus       156 ~kcL~-dP~kRpSa~ELL~--hPff~~~  180 (502)
                      .+||. ||.+||++++++.  ++||...
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999 9999999999987  7888643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=275.48  Aligned_cols=169  Identities=24%  Similarity=0.349  Sum_probs=144.8

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++.+.                ..+++..+..++.||+.||.|||+++  ||||||||+|||++.+ +.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~-~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC-CceEE
Confidence            68899999999764                57999999999999999999999998  9999999999999987 69999


Q ss_pred             EecCCceeccCCCCcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccC-CCCCCCChHHHHHHhhcCCCCCc
Q 010730           65 GDLGLAAILRGSQQAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY-PYSECSNPAQIYKKVTSGKLPGA  142 (502)
Q Consensus        65 ~DFGlA~~~~~~~~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~-Pf~~~~~~~ql~~kI~~g~~p~~  142 (502)
                      +|||+++............||+.|+|||.+. +.|+.++|||||||++|||++|.. ||. ..+..++++.+..+..+ .
T Consensus       169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~~~~~~~~i~~~~~~-~  246 (309)
T d1fvra_         169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGYRL-E  246 (309)
T ss_dssp             CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGGTCCC-C
T ss_pred             ccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhcCCC-C
Confidence            9999998765444445667999999999875 569999999999999999999764 565 47888999999887655 3


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+...++++++||.+||. ||.+|||++|+|++
T Consensus       247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            445568899999999999 99999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-32  Score=272.80  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=146.3

Q ss_pred             CCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE
Q 010730            1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKI   64 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL   64 (502)
                      |+.+|+|.+++...                ..+++..++.|+.||+.||+|||+++  ||||||||+|||++.+ +.+||
T Consensus       100 ~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~-~~~kl  176 (299)
T d1fgka_         100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI  176 (299)
T ss_dssp             CCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEE
T ss_pred             ccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCC-CCeEe
Confidence            68999999999755                35899999999999999999999999  9999999999999987 79999


Q ss_pred             EecCCceeccCCC---CcccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCC
Q 010730           65 GDLGLAAILRGSQ---QAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL  139 (502)
Q Consensus        65 ~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~  139 (502)
                      +|||+++......   ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..++++.+..+..
T Consensus       177 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~i~~~~~  255 (299)
T d1fgka_         177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR  255 (299)
T ss_dssp             CSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCC
T ss_pred             ccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHHHHHcCCC
Confidence            9999998764332   234467999999999775 569999999999999999998 7888865 677888888888765


Q ss_pred             CCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      + ..+...++++++||.+||. ||.+|||+.|||+.
T Consensus       256 ~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~  290 (299)
T d1fgka_         256 M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  290 (299)
T ss_dssp             C-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            5 3455568899999999998 99999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.9e-32  Score=272.84  Aligned_cols=168  Identities=21%  Similarity=0.314  Sum_probs=142.3

Q ss_pred             CCCCCcHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 010730            1 MFTSGTLREYRKKYT------------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN   56 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~------------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~   56 (502)
                      |+.+|+|.+++....                        .+++..+..++.||+.||+|||+++  ||||||||+|||++
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld  174 (301)
T d1lufa_          97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG  174 (301)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEEC
Confidence            578999999997533                        3899999999999999999999998  99999999999999


Q ss_pred             CCCCcEEEEecCCceeccCCC---CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhcc-CCCCCCCChHHHH
Q 010730           57 GHLGQIKIGDLGLAAILRGSQ---QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIY  131 (502)
Q Consensus        57 ~~~g~vKL~DFGlA~~~~~~~---~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~-~Pf~~~~~~~ql~  131 (502)
                      .+ +.+||+|||+++.+....   ...+..||+.|+|||++.+ .|+.++|||||||++|||++|. +||.+ .+..++.
T Consensus       175 ~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~~e~~  252 (301)
T d1lufa_         175 EN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVI  252 (301)
T ss_dssp             GG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHH
T ss_pred             CC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CCHHHHH
Confidence            87 799999999998654322   2345679999999998764 6999999999999999999986 56655 7788888


Q ss_pred             HHhhcCCCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       132 ~kI~~g~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ..+..+..+. .+...++++.+||.+||. +|.+|||+.||++
T Consensus       253 ~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         253 YYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999888653 445567899999999999 9999999999976

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.8e-32  Score=267.32  Aligned_cols=169  Identities=22%  Similarity=0.327  Sum_probs=140.8

Q ss_pred             CCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||+++.+..... 
T Consensus        91 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~~~  167 (273)
T d1u46a_          91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDH  167 (273)
T ss_dssp             CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCE
T ss_pred             eecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhhcccCCCc
Confidence            6789999998765 457999999999999999999999998  9999999999999987 6999999999998754332 


Q ss_pred             ---cccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ---~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                         .....||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .+..++..++.........+...+..+++
T Consensus       168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  246 (273)
T d1u46a_         168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYN  246 (273)
T ss_dssp             EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred             ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccHHHHH
Confidence               233567889999998864 58999999999999999998 8999987 56666767776555444455566889999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhc
Q 010730          154 FVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ||.+||. ||.+|||+.||++
T Consensus       247 li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         247 VMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            9999999 9999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.9e-32  Score=275.84  Aligned_cols=171  Identities=27%  Similarity=0.369  Sum_probs=125.9

Q ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010730            4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVI   83 (502)
Q Consensus         4 gGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~v   83 (502)
                      .|+|.+.+  .+.+++..++.+++||+.||+|||++|  |+||||||+|||++.+ +.+|++|||+++...........+
T Consensus       105 ~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~  179 (355)
T d2b1pa1         105 DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV  179 (355)
T ss_dssp             SEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC--------------
T ss_pred             chHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhhcccccccccccc
Confidence            34555554  357999999999999999999999999  9999999999999987 789999999998776666667788


Q ss_pred             CCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhc----------------------CCCC
Q 010730           84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS----------------------GKLP  140 (502)
Q Consensus        84 GTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~----------------------g~~p  140 (502)
                      ||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.. ......++..                      ...+
T Consensus       180 ~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (355)
T d2b1pa1         180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK  258 (355)
T ss_dssp             -CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC
T ss_pred             ccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcc
Confidence            9999999998864 58999999999999999999999997643 3332222211                      1000


Q ss_pred             C------------------cccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 G------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 ~------------------~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                      .                  ......++++++||.+||. ||.+||||+|||+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            0                  0011235678999999999 99999999999999999853

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=263.55  Aligned_cols=167  Identities=19%  Similarity=0.351  Sum_probs=138.1

Q ss_pred             CCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010730            1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~--~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~   78 (502)
                      |+.+|+|.+|+.+.  ..+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+ +.+||+|||+++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecCCC--
Confidence            68899999999654  35999999999999999999999998  9999999999999987 79999999999875432  


Q ss_pred             cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHHHHH
Q 010730           79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG  156 (502)
Q Consensus        79 ~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~LI~  156 (502)
                      .....+|+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+. ++...++++++||.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~  234 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMK  234 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHH
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence            34457899999999875 569999999999999999998 6877765 57778888888876653 45556789999999


Q ss_pred             Hhhh-CcCCCCCHHHHhcC
Q 010730          157 KCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       157 kcL~-dP~kRpSa~ELL~h  174 (502)
                      +||. ||.+|||+.+|+++
T Consensus       235 ~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHH
Confidence            9999 99999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=266.46  Aligned_cols=169  Identities=24%  Similarity=0.390  Sum_probs=142.2

Q ss_pred             CCCCCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 010730            1 MFTSGTLREYRKKYT------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQI   62 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~------------------~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~v   62 (502)
                      |+.+|+|.+++.+..                  .+++..++.|+.||+.||+|||+++  ||||||||+||+++.+ +.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~-~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETT-TEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccccc-Ccc
Confidence            688999999997654                  5999999999999999999999999  9999999999999987 799


Q ss_pred             EEEecCCceeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhh-ccCCCCCCCChHHHHHHhhcC
Q 010730           63 KIGDLGLAAILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG  137 (502)
Q Consensus        63 KL~DFGlA~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLT-G~~Pf~~~~~~~ql~~kI~~g  137 (502)
                      |++|||+++.......   .....||+.|+|||++. +.++.++|||||||++|||+| |.+||........+++.+..+
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~  264 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG  264 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            9999999987654322   23467899999999876 568999999999999999999 666676655556666666555


Q ss_pred             CCCCcccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      ..+ ..+...+..+.+||.+||. ||.+|||+.|||+
T Consensus       265 ~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         265 FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            443 4445568899999999998 9999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-31  Score=264.01  Aligned_cols=170  Identities=20%  Similarity=0.310  Sum_probs=141.8

Q ss_pred             CCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010730            1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQ-   78 (502)
Q Consensus         1 ~~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~-   78 (502)
                      |+.+|+|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+ +.+||+|||+++....... 
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEecccchhhccccccc
Confidence            68899999999854 46888899999999999999999998  9999999999999987 7999999999987643321 


Q ss_pred             ----cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCChHHHHHHhhcCCCCCcccccccHHHHH
Q 010730           79 ----AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR  153 (502)
Q Consensus        79 ----~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql~~kI~~g~~p~~~~~~~s~~l~~  153 (502)
                          .....||+.|+|||++. +.++.++|||||||++|||+||..||....+..++...+..+..+. .+...++.+.+
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~l~~  265 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLYE  265 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcHHHHH
Confidence                22357899999999875 5699999999999999999998888877667777788888887653 44556789999


Q ss_pred             HHHHhhh-CcCCCCCHHHHhcC
Q 010730          154 FVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       154 LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ||.+||. ||.+||++.|++++
T Consensus       266 li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         266 VMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999 99999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-30  Score=261.18  Aligned_cols=169  Identities=24%  Similarity=0.383  Sum_probs=143.2

Q ss_pred             CCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCc
Q 010730            1 MFTSGTLREYRKKY----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLA   70 (502)
Q Consensus         1 ~~tgGsL~~yi~k~----------~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA   70 (502)
                      |+.+|+|.+|+...          ..+++..+..++.||+.||.|||+++  |+||||||+|||++.+ +.+||+|||++
T Consensus       104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~-~~~Kl~DFGla  180 (308)
T d1p4oa_         104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT  180 (308)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CCEEECCTTCC
T ss_pred             ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-ceEEEeecccc
Confidence            68899999998643          34789999999999999999999998  9999999999999987 79999999999


Q ss_pred             eeccCCCC---cccccCCCcccCccccc-cCCCCcccchhHHHHHHHHhhcc-CCCCCCCChHHHHHHhhcCCCCCcccc
Q 010730           71 AILRGSQQ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIYKKVTSGKLPGAFHR  145 (502)
Q Consensus        71 ~~~~~~~~---~~s~vGTp~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~-~Pf~~~~~~~ql~~kI~~g~~p~~~~~  145 (502)
                      +.+.....   .....||+.|+|||.+. +.|+.++|||||||++|||+||. +||.+ .+..+++..+..+..+. .+.
T Consensus       181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~p~  258 (308)
T d1p4oa_         181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD-KPD  258 (308)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC-CCT
T ss_pred             eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCC-Ccc
Confidence            86643322   23457899999999876 55889999999999999999985 66655 77788888888877653 344


Q ss_pred             cccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       146 ~~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      ..++.+.++|.+||. +|.+|||+.+|+++
T Consensus       259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            567899999999999 99999999999983

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-30  Score=258.10  Aligned_cols=172  Identities=27%  Similarity=0.388  Sum_probs=134.4

Q ss_pred             CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEEecCCceecc
Q 010730            1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILR   74 (502)
Q Consensus         1 ~~tgGsL~~yi~k~~~L~e~~i~~i~~QIL~gL~YLHs~------g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~   74 (502)
                      |+.+|+|.+++++. .+++..+..++.||+.||+|||+.      .++||||||||+|||++.+ +.+||+|||+++...
T Consensus        82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEE
T ss_pred             cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCcccccc
Confidence            68899999999875 699999999999999999999974      2349999999999999887 799999999998775


Q ss_pred             CCC-----CcccccCCCcccCccccccC-------CCCcccchhHHHHHHHHhhccCCCCCC--------------CChH
Q 010730           75 GSQ-----QAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPA  128 (502)
Q Consensus        75 ~~~-----~~~s~vGTp~Y~APEvl~~~-------ys~~~DIWSLGviLyeLLTG~~Pf~~~--------------~~~~  128 (502)
                      ...     .....+||+.|||||++.+.       ++.++|||||||+||||+||..||...              ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            432     23457899999999988643       567899999999999999998876321              2334


Q ss_pred             HHHHHhhcCCCCCccccc-----ccHHHHHHHHHhhh-CcCCCCCHHHHhcC
Q 010730          129 QIYKKVTSGKLPGAFHRI-----QDAEARRFVGKCLE-NVSKRLPAKELLLD  174 (502)
Q Consensus       129 ql~~kI~~g~~p~~~~~~-----~s~~l~~LI~kcL~-dP~kRpSa~ELL~h  174 (502)
                      .+.+.+..+.+.+.++..     ....+.+++.+||. ||.+|||+.||+++
T Consensus       240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            455555554443222221     12458899999998 99999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=4.9e-30  Score=254.00  Aligned_cols=175  Identities=18%  Similarity=0.309  Sum_probs=134.1

Q ss_pred             CCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEEecCCceeccCCC-
Q 010730            2 FTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQIKIGDLGLAAILRGSQ-   77 (502)
Q Consensus         2 ~tgGsL~~yi~k-~~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~--~~g~vKL~DFGlA~~~~~~~-   77 (502)
                      +.+|+|.+++.. .+.+++..++.++.||+.||+|||+++  ||||||||+|||++.  ....+||+|||+|+.+.... 
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            457788777765 567999999999999999999999999  999999999999864  23579999999999875432 


Q ss_pred             -------CcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCCCChHHH--HHHhhcCCC---CCccc
Q 010730           78 -------QAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--YKKVTSGKL---PGAFH  144 (502)
Q Consensus        78 -------~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~~ql--~~kI~~g~~---p~~~~  144 (502)
                             ...+.+||+.|||||++.+ .|+.++|||||||++|||+||..||.........  +.+......   .....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   2345689999999998875 4999999999999999999999999764332221  212211111   11223


Q ss_pred             ccccHHHHHHHHHhhh-CcCCCCCHH---HHhcCCCCc
Q 010730          145 RIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLA  178 (502)
Q Consensus       145 ~~~s~~l~~LI~kcL~-dP~kRpSa~---ELL~hPff~  178 (502)
                      ...++++.+||.+||. +|.+||++.   ++|+++|.+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            3457889999999999 999999976   556777654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=2.4e-29  Score=249.70  Aligned_cols=170  Identities=16%  Similarity=0.255  Sum_probs=135.1

Q ss_pred             CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEEecCCceeccCC
Q 010730            2 FTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG----HLGQIKIGDLGLAAILRGS   76 (502)
Q Consensus         2 ~tgGsL~~yi~k~-~~L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~----~~g~vKL~DFGlA~~~~~~   76 (502)
                      +.+|+|.+++... +.+++..+..++.||+.||+|||++|  ||||||||+|||++.    ..+.+||+|||+|+.....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            4589999999775 46999999999999999999999999  999999999999964    2368999999999876432


Q ss_pred             --------CCcccccCCCcccCcccccc-CCCCcccchhHHHHHHHHhhccCCCCCC--CChHHHHHHhhcCCCC---Cc
Q 010730           77 --------QQAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLP---GA  142 (502)
Q Consensus        77 --------~~~~s~vGTp~Y~APEvl~~-~ys~~~DIWSLGviLyeLLTG~~Pf~~~--~~~~ql~~kI~~g~~p---~~  142 (502)
                              ....+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.  .+....+.++...+.+   ..
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence                    12345789999999998865 4999999999999999999999999753  3344444444332221   11


Q ss_pred             ccccccHHHHHHHHHhhh-CcCCCCCHHHHhc
Q 010730          143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL  173 (502)
Q Consensus       143 ~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~  173 (502)
                      +....++++.+++..|+. +|.+||+++.+.+
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            223356789999999998 9999998766543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2.2e-29  Score=254.22  Aligned_cols=164  Identities=27%  Similarity=0.414  Sum_probs=125.0

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC-----CcEEEEecCCceeccCCCCcccccCCC
Q 010730           13 KYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHL-----GQIKIGDLGLAAILRGSQQAHSVIGTP   86 (502)
Q Consensus        13 k~~~L~e~~i~~i~~QIL~gL~YLHs-~g~~IIHRDLKPeNILl~~~~-----g~vKL~DFGlA~~~~~~~~~~s~vGTp   86 (502)
                      ....+++..++.++.||+.||+|||+ +|  |+||||||+|||++...     ..+|++|||.+.....  .....+||+
T Consensus       118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~  193 (362)
T d1q8ya_         118 EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTR  193 (362)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCG
T ss_pred             cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccc
Confidence            44679999999999999999999997 77  99999999999997542     1499999999986543  345678999


Q ss_pred             cccCccccc-cCCCCcccchhHHHHHHHHhhccCCCCCCCCh------HHHHHHhh-cCCCC------------------
Q 010730           87 EFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP------AQIYKKVT-SGKLP------------------  140 (502)
Q Consensus        87 ~Y~APEvl~-~~ys~~~DIWSLGviLyeLLTG~~Pf~~~~~~------~ql~~kI~-~g~~p------------------  140 (502)
                      .|+|||++. ..|+.++||||+||++++|++|+.||......      ..+.+.+. -|..+                  
T Consensus       194 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  273 (362)
T d1q8ya_         194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG  273 (362)
T ss_dssp             GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred             cccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccch
Confidence            999999775 45999999999999999999999999642211      11111100 00000                  


Q ss_pred             --------------------CcccccccHHHHHHHHHhhh-CcCCCCCHHHHhcCCCCcCC
Q 010730          141 --------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD  180 (502)
Q Consensus       141 --------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpSa~ELL~hPff~~~  180 (502)
                                          ..+....++++++||.+||. ||.+||||+|+|+||||+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence                                01112235789999999999 99999999999999999844

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.25  E-value=3.5e-13  Score=123.65  Aligned_cols=82  Identities=21%  Similarity=0.206  Sum_probs=62.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC------
Q 010730           17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAILRGSQQAHSVIGTPEFMA------   90 (502)
Q Consensus        17 L~e~~i~~i~~QIL~gL~YLHs~g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~~~~~~~~~s~vGTp~Y~A------   90 (502)
                      ++...+..++.||+.+|.|||.+|  |+||||||+|||++.+  .++|+|||+|........ .      .|..      
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~liDFG~a~~~~~~~~-~------~~l~rd~~~~  168 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGW-R------EILERDVRNI  168 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEECCCTTCEETTSTTH-H------HHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEEECCCcccCCCCCc-H------HHHHHHHHHH
Confidence            556677889999999999999999  9999999999999864  699999999976543211 1      1111      


Q ss_pred             ccccccCCCCcccchhHHH
Q 010730           91 PELYEEDYNELVDIYSFGM  109 (502)
Q Consensus        91 PEvl~~~ys~~~DIWSLGv  109 (502)
                      .+.+...|+.++|+||+.-
T Consensus       169 ~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         169 ITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             HHHHHHHHCCCCCHHHHHH
T ss_pred             HHHHcCCCCCcccHHHHHH
Confidence            1234567899999999753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=88.61  E-value=0.077  Score=49.71  Aligned_cols=29  Identities=38%  Similarity=0.432  Sum_probs=25.0

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCce
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAA   71 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~   71 (502)
                      +|||+|+.++||+++++ ...-++||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccc-cceeEecccccc
Confidence            59999999999999976 455799999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=84.81  E-value=0.33  Score=45.86  Aligned_cols=28  Identities=25%  Similarity=0.140  Sum_probs=22.9

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           42 PVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        42 ~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ++||+|+.+.|||+++.   ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~---~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG---PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC---ceEEechhccc
Confidence            58999999999999743   45899998753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=82.62  E-value=0.32  Score=43.48  Aligned_cols=29  Identities=34%  Similarity=0.337  Sum_probs=23.8

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           43 VIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        43 IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ++|+|+.|.||+++++ +.+-|+||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCC-ceEEEeechhccc
Confidence            7899999999999864 3456999997753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=81.77  E-value=0.3  Score=43.49  Aligned_cols=29  Identities=28%  Similarity=0.220  Sum_probs=24.1

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           43 VIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        43 IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ++|+|+.|.||+++++ +.+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENG-RFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence            7999999999999875 3467999997743

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=80.23  E-value=0.83  Score=44.31  Aligned_cols=31  Identities=32%  Similarity=0.463  Sum_probs=25.7

Q ss_pred             CCCeEecCCCCCcEEEeCCCCcEEEEecCCcee
Q 010730           40 DPPVIHRDLKCDNIFVNGHLGQIKIGDLGLAAI   72 (502)
Q Consensus        40 g~~IIHRDLKPeNILl~~~~g~vKL~DFGlA~~   72 (502)
                      ...++|+|+.|.|||++++  .++|+||..+..
T Consensus       222 ~~~LiHGDl~~gNIlv~~~--~~~vID~E~a~~  252 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY  252 (392)
T ss_dssp             CCEEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred             CcceeccCCcCCceeEcCC--ceEEechhhccc
Confidence            3459999999999999875  589999987743